Citrus Sinensis ID: 046502
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 608 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LV48 | 652 | Proline-rich receptor-lik | yes | no | 0.876 | 0.817 | 0.651 | 0.0 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.825 | 0.700 | 0.573 | 1e-161 | |
| Q9ZNQ8 | 633 | Proline-rich receptor-lik | no | no | 0.743 | 0.714 | 0.603 | 1e-152 | |
| Q8GX23 | 670 | Proline-rich receptor-lik | no | no | 0.636 | 0.577 | 0.660 | 1e-148 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.611 | 0.730 | 0.644 | 1e-139 | |
| Q1PEM5 | 513 | Proline-rich receptor-lik | no | no | 0.595 | 0.705 | 0.625 | 1e-135 | |
| Q9LS95 | 700 | Putative proline-rich rec | no | no | 0.578 | 0.502 | 0.722 | 1e-135 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.809 | 0.692 | 0.491 | 1e-131 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.746 | 0.630 | 0.487 | 1e-124 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.746 | 0.666 | 0.461 | 1e-119 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 677 bits (1748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/556 (65%), Positives = 428/556 (76%), Gaps = 23/556 (4%)
Query: 59 PPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCR 118
PP+TPS S+P + + + PSPP+ D G+STG+VVG+AIGG+A++V+++L+ L C+
Sbjct: 109 PPNTPSGSTPRTP---SNTKPSPPS--DSSDGLSTGVVVGIAIGGVAILVILTLICLLCK 163
Query: 119 RKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVAS 178
+KRRRR DDEA Y PPP + RP+ H V S
Sbjct: 164 KKRRRRHDDEAAYYVPPPPPSGPKAG--------GPYGGQQQYWQQQNASRPSDNHVVTS 215
Query: 179 RPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPI-PPPSLGLSLGFLKSTFTYEELAR 237
PP P P PPPPP + SS S+ P+ PPPS GL LGF KSTFTYEEL+R
Sbjct: 216 LPPPKPPSPPRKPPPPPPPPAFMSSSGGSDYSDLPVLPPPSPGLVLGFSKSTFTYEELSR 275
Query: 238 ATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH 297
AT+GFS+ANLLGQGGFGYVHKG+LP+GKEVA+KQLKAGSGQGER FQAEVEIISRVHH+H
Sbjct: 276 ATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRH 335
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
LVSL+GY AG QR+LV EFV +N LEFHLHGKGRPTM+W TRLKIALG AKGL+YLHED
Sbjct: 336 LVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHED 395
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
C+PKIIHRDIKA+NIL+DFKFEAKVADFGLAK+ASD THVSTRVMGTFGYLAPEYA+SG
Sbjct: 396 CNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASG 455
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIEDGNFDTLVDPK 474
KLTEKSDVFSFGV+LLELI G RPVD+ + +++D+L ARPLLNRA E+G+F+ L D K
Sbjct: 456 KLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEGDFEGLADSK 515
Query: 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNEGIRPGQSSVY- 533
+ NEY+ EMARMVACAAACVRHSARRRPR+SQIVR LEG+ SL+DLNEG+RPG S+VY
Sbjct: 516 MGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNEGMRPGHSNVYS 575
Query: 534 ---GSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSSSSEGHNTREI 590
GS DYDT QYN+D+ KFRKMAL +QE + EY+ PTSDYGL+ S SSSEG TRE+
Sbjct: 576 SYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEYSNPTSDYGLYPSGSSSEGQATREM 635
Query: 591 EMGKARKNSQSQGFSG 606
EMGK +K QG+SG
Sbjct: 636 EMGKIKKT--GQGYSG 649
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 568 bits (1465), Expect = e-161, Method: Compositional matrix adjust.
Identities = 319/556 (57%), Positives = 390/556 (70%), Gaps = 54/556 (9%)
Query: 60 PSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGG-LAVIVVVSLLILRCR 118
PSTPS + P S+P A+S +S G +VG+AIGG ++V ++L+ C+
Sbjct: 204 PSTPS--TTPGSSPPAQSSKE----------LSKGAMVGIAIGGGFVLLVALALIFFLCK 251
Query: 119 RKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVAS 178
+KRRR D+EA PP PYGG+QQ QN + HVV P P P
Sbjct: 252 KKRRR--DNEA------PPAPIDGVPYGGQQQ---QNASRRSDHVVMSVPPPKSPSSAPP 300
Query: 179 RPPHSPVYTPSPPPPPPFMSSSGGSSS--NYSGSEAPIPPPS--LGLSLGFLKSTFTYEE 234
RPPH FMSS NYS ++ +PPPS L L LG + TF YEE
Sbjct: 301 RPPH-------------FMSSGSSGDYDSNYS-DQSVLPPPSPGLALGLGIYQGTFNYEE 346
Query: 235 LARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH 294
L+RAT+GFS+ANLLGQGGFGYV KG+L NGKEVA+KQLK GS QGER FQAEV IISRVH
Sbjct: 347 LSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGIISRVH 406
Query: 295 HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354
H+HLV+LVGY A +QR+LV EFV +NTLEFHLHGKGRPTM+W +RLKIA+G AKGL+YL
Sbjct: 407 HRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIAVGSAKGLSYL 466
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
HE+C+PKIIHRDIKA+NIL+DFKFEAKVADFGLAK+ASD THVSTRVMGTFGYLAPEYA
Sbjct: 467 HENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYA 526
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIEDGNFDTLV 471
SSGKLTEKSDVFSFGV+LLELI G RP+D + +++L ARPLLN+ E GNF+ +V
Sbjct: 527 SSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSELGNFEVVV 586
Query: 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNEGIRPGQSS 531
D KL+NEY+ EMARMVACAAACVR +A RRPR+ Q+ R LEG+ S +DLN+GI PG S+
Sbjct: 587 DKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSDLNQGITPGHSN 646
Query: 532 VY----GSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSSSSEGHNT 587
VY GS DYD+ Q NE + KFRK+ L +Q++ Y+ P S+Y L+ S SS++G T
Sbjct: 647 VYGSSGGSTDYDSSQDNEGMNKFRKVGLETQDL-----YSNPISEYDLYPSWSSTDGQTT 701
Query: 588 REIEMGKARKNSQSQG 603
+ G ++ Q G
Sbjct: 702 QGKATGNIKRPGQGYG 717
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZNQ8|PERK4_ARATH Proline-rich receptor-like protein kinase PERK4 OS=Arabidopsis thaliana GN=PERK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 538 bits (1386), Expect = e-152, Method: Compositional matrix adjust.
Identities = 289/479 (60%), Positives = 344/479 (71%), Gaps = 27/479 (5%)
Query: 91 VSTGLVVGLAIG-GLAVIVVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQ 149
+T ++VG+ +G GL +IV LI+ C R++++R+D P P+ Y G
Sbjct: 148 TNTAIIVGVLVGAGLLMIV----LIIVCLRRKKKRKD-----SFYPEPMKGNQYQYYGNN 198
Query: 150 QHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSG 209
+ + H+ +Q P P P +SG SS YSG
Sbjct: 199 NNNNASQNYPNWHLNSQGQNQQSTGGWGGGGPSPPPPPRMP--------TSGEDSSMYSG 250
Query: 210 SEAPI-PPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVA 268
P+ PPPS L+LGF KSTFTY+ELA AT GF+DANLLGQGGFGYVHKGVLP+GKEVA
Sbjct: 251 PSRPVLPPPSPALALGFNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVA 310
Query: 269 IKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLH 328
+K LKAGSGQGER FQAEV+IISRVHH++LVSLVGY A QRMLV EFV + TLE+HLH
Sbjct: 311 VKSLKAGSGQGEREFQAEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLH 370
Query: 329 GKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388
GK P M++ TRL+IALG AKGLAYLHEDCHP+IIHRDIK+ANILLDF F+A VADFGLA
Sbjct: 371 GKNLPVMEFSTRLRIALGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLA 430
Query: 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTF 448
KL SD THVSTRVMGTFGYLAPEYASSGKLTEKSDVFS+GVMLLELI G RPVD++ T
Sbjct: 431 KLTSDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSIT- 489
Query: 449 MEDNL---ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRI 505
M+D L ARPL+ RA+EDGNF+ L D +L YN EMARMV CAAA +RHS R+RP++
Sbjct: 490 MDDTLVDWARPLMARALEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKM 549
Query: 506 SQIVRTLEGDASLADLNEGIRPGQSSVYGSL----DYDTMQYNEDLKKFRKMALNSQEI 560
SQIVR LEG+ SL LNEG++PG S+VYGSL DY YN D+KKFR++AL+SQE
Sbjct: 550 SQIVRALEGEVSLDALNEGVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIALSSQEF 608
|
Required during abscisic acid (ABA)-mediated activation of Ca(2+) channels. Regulates ABA signaling pathways. Modulates the expression of genes related to cell elongation and ABA signaling during root growth. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 524 bits (1349), Expect = e-148, Method: Compositional matrix adjust.
Identities = 267/404 (66%), Positives = 320/404 (79%), Gaps = 17/404 (4%)
Query: 204 SSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPN 263
+SN +G A IP P +LG +STFTY+EL+ AT+GF+ +NLLGQGGFGYVHKGVLP+
Sbjct: 276 ASNLTGRTA-IPSPQAA-TLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPS 333
Query: 264 GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323
GKEVA+K LK GSGQGER FQAEV+IISRVHH+HLVSLVGY +G QR+LV EF+ +NTL
Sbjct: 334 GKEVAVKSLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTL 393
Query: 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 383
EFHLHGKGRP +DWPTR+KIALG A+GLAYLHEDCHP+IIHRDIKAANILLDF FE KVA
Sbjct: 394 EFHLHGKGRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVA 453
Query: 384 DFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVD 443
DFGLAKL+ D YTHVSTRVMGTFGYLAPEYASSGKL++KSDVFSFGVMLLELI G P+D
Sbjct: 454 DFGLAKLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLD 513
Query: 444 STHTFMEDNL---ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSAR 500
T MED+L ARPL +A +DG+++ L DP+L Y+H EM +M +CAAA +RHSAR
Sbjct: 514 LTGE-MEDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSAR 572
Query: 501 RRPRISQIVRTLEGDASLADLNEGIRPGQSSVYG----SLDYDTMQYNEDLKKFRKMALN 556
RRP++SQIVR LEGD S+ DL+EG RPGQS+ S +YD Y D+KKF+K+AL
Sbjct: 573 RRPKMSQIVRALEGDMSMDDLSEGTRPGQSTYLSPGSVSSEYDASSYTADMKKFKKLALE 632
Query: 557 SQEISASSEYNRPTSDYGLHSSSSSSEGHNTREIEMGKARKNSQ 600
++E SSEY TS+YGL+ S+SSSE E+ G ++N Q
Sbjct: 633 NKEYQ-SSEYGG-TSEYGLNPSASSSE-----EMNRGSMKRNPQ 669
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 496 bits (1278), Expect = e-139, Method: Compositional matrix adjust.
Identities = 247/383 (64%), Positives = 300/383 (78%), Gaps = 11/383 (2%)
Query: 227 KSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAE 286
++ FTYE+L++AT FS+ NLLGQGGFGYVH+GVL +G VAIKQLK+GSGQGER FQAE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 287 VEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG 346
++ ISRVHH+HLVSL+GY G+QR+LV EFV + TLEFHLH K RP M+W R+KIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
AKGLAYLHEDC+PK IHRD+KAANIL+D +EAK+ADFGLA+ + D THVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDN----LARPLLNRAI 462
GYLAPEYASSGKLTEKSDVFS GV+LLELI G RPVD + F +D+ A+PL+ +A+
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLN 522
DGNFD LVDP+L N+++ NEM RMVACAAA VRHSA+RRP++SQIVR EG+ S+ DL
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 523 EGIRPGQSSVY---GSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSS 579
EG PGQS++Y GS DY + QY EDLKKF+KMA S+ SSE + TSD G + S
Sbjct: 428 EGAAPGQSTIYSLDGSSDYSSTQYKEDLKKFKKMAFESKTF-GSSECSGLTSDNGQNPSG 486
Query: 580 SSS--EGH-NTREIEMGKARKNS 599
SSS EG T+EIE K K++
Sbjct: 487 SSSITEGQRTTQEIEPEKNTKDT 509
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 481 bits (1239), Expect = e-135, Method: Compositional matrix adjust.
Identities = 244/390 (62%), Positives = 297/390 (76%), Gaps = 28/390 (7%)
Query: 166 QPPRPAPPHPVASRPPHSPVYTP--SPPPPPPFMSSSGGSSSNYSG-------------- 209
PP PA P + + P +P TP S PP P S+G G
Sbjct: 90 NPPPPASP---SGQEPTTPTMTPGFSLSPPSPSRLSTGAVVGISIGGGVFVLTLIFFLCK 146
Query: 210 -----SEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNG 264
+ +P P +GL LG +STFTY ELARAT+ FS+ANLLG+GGFG+V+KG+L NG
Sbjct: 147 KKRPRDDKALPAP-IGLVLGIHQSTFTYGELARATNKFSEANLLGEGGFGFVYKGILNNG 205
Query: 265 KEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLE 324
EVA+KQLK GS QGE+ FQAEV IIS++HH++LVSLVGY AG+QR+LV EFV +NTLE
Sbjct: 206 NEVAVKQLKVGSAQGEKEFQAEVNIISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLE 265
Query: 325 FHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD 384
FHLHGKGRPTM+W RLKIA+ +KGL+YLHE+C+PKIIHRDIKAANIL+DFKFEAKVAD
Sbjct: 266 FHLHGKGRPTMEWSLRLKIAVSSSKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVAD 325
Query: 385 FGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDS 444
FGLAK+A D THVSTRVMGTFGYLAPEYA+SGKLTEKSDV+SFGV+LLELI G RPVD+
Sbjct: 326 FGLAKIALDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDA 385
Query: 445 THTFMEDNL---ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR 501
+ + +D+L ARPLL +A+E+ NF+ L D KL+NEY+ EMARMVACAAACVR++ARR
Sbjct: 386 NNVYADDSLVDWARPLLVQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARR 445
Query: 502 RPRISQIVRTLEGDASLADLNEGIRPGQSS 531
RPR+ Q+VR LEG+ S +DLN+GI PG S+
Sbjct: 446 RPRMDQVVRVLEGNISPSDLNQGITPGHSN 475
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 481 bits (1238), Expect = e-135, Method: Compositional matrix adjust.
Identities = 260/360 (72%), Positives = 299/360 (83%), Gaps = 8/360 (2%)
Query: 222 SLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGER 281
+LGF KSTFTY+ELA AT GFS + LLGQGGFGYVHKG+LPNGKE+A+K LKAGSGQGER
Sbjct: 317 ALGFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGER 376
Query: 282 VFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL 341
FQAEV+IISRVHH+ LVSLVGY AG QRMLV EF+ ++TLEFHLHGK +DWPTRL
Sbjct: 377 EFQAEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRL 436
Query: 342 KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR 401
KIALG AKGLAYLHEDCHP+IIHRDIKA+NILLD FEAKVADFGLAKL+ D THVSTR
Sbjct: 437 KIALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTR 496
Query: 402 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLL 458
+MGTFGYLAPEYASSGKLT++SDVFSFGVMLLEL+ G RPVD T MED+L ARP+
Sbjct: 497 IMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGE-MEDSLVDWARPIC 555
Query: 459 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASL 518
A +DG++ LVDP+L N+Y +EMA+MVACAAA VRHSARRRP++SQIVR LEGDA+L
Sbjct: 556 LNAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATL 615
Query: 519 ADLNEGIRPGQSSVYG---SLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGL 575
DL+EG + GQSS G S DYD+ Y+ D+KKFRK+AL+S E ASSEY TS+YGL
Sbjct: 616 DDLSEGGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVALDSHEYGASSEYGN-TSEYGL 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1203), Expect = e-131, Method: Compositional matrix adjust.
Identities = 266/541 (49%), Positives = 334/541 (61%), Gaps = 49/541 (9%)
Query: 48 SLTPPPTSGAPPPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVI 107
+L P T+ P ++PS P S N V PP+ + GGG + G AI G AVI
Sbjct: 195 ALPPKSTAAGGPLTSPSRGVPSSGNSVP--PPA-----NSGGGYQGKTMAGFAIAGFAVI 247
Query: 108 VVVSLLILRCRRKRRRRRDDEAGYCTLPPP-LAPKVDPYGGRQQHWQQNVPPSAAHVVTQ 166
+++++ L RRK++R D + LPP + K D + + Q
Sbjct: 248 ALMAVVFL-VRRKKKRNIDAYSDSQYLPPSNFSIKSDGF-----------------LYGQ 289
Query: 167 PPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFL 226
P P S F S GG SGS P S + G
Sbjct: 290 NPTKGYSGPGGYNSQQQSNSGNS------FGSQRGGGGYTRSGS----APDSAVMGSG-- 337
Query: 227 KSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAE 286
++ FTYEEL T+GFS N+LG+GGFG V+KG L +GK VA+KQLK GSGQG+R F+AE
Sbjct: 338 QTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAE 397
Query: 287 VEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG 346
VEIISRVHH+HLVSLVGY A S+R+L+ E+V + TLE HLHGKGRP ++W R++IA+G
Sbjct: 398 VEIISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIG 457
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
AKGLAYLHEDCHPKIIHRDIK+ANILLD +FEA+VADFGLAKL THVSTRVMGTF
Sbjct: 458 SAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTF 517
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIE 463
GYLAPEYA SGKLT++SDVFSFGV+LLELI G +PVD E++L ARPLL++AIE
Sbjct: 518 GYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIE 577
Query: 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNE 523
G+F LVD +L Y NE+ RM+ AAACVRHS +RPR+ Q+VR L+ + + D++
Sbjct: 578 TGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISN 637
Query: 524 GIRPGQSSVYGSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSSSSE 583
G + GQSS YD+ QYN D KFRKMA + S S Y + DY + S S
Sbjct: 638 GNKVGQSSA-----YDSGQYNNDTMKFRKMAFGFDDSSDSGMY---SGDYSVQDSRKGSN 689
Query: 584 G 584
G
Sbjct: 690 G 690
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 240/492 (48%), Positives = 314/492 (63%), Gaps = 38/492 (7%)
Query: 96 VVGLAIGGLAVIVVVSLLILRCRRKRRRRRDDEAGYCTLP-PPLAPKVDPYGGRQQHWQQ 154
+VG+A+ G A++ ++ ++ L RRK++R D LP P + K D + Q
Sbjct: 247 MVGMAVAGFAIMALIGVVFL-VRRKKKRNIDSYNHSQYLPHPNFSVKSDGFLYGQD---- 301
Query: 155 NVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPI 214
P S P+ +Y S +S G + Y +
Sbjct: 302 ------------------PGKGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQS 343
Query: 215 PPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKA 274
LG ++ F+YEELA T GF+ N+LG+GGFG V+KG L +GK VA+KQLKA
Sbjct: 344 SGTPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKA 403
Query: 275 GSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPT 334
GSGQG+R F+AEVEIISRVHH+HLVSLVGY + R+L+ E+V++ TLE HLHGKG P
Sbjct: 404 GSGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPV 463
Query: 335 MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394
++W R++IA+G AKGLAYLHEDCHPKIIHRDIK+ANILLD ++EA+VADFGLA+L
Sbjct: 464 LEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTT 523
Query: 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL- 453
THVSTRVMGTFGYLAPEYASSGKLT++SDVFSFGV+LLEL+ G +PVD T E++L
Sbjct: 524 QTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLV 583
Query: 454 --ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511
ARPLL +AIE G+ L+D +L Y +E+ RM+ AAACVRHS +RPR+ Q+VR
Sbjct: 584 EWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRA 643
Query: 512 LEGDASLADLNEGIRPGQSSVYGSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTS 571
L+ D D++ GI+ GQS+ YD+ QYNED+ KFRKMA S Y+
Sbjct: 644 LDCDGDSGDISNGIKIGQSTT-----YDSGQYNEDIMKFRKMAFGGDNSVESGLYS---- 694
Query: 572 DYGLHSSSSSSE 583
G +S+ SSS+
Sbjct: 695 --GNYSAKSSSD 704
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 430 bits (1105), Expect = e-119, Method: Compositional matrix adjust.
Identities = 243/526 (46%), Positives = 325/526 (61%), Gaps = 72/526 (13%)
Query: 66 SSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRR 125
+ P S+N P S P G V TG +V AIG + +V +SL ++ R+R+R
Sbjct: 212 TGPASNNGNNTLPSSSP----GKSEVGTGGIV--AIGVIVGLVFLSLFVMGVWFTRKRKR 265
Query: 126 DDEAGYC--TLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHS 183
D + T+PP P + VV R + P
Sbjct: 266 KDPGTFVGYTMPPSAYSS----------------PQGSDVVLFNSRSSAP---------- 299
Query: 184 PVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFS 243
P M S GS Y+ S++ + + +S F+Y+EL++ T GFS
Sbjct: 300 -----------PKMRSHSGSDYMYASSDSGM--------VSNQRSWFSYDELSQVTSGFS 340
Query: 244 DANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
+ NLLG+GGFG V+KGVL +G+EVA+KQLK G QGER F+AEVEIISRVHH+HLV+LVG
Sbjct: 341 EKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVG 400
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
Y + R+LV ++V +NTL +HLH GRP M W TR+++A G A+G+AYLHEDCHP+II
Sbjct: 401 YCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAGAARGIAYLHEDCHPRII 460
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLAS--DVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
HRDIK++NILLD FEA VADFGLAK+A D+ THVSTRVMGTFGY+APEYA+SGKL+E
Sbjct: 461 HRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSE 520
Query: 422 KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIEDGNFDTLVDPKLHNE 478
K+DV+S+GV+LLELI G +PVD++ +++L ARPLL +AIE+ FD LVDP+L
Sbjct: 521 KADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENEEFDELVDPRLGKN 580
Query: 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNEGIRPGQSSVYGSLDY 538
+ EM RMV AAACVRHSA +RP++SQ+VR L+ D+ G+RPGQS V +
Sbjct: 581 FIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDITNGMRPGQSQV-----F 635
Query: 539 DTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSSSSEG 584
D+ Q + ++ F++MA SQ+ S SD+ S S SS G
Sbjct: 636 DSRQQSAQIRMFQRMAFGSQDYS---------SDFFDRSQSHSSWG 672
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 608 | ||||||
| 121308607 | 665 | PERK1-like protein kinase [Nicotiana tab | 0.856 | 0.783 | 0.709 | 0.0 | |
| 359484580 | 650 | PREDICTED: proline-rich receptor-like pr | 0.838 | 0.784 | 0.746 | 0.0 | |
| 255546475 | 670 | ATP binding protein, putative [Ricinus c | 0.845 | 0.767 | 0.749 | 0.0 | |
| 449443147 | 672 | PREDICTED: proline-rich receptor-like pr | 0.838 | 0.758 | 0.723 | 0.0 | |
| 13877617 | 652 | protein kinase-like protein [Arabidopsis | 0.876 | 0.817 | 0.651 | 0.0 | |
| 227206330 | 615 | AT3G24550 [Arabidopsis thaliana] | 0.876 | 0.866 | 0.651 | 0.0 | |
| 15230130 | 652 | proline extensin-like receptor kinase 1 | 0.876 | 0.817 | 0.651 | 0.0 | |
| 356520519 | 671 | PREDICTED: proline-rich receptor-like pr | 0.807 | 0.731 | 0.713 | 0.0 | |
| 356520517 | 672 | PREDICTED: proline-rich receptor-like pr | 0.809 | 0.732 | 0.705 | 0.0 | |
| 449520249 | 639 | PREDICTED: proline-rich receptor-like pr | 0.878 | 0.835 | 0.657 | 0.0 |
| >gi|121308607|dbj|BAF43699.1| PERK1-like protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 728 bits (1878), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/531 (70%), Positives = 430/531 (80%), Gaps = 10/531 (1%)
Query: 85 DDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRRDDEAGYC--TLPPPLAPKV 142
D+G GVSTGLVVG+AIGG+ ++ V+SLL + C R+++RR Y PPP+ K
Sbjct: 130 DEGSSGVSTGLVVGIAIGGVLILAVLSLLFICCSRRKKRRNHGPVEYYPPAQPPPMGYKA 189
Query: 143 DPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGG 202
DPYG HWQ N P A HVV+ PP+P+PP ASRPPHSPV S PPPP S
Sbjct: 190 DPYGDPVHHWQHNAPSPADHVVSIPPKPSPPPAGASRPPHSPVTASSLQPPPPPPYMSSS 249
Query: 203 SSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLP 262
+S+ P+PPPS G+ LGF KSTFTYEEL RATDGFS+ANLLGQGGFGYVH+GVLP
Sbjct: 250 GASSNYSGFDPLPPPSPGMVLGFSKSTFTYEELVRATDGFSNANLLGQGGFGYVHRGVLP 309
Query: 263 NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNT 322
NGKEVA+KQLKAGSGQGER FQAEVEIISRVHHKHLVSLVGY GSQR+LV EFV +NT
Sbjct: 310 NGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNT 369
Query: 323 LEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382
LEFHLHGKGRP +DWP RLKIALG AKGLAYLHEDC PKIIHRDIKAANIL+DF FEAKV
Sbjct: 370 LEFHLHGKGRPPLDWPIRLKIALGSAKGLAYLHEDCQPKIIHRDIKAANILVDFNFEAKV 429
Query: 383 ADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPV 442
ADFGLAKL SDV THVSTRVMGTFGYLAPEYASSGKLTEKSDVFS+G+MLLELI G RPV
Sbjct: 430 ADFGLAKLTSDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSYGIMLLELITGRRPV 489
Query: 443 DSTHTFMEDNL---ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSA 499
DS+ T+M+D+L ARP L RA+ED FD+L+DP+L N+YNHNE+ARMVACAAACVRHSA
Sbjct: 490 DSSQTYMDDSLVDWARPQLTRALEDEKFDSLIDPRLGNDYNHNEVARMVACAAACVRHSA 549
Query: 500 RRRPRISQIVRTLEGDASLADLNEGIRPGQSSVY---GSLDYDTMQYNEDLKKFRKMALN 556
RRRPR+SQ+VR LEGD SL+DLNEGIRPG S+VY GS DYD QYNED+KKFRKMAL
Sbjct: 550 RRRPRMSQVVRALEGDVSLSDLNEGIRPGHSTVYSSHGSSDYDASQYNEDMKKFRKMALG 609
Query: 557 SQEISASSEYNRPTSDYGLHSSSSSSEGHNTREIEMGKARKNSQSQGFSGS 607
SQE ++ +Y+ PTS+YGL+ S SSSEG TRE+EMG+ +K+ S+GFSGS
Sbjct: 610 SQEYGSTGQYSNPTSEYGLYPSGSSSEGQPTREMEMGRTKKD--SRGFSGS 658
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484580|ref|XP_002284430.2| PREDICTED: proline-rich receptor-like protein kinase PERK1-like isoform 2 [Vitis vinifera] gi|297738823|emb|CBI28068.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/525 (74%), Positives = 442/525 (84%), Gaps = 15/525 (2%)
Query: 91 VSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQ 150
VSTGLVVG+AIGG+ ++VV+SLL + C++K+RR D Y +PPP PK DPYGG Q
Sbjct: 128 VSTGLVVGIAIGGVVILVVLSLLFICCKKKKRR--DHRQDY-YVPPPPGPKNDPYGGPPQ 184
Query: 151 HWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPP--FMSSSGGSSSNYS 208
WQ NVPP A H VT P+P+PP ASRPPHSPV P+PPPPP F+SSSGGS SNYS
Sbjct: 185 QWQHNVPPPADHAVTVFPKPSPPPGTASRPPHSPVQVPTPPPPPQPPFVSSSGGSGSNYS 244
Query: 209 GSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVA 268
GS+ P+PPPS ++LGF KSTFTYEEL ATDGFS+ANLLGQGGFGYVH+GVLPNGKEVA
Sbjct: 245 GSDNPLPPPSPSIALGFSKSTFTYEELVMATDGFSNANLLGQGGFGYVHRGVLPNGKEVA 304
Query: 269 IKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLH 328
+KQLKAGSGQGER FQAEVEIISRVHHKHLV+L GY GS R+LV EFV +NTLEFHLH
Sbjct: 305 VKQLKAGSGQGEREFQAEVEIISRVHHKHLVTLAGYCITGSHRLLVYEFVPNNTLEFHLH 364
Query: 329 GKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388
GKGRPTMDW TRLKIALG AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA
Sbjct: 365 GKGRPTMDWSTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 424
Query: 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTF 448
K +SD THVSTRVMGTFGYLAPEYA+SGKL++KSDVFSFGVMLLEL+ G RPVD+ TF
Sbjct: 425 KFSSDANTHVSTRVMGTFGYLAPEYAASGKLSDKSDVFSFGVMLLELLTGRRPVDANQTF 484
Query: 449 MEDNL---ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRI 505
MED+L ARPLL RA+EDGNFDTLVDP+L +YNH+EMARMVACAAACVRHSARRRPR+
Sbjct: 485 MEDSLVDWARPLLTRALEDGNFDTLVDPRLQKDYNHHEMARMVACAAACVRHSARRRPRM 544
Query: 506 SQIVRTLEGDASLADLNEGIRPGQ---SSVYGSLDYDTMQYNEDLKKFRKMALNSQEISA 562
SQIVR LEGDASL+DLNEG+RPGQ S +GS DYDT QYNED+ KFRKMAL S++
Sbjct: 545 SQIVRALEGDASLSDLNEGMRPGQSSIYSSHGSSDYDTNQYNEDMIKFRKMALASRDY-G 603
Query: 563 SSEYNRPTSDYGLHSSSSSSEGH-NTREIEMGKARKNSQSQGFSG 606
SSEY+ PTS+YGL+ S SSSEG TRE+EMGK +K+ S+G+SG
Sbjct: 604 SSEYSGPTSEYGLYPSGSSSEGQRTTREMEMGKMKKD--SRGYSG 646
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255546475|ref|XP_002514297.1| ATP binding protein, putative [Ricinus communis] gi|223546753|gb|EEF48251.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 686 bits (1771), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/523 (74%), Positives = 440/523 (84%), Gaps = 9/523 (1%)
Query: 90 GVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQ 149
G+STG+VVG+AIGG+A+++V+SLL + CR+KRRRR D+ A Y PP +Q
Sbjct: 151 GISTGVVVGIAIGGVAILLVLSLLCICCRKKRRRRDDEAAYYVPPPPGPKDGPYGGQQQQ 210
Query: 150 QHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSG 209
Q PP V T P+P PP PVASRPPH TP PPPPPPFMSSSGGS SNYSG
Sbjct: 211 HWQQHAPPPD--RVFTAMPKPNPPPPVASRPPHPASMTPPPPPPPPFMSSSGGSGSNYSG 268
Query: 210 SEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAI 269
SE P+PPPS GL+L F KSTF++EELARATDGFS+ANLLGQGGFGYVH+GVLP+GKEVA+
Sbjct: 269 SENPLPPPSPGLALSFSKSTFSFEELARATDGFSNANLLGQGGFGYVHRGVLPSGKEVAV 328
Query: 270 KQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHG 329
KQLKAGSGQGER FQAE+EIISRVHHKHLVSLVGY GSQR+LV EFV +NTLEFHLHG
Sbjct: 329 KQLKAGSGQGEREFQAEIEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHG 388
Query: 330 KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389
KGRPTMDWPTRLKIALG AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK
Sbjct: 389 KGRPTMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 448
Query: 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM 449
+SD THVSTRVMGTFGYLAPEYA+SGKLT+KSDVFSFG+MLLELI G RPVD+ +
Sbjct: 449 FSSDFNTHVSTRVMGTFGYLAPEYAASGKLTDKSDVFSFGIMLLELITGRRPVDANPAYA 508
Query: 450 EDNL---ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRIS 506
+D+L ARPLL RA+EDGNFDTL DPKL N+Y+HNEMARMVA AAACVRHSARRRPR+S
Sbjct: 509 DDSLVDWARPLLTRALEDGNFDTLADPKLQNDYDHNEMARMVASAAACVRHSARRRPRMS 568
Query: 507 QIVRTLEGDASLADLNEGIRPGQSSV--YGSLDYDTMQYNEDLKKFRKMALNSQEISASS 564
Q+VR LEGD +L+DLNEGIRPG SS+ YGS DYDT QYNED+KKFRKMAL SQE ASS
Sbjct: 569 QVVRALEGDVALSDLNEGIRPGHSSLYSYGSSDYDTSQYNEDMKKFRKMALGSQEYGASS 628
Query: 565 EYNRPTSDYGLHSSSSSSEGHNTREIEMGKARKNSQSQGFSGS 607
EY+ PTS+YGL+ S SSSEGHNTRE+EMGK ++N SQGFSG+
Sbjct: 629 EYSGPTSEYGLYPSGSSSEGHNTREMEMGKMKRN--SQGFSGN 669
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449443147|ref|XP_004139342.1| PREDICTED: proline-rich receptor-like protein kinase PERK1-like [Cucumis sativus] gi|449516294|ref|XP_004165182.1| PREDICTED: proline-rich receptor-like protein kinase PERK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 684 bits (1766), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/524 (72%), Positives = 423/524 (80%), Gaps = 14/524 (2%)
Query: 91 VSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQ 150
+STGLVVG+AIGG+ VIV++ ++ C K+RRRR DE G+ PPP PKVDPY G+QQ
Sbjct: 153 ISTGLVVGIAIGGV-VIVLLLSILCLCCTKKRRRRRDEEGFYPHPPP-DPKVDPYAGQQQ 210
Query: 151 HWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGS 210
WQ N P +V P+P+PP VASRPPHSP PP PPP SS G S +
Sbjct: 211 -WQNNAPLPPDPLVGMVPKPSPPPVVASRPPHSPTGI-RPPLPPPLYMSSSGGSGSMYSG 268
Query: 211 EAPIPPPSLG--LSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVA 268
PP ++ GF KSTFTYEELA ATDGFSDANLLGQGGFGYVH+GVLPNGKEVA
Sbjct: 269 PETPLPPPPPPHMAYGFSKSTFTYEELAMATDGFSDANLLGQGGFGYVHRGVLPNGKEVA 328
Query: 269 IKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLH 328
+KQLKAGSGQGER FQAEV+IISRVHHKHLVSLVGY GSQR+LV EFV +NTLEFHLH
Sbjct: 329 VKQLKAGSGQGEREFQAEVDIISRVHHKHLVSLVGYCITGSQRLLVYEFVANNTLEFHLH 388
Query: 329 GKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388
GKGRPTMDW TRLKIALG AKGLAY+HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA
Sbjct: 389 GKGRPTMDWQTRLKIALGSAKGLAYIHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 448
Query: 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTF 448
K SDV THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI G RPVD ++T
Sbjct: 449 KFTSDVNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRRPVDMSNTA 508
Query: 449 MEDNL---ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRI 505
MED+L ARPL+NRA+EDGNFD LVDP+L N YNHNEMARMVACAAACVRHSA+RRPR+
Sbjct: 509 MEDSLVDWARPLMNRALEDGNFDVLVDPRLQNNYNHNEMARMVACAAACVRHSAKRRPRM 568
Query: 506 SQIVRTLEGDASLADLNEGIRPGQ---SSVYGSLDYDTMQYNEDLKKFRKMALNSQEISA 562
SQ+VR LEGD+SL+DLNEG++PGQ S +GS DYDT QYNEDL+KFRK+AL S E A
Sbjct: 569 SQVVRALEGDSSLSDLNEGVKPGQSSMYSSHGSSDYDTHQYNEDLRKFRKVALGSTEYGA 628
Query: 563 SSEYNRPTSDYGLHSSSSSSEGHNTREIEMGKARKNSQSQGFSG 606
SSEY+ PTS+YGL+ S SSSEG TRE+E A+K +S GFSG
Sbjct: 629 SSEYSGPTSEYGLYPSGSSSEGQTTREMETRTAKK--ESGGFSG 670
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|13877617|gb|AAK43886.1|AF370509_1 protein kinase-like protein [Arabidopsis thaliana] gi|30725492|gb|AAP37768.1| At3g24600 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/556 (65%), Positives = 428/556 (76%), Gaps = 23/556 (4%)
Query: 59 PPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCR 118
PP+TPS S+P + + + PSPP+ D G+STG+VVG+AIGG+A++V+++L+ L C+
Sbjct: 109 PPNTPSGSTPRTP---SNTKPSPPS--DSSDGLSTGVVVGIAIGGVAILVILTLICLLCK 163
Query: 119 RKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVAS 178
+KRRRR DDEA Y PPP + RP+ H V S
Sbjct: 164 KKRRRRHDDEAAYYVPPPPPSGPKAG--------GPYGGQQQYWQQQNASRPSDNHVVTS 215
Query: 179 RPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPI-PPPSLGLSLGFLKSTFTYEELAR 237
PP P P PPPPP + SS S+ P+ PPPS GL LGF KSTFTYEEL+R
Sbjct: 216 LPPPKPPSPPRKPPPPPPPPAFMSSSGGSDYSDLPVLPPPSPGLVLGFSKSTFTYEELSR 275
Query: 238 ATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH 297
AT+GFS+ANLLGQGGFGYVHKG+LP+GKEVA+KQLKAGSGQGER FQAEVEIISRVHH+H
Sbjct: 276 ATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRH 335
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
LVSL+GY AG QR+LV EFV +N LEFHLHGKGRPTM+W TRLKIALG AKGL+YLHED
Sbjct: 336 LVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHED 395
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
C+PKIIHRDIKA+NIL+DFKFEAKVADFGLAK+ASD THVSTRVMGTFGYLAPEYA+SG
Sbjct: 396 CNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASG 455
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIEDGNFDTLVDPK 474
KLTEKSDVFSFGV+LLELI G RPVD+ + +++D+L ARPLLNRA E+G+F+ L D K
Sbjct: 456 KLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEGDFEGLADSK 515
Query: 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNEGIRPGQSSVY- 533
+ NEY+ EMARMVACAAACVRHSARRRPR+SQIVR LEG+ SL+DLNEG+RPG S+VY
Sbjct: 516 MGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNEGMRPGHSNVYS 575
Query: 534 ---GSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSSSSEGHNTREI 590
GS DYDT QYN+D+ KFRKMAL +QE + EY+ PTSDYGL+ S SSSEG TRE+
Sbjct: 576 SYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEYSNPTSDYGLYPSGSSSEGQATREM 635
Query: 591 EMGKARKNSQSQGFSG 606
EMGK +K QG+SG
Sbjct: 636 EMGKIKKT--GQGYSG 649
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|227206330|dbj|BAH57220.1| AT3G24550 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/556 (65%), Positives = 428/556 (76%), Gaps = 23/556 (4%)
Query: 59 PPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCR 118
PP+TPS S+P + + + PSPP+ D G+STG+VVG+AIGG+A++V+++L+ L C+
Sbjct: 72 PPNTPSGSTPRTP---SNTKPSPPS--DSSDGLSTGVVVGIAIGGVAILVILTLICLLCK 126
Query: 119 RKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVAS 178
+KRRRR DDEA Y PPP + RP+ H V S
Sbjct: 127 KKRRRRHDDEAAYYVPPPPPSGPKAG--------GPYGGQQQYWQQQNASRPSDNHVVTS 178
Query: 179 RPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPI-PPPSLGLSLGFLKSTFTYEELAR 237
PP P P PPPPP + SS S+ P+ PPPS GL LGF KSTFTYEEL+R
Sbjct: 179 LPPPKPPSPPRKPPPPPPPPAFMSSSGGSDYSDLPVLPPPSPGLVLGFSKSTFTYEELSR 238
Query: 238 ATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH 297
AT+GFS+ANLLGQGGFGYVHKG+LP+GKEVA+KQLKAGSGQGER FQAEVEIISRVHH+H
Sbjct: 239 ATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRH 298
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
LVSL+GY AG QR+LV EFV +N LEFHLHGKGRPTM+W TRLKIALG AKGL+YLHED
Sbjct: 299 LVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHED 358
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
C+PKIIHRDIKA+NIL+DFKFEAKVADFGLAK+ASD THVSTRVMGTFGYLAPEYA+SG
Sbjct: 359 CNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASG 418
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIEDGNFDTLVDPK 474
KLTEKSDVFSFGV+LLELI G RPVD+ + +++D+L ARPLLNRA E+G+F+ L D K
Sbjct: 419 KLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEGDFEGLADSK 478
Query: 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNEGIRPGQSSVY- 533
+ NEY+ EMARMVACAAACVRHSARRRPR+SQIVR LEG+ SL+DLNEG+RPG S+VY
Sbjct: 479 MGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNEGMRPGHSNVYS 538
Query: 534 ---GSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSSSSEGHNTREI 590
GS DYDT QYN+D+ KFRKMAL +QE + EY+ PTSDYGL+ S SSSEG TRE+
Sbjct: 539 SYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEYSNPTSDYGLYPSGSSSEGQATREM 598
Query: 591 EMGKARKNSQSQGFSG 606
EMGK +K QG+SG
Sbjct: 599 EMGKIKKT--GQGYSG 612
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15230130|ref|NP_189098.1| proline extensin-like receptor kinase 1 [Arabidopsis thaliana] gi|75335529|sp|Q9LV48.1|PERK1_ARATH RecName: Full=Proline-rich receptor-like protein kinase PERK1; AltName: Full=Proline-rich extensin-like receptor kinase 1; Short=AtPERK1 gi|9294050|dbj|BAB02007.1| protein kinase-like protein [Arabidopsis thaliana] gi|15983765|gb|AAL10479.1| AT3g24550/MOB24_8 [Arabidopsis thaliana] gi|16649063|gb|AAL24383.1| protein kinase-like protein [Arabidopsis thaliana] gi|20260332|gb|AAM13064.1| unknown protein [Arabidopsis thaliana] gi|22136228|gb|AAM91192.1| protein kinase-like protein [Arabidopsis thaliana] gi|30725474|gb|AAP37759.1| At3g24550 [Arabidopsis thaliana] gi|332643399|gb|AEE76920.1| proline extensin-like receptor kinase 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 677 bits (1748), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/556 (65%), Positives = 428/556 (76%), Gaps = 23/556 (4%)
Query: 59 PPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCR 118
PP+TPS S+P + + + PSPP+ D G+STG+VVG+AIGG+A++V+++L+ L C+
Sbjct: 109 PPNTPSGSTPRTP---SNTKPSPPS--DSSDGLSTGVVVGIAIGGVAILVILTLICLLCK 163
Query: 119 RKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVAS 178
+KRRRR DDEA Y PPP + RP+ H V S
Sbjct: 164 KKRRRRHDDEAAYYVPPPPPSGPKAG--------GPYGGQQQYWQQQNASRPSDNHVVTS 215
Query: 179 RPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPI-PPPSLGLSLGFLKSTFTYEELAR 237
PP P P PPPPP + SS S+ P+ PPPS GL LGF KSTFTYEEL+R
Sbjct: 216 LPPPKPPSPPRKPPPPPPPPAFMSSSGGSDYSDLPVLPPPSPGLVLGFSKSTFTYEELSR 275
Query: 238 ATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH 297
AT+GFS+ANLLGQGGFGYVHKG+LP+GKEVA+KQLKAGSGQGER FQAEVEIISRVHH+H
Sbjct: 276 ATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEIISRVHHRH 335
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
LVSL+GY AG QR+LV EFV +N LEFHLHGKGRPTM+W TRLKIALG AKGL+YLHED
Sbjct: 336 LVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIALGSAKGLSYLHED 395
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
C+PKIIHRDIKA+NIL+DFKFEAKVADFGLAK+ASD THVSTRVMGTFGYLAPEYA+SG
Sbjct: 396 CNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFGYLAPEYAASG 455
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIEDGNFDTLVDPK 474
KLTEKSDVFSFGV+LLELI G RPVD+ + +++D+L ARPLLNRA E+G+F+ L D K
Sbjct: 456 KLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEEGDFEGLADSK 515
Query: 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNEGIRPGQSSVY- 533
+ NEY+ EMARMVACAAACVRHSARRRPR+SQIVR LEG+ SL+DLNEG+RPG S+VY
Sbjct: 516 MGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDLNEGMRPGHSNVYS 575
Query: 534 ---GSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSSSSEGHNTREI 590
GS DYDT QYN+D+ KFRKMAL +QE + EY+ PTSDYGL+ S SSSEG TRE+
Sbjct: 576 SYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEYSNPTSDYGLYPSGSSSEGQATREM 635
Query: 591 EMGKARKNSQSQGFSG 606
EMGK +K QG+SG
Sbjct: 636 EMGKIKKT--GQGYSG 649
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520519|ref|XP_003528909.1| PREDICTED: proline-rich receptor-like protein kinase PERK15-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 668 bits (1723), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/510 (71%), Positives = 411/510 (80%), Gaps = 19/510 (3%)
Query: 107 IVVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQ 166
++V+S+L + CR+K+RRR D+E PP PK D YGG + WQ NVPP HVV+
Sbjct: 171 LLVLSILCICCRKKKRRR-DEEYYAPPPQPPRGPKDDAYGGPPRQWQHNVPPPQDHVVSM 229
Query: 167 PPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFL 226
P P P PPPPPPF+ SSGGS SNYSG E +PPPS G++LGF
Sbjct: 230 MPPKPSPPPAPPAYA-----AQPPPPPPPFIISSGGSGSNYSGGEF-LPPPSPGIALGFS 283
Query: 227 KSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAE 286
KSTFTYEELARATDGFSDANLLGQGGFGYVH+G+LPNGKEVA+KQLKAGSGQGER FQAE
Sbjct: 284 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLKAGSGQGEREFQAE 343
Query: 287 VEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG 346
VEIISRVHHKHLVSLVGY GSQR+LV EFV +NTLEFHLHG+GRPTMDWPTRL+IALG
Sbjct: 344 VEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGRGRPTMDWPTRLRIALG 403
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK +SDV THVSTRVMGTF
Sbjct: 404 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKFSSDVNTHVSTRVMGTF 463
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIE 463
GYLAPEYASSGKLT+KSDVFS+GVMLLELI G RPVD TFMED+L ARPLL RA+E
Sbjct: 464 GYLAPEYASSGKLTDKSDVFSYGVMLLELITGRRPVDKNQTFMEDSLVDWARPLLTRALE 523
Query: 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNE 523
+ +FD+++DP+L N+Y+ NEMARMVA AAAC+RHSA+RRPR+SQ+VR LEGD SLADLNE
Sbjct: 524 EDDFDSIIDPRLQNDYDPNEMARMVASAAACIRHSAKRRPRMSQVVRALEGDVSLADLNE 583
Query: 524 GIRPGQSSVYGSL---DYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSS 580
GIRPG S++Y S DYDT QY ED+KKFRKMAL +QE ASSEY+ TS+YGL+ S S
Sbjct: 584 GIRPGHSTMYSSHESSDYDTAQYKEDMKKFRKMALGTQEYGASSEYSAATSEYGLNPSGS 643
Query: 581 SSEGHN---TREIEMGKARKNSQSQGFSGS 607
SSE + TRE+EM RK SQGFSGS
Sbjct: 644 SSEAQSRQTTREMEM---RKMKNSQGFSGS 670
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520517|ref|XP_003528908.1| PREDICTED: proline-rich receptor-like protein kinase PERK15-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 666 bits (1719), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/510 (70%), Positives = 408/510 (80%), Gaps = 18/510 (3%)
Query: 107 IVVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQ 166
++V+S+L + CR+K+RRR ++ PP D YGG + WQ NVPP HVV+
Sbjct: 171 LLVLSILCICCRKKKRRRDEEYYAPPPQPPRGPKADDAYGGPPRQWQHNVPPPQDHVVSM 230
Query: 167 PPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFL 226
P P P PPPPPPF+ SSGGS SNYSG E +PPPS G++LGF
Sbjct: 231 MPPKPSPPPAPPAYA-----AQPPPPPPPFIISSGGSGSNYSGGEF-LPPPSPGIALGFS 284
Query: 227 KSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAE 286
KSTFTYEELARATDGFSDANLLGQGGFGYVH+G+LPNGKEVA+KQLKAGSGQGER FQAE
Sbjct: 285 KSTFTYEELARATDGFSDANLLGQGGFGYVHRGILPNGKEVAVKQLKAGSGQGEREFQAE 344
Query: 287 VEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG 346
VEIISRVHHKHLVSLVGY GSQR+LV EFV +NTLEFHLHG+GRPTMDWPTRL+IALG
Sbjct: 345 VEIISRVHHKHLVSLVGYCITGSQRLLVYEFVPNNTLEFHLHGRGRPTMDWPTRLRIALG 404
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK +SDV THVSTRVMGTF
Sbjct: 405 SAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKFSSDVNTHVSTRVMGTF 464
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIE 463
GYLAPEYASSGKLT+KSDVFS+GVMLLELI G RPVD TFMED+L ARPLL RA+E
Sbjct: 465 GYLAPEYASSGKLTDKSDVFSYGVMLLELITGRRPVDKNQTFMEDSLVDWARPLLTRALE 524
Query: 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNE 523
+ +FD+++DP+L N+Y+ NEMARMVA AAAC+RHSA+RRPR+SQ+VR LEGD SLADLNE
Sbjct: 525 EDDFDSIIDPRLQNDYDPNEMARMVASAAACIRHSAKRRPRMSQVVRALEGDVSLADLNE 584
Query: 524 GIRPGQSSVYGSL---DYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSS 580
GIRPG S++Y S DYDT QY ED+KKFRKMAL +QE ASSEY+ TS+YGL+ S S
Sbjct: 585 GIRPGHSTMYSSHESSDYDTAQYKEDMKKFRKMALGTQEYGASSEYSAATSEYGLNPSGS 644
Query: 581 SSEGHN---TREIEMGKARKNSQSQGFSGS 607
SSE + TRE+EM RK SQGFSGS
Sbjct: 645 SSEAQSRQTTREMEM---RKMKNSQGFSGS 671
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449520249|ref|XP_004167146.1| PREDICTED: proline-rich receptor-like protein kinase PERK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 657 bits (1694), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/564 (65%), Positives = 422/564 (74%), Gaps = 30/564 (5%)
Query: 50 TPPPTSGAPPPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVV 109
+P P SG+ P++P D P P S PS GVS GLV G+AI G+ V+VV
Sbjct: 99 SPTPPSGSGTPASPGDDLPGRDLPPPSSSPSS--------GVSAGLVAGVAIAGVVVVVV 150
Query: 110 VSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPR 169
+++ C RK+RRR D+EA Y PPP + K PYG +Q HWQ + PP A H+V
Sbjct: 151 ALIIMFLCMRKKRRR-DEEAYYRPPPPPPSYKDGPYGQQQHHWQSHPPPPADHIVG---- 205
Query: 170 PAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKST 229
V P PP SG + S S PIP + LGF +S+
Sbjct: 206 -----AVPKPSPPPAPRPQLSPPIINSSGGSGSNYSGSENSLVPIPSS---IPLGFSQSS 257
Query: 230 FTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEI 289
FTYEELA ATDGFS+ANLLGQGGFGYVHKGVLPNGKEVA+KQLKAGSGQGER FQAEVEI
Sbjct: 258 FTYEELAMATDGFSEANLLGQGGFGYVHKGVLPNGKEVAVKQLKAGSGQGEREFQAEVEI 317
Query: 290 ISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK 349
ISRVHH+HLVSLVGY GS+R+LV EFV ++TLEFHLHGKGRPTMDWPTRLKIALG AK
Sbjct: 318 ISRVHHRHLVSLVGYCITGSRRLLVYEFVPNDTLEFHLHGKGRPTMDWPTRLKIALGSAK 377
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL 409
GLAYLHEDC+PKIIHRDIKAANILLD KFEAKVADFGLAKL+SDV THVSTRVMGTFGYL
Sbjct: 378 GLAYLHEDCNPKIIHRDIKAANILLDLKFEAKVADFGLAKLSSDVNTHVSTRVMGTFGYL 437
Query: 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIEDGN 466
APEYASSGKLTEKSDVFSFGVMLLE+I G RPVD+T +FM+D L ARPLL RA EDG+
Sbjct: 438 APEYASSGKLTEKSDVFSFGVMLLEMITGRRPVDTTQSFMDDGLLDWARPLLLRATEDGH 497
Query: 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNEGIR 526
+D+LVDPKL + Y+HNEMARMVACAAACVRHSARRRPR+SQ+V LEG++SL+DLNEGIR
Sbjct: 498 YDSLVDPKLRDNYDHNEMARMVACAAACVRHSARRRPRMSQVVHALEGESSLSDLNEGIR 557
Query: 527 PGQSSV---YGSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSSSSE 583
PG S+V YGS DYDT QYNEDLKKFRKMAL SQE SEY+ TS+YGL+ S SS +
Sbjct: 558 PGHSTVYSSYGSSDYDTAQYNEDLKKFRKMALASQEY--GSEYSEQTSEYGLYPSGSSGD 615
Query: 584 GHNTREIEMGKARKNSQSQGFSGS 607
G TRE+EM + +S GFSGS
Sbjct: 616 GQTTREMEM-RTTGMKESGGFSGS 638
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 608 | ||||||
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.625 | 0.582 | 0.714 | 1.5e-155 | |
| UNIPROTKB|Q9ARH1 | 647 | Q9ARH1 "Receptor protein kinas | 0.625 | 0.587 | 0.714 | 1.9e-155 | |
| TAIR|locus:2093999 | 700 | PERK6 "proline-rich extensin-l | 0.603 | 0.524 | 0.665 | 1.8e-126 | |
| TAIR|locus:2139474 | 670 | PERK5 "proline-rich extensin-l | 0.601 | 0.546 | 0.650 | 3.7e-126 | |
| TAIR|locus:2010282 | 699 | PERK7 "proline-rich extensin-l | 0.587 | 0.510 | 0.679 | 3.1e-125 | |
| TAIR|locus:2046268 | 633 | PERK4 "proline-rich extensin-l | 0.555 | 0.533 | 0.699 | 3.5e-123 | |
| TAIR|locus:2018209 | 509 | PERK15 "proline-rich extensin- | 0.611 | 0.730 | 0.605 | 7.9e-117 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.597 | 0.511 | 0.562 | 9.5e-105 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.557 | 0.470 | 0.582 | 1.6e-102 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.557 | 0.497 | 0.551 | 8.2e-99 |
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1428 (507.7 bits), Expect = 1.5e-155, Sum P(2) = 1.5e-155
Identities = 278/389 (71%), Positives = 321/389 (82%)
Query: 225 FLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQ 284
F KSTFTYEEL+RAT+GFS+ANLLGQGGFGYVHKG+LP+GKEVA+KQLKAGSGQGER FQ
Sbjct: 263 FSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQ 322
Query: 285 AEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA 344
AEVEIISRVHH+HLVSL+GY AG QR+LV EFV +N LEFHLHGKGRPTM+W TRLKIA
Sbjct: 323 AEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPTMEWSTRLKIA 382
Query: 345 LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMG 404
LG AKGL+YLHEDC+PKIIHRDIKA+NIL+DFKFEAKVADFGLAK+ASD THVSTRVMG
Sbjct: 383 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMG 442
Query: 405 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRA 461
TFGYLAPEYA+SGKLTEKSDVFSFGV+LLELI G RPVD+ + +++D+L ARPLLNRA
Sbjct: 443 TFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRA 502
Query: 462 IEDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRISQIVRTLEGDASLADL 521
E+G+F+ L D K+ NEY+ E HSARRRPR+SQIVR LEG+ SL+DL
Sbjct: 503 SEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDL 562
Query: 522 NEGIRPGQSSVY----GSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHX 577
NEG+RPG S+VY GS DYDT QYN+D+ KFRKMAL +QE + EY+ PTSDYGL+
Sbjct: 563 NEGMRPGHSNVYSSYGGSTDYDTSQYNDDMIKFRKMALGTQEYGTTGEYSNPTSDYGLYP 622
Query: 578 XXXXXEGHNTREIEMGKARKNSQSQGFSG 606
EG TRE+EMGK +K Q G+SG
Sbjct: 623 SGSSSEGQATREMEMGKIKKTGQ--GYSG 649
|
|
| UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)] | Back alignment and assigned GO terms |
|---|
Score = 1428 (507.7 bits), Expect = 1.9e-155, Sum P(2) = 1.9e-155
Identities = 278/389 (71%), Positives = 323/389 (83%)
Query: 225 FLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQ 284
F KSTFTYEELARAT+GFS+ANLLGQGGFGYVHKGVLP+GKEVA+KQLK GSGQGER FQ
Sbjct: 258 FSKSTFTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQ 317
Query: 285 AEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA 344
AEVEIISRVHH+HLVSLVGY AG++R+LV EFV +N LE HLHG+GRPTM+W TRLKIA
Sbjct: 318 AEVEIISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGEGRPTMEWSTRLKIA 377
Query: 345 LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMG 404
LG AKGL+YLHEDC+PKIIHRDIKA+NIL+DFKFEAKVADFGLAK+ASD THVSTRVMG
Sbjct: 378 LGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMG 437
Query: 405 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRA 461
TFGYLAPEYA+SGKLTEKSDVFSFGV+LLELI G RPVD+ + +++D+L ARPLLNRA
Sbjct: 438 TFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRA 497
Query: 462 IEDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRISQIVRTLEGDASLADL 521
E G+F+ L D K++N Y+ E HSARRRPR+SQIVR LEG+ SL+DL
Sbjct: 498 SEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEGNVSLSDL 557
Query: 522 NEGIRPGQSSVY----GSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHX 577
NEG+RPGQS+VY GS DYD+ QYNED+KKFRKMAL +QE +A+ EY+ PTSDYGL+
Sbjct: 558 NEGMRPGQSNVYSSYGGSTDYDSSQYNEDMKKFRKMALGTQEYNATGEYSNPTSDYGLYP 617
Query: 578 XXXXXEGHNTREIEMGKARKNSQSQGFSG 606
EG TRE+EMGK ++ Q G+SG
Sbjct: 618 SGSSSEGQTTREMEMGKIKRTGQ--GYSG 644
|
|
| TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1242 (442.3 bits), Expect = 1.8e-126, P = 1.8e-126
Identities = 253/380 (66%), Positives = 290/380 (76%)
Query: 225 FLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQ 284
F KSTFTY+ELA AT GFS + LLGQGGFGYVHKG+LPNGKE+A+K LKAGSGQGER FQ
Sbjct: 320 FNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQ 379
Query: 285 AEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA 344
AEV+IISRVHH+ LVSLVGY AG QRMLV EF+ ++TLEFHLHGK +DWPTRLKIA
Sbjct: 380 AEVDIISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTRLKIA 439
Query: 345 LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMG 404
LG AKGLAYLHEDCHP+IIHRDIKA+NILLD FEAKVADFGLAKL+ D THVSTR+MG
Sbjct: 440 LGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMG 499
Query: 405 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRA 461
TFGYLAPEYASSGKLT++SDVFSFGVMLLEL+ G RPVD T MED+L ARP+ A
Sbjct: 500 TFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGE-MEDSLVDWARPICLNA 558
Query: 462 IEDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRISQIVRTLEGDASLADL 521
+DG++ LVDP+L N+Y +E HSARRRP++SQIVR LEGDA+L DL
Sbjct: 559 AQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATLDDL 618
Query: 522 NEGIRPGQSSVYG---SLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHXX 578
+EG + GQSS G S DYD+ Y+ D+KKFRK+AL+S E ASSEY TS+YGL
Sbjct: 619 SEGGKAGQSSFLGRGSSSDYDSSTYSADMKKFRKVALDSHEYGASSEYGN-TSEYGLDPS 677
Query: 579 XXXXEGHNTREIEMGKARKN 598
E EI G A N
Sbjct: 678 SSSSE-----EIRRGGANNN 692
|
|
| TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1239 (441.2 bits), Expect = 3.7e-126, P = 3.7e-126
Identities = 248/381 (65%), Positives = 295/381 (77%)
Query: 227 KSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAE 286
+STFTY+EL+ AT+GF+ +NLLGQGGFGYVHKGVLP+GKEVA+K LK GSGQGER FQAE
Sbjct: 297 QSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLGSGQGEREFQAE 356
Query: 287 VEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG 346
V+IISRVHH+HLVSLVGY +G QR+LV EF+ +NTLEFHLHGKGRP +DWPTR+KIALG
Sbjct: 357 VDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGKGRPVLDWPTRVKIALG 416
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
A+GLAYLHEDCHP+IIHRDIKAANILLDF FE KVADFGLAKL+ D YTHVSTRVMGTF
Sbjct: 417 SARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKLSQDNYTHVSTRVMGTF 476
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIE 463
GYLAPEYASSGKL++KSDVFSFGVMLLELI G P+D T MED+L ARPL +A +
Sbjct: 477 GYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGE-MEDSLVDWARPLCLKAAQ 535
Query: 464 DGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRISQIVRTLEGDASLADLNE 523
DG+++ L DP+L Y+H E HSARRRP++SQIVR LEGD S+ DL+E
Sbjct: 536 DGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQIVRALEGDMSMDDLSE 595
Query: 524 GIRPGQSSVY--GSL--DYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHXXX 579
G RPGQS+ GS+ +YD Y D+KKF+K+AL ++E SSEY TS+YGL+
Sbjct: 596 GTRPGQSTYLSPGSVSSEYDASSYTADMKKFKKLALENKEYQ-SSEYGG-TSEYGLNPSA 653
Query: 580 XXXEGHNTREIEMGKARKNSQ 600
E E+ G ++N Q
Sbjct: 654 SSSE-----EMNRGSMKRNPQ 669
|
|
| TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1210 (431.0 bits), Expect = 3.1e-125, Sum P(2) = 3.1e-125
Identities = 248/365 (67%), Positives = 279/365 (76%)
Query: 225 FLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQ 284
F STFTYEELA AT GFS LLGQGGFGYVHKG+LPNGKE+A+K LKAGSGQGER FQ
Sbjct: 319 FNNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQ 378
Query: 285 AEVEIISRVHHKHLVSLVGYYT-AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKI 343
AEVEIISRVHH+HLVSLVGY + AG QR+LV EF+ ++TLEFHLHGK MDWPTRLKI
Sbjct: 379 AEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPTRLKI 438
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403
ALG AKGLAYLHEDCHPKIIHRDIKA+NILLD FEAKVADFGLAKL+ D THVSTRVM
Sbjct: 439 ALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVSTRVM 498
Query: 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNR 460
GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI G PVD + MED+L ARPL R
Sbjct: 499 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGD-MEDSLVDWARPLCMR 557
Query: 461 AIEDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRISQIVRTLEGDASLAD 520
+DG + LVDP L ++Y E HS RRRP++SQIVRTLEGDASL D
Sbjct: 558 VAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGDASLDD 617
Query: 521 LNEGIRPGQSSV--YGSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHXX 578
L++G++P QSS GS DY+ Y +++KFRK+ L S++ ASSEY TS+YGL
Sbjct: 618 LDDGVKPKQSSSGGEGSSDYEMGTYGAEMRKFRKVTLESRDYGASSEYGA-TSEYGLDPS 676
Query: 579 XXXXE 583
E
Sbjct: 677 SSSSE 681
|
|
| TAIR|locus:2046268 PERK4 "proline-rich extensin-like receptor kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1211 (431.4 bits), Expect = 3.5e-123, P = 3.5e-123
Identities = 242/346 (69%), Positives = 276/346 (79%)
Query: 225 FLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQ 284
F KSTFTY+ELA AT GF+DANLLGQGGFGYVHKGVLP+GKEVA+K LKAGSGQGER FQ
Sbjct: 267 FNKSTFTYQELAAATGGFTDANLLGQGGFGYVHKGVLPSGKEVAVKSLKAGSGQGEREFQ 326
Query: 285 AEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA 344
AEV+IISRVHH++LVSLVGY A QRMLV EFV + TLE+HLHGK P M++ TRL+IA
Sbjct: 327 AEVDIISRVHHRYLVSLVGYCIADGQRMLVYEFVPNKTLEYHLHGKNLPVMEFSTRLRIA 386
Query: 345 LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMG 404
LG AKGLAYLHEDCHP+IIHRDIK+ANILLDF F+A VADFGLAKL SD THVSTRVMG
Sbjct: 387 LGAAKGLAYLHEDCHPRIIHRDIKSANILLDFNFDAMVADFGLAKLTSDNNTHVSTRVMG 446
Query: 405 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRA 461
TFGYLAPEYASSGKLTEKSDVFS+GVMLLELI G RPVD++ T M+D L ARPL+ RA
Sbjct: 447 TFGYLAPEYASSGKLTEKSDVFSYGVMLLELITGKRPVDNSIT-MDDTLVDWARPLMARA 505
Query: 462 IEDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRISQIVRTLEGDASLADL 521
+EDGNF+ L D +L YN E HS R+RP++SQIVR LEG+ SL L
Sbjct: 506 LEDGNFNELADARLEGNYNPQEMARMVTCAAASIRHSGRKRPKMSQIVRALEGEVSLDAL 565
Query: 522 NEGIRPGQSSVYGSL----DYDTMQYNEDLKKFRKMALNSQEISAS 563
NEG++PG S+VYGSL DY YN D+KKFR++AL+SQE S
Sbjct: 566 NEGVKPGHSNVYGSLGASSDYSQTSYNADMKKFRQIALSSQEFPVS 611
|
|
| TAIR|locus:2018209 PERK15 "proline-rich extensin-like receptor kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1151 (410.2 bits), Expect = 7.9e-117, P = 7.9e-117
Identities = 232/383 (60%), Positives = 285/383 (74%)
Query: 227 KSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAE 286
++ FTYE+L++AT FS+ NLLGQGGFGYVH+GVL +G VAIKQLK+GSGQGER FQAE
Sbjct: 128 QNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAE 187
Query: 287 VEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG 346
++ ISRVHH+HLVSL+GY G+QR+LV EFV + TLEFHLH K RP M+W R+KIALG
Sbjct: 188 IQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEKERPVMEWSKRMKIALG 247
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
AKGLAYLHEDC+PK IHRD+KAANIL+D +EAK+ADFGLA+ + D THVSTR+MGTF
Sbjct: 248 AAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGTF 307
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL----ARPLLNRAI 462
GYLAPEYASSGKLTEKSDVFS GV+LLELI G RPVD + F +D+ A+PL+ +A+
Sbjct: 308 GYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQAL 367
Query: 463 EDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRISQIVRTLEGDASLADLN 522
DGNFD LVDP+L N+++ NE HSA+RRP++SQIVR EG+ S+ DL
Sbjct: 368 NDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFEGNISIDDLT 427
Query: 523 EGIRPGQSSVY---GSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLH--X 577
EG PGQS++Y GS DY + QY EDLKKF+KMA S+ SSE + TSD G +
Sbjct: 428 EGAAPGQSTIYSLDGSSDYSSTQYKEDLKKFKKMAFESKTFG-SSECSGLTSDNGQNPSG 486
Query: 578 XXXXXEGHNT-REIEMGKARKNS 599
EG T +EIE K K++
Sbjct: 487 SSSITEGQRTTQEIEPEKNTKDT 509
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1037 (370.1 bits), Expect = 9.5e-105, P = 9.5e-105
Identities = 213/379 (56%), Positives = 264/379 (69%)
Query: 230 FTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEI 289
FTYEEL T+GFS N+LG+GGFG V+KG L +GK VA+KQLK GSGQG+R F+AEVEI
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 290 ISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK 349
ISRVHH+HLVSLVGY A S+R+L+ E+V + TLE HLHGKGRP ++W R++IA+G AK
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAK 460
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL 409
GLAYLHEDCHPKIIHRDIK+ANILLD +FEA+VADFGLAKL THVSTRVMGTFGYL
Sbjct: 461 GLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYL 520
Query: 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIEDGN 466
APEYA SGKLT++SDVFSFGV+LLELI G +PVD E++L ARPLL++AIE G+
Sbjct: 521 APEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGD 580
Query: 467 FDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRISQIVRTLEGDASLADLNEGIR 526
F LVD +L Y NE HS +RPR+ Q+VR L+ + + D++ G +
Sbjct: 581 FSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNK 640
Query: 527 PGQSSVYGSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHXXXXXXEGHN 586
GQSS Y D+ QYN D KFRKMA + S S Y+ DY + +G N
Sbjct: 641 VGQSSAY-----DSGQYNNDTMKFRKMAFGFDDSSDSGMYS---GDYSVQDSR---KGSN 689
Query: 587 TREIEMGKARKNSQSQGFS 605
E R ++++ F+
Sbjct: 690 GASSEF--TRNETENRNFN 706
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1016 (362.7 bits), Expect = 1.6e-102, P = 1.6e-102
Identities = 205/352 (58%), Positives = 257/352 (73%)
Query: 230 FTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEI 289
F+YEELA T GF+ N+LG+GGFG V+KG L +GK VA+KQLKAGSGQG+R F+AEVEI
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 290 ISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK 349
ISRVHH+HLVSLVGY + R+L+ E+V++ TLE HLHGKG P ++W R++IA+G AK
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSKRVRIAIGSAK 478
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL 409
GLAYLHEDCHPKIIHRDIK+ANILLD ++EA+VADFGLA+L THVSTRVMGTFGYL
Sbjct: 479 GLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYL 538
Query: 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRAIEDGN 466
APEYASSGKLT++SDVFSFGV+LLEL+ G +PVD T E++L ARPLL +AIE G+
Sbjct: 539 APEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGD 598
Query: 467 FDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRISQIVRTLEGDASLADLNEGIR 526
L+D +L Y +E HS +RPR+ Q+VR L+ D D++ GI+
Sbjct: 599 LSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSGDISNGIK 658
Query: 527 PGQSSVYGSLDYDTMQYNEDLKKFRKMAL---NSQEISA-SSEYN-RPTSDY 573
GQS+ Y D+ QYNED+ KFRKMA NS E S Y+ + +SD+
Sbjct: 659 IGQSTTY-----DSGQYNEDIMKFRKMAFGGDNSVESGLYSGNYSAKSSSDF 705
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 981 (350.4 bits), Expect = 8.2e-99, P = 8.2e-99
Identities = 193/350 (55%), Positives = 257/350 (73%)
Query: 227 KSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAE 286
+S F+Y+EL++ T GFS+ NLLG+GGFG V+KGVL +G+EVA+KQLK G QGER F+AE
Sbjct: 324 RSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAE 383
Query: 287 VEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG 346
VEIISRVHH+HLV+LVGY + R+LV ++V +NTL +HLH GRP M W TR+++A G
Sbjct: 384 VEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPVMTWETRVRVAAG 443
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS--DVYTHVSTRVMG 404
A+G+AYLHEDCHP+IIHRDIK++NILLD FEA VADFGLAK+A D+ THVSTRVMG
Sbjct: 444 AARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMG 503
Query: 405 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL---ARPLLNRA 461
TFGY+APEYA+SGKL+EK+DV+S+GV+LLELI G +PVD++ +++L ARPLL +A
Sbjct: 504 TFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQA 563
Query: 462 IEDGNFDTLVDPKLHNEYNHNEXXXXXXXXXXXXXHSARRRPRISQIVRTLEGDASLADL 521
IE+ FD LVDP+L + E HSA +RP++SQ+VR L+ D+
Sbjct: 564 IENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEATDI 623
Query: 522 NEGIRPGQSSVYGSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTS 571
G+RPGQS V+ D+ Q + ++ F++MA SQ+ S S ++R S
Sbjct: 624 TNGMRPGQSQVF-----DSRQQSAQIRMFQRMAFGSQDYS-SDFFDRSQS 667
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LV48 | PERK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6510 | 0.8766 | 0.8174 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 608 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-46 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-45 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-36 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-31 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-29 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-26 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-25 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-24 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-21 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-20 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-17 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 6e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-17 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-15 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 7e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-10 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-09 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-07 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| PHA03291 | 401 | PHA03291, PHA03291, envelope glycoprotein I; Provi | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 5e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 8e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-05 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 3e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-05 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 5e-05 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-05 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 7e-05 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 1e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 1e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-04 | |
| pfam02480 | 437 | pfam02480, Herpes_gE, Alphaherpesvirus glycoprotei | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| pfam01034 | 207 | pfam01034, Syndecan, Syndecan domain | 2e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-04 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-04 | |
| TIGR03921 | 350 | TIGR03921, T7SS_mycosin, type VII secretion-associ | 3e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-04 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-04 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 5e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 6e-04 | |
| PLN02983 | 274 | PLN02983, PLN02983, biotin carboxyl carrier protei | 6e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 6e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 7e-04 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 7e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-04 | |
| PRK12495 | 226 | PRK12495, PRK12495, hypothetical protein; Provisio | 9e-04 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.001 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 0.001 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 0.001 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| pfam03109 | 117 | pfam03109, ABC1, ABC1 family | 0.001 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.002 | |
| TIGR00601 | 378 | TIGR00601, rad23, UV excision repair protein Rad23 | 0.002 | |
| TIGR03921 | 350 | TIGR03921, T7SS_mycosin, type VII secretion-associ | 0.002 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 0.002 | |
| COG3889 | 872 | COG3889, COG3889, Predicted solute binding protein | 0.002 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.003 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 0.003 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.003 | |
| PRK13042 | 291 | PRK13042, PRK13042, superantigen-like protein; Rev | 0.003 | |
| PLN02217 | 670 | PLN02217, PLN02217, probable pectinesterase/pectin | 0.003 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 0.003 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.003 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 0.004 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-50
Identities = 72/192 (37%), Positives = 105/192 (54%), Gaps = 9/192 (4%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGER-VFQAEVEIISRVHHKHLVSLVGYY 305
LG+GGFG V+ GK+VAIK +K E+EI+ +++H ++V L G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
+ LV E+ +L+ L + + L+I L +GL YLH + IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLHS--N-GIIHR 116
Query: 366 DIKAANILLDFK-FEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE-YASSGKLTEKS 423
D+K NILLD + K+ADFGL+KL + + + T V GT Y+APE G +EKS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 424 DVFSFGVMLLEL 435
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-46
Identities = 83/281 (29%), Positives = 123/281 (43%), Gaps = 45/281 (16%)
Query: 248 LGQGGFGYVHKGVL-----PNGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSL 301
LG+G FG V+KG L +VA+K LK G+ + ER F E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+G T G +V E++ L L G + L++AL AKG+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLESK---N 122
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
+HRD+ A N L+ K++DFGL++ + D Y ++APE GK T
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182
Query: 421 EKSDVFSFGVMLLELIIGCR------PVDSTHTFMEDN--LARPLLNRAIEDGNFDTLVD 472
KSDV+SFGV+L E+ + +ED L RP
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP---------------- 226
Query: 473 PKLHNEYNHNEMAR-MVACAAACVRHSARRRPRISQIVRTL 512
E +E+ M+ C A + RP S++V L
Sbjct: 227 -----ENCPDELYELMLQCWA----YDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 8e-46
Identities = 65/202 (32%), Positives = 94/202 (46%), Gaps = 9/202 (4%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLV 299
+ LG+G FG V+ GK VAIK +K + +R E++I+ ++ H ++V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
L + + LV E+ L L +GR + D R L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-AR-FYLRQILSALEYLHSK-- 116
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
I+HRD+K NILLD K+ADFGLA+ T +GT Y+APE
Sbjct: 117 -GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGY 173
Query: 420 TEKSDVFSFGVMLLELIIGCRP 441
+ D++S GV+L EL+ G P
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 2e-45
Identities = 85/287 (29%), Positives = 126/287 (43%), Gaps = 44/287 (15%)
Query: 246 NLLGQGGFGYVHKGVL----PNGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
LG+G FG V+KG L EVA+K LK + + ER F E ++ ++ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGK-------GRPTMDWPTRLKIALGFAKGLAY 353
L+G T LV E++ L +L + T+ L A+ AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFG----YL 409
L K +HRD+ A N L+ K++DFGL++ DVY R ++
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSR---DVYDDDYYRKKTGGKLPIRWM 174
Query: 410 APEYASSGKLTEKSDVFSFGVMLLELI-IGCRPVD--STHTFMEDNLARPLLNRAIEDGN 466
APE G T KSDV+SFGV+L E+ +G P S +E + G
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLE----------YLRKGY 224
Query: 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
L P EY +E+ ++ C + RP S++V LE
Sbjct: 225 R--LPKP----EYCPDELYELMLS---CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 70/195 (35%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 248 LGQGGFGYVHKGVL--PNGK---EVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSL 301
LG+G FG V+KG L GK EVA+K LK + + + F E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+G T +V E++ L +L K RP + L AL A+G+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
IHRD+ A N L+ K++DFGL++ L D Y ++APE GK T
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGKFT 181
Query: 421 EKSDVFSFGVMLLEL 435
KSDV+SFGV+L E+
Sbjct: 182 SKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 4e-44
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 15/197 (7%)
Query: 248 LGQGGFGYVHKGVL-----PNGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSL 301
LG+G FG V+KG L EVA+K LK + + + F E I+ ++ H ++V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 302 VGYYTAGSQRMLVCEFVTS-NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
+G T M+V E++ + L++ L + L AL A+G+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDY-LRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLAS--DVYTHVSTRVMGTFGYLAPEYASSGK 418
IHRD+ A N L+ K++DFGL++ D Y ++ ++APE GK
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGK 180
Query: 419 LTEKSDVFSFGVMLLEL 435
T KSDV+SFGV+L E+
Sbjct: 181 FTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 6e-42
Identities = 84/268 (31%), Positives = 117/268 (43%), Gaps = 25/268 (9%)
Query: 248 LGQGGFGYVHKGVLPN-GKEVAIKQLK---AGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
LG G FG V+K GK VA+K LK S + + E+ I+ R+ H ++V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPNIVRLID 65
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ LV E+ L +L G + KIAL +GL YLH + II
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE-YASSGKLTEK 422
HRD+K NILLD K+ADFGLAK + ++T V GT Y+APE K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 423 SDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL-LNRAIEDGNFDTLVDPKLHNEYNH 481
DV+S GV+L EL+ G P F +N+ L L R I +
Sbjct: 180 VDVWSLGVILYELLTGKPP------FSGENILDQLQLIRRILGP------PLEFDEPKWS 227
Query: 482 NEMARMVACAAACVRHSARRRPRISQIV 509
+ C+ +RP +I+
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 246 NLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERV--FQAEVEIISRVHHKHLVSLV 302
LLG+G FG V+ + G+ +A+K ++ E + + E+ I+S + H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 303 GYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK----GLAYLHE 356
G + L E+V+ +L L G+ ++ + + GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP---EPVIRK---YTRQILEGLAYLHS 119
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYAS 415
+ I+HRDIK ANIL+D K+ADFG AK D+ T T + GT ++APE
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRP 441
+ +D++S G ++E+ G P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 68/198 (34%), Positives = 101/198 (51%), Gaps = 7/198 (3%)
Query: 242 FSDANLLGQGGFGYVHKG-VLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
F +G+GGFG V+K GKEVAIK +K S + + E++I+ + H ++V
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
G Y + +V EF + +L+ L + + + KGL YLH +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGLEYLHSN--- 117
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
IIHRDIKAANILL E K+ DFGL+ SD T ++GT ++APE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD--TKARNTMVGTPYWMAPEVINGKPYD 175
Query: 421 EKSDVFSFGVMLLELIIG 438
K+D++S G+ +EL G
Sbjct: 176 YKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 72/195 (36%), Positives = 105/195 (53%), Gaps = 6/195 (3%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
F+ LG G FG V +G+ N VAIK LK+ ++ FQ EV+ + R+ HKHL+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ G ++ E + +L L + + + +A A+G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---N 124
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKL-ASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
IHRD+ A NIL+ KVADFGLA+L DVY ++ + + APE AS G +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFS 182
Query: 421 EKSDVFSFGVMLLEL 435
KSDV+SFG++L E+
Sbjct: 183 TKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 66/189 (34%), Positives = 102/189 (53%), Gaps = 9/189 (4%)
Query: 247 LLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
+G+G FG V G G++VA+K LK S + F AE +++ + H +LV L+G
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVL 70
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
G+ +V E++ +L +L +GR + +L AL +G+ YL E +HRD
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRD 127
Query: 367 IKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 426
+ A N+L+ AKV+DFGLAK AS S ++ + APE K + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEAS--QGQDSGKL--PVKWTAPEALREKKFSTKSDVW 183
Query: 427 SFGVMLLEL 435
SFG++L E+
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 246 NLLGQGGFGYVHKGVLPN-----GKEVAIKQLKA-GSGQGERVFQAEVEIISRVHHKHLV 299
LG+G FG V G++VA+K L G Q F+ E+EI+ + H+++V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 300 SLVGYYTAGSQR--MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
G R L+ E++ S +L +L + R ++ L + KG+ YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS---DVYTHVSTRVMGTFGYLAPEYA 414
+ IHRD+ A NIL++ + K++DFGLAK+ D Y F Y APE
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ K + SDV+SFGV L EL P
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 66/191 (34%), Positives = 97/191 (50%), Gaps = 8/191 (4%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG V G +VA+K LK G+ E F E +I+ ++ H LV L +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
+V E+++ +L L + P + +A A+G+AYL IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDL 129
Query: 368 KAANILLDFKFEAKVADFGLAKL-ASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
A NIL+ K+ADFGLA+L D YT + + APE A+ G+ T KSDV
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIKSDV 187
Query: 426 FSFGVMLLELI 436
+SFG++L E++
Sbjct: 188 WSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 8e-30
Identities = 66/192 (34%), Positives = 99/192 (51%), Gaps = 10/192 (5%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG V +G+ N VA+K LK G+ + F AE +I+ ++ H L+ L T
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD-FLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
+V E + +L +L G + P + +A A G+AYL + IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY---IHRDL 129
Query: 368 KAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTF--GYLAPEYASSGKLTEKSD 424
A N+L+ KVADFGLA+ + D+Y R F + APE A + + KSD
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYE---AREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 425 VFSFGVMLLELI 436
V+SFG++L E++
Sbjct: 187 VWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 74/274 (27%), Positives = 125/274 (45%), Gaps = 38/274 (13%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLK-AGSGQGERVF-QAEVEIISRVHHKHLVSLV 302
+G+G FG V+ +GK +K++ + + ER EV+I+ +++H +++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLH---GKGRPT-----MDWPTRLKIALGFAKGLAYL 354
+ + +V E+ L + +G+P +DW +L L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYL 119
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
H KI+HRDIK NI L K+ DFG++K+ S T V GT YL+PE
Sbjct: 120 HSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELC 175
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474
+ KSD++S G +L EL P F +NL L + I G + P
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHP------FEGENLLE-LALK-ILKGQY-----PP 222
Query: 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQI 508
+ ++Y+ +E+ +V ++ ++ RP I+QI
Sbjct: 223 IPSQYS-SELRNLV---SSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 86/279 (30%), Positives = 135/279 (48%), Gaps = 36/279 (12%)
Query: 246 NLLGQGGFGYVHKGVL--PNGKE--VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
++G G FG V +G L P KE VAIK LKAGS +R+ F E I+ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHL-HGKGRPTMDWPTRL-KIALGFAKGLAYLHEDC 358
L G T M++ E++ + +L+ L G+ T +L + G A G+ YL E
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT---VGQLVGMLRGIASGMKYLSEMN 126
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTFGYLAPEYAS 415
+ +HRD+ A NIL++ KV+DFGL++ + YT ++ + APE +
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIA 181
Query: 416 SGKLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474
K T SDV+SFG+++ E++ G RP +++ + +A+EDG L P
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERPY--------WDMSNQDVIKAVEDGY--RLPPPM 231
Query: 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+ M C + RP SQIV TL+
Sbjct: 232 DCPSALYQLM-------LDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 69/212 (32%), Positives = 96/212 (45%), Gaps = 19/212 (8%)
Query: 247 LLGQGGFGYVHKGVLPNGKEVAIKQLK---AGSGQGERVFQAEVEIISRV-HHKHLVSLV 302
LG+G FG V+ K VA+K L + F E++I++ + H ++V L
Sbjct: 7 KLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHL-HGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
++ LV E+V +LE L + + L I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121
Query: 362 IIHRDIKAANILLDFK-FEAKVADFGLAKLASDVYTHVSTR-----VMGTFGYLAPEYAS 415
IIHRDIK NILLD K+ DFGLAKL D + S +GT GY+APE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 416 SGKL---TEKSDVFSFGVMLLELIIGCRPVDS 444
L + SD++S G+ L EL+ G P +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEG 213
|
Length = 384 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 70/194 (36%), Positives = 103/194 (53%), Gaps = 13/194 (6%)
Query: 248 LGQGGFGYVHKGV--LPNGKE--VAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLV 302
LG G FG V KGV + +GKE VA+K LK G++ F E +++++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
G G MLV E L +L K R + ++A A G+AYL E H
Sbjct: 63 GV-CKGEPLMLVMELAPLGPLLKYL--KKRREIPVSDLKELAHQVAMGMAYL-ESKH--F 116
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKL--ASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
+HRD+ A N+LL + +AK++DFG+++ A Y +T + APE + GK +
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176
Query: 421 EKSDVFSFGVMLLE 434
KSDV+S+GV L E
Sbjct: 177 SKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLK-AGSGQGE-RVFQAEVEIISRVHHKHLVSLV 302
+L+G+G FG V+KG+ L G VAIKQ+ + + E++++ + H ++V +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA---KGLAYLHEDCH 359
G ++ E+ + +L + G +P L +A+ +GLAYLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGP----FPESL-VAVYVYQVLQGLAYLHEQ-- 118
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLA-KLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
+IHRDIKAANIL K+ADFG+A KL + V+GT ++APE
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGTPYWMAPEVIEMSG 175
Query: 419 LTEKSDVFSFGVMLLELIIG 438
+ SD++S G ++EL+ G
Sbjct: 176 ASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 78/263 (29%), Positives = 121/263 (46%), Gaps = 30/263 (11%)
Query: 248 LGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVG-Y 304
LGQG G V+K P GK A+K++ + + E++ + ++V G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAKGLAYLHEDCHPKI 362
Y G +V E++ +L L K P + IA KGL YLH H I
Sbjct: 69 YKEGEIS-IVLEYMDGGSLA-DLLKKVGK---IPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEK 422
IHRDIK +N+L++ K E K+ADFG++K+ + +T V GT Y++PE +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYA 180
Query: 423 SDVFSFGVMLLELIIGCRPVDS--THTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480
+D++S G+ LLE +G P +F E L +AI DG P L E
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFE-------LMQAICDGP-----PPSLPAEEF 228
Query: 481 HNEMARMVACAAACVRHSARRRP 503
E ++ C++ ++RP
Sbjct: 229 SPEFRDFISA---CLQKDPKKRP 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 71/210 (33%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 248 LGQGGFGYV----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHHKHLV 299
LG+G FG V K GK A+K LK + E E I+SR++H +V
Sbjct: 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIV 56
Query: 300 SLVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGLAYL 354
L +Y ++ L V E+ L HL +GR + + R +I L L YL
Sbjct: 57 KL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAAEIVLA----LEYL 109
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
H II+RD+K NILLD K+ DFGLAK S + +T GT YLAPE
Sbjct: 110 HSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVL 165
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRPVDS 444
+ D +S GV+L E++ G P +
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 248 LGQGGFGYVHKGVLPN------GKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
LGQG FG V++G+ VAIK + + ER+ F E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDW------PTRLKI---ALGFAKGL 351
L+G + G ++V E + L+ +L + RP + PT K A A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH----VSTRVMGTFG 407
AYL K +HRD+ A N ++ K+ DFG+ + D+Y + +
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTR---DIYETDYYRKGGKGLLPVR 186
Query: 408 YLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++APE G T KSDV+SFGV+L E+
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 248 LGQGGFGYVHKGV-LPNGK----EVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSL 301
LG G FG V+KGV +P G+ VAIK L+ + + + E +++ V H H+V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+G SQ L+ + + L ++ + + L + AKG++YL E +
Sbjct: 75 LGI-CLSSQVQLITQLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQIAKGMSYLEEK---R 129
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTFGYLAPEYASSGK 418
++HRD+ A N+L+ K+ DFGLAKL Y +V ++A E
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--PIKWMALESILHRI 187
Query: 419 LTEKSDVFSFGVMLLELI-IGCRPVDS 444
T KSDV+S+GV + EL+ G +P +
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 72/198 (36%), Positives = 105/198 (53%), Gaps = 15/198 (7%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG V G +VA+K LK G+ E F E +I+ ++ H LV L Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQL---YAV 69
Query: 308 GSQR--MLVCEFVTSNTL-EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
S+ +V E+++ +L +F G+GR + P + +A A G+AY+ IH
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIER---MNYIH 125
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF--GYLAPEYASSGKLTEK 422
RD+++ANIL+ K+ADFGLA+L D + R F + APE A G+ T K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 423 SDVFSFGVMLLELIIGCR 440
SDV+SFG++L EL+ R
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 3e-25
Identities = 63/188 (33%), Positives = 93/188 (49%), Gaps = 5/188 (2%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
+G G FG V G ++VAIK ++ G+ E F E +++ ++ H LV L G T
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
S LV EF+ L +L + R T L + L +G+AYL +IHRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDL 126
Query: 368 KAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 427
A N L+ KV+DFG+ + D ST + +PE S K + KSDV+S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWS 186
Query: 428 FGVMLLEL 435
FGV++ E+
Sbjct: 187 FGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 36/204 (17%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG+G +G V+K + G+ VAIK + E E+ I+ + ++V G Y
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQE--IIKEISILKQCDSPYIVKYYGSY 67
Query: 306 TAGSQRMLVCEF-----------VTSNTLEFHLHGKGRPTMDWPTRLKIAL---GFAKGL 351
+ +V E+ +T+ TL T +IA KGL
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTL---------------TEEEIAAILYQTLKGL 112
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAP 411
YLH + K IHRDIKA NILL+ + +AK+ADFG++ +D +T V+GT ++AP
Sbjct: 113 EYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAP 168
Query: 412 EYASSGKLTEKSDVFSFGVMLLEL 435
E K+D++S G+ +E+
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 71/192 (36%), Positives = 101/192 (52%), Gaps = 13/192 (6%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LGQG FG V G VAIK LK G+ E Q E +++ ++ H+ LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLVQL---YAV 69
Query: 308 GSQR--MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
S+ +V E+++ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF--GYLAPEYASSGKLTEKS 423
D++AANIL+ KVADFGLA+L D + R F + APE A G+ T KS
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIKS 184
Query: 424 DVFSFGVMLLEL 435
DV+SFG++L EL
Sbjct: 185 DVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 29/211 (13%)
Query: 248 LGQGGFGYVHKGVLPNGKE------VAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVS 300
LG+G FG V G + + VA+K LK S + F+ E E+++ H+++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHL--HG-------KGRPTMDWPTR---LKIALGFA 348
G T G ++V E++ L L HG M T L+IA+ A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT--- 405
G+ YL +HRD+ N L+ + K+ DFG+++ DVYT RV G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR---DVYTTDYYRVGGHTML 186
Query: 406 -FGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++ PE K T +SDV+SFGV+L E+
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 6e-24
Identities = 81/276 (29%), Positives = 127/276 (46%), Gaps = 32/276 (11%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKEV-AIKQLKAGSGQGERVFQA--EVEIISRVHHKHL 298
F N +G+G FG V K V K V A+KQ+ +A E +++++ ++
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHG-KGRPTMD---WPTRLKIALGFAKGLAYL 354
+ + + +V E+ + L L +GRP + W ++I LG LA+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
H KI+HRDIK+ N+ LD K+ D G+AKL SD T+ + ++GT YL+PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELC 173
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474
EKSDV++ GV+L E G P D+ + A L I G F P
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDA-----NNQGA---LILKIIRGVF-----PP 220
Query: 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
+ Y+ ++ C+ R+RP Q++R
Sbjct: 221 VSQMYS----QQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-23
Identities = 64/188 (34%), Positives = 101/188 (53%), Gaps = 11/188 (5%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
+G+G FG V +G G++VA+K +K + F E +++++HHK+LV L+G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
+V E ++ L L +GR + L+ +L A+G+ YL K++HRD+
Sbjct: 71 NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDL 126
Query: 368 KAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFS 427
A NIL+ AKV+DFGLA++ S + V T APE K + KSDV+S
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSDVWS 182
Query: 428 FGVMLLEL 435
+GV+L E+
Sbjct: 183 YGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 2e-23
Identities = 65/191 (34%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG V G +VAIK LK GS E F AE ++ ++ H LV L T
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
++ E++ + +L L + + +A A+G+A++ + IHRD+
Sbjct: 73 -EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRDL 128
Query: 368 KAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF--GYLAPEYASSGKLTEKSDV 425
+AANIL+ K+ADFGLA+L D + R F + APE + G T KSDV
Sbjct: 129 RAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 426 FSFGVMLLELI 436
+SFG++L E++
Sbjct: 187 WSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRVHHKHLVSL 301
N +G G FG V+ V L G+ +A+K+++ + + E++++ + H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVK- 63
Query: 302 VGYYTAGSQRMLVC---EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
YY R V E+ + TLE L +D L +GLAYLH
Sbjct: 64 --YYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH- 118
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRV---MGTFGYLAPEYAS 415
I+HRDIK ANI LD K+ DFG A + T + V GT Y+APE +
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 416 SGKLTEK---SDVFSFGVMLLELIIGCRP 441
GK +D++S G ++LE+ G RP
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 3e-23
Identities = 75/198 (37%), Positives = 104/198 (52%), Gaps = 15/198 (7%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LGQG FG V G +VAIK LK G+ E F E +I+ ++ H LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL---YAV 69
Query: 308 GSQR--MLVCEFVTSNTL-EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
S+ +V EF+ +L +F G G+ + P + +A A G+AY+ IH
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIER---MNYIH 125
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF--GYLAPEYASSGKLTEK 422
RD++AANIL+ K+ADFGLA+L D + R F + APE A G+ T K
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 423 SDVFSFGVMLLELIIGCR 440
SDV+SFG++L EL+ R
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
+ + +G+G G V+K GKEVAIK+++ E + E+ I+ H ++V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVD 79
Query: 301 LVGYYTAGSQRMLVCEFVTSNTL----EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE 356
Y G + +V E++ +L + M+ P + +GL YLH
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGL-AKLASDVYTHVSTRVMGTFGYLAPEYAS 415
+IHRDIK+ NILL K+ADFG A+L + S V+GT ++APE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIK 189
Query: 416 SGKLTEKSDVFSFGVMLLELIIG 438
K D++S G+M +E+ G
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 247 LLGQGGFGYVHKGVLP-----NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+G FG V G+ VA+K+L+ + + R F+ E+EI+ + H ++V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 302 VGY-YTAGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
G Y+AG + + LV E++ +L +L K R +D L A KG+ YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSK-- 127
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMG---TFGYLAPEYASS 416
+ +HRD+ NIL++ + K+ DFGL K+ + R G F Y APE +
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTE 185
Query: 417 GKLTEKSDVFSFGVMLLELIIGC 439
K + SDV+SFGV+L EL
Sbjct: 186 SKFSVASDVWSFGVVLYELFTYS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 6e-23
Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 13/210 (6%)
Query: 246 NLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
+ LG G +G V++GV VA+K LK + + E F E ++ + H +LV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 70
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
T ++ EF+T L +L R ++ L +A + + YL + IH
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIH 127
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLAS-DVYT-HVSTRVMGTFGYLAPEYASSGKLTEK 422
RD+ A N L+ KVADFGL++L + D YT H + + APE + K + K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIK 185
Query: 423 SDVFSFGVMLLELII-GCRP---VDSTHTF 448
SDV++FGV+L E+ G P +D + +
Sbjct: 186 SDVWAFGVLLWEIATYGMSPYPGIDLSQVY 215
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 21/201 (10%)
Query: 248 LGQGGFGYVHK-GVLPNGKEVAIKQ--LKAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
+G+G G V K G+ VA+K+ L+ G E++ + H ++V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
+ GS +LV E++ S L L + RP + + KG+AY+H + I+H
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMHAN---GIMH 122
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASD----VYTH-VSTRVMGTFGYLAPE--YASSG 417
RD+K AN+L+ K+ADFGLA+L S+ +Y+H V+TR Y APE Y +
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR-----WYRAPELLYGAR- 176
Query: 418 KLTEKSDVFSFGVMLLELIIG 438
K D+++ G + EL+ G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-22
Identities = 86/288 (29%), Positives = 134/288 (46%), Gaps = 55/288 (19%)
Query: 247 LLGQGGFGYVHKGVL--PNGKE--VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSL 301
++G G FG V +G+L P KE VAIK LK G + +R F +E I+ + H +++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGK-GRPTMDWPTRLKIAL-GFAKGLAYLHEDCH 359
G T M++ E++ + L+ +L G + +L L G A G+ YL + +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFS---SYQLVGMLRGIAAGMKYLSDMNY 128
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASD----VYTHVSTRVMGTFGYLAPEYAS 415
+HRD+ A NIL++ E KV+DFGL+++ D YT ++ + APE +
Sbjct: 129 ---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIA 183
Query: 416 SGKLTEKSDVFSFGVMLLELI-IGCRPV--DSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472
K T SDV+SFG+++ E++ G RP S H M +AI DG
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM----------KAINDG------- 226
Query: 473 PKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRISQIVRTLE 513
+ + C +A C + RRPR IV L+
Sbjct: 227 ---------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 2e-22
Identities = 61/190 (32%), Positives = 94/190 (49%), Gaps = 9/190 (4%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG VH G +VAIK ++ G+ E F E +++ ++ H +LV L G T
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 308 GSQRMLVCEFVTSNTLEFHLHG-KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
+V E++ + L +L KG+ +W L + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 367 IKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
+ A N L+ KV+DFGLA+ + D YT S + PE + + KSDV
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 426 FSFGVMLLEL 435
+SFGV++ E+
Sbjct: 185 WSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-22
Identities = 61/191 (31%), Positives = 95/191 (49%), Gaps = 8/191 (4%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG V G N +VA+K LK G+ + F E ++ + H LV L T
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
++ E++ +L L + P + + A+G+AY+ + IHRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---IHRDL 129
Query: 368 KAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF--GYLAPEYASSGKLTEKSDV 425
+AAN+L+ K+ADFGLA++ D + R F + APE + G T KSDV
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 426 FSFGVMLLELI 436
+SFG++L E++
Sbjct: 188 WSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 60/197 (30%), Positives = 82/197 (41%), Gaps = 13/197 (6%)
Query: 247 LLGQGGFGYVHKG--VLPNGK--EVAIKQLKAGSGQG-ERVFQAEVEIISRVHHKHLVSL 301
LG G FG V +G GK VA+K LK+ F E I+ + H++L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
G M+V E +L L T A+ A G+ YL +
Sbjct: 62 YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---R 117
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLA---KLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
IHRD+ A NILL + K+ DFGL D Y + F + APE +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWCAPESLRTRT 176
Query: 419 LTEKSDVFSFGVMLLEL 435
+ SDV+ FGV L E+
Sbjct: 177 FSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 248 LGQGGFGYVHKGVLPNGKE----VAIKQ--LKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+G FG + L E V K+ L S + R E+ I+S + H ++++
Sbjct: 8 LGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 302 VGYYTAGSQRMLVCEFVTSNTL-EFHLHGKGRPTMDWPTRLKIALGF--AKGLAYLHEDC 358
++ + ++ E+ TL + + KG+ + + + F ++Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL---FEEEMVLWYLFQIVSAVSYIHKA- 120
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
I+HRDIK NI L K+ DFG++K+ Y+ T V+GT Y++PE K
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVK 177
Query: 419 LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478
KSD+++ G +L EL+ R TF N L I GN+ +V
Sbjct: 178 YNFKSDIWALGCVLYELLTLKR------TFDATNP--LNLVVKIVQGNYTPVVSV----- 224
Query: 479 YNHNEMARMVACAAACVRHSARRRPRISQIV 509
Y+ +E+ +V + ++ +RP +++
Sbjct: 225 YS-SELISLV---HSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 58/190 (30%), Positives = 93/190 (48%), Gaps = 6/190 (3%)
Query: 247 LLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSLVGYY 305
+G+G FG V+KGVL EVA+K ++ + F E EI+ + H ++V L+G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
+V E V +L L K + L+++L A G+ YL IHR
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESKN---CIHR 117
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASD-VYTHVSTRVMGTFGYLAPEYASSGKLTEKSD 424
D+ A N L+ K++DFG+++ +YT + APE + G+ T +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESD 177
Query: 425 VFSFGVMLLE 434
V+S+G++L E
Sbjct: 178 VWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 16/210 (7%)
Query: 240 DGFSDANLLGQGGFGYVHKGVLPNGKEV-AIKQLKAGSGQG--ERVFQAEVEIISRVHHK 296
+ + + LG+G G V K L N + A+K + +++ + E+EI
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSP 59
Query: 297 HLVSLVGYYTAGSQRML--VCEFVTSNTLEF---HLHGKGRPTMDWPTRLKIALGFAKGL 351
++V G + S + E+ +L+ + +G + KIA KGL
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVLKGL 118
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAP 411
+YLH KIIHRDIK +NILL K + K+ DFG ++ ++ ++ GT Y+AP
Sbjct: 119 SYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG---VSGELVNSLAGTFTGTSFYMAP 172
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
E + SDV+S G+ LLE+ P
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 61/189 (32%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
+G+G FG V G G +VA+K +K + + F AE +++++ H +LV L+G
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 308 GSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
+ +V E++ +L +L +GR + LK +L + + YL + +HRD
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRD 127
Query: 367 IKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 426
+ A N+L+ AKV+DFGL K AS V T APE K + KSDV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKSDVW 183
Query: 427 SFGVMLLEL 435
SFG++L E+
Sbjct: 184 SFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 27/210 (12%)
Query: 246 NLLGQGGFGYVHKGVL------PNGKEVAIKQL-KAGSGQGERVFQAEVEIISRVHHKHL 298
LG G FG V++G+ +VA+K L ++ S Q E F E I+S+ +H+++
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL------KIALGFAKGLA 352
V L+G R ++ E + L+ L + RP + P+ L A AKG
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLR-ENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKLASDVYT----HVSTRVMGT 405
YL E+ IHRDI A N LL K AK+ADFG+A+ D+Y R M
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR---DIYRASYYRKGGRAMLP 184
Query: 406 FGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++ PE G T K+DV+SFGV+L E+
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 31/213 (14%)
Query: 248 LGQGGFGYVHKG--VLPNGKE----VAIKQLK-AGSGQGERVFQAEVEIISRVHHKHLVS 300
LG+G FG V+KG PN + VAIK LK + ++ F+ E E++S + H ++V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 301 LVGYYTAGSQRMLVCEFVTSNTL-EFHL-------------HGKGRPTMDWPTRLKIALG 346
L+G T ++ E++ L EF + + ++D L IA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT- 405
A G+ YL +HRD+ A N L+ K++DFGL++ D+Y+ RV
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQSKS 186
Query: 406 ---FGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++ PE GK T +SD++SFGV+L E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 67/208 (32%), Positives = 89/208 (42%), Gaps = 33/208 (15%)
Query: 248 LGQGGFGYV----HKGVLPNGKEVAIKQLKAG----SGQGERVFQAEVEIISRVHHKHLV 299
LG G FG V HK +GK A+K L Q E V E I+ + H LV
Sbjct: 9 LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVL-NEKRILQSIRHPFLV 64
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGLAYLHE 356
+L G + S LV E+V L HL GR R ++ L YLH
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-ARFYAAQVVLALE----YLH- 118
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM---GTFGYLAPEY 413
I++RD+K N+LLD K+ DFG AK V R GT YLAPE
Sbjct: 119 --SLDIVYRDLKPENLLLDSDGYIKITDFGFAK-------RVKGRTYTLCGTPEYLAPEI 169
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
S + D ++ G+++ E++ G P
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 65/211 (30%), Positives = 107/211 (50%), Gaps = 16/211 (7%)
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGER-VFQAEVEIISRVHHKH 297
D LG G G V K + P GK +A+K ++ + + E++I+ + + +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 298 LVSLVG-YYTAGSQRMLVC-EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH 355
+V G +Y G + +C E++ +L+ + + + + KIA+ KGL YLH
Sbjct: 61 IVGFYGAFYNNG--DISICMEYMDGGSLD-KILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYTHVSTRVMGTFGYLAPEY 413
E H KIIHRD+K +NIL++ + + K+ DFG++ + S T V GT Y+APE
Sbjct: 118 EK-H-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPER 170
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRPVDS 444
+ KSD++S G+ L+EL G P
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 241 GFSDANLLGQGGFGYVHKGVLPNGKEV-AIKQ------LKAGSGQGERVFQAEVEIISRV 293
F ++G+G FG V + K++ A+K ++ GS + V E I+ +
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVR--NVLN-ERRILQEL 57
Query: 294 HHKHLVSLVGYYT-AGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGL 351
+H LV+L +Y+ + M LV + + L +HL K + + + + I L
Sbjct: 58 NHPFLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-QVKFWIC-EIVLAL 113
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KLASDVYTHVSTRVMGTFGYLA 410
YLH IIHRDIK NILLD + + DF +A K+ D T T GT GY+A
Sbjct: 114 EYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMA 167
Query: 411 PEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
PE + D +S GV E + G RP
Sbjct: 168 PEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 5e-21
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 30/206 (14%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRVHHKHLVSLVG 303
LG+G +G V+K G+ VA+K+++ + + E + E+ ++ + H ++V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-EGIPSTALREISLLKELKHPNIVKLLD 65
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ LV E+ + L+ +L + P + I +GLAY H H +I+
Sbjct: 66 VIHTERKLYLVFEYCDMD-LKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCHS--H-RIL 120
Query: 364 HRDIKAANILLDFKFEAKVADFGLAK---LASDVYTHVSTRVMGTFGYLAPE-------Y 413
HRD+K NIL++ K+ADFGLA+ + YTH V+ T Y APE Y
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV-TLWYRAPEILLGSKHY 176
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGC 439
+++ D++S G + E+I G
Sbjct: 177 STA------VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 11/208 (5%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQ--LKAGSGQGERVFQAEVEIISRVHHKHL 298
F+ +G+G FG V+K + + VAIK L+ + E + Q E++ +S+ ++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDI-QQEIQFLSQCRSPYI 61
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
G + GS+ ++ E+ + L G+ +D I GL YLHE+
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSC-LDLLKPGK--LDETYIAFILREVLLGLEYLHEE- 117
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
IHRDIKAANILL + + K+ADFG++ + + +T V GT ++APE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSG 174
Query: 419 LTEKSDVFSFGVMLLELIIGCRPVDSTH 446
EK+D++S G+ +EL G P+ H
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLH 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 23/211 (10%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGER----------VFQAEVEIISRVHH 295
L+G+G +G V+ + + G+ +A+KQ++ + R ++E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLE--FHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
++V +G+ T + E+V ++ +G+ + R +GLAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VRF-FTEQVLEGLAY 123
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPE 412
LH I+HRD+KA N+L+D K++DFG++K + D+Y + M G+ ++APE
Sbjct: 124 LHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 413 YASSGK--LTEKSDVFSFGVMLLELIIGCRP 441
S + K D++S G ++LE+ G RP
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 73/219 (33%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 246 NLLGQGGFGYVHKG----VLPNGKE---VAIKQLKAGSGQGERV-FQAEVEIISRVHHKH 297
N LG G FG V++G +L G VA+K L+ G+ E+ F E ++S +H +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGK-----GRPTMDWPTRLKIALGFAKGLA 352
+V L+G + ++ E + L +L G P + L I L AKG
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEA-----KVADFGLAKLASDVYTHVSTRVMGT-- 405
YL E H IHRD+ A N L+ K K+ DFGLA+ D+Y R G
Sbjct: 121 YL-EQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR---DIYKSDYYRKEGEGL 174
Query: 406 --FGYLAPEYASSGKLTEKSDVFSFGVMLLE-LIIGCRP 441
++APE GK T +SDV+SFGV++ E L +G +P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 11/199 (5%)
Query: 248 LGQGGFGYVHK-GVLPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
LG+GGFG V V GK A K+L + +GE++ E +I+ +V + +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ LV + L++H++ G P + A GL +LH+ +I+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117
Query: 364 HRDIKAANILLDFKFEAKVADFGLA-KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEK 422
+RD+K N+LLD +++D GLA +L GT GY+APE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYDFS 174
Query: 423 SDVFSFGVMLLELIIGCRP 441
D F+ G L E+I G P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-----RVFQAEVEIISRVHHKHLVS 300
LLG G FG V++G+ L +G A+K++ + + E+ ++S++ H ++V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGR---PTMDWPTRLKIALGFAKGLAYLHED 357
+G + E V +L L G P + TR GL YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHDR 121
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-----GTFGYLAPE 412
+HRDIK ANIL+D K+ADFG+AK V G+ ++APE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAPE 171
Query: 413 Y-ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
A G +D++S G +LE+ G P
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 5e-20
Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
+G G +G V+K + G+ VAIK +K G + Q E+ ++ H ++V+ G Y
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA------LGFAKGLAYLHEDCHP 360
+ +V E+ +L+ P + L+IA L KGLAYLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPL----SELQIAYVCRETL---KGLAYLHET--- 120
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR--VMGTFGYLAPEYA---S 415
IHRDIK ANILL + K+ADFG++ + ++ R +GT ++APE A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLT---ATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446
G K D+++ G+ +EL P+ H
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPPMFDLH 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 7e-20
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGER---VFQA--EVEIISRVHHKHLVSL 301
+G+G +G V+K G+ VA+K+++ + E+ A E++++ ++ H ++V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 302 VGYYT--AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK-IALGFAKGLAYLHEDC 358
T +V E++ + + + T ++K +GL YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES---QIKCYMKQLLEGLQYLH--- 117
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE------ 412
I+HRDIK +NIL++ K+ADFGLA+ + + T + T Y PE
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGAT 177
Query: 413 -YASSGKLTEKSDVFSFGVMLLELIIGCRPV 442
Y + D++S G +L EL +G +P+
Sbjct: 178 RY------GPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 8e-20
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 25/207 (12%)
Query: 248 LGQGGFGYVH----KGVLPNGKE--VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
LGQG FG V+ KGV+ + E VAIK + + ER+ F E ++ + H+V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHG-----KGRPTMDWPT---RLKIALGFAKGLA 352
L+G + G +++ E +T L+ +L + P P+ +++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT----FGY 408
YL+ + K +HRD+ A N ++ F K+ DFG+ + D+Y R G +
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYRKGGKGLLPVRW 187
Query: 409 LAPEYASSGKLTEKSDVFSFGVMLLEL 435
++PE G T SDV+SFGV+L E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 9/204 (4%)
Query: 242 FSDANLLGQGGFGYVHK-GVLPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKH 297
F +LG+GGFG V V GK A K+L + +GE + E +I+ +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
+VSL Y LV + L+FH++ G + + A GL LH++
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
+I++RD+K NILLD +++D GLA + T + RV GT GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 176
Query: 418 KLTEKSDVFSFGVMLLELIIGCRP 441
+ T D ++ G +L E+I G P
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 69/305 (22%)
Query: 232 YEELARATDGFSDANLLGQGGFGYVHKGV--LPNGKEVAIKQLKAGS-GQGER-VFQAEV 287
YE L +G+G FG V K V +GK + K++ G+ + E+ +EV
Sbjct: 2 YEVLET----------IGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV 50
Query: 288 EIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL-----EFHLHG----------KGR 332
I+ + H ++V YY R SN E+ G K R
Sbjct: 51 NILRELKHPNIV---RYY----DR----IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER 99
Query: 333 PTMDWPTRLKIALGFAKGLAYLHEDCH------PKIIHRDIKAANILLDFKFEAKVADFG 386
++ +I + L L+E CH ++HRD+K ANI LD K+ DFG
Sbjct: 100 KYIEEEFIWRI---LTQLLLALYE-CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155
Query: 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446
LAK+ + T V GT Y++PE + EKSD++S G ++ EL P +
Sbjct: 156 LAKILGHDSSFAKTYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR- 213
Query: 447 TFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRIS 506
++ L I++G F + P ++ E+ ++ + + +RP
Sbjct: 214 NQLQ-------LASKIKEGKFRRI--PYRYSS----ELNEVI---KSMLNVDPDKRPSTE 257
Query: 507 QIVRT 511
++++
Sbjct: 258 ELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 17/210 (8%)
Query: 247 LLGQGGFGYVHKGV-LPNGKE----VAIKQLKAGSGQGERVFQAEVE---IISRVHHKHL 298
LLG G FG VHKG+ +P G VAIK ++ SG+ + FQ + + + H ++
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR--QTFQEITDHMLAMGSLDHAYI 71
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
V L+G G+ LV + +L H+ + R ++D L + AKG+ YL E
Sbjct: 72 VRLLGI-CPGASLQLVTQLSPLGSLLDHVR-QHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLA-SDVYTHVSTRVMGTFGYLAPEYASSG 417
++HR++ A NILL ++ADFG+A L D + + ++A E G
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 418 KLTEKSDVFSFGVMLLELI-IGCRPVDSTH 446
+ T +SDV+S+GV + E++ G P
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 2e-19
Identities = 65/205 (31%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVF-QAEVEIISRVHHKHLVSLVGYY 305
+G G V+ + LPN ++VAIK++ Q + EV+ +S+ +H ++V +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWP-----TRLKIALGFAKGLAYLHEDCHP 360
G + LV +++ +L + P T LK L KGL YLH +
Sbjct: 69 VVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKEVL---KGLEYLHSNGQ- 123
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGL-AKLASDVYTHVSTR--VMGTFGYLAPEYASSG 417
IHRDIKA NILL K+ADFG+ A LA R +GT ++APE
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181
Query: 418 K-LTEKSDVFSFGVMLLELIIGCRP 441
K+D++SFG+ +EL G P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 70/207 (33%), Positives = 109/207 (52%), Gaps = 18/207 (8%)
Query: 247 LLGQGGFGYVHKGVL--PNGKE--VAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSL 301
++G G FG V +G L P +E VAIK LK+G + + R F +E I+ + H +++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 302 VGYYTAGSQRMLVCEFVTSNTLE-FHLHGKGRPTMDWPTRLKIAL-GFAKGLAYLHEDCH 359
G T M++ EF+ + L+ F G+ T +L L G A G+ YL E +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFT---VIQLVGMLRGIAAGMKYLSEMNY 127
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMG---TFGYLAPEYAS 415
+HRD+ A NIL++ KV+DFGL++ L D T +G + APE +
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 416 SGKLTEKSDVFSFGVMLLELI-IGCRP 441
K T SDV+S+G+++ E++ G RP
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 9/207 (4%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKEV-AIKQLKAGSGQGE-RVFQAEVEIISRVHHKHLV 299
F+ +G+G FG V KG+ ++V AIK + + E Q E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
G Y G++ ++ E++ + L T LK L KGL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSE-- 120
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
K IHRDIKAAN+LL + + K+ADFG+A +D +T V GT ++APE
Sbjct: 121 -KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAY 178
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTH 446
K+D++S G+ +EL G P H
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMH 205
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 23/208 (11%)
Query: 248 LGQGGFGYVH----KGVLPNGKE--VAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+G FG V +LP + VA+K LK S + FQ E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLH-----------GKGRP--TMDWPTRLKIALGFA 348
G T G ++V E++ L L G+ + L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFG 407
G+ YL H +HRD+ N L+ K+ DFG+++ + S Y V R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 408 YLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++ PE K T +SD++SFGV+L E+
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 35/211 (16%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV---FQA--EVEIISRVHHKHLV 299
LG+G + V+K G+ VAIK++K G + + F A E++++ + H +++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK-IALGFAKGLAYLHEDC 358
L+ + S LV EF+ ++ LE + K P +K L +GL YLH +
Sbjct: 66 GLLDVFGHKSNINLVFEFMETD-LEKVIKDKSIVLT--PADIKSYMLMTLRGLEYLHSN- 121
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTH-VSTRVMGTFGYLAPE-- 412
I+HRD+K N+L+ K+ADFGLA+ + TH V TR Y APE
Sbjct: 122 --WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----YRAPELL 174
Query: 413 -----YASSGKLTEKSDVFSFGVMLLELIIG 438
Y D++S G + EL++
Sbjct: 175 FGARHYGVG------VDMWSVGCIFAELLLR 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-19
Identities = 76/270 (28%), Positives = 123/270 (45%), Gaps = 32/270 (11%)
Query: 247 LLGQGGFGYVHKGVLPNG-KEVAIKQLKA-GSGQGER-VFQAEVEIISRVHHKHLVSLVG 303
++G+G FG VH K V IKQ+ + ER Q E +++ + H +++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ M+V E+ TL ++ + +D T L F + L LH I+
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF---FVQILLALHHVHTKLIL 123
Query: 364 HRDIKAANILLD-FKFEAKVADFGLAKL---ASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
HRD+K NILLD K K+ DFG++K+ S YT V+GT Y++PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-----VVGTPCYISPELCEGKPY 178
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479
+KSD+++ G +L EL R F NL P L I G F + D Y
Sbjct: 179 NQKSDIWALGCVLYELASLKR------AFEAANL--PALVLKIMSGTFAPISD-----RY 225
Query: 480 NHNEMARMVACAAACVRHSARRRPRISQIV 509
+ ++ +++ + + +RP++SQI+
Sbjct: 226 S-PDLRQLI---LSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 4e-19
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 25/218 (11%)
Query: 248 LGQGGFGYVHKGVL----PN----GKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHL 298
LG+G FG V L P G+ VA+K LK GQ ++ E+ I+ ++H+++
Sbjct: 12 LGEGHFGKV---SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 299 VSLVGYYTAGSQR--MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE 356
V G + + L+ E+V +L +L + ++ L A +G+AYLH
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMG---TFGYLAPEY 413
IHRD+ A N+LLD K+ DFGLAK + + + R G F Y A E
Sbjct: 126 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVEC 181
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHT-FME 450
K + SDV+SFGV L EL+ C S F E
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE 219
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 67/204 (32%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 242 FSDANLLGQGGFGYVHK-GVLPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKH 297
F +LG+GGFG V V GK A K+L + +GE + E I+ +V+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
+VSL Y LV + L+FH++ G P D + A GL L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
+I++RD+K NILLD + +++D GLA + T V RV GT GY+APE ++
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNE 176
Query: 418 KLTEKSDVFSFGVMLLELIIGCRP 441
K T D + G ++ E+I G P
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 70/209 (33%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 246 NLLGQGGFGYVHKGVL--PNGKEV--AIKQLKAGSGQGE-RVFQAEVEIISRVHHKHLVS 300
++G+G FG V+ G L +G+++ A+K L + E F E I+ H +++S
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTR---LKIALGF----AKGLAY 353
L+G L E L + HG R + T +K +GF AKG+ Y
Sbjct: 61 LLGI-------CLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY------THVSTRVMGTFG 407
L K +HRD+ A N +LD F KVADFGLA+ D+Y H T
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLAR---DIYDKEYYSVHNHTGAKLPVK 167
Query: 408 YLAPEYASSGKLTEKSDVFSFGVMLLELI 436
++A E + K T KSDV+SFGV+L EL+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 5e-19
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQ--LKAGSGQGER-------VFQAEVEIISRVHHK 296
L+G G FG V+ G+ +G+ +A+KQ L + S + E+ ++ + H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 297 HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE 356
++V +G + E+V ++ L+ G + KGL YLH
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHN 124
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR-----VMGTFGYLAP 411
IIHRDIK ANIL+D K K++DFG++K T + G+ ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
E T K+D++S G +++E++ G P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-18
Identities = 70/275 (25%), Positives = 126/275 (45%), Gaps = 24/275 (8%)
Query: 244 DANLLGQGGFGYVHKG-VLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLV 302
+ N++ +G G +KG + NG + +K++ + +E+ + ++ H ++V L+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEIN----DVNSIPSSEIADMGKLQHPNIVKLI 749
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
G + L+ E++ L L + W R KIA+G AK L +LH C P +
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEK 422
+ ++ I++D K E + L +D +S+ Y+APE + +TEK
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS------AYVAPETRETKDITEK 858
Query: 423 SDVFSFGVMLLELIIGCRPVDSTHTFMED--NLARPLLNRAIEDGNFDTLVDP--KLHNE 478
SD++ FG++L+EL+ G P D+ AR D + D +DP +
Sbjct: 859 SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR----YCYSDCHLDMWIDPSIRGDVS 914
Query: 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
N NE+ ++ A C RP + +++TLE
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 61/209 (29%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 248 LGQGGFGYVH---KGVLPNGKEVAIKQLKAGSGQGERVFQ---AEVEIISRVHHKHLVSL 301
+ +G +G V K G AIK +K + E +I+S+ ++V L
Sbjct: 1 ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 302 VGYYT-AGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
YY+ G + + LV E++ L L G D R+ IA L YLH +
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-ARIYIA-EIVLALEYLHSN-- 112
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLAS-------DVYTHVSTRVMGTFGYLAPE 412
IIHRD+K NIL+D K+ DFGL+K+ + R++GT Y+APE
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
++ D +S G +L E ++G P
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 61/191 (31%), Positives = 99/191 (51%), Gaps = 9/191 (4%)
Query: 247 LLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSLVGYY 305
LLG+G FG V KG L + VA+K K Q ++ F +E I+ + H ++V L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH-EDCHPKIIH 364
T +V E V L K + + +K AL A G+AYL ++C IH
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASD-VYTHVSTRVMGTFGYLAPEYASSGKLTEKS 423
RD+ A N L+ K++DFG+++ D +Y+ + + + APE + G+ + +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSES 175
Query: 424 DVFSFGVMLLE 434
DV+S+G++L E
Sbjct: 176 DVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 79/274 (28%), Positives = 130/274 (47%), Gaps = 37/274 (13%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG V G +VAIK +K GS E F E +++ ++ H+ LV L G T
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 308 GSQRMLVCEFVTSNTLEFHL--HGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
+V E++++ L +L HGK R L++ +G+AYL + IHR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGK-RFQPS--QLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 366 DIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGT---FGYLAPEYASSGKLTE 421
D+ A N L+D + KV+DFGL++ + D Y T +G+ + PE K +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEY----TSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 422 KSDVFSFGVMLLELI-IGCRPVDS-THTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479
KSDV++FGV++ E+ +G P + ++ + +++ L L P L +E
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-----------RLYRPHLASE- 228
Query: 480 NHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
++ A +C A RP Q++ ++E
Sbjct: 229 ------KVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 242 FSDANLLGQGGFGYVHK-GVLPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKH 297
F +LG+GGFG V V GK A K+L + +GE + E +I+ +V+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
+VSL Y LV + L+FH++ G P D + A GL LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
+I++RD+K NILLD +++D GLA + T + RV GT GY+APE +
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNE 176
Query: 418 KLTEKSDVFSFGVMLLELIIGCRP 441
+ T D + G ++ E+I G P
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 67/206 (32%), Positives = 110/206 (53%), Gaps = 18/206 (8%)
Query: 247 LLGQGGFGYVHKGVL--PNGKE--VAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSL 301
++G G FG V G L P +E VAIK LKAG + + R F +E I+ + H +++ L
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 302 VGYYTAGSQRMLVCEFVTSNTLE-FHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
G T M+V E++ + +L+ F G+ T+ + + G A G+ YL + +
Sbjct: 71 EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTV--IQLVGMLRGIASGMKYLSDMGY- 127
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASD----VYTHVSTRVMGTFGYLAPEYASS 416
+HRD+ A NIL++ KV+DFGL+++ D YT ++ + APE +
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPEAIAY 183
Query: 417 GKLTEKSDVFSFGVMLLELI-IGCRP 441
K T SDV+S+G+++ E++ G RP
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 66/204 (32%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 242 FSDANLLGQGGFGYV-HKGVLPNGKEVAIKQLKAGSGQGERVFQ---AEVEIISRVHHKH 297
F+D +G G FG V + + VAIK++ Q +Q EV + ++ H +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 298 LVSLVGYYTAGSQRMLVCEFV---TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354
+ G Y LV E+ S+ LE H + + I G +GLAYL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVH-----KKPLQEVEIAAICHGALQGLAYL 131
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY- 413
H IHRDIKA NILL K+ADFG A L S + V GT ++APE
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVI 183
Query: 414 --ASSGKLTEKSDVFSFGVMLLEL 435
G+ K DV+S G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 68/205 (33%), Positives = 106/205 (51%), Gaps = 20/205 (9%)
Query: 248 LGQGGFGYVH------KGVLPNGKEVAIKQLKAGSGQGERV--FQAEVEIISRVHHKHLV 299
LG+G FG V +G G++VA+K LK SG G + + E+EI+ ++H+++V
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIV 69
Query: 300 SLVGYYT--AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
G T G+ L+ EF+ S +L+ +L + + ++ +LK A+ KG+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD---VYTHVSTRVMGTFGYLAPEYA 414
+ +HRD+ A N+L++ + + K+ DFGL K YT F Y APE
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGC 439
K SDV+SFGV L EL+ C
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYC 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 62/191 (32%), Positives = 95/191 (49%), Gaps = 9/191 (4%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG V +VA+K +K GS E F AE ++ + H LV L T
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVTK 72
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
++ EF+ +L L P + + A+G+A++ + + IHRD+
Sbjct: 73 -EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDL 128
Query: 368 KAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF--GYLAPEYASSGKLTEKSDV 425
+AANIL+ K+ADFGLA++ D + R F + APE + G T KSDV
Sbjct: 129 RAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 426 FSFGVMLLELI 436
+SFG++L+E++
Sbjct: 187 WSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 69/273 (25%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 241 GFSDANLLGQGGFGYVHK-GVLPNGKEVAIKQLKAGS-GQGERVFQA-EVEIISRVHHKH 297
F LG+G +G V+K L + + A+K++ GS Q ER E+ I++ V+H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAKGLAYLH 355
++S + G++ +V E+ L + + + P + +I + +GL LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS 415
E KI+HRD+K+ANILL K+ D G++K+ +GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT---QIGTPHYMAPEVWK 174
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475
+ KSD++S G +L E+ P ++ M+D L ++ G + P +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARS--MQD------LRYKVQRGKY-----PPI 221
Query: 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQI 508
Y+ ++ + + ++ + RP +I
Sbjct: 222 PPIYS-QDLQNFI---RSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 21/203 (10%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA--EVEIISRVHHKHLVSLVGY 304
+G+G +G V+K G+ VAIK++K A E++++ ++H +++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK-IALGFAKGLAYLHEDCHPKII 363
+ LV EF+ ++ + K R + +K +GLA+ H I+
Sbjct: 67 FRHKGDLYLVFEFMDTDLYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCHSH---GIL 120
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLA---SDVYTH-VSTRVMGTFGYLAPE-YASSGK 418
HRD+K N+L++ + K+ADFGLA+ YTH V TR Y APE
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKG 175
Query: 419 LTEKSDVFSFGVMLLELIIGCRP 441
+ D++S G + EL+ RP
Sbjct: 176 YSTPVDIWSVGCIFAELLSR-RP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 45/229 (19%)
Query: 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQL---------KAGSGQGERVFQAEVEIIS 291
F ++G+G F V KE AIK L K + E+ E+++
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK------EVLT 56
Query: 292 RV-HHKHLVSLVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA 348
R+ H ++ L YYT + L V E+ + L ++ G TR A
Sbjct: 57 RLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRFYAAE-IL 112
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM----- 403
L YLH IIHRD+K NILLD K+ DFG AK+ + S +
Sbjct: 113 LALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 404 --------------GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIG 438
GT Y++PE + + SD+++ G ++ +++ G
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-18
Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 248 LGQGGFGYVHKGV------LPNGKEVAIKQLKAGSGQGE-RVFQAEVEIISRVHHKHLVS 300
LG+G FG V K VA+K LK + E R +E ++ +V+H H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLH-------------GKGRPTMDW-----PTRLK 342
L G + +L+ E+ +L L G + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 343 IALGFA----KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398
+ FA +G+ YL E K++HRD+ A N+L+ + K++DFGL++ DVY
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR---DVYEED 181
Query: 399 S--TRVMGTF--GYLAPEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
S R G ++A E T +SDV+SFGV+L E++ +G P
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 9/207 (4%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKEV-AIKQLKAGSGQGE-RVFQAEVEIISRVHHKHLV 299
F+ +G+G FG V+KG+ KEV AIK + + E Q E+ ++S+ ++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
G Y G++ ++ E++ + L T L+ L KGL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSE-- 120
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
+ IHRDIKAAN+LL + + K+ADFG+A +D +T V GT ++APE
Sbjct: 121 -RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTH 446
K+D++S G+ +EL G P H
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLH 205
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 6e-18
Identities = 61/193 (31%), Positives = 97/193 (50%), Gaps = 11/193 (5%)
Query: 248 LGQGGFGYVHKGVLPNGK---EVAIKQLKAGSGQGER-VFQAEVEIISRVHHKHLVSLVG 303
LG G FG V KGV K +VAIK LK + + R E EI+ ++ + ++V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
A + MLV E + L L GK + + +++ + G+ YL +
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFV 117
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKL--ASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
HRD+ A N+LL + AK++DFGL+K A D Y + + APE + K +
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177
Query: 422 KSDVFSFGVMLLE 434
+SDV+S+G+ + E
Sbjct: 178 RSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 13/195 (6%)
Query: 248 LGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
LG G FG V+K G A K ++ S + F E++I+S H ++V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
++ ++ EF L+ + R + P + + L +LH K+IHRD
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSH---KVIHRD 128
Query: 367 IKAANILLDFKFEAKVADFGL-AKLASDVYTHVSTRVMGTFGYLAPEYA-----SSGKLT 420
+KA NILL + K+ADFG+ AK S + + +GT ++APE
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNPYD 186
Query: 421 EKSDVFSFGVMLLEL 435
K+D++S G+ L+EL
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQG-ERVFQAEVEIISRVHHKHLVSLVGYY 305
LG G G V K +P G +A K + G+ + E++I+ ++VS G +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL----KIALGFAKGLAYLHEDCHPK 361
+ + EF+ +L+ G P + KIA+ +GL YL+
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVHR-- 124
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
I+HRDIK +NIL++ + + K+ DFG++ ++ ++ +GT Y++PE GK T
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 422 KSDVFSFGVMLLELIIGCRPVD 443
KSDV+S G+ ++EL +G P
Sbjct: 182 KSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 58/201 (28%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 247 LLGQGGFGYVHKGV--LPNGKE--VAIKQLKAGSGQGER-VFQAEVEIISRVHHKHLVSL 301
+G+G FG V++GV P ++ VA+K K + R F E I+ + H H+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+G T + +V E L +L + ++D + + + + LAYL +
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQ-VNKYSLDLASLILYSYQLSTALAYLESK---R 127
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
+HRDI A N+L+ K+ DFGL++ D + +++ ++APE + + T
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 422 KSDVFSFGVMLLE-LIIGCRP 441
SDV+ FGV + E L++G +P
Sbjct: 188 ASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 7e-18
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-----RVFQAEVEIISRVHHKHLVS 300
LLGQG FG V+ + G+E+A+KQ+ E + E++++ + H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
G + E++ +++ L G + TR K +G+ YLH +
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTR-KYTRQILEGVEYLHSN--- 123
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS--TRVMGTFGYLAPEYASSGK 418
I+HRDIK ANIL D K+ DFG +K + + + V GT +++PE S
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 419 LTEKSDVFSFGVMLLELI 436
K+DV+S G ++E++
Sbjct: 184 YGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 9e-18
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 242 FSDANLLGQGGFGYVHK-GVLPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKH 297
F +LG+GGFG V V GK A K+L + +GE + E +I+ +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
+V+L Y LV + L+FH++ G P + L A GL LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLA-KLASDVYTHVSTRVMGTFGYLAPEYASS 416
++RD+K NILLD +++D GLA K+ + RV GT GY+APE ++
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRV-GTVGYMAPEVLNN 175
Query: 417 GKLTEKSDVFSFGVMLLELIIGCRP 441
+ T D + G ++ E+I G P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 30/220 (13%)
Query: 248 LGQGGFGYVHK----------GVLPNGKE-----VAIKQLKAGSGQGERV-FQAEVEIIS 291
LG+G FG VH G + VA+K L+A + R F E++I+S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 292 RVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHL----------HGKGRPTMDWPTRL 341
R+ + +++ L+G + ++ E++ + L L H P++ L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 342 KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVST 400
+A+ A G+ YL +HRD+ N L+ + K+ADFG+++ L S Y +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCR 440
R + ++A E GK T SDV++FGV L E+ C+
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 68/222 (30%), Positives = 99/222 (44%), Gaps = 19/222 (8%)
Query: 247 LLGQGGFGYVHKGVLPNGKEV-AIKQLKAGS-GQGERV--FQAEVEIISRV-HHKHLVSL 301
+LG+G FG V L E+ A+K LK Q + V E +++ H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ + V E+V L FH+ GR D P A GL +LHE
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFLHER---G 116
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYASSGKLT 420
II+RD+K N+LLD + K+ADFG+ K + V+T GT Y+APE S
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPYG 174
Query: 421 EKSDVFSFGVMLLELIIGCRPVDST------HTFMEDNLARP 456
D ++ GV+L E++ G P + + +ED + P
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 67/208 (32%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 248 LGQGGFGYV----HKGVLPNGKEVAIKQLKAG---------SGQGE-RVFQAEVEIISRV 293
LG+G FG V +K G+ AIK LK G S E R+F E +
Sbjct: 7 LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIF----ETANSE 59
Query: 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
H LV+L + V E+ L H+H P + A GL Y
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQY 116
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY 413
LHE+ KI++RD+K N+LLD + K+ADFGL K ST GT +LAPE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEV 172
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ T D + GV++ E+++G P
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 76/270 (28%), Positives = 116/270 (42%), Gaps = 31/270 (11%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG VH G +VAIK + G+ E F E +++ ++ H LV L G T
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 308 GSQRMLVCEFVTSNTLEFHL---HGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
+V EF+ + L +L GK M L + +G+ YL + IH
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEYLERN---SFIH 123
Query: 365 RDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKS 423
RD+ A N L+ KV+DFG+ + + D YT S+ + PE + K + KS
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 424 DVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHN 482
DV+SFGV++ E+ G P + + N + I G L PKL + +
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEK-----KSNYE---VVEMISRGF--RLYRPKLASMTVYE 232
Query: 483 EMARMVACAAACVRHSARRRPRISQIVRTL 512
M C RP ++++R +
Sbjct: 233 VMYS-------CWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 247 LLGQGGFGYVHKG-VLPNGKEVAIKQLKAGSGQGE--RVFQAEVEIISRVHHKHLVSLVG 303
++G+G +G V K G+ VAIK+ K + + EV+++ ++ H+++V+L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPT-MDWPTRLKIALGFAKGLAYLHEDCHPKI 362
+ + LV E+V LE + P + + +AY H I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSH---NI 121
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKL----ASDVYT-HVSTRVMGTFGYLAPE----Y 413
IHRDIK NIL+ K+ DFG A+ + T +V+TR Y APE
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR-----WYRAPELLVGD 176
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ GK DV++ G ++ EL+ G P
Sbjct: 177 TNYGK---PVDVWAIGCIMAELLDG-EP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 16/210 (7%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQL------KAGSGQGERVFQAEVEIISRVHHKHLV 299
+LG+G +G V+ G+ G+ +A+KQ+ + + Q EV+++ + H ++V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
+G + + EFV ++ L+ G + P K G+AYLH +C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC- 122
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-----GTFGYLAPEYA 414
++HRDIK N++L K+ DFG A+ + V H + M GT ++APE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRPVDS 444
+ KSD++S G + E+ G P+ S
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 6e-17
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 248 LGQGGFGYVHKGVLPN------GKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
LGQG FG V++G + VA+K + + ER+ F E ++ H+V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHL--------HGKGRPTMDWPTRLKIALGFAKGLA 352
L+G + G ++V E + L+ +L + GRP +++A A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT----FGY 408
YL+ K +HRD+ A N ++ F K+ DFG+ + D+Y R G +
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR---DIYETDYYRKGGKGLLPVRW 187
Query: 409 LAPEYASSGKLTEKSDVFSFGVMLLEL 435
+APE G T SD++SFGV+L E+
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 85/299 (28%), Positives = 127/299 (42%), Gaps = 54/299 (18%)
Query: 166 QPPRPAPP-----HPVASRPPHSPVYT-PSP----------PPPPPFMSSSGGSSSNYSG 209
QPP P H SRP P T P P P PPP SSS SSS+ SG
Sbjct: 5 QPPPGVPLPSTARHTTKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASG 64
Query: 210 SEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVA 268
S EL R N +G G G V+K + P G+ A
Sbjct: 65 SAPSAAKS--------------LSELERV-------NRIGSGAGGTVYKVIHRPTGRLYA 103
Query: 269 IKQLKAGSGQG-ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHL 327
+K + R E+EI+ V+H ++V + + ++ EF+ +LE
Sbjct: 104 LKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--- 160
Query: 328 HGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL 387
G D +A G+AYLH I+HRDIK +N+L++ K+ADFG+
Sbjct: 161 ---GTHIADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGV 214
Query: 388 AKLASDVYTHVSTRVMGTFGYLAPEYASS----GKLTEKS-DVFSFGVMLLELIIGCRP 441
+++ + ++ V GT Y++PE ++ G + D++S GV +LE +G P
Sbjct: 215 SRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 64/217 (29%), Positives = 107/217 (49%), Gaps = 26/217 (11%)
Query: 248 LGQGGFGYVHKG--VLP---NGKEVAIKQLK-AGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+ FG ++KG LP + + VAIK LK + Q FQ E +++ +HH ++V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 302 VGYYTAGSQRMLVCEFVTSNTL-EFHL--------------HGKGRPTMDWPTRLKIALG 346
+G T ++ E++ L EF + G + ++D L IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGT 405
A G+ YL +H+D+ A NIL+ + K++D GL++ + S Y V + +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 406 FGYLAPEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
++ PE GK + SD++SFGV+L E+ G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 16/223 (7%)
Query: 248 LGQGGFGYV------HKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+GGFG V + G + K++ K+LK SG E++ E EI+ +V+ +V+L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSG--EKMALLEKEILEKVNSPFIVNL 58
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ + + LV + L++H++ G ++ + + G+ +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
I++RD+K N+LLD + +++D GLA D T T+ GT GY+APE +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYSY 173
Query: 422 KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIED 464
D F+ G + E++ G P E L R +ED
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKD---HKEKVAKEELKRRTLED 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 248 LGQGGFGYVHK----GVLPNGKE--VAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVS 300
+GQG FG V + G+LP VA+K LK S + FQ E +++ H ++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 301 LVGYYTAGSQRMLVCEFV--------------------TSNTLEFHLHGKGRPTMDWPTR 340
L+G G L+ E++ + +T G + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 341 LKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KLASDVYTHVS 399
L IA A G+AYL E K +HRD+ N L+ K+ADFGL+ + S Y S
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++ PE + T +SDV+++GV+L E+
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 28/212 (13%)
Query: 246 NLLGQGGFGYVHKG-VLPNG--KEVAIKQLKAGSGQGE-RVFQAEVEIISRV-HHKHLVS 300
+++G+G FG V K + +G + AIK++K + + + R F E+E++ ++ HH ++++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 301 LVGYYTAGSQRMLVCEFV----------TSNTLE----FHLHGKGRPTMDWPTRLKIALG 346
L+G L E+ S LE F + T+ L A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
A+G+ YL + + IHRD+ A NIL+ + AK+ADFGL++ +VY + MG
Sbjct: 133 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV---KKTMGRL 185
Query: 407 G--YLAPEYASSGKLTEKSDVFSFGVMLLELI 436
++A E + T SDV+S+GV+L E++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 30/213 (14%)
Query: 246 NLLGQGGFGYVHKGVLP---NGKEVAIKQLKA-GSGQGERVFQAEVEIISRV-HHKHLVS 300
+++G+G FG V + ++ AIK LK S R F E+E++ ++ HH ++++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 301 LVGYYTAGSQRMLVCEFVT-SNTLEF--------------HLHGKGRPTMDWPTRLKIAL 345
L+G + E+ N L+F HG T+ L+ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAS-TLTSQQLLQFAS 126
Query: 346 GFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT 405
A G+ YL E + IHRD+ A N+L+ +K+ADFGL++ +VY + MG
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-GEEVYV---KKTMGR 179
Query: 406 FG--YLAPEYASSGKLTEKSDVFSFGVMLLELI 436
++A E + T KSDV+SFGV+L E++
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 65/227 (28%), Positives = 96/227 (42%), Gaps = 43/227 (18%)
Query: 248 LGQGGFGYVH------------KGVLPNGKE-----VAIKQLKAGSGQGERV-FQAEVEI 289
LG+G FG VH K N VA+K L+ + R F EV+I
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 290 ISRVHHKHLVSLVG-------------YYTAG--SQRMLVCEFVTSNTLEFHLHGKGRPT 334
+SR+ ++ L+G Y G +Q + TS +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC------NSKS 126
Query: 335 MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASD 393
+ + T L +A A G+ YL +HRD+ N L+ + K+ADFG+++ L S
Sbjct: 127 LSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS 183
Query: 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCR 440
Y V R ++A E GK T KSDV++FGV L E++ CR
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCR 230
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 4e-16
Identities = 67/209 (32%), Positives = 107/209 (51%), Gaps = 13/209 (6%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEV----AIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
+LG G FG V+KG+ +P G+ V AIK L +G V F E I++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
L+G + + + LV + + L ++H + + + L + AKG+ YL E
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVH-EHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
+++HRD+ A N+L+ K+ DFGLA+ L D + + ++A E K
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 420 TEKSDVFSFGVMLLELI-IGCRPVDSTHT 447
T +SDV+S+GV + EL+ G +P D T
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPT 217
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 248 LGQGGFGYVH----KGVLPNGKE--VAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+G FG V + P + VA+K LK S + F E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHL--HG-------KGRPTMDWPTR--LKIALGFAKG 350
G G ++V E++ L L HG +G + L IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 351 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYL 409
+ YL +HRD+ N L+ K+ DFG+++ + S Y V M ++
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 410 APEYASSGKLTEKSDVFSFGVMLLEL 435
PE K T +SDV+S GV+L E+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 69/204 (33%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKEV-AIKQLKAGSGQGERVFQ---AEVEIISRVHHKH 297
F+D +G G FG V+ EV AIK++ Q +Q EV+ + R+ H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 298 LVSLVGYYTAGSQRMLVCEFV---TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354
+ G Y LV E+ S+ LE H +P + I G +GLAYL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA-AITHGALQGLAYL 141
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY- 413
H +IHRDIKA NILL + K+ADFG A +AS + V GT ++APE
Sbjct: 142 HSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVI 193
Query: 414 --ASSGKLTEKSDVFSFGVMLLEL 435
G+ K DV+S G+ +EL
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 70/231 (30%), Positives = 106/231 (45%), Gaps = 22/231 (9%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-RVFQAEVEIISRVHHKHLV 299
F+ +G+G FG V KG+ K VAIK + + E Q E+ ++S+ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
G Y ++ ++ E++ + L T L+ L KGL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 120
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
K IHRDIKAAN+LL E K+ADFG+A +D +T V GT ++APE
Sbjct: 121 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAY 178
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTHTF-------------MEDNLARPL 457
K+D++S G+ +EL G P H +E N ++PL
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 229
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 62/201 (30%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 248 LGQGGFGYVHKGVLPN-GKE-----VAIKQLKAGSGQGER-VFQAEVEIISRV-HHKHLV 299
LG G FG V + K VA+K LK + ER +E++I+S + +H+++V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL-HEDC 358
+L+G T G +++ E+ L L K + L + AKG+A+L ++C
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC 162
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT----FGYLAPEYA 414
IHRD+ A N+LL K+ DFGLA+ D+ + V G ++APE
Sbjct: 163 ----IHRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 415 SSGKLTEKSDVFSFGVMLLEL 435
+ T +SDV+S+G++L E+
Sbjct: 216 FNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 25/207 (12%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHH---KHLVSL 301
L+G+G +G V++G +P G+ VA+K + + + Q EV ++S++ ++
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK---IALGFAK---GLAYLH 355
G Y G + ++ E + G T+ + I++ + L Y+H
Sbjct: 68 YGSYLKGPRLWIIME---------YAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIH 118
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS 415
+ +IHRDIKAANIL+ K+ DFG+A L + + ST V GT ++APE +
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVIT 174
Query: 416 SGKLTE-KSDVFSFGVMLLELIIGCRP 441
GK + K+D++S G+ + E+ G P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 24/209 (11%)
Query: 248 LGQGGFGYVH----KGVLPNGKE--VAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+G FG V + P + VA+K LK + + FQ E E+++ + H+H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHL--HG-------KGRP-----TMDWPTRLKIALGF 347
G G ++V E++ L L HG G+P + L IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTF 406
A G+ YL +HRD+ N L+ K+ DFG+++ + S Y V M
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++ PE K T +SDV+SFGV+L E+
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 247 LLGQGGFG--YVHKGVLPNGKEVAIKQLK---AGSGQGERVFQA---EVEIISRVHHKHL 298
LG G F Y + V G +A+KQ+ S + E V +A E+ +++R++H H+
Sbjct: 7 QLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
+ ++G S L E++ ++ L G + +GL+YLHE+
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN- 122
Query: 359 HPKIIHRDIKAANILLDFKFE-AKVADFGLA-KLASDVY--THVSTRVMGTFGYLAPEYA 414
+IIHRD+K AN+L+D + ++ADFG A +LA+ +++GT ++APE
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ DV+S G +++E+ P
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 65/204 (31%), Positives = 95/204 (46%), Gaps = 23/204 (11%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKE-VAIKQLKAGSGQGERVFQ---AEVEIISRVHHKH 297
F + +G G FG V+ + E VA+K++ Q +Q EV+ + ++ H +
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 298 LVSLVGYYTAGSQRMLVCEFV---TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354
+ G Y LV E+ S+ LE H +P + I G +GLAYL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA-AITHGALQGLAYL 137
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY- 413
H +IHRDIKA NILL + K+ADFG A +S + V GT ++APE
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVI 189
Query: 414 --ASSGKLTEKSDVFSFGVMLLEL 435
G+ K DV+S G+ +EL
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 73/223 (32%), Positives = 97/223 (43%), Gaps = 24/223 (10%)
Query: 247 LLGQGGFGYVHKGVLPNGKEV-AIKQLKAGSGQGERVFQ---AEVEIISR------VHHK 296
+LG+G FG V L E AIK LK + V + E ++ R H
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKK-----DVVLEDDDVECTMVERRVLALAWEHP 56
Query: 297 HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE 356
L L + V E++ L FH+ GR D A GL +LH+
Sbjct: 57 FLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHK 114
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS 416
II+RD+K N+LLD K+ADFG+ K + ST GT Y+APE
Sbjct: 115 K---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEILKG 170
Query: 417 GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459
K E D +SFGV+L E++IG P H ED L +LN
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPF---HGEDEDELFDSILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 78/273 (28%), Positives = 128/273 (46%), Gaps = 37/273 (13%)
Query: 247 LLGQGGFGYVHKGVL--PNGKE--VAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSL 301
+LG G FG + +G L P+ +E VAI L+AG S + R F AE + + H ++V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
G T G+ M+V E++++ L+ L K + + + G A G+ YL E +
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMGMLPGLASGMKYLSEMGY-- 128
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASD----VYTHVSTRVMGTFGYLAPEYASSG 417
+H+ + A +L++ K++ F +L D +YT +S + + APE
Sbjct: 129 -VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL--WAAPEAIQYH 183
Query: 418 KLTEKSDVFSFGVMLLELI-IGCRPV-DSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475
+ SDV+SFG+++ E++ G RP D + +D + +A+EDG L P+
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVI------KAVEDGF--RLPAPRN 232
Query: 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQI 508
H M C + RPR SQI
Sbjct: 233 CPNLLHQLMLD-------CWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 75/300 (25%), Positives = 126/300 (42%), Gaps = 51/300 (17%)
Query: 230 FTYEELARATDGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGE-RVFQAEV 287
FT E+L D +G+G FG V+K + G +A+K++++ + E + ++
Sbjct: 1 FTAEDL-------KDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDL 53
Query: 288 EIISRVHHKHLVSLVGYYTA----GSQRMLVC-EFVTSNTLEFH--LHGKGRPTMDWPTR 340
+++ R +V +Y A G +C E + + +F+ ++ + +
Sbjct: 54 DVVMR--SSDCPYIVKFYGALFREGD--CWICMELMDISLDKFYKYVYEVLKSVIPEEIL 109
Query: 341 LKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KLASDVYTHVS 399
KIA+ K L YL E+ KIIHRD+K +NILLD K+ DFG++ +L +
Sbjct: 110 GKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---AK 164
Query: 400 TRVMGTFGYLAPE-YASSG--KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME--DNLA 454
TR G Y+APE S +SDV+S G+ L E+ G P + D L
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP---KWNSVFDQLT 221
Query: 455 RPLLNRAIEDGNFDTLVD---PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511
+V P L N V C+ +RP+ +++
Sbjct: 222 --------------QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 247 LLGQGGFGYVHKGV---LPNGKE---VAIKQLKAGSGQGERV-FQAEVEIISRV-HHKHL 298
LG+G FG V K L N E VA+K LK + + + +E+E++ + HK++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTM-------DWPTRLKI-------- 343
++L+G T +V E+ L L + RP P +
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV----YTHVS 399
A A+G+ +L K IHRD+ A N+L+ K+ADFGLA+ D+ Y +
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR---DIHHIDYYRKT 191
Query: 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 436
T ++APE T +SDV+SFGV+L E+
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA--------EVEIISRV-HHKH 297
LG G FG V+ G+ VAIK++K + F + EV+ + ++ H +
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
+V L + + V E++ N + KG+P I +GLA++H+
Sbjct: 60 IVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKP-FSESVIRSIIYQILQGLAHIHK- 117
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYT-HVSTRVMGTFGYLAPE-- 412
H HRD+K N+L+ K+ADFGLA+ + YT +VSTR Y APE
Sbjct: 118 -H-GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEIL 170
Query: 413 -----YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
Y+S D+++ G ++ EL RP
Sbjct: 171 LRSTSYSS------PVDIWALGCIMAELYT-LRP 197
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 52/196 (26%), Positives = 102/196 (52%), Gaps = 14/196 (7%)
Query: 248 LGQGGFGYVHKG-VLPNGKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG G G V+K L + +A+K + + + ++ +E+EI+ + +++ G +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
++ + EF+ +L+ ++ K + +IA+ KGL YL KI+HR
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYLWS---LKILHR 119
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
D+K +N+L++ + + K+ DFG +++ + ++ +GT Y+APE S + SDV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFG---VSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDV 176
Query: 426 FSFGVMLLELIIGCRP 441
+S G+ +EL +G P
Sbjct: 177 WSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 36/221 (16%)
Query: 238 ATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HH 295
T F ++G+G +G V+K G+ VAIK + + E + + E I+ + +H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEI-KEEYNILRKYSNH 62
Query: 296 KHLVSLVGYY------TAGSQRMLVCEFVTSNT---LEFHLHGKGRPTMDWPTRLK---- 342
++ + G + Q LV E + L L KG+ RLK
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-------RLKEEWI 115
Query: 343 --IALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL-AKLASDVYTHVS 399
I +GLAYLHE+ K+IHRDIK NILL E K+ DFG+ A+L S + +
Sbjct: 116 AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172
Query: 400 TRVMGTFGYLAPEY-ASSGKLTE----KSDVFSFGVMLLEL 435
+GT ++APE A + +SDV+S G+ +EL
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 16/198 (8%)
Query: 248 LGQGGFGYVH------KGVLPNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVS 300
LG+GGFG V G L K++ K+LK G +G V E I+++VH + +VS
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV---EKRILAKVHSRFIVS 57
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
L + + LV + L +H++ + P P GL +LH+
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR- 116
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
+II+RD+K N+LLD +++D GLA D + + GT G++APE +
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEE 173
Query: 419 LTEKSDVFSFGVMLLELI 436
D F+ GV L E+I
Sbjct: 174 YDFSVDYFALGVTLYEMI 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 11/180 (6%)
Query: 264 GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323
G++VA+K++ Q + EV I+ H ++V + Y G + +V EF+ L
Sbjct: 44 GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103
Query: 324 -EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382
+ H + M+ + L K L++LH +IHRDIK+ +ILL K+
Sbjct: 104 TDIVTHTR----MNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKL 156
Query: 383 ADFGL-AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+DFG A+++ +V S ++GT ++APE S + D++S G+M++E++ G P
Sbjct: 157 SDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 60/228 (26%), Positives = 90/228 (39%), Gaps = 47/228 (20%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA--------------EVEII 290
LG+G +G V K GK VAIK++K + E++I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 291 SRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK------IA 344
+ + H++++ LV Y G LV + + + +D RL I
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDI---------MASDLKKVVDRKIRLTESQVKCIL 125
Query: 345 LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KLASDVY-------- 395
L GL LH+ +HRD+ ANI ++ K K+ADFGLA + Y
Sbjct: 126 LQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 396 THVSTRVMG----TFGYLAPE-YASSGKLTEKSDVFSFGVMLLELIIG 438
T M T Y APE + K D++S G + EL+ G
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 71/207 (34%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 246 NLLGQGGFGYV----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHHKH 297
LG G FG V HKG G+ AIK LK Q + V Q E I+ + H
Sbjct: 24 ETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQ-EKSILMELSHPF 79
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPT--RLKIALGFAKGLAYLH 355
+V+++ + ++ + EFV L HL GR D ++ L F YLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFE----YLH 135
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD-VYTHVSTRVMGTFGYLAPEYA 414
II+RD+K N+LLD K KV DFG AK D +T + GT YLAPE
Sbjct: 136 SK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYLAPEVI 187
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRP 441
S + D ++ GV+L E I G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 30/213 (14%)
Query: 246 NLLGQGGFGYVHKGVLPNG---KEVAIKQLKAGSGQGE-RVFQAEVEIISRV-HHKHLVS 300
+++G+G FG V K + + AIK++K + + + R F E+E++ ++ HH ++++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 301 LVGYYTAGSQRMLVCEFVT-SNTLEF--------------HLHGKGRPTMDWPTRLKIAL 345
L+G L E+ N L+F + T+ L A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS-TLSSQQLLHFAA 119
Query: 346 GFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT 405
A+G+ YL + + IHRD+ A NIL+ + AK+ADFGL++ +VY + MG
Sbjct: 120 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-GQEVYV---KKTMGR 172
Query: 406 FG--YLAPEYASSGKLTEKSDVFSFGVMLLELI 436
++A E + T SDV+S+GV+L E++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 76/276 (27%), Positives = 116/276 (42%), Gaps = 39/276 (14%)
Query: 248 LGQGGFGYVHKGVL-PNGKEVAIK--------QLKAGSGQGERVFQAEVEIISRVHHKHL 298
+G+G FG V G L + VA+K LKA F E I+ + H ++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-------FLQEARILKQYSHPNI 55
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
V L+G T +V E V L +G P + +++ A G+ YL
Sbjct: 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH 114
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD-VYTHVSTRVMGTFGYLAPEYASSG 417
IHRD+ A N L+ K K++DFG+++ D VY + APE + G
Sbjct: 115 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171
Query: 418 KLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476
+ + +SDV+SFG++L E +G P NL+ AIE G L P+L
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVPY--------ANLSNQQTREAIEQGV--RLPCPELC 221
Query: 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512
+ + M R C + +RP S + + L
Sbjct: 222 PDAVYRLMER-------CWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 6e-15
Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 248 LGQGGFGYVHKGVLPNGKE-----------------VAIKQLKAGSGQGERV-FQAEVEI 289
LG+G FG VH + N ++ VA+K L+ + + R F EV+I
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 290 ISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLH--------GKGR--------- 332
+SR+ +++ L+G ++ E++ + L L G
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 333 PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LA 391
P + + + L +AL A G+ YL +HRD+ N L+ K+ADFG+++ L
Sbjct: 133 PAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 392 SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCR 440
+ Y + R + ++A E GK T SDV++FGV L E+++ C+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 55/205 (26%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 248 LGQGGFGYVHKGVL--PNGKEVAIKQLKAGSGQGE-RVFQAEVEIISRVHHKHLVSLVGY 304
LG+G +G V+K VL P G +A+K+++ + + E++I+ + ++V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPT--MDWPTRLKIALGFAKGLAYLHEDCHPKI 362
+ + E++ + +L+ L+ G T + +I KGL +L E+ + I
Sbjct: 68 FFIEGAVYMCMEYMDAGSLD-KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE- 421
IHRD+K N+L++ + K+ DFG ++ ++ ++ +G Y+APE SG +
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFG---VSGNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181
Query: 422 -----KSDVFSFGVMLLELIIGCRP 441
+SDV+S G+ +LE+ +G P
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 64/278 (23%), Positives = 122/278 (43%), Gaps = 28/278 (10%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLK----AGSGQGERVFQAEVEIISRV 293
F +G+G F V+K + L +G+ VA+K+++ + + + E++++ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQL 59
Query: 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEF---HLHGKGRPTMDWPTRLKIALGFAKG 350
H +++ + + ++ +V E + L H + R + T K +
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLCSA 118
Query: 351 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLA 410
L ++H +I+HRDIK AN+ + K+ D GL + S T + V GT Y++
Sbjct: 119 LEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 411 PEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470
PE KSD++S G +L E+ P F D + L + IE ++
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLYSLCKKIEKCDY--- 225
Query: 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQI 508
P L ++ E+ +V + C+ +RP IS +
Sbjct: 226 --PPLPADHYSEELRDLV---SRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 64/204 (31%), Positives = 93/204 (45%), Gaps = 23/204 (11%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQ---AEVEIISRVHHKH 297
FSD +G G FG V+ + N + VAIK++ Q +Q EV + ++ H +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 298 LVSLVGYYTAGSQRMLVCEFV---TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354
+ G Y LV E+ S+ LE H +P + + G +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA-AVTHGALQGLAYL 131
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY- 413
H +IHRD+KA NILL K+ DFG A + + V GT ++APE
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVI 183
Query: 414 --ASSGKLTEKSDVFSFGVMLLEL 435
G+ K DV+S G+ +EL
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 1e-14
Identities = 70/217 (32%), Positives = 99/217 (45%), Gaps = 24/217 (11%)
Query: 247 LLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVE---IISRV-----HHKH 297
+LG+G FG V L G+ A+K LK + + +VE + RV +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALK----KDVVLIDDDVECTMVEKRVLALAWENPF 57
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
L L + V EF+ L FH+ KGR D A GL +LH
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR--FDLYRATFYAAEIVCGLQFLHSK 115
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASS 416
II+RD+K N++LD K+ADFG+ K +V+ + ++ GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQG 170
Query: 417 GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL 453
K T D +SFGV+L E++IG P H ED L
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPF---HGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 72/239 (30%), Positives = 98/239 (41%), Gaps = 26/239 (10%)
Query: 247 LLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVE---IISRV-----HHKH 297
+LG+G FG V L + AIK LK + + +VE + RV H
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSLAWEHPF 57
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
L L + V E++ L FH+ + D P A GL +LH
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK--FDLPRATFYAAEIICGLQFLHSK 115
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYTHVSTRVMGTFGYLAPEYAS 415
I++RD+K NILLD K+ADFG+ K + D T GT Y+APE
Sbjct: 116 ---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEILL 169
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRP---VDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471
K D +SFGV+L E++IG P D F + P R + D LV
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILV 228
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 13/210 (6%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKE----VAIKQLK-AGSGQGERVFQAEVEIISRVHH 295
F +LG G FG V+KG+ +P G++ VAIK+L+ A S + + E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH 355
H+ L+G + +++ L++ K + L + AKG+ YL
Sbjct: 69 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLE 126
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYA 414
E +++HRD+ A N+L+ K+ DFGLAK L +D + + ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 415 SSGKLTEKSDVFSFGVMLLELI-IGCRPVD 443
T +SDV+S+GV + EL+ G +P D
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 63/194 (32%), Positives = 94/194 (48%), Gaps = 13/194 (6%)
Query: 248 LGQGGFGYVHKGVL---PNGKEVAIKQLKAGSGQG--ERVFQAEVEIISRVHHKHLVSLV 302
LG G FG V KG+ + K VA+K LK + + E ++ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
G A S MLV E L L T T L + + G+ YL E
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVHQV--SMGMKYLEET---NF 116
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAK-LASDV-YTHVSTRVMGTFGYLAPEYASSGKLT 420
+HRD+ A N+LL + AK++DFGL+K L +D Y T + APE + K +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 421 EKSDVFSFGVMLLE 434
KSDV+SFGV++ E
Sbjct: 177 SKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 20/215 (9%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG+G +G V K +P G +A+K+++A + Q ++ +++I R V +Y
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS--VDCPYTVTFY 66
Query: 306 TAGSQR--MLVCEFVTSNTLE-F--HLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
A + + +C V +L+ F ++ KG T+ KIA+ K L YLH
Sbjct: 67 GALFREGDVWICMEVMDTSLDKFYKKVYDKGL-TIPEDILGKIAVSIVKALEYLHSKL-- 123
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLA-KLASDVYTHVSTRVMGTFGYLAPEY----AS 415
+IHRD+K +N+L++ + K+ DFG++ L V T G Y+APE +
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELN 180
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
KSDV+S G+ ++EL G P DS T +
Sbjct: 181 QKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 55/181 (30%), Positives = 94/181 (51%), Gaps = 11/181 (6%)
Query: 263 NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNT 322
GK+VA+K++ Q + EV I+ HH+++V + Y G + +V EF+
Sbjct: 46 TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105
Query: 323 L-EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAK 381
L + H + M+ + L + L+YLH +IHRDIK+ +ILL K
Sbjct: 106 LTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIK 158
Query: 382 VADFGL-AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCR 440
++DFG A+++ +V S ++GT ++APE S + D++S G+M++E+I G
Sbjct: 159 LSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 441 P 441
P
Sbjct: 217 P 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 28/211 (13%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA--EVEIISRVHHKHL 298
F N +G+G +G V++ +G+ VA+K+++ + + + E+ ++ + H ++
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 299 VSLVGYYTAGSQR------MLVCEFVTSNTLEFHLHGKGRPTMDWP---TRLK-IALGFA 348
V L G M CE ++ L+ M P +++K + L
Sbjct: 69 VELK-EVVVGKHLDSIFLVMEYCEQDLASLLD---------NMPTPFSESQVKCLMLQLL 118
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY 408
+GL YLHE+ IIHRD+K +N+LL K K+ADFGLA+ ++ +V+ T Y
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWY 174
Query: 409 LAPEYA-SSGKLTEKSDVFSFGVMLLELIIG 438
APE T D+++ G +L EL+
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLKAGSGQGE--RVFQAEVEIISRVHHKHLVS 300
L+G+G +G V HK G+ VAIK+ ++ E+ ++ ++ H++LV+
Sbjct: 8 LVGEGSYGMVMKCKHK---ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 301 LVGYYTAGSQRMLVCEFVTS---NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
L+ + + LV EFV + LE + +G +D K +G+ + H
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSH 119
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LAS--DVYT-HVSTRVMGTFGYLAPEY 413
IIHRDIK NIL+ K+ DFG A+ LA+ +VYT +V+TR Y APE
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPEL 171
Query: 414 -ASSGKLTEKSDVFSFGVMLLELIIG 438
K D+++ G ++ E++ G
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
+GQG G V+ + + G+EVAIKQ+ + + E+ ++ H ++V+ + Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
G + +V E++ +L + MD + + L +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 140
Query: 367 IKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 426
IK+ NILL K+ DFG + + ST V GT ++APE + K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 427 SFGVMLLELIIGCRP 441
S G+M +E++ G P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 242 FSDANL-----LGQGGFGYVHKGVLPNGKE------VAIKQLKAGSGQGERV-FQAEVEI 289
F +NL LG+G FG V +E V +K L+ + + F+ E+++
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 290 ISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL-EFHLHGKGR------PTMDWPTRLK 342
++ HK++V L+G ++ E+ L +F K + P + ++
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121
Query: 343 IALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYTHVST 400
+ A G+ +L + +HRD+ A N L+ + E KV+ L+K S+ Y +
Sbjct: 122 LCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
+ +LAPE + KSDV+SFGV++ E+
Sbjct: 179 LI--PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-14
Identities = 59/192 (30%), Positives = 88/192 (45%), Gaps = 18/192 (9%)
Query: 264 GKEVAIKQLKAGSGQGERV---FQAEVEIISRVHHKHLVSLVGYYTAGSQRML-VCEFVT 319
G EVAIK L+ + + E F+ E + +R++H ++V+L+ A + V E+V
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL---DF 376
TL L G RL L LA H I+HRD+K NI++
Sbjct: 63 GRTLREVLAADGALPAGETGRL--MLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 377 KFEAKVADFGLAKLASDVYTHVSTR------VMGTFGYLAPEYASSGKLTEKSDVFSFGV 430
+ AKV DFG+ L V V+GT Y APE +T SD++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 431 MLLELIIGCRPV 442
+ LE + G R V
Sbjct: 178 IFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 62/203 (30%), Positives = 86/203 (42%), Gaps = 21/203 (10%)
Query: 248 LGQGGFGYVHK-GVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHHKHLVSLV 302
LG GGFG V V + A+K +K GQ E +F E EI+ +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMD-WPTRLKIALGFAKGLAYLHEDCHPK 361
+ ++ E+ L L +G D + R IA YLH
Sbjct: 60 RTFKDKKYIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIA-CVVLAFEYLHNR---G 113
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDV---YTHVSTRVMGTFGYLAPEYASSGK 418
II+RD+K N+LLD K+ DFG AK +T GT Y+APE +
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-----GTPEYVAPEIILNKG 168
Query: 419 LTEKSDVFSFGVMLLELIIGCRP 441
D +S G++L EL+ G P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-----RVFQAEVEIISRVHHKHLVS 300
LLGQG FG V+ + G+E+A KQ++ E + E++++ + H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 301 LVGYYTAGSQRMLVC--EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
G +++ L E++ +++ L G T + TR K +G++YLH +
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALT-ESVTR-KYTRQILEGMSYLHSN- 125
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTR-VMGTFGYLAPEYASS 416
I+HRDIK ANIL D K+ DFG +K L + + R V GT +++PE S
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG 183
Query: 417 GKLTEKSDVFSFGVMLLELI 436
K+DV+S G ++E++
Sbjct: 184 EGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 14/211 (6%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
+GQG G V+ + + G+EVAIKQ+ + + E+ ++ + ++V+ + Y
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
G + +V E++ +L + MD + + L +LH + ++IHRD
Sbjct: 87 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN---QVIHRD 140
Query: 367 IKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 426
IK+ NILL K+ DFG + + ST V GT ++APE + K D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 427 SFGVMLLELIIGCRPVDSTHTFMEDNLARPL 457
S G+M +E++ G P ++ +N R L
Sbjct: 200 SLGIMAIEMVEGEPP------YLNENPLRAL 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
+GQG G V + + G+EVAIKQ+ + + E+ ++ + + ++V+ + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
G + +V E++ +L + MD + + L +LH + ++IHRD
Sbjct: 87 VGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLHAN---QVIHRD 140
Query: 367 IKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 426
IK+ N+LL K+ DFG + + ST V GT ++APE + K D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 199
Query: 427 SFGVMLLELIIGCRP 441
S G+M +E++ G P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 247 LLGQGGFGYVHKG-VLPNGKEVAIKQLKAGSGQGE--RVFQAEVEIISRVHH-KHLVSLV 302
+G G G V+K G +A+KQ++ + E R+ +++++ + H ++V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM-DLDVVLKSHDCPYIVKCY 80
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAKGLAYLHEDCHP 360
GY+ S + +C + S L+ L P P + K+ + K L YL E H
Sbjct: 81 GYFITDSD-VFICMELMSTCLDKLLKRIQGPI---PEDILGKMTVAIVKALHYLKEK-H- 134
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
+IHRD+K +NILLD K+ DFG++ D TR G Y+APE
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERIDPPDPN 192
Query: 421 EK----SDVFSFGVMLLELIIGCRPVDSTHT 447
K +DV+S G+ L+EL G P + T
Sbjct: 193 PKYDIRADVWSLGISLVELATGQFPYKNCKT 223
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 47/151 (31%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANI 372
V E+V L +H+ G+ P + A + GL +LH II+RD+K N+
Sbjct: 78 FVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNV 132
Query: 373 LLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFGVM 431
+LD + K+ADFG+ K + V+TR GT Y+APE + + D +++GV+
Sbjct: 133 MLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 190
Query: 432 LLELIIGCRPVDST------HTFMEDNLARP 456
L E++ G P D + ME N++ P
Sbjct: 191 LYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 13/195 (6%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
LG G FG V+K G A K ++ S + + E+EI++ +H ++V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
+ ++ EF ++ + R + P I + L YLH KIIHRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTE-PQIQVICRQMLEALQYLHSM---KIIHRD 135
Query: 367 IKAANILLDFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTE---- 421
+KA N+LL + K+ADFG++ A +V T +GT ++APE + +
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 422 -KSDVFSFGVMLLEL 435
K+D++S G+ L+E+
Sbjct: 194 YKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
+LG+G +G V+ L +AIK++ + + E+ + S + H+++V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMD-WPTRLKIALGFAKGLAYLHEDCHPKIIH 364
+ + E V +L L K P D T + +GL YLH++ +I+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 365 RDIKAANILLD-FKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK--LTE 421
RDIK N+L++ + K++DFG +K + + T GT Y+APE G
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRGYGA 190
Query: 422 KSDVFSFGVMLLELIIGCRP 441
+D++S G ++E+ G P
Sbjct: 191 PADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 68/232 (29%), Positives = 106/232 (45%), Gaps = 29/232 (12%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKEV-AIKQLKAGSGQGERVFQAE-VE---IISRV--- 293
F+ +LG+G FG V E+ AIK LK + + Q + VE + RV
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKK-----DVIIQDDDVECTMVEKRVLAL 56
Query: 294 --HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGL 351
L L + + V E+V L +H+ G+ P + A A GL
Sbjct: 57 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK--FKEPHAVFYAAEIAIGL 114
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLA 410
+LH II+RD+K N++LD + K+ADFG+ K +++ +TR GT Y+A
Sbjct: 115 FFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIA 169
Query: 411 PEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDST------HTFMEDNLARP 456
PE + + D ++FGV+L E++ G P D + ME N++ P
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP 221
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 27/208 (12%)
Query: 247 LLGQGGFGYVHKGVLPNG-------KEVAIKQLKAGSGQGER-----VFQAEVEII-SRV 293
LG G FG V+K N KE+ + G + ER +EV II ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHG----KGRPTMD--WPTRLKIALGF 347
H ++V + + +V + + L H + K R T + W +++ L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA- 125
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFG 407
L YLH++ +I+HRD+ NI+L + + DFGLAK T V+GT
Sbjct: 126 ---LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP--ESKLTSVVGTIL 178
Query: 408 YLAPEYASSGKLTEKSDVFSFGVMLLEL 435
Y PE + EK+DV++FG +L ++
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 248 LGQGGFGYVH-KGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
+G+G G V V +GK VA+K++ Q + EV I+ H+++V + Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 307 AGSQRMLVCEFVTSNTL-EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
G + +V EF+ L + H + M+ + L K L+ LH +IHR
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLKALSVLHAQ---GVIHR 140
Query: 366 DIKAANILLDFKFEAKVADFGL-AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSD 424
DIK+ +ILL K++DFG A+++ +V S ++GT ++APE S + D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVD 198
Query: 425 VFSFGVMLLELIIGCRP 441
++S G+M++E++ G P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 14/211 (6%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
+GQG G V+ + + G+EVAI+Q+ + + E+ ++ + ++V+ + Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
G + +V E++ +L + MD + + L +LH + ++IHRD
Sbjct: 88 VGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRD 141
Query: 367 IKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVF 426
IK+ NILL K+ DFG + + ST V GT ++APE + K D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIW 200
Query: 427 SFGVMLLELIIGCRPVDSTHTFMEDNLARPL 457
S G+M +E+I G P ++ +N R L
Sbjct: 201 SLGIMAIEMIEGEPP------YLNENPLRAL 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 67/235 (28%), Positives = 99/235 (42%), Gaps = 27/235 (11%)
Query: 345 LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL-ASDVYTHVSTRVM 403
L F + L +H +IHRDIK+ANILL K+ DFG +K+ A+ V V
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVD--STHTFMEDNLARPLLNRA 461
GT Y+APE ++K+D+FS GV+L EL+ RP D + M LA
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA------- 259
Query: 462 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADL 521
G +D L EM +V A + +RRP S+++ ++ L
Sbjct: 260 ---GRYDPLPPSI------SPEMQEIV---TALLSSDPKRRPSSSKLLNMPICKLFISGL 307
Query: 522 NEGIRPGQSSVYGSLD----YDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSD 572
E I Q G L Q + L+ R+ + E S S+ + +
Sbjct: 308 LE-IVQTQPGFSGPLRDTISRQIQQTKQLLQVERRRIVRQMEESLSTAASTTILE 361
|
Length = 496 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 16/222 (7%)
Query: 247 LLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQA---EVEIISRVH-HKHLVSL 301
+LG+G FG V L +G+ A+K LK + + E I+S H L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ + V EFV L FH+ R D A L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEITSALMFLHDK---G 116
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYASSGKLT 420
II+RD+K N+LLD + K+ADFG+ K ++ +T GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 421 EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462
D ++ GV+L E++ G P ++ + ED+L +LN +
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEV 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 38/101 (37%), Positives = 62/101 (61%), Gaps = 5/101 (4%)
Query: 342 KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR 401
KI++ +GL YL E H KI+HRD+K +NIL++ + E K+ DFG++ D ++
Sbjct: 103 KISIAVLRGLTYLREK-H-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS 157
Query: 402 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPV 442
+GT Y++PE T +SD++S G+ L+E+ IG P+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 249 GQGGFGYVHKGVLPN---GKEVAIKQLKAGSGQGERVFQA---EVEIISRVHHKHLVSLV 302
G+G +G V+K N GKE AIK+ K Q + Q+ E+ ++ + H+++VSLV
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 303 GYY---TAGSQRMLV--CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA--KGLAYLH 355
+ S +L E ++FH K P + +L + G+ YLH
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSI---PPSMVKSLLWQILNGVHYLH 125
Query: 356 EDCHPKIIHRDIKAANILL----DFKFEAKVADFGLAKLASDVYTHVST--RVMGTFGYL 409
+ ++HRD+K ANIL+ + K+ D GLA+L + ++ V+ T Y
Sbjct: 126 SNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR 182
Query: 410 APEYASSGK-LTEKSDVFSFGVMLLELI 436
APE + T+ D+++ G + EL+
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 248 LGQGGFGYVHKGVLPNGKEVA---IKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSLVG 303
+G G FG V G G A +K+L+A + E++ F EV+ ++H +++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHG-KGRPTMDWPTRL--KIALGFAKGLAYLHEDCHP 360
+LV EF L+ +L +G + ++A A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLA--KLASDVYTHVSTRVMGTFGYLAPEYASS-- 416
IH D+ N L K+ D+GLA + D Y + +LAPE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEIRG 178
Query: 417 -----GKLTEKSDVFSFGVMLLEL 435
T+KS+++S GV + EL
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 248 LGQGGFGYVH----KGVLPNGKE-------------VAIKQLKAGSGQGERV-FQAEVEI 289
LG+G FG VH +G+ + VA+K L+ + + R F E++I
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 290 ISRVHHKHLVSLVGYYTAGSQRMLVCE---------FVTSNTLEFHLHGKGRPTMDWPTR 340
+SR+ +++ L+ ++ E F++ + + T+ + T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 341 LKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVS 399
+ +A A G+ YL +HRD+ N L+ + K+ADFG+++ L S Y +
Sbjct: 133 IFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCR 440
R + +++ E GK T SDV++FGV L E++ C+
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 5e-13
Identities = 60/196 (30%), Positives = 100/196 (51%), Gaps = 18/196 (9%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
+G G +G V+K L G+ A+K +K G + Q E+ ++ H ++V+ G Y
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL---GFAKGLAYLHEDCHPKII 363
+ + + E+ +L+ H G P + L+IA +GLAYLH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTG-PL----SELQIAYVCRETLQGLAYLHSKGK---M 128
Query: 364 HRDIKAANILLDFKFEAKVADFGL-AKLASDVYTHVSTRVMGTFGYLAPEYAS---SGKL 419
HRDIK ANILL + K+ADFG+ AK+ + + S +GT ++APE A+ +G
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEVAAVEKNGGY 186
Query: 420 TEKSDVFSFGVMLLEL 435
+ D+++ G+ +EL
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 62/222 (27%), Positives = 104/222 (46%), Gaps = 38/222 (17%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL-----KAGSGQGERVF----QAEVEIISRVHHKH 297
LG+G FG V+K + G+ VA+K++ K G F E++I+ ++ H +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-------FPITALREIKILKKLKHPN 68
Query: 298 LVSLVGY---YTAGSQRMLVCEFVTSNTLEFHLHGK-GRPTMDW-PTRLK-IALGFAKGL 351
+V L+ S+R ++ + ++ L G P++ +++K L +G+
Sbjct: 69 VVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGI 128
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL----------ASDVYTHVSTR 401
YLHE+ I+HRDIKAANIL+D + K+ADFGLA+ T T
Sbjct: 129 NYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 402 VMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELIIGCRPV 442
++ T Y PE + T D++ G + E+ RP+
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 6e-13
Identities = 59/218 (27%), Positives = 104/218 (47%), Gaps = 18/218 (8%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLV 299
F L+G G +G V+KG + G+ AIK + +G E + E+ ++ + HH+++
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 300 SLVGYYTAGS------QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
+ G + + Q LV EF + ++ + T+ I +GL++
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY 413
LH+ K+IHRDIK N+LL E K+ DFG++ +T +GT ++APE
Sbjct: 127 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 182
Query: 414 ASSGKLTE-----KSDVFSFGVMLLELIIGCRPVDSTH 446
+ + + KSD++S G+ +E+ G P+ H
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-----RVFQAEVEIISRVHHKHLVS 300
LLG+G FG V+ G+E+A+KQ+ E + E++++ + H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 301 LVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
G ++ L E++ +++ L G T + R + +G++YLH +
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGVSYLHSN- 125
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS--TRVMGTFGYLAPEYASS 416
I+HRDIK ANIL D K+ DFG +K + + V GT +++PE S
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 417 GKLTEKSDVFSFGVMLLELI 436
K+DV+S ++E++
Sbjct: 184 EGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 48/151 (31%), Positives = 76/151 (50%), Gaps = 14/151 (9%)
Query: 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANI 372
V E+V L + + GR P + A A GL +LH II+RD+K N+
Sbjct: 78 FVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV 132
Query: 373 LLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYASSGKLTEKSDVFSFGVM 431
+LD + K+ADFG+ K +++ V+T+ GT Y+APE + + D ++FGV+
Sbjct: 133 MLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 190
Query: 432 LLELIIGCRPVDST------HTFMEDNLARP 456
L E++ G P + + ME N+A P
Sbjct: 191 LYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 221
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 69/276 (25%), Positives = 124/276 (44%), Gaps = 43/276 (15%)
Query: 248 LGQGGFGYV----HKGVLPNGKEVAIKQL--KAGSGQGERVFQAEVEIISRVHHKHLVSL 301
+G+G +G V H+ +GK+ IK+L + S + + + E +++S++ H ++V+
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 302 VGYYTAGS-QRMLVCEFVTSNTLEFHL-HGKG-----RPTMDWPTRLKIALGFAKGLAYL 354
+ +V F L L KG ++W ++ +AL YL
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QYL 118
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
HE I+HRD+K N+ L KV D G+A++ + ST ++GT Y++PE
Sbjct: 119 HEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELF 174
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474
S+ KSDV++ G + E+ H F ++ L+ R IE G P
Sbjct: 175 SNKPYNYKSDVWALGCCVYEM------ATLKHAFNAKDM-NSLVYRIIE-GKL-----PP 221
Query: 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
+ +Y+ E+ ++ A + +RP + I+R
Sbjct: 222 MPKDYS-PELGELI---ATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 247 LLGQGGFGYVHKGVLPNGKE-VAIKQLKAGS----GQGERVFQAEVEIISRVHHKHLVSL 301
+G G FG VH + A+K + Q + V E ++ V H ++ L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHV-HNEKRVLKEVSHPFIIRL 66
Query: 302 VGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
++T QR L + E+V L +L GR + T L A L YLH
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS--TGLFYASEIVCALEYLHSK-- 120
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASD-VYTHVSTRVMGTFGYLAPEYASSGK 418
+I++RD+K NILLD + K+ DFG AK D +T + GT YLAPE S
Sbjct: 121 -EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAPEVIQSKG 174
Query: 419 LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL 453
+ D ++ G+++ E+++G P F +DN
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPP------FFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 10/193 (5%)
Query: 248 LGQGGFG--YVHKGVLPNGKEVAIKQ--LKAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
+G+G FG Y+ K + + IK+ L + + + EV +++++ H ++V+
Sbjct: 8 IGEGSFGKIYLAKAKSDS-EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ + +V E+ L ++ + L + + GL ++H+ KI+
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KIL 123
Query: 364 HRDIKAANILLDFK-FEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEK 422
HRDIK+ NI L AK+ DFG+A+ +D ++ +GT YL+PE + K
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEICQNRPYNNK 182
Query: 423 SDVFSFGVMLLEL 435
+D++S G +L EL
Sbjct: 183 TDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 58/270 (21%), Positives = 114/270 (42%), Gaps = 38/270 (14%)
Query: 255 YVHKGVLPNGKEVAIKQLKA---GSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311
++KG+ N KEV I+ K G + + E++ + R+ +++ + G+
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 312 M----LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE-DCHPKIIHRD 366
+ L+ E+ T L L + + + T+L +A+ KGL L++ P +++
Sbjct: 94 LPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKN 148
Query: 367 IKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASS--GKLTEKS 423
+ + + L+ ++ K+ GL K L+S + +V+ V Y + + + + T K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKD 203
Query: 424 DVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483
D++S GV+L E+ G P + NL + I + N + E
Sbjct: 204 DIYSLGVVLWEIFTGKIPFE--------NLTTKEIYDLIINKNNSLKLPLDCPLEIKC-- 253
Query: 484 MARMVACAAACVRHSARRRPRISQIVRTLE 513
AC H + +RP I +I+ L
Sbjct: 254 ------IVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAI----KQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
LG G FG V+K KE + K + S + + E++I++ H ++V L+
Sbjct: 13 LGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ + ++ EF ++ + RP + R+ + + L YLHE+ KII
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHEN---KII 125
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTE- 421
HRD+KA NIL + K+ADFG++ A + T +GT ++APE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 183
Query: 422 ----KSDVFSFGVMLLEL 435
K+DV+S G+ L+E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 53/186 (28%), Positives = 90/186 (48%), Gaps = 21/186 (11%)
Query: 263 NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNT 322
+G++VA+K + Q + EV I+ H+++V + Y G + ++ EF
Sbjct: 45 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF----- 99
Query: 323 LEFHLHGKGRPTMDWPTRLK------IALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF 376
L G + TRL + + L YLH +IHRDIK+ +ILL
Sbjct: 100 ----LQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTL 152
Query: 377 KFEAKVADFGL-AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
K++DFG A+++ DV S ++GT ++APE S + D++S G+M++E+
Sbjct: 153 DGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 436 IIGCRP 441
+ G P
Sbjct: 211 VDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 21/210 (10%)
Query: 247 LLGQGGFGYVHKGV-LPNGKE----VAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVS 300
+LG G FG V+KG+ +P+G+ VAIK L+ S + + E +++ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGR----PTMDWPTRLKIALGFAKGLAYLHE 356
L+G + +++ L++ K R ++W ++ AKG++YL E
Sbjct: 74 LLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS-DVYTHVSTRVMGTFGYLAPEYAS 415
+++HRD+ A N+L+ K+ DFGLA+L D + + ++A E
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 416 SGKLTEKSDVFSFGVMLLELI-IGCRPVDS 444
+ T +SDV+S+GV + EL+ G +P D
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 65/282 (23%), Positives = 122/282 (43%), Gaps = 56/282 (19%)
Query: 248 LGQGGFGYVHKGVL----PNGKEVAIKQLKAGSGQGERVFQA--EVEIISRVHHKHLVSL 301
+G+G FG K +L +GK+ IK++ + ++ EV ++S + H ++V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHG-KG-----RPTMDWPTRLKIALGFAKGLAYLH 355
+ +V ++ L ++ +G +DW ++ +AL ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVH 118
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS 415
+ KI+HRDIK+ NI L K+ DFG+A++ + T +GT YL+PE
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICE 174
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV---- 471
+ KSD+++ G +L E+ L A E GN LV
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT--------------------LKHAFEAGNMKNLVLKII 214
Query: 472 ---DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
P + + Y++ ++ +V + + + R RP ++ I+
Sbjct: 215 RGSYPPVSSHYSY-DLRNLV---SQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 28/213 (13%)
Query: 248 LGQGGFGYV--------HKGVLPNGKEVAIKQLKAGSGQGERV-FQAEVEIISRV-HHKH 297
LG+G FG V K VA+K LK + + + +E+E++ + HK+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWP---TRL-----------KI 343
+++L+G T ++ E+ + L +L + P M++ R+
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-YTHVSTRV 402
A+G+ YL K IHRD+ A N+L+ K+ADFGLA+ +++ Y +T
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 403 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++APE T +SDV+SFGV++ E+
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 8/92 (8%)
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL 409
G+ LH+ IIHRDIK N+L+D K+ DFGL++ + + +GT YL
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG-----LENKKFVGTPDYL 160
Query: 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
APE + SD +S G ++ E + G P
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 248 LGQGGFGYVHK----GVLPNGKE----VAIKQLK-AGSGQGERVFQAEVEIISRV-HHKH 297
LG+G FG V + G+ + + VA+K LK + + +E+E++ + HK+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMD--------------WPTRLKI 343
+++L+G T ++ E+ L L + P D + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-YTHVSTRV 402
A A+G+ YL + IHRD+ A N+L+ K+ADFGLA+ D+ Y ++
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 403 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++APE T +SDV+SFG+++ E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 248 LGQGGFGYVHKGVL-------PNG-KEVAIKQLKAGSGQGERV-FQAEVEIISRV-HHKH 297
LG+G FG V PN +VA+K LK+ + + + +E+E++ + HK+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDW---PTR-----------LKI 343
+++L+G T ++ E+ + L +L + P M++ PT+ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-YTHVSTRV 402
A A+G+ YL K IHRD+ A N+L+ K+ADFGLA+ + Y +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 403 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++APE T +SDV+SFGV+L E+
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 58/200 (29%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-----RVFQAEVEIISRVHHKHLVS 300
LLGQG FG V+ G+E+A+KQ++ E + E++++ + H+ +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 301 LVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
G +R L E + +++ L G T + TR K +G++YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTEN-VTR-KYTRQILEGVSYLHSN- 125
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS--TRVMGTFGYLAPEYASS 416
I+HRDIK ANIL D K+ DFG +K + + V GT +++PE S
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 417 GKLTEKSDVFSFGVMLLELI 436
K+D++S G ++E++
Sbjct: 184 EGYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 240 DGFSDANLLGQGGFGYVHKGVLPNGK--EVAIKQLKAG----SGQGERVFQAEVEIISRV 293
+ F+ LG G FG V N VAIK+ + Q + VF +E +I++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYI 88
Query: 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
+H V+L G + S LV EFV L R D + +A +
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND------VGCFYAAQIVL 142
Query: 354 LHEDCHP-KIIHRDIKAANILLDFKFEAKVADFGLAKLA-SDVYTHVSTRVMGTFGYLAP 411
+ E I++RD+K N+LLD K+ DFG AK+ + YT + GT Y+AP
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-----LCGTPEYIAP 197
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
E + + +D ++ G+ + E+++GC P
Sbjct: 198 EILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-12
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 242 FSDANLLGQGGFGYVHKGVLP----NGKEVAIKQLKA---GSGQGERVFQAEVEIISRVH 294
F+ +LG+G FG V + L + ++VA+K LKA S E F E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEE-FLREAACMKEFD 59
Query: 295 HKHLVSLVG--YYTAGSQR----MLVCEFVTSNTLEFHLH----GKGRPTMDWPTRLKIA 344
H +++ L+G + R M++ F+ L L G+ T+ T ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 345 LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYTHVSTRV 402
+ A G+ YL IHRD+ A N +L+ VADFGL+K + D Y
Sbjct: 120 IDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 403 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 436
+ +LA E + T SDV++FGV + E++
Sbjct: 177 L-PVKWLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 60/267 (22%), Positives = 114/267 (42%), Gaps = 24/267 (8%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQ---AEVEIISRVHHKHLVSLVG 303
+G+G F V++ L + K VA+K+++ + Q E++++ +++H +++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 304 YYTAGSQRMLVCEFVTSNTLE--FHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ ++ +V E + L K + + T K + + ++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---R 126
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
++HRDIK AN+ + K+ D GL + S T + V GT Y++PE
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185
Query: 422 KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481
KSD++S G +L E+ P F D + L + IE ++ L P H
Sbjct: 186 KSDIWSLGCLLYEMAALQSP------FYGDKMNLFSLCQKIEQCDYPPL--PTEHYSEKL 237
Query: 482 NEMARMVACAAACVRHSARRRPRISQI 508
E+ M C+ +RP I +
Sbjct: 238 RELVSM------CIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 7e-12
Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-RVFQAEVEIISRVHHKHLVSLVGYY 305
LG+G + V+KG G+ VA+K++ + +G E+ ++ + H+++V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 306 TAGSQRMLVCEFVTSNTLEF-HLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
++ MLV E++ + ++ HG +D T KG+A+ HE+ +++H
Sbjct: 68 HTENKLMLVFEYMDKDLKKYMDTHGVRGA-LDPNTVKSFTYQLLKGIAFCHEN---RVLH 123
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKS- 423
RD+K N+L++ + E K+ADFGLA+ S V+ T Y AP+ + S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSI 182
Query: 424 DVFSFGVMLLELIIG 438
D++S G ++ E+I G
Sbjct: 183 DIWSVGCIMAEMITG 197
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 28/213 (13%)
Query: 248 LGQGGFGYV--------HKGVLPNGKEVAIKQLKA-GSGQGERVFQAEVEIISRV-HHKH 297
LG+G FG V K VA+K LK + + +E+E++ + HK+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDW-------PTR-------LKI 343
+++L+G T ++ E+ + L +L + P MD+ P +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-YTHVSTRV 402
A A+G+ YL K IHRD+ A N+L+ K+ADFGLA+ ++ Y +T
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 403 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++APE T +SDV+SFGV+L E+
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 22/207 (10%)
Query: 247 LLGQGGFGYVHKGVL--PNGK--EVAIKQLKA-GSGQGE-RVFQAEVEIISRVHHKHLVS 300
+LG+G FG V +G L +G +VA+K +K E F +E + H +++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 301 LVGYYTAGSQR------MLVCEFVTSNTLEFHLH----GKGRPTMDWPTRLKIALGFAKG 350
L+G S M++ F+ L L G + T LK + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 351 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYTHVSTRVMGTFGY 408
+ YL IHRD+ A N +L VADFGL+K + D Y M +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-PVKW 181
Query: 409 LAPEYASSGKLTEKSDVFSFGVMLLEL 435
+A E + T KSDV++FGV + E+
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 53/225 (23%)
Query: 240 DGFSDANLLGQGGFGYVHKGVLPNGKE-VAIKQLKAGSGQGERVFQA---------EVEI 289
D + + + +G G +G V VAIK+L R FQ+ E+ +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRL 67
Query: 290 ISRVHHKHLVSLVGYYTAGSQRM------LVCEFVTSNTLEFHLHG--KGRPTMDWPTRL 341
+ + H++++ L+ +T S LV + ++ L+ K + D +
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGAD-----LNNIVKCQKLSDDHIQF 122
Query: 342 KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-HVST 400
+ +GL Y+H IIHRD+K +NI ++ E K+ DFGLA+ D T +V+T
Sbjct: 123 -LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVAT 178
Query: 401 RVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELIIG 438
R Y APE Y + D++S G ++ EL+ G
Sbjct: 179 R-----WYRAPEIMLNWMHY------NQTVDIWSVGCIMAELLTG 212
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 65/202 (32%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 247 LLGQGGFG---YVHKGVLPN-GKEVAIKQLKAGSGQ-GERV-FQAEVEIISRVHHKHLVS 300
+LGQG FG V K P+ G+ A+K LK + + +RV + E +I++ V+H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG-FAKGLAYLHEDCH 359
L + + L+ +F+ L L + M +K L A L +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLAELALALDHLHS--- 116
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
II+RD+K NILLD + K+ DFGL+K + D + + GT Y+APE +
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-HEKKAYSFCGTVEYMAPEVVNRRGH 175
Query: 420 TEKSDVFSFGVMLLELIIGCRP 441
T+ +D +SFGV++ E++ G P
Sbjct: 176 TQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 61/220 (27%), Positives = 106/220 (48%), Gaps = 22/220 (10%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLV 299
F ++G G +G V+KG + G+ AIK + + E + + E+ ++ + HH+++
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI-KLEINMLKKYSHHRNIA 76
Query: 300 SLVGYYTAGS------QRMLVCEFVTSNTL-EFHLHGKGRP-TMDWPTRLKIALGFAKGL 351
+ G + S Q LV EF + ++ + + KG DW I +GL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAP 411
A+LH K+IHRDIK N+LL E K+ DFG++ +T +GT ++AP
Sbjct: 135 AHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 190
Query: 412 EYASSGKLTE-----KSDVFSFGVMLLELIIGCRPVDSTH 446
E + + + +SD++S G+ +E+ G P+ H
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 64/224 (28%), Positives = 104/224 (46%), Gaps = 45/224 (20%)
Query: 232 YEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEV-EI 289
YEEL +G+G +G V+K L G+ VA+K+++ + E + + + EI
Sbjct: 1 YEEL----------AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREI 49
Query: 290 -----ISRVHHKHLVSL----VGYYTAGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPT 339
+ H ++V L G T ++ LV E V + L +L +P + T
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPET 108
Query: 340 RLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399
+ +G+ +LH H +I+HRD+K NIL+ + K+ADFGLA+ +Y+
Sbjct: 109 IKDLMRQLLRGVDFLH--SH-RIVHRDLKPQNILVTSDGQVKIADFGLAR----IYSFEM 161
Query: 400 --TRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLEL 435
T V+ T Y APE YA+ D++S G + EL
Sbjct: 162 ALTSVVVTLWYRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 46/146 (31%), Positives = 67/146 (45%), Gaps = 7/146 (4%)
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
LV+L + ++ L+ ++V L HL+ + T R+ IA L +LH+
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA-EIVLALDHLHQ- 123
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
II+RDIK NILLD + + DFGL+K + GT Y+APE G
Sbjct: 124 --LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 418 KLTEKS--DVFSFGVMLLELIIGCRP 441
D +S GV+ EL+ G P
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 18/196 (9%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
+G G +G V+K + G+ AIK +K G+ V Q E+ ++ H ++V+ G Y
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 307 AGSQRMLVCEFVTSNTLE--FHLHGK-GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ + EF +L+ +H+ G + + +R + +GL YLH +
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK---M 128
Query: 364 HRDIKAANILLDFKFEAKVADFGL-AKLASDVYTHVSTRVMGTFGYLAPEYAS---SGKL 419
HRDIK ANILL K+ADFG+ A++ + + S +GT ++APE A+ G
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAAVERKGGY 186
Query: 420 TEKSDVFSFGVMLLEL 435
+ D+++ G+ +EL
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 64/221 (28%), Positives = 97/221 (43%), Gaps = 13/221 (5%)
Query: 247 LLGQGGFGYVHKGVLP-NGKEVAIKQLKAG---SGQGERVFQAEVEIISR-VHHKHLVSL 301
++G+G FG V +GK A+K L+ + + ++ AE ++ + V H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ + V +FV L FHL + R + R A A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEPRARFYAA-EIASALGYLHS---IN 116
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
I++RD+K NILLD + + DFGL K + +T GT YLAPE
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 422 KSDVFSFGVMLLELIIGCRPVDS--THTFMEDNLARPLLNR 460
D + G +L E++ G P ++ L +PL+ R
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 51/222 (22%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA------------EVEIISRV- 293
LG+G +G V K + + VA+K ++F A E+ + +
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFREIMFLQELG 64
Query: 294 HHKHLVSLVGYYTAGSQR--MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK------IAL 345
H ++V L+ A + + LV E+ +E LH R + L+ I
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANI-----LEDVHKRYIMY 114
Query: 346 GFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-- 403
K L Y+H +IHRD+K +NILL+ K+ADFGLA+ S++ + V+
Sbjct: 115 QLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171
Query: 404 --GTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELIIGCRPV 442
T Y APE S + T+ D++S G +L E+++G +P+
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPL 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 18/220 (8%)
Query: 247 LLGQGGFGYVHKGVLPNGKEV-AIKQLKAGS-GQGERV--FQAEVEIIS-RVHHKHLVSL 301
+LG+G FG V L EV AIK LK Q + V E I++ H L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ + V E+V L F + + R D P A L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSR-KFDEPRSRFYAAEVTLALMFLHRH---G 116
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
+I+RD+K NILLD + K+ADFG+ K + + V T T GT Y+APE +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQELEY 173
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459
D ++ GV++ E++ G P ++ + ED+L +L+
Sbjct: 174 GPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILH 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 63/225 (28%), Positives = 99/225 (44%), Gaps = 16/225 (7%)
Query: 247 LLGQGGFGYVHKGVLPN-GKEVAIKQL---KAGSGQGERVFQAE---VEIISRVHHKHLV 299
++G+GGFG V+ + GK A+K L + QGE + E + ++S +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
+ + + + + + L +HL G A GL ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF- 117
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
+++RD+K ANILLD +++D GLA S H S +GT GY+APE G
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVLQKGTA 172
Query: 420 TEKS-DVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463
+ S D FS G ML +L+ G P T + + R L +E
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 247 LLGQGGFGYVHKGVL----PNGKEVAIKQLKAGS---GQGERVF-QAEVEIISRVHHKHL 298
+LG+GG+G V + GK A+K LK + Q + +AE I+ V H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMD----WPTRLKIALGFAKGLAYL 354
V L+ + G + L+ E+++ L HL +G D + + + +AL +L
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------HL 116
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYTHVSTRVMGTFGYLAPE 412
H II+RD+K NILLD + K+ DFGL K + TH GT Y+APE
Sbjct: 117 H---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPE 170
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ D +S G ++ +++ G P
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 68/220 (30%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 248 LGQGGFGYV----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHHKHLV 299
+G+G FG V HK +GK A+K L+ + + + + ++ V H LV
Sbjct: 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
L + + V ++V L FHL + R + R A A L YLH
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPEPRARF-YAAEIASALGYLHS--- 114
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
II+RD+K NILLD + + DFGL K + ST GT YLAPE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQPY 173
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDS-THTFMEDN-LARPL 457
D + G +L E++ G P S M DN L +PL
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 61/206 (29%), Positives = 104/206 (50%), Gaps = 34/206 (16%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRVHHKHLVSLVG 303
+G+G +G V+KG G+ VA+K+++ S + E V E+ ++ + H ++V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLH--GKGRPTMDWPTRLKIALGFAKGLAYLHED---- 357
S+ L+ EF++ + L+ +L KG+ MD +K +YL++
Sbjct: 67 VLMQESRLYLIFEFLSMD-LKKYLDSLPKGQ-YMD-AELVK---------SYLYQILQGI 114
Query: 358 --CHP-KIIHRDIKAANILLDFKFEAKVADFGLAK---LASDVYTHVSTRVMGTFGYLAP 411
CH +++HRD+K N+L+D K K+ADFGLA+ + VYTH T Y AP
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRAP 170
Query: 412 E-YASSGKLTEKSDVFSFGVMLLELI 436
E S + + D++S G + E+
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 9/171 (5%)
Query: 272 LKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKG 331
+KA +G E++I+ + H+ +++L+ Y S VC + + +
Sbjct: 124 VKAVTGGKT--PGREIDILKTISHRAIINLIHAYRWKS---TVCMVMPKYKCDLFTYVDR 178
Query: 332 RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-KL 390
+ + I + LAYLH IIHRD+K NI LD A + DFG A KL
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 391 ASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ T GT +PE + K+D++S G++L E+ +
Sbjct: 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQA--EVEIISRVHHK 296
D + LG+G + V+KG NGK VA+K ++ +G F A E ++ + H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP-FTAIREASLLKGLKHA 63
Query: 297 HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL-GFAKGLAYLH 355
++V L LV E+V ++ ++ P P +K+ L +GL+Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE-YA 414
+ I+HRD+K N+L+ E K+ADFGLA+ A V +H + + T Y P+
Sbjct: 121 QR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLL 176
Query: 415 SSGKLTEKSDVFSFGVMLLELIIG 438
S + + D++ G + +E+I G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 67/228 (29%), Positives = 105/228 (46%), Gaps = 19/228 (8%)
Query: 233 EELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIIS 291
E L TD + +G+G +G V+K +G A+K L S E + +AE I+
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI-EAEYNILQ 73
Query: 292 RV-HHKHLVSLVG-YYTA----GSQRMLVCEFVTSNTLEFHLHG--KGRPTMDWPTRLKI 343
+ +H ++V G +Y A G Q LV E ++ + G +D I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403
G GL +LH + +IIHRD+K NILL + K+ DFG++ + +T V
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 189
Query: 404 GTFGYLAPEYASSGKLTEKS-----DVFSFGVMLLELIIGCRPVDSTH 446
GT ++APE + + + S DV+S G+ +EL G P+ H
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH 237
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 50/216 (23%), Positives = 104/216 (48%), Gaps = 17/216 (7%)
Query: 235 LARATDGFSDANLLGQGGFGYVHKGVL-----PNGKEVAIKQLKAGSGQGER-VFQAEVE 288
+A + D + ++LL +G FG + G+L +EV +K +K + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 289 IISRVHHKHLVSLVGYYTAGSQRMLVCE-FVTSNTLEFHL----HGKGRPTMDWPTR--L 341
++ + H++++ ++ + V ++ L+ L G+ T+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 342 KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVST 400
+A+ A G++YLH+ +IH+DI A N ++D + + K+ D L++ L Y +
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 436
++A E + + + SDV+SFGV+L EL+
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 45/159 (28%), Positives = 86/159 (54%), Gaps = 11/159 (6%)
Query: 286 EVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KI 343
E++++ + ++V G + + + + E + +L+ L GR P ++ K+
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKV 108
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403
++ KGL YL E KI+HRD+K +NIL++ + E K+ DFG++ D ++ +
Sbjct: 109 SIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFV 163
Query: 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPV 442
GT Y++PE + +SD++S G+ L+E+ IG P+
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 34/217 (15%)
Query: 237 RATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA-------EVE 288
R+ D + N + +G +G V++ G+ VA+K+LK E+ + E+
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKM-----EKEKEGFPITSLREIN 56
Query: 289 IISRVHHKHLVSL----VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWP---TRL 341
I+ ++ H ++V++ VG + + +V E+V E L TM P + +
Sbjct: 57 ILLKLQHPNIVTVKEVVVG--SNLDKIYMVMEYV-----EHDLKS-LMETMKQPFLQSEV 108
Query: 342 K-IALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400
K + L G+A+LH++ I+HRD+K +N+LL+ + K+ DFGLA+ T
Sbjct: 109 KCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYT 164
Query: 401 RVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELI 436
+++ T Y APE + + + D++S G + EL+
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 248 LGQGGFGYVHKGVL------PNGKEVAIKQLK-AGSGQGERVFQAEVEIISRVHHKHLVS 300
LG+ FG V+KG L + VAIK LK G F+ E + SR+ H ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALG 346
L+G T ++ + + + L L + + T++ + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT- 405
A G+ +L ++H+D+ N+L+ K K++D GL + +VY ++MG
Sbjct: 133 IAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR---EVYAADYYKLMGNS 186
Query: 406 ---FGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
+++PE GK + SD++S+GV+L E+
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 57/198 (28%), Positives = 90/198 (45%), Gaps = 20/198 (10%)
Query: 248 LGQGGFGYVHKG-VLPNGKEVAIKQLKAGSGQGERVFQ-AEVEIISRV-HHKHLVSLVGY 304
+G+G F V K GK AIK +K E+V E++ + R+ H +++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 305 -YTAGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
+ + R+ LV E + N E + G+ RP + K L ++H I
Sbjct: 67 LFDRKTGRLALVFELMDMNLYEL-IKGRKRP-LPEKRVKSYMYQLLKSLDHMH---RNGI 121
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDV--YT-HVSTRVMGTFGYLAPE-YASSGK 418
HRDIK NIL+ K+ADFG + YT ++STR Y APE + G
Sbjct: 122 FHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTR-----WYRAPECLLTDGY 175
Query: 419 LTEKSDVFSFGVMLLELI 436
K D+++ G + E++
Sbjct: 176 YGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 39/119 (32%), Positives = 69/119 (57%), Gaps = 6/119 (5%)
Query: 342 KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR 401
K+++ +GLAYL E +I+HRD+K +NIL++ + E K+ DFG++ D ++
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANS 161
Query: 402 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTF-MEDNLARPLLN 459
+GT Y++PE + +SD++S G+ L+EL IG P+ +E RP+++
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVD 220
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 8/158 (5%)
Query: 285 AEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA 344
AE ++++V+ +V L + + + LV F+ L HL +GR + +R +
Sbjct: 42 AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDL---SRARFY 98
Query: 345 LG-FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403
L LH+ +I+RD+K NILLD++ + DFGL KL +T
Sbjct: 99 TAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FC 154
Query: 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
GT YLAPE T+ D ++ GV+L E++ G P
Sbjct: 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 46/225 (20%)
Query: 232 YEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSG--QGERVFQAEVE 288
YE+L++ +G+G +G V K G+ VAIK+ +++ E+
Sbjct: 3 YEKLSK----------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR 52
Query: 289 IISRVHHKHLVSLVGYYTAGSQRMLV---CEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL 345
++ ++ H +LV+L+ + + LV C+ N LE + G + KI
Sbjct: 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIW 107
Query: 346 GFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS---DVYT-HVSTR 401
+ + + H+ IHRD+K NIL+ + + K+ DFG A++ + D YT +V+TR
Sbjct: 108 QTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR 164
Query: 402 VMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELIIGC 439
Y APE Y DV++ G + EL+ G
Sbjct: 165 -----WYRAPELLVGDTQYGPP------VDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 51/229 (22%)
Query: 237 RATDGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQA--EVEIISRV 293
R D F +G+G +G V+K + G+ VA+K+++ + + A E++I+ ++
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 294 HHKHLVSLVGYYTAGSQRM----------LVCEFV--------TSNTLEF---HLHGKGR 332
+H+++V+L T + LV E++ S + F H+ +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 333 PTMDWPTRLKIALGFAKGLAYLHEDCHPK-IIHRDIKAANILLDFKFEAKVADFGLAKL- 390
++ GL Y CH K +HRDIK +NILL+ K + K+ADFGLA+L
Sbjct: 124 QLLE-------------GLNY----CHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
Query: 391 ---ASDVYTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLEL 435
S YT+ +V+ T Y PE + DV+S G +L EL
Sbjct: 167 NSEESRPYTN---KVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 51/222 (22%), Positives = 69/222 (31%), Gaps = 9/222 (4%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
PP P PP++ + PP PA RP + +T P P S P G P
Sbjct: 2552 PPPLPPAAPPAAPDRSVPPPRPAPRPSEPA-VTSRARRPDAPPQSARPRAPVDDRGDPRG 2610
Query: 61 STPSDSSPPSSNPVARSPPSP-PTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRR 119
P PP ++ PPSP P ++ + VS R RR
Sbjct: 2611 PAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVS----RPRR 2666
Query: 120 KRRRRRDDEAGYCT---LPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPV 176
RR R +A P V P A P PP P
Sbjct: 2667 ARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPA 2726
Query: 177 ASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPS 218
A+R + PP P ++ G + + PP+
Sbjct: 2727 AARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPA 2768
|
Length = 3151 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 12/200 (6%)
Query: 248 LGQGGFGYVHKGVLPNGKE-VAIKQLK---AGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
+G+G +G V K E VA+K+++ G + E+ ++ + HK++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ + LV E+ + ++ G +D KGLA+ H ++
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSH---NVL 121
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKS 423
HRD+K N+L++ E K+ADFGLA+ S V+ T Y P+ KL S
Sbjct: 122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 180
Query: 424 -DVFSFGVMLLELIIGCRPV 442
D++S G + EL RP+
Sbjct: 181 IDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 42/115 (36%), Positives = 59/115 (51%), Gaps = 7/115 (6%)
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL 409
GL ++H +++RD+K ANILLD +++D GLA S H S +GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162
Query: 410 APEYASSGKLTEKS-DVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463
APE G + S D FS G ML +L+ G P T + + R L A+E
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 50/204 (24%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQ---GERVFQAEVEIISRVHHKHLVSLVG 303
+G G +G V + +GK+VAIK++ +R + E++I+ H +++++
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIRD 71
Query: 304 YYTA----GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTR--LKIALGFAKGLAYLHED 357
+V + + S+ L +H P + R L L +GL Y+H
Sbjct: 72 ILRPPGADFKDVYVVMDLMESD-LHHIIHSDQ-PLTEEHIRYFLYQLL---RGLKYIHSA 126
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA---SDVYTHVSTRVMGTFGYLAPEYA 414
+IHRD+K +N+L++ E ++ DFG+A+ + + T + T Y APE
Sbjct: 127 N---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 415 -SSGKLTEKSDVFSFGVMLLELII 437
S + T D++S G + E++
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLG 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 247 LLGQGGFGYVHKGVL----PNGKEVAIKQL-KAGSGQGERVFQA--EVEIISRVHHKHLV 299
LLG+G FG V +L GK A+K L K + V E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
+L + + V E+ L FHL + + D R A L YLH
Sbjct: 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARFYGA-EIVSALGYLHSC-- 114
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYASSGK 418
+++RD+K N++LD K+ DFGL K + + + GT YLAPE
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDND 171
Query: 419 LTEKSDVFSFGVMLLELIIGCRP 441
D + GV++ E++ G P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 65/254 (25%), Positives = 93/254 (36%), Gaps = 55/254 (21%)
Query: 240 DGFSDANLLGQGGFGYV----HKGVLPNGKEVAIKQLKAG----SGQGERVFQAEVEIIS 291
D F ++G+G FG V K G+ A+K L+ Q +AE +I++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDK---DTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILA 56
Query: 292 RVHHKHLVSLVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK 349
+V L YY+ + L V E++ L L K + R IA
Sbjct: 57 DADSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVL- 112
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-------------------- 389
L +H+ IHRDIK NIL+D K+ADFGL K
Sbjct: 113 ALDSVHKLGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 390 --------LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ +GT Y+APE + D +S GV+L E++ G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 442 VDSTHTFMEDNLAR 455
F D L
Sbjct: 230 ------FYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 59/267 (22%), Positives = 118/267 (44%), Gaps = 24/267 (8%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQ---AEVEIISRVHHKHLVSLVG 303
+G+G F V++ L +G VA+K+++ + E++++ +++H +++
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLH--GKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ ++ +V E + L + K + + T K + L ++H +
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---R 126
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
++HRDIK AN+ + K+ D GL + S T + V GT Y++PE
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 185
Query: 422 KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481
KSD++S G +L E+ P F D + L + IE ++ P L +++
Sbjct: 186 KSDIWSLGCLLYEMAALQSP------FYGDKMNLYSLCKKIEQCDY-----PPLPSDHYS 234
Query: 482 NEMARMVACAAACVRHSARRRPRISQI 508
E+ ++V C+ +RP I+ +
Sbjct: 235 EELRQLV---NMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 58/200 (29%), Positives = 86/200 (43%), Gaps = 37/200 (18%)
Query: 231 TYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA--EV 287
YE+LA+ +GQG FG V K + VA+K++ + + A E+
Sbjct: 13 KYEKLAK----------IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREI 62
Query: 288 EIISRVHHKHLVSLV--------GYYTAGSQRMLVCEFVTSNTLEFHLHG---KGRPTMD 336
+I+ + H+++V+L+ Y LV EF E L G
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVKFT 117
Query: 337 WPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS---- 392
K+ GL Y+H + KI+HRD+KAANIL+ K+ADFGLA+ S
Sbjct: 118 LSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKN 174
Query: 393 DVYTHVSTRVMGTFGYLAPE 412
+ RV+ T Y PE
Sbjct: 175 SKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLK---AGSGQGERVFQAEVEIISRVH 294
T+ + D +G G FG V G+ VAIK++ + +R ++ E++++ +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67
Query: 295 HKHLVSLVGYYTAGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
H++++SL + + + + V E + + + H RP + +GL Y
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGT---DLHRLLTSRPLEKQFIQY-FLYQILRGLKY 123
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPE 412
+H ++HRD+K +NIL++ + K+ DFGLA++ T +VSTR Y APE
Sbjct: 124 VHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPE 175
Query: 413 YASS-GKLTEKSDVFSFGVMLLELIIG 438
+ K + D++S G + E++ G
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEG 202
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 29/204 (14%)
Query: 248 LGQGGFGYVHKGVLPNGKEVA------IKQLKAGSGQGERVFQAEVE--IISRVHHKHLV 299
LG+G FG V+ ++ + K VA +K++ G QA E ++S++ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLH-----GKGRP---TMDWPTRLKIALGFAKGL 351
+ ++ E+ L+ L GK +W +L + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAP 411
Y+H+ +I+HRD+KA NI L K+ DFG+++L ++T GT Y++P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGS-CDLATTFTGTPYYMSP 174
Query: 412 EYASSGKLTEKSDVFSFGVMLLEL 435
E KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 31/212 (14%)
Query: 248 LGQGGFGYVHKGVL-------PNGKEVAIKQLKAGSGQGERV---FQAEVEIISRVHHKH 297
LGQG F ++KGVL G + + G R F ++S++ HKH
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLH-GKGRPTMDWPTRLKIALGFAKGLAYLHE 356
LV L G + ++V E+V L+ LH K ++ W +L +A A L YL +
Sbjct: 63 LVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 357 DCHPKIIHRDIKAANILL-------DFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL 409
K++H ++ NIL+ + K++D G+ V ++
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE-----RIPWI 171
Query: 410 APEYASSG--KLTEKSDVFSFGVMLLELIIGC 439
APE +G LT +D +SFG LLE+
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNG 203
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 12/208 (5%)
Query: 248 LGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQA-EVEIISRVHHKHLVSLVGYY 305
LG+G + V KG VA+K+++ +G EV ++ + H ++V+L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL-GFAKGLAYLHEDCHPKIIH 364
LV E++ S+ ++ + +M +KI + +GL+Y H KI+H
Sbjct: 73 HTERCLTLVFEYLDSDLKQYLDNCGNLMSMH---NVKIFMFQLLRGLSYCH---KRKILH 126
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE-YASSGKLTEKS 423
RD+K N+L++ K E K+ADFGLA+ A V T + + T Y P+ S + +
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 424 DVFSFGVMLLELIIGCRPVDSTHTFMED 451
D++ G +L E+ G RP+ T E+
Sbjct: 186 DMWGVGCILYEMATG-RPMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 21/199 (10%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRVHHKHLVSLVG 303
+G+G +G V+K G+ VA+K+++ + + E V E+ ++ ++H ++V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLD 65
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL-GFAKGLAYLHEDCHP-K 361
+ ++ LV EF+ + L+ ++ +D P +K L +G+AY CH +
Sbjct: 66 VVHSENKLYLVFEFLDLD-LKKYMDSSPLTGLD-PPLIKSYLYQLLQGIAY----CHSHR 119
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAK---LASDVYTHVSTRVMGTFGYLAPEYASSGK 418
++HRD+K N+L+D + K+ADFGLA+ + YTH V+ T Y APE +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLGSR 175
Query: 419 LTEKS-DVFSFGVMLLELI 436
D++S G + E++
Sbjct: 176 QYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 248 LGQGGFGYVHKGVLPNGK---EVAIKQLKAGSGQGERV--FQAEVEIISRVHHKHLVSLV 302
LG+G FG V +G L +VA+K +K + F +E + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 303 GYYTAGSQR------MLVCEFVTSNTLE-FHLHGK-GRPTMDWPTRL--KIALGFAKGLA 352
G + +++ F+ L F L+ + G PT++ K A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYTHVSTRVMGTFGYLA 410
YL IHRD+ A N +L+ VADFGL+K D Y M ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM-PVKWIA 182
Query: 411 PEYASSGKLTEKSDVFSFGVMLLEL 435
E + T KSDV+SFGV + E+
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 248 LGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQA--EVEIISRVH---HKHLVSL 301
+G G +G V+K P+ G VA+K ++ + + EV ++ R+ H ++V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 302 VGY-YTAGSQR----MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE 356
+ T+ + R LV E V + L +L P + T + F +GL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQD-LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS 416
+C I+HRD+K NIL+ + K+ADFGLA++ S T V+ T Y APE
Sbjct: 127 NC---IVHRDLKPENILVTSGGQVKLADFGLARIYS--CQMALTPVVVTLWYRAPEVLLQ 181
Query: 417 GKLTEKSDVFSFGVMLLEL 435
D++S G + E+
Sbjct: 182 STYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 8e-10
Identities = 64/203 (31%), Positives = 89/203 (43%), Gaps = 18/203 (8%)
Query: 247 LLGQGGFGYVHKGVL----PNGKEVAIKQLKAGS--GQGERVFQ-AEVEIISRVHHKHLV 299
LLG+G FG V +L +GK A+K LK + E E ++ H L
Sbjct: 2 LLGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
SL + + V E+V L FHL + R + TR A L YLH
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGA-EIVSALDYLHSG-- 114
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLA-SDVYTHVSTRVMGTFGYLAPEYASSGK 418
KI++RD+K N++LD K+ DFGL K +D T + GT YLAPE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLEDND 171
Query: 419 LTEKSDVFSFGVMLLELIIGCRP 441
D + GV++ E++ G P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 63/233 (27%), Positives = 115/233 (49%), Gaps = 30/233 (12%)
Query: 248 LGQGGFGYVHKGVLPNGK---EVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
+G+G +G+V+K +GK E A+KQ++ G+G + E+ ++ + H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIE-GTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 305 YTAGSQRMLVCEFVTS-----NTLEFHLHGKG-RPTMDWPTRLKIALGFA--KGLAYLHE 356
+ + S R + F + + ++FH K + M P + +L + G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 357 DCHPKIIHRDIKAANILL----DFKFEAKVADFGLAKLASDVYTHVS--TRVMGTFGYLA 410
+ ++HRD+K ANIL+ + K+AD G A+L + ++ V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 411 PEYASSGK-LTEKSDVFSFGVMLLEL-----IIGCRPVD--STHTFMEDNLAR 455
PE + T+ D+++ G + EL I CR D +++ F D L R
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 60/223 (26%), Positives = 105/223 (47%), Gaps = 38/223 (17%)
Query: 248 LGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQA--EVEIISRVHHKHLVSLVGY 304
LG+G + V+KG G+ VA+K+++ +G F A E ++ + H ++V+L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHDI 71
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDW------PTRLKIAL-GFAKGLAYLHED 357
LV E++ ++ ++ MD +++ L +GLAY H
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQY---------MDDCGGGLSMHNVRLFLFQLLRGLAYCH-- 120
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAP------ 411
+++HRD+K N+L+ + E K+ADFGLA+ A V + + + T Y P
Sbjct: 121 -QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRPPDVLLGS 178
Query: 412 -EYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL 453
EY++S D++ G + E+ G RP+ T +ED L
Sbjct: 179 TEYSTS------LDMWGVGCIFYEMATG-RPLFPGSTDVEDQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 67/243 (27%), Positives = 109/243 (44%), Gaps = 30/243 (12%)
Query: 248 LGQGGFGYVHKGVLPNG---KEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVG 303
+G G FG V G + +G +V +K+L+ + Q + F E + + H +L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRP---TMDWPTRLKIALGFAKGLAYLHEDCHP 360
T + +LV EF L+ +L + T D T ++A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLA--KLASDVYTHVSTRVMGTFGYLAPEYASS-- 416
IH D+ N LL K+ D+GL+ K D Y ++ ++APE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV-TPDQLWVPLRWIAPELVDEVH 178
Query: 417 GKL-----TEKSDVFSFGVMLLELI-IGCRPVDS-------THTFMEDN--LARPLLNRA 461
G L T++S+V+S GV + EL +G +P T+T E L +P L
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238
Query: 462 IED 464
+ D
Sbjct: 239 LSD 241
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 47/222 (21%), Positives = 74/222 (33%), Gaps = 28/222 (12%)
Query: 1 PPIT---PALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPS-LSSLTPPPTSG 56
PP T PA PP++ + PP RP +S + P+ P+ + P +
Sbjct: 2760 PPTTAGPPAPAPPAAPAAGPPRRLT--RPAVASLSESRESLPSPWDPADPPAAVLAPAAA 2817
Query: 57 APPPSTPSDSSPPSSNPVARSP-----PSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVS 111
PP ++P+ PP ++ +P P PP+ GG G V +
Sbjct: 2818 LPPAASPAGPLPPPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAA 2877
Query: 112 LLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPA 171
RR R P ++ + + ++ P A PP+P
Sbjct: 2878 PARPPVRRLAR-------------PAVSRSTESFALPPDQPERPPQPQAP----PPPQPQ 2920
Query: 172 PPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAP 213
P P +P P P P PP + G+ P
Sbjct: 2921 PQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQP 2962
|
Length = 3151 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 11/99 (11%)
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM----G 404
+GL Y+H ++HRD+K +N+LL+ + K+ DFGLA++A H T +
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP--EHDHTGFLTEYVA 171
Query: 405 TFGYLAPEYASSGKLTEKS-DVFSFGVMLLELIIGCRPV 442
T Y APE + K K+ D++S G +L E++ RP+
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS-NRPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRVHHKH 297
F +G+G +G V+K G+ VA+K+++ + + E V E+ ++ ++H +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPN 60
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK-------- 349
+V L+ ++ LV EF+ + +F MD I L K
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKF---------MDASPLSGIPLPLIKSYLFQLLQ 111
Query: 350 GLAYLHEDCHP-KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY 408
GLA+ CH +++HRD+K N+L++ + K+ADFGLA+ A V T + T Y
Sbjct: 112 GLAF----CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVVTLWY 166
Query: 409 LAPEYASSGKL-TEKSDVFSFGVMLLELI 436
APE K + D++S G + E++
Sbjct: 167 RAPEILLGCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 21/233 (9%)
Query: 229 TFTYEELARATDGFSDANLLGQGGFGYVHKGVL--PNGKEVAIKQLKAGSGQGERVFQAE 286
T ++ +D + +G+G +G V K VL NG + A+K L E + +AE
Sbjct: 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEI-EAE 64
Query: 287 VEIISRVH-HKHLVSLVGYY-----TAGSQRMLVCEFVTSNTLEFHLHG--KGRPTMDWP 338
I+ + H ++V G Y G Q LV E ++ + G K M+ P
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 339 TRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398
I GL +LH + K IHRD+K NILL + K+ DFG++ +
Sbjct: 125 IIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 399 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446
+T V GT ++APE + + DV+S G+ +EL G P+ H
Sbjct: 182 NTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH 233
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 48/147 (32%), Positives = 72/147 (48%), Gaps = 11/147 (7%)
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
+V L + S LV ++++ L +HL +GR + D + IA L +LH+
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED-RAKFYIA-ELVLALEHLHKY 115
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYTHVSTRVMGTFGYLAPEYAS 415
I++RD+K NILLD + DFGL+K L + T+ GT YLAPE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT---FCGTTEYLAPEVLL 169
Query: 416 SGK-LTEKSDVFSFGVMLLELIIGCRP 441
K T+ D +S GV++ E+ G P
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLKAGS---GQGERVFQAEVEIISR-VHHKHL 298
++G+G FG V HK K A+K L+ + + E+ +E ++ + V H L
Sbjct: 2 VIGKGSFGKVLLARHKA---EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
V L + + V +++ L +HL + R ++ R A A L YLH
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHS-- 114
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
I++RD+K NILLD + + DFGL K + ST GT YLAPE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQP 172
Query: 419 LTEKSDVFSFGVMLLELIIGCRPVDSTHTF-MEDN-LARPL 457
D + G +L E++ G P S +T M DN L +PL
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 39/218 (17%)
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVEI 289
D + D +G G +G V + G +VAIK+L R FQ+ E+ +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKL-------YRPFQSELFAKRAYRELRL 67
Query: 290 ISRVHHKHLVSLVGYYTAGSQR------MLVCEFVTSNTLEFHLHGK-GRPTMDWPTRLK 342
+ + H++++ L+ +T LV F+ ++ + H K + +
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF----- 122
Query: 343 IALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA-SDVYTHVSTR 401
+ KGL Y+H IIHRD+K N+ ++ E K+ DFGLA+ S++ +V TR
Sbjct: 123 LVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR 179
Query: 402 VMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIG 438
Y APE + T+ D++S G ++ E++ G
Sbjct: 180 -----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 23/205 (11%)
Query: 248 LGQGGFGYVHKGVLPNGKE-VAIKQLKAGSGQGERVFQA--------EVEIISRVHHKHL 298
+GQGG+G V + E VA+K++K +F+ E +I++ + L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKK-----SLLFKLNEVRHVLTERDILTTTKSEWL 63
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
V L+ + L E+V L+ G + D R +A F + LHE
Sbjct: 64 VKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH-ARFYMAEMFE-AVDALHE-- 119
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
IHRD+K N L+D K+ DFGL+K Y + V+G+ Y+APE
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLSK-GIVTYAN---SVVGSPDYMAPEVLRGKG 174
Query: 419 LTEKSDVFSFGVMLLELIIGCRPVD 443
D +S G ML E + G P
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 3e-09
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 16/96 (16%)
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-------HVSTR 401
+GL YLH +IHRD+K +NIL++ + K+ DFGLA+ +V TR
Sbjct: 114 RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 402 VMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELI 436
Y APE SS + T+ D++S G + EL+
Sbjct: 171 W-----YRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 35/82 (42%), Positives = 51/82 (62%), Gaps = 1/82 (1%)
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASD-VYTHVSTRVMGTFGYLAPEYASSGKL 419
K++HRD+K+ANI L K+ DFG +K SD V V++ GT YLAPE +
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248
Query: 420 TEKSDVFSFGVMLLELIIGCRP 441
++K+D++S GV+L EL+ RP
Sbjct: 249 SKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 6/150 (4%)
Query: 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
+H LV L + S+ V E+V L FH+ + R + R A + L Y
Sbjct: 54 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSA-EISLALNY 111
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY 413
LHE II+RD+K N+LLD + K+ D+G+ K ++ GT Y+APE
Sbjct: 112 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEI 167
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRPVD 443
D ++ GV++ E++ G P D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 7e-09
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKE-VAIKQLKAGSGQGE--RVFQAEVEIISRVHHKHL 298
F ++G+G +G V K KE VAIK+ K E E++++ + +++
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEF-HLHGKGRPTMDWPTRLKIAL-GFAKGLAYLHE 356
V L + + LV E+V N LE G P P +++ + K + + H+
Sbjct: 63 VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVP----PEKVRSYIYQLIKAIHWCHK 118
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS 416
+ I+HRDIK N+L+ K+ DFG A+ S+ T + T Y +PE
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175
Query: 417 GKLTEKSDVFSFGVMLLEL 435
+ D++S G +L EL
Sbjct: 176 APYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 46/146 (31%), Positives = 67/146 (45%), Gaps = 6/146 (4%)
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
LV L + S+ LV E+V L FH+ + R + R A L +LHE
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQ-RQRKLPEEHARF-YAAEICIALNFLHER 115
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
II+RD+K N+LLD K+ D+G+ K ST GT Y+APE
Sbjct: 116 ---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGE 171
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVD 443
+ D ++ GV++ E++ G P D
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 50/213 (23%), Positives = 68/213 (31%), Gaps = 28/213 (13%)
Query: 17 PPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPP----PSTPSD------- 65
PPP P PP++ + PP PA P + + APP P P D
Sbjct: 2551 PPPPLPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRAPVDDRGDPRG 2610
Query: 66 SSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRR 125
+PPS P P PP + R R RR RR
Sbjct: 2611 PAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDP-APGRVSRPRRARR 2669
Query: 126 DDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPV 185
A + PP Q ++ +T P PP P PH+ V
Sbjct: 2670 LGRAAQASSPP-------------QRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALV 2716
Query: 186 YTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPS 218
S P PP +++ +S + AP P+
Sbjct: 2717 ---SATPLPPGPAAARQASPALPAAPAPPAVPA 2746
|
Length = 3151 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 54/171 (31%), Positives = 76/171 (44%), Gaps = 8/171 (4%)
Query: 289 IISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA 348
++ + H LV L + + V ++V L FHL + R ++ R A A
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEPRARF-YAAEVA 106
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY 408
+ YLH II+RD+K NILLD + + DFGL K + ST GT Y
Sbjct: 107 SAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEY 162
Query: 409 LAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH-TFMEDN-LARPL 457
LAPE D + G +L E++ G P S + M DN L +PL
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/231 (25%), Positives = 110/231 (47%), Gaps = 26/231 (11%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQA-EVEIISRVHHKHLVSLVGYYT 306
+G+G +G+V+K +GK+ LK G G + E+ ++ + H +++SL +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 307 AGSQRMLVCEFVTS-----NTLEFHLHGKG-RPTMDWPTRLKIALGFA--KGLAYLHEDC 358
+ + R + F + + ++FH K + + P + +L + G+ YLH +
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 359 HPKIIHRDIKAANILL----DFKFEAKVADFGLAKLASDVYTHVS--TRVMGTFGYLAPE 412
++HRD+K ANIL+ + K+AD G A+L + ++ V+ TF Y APE
Sbjct: 129 ---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 413 YASSGK-LTEKSDVFSFGVMLLEL-----IIGCRPVD--STHTFMEDNLAR 455
+ T+ D+++ G + EL I CR D +++ + D L R
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 11/168 (6%)
Query: 272 LKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKG 331
+KAG G E I+ ++H ++ L G +T L+ ++ L +L K
Sbjct: 122 IKAGQRGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD-LYCYLAAKR 177
Query: 332 R-PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390
D L I + + YLHE+ +IIHRDIKA NI ++ + + DFG A
Sbjct: 178 NIAICDI---LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF 231
Query: 391 ASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIG 438
D+ + GT APE + D++S G++L E+
Sbjct: 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRVHH 295
D + +G+G +G V+K GK VA+K+ + + E + E+ ++ +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSE 59
Query: 296 K-HLVSL-----VGYYTAGSQRMLVCEFVTSNTLEF-HLHGKGRPT-MDWPTRLKIALGF 347
++V L V LV E++ S+ +F +G+G + T
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKLAS---DVYTHVSTRVM 403
KG+A+ H+ ++HRD+K N+L+D K K+AD GL + S YTH +
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EI 172
Query: 404 GTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELI 436
T Y APE S + D++S G + E+
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 49/194 (25%), Positives = 92/194 (47%), Gaps = 12/194 (6%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLK-AGSGQGERVFQAEVEIISRVHHKHLVSL 301
++G+G FG H + ++ A+K+++ S + E +++++ H ++V+
Sbjct: 7 VVGEGSFGRALLVQHVN---SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ A +V E+ L + + T L+ + G+ ++HE +
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---R 120
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
++HRDIK+ NI L + K+ DFG A+L + + T V GT Y+ PE +
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNN 179
Query: 422 KSDVFSFGVMLLEL 435
KSD++S G +L EL
Sbjct: 180 KSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 46/153 (30%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 295 HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMD----WPTRLKIALGFAKG 350
H LV L + S+ V EFV+ L FH+ + + + + + +AL F
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNF--- 111
Query: 351 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLA 410
LHE II+RD+K N+LLD + K+ D+G+ K ST GT Y+A
Sbjct: 112 ---LHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIA 164
Query: 411 PEYASSGKLTEKSDVFSFGVMLLELIIGCRPVD 443
PE D ++ GV++ E++ G P D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY 408
+GL YLH +IIHRD+K NI ++ + + D G A+ V + GT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVET 222
Query: 409 LAPEYASSGKLTEKSDVFSFGVMLLELI 436
APE + K K+D++S G++L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 248 LGQGGFGYVHKGVLPNGK--------EVAIKQL-KAGSGQGERVFQAEVEIISRVHHKHL 298
LGQG F + KG+ EV +K L K+ E F+A ++S++ HKHL
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEA-ASMMSQLSHKHL 61
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
V G G + ++V E+V +L+ +L K + ++ +L++A A L +L +
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWALHFLEDK- 119
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD--VYTHVSTRVMGT--FGYLAPEYA 414
+ H ++ A N+LL + + K + KL SD + V + + ++ PE
Sbjct: 120 --GLTHGNVCAKNVLLIREEDRKTGNPPFIKL-SDPGISITVLPKEILLERIPWVPPECI 176
Query: 415 SSGK-LTEKSDVFSFGVMLLELIIG 438
+ + L+ +D +SFG L E+ G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 13/210 (6%)
Query: 248 LGQGGFGYVHKGVLPNGKE-VAIKQLKAGSGQGERVFQA-EVEIISRVHHKHLVSLVGYY 305
LG+G + V KG + VA+K+++ +G EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL-GFAKGLAYLHEDCHPKIIH 364
LV E++ + ++ +M +KI L +GLAY H K++H
Sbjct: 74 HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRR---KVLH 127
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE-YASSGKLTEKS 423
RD+K N+L++ + E K+ADFGLA+ A V T + + T Y P+ S + + +
Sbjct: 128 RDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQI 186
Query: 424 DVFSFGVMLLELIIGCRPVDSTHTFMEDNL 453
D++ G + E+ G RP+ T +ED L
Sbjct: 187 DMWGVGCIFFEMASG-RPLFPGST-VEDEL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 39/228 (17%)
Query: 240 DGFSDANLLGQGGFGYVHKGVLPNGKEV----AIKQLKAGS----GQGERVFQAEVEIIS 291
+ F L+ G +G V+ L KE A+K++ + Q ++VF E +I++
Sbjct: 1 EDFETIKLISNGAYGAVY---LVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILT 56
Query: 292 RVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA-LGFAK- 349
+ +VS+ + +V E+V L G + +A + FA+
Sbjct: 57 FAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAET 110
Query: 350 --GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-----LASDVYTH----- 397
L YLH + I+HRD+K N+L+ K+ DFGL+K L +++Y
Sbjct: 111 VLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKD 167
Query: 398 ----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ +V GT Y+APE + D ++ G++L E ++GC P
Sbjct: 168 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 37/99 (37%), Positives = 51/99 (51%), Gaps = 11/99 (11%)
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT-- 405
A+G+ +L K IHRD+ A NILL K+ DFGLA+ D+Y G
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGDAR 236
Query: 406 --FGYLAPEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
++APE T +SDV+SFGV+L E+ +G P
Sbjct: 237 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 52/196 (26%), Positives = 97/196 (49%), Gaps = 13/196 (6%)
Query: 248 LGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQA--EVEIISRVHHKHLVSLVGY 304
LG+G + V+KG+ NG+ VA+K + + +G F A E ++ + H ++V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHDI 71
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL-GFAKGLAYLHEDCHPKII 363
V E++ ++ ++ + P P +++ + +GLAY+H I+
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIH---GQHIL 125
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE-YASSGKLTEK 422
HRD+K N+L+ + E K+ADFGLA+ S S+ V+ T Y P+ + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSA 184
Query: 423 SDVFSFGVMLLELIIG 438
D++ G + +E++ G
Sbjct: 185 LDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 26/216 (12%)
Query: 242 FSDANLLGQGGFGYV--------HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEI 289
F +LG G +G V H +GK A+K LK + + + E ++
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHD----SGKLYAMKVLKKATIVQKAKTTEHTRTERQV 57
Query: 290 ISRVHHK-HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG-F 347
+ + LV+L + ++ L+ +++ L HL + R ++I G
Sbjct: 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEI 114
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFG 407
L +LH+ II+RDIK NILLD + DFGL+K + + GT
Sbjct: 115 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 408 YLAPEYASSGKLTEKS--DVFSFGVMLLELIIGCRP 441
Y+AP+ G D +S GV++ EL+ G P
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 38/104 (36%), Positives = 51/104 (49%), Gaps = 11/104 (10%)
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT-- 405
AKG+ +L K IHRD+ A NILL K+ DFGLA+ D+Y G
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGDAR 242
Query: 406 --FGYLAPEYASSGKLTEKSDVFSFGVMLLELI-IGCRPVDSTH 446
++APE T +SDV+SFGV+L E+ +G P
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 248 LGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQA-EVEIISRVHHKHLVSLVGYY 305
LG+G + V+KG VA+K+++ +G EV ++ + H ++V+L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 306 TAGSQRMLVCEFVTSNTLEF--------HLHGKGRPTMDWPTRLKIAL-GFAKGLAYLHE 356
LV E++ + ++ ++H +K+ L +GL Y H
Sbjct: 74 HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN-----------VKLFLFQLLRGLNYCHR 122
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE-YAS 415
K++HRD+K N+L++ + E K+ADFGLA+ A + T + + T Y P+
Sbjct: 123 R---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLG 178
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRPV 442
S + + D++ G + E+ G RP+
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTG-RPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 31/89 (34%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY 408
+GL Y+H ++HRD+K +N+LL+ + K+ DFGLA+ S+ ++ V+ T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174
Query: 409 LAPE-YASSGKLTEKSDVFSFGVMLLELI 436
APE + + T DV+S G + EL+
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 38/109 (34%), Positives = 57/109 (52%), Gaps = 16/109 (14%)
Query: 336 DWPTRLKIALGF----AKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390
WP L L F A+G+ +L ++C IHRD+ A N+LL AK+ DFGLA+
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLAR- 260
Query: 391 ASDVYTHVSTRVMGT----FGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
D+ + V G ++APE T +SDV+S+G++L E+
Sbjct: 261 --DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 35/223 (15%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERV--FQAEVEIISRVHHKHLVSLVGYY 305
++ K P VA+K++ S E + Q E+ ++ H +++ V +
Sbjct: 10 FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 306 TAGSQRMLVCEFV----TSNTLEFHLHGKGRPTMDWPTRLKIAL---GFAKGLAYLHEDC 358
S+ +V + + L+ H + L IA L Y+H
Sbjct: 69 IVDSELYVVSPLMAYGSCEDLLKTHF-------PEGLPELAIAFILKDVLNALDYIH--- 118
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADF---------GLAKLASDVYTHVSTRVMGTFGYL 409
IHR +KA++ILL + ++ G + + S + + +L
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WL 175
Query: 410 APE--YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH-TFM 449
+PE + EKSD++S G+ EL G P T M
Sbjct: 176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 7e-08
Identities = 32/84 (38%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 363 IHRDIKAANILLDFKFEAKVADFGLA-KLASDVYTHVSTRVMGTFGYLAPEYASS----G 417
IHRD+K N+LLD K+ADFG K+ ++ T V GT Y++PE S G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 418 KLTEKSDVFSFGVMLLELIIGCRP 441
+ D +S GV L E+++G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 29/209 (13%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
N++G G FG V++ + + ++VAIK++ Q + E+ I+ ++H +++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVL----QDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 305 YTAGSQRM--------LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGF--AKGLAYL 354
Y + +V EF+ T+ ++ R P L + + LAY+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFI-PQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEA-KVADFGLAK--LASD-VYTHVSTRVMGTFGYLA 410
H I HRD+K N+L+D K+ DFG AK LA +++ +R Y A
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRA 238
Query: 411 PEYA-SSGKLTEKSDVFSFGVMLLELIIG 438
PE + T D++S G ++ E+I+G
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 247 LLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERV---FQAEVEIISRVHHKHLVSLV 302
L+G+GG G V+ P + VA+K+++ + + F E +I + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC---- 358
+ G ++ TL+ L L L+ H+ C
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLK-SLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 359 --HPK-IIHRDIKAANILLDFKFEAKVADFGLAK---------LASDVYTHVST------ 400
H K ++HRD+K NILL E + D+G A L DV
Sbjct: 128 YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187
Query: 401 --RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 436
+++GT Y+APE +E +D+++ GV+L +++
Sbjct: 188 PGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 51/188 (27%), Positives = 86/188 (45%), Gaps = 28/188 (14%)
Query: 264 GKEVAIKQLK---AGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLV 314
G VA+K+L +R ++ E+ ++ V+HK+++SL+ +T LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104
Query: 315 CEFVTSNTLE-FHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANIL 373
E + +N + H+ +D + G+ +LH IIHRD+K +NI+
Sbjct: 105 MELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 155
Query: 374 LDFKFEAKVADFGLAKLASDVYT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 430
+ K+ DFGLA+ A + +V TR Y APE E D++S G
Sbjct: 156 VKSDCTLKILDFGLARTACTNFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGC 210
Query: 431 MLLELIIG 438
++ EL+ G
Sbjct: 211 IMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 41/122 (33%), Positives = 63/122 (51%), Gaps = 18/122 (14%)
Query: 334 TMDWPTRLKIALGFAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392
+D L + AKG+++L ++C IHRD+ A NILL K+ DFGLA+
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR--- 262
Query: 393 DVYTHVSTRVMGT----FGYLAPEYASSGKLTEKSDVFSFGVMLLELI-IGCR-----PV 442
D+ + V G ++APE + T +SDV+S+G++L E+ +G PV
Sbjct: 263 DIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322
Query: 443 DS 444
DS
Sbjct: 323 DS 324
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 37/99 (37%), Positives = 52/99 (52%), Gaps = 11/99 (11%)
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT-- 405
A+G+ +L K IHRD+ A NILL K+ DFGLA+ D+Y G+
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYVRKGSAR 237
Query: 406 --FGYLAPEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
++APE T +SDV+SFGV+L E+ +G P
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 248 LGQGGFGYVHKGV-LPNG-KEVAIKQLKAGSGQGERVFQA--EVEIISRVH---HKHLVS 300
+G+G +G V K L NG + VA+K+++ +G+ EV ++ + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 301 LVGYYTAG-----SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH 355
L T ++ LV E V + L +L P + T + +GL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS 415
+++HRD+K NIL+ + K+ADFGLA++ S + T V+ T Y APE
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLWYRAPEVLL 182
Query: 416 SGKLTEKSDVFSFGVMLLEL 435
D++S G + E+
Sbjct: 183 QSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 24/87 (27%), Positives = 36/87 (41%), Gaps = 2/87 (2%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
P PPSSS P +P P S S + PP + + PT+ +PPP
Sbjct: 179 PASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPP 238
Query: 61 STPSDSSPPSS--NPVARSPPSPPTGD 85
+ PP P++ + P+PP+
Sbjct: 239 GPAAPPPPPVQQVPPLSTAKPTPPSAS 265
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS-DVYTHVSTRVMGTFG 407
+GL YLH I+HRDIK N+L++ K+ DFGLA++ D H++ V+ +
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 408 YLAPE-YASSGKLTEKSDVFSFGVMLLELI 436
Y APE S T D++S G + EL+
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 36/97 (37%), Positives = 54/97 (55%), Gaps = 8/97 (8%)
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS---TRVMGTF 406
GL Y+H ++HRD+K N+L++ E K+ DFGLA+ S+ + T + T
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 407 GYLAPEYASSGKLTEKS-DVFSFGVMLLELIIGCRPV 442
Y APE S + K+ DV+S G +L EL +G +PV
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 32/92 (34%), Positives = 47/92 (51%), Gaps = 11/92 (11%)
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT---HVSTRVMGTF 406
G+ +LH IIHRD+K +NI++ K+ DFGLA+ A + +V TR
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIG 438
Y APE E D++S G ++ E+I G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 56/210 (26%), Positives = 84/210 (40%), Gaps = 32/210 (15%)
Query: 247 LLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEII----------SRV--- 293
LLG+G FG K + +++ G ++ + EV I SRV
Sbjct: 2 LLGKGTFG----------KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 51
Query: 294 -HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLA 352
H L +L + + V E+ L FHL + R + R A L
Sbjct: 52 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA-EIVSALE 109
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAP 411
YLH +++RDIK N++LD K+ DFGL K + + + GT YLAP
Sbjct: 110 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAP 164
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
E D + GV++ E++ G P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 56/229 (24%), Positives = 74/229 (32%), Gaps = 49/229 (21%)
Query: 1 PPITPALGPPSSSSLTPPP-ITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPP 59
P +G +S + PPP TP P + S TP P PA + + +L P A P
Sbjct: 2686 RAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPLPPGPAAARQASPALPAAPAPPAVP 2745
Query: 60 --PSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRC 117
P+TP + P+ P PP+P G L A+ L+
Sbjct: 2746 AGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPRRLTRP-AVASLS------------ 2792
Query: 118 RRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVA 177
+LP P P P + A + PA P P
Sbjct: 2793 -----------ESRESLPSPWDPADPPA----------AVLAPAAALPPAASPAGPLP-- 2829
Query: 178 SRPPHSPVYTPSPPPPPPFMSSS--------GGSSSNYSGSEAPIPPPS 218
PP S T PPPP P S GG S +P P+
Sbjct: 2830 --PPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPA 2876
|
Length = 3151 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 53/209 (25%), Positives = 82/209 (39%), Gaps = 29/209 (13%)
Query: 247 LLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEV--------------EIISR 292
LLG+G FG K + +K+ G ++ + EV ++
Sbjct: 2 LLGKGTFG----------KVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 51
Query: 293 VHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLA 352
H L +L + + V E+ L FHL + R + R A L
Sbjct: 52 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA-EIVSALD 109
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE 412
YLH + +++RD+K N++LD K+ DFGL K + T GT YLAPE
Sbjct: 110 YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPE 166
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
D + GV++ E++ G P
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 56/218 (25%), Positives = 94/218 (43%), Gaps = 54/218 (24%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEV---------EIISRVHHK 296
+G G +G V + G++VAIK+L R FQ+E+ ++ + H+
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKL-------SRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 297 HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA-------- 348
+++ L+ +T+ +F+L P M T L+ +G
Sbjct: 75 NVIGLLDVFTSAV--------SGDEFQDFYLV---MPYMQ--TDLQKIMGHPLSEDKVQY 121
Query: 349 ------KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-HVSTR 401
GL Y+H IIHRD+K N+ ++ E K+ DFGLA+ A T +V TR
Sbjct: 122 LVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 178
Query: 402 VMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIG 438
Y APE + + D++S G ++ E++ G
Sbjct: 179 -----WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-07
Identities = 34/100 (34%), Positives = 49/100 (49%), Gaps = 14/100 (14%)
Query: 363 IHRDIKAANILLDFKFEAKVADFG-LAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
+HRDIK N+L+D K+ADFG A+L ++ S +GT Y+APE ++
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTAN-KMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 422 KS------DVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR 455
K D +S GV+ E+I G P F E A+
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSP------FHEGTSAK 216
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 32/85 (37%), Positives = 44/85 (51%), Gaps = 6/85 (7%)
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLA-KLASDVYTHVSTRVMGTFGYLAPEYASS---- 416
+IHRD+K N+LLD K+ADFG K+ T V GT Y++PE S
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 417 GKLTEKSDVFSFGVMLLELIIGCRP 441
G + D +S GV L E+++G P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 9e-07
Identities = 54/215 (25%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 242 FSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
+ D LG G G V V + K VA+K++ Q + E++II R+ H ++V
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG---------FA--- 348
+ Y G + E V + E + + M+ + G F
Sbjct: 67 V--YEVLGPSGSDLTEDV-GSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQL 123
Query: 349 -KGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLASDVYTHVSTRVMG-- 404
+GL Y+H ++HRD+K AN+ ++ + K+ DFGLA++ Y+H G
Sbjct: 124 LRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV 180
Query: 405 TFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELIIG 438
T Y +P S T+ D+++ G + E++ G
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 50/227 (22%), Positives = 94/227 (41%), Gaps = 45/227 (19%)
Query: 240 DGFSDANLLGQGGFGYVHKGVLPNGKEV----------AIKQLKAGSGQGER--VFQAEV 287
D F ++G+G FG V + + + + +K+ + + ER + +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 288 EIISRVHH-----KHLVSLVGYYTAGSQRMLVCEF---VTSNTLEFHLHGKGRPTMDWPT 339
+ I+ +H+ +L ++ YY G L+ +F + + F++
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI------------ 108
Query: 340 RLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399
A+ + +H +HRDIK N+LLD ++ADFG + T S
Sbjct: 109 --------AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160
Query: 400 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELIIGCRP 441
+ +GT Y++PE + GK + D +S GV + E++ G P
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 7/94 (7%)
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA-SDVYTHVS-TRVMGTF 406
+ L Y+H + HRD+K NIL + + K+ DFGLA++A +D T + T + T
Sbjct: 114 RALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 407 GYLAPEYASS--GKLTEKSDVFSFGVMLLELIIG 438
Y APE S K T D++S G + E++ G
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223033 PHA03291, PHA03291, envelope glycoprotein I; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 47/211 (22%), Positives = 73/211 (34%), Gaps = 30/211 (14%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPP----TTPALSPPSLSSLTPPPTSG 56
P P LGP + P P R +S TP P + P+ + P+ S+ P +G
Sbjct: 191 PLSAPRLGP--ADVFVPATPRPTPRTTASPETTPTPSTTTSPPSTTIPAPSTTIAAPQAG 248
Query: 57 APPPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSL---- 112
P + + + P A + P + ++ ++ +AI ++I V L
Sbjct: 249 TTPEAEGTPAPPTPGGGEAPPANATPAPEASRYELTVTQIIQIAIPA-SIIACVFLGSCA 307
Query: 113 --LILRCRRKRRRRRD---------------DEAGYCTLPPPL--APKVDPYGGRQQHWQ 153
L RCRR+RRR +EA L L P P +++ Q
Sbjct: 308 CCLHRRCRRRRRRPARIYRPPSPVAPSISAVNEAALARLGDELKRHPPESPRRSKRRSSQ 367
Query: 154 QNVPPSAAHVVTQPPRPAPPHPVASRPPHSP 184
VP A + R P P
Sbjct: 368 TMVPSLTAISEESEAPAVVELSRSPRRPGGP 398
|
Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 38/119 (31%), Positives = 49/119 (41%), Gaps = 29/119 (24%)
Query: 342 KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKLASDVYTHVST 400
KI + L LH+ H IIH DIK N+L D K + D+GL K + T
Sbjct: 113 KIIRQLVEALNDLHK--H-NIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGT 162
Query: 401 RVM--GTFGYLAPEYASSGKLTEKSDVFSF-----GVMLLELIIGCRPVDSTHTFMEDN 452
GT Y +PE K+ + SF GV+ EL+ G H F ED
Sbjct: 163 PSCYDGTLDYFSPE-----KIKGHNYDVSFDWWAVGVLTYELLTG------KHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 32/84 (38%), Positives = 44/84 (52%), Gaps = 6/84 (7%)
Query: 363 IHRDIKAANILLDFKFEAKVADFGLA-KLASDVYTHVSTRVMGTFGYLAPEYASS----G 417
IHRD+K N+LLD K+ADFG K+ + T V GT Y++PE S G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 418 KLTEKSDVFSFGVMLLELIIGCRP 441
+ D +S GV L E+++G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 35/215 (16%), Positives = 52/215 (24%), Gaps = 11/215 (5%)
Query: 3 ITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPST 62
+ +GP ++ P PA P + P +P + + +
Sbjct: 584 VEAVVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAP 643
Query: 63 PSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRR 122
+ P +P + P G DG + G A +
Sbjct: 644 APGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAA--------PAG 695
Query: 123 RRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPH 182
A PP DP Q Q PS A P P P P
Sbjct: 696 AAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAP 755
Query: 183 SPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPP 217
+ P P P + + SE
Sbjct: 756 AQPPPPPAPAPAA---APAAAPPPSPPSEEEEMAE 787
|
Length = 824 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 55/197 (27%), Positives = 95/197 (48%), Gaps = 16/197 (8%)
Query: 248 LGQGGFGYVHKGVLPNGKE-VAIKQLKAGSGQGERVFQA---EVEIISRVHHKHLVSLVG 303
+G+G +G V+K E +A+K+++ + E V E+ ++ + H ++V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL-KIAL-GFAKGLAYLHEDCHPK 361
+ + LV E++ L+ H P RL K L +G+AY H +
Sbjct: 69 VVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---R 122
Query: 362 IIHRDIKAANILLDFKFEA-KVADFGLAKLASDVYTHVSTRVMGTFGYLAPE-YASSGKL 419
++HRD+K N+L+D + A K+ADFGLA+ A + T + T Y APE S
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVVTLWYRAPEILLGSRHY 181
Query: 420 TEKSDVFSFGVMLLELI 436
+ D++S G + E++
Sbjct: 182 STPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 10/92 (10%)
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFG 407
+GL Y+H IIHRD+K +N+ ++ E K+ DFGLA+ D T +V+TR
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 408 YLAPEYASSG-KLTEKSDVFSFGVMLLELIIG 438
Y APE + + D++S G ++ EL+ G
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 51/221 (23%), Positives = 73/221 (33%), Gaps = 11/221 (4%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPA--LSPPSLSSLTPPPTSGAP 58
PP P PP S P ++ LRP S P + PA SP +++S A
Sbjct: 118 PPTPPPASPPPS---PAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAAL 174
Query: 59 PPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCR 118
P S+P +++ S+P A PPS P + + A
Sbjct: 175 PLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPA-----PAPGRSAA 229
Query: 119 RKRRRRRDDEAGYCTLPPPLAPKVD-PYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVA 177
D + + P+ + P A+ RP P +
Sbjct: 230 DDAGASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSS 289
Query: 178 SRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPS 218
S SP +PS P P SS SSS+ S E+ S
Sbjct: 290 SPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTS 330
|
Length = 1352 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 46/231 (19%), Positives = 61/231 (26%), Gaps = 20/231 (8%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPAL-------------SPPSLS 47
P P PP+S +P P + P S PP +P S +
Sbjct: 114 PDPPPPTPPPASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAA 173
Query: 48 SLTPPPTSGAPPPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVI 107
P A PS+P PPS+ P A SP P S+
Sbjct: 174 LPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAG 233
Query: 108 VVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQP 167
S P P + + N P S
Sbjct: 234 ASSS-----DSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRP--GPAS 286
Query: 168 PRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPS 218
+P S P SP P+P P SSS S+ S + +
Sbjct: 287 SSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSR 337
|
Length = 1352 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-06
Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 10/92 (10%)
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFG 407
+GL Y+H IIHRD+K +N+ ++ E ++ DFGLA+ A D T +V+TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 408 YLAPEYASSG-KLTEKSDVFSFGVMLLELIIG 438
Y APE + + D++S G ++ EL+ G
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 58/228 (25%), Positives = 95/228 (41%), Gaps = 47/228 (20%)
Query: 240 DGFSDANLLGQGGFGYVHKGVLPNGKEV----------AIKQLKAGSGQGER--VFQAEV 287
+ F ++G+G FG V L N +V +K+ + + ER + +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 288 EIISRVHH-----KHLVSLVGYYTAGSQRMLVCEF---VTSNTLEFHLHGKGRPTMDWPT 339
+ I+ +H+ +L ++ YY G L+ +F + + F+L
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL-----------A 109
Query: 340 RLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG-LAKLASDVYTHV 398
+ IA+ L Y +HRDIK NIL+D ++ADFG KL D
Sbjct: 110 EMVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160
Query: 399 STRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELIIGCRP 441
S V GT Y++PE + GK + D +S GV + E++ G P
Sbjct: 161 SVAV-GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 12/94 (12%)
Query: 1 PPITPALGPPSSSSLTP--PPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAP 58
P P P++++ +P P P+ RP ++++ PP P + + P P + P
Sbjct: 362 PVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVA--P 419
Query: 59 PPSTPSDSSPPSSN--------PVARSPPSPPTG 84
P +S+P + P P P
Sbjct: 420 PVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEE 453
|
Length = 585 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 19/203 (9%)
Query: 248 LGQGGFGYVHKGVL---PNGKEVAIKQLKAGSGQGER-VFQAEVEIISRVHHKHLVSLVG 303
+G G FG V + V +K+LKA + E+ F + + + H +++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAKGLAYLHEDCHPK 361
+LV E+ L+ +L + + L ++A A G+ ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 362 IIHRDIKAANILLDFKFEAKVADFGL--AKLASDVYTHVSTRVMGTFGYLAPEYASS--G 417
+H D+ N L KV D+G+ ++ D Y +LAPE G
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELVGEFHG 178
Query: 418 KL-----TEKSDVFSFGVMLLEL 435
L T+ S+V++ GV L EL
Sbjct: 179 GLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 8e-06
Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 20/181 (11%)
Query: 265 KEVAIKQLK---AGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG------SQRMLVC 315
+ VAIK+L +R ++ E+ ++ V+HK+++SL+ +T LV
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 101
Query: 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD 375
E + +N + M + + G+ +LH IIHRD+K +NI++
Sbjct: 102 ELMDANLCQVIQMELDHERMSY-----LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 153
Query: 376 FKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
K+ DFGLA+ A + + T + T Y APE E D++S G ++ E+
Sbjct: 154 SDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 436 I 436
+
Sbjct: 212 V 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 64/260 (24%), Positives = 97/260 (37%), Gaps = 80/260 (30%)
Query: 240 DGFSDANLLGQGGFGYV----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIIS 291
D F ++G+G FG V K G A+K+L+ Q V +AE +I++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKSEMLEKEQVAHV-RAERDILA 56
Query: 292 RVHHKHLVSLVGYYTAGSQR--MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA----- 344
+ +V L YY+ + L+ E++ + L K T + TR IA
Sbjct: 57 EADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIAETILA 113
Query: 345 ------LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL----------- 387
LG+ IHRDIK N+LLD K K++DFGL
Sbjct: 114 IDSIHKLGY---------------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158
Query: 388 -----------AKLASDVYTHVSTR---------------VMGTFGYLAPEYASSGKLTE 421
L S R +GT Y+APE +
Sbjct: 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNK 218
Query: 422 KSDVFSFGVMLLELIIGCRP 441
+ D +S GV++ E+++G P
Sbjct: 219 ECDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 47/181 (25%), Positives = 84/181 (46%), Gaps = 16/181 (8%)
Query: 265 KEVAIKQLK---AGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT-AGSQRMLVCEFVTS 320
+ VAIK+L +R ++ E+ ++ V+HK+++ L+ +T S ++
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 108
Query: 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380
++ +L + +D + G+ +LH IIHRD+K +NI++
Sbjct: 109 ELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTL 165
Query: 381 KVADFGLAKLASDVYT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII 437
K+ DFGLA+ A + +V TR Y APE E D++S G ++ E+I
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 438 G 438
G
Sbjct: 221 G 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 19/75 (25%), Positives = 28/75 (37%), Gaps = 1/75 (1%)
Query: 5 PALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPS 64
PA P S++ P + S T PA +PP++S P PPST
Sbjct: 386 PAAAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVSVDPPAAVP-VNPPSTAP 444
Query: 65 DSSPPSSNPVARSPP 79
+ P+ + P
Sbjct: 445 QAVRPAQFKEEKKIP 459
|
Length = 614 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 29/81 (35%), Positives = 42/81 (51%), Gaps = 1/81 (1%)
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA-SSGKLT 420
I++RDIK NILLD + + DFGL+K + GT Y+APE G
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185
Query: 421 EKSDVFSFGVMLLELIIGCRP 441
+ D +S G+++ EL+ G P
Sbjct: 186 KAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 24/88 (27%), Positives = 29/88 (32%), Gaps = 4/88 (4%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPT----SG 56
T P PPSSS P +P P S S + PP
Sbjct: 162 DVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQS 221
Query: 57 APPPSTPSDSSPPSSNPVARSPPSPPTG 84
PP +P + PS P +PP PP
Sbjct: 222 DTPPPSPESPTNPSPPPGPAAPPPPPVQ 249
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 283 FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLH-GKGRPTMDWPTRL 341
F ++S+V H HL + G GS+ ++V EFV L+ L KGR + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 342 KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA-------KVADFGLAKLASDV 394
+A A L+YL + ++H ++ A NILL A K++D G++ A
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR 177
Query: 395 YTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLEL 435
V ++APE G L+ +D +SFG LLE+
Sbjct: 178 EERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 25/84 (29%), Positives = 35/84 (41%), Gaps = 10/84 (11%)
Query: 11 SSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPS 70
+ + PP TP P TP P+ PA SP S S P A +PS+ S +
Sbjct: 80 GTGKVAPPAATPTSAP------TPTPSPPA-SPASGMSAAPA---SAVEEKSPSEESATA 129
Query: 71 SNPVARSPPSPPTGDDGGGGVSTG 94
+ P + S P +G D + G
Sbjct: 130 TAPESPSTSVPSSGSDAASTLVVG 153
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 11/175 (6%)
Query: 266 EVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEF 325
+V +K L F ++ +V HKH+V L G + ++V EFV L+
Sbjct: 34 KVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDL 93
Query: 326 HLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385
+H K + P + K+A A L+YL ED ++H ++ NILL E +
Sbjct: 94 FMHRKSDV-LTTPWKFKVAKQLASALSYL-ED--KDLVHGNVCTKNILL--AREGIDGEC 147
Query: 386 GLAKLASD--VYTHVSTR--VMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLEL 435
G SD + V +R + ++APE K L+ +D +SFG L E+
Sbjct: 148 GPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 30/85 (35%), Positives = 46/85 (54%), Gaps = 7/85 (8%)
Query: 363 IHRDIKAANILLDFKFEAKVADFG-LAKLASDVYTHVSTRVMGTFGYLAPEYASS----- 416
+HRDIK N+LLD ++ADFG +L +D T S +GT Y++PE +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD-GTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 417 GKLTEKSDVFSFGVMLLELIIGCRP 441
G+ + D +S GV + E++ G P
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 40/247 (16%), Positives = 66/247 (26%), Gaps = 9/247 (3%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
+ PA S P P +P PP+ +PPP+ L+ P
Sbjct: 93 STLAPASPAREGSPTPPGPSSPDPPPPTPPPASPPPSPA-------PDLSEMLRPVGSPG 145
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRK 120
P+ S P + A + +S+ A S +
Sbjct: 146 PPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPR 205
Query: 121 RRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRP 180
RR + + P P + + S+ P P
Sbjct: 206 PPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITL 265
Query: 181 PHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATD 240
P + ++ S P SSS+ +P P PS S S + + +
Sbjct: 266 P-TRIWEASGWNGPSSRPGPASSSSSPRER-SPSPSPSSPGSGPAPSSPRASSSSSSSRE 323
Query: 241 GFSDANL 247
S +
Sbjct: 324 SSSSSTS 330
|
Length = 1352 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 37/235 (15%), Positives = 53/235 (22%), Gaps = 24/235 (10%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
P P + +S AL S P++P PP +
Sbjct: 151 SPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAAASPRPPRRS 210
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRK 120
S S S+ + RS S G + + + L
Sbjct: 211 SPISASASSPAPAPGRSAADDAGASSSDSSSSESSGCGWGPENECPLPRPAPITL----P 266
Query: 121 RRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQP------------- 167
R + P A R + P S +
Sbjct: 267 TRIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSSPGSGPAPSSPRASSSSSSSRESSS 326
Query: 168 ----PRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPS 218
A P SP +PSP PPP + SS + P
Sbjct: 327 SSTSSSSESSRGAAVSPGPSPSRSPSPSRPPP---PADPSSPRKRPRPSRAPSSP 378
|
Length = 1352 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 7e-05
Identities = 38/204 (18%), Positives = 53/204 (25%), Gaps = 36/204 (17%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
PP PA P ++++ PA R P+ +L A P + P P + AP
Sbjct: 402 PPAAPAAAPAAAAAARAVAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPAA-APAA 460
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRK 120
+ ++ P A +
Sbjct: 461 AARPAAAGPRPVAAAAAAAPARAAPAA--------------------------------A 488
Query: 121 RRRRRDDEAGYCTLPPPLA-PKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPA--PPHPVA 177
DD + LPP A P W P A P A
Sbjct: 489 PAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAA 548
Query: 178 SRPPHSPVYTPSPPPPPPFMSSSG 201
P + P P PP S+SG
Sbjct: 549 PAPRAAAATEPVVAPRPPRASASG 572
|
Length = 700 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 27/90 (30%), Positives = 42/90 (46%), Gaps = 3/90 (3%)
Query: 6 ALGPPSSSSLTP-PPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPS 64
A+ P++++ P PP P ++ + PP P + P P + PPP+ P+
Sbjct: 30 AIALPATANADPAPPPPPPSTAAAAPAPAAPPPPPPPAAPPAPQPDDPNAAPPPPPADPN 89
Query: 65 DSSPPSSNPVARSPPSPPTG--DDGGGGVS 92
PP +P A PP+P G D+ GG S
Sbjct: 90 APPPPPVDPNAPPPPAPEPGRIDNAVGGFS 119
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 16/108 (14%)
Query: 348 AKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
A+G+ +L ++C +HRD+ A N+LL K+ DFGLA+ +VS TF
Sbjct: 247 ARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG--STF 300
Query: 407 ---GYLAPEYASSGKLTEKSDVFSFGVMLLELI-IGCRP-----VDST 445
++APE T SDV+S+G++L E+ +G P VDST
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 24/86 (27%), Positives = 28/86 (32%), Gaps = 10/86 (11%)
Query: 4 TPALGPPSSSSLTPPPITPALRPPSSSSLTPP--PTTPALSPPSLSSLTPPPTSGAPPPS 61
+PA P P P P P P P L S PT PP
Sbjct: 383 SPAGSPDVKKKAPEPD------LPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPPV 436
Query: 62 TPSDSSPPSSNPVARSPPSPPTGDDG 87
S PPS P A +P + +G G
Sbjct: 437 ARSAPLPPS--PQASAPRNVASGKPG 460
|
Length = 620 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 2e-04
Identities = 16/82 (19%), Positives = 26/82 (31%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
A P+ ++ P PA P S P A SPP ++ + P
Sbjct: 414 AAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAA 473
Query: 61 STPSDSSPPSSNPVARSPPSPP 82
P+ + P+ +P
Sbjct: 474 PEPTAAPAPAPPAAPAPAAAPA 495
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 2e-04
Identities = 8/79 (10%), Positives = 23/79 (29%)
Query: 5 PALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPS 64
P +++ + + ++ P PA + + P P + A + P+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 65 DSSPPSSNPVARSPPSPPT 83
++ +
Sbjct: 98 APPAAAAAAAPAAAAVEDE 116
|
Length = 1228 |
| >gnl|CDD|217059 pfam02480, Herpes_gE, Alphaherpesvirus glycoprotein E | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 19/78 (24%), Positives = 29/78 (37%), Gaps = 10/78 (12%)
Query: 49 LTPPPTSGAPPPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIV 108
+ P P + P +PPSP T L++ + G AV++
Sbjct: 315 VHRPRLGALDSIE--PPPPPTPTPPAEIAPPSPGT--------RPYLLLLAGVLGAAVLL 364
Query: 109 VVSLLILRCRRKRRRRRD 126
+V L+ RRRRR
Sbjct: 365 LVVGLLAWVCVTRRRRRK 382
|
Glycoprotein E (gE) of Alphaherpesvirus forms a complex with glycoprotein I (gI) (pfam01688), functioning as an immunoglobulin G (IgG) Fc binding protein. gE is involved in virus spread but is not essential for propagation. Length = 437 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 33/113 (29%), Positives = 50/113 (44%), Gaps = 34/113 (30%)
Query: 363 IHRDIKAANILLDFKFEAKVADFGLA-----------------KLASD-VYTHVSTR--- 401
IHRDIK N+LLD K K++DFGL L SD + +++++
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 402 -------------VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+GT Y+APE + D +S GV++ E++IG P
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|216257 pfam01034, Syndecan, Syndecan domain | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 26/137 (18%), Positives = 43/137 (31%), Gaps = 19/137 (13%)
Query: 2 PITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPS 61
P P ++S TPP +T PS+ TT A + S + PS
Sbjct: 62 PSDDEDSEPVTTSATPPKLTTTSSSPSND------TTTASTSTKTSPTVSTTVTTTTSPS 115
Query: 62 TPSDSSPPSSNPVARSPPSPPTGDDGGG-------GVSTGLVVGLAIGGLAVIVVVSLLI 114
++ + V ++ G +G L + +V L+
Sbjct: 116 ETDTEEATTTVSTETPTEGGSSAATDPSKNLLERKEVLAAVIAGGVVGLLFAVFLVMFLV 175
Query: 115 LRCRRKRRRRRDDEAGY 131
R ++K DE Y
Sbjct: 176 YRMKKK------DEGSY 186
|
Syndecans are transmembrane heparin sulfate proteoglycans which are implicated in the binding of extracellular matrix components and growth factors. Length = 207 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 29/106 (27%), Positives = 35/106 (33%), Gaps = 9/106 (8%)
Query: 1 PPITPALGP-PSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPP 59
P PA P L P ++ R S +L P P + P P PP
Sbjct: 2871 PAAKPAAPARPPVRRLARPAVS---RSTESFALPPDQPERPPQPQAPPPPQPQPQPPPPP 2927
Query: 60 PSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLA 105
P PP P P PT D G G +G V +G L
Sbjct: 2928 QPQPPPPPPPRPQP-----PLAPTTDPAGAGEPSGAVPQPWLGALV 2968
|
Length = 3151 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 17/84 (20%), Positives = 24/84 (28%), Gaps = 6/84 (7%)
Query: 135 PPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPP 194
PP +P V + + + PP P+ P PSPPP P
Sbjct: 187 PPSSSPGVPSFPSPPEDPSSPSDS------SLPPAPSSFQSDTPPPSPESPTNPSPPPGP 240
Query: 195 PFMSSSGGSSSNYSGSEAPIPPPS 218
+ P PP +
Sbjct: 241 AAPPPPPVQQVPPLSTAKPTPPSA 264
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 17/81 (20%), Positives = 26/81 (32%)
Query: 5 PALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPS 64
P P S P P+ S+ T A++ + P +P
Sbjct: 358 PPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPAGRPRPSPL 417
Query: 65 DSSPPSSNPVARSPPSPPTGD 85
D+ S AR P P+G+
Sbjct: 418 DAGAASGAFYARYPLLTPSGE 438
|
Length = 1352 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 20/75 (26%), Positives = 33/75 (44%), Gaps = 4/75 (5%)
Query: 13 SSLTPPPITPALRPPSSSSLTP--PPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSP-P 69
+ L P P P P++++ +P P P+ P + ++ PP +TP P P
Sbjct: 358 ALLVPVPA-PQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRP 416
Query: 70 SSNPVARSPPSPPTG 84
+ PV +P S P
Sbjct: 417 VAPPVPHTPESAPKL 431
|
Length = 585 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 3e-04
Identities = 18/84 (21%), Positives = 26/84 (30%), Gaps = 3/84 (3%)
Query: 1 PPITPALGPP-SSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPP 59
P + P P +S+ T P P + + PP + P +P T A
Sbjct: 368 PEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTSQLLAARQ 427
Query: 60 P--STPSDSSPPSSNPVARSPPSP 81
+ S P A S P
Sbjct: 428 QLQRAQGATKAKKSEPAAASRARP 451
|
Length = 647 |
| >gnl|CDD|234398 TIGR03921, T7SS_mycosin, type VII secretion-associated serine protease mycosin | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 26/74 (35%), Positives = 32/74 (43%), Gaps = 8/74 (10%)
Query: 55 SGAPPPST--PSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSL 112
+G PP P +P + PVA P PP D G V+ L GLA + VV
Sbjct: 283 TGELPPEDGRPLRPAPAPARPVAAPAPPPPPDDTPRGRVA------LWGAGLAALAVVVG 336
Query: 113 LILRCRRKRRRRRD 126
L R+R RRR
Sbjct: 337 LAAAAVRRRGRRRR 350
|
Members of this family are subtilisin-related serine proteases, found strictly in the Actinobacteria and associated with type VII secretion operons. The designation mycosin is used for members from Mycobacterium [Protein fate, Protein and peptide secretion and trafficking, Protein fate, Protein modification and repair]. Length = 350 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 25/86 (29%), Positives = 30/86 (34%), Gaps = 3/86 (3%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
P PS SSL P P + P S P T PP ++ PPP PP
Sbjct: 198 PSPPEDPSSPSDSSLPPAPSSFQSDTPPPS---PESPTNPSPPPGPAAPPPPPVQQVPPL 254
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDD 86
ST + P +S A D
Sbjct: 255 STAKPTPPSASATPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 14/84 (16%), Positives = 25/84 (29%), Gaps = 2/84 (2%)
Query: 1 PPITPALGPPSSS--SLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAP 58
P P P+++ + PA P +++S P A P + P +
Sbjct: 380 TPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAAPAAAAPAAAPA 439
Query: 59 PPSTPSDSSPPSSNPVARSPPSPP 82
+P A + P
Sbjct: 440 AAPAAVALAPAPPAQAAPETVAIP 463
|
Length = 618 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 32/107 (29%), Positives = 55/107 (51%), Gaps = 10/107 (9%)
Query: 333 PTMDWPTRLKIALGFAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391
P + + + + A G+ +L ++C +HRD+ A N+L+ K+ DFGLA+
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDI 289
Query: 392 SDVYTHVSTRVMGTF---GYLAPEYASSGKLTEKSDVFSFGVMLLEL 435
++S TF ++APE + T SDV+SFG++L E+
Sbjct: 290 MRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 31/225 (13%), Positives = 48/225 (21%), Gaps = 26/225 (11%)
Query: 4 TPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTP 63
P ++ PP + P ++ P A + P+ + + A + P
Sbjct: 587 VVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAG---AAAAPAEASAAP 643
Query: 64 SDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRR 123
+ + + G G A
Sbjct: 644 APGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAP-------AAPAGA 696
Query: 124 RRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAP----------- 172
A PP DP Q Q PS A P P P
Sbjct: 697 APAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPA 756
Query: 173 -----PHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEA 212
P P + P + P S + +A
Sbjct: 757 QPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDDEDRRDA 801
|
Length = 824 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 26/106 (24%), Positives = 37/106 (34%), Gaps = 5/106 (4%)
Query: 1 PPITPALGPPSSSSLTPPPITP-ALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPP 59
P P P + P P A + +++ P PA + P + P AP
Sbjct: 413 APAAPPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVA---IPVRVAPE 469
Query: 60 PSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLA 105
P+ S + P++ P A GD V L AI LA
Sbjct: 470 PAVASAAPAPAAAPAAARLTPTEEGDVWHATVQQ-LAAAEAITALA 514
|
Length = 618 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 6e-04
Identities = 13/82 (15%), Positives = 28/82 (34%)
Query: 11 SSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPS 70
S P A ++S+ P A + P+ + + P P+ + ++
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 71 SNPVARSPPSPPTGDDGGGGVS 92
+ P A + + P V+
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEVT 118
|
Length = 1228 |
| >gnl|CDD|215533 PLN02983, PLN02983, biotin carboxyl carrier protein of acetyl-CoA carboxylase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 33/89 (37%), Positives = 43/89 (48%), Gaps = 8/89 (8%)
Query: 17 PPPITP--ALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSS-PPSSNP 73
PPP P ++PP ++ P A PS + +PPPT +PPP+ SS PP +P
Sbjct: 144 PPPPAPVVMMQPPPPHAMPPASPPAAQPAPSAPASSPPPTPASPPPAKAPKSSHPPLKSP 203
Query: 74 VA----RSP-PSPPTGDDGGGGVSTGLVV 97
+A RSP P P G V G VV
Sbjct: 204 MAGTFYRSPAPGEPPFVKVGDKVQKGQVV 232
|
Length = 274 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 48/220 (21%), Positives = 61/220 (27%), Gaps = 37/220 (16%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
+ AL P + P + P S P P TP PPP
Sbjct: 67 QQVNAALPPAPAPQSPQPDQQQQSQAPPSHQY-PSQLPPQQVQSVPQQPTPQQEPYYPPP 125
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRK 120
S P PP+ P A+ P PP +++
Sbjct: 126 SQPQP--PPAQQPQAQQPQPPP--------------------------------QVPQQQ 151
Query: 121 RRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRP 180
+ + + Y PPP A G P S P A P + P
Sbjct: 152 QYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQPPYSGAP 211
Query: 181 PHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLG 220
P Y PP P P+M G N PPPS G
Sbjct: 212 PSQQFY--GPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQG 249
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 26/92 (28%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 5 PALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPS 64
PA+ + S PP P + PPP P PP PPP PPP P
Sbjct: 2889 PAVSRSTESFALPPDQPERPPQPQA----PPPPQPQPQPPPPPQPQPPP----PPPPRPQ 2940
Query: 65 DSSPPSSNPVARSPPSPPTGDDGGGGVSTGLV 96
P+++P PS G + G V
Sbjct: 2941 PPLAPTTDPAGAGEPSGAVPQPWLGALVPGRV 2972
|
Length = 3151 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 21/75 (28%), Positives = 31/75 (41%), Gaps = 5/75 (6%)
Query: 28 SSSSLTPPPTTPALSPPSLSSLT---PPPTSGAPPPSTPSDSSPPSSNPVARSPPSP-PT 83
+ + PP TP S P+ + P A P S + SP + A +P SP +
Sbjct: 80 GTGKVAPPAATPT-SAPTPTPSPPASPASGMSAAPASAVEEKSPSEESATATAPESPSTS 138
Query: 84 GDDGGGGVSTGLVVG 98
G ++ LVVG
Sbjct: 139 VPSSGSDAASTLVVG 153
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 31/113 (27%), Positives = 48/113 (42%), Gaps = 34/113 (30%)
Query: 363 IHRDIKAANILLDFKFEAKVADFGL------------------------------AKLAS 392
IHRDIK N+LLD K K++DFGL +K +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 393 DVYT----HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ + ++ +GT Y+APE + D +S GV++ E++IG P
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|183558 PRK12495, PRK12495, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 18/83 (21%), Positives = 28/83 (33%), Gaps = 6/83 (7%)
Query: 9 PPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSP 68
P + + PP +SS + P + ++ P P+TP +
Sbjct: 102 PAAEAEAADQS-----APPEASSTSATDEAATDPPATAAARDGPTPDPTAQPATPDERRS 156
Query: 69 PSSNPVARS-PPSPPTGDDGGGG 90
P P PP+P T D G
Sbjct: 157 PRQRPPVSGEPPTPSTPDAHVAG 179
|
Length = 226 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 56/218 (25%), Positives = 73/218 (33%), Gaps = 38/218 (17%)
Query: 16 TPPPITP-ALRPPSSS-SLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPSSNP 73
PP + A R P ++ T PP P + P+ ++ P GA P +
Sbjct: 257 PPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVWGAALAGAP-----LALPA 311
Query: 74 VARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCR-----RKRRRR---- 124
PP P GD G A+ VV L R KRRR
Sbjct: 312 PPDPPPPAPAGDAEEEDDEDG----------AMEVVSPLPRPRQHYPLGFPKRRRPTWTP 361
Query: 125 ----RDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRP 180
D AG P A P R+ P + RPA P P AS P
Sbjct: 362 PSSLEDLSAG--RHHPKRASL--PTRKRRSARHAATPFARGPGGDDQTRPAAPVP-ASVP 416
Query: 181 PHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPS 218
+P P+ PPPP ++ S+ + P PPP
Sbjct: 417 TPAPTPVPASAPPPP---ATPLPSAEPGSDDGPAPPPE 451
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 32/195 (16%), Positives = 47/195 (24%), Gaps = 23/195 (11%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
P A P++ + PA + + P + A
Sbjct: 615 PAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAG 674
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRK 120
+ PP+ P A + P+ + G A A +
Sbjct: 675 GAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAA--------- 725
Query: 121 RRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRP 180
+ A +P P P P P A PP PAP A+ P
Sbjct: 726 QGASAPSPAADDPVPLPPEPDDPP-----------DPAGAPAQPPPPPAPAPAAAPAAAP 774
Query: 181 PHSPVYTPSPPPPPP 195
P PS
Sbjct: 775 ---PPSPPSEEEEMA 786
|
Length = 824 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 41/219 (18%), Positives = 53/219 (24%), Gaps = 40/219 (18%)
Query: 5 PALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAP-----P 59
+ P T P + S P+ S T P S A P
Sbjct: 49 ELAAVTVVAGAAACDRFEPPTGPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTP 108
Query: 60 PSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRR 119
P S PP + P A PPSP +LR
Sbjct: 109 PGPSSPDPPPPTPPPASPPPSPAPDLSE--------------------------MLRPVG 142
Query: 120 KRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASR 179
P A D RQ + P A + PP PP +
Sbjct: 143 SPGPPPAASPPAAGASPA-AVASDAASSRQAALPLSSPEETARAPSSPPAEPPPSTPPAA 201
Query: 180 PPHSP--------VYTPSPPPPPPFMSSSGGSSSNYSGS 210
P SP P P ++ +S+ S
Sbjct: 202 ASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSS 240
|
Length = 1352 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 36/193 (18%), Positives = 54/193 (27%), Gaps = 34/193 (17%)
Query: 23 ALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPSSNPVARSPPSPP 82
A RP S P T A +P + P P + AP + P+ ++PP++ A + +
Sbjct: 362 AFRPGQSGGGAGPAT-AAAAPVA----QPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAA 416
Query: 83 TGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKV 142
+ LA R+ P AP
Sbjct: 417 RAVAAAPARRSPAPEALAAA--------------------RQASARGPGGAPAPAPAPAA 456
Query: 143 DPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGG 202
P P+AA A P + P +P PPP +
Sbjct: 457 APAAA--------ARPAAAGPRP-VAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFA 507
Query: 203 SSSNYSGSEAPIP 215
S + AP
Sbjct: 508 SPAPAQPDAAPAG 520
|
Length = 700 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 17/197 (8%)
Query: 262 PNGKEVAIK--QLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319
P G V ++ L+ + + + Q EV + H ++++ +T GS ++ F+
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE 379
+ L M I G +GL YLH++ + IHR+IKA++IL+ +
Sbjct: 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGY---IHRNIKASHILI--SGD 137
Query: 380 AKVADFGLAKLASDVYTHVSTRVMGTF--------GYLAPEYASSG--KLTEKSDVFSFG 429
V+ GL+ L S V +V+ F +L+PE KSD++S G
Sbjct: 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVG 197
Query: 430 VMLLELIIGCRPVDSTH 446
+ EL G P
Sbjct: 198 ITACELATGRVPFQDML 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 17/73 (23%), Positives = 22/73 (30%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
TP S P P P + PPP A S + P S PPP
Sbjct: 520 TAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPPPP 579
Query: 61 STPSDSSPPSSNP 73
+ P+ +
Sbjct: 580 IPEEPTPSPTKDS 592
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 17/73 (23%), Positives = 25/73 (34%)
Query: 11 SSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPS 70
S S + TP S P P P + + PPP A S+ + + P+
Sbjct: 513 QSGSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPA 572
Query: 71 SNPVARSPPSPPT 83
+ P PT
Sbjct: 573 DSSPPPPIPEEPT 585
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 14/81 (17%), Positives = 23/81 (28%)
Query: 7 LGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDS 66
L S + P + S P P P+ ++ TP P P P +
Sbjct: 360 LPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPA 419
Query: 67 SPPSSNPVARSPPSPPTGDDG 87
P +P + +
Sbjct: 420 EPTEPSPTPPANAANAPPSLN 440
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 0.001
Identities = 18/73 (24%), Positives = 26/73 (35%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
P P + TPP P P + PPPT S + + + + P P
Sbjct: 522 KTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSPPPPIP 581
Query: 61 STPSDSSPPSSNP 73
P+ S S+P
Sbjct: 582 EEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|111949 pfam03109, ABC1, ABC1 family | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.001
Identities = 17/58 (29%), Positives = 28/58 (48%), Gaps = 13/58 (22%)
Query: 218 SLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAG 275
LG + + + F E +A A+ + Q VH+ VL +G+EVA+K + G
Sbjct: 2 ELGAPVEEVFAEFDEEPIAAAS--------IAQ-----VHRAVLKDGEEVAVKVQRPG 46
|
This family includes ABC1 from yeast and AarF from E. coli. These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex and E. coli AarF is required for ubiquinone production. It has been suggested that members of the ABC1 family are novel chaperonins. These proteins are unrelated to the ABC transporter proteins. Length = 117 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 5/107 (4%)
Query: 330 KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389
K RP + TR I + Y+H+ K+IHRDIK NI L+ + + DFG A
Sbjct: 261 KDRP-LLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAM 315
Query: 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 436
+GT +PE + E +D++S G++LL+++
Sbjct: 316 PFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 250 QGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERV---FQAEVEIISRVHHKHLVSLVGYY 305
+G FG V+ G N K A+K +K + + QAE + ++ +V L YY
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL--YY 71
Query: 306 T--AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ + + LV E++ ++ LH G D +K A L YLH II
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GII 126
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKL 390
HRD+K N+L+ + K+ DFGL+K+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 52/233 (22%), Positives = 60/233 (25%), Gaps = 57/233 (24%)
Query: 1 PPITPALGPPSSSSLTPPPITP-----------ALRPPSSSSLTPPPTTPALSP-PSLSS 48
PP + P PPP P RPPS P PA P +
Sbjct: 2830 PPTSAQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSR----SPAAKPAAPARPPVRR 2885
Query: 49 LTPPPTSGAPPP-STPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVI 107
L P S + + P D P A PP P
Sbjct: 2886 LARPAVSRSTESFALPPDQPERPPQPQAPPPPQPQPQPP--------------------- 2924
Query: 108 VVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQP 167
+ + PPLAP DP G + P A V P
Sbjct: 2925 ------------PPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVPQPWLGALV---P 2969
Query: 168 PRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSG---SEAPIPPP 217
R A P P P+ PP S SS S E PPP
Sbjct: 2970 GRVAVPRFRVP-QPAPSREAPASSTPPLTGHSLSRVSSWASSLALHEETDPPP 3021
|
Length = 3151 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 22/85 (25%), Positives = 28/85 (32%), Gaps = 7/85 (8%)
Query: 134 LPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPP 193
P P+ P P + N+PP T P P PP PVA PH P
Sbjct: 375 APSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPVAPPVPH-------TPES 427
Query: 194 PPFMSSSGGSSSNYSGSEAPIPPPS 218
P ++ + P PP
Sbjct: 428 APKLTRAAIPVDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|233045 TIGR00601, rad23, UV excision repair protein Rad23 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 23/77 (29%), Positives = 26/77 (33%), Gaps = 9/77 (11%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
P TP P + S P P S S P SP S+ P S P
Sbjct: 87 PAATPTSAPTPTPS-------PPASPASGMSAAPASAVEEKSPSEESATATAPES--PST 137
Query: 61 STPSDSSPPSSNPVARS 77
S PS S +S V S
Sbjct: 138 SVPSSGSDAASTLVVGS 154
|
All proteins in this family for which functions are known are components of a multiprotein complex used for targeting nucleotide excision repair to specific parts of the genome. In humans, Rad23 complexes with the XPC protein. This family is based on the phylogenomic analysis of JA Eisen (1999, Ph.D. Thesis, Stanford University) [DNA metabolism, DNA replication, recombination, and repair]. Length = 378 |
| >gnl|CDD|234398 TIGR03921, T7SS_mycosin, type VII secretion-associated serine protease mycosin | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 23/73 (31%), Positives = 27/73 (36%), Gaps = 8/73 (10%)
Query: 52 PPTSGAPPPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVS 111
P P + PVA P PP D G V+ + G + LAV VV
Sbjct: 286 LPPEDGRPLRPAPAPAR----PVAAPAPPPPPDDTPRGRVA---LWGAGLAALAV-VVGL 337
Query: 112 LLILRCRRKRRRR 124
RR RRRR
Sbjct: 338 AAAAVRRRGRRRR 350
|
Members of this family are subtilisin-related serine proteases, found strictly in the Actinobacteria and associated with type VII secretion operons. The designation mycosin is used for members from Mycobacterium [Protein fate, Protein and peptide secretion and trafficking, Protein fate, Protein modification and repair]. Length = 350 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 17/87 (19%), Positives = 29/87 (33%), Gaps = 7/87 (8%)
Query: 5 PALGPPSSSSLTPPPI-TPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTP 63
A P + P PA P + ++ P P + S+ PP + P P
Sbjct: 371 EAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAP--AAAASAPAAPPAAAPPAPVAA 428
Query: 64 SDS----SPPSSNPVARSPPSPPTGDD 86
+ + P++ P A + P
Sbjct: 429 PAAAAPAAAPAAAPAAVALAPAPPAQA 455
|
Length = 618 |
| >gnl|CDD|226406 COG3889, COG3889, Predicted solute binding protein [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 23/107 (21%), Positives = 37/107 (34%), Gaps = 11/107 (10%)
Query: 13 SSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPSSN 72
+P L + S+ + T ++ + T TS P T S + +S
Sbjct: 776 VPQSPTKTETTLSYSAYSNTSILIETTSVVITKTVTQTQTTTSSPSPTQTTSPTQTSTST 835
Query: 73 PVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRR 119
SP TG G + G + + V + L+LR RR
Sbjct: 836 TTTTSPSQTTTG---------GGICGPIV--IIVGLAALALLLRRRR 871
|
Length = 872 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 12/53 (22%), Positives = 21/53 (39%)
Query: 33 TPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPSSNPVARSPPSPPTGD 85
P P + A P+ ++ PP + APP + + P ++ P P
Sbjct: 381 APAPPSAAWGAPTPAAPAAPPPAAAPPVPPAAPARPAAARPAPAPAPPAAAAP 433
|
Length = 576 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 41/161 (25%), Positives = 61/161 (37%), Gaps = 23/161 (14%)
Query: 297 HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMD----WPTRLKIALGFAKGLA 352
++V L Y + LV + L H+ + W + +AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL------D 99
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE 412
LH + I+ RD+ NILLD + ++ F D + M Y APE
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPE 152
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIG-----CRPVD-STHT 447
+ TE D +S G +L EL+ G C P +THT
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHT 193
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.003
Identities = 28/88 (31%), Positives = 33/88 (37%), Gaps = 12/88 (13%)
Query: 5 PALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPST-P 63
PA P+S P PA PP P P+ P S PPP P P+T P
Sbjct: 407 PAAPVPASVPTPAPTPVPASAPP-----PPATPLPSAEPGSDDGPAPPPERQPPAPATEP 461
Query: 64 SDSSPPSSNPVA------RSPPSPPTGD 85
+ P + A R PP PP D
Sbjct: 462 APDDPDDATRKALDALRERRPPEPPGAD 489
|
Length = 3151 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 32/211 (15%), Positives = 45/211 (21%), Gaps = 30/211 (14%)
Query: 8 GPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSS 67
P ++ PP P+SS PA + P P A P+ S +
Sbjct: 590 PAPGAAGGEGPP------APASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAP 643
Query: 68 PPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRRDD 127
P P D GG G A
Sbjct: 644 APGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAP---------------- 687
Query: 128 EAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYT 187
P AP + PP+ P ++ P +
Sbjct: 688 -------AAPAAPAGAA-PAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPV 739
Query: 188 PSPPPPPPFMSSSGGSSSNYSGSEAPIPPPS 218
P PP P +G +
Sbjct: 740 PLPPEPDDPPDPAGAPAQPPPPPAPAPAAAP 770
|
Length = 824 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 34/125 (27%), Positives = 48/125 (38%), Gaps = 46/125 (36%)
Query: 363 IHRDIKAANILLDFKFEAKVADFGL----------------------AKLASDVYTHVST 400
IHRDIK NIL+D K+ DFGL + SD++ VS
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 401 ------------------------RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 436
++GT Y+APE T+ D +S GV+L E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 437 IGCRP 441
+G P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|183854 PRK13042, PRK13042, superantigen-like protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 20/65 (30%), Positives = 32/65 (49%), Gaps = 6/65 (9%)
Query: 23 ALRPPSS---SSLTPPPTTPALSP-PSLSSLTPPPTSGAPPPSTPSDSSPPSSNPVARSP 78
A P S+ + + PP+T +P ++ TPP T P TP+ ++P S+ +P
Sbjct: 30 ATTPSSTKVEAPQSTPPSTKVEAPQSKPNATTPPSTKVEAPQQTPNATTPSSTK--VETP 87
Query: 79 PSPPT 83
SP T
Sbjct: 88 QSPTT 92
|
Length = 291 |
| >gnl|CDD|215130 PLN02217, PLN02217, probable pectinesterase/pectinesterase inhibitor | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.003
Identities = 22/63 (34%), Positives = 31/63 (49%), Gaps = 5/63 (7%)
Query: 20 ITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPSSNPVARSPP 79
+ P+ PP+ +PP T + PS S PP + P +TP SSP SS VA +
Sbjct: 593 VAPSTSPPAGHLGSPPATPSKIVSPSTS---PPASHLGSPSTTP--SSPESSIKVASTET 647
Query: 80 SPP 82
+ P
Sbjct: 648 ASP 650
|
Length = 670 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 25/80 (31%), Positives = 35/80 (43%), Gaps = 5/80 (6%)
Query: 1 PPITPA-LGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPP 59
P ++P+ GPP +S PP + P P + TP ++PPS PP
Sbjct: 553 PKVSPSDRGPPKAS---PPVMAPPSTGPRVMA-TPSTGPRDMAPPSTGPRQQAKCKDGPP 608
Query: 60 PSTPSDSSPPSSNPVARSPP 79
S P + PPSS P +P
Sbjct: 609 ASGPHEKQPPSSAPRDMAPS 628
|
Length = 1000 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.003
Identities = 50/200 (25%), Positives = 83/200 (41%), Gaps = 33/200 (16%)
Query: 262 PNGKEVAIKQLKAGSGQGERV--FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319
P G+ V ++++ + E V Q E+ + +H ++V + A ++ +V F+
Sbjct: 23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 320 SNTLEFHLHGKGRPT-----MDWPTRLKIA---LGFAKGLAYLHEDCHPKIIHRDIKAAN 371
+G + MD + L IA G K L Y+H H +HR +KA++
Sbjct: 83 --------YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASH 131
Query: 372 ILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF--------GYLAPEYASSG--KLTE 421
IL+ + KV GL S + RV+ F +L+PE
Sbjct: 132 ILI--SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDA 189
Query: 422 KSDVFSFGVMLLELIIGCRP 441
KSD++S G+ EL G P
Sbjct: 190 KSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 31/121 (25%), Positives = 46/121 (38%), Gaps = 42/121 (34%)
Query: 363 IHRDIKAANILLDFKFEAKVADFGL----------------------AKLASDVYTHVST 400
IHRDIK NIL+D K+ DFGL + S+ ++ +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 401 RVM--------------------GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCR 440
+ GT Y+APE T+ D +S GV+L E+++G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 441 P 441
P
Sbjct: 243 P 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 51/240 (21%), Positives = 67/240 (27%), Gaps = 56/240 (23%)
Query: 1 PPITPALGPPSSSSLTPPPIT------PALRPPSSSSLTPPPTTPALSPPSLSSLTPPPT 54
PP + + PPP P P ++ P LS S SL P
Sbjct: 178 PPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRL 237
Query: 55 SGAPPPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLI 114
PP P +S S P A S P + G G +
Sbjct: 238 PSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHAL------------------ 279
Query: 115 LRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVT--------- 165
+ G L P + P+G Q PS A +
Sbjct: 280 -------------QQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSAL 326
Query: 166 ---QPPR-----PAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPP 217
QPPR PAP P PP +P+ P P S + + +PPP
Sbjct: 327 QPQQPPREQPLPPAPSMPHIKPPPTTPI--PQLPNQSHKHPPHLQGPSPFPQMPSNLPPP 384
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 608 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.52 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.38 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.33 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.03 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.87 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.76 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.66 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.53 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.53 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.51 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.42 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.38 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.35 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.3 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.29 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.23 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.17 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.14 | |
| PF01102 | 122 | Glycophorin_A: Glycophorin A; InterPro: IPR001195 | 98.1 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.06 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.05 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.0 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.89 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.81 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.79 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.79 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.77 | |
| PF04478 | 154 | Mid2: Mid2 like cell wall stress sensor; InterPro: | 97.67 | |
| PTZ00382 | 96 | Variant-specific surface protein (VSP); Provisiona | 97.67 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.63 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.61 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.56 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.3 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.27 | |
| PF08693 | 40 | SKG6: Transmembrane alpha-helix domain; InterPro: | 97.25 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.23 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.2 | |
| PLN02236 | 344 | choline kinase | 97.17 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.15 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 97.0 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.92 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.91 | |
| PF03302 | 397 | VSP: Giardia variant-specific surface protein; Int | 96.9 | |
| PF13908 | 179 | Shisa: Wnt and FGF inhibitory regulator | 96.65 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.62 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.6 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.54 | |
| COG3889 | 872 | Predicted solute binding protein [General function | 96.52 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.44 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-62 Score=511.73 Aligned_cols=289 Identities=55% Similarity=0.903 Sum_probs=255.1
Q ss_pred ccccCHHHHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEE
Q 046502 227 KSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306 (608)
Q Consensus 227 ~~~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~ 306 (608)
...|+|+||..||++|+..++||+|+||.||+|.+.+|+.||||++.....+..++|.+|+++|.+++|+|||+|+|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 45799999999999999999999999999999999999999999988765442556999999999999999999999999
Q ss_pred eCC-eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 307 AGS-QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 307 ~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
+++ +++||||||++|+|+++|+......|+|.+|++||.++|+||+|||+.|.+.|||||||++|||||+++++||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 999 5999999999999999999865437899999999999999999999999989999999999999999999999999
Q ss_pred eccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 386 GLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 386 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
|||+.......+..+...||++|+||||+..+.+++|+|||||||+|+||+||+++++.........+ ..|....++++
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l-~~w~~~~~~~~ 300 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL-VEWAKPLLEEG 300 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH-HHHHHHHHHCc
Confidence 99976654122222222799999999999999999999999999999999999999987653333333 34567778888
Q ss_pred CCCcccCcccc-CcCCH-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 466 NFDTLVDPKLH-NEYNH-NEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 466 ~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
++.+++|+.+. ..+.. .++.+++.+|.+|++.++..||+|.||+++|+...
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999998 66665 78999999999999999999999999999996543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=415.53 Aligned_cols=252 Identities=33% Similarity=0.531 Sum_probs=209.4
Q ss_pred cCCccccCCceEEEEEEecCCcE-EEEEEcccCCchh--HHHHHHHHHHHHhcCCCCccceeeEEEeCC-eeEEEEeecc
Q 046502 244 DANLLGQGGFGYVHKGVLPNGKE-VAIKQLKAGSGQG--ERVFQAEVEIISRVHHKHLVSLVGYYTAGS-QRMLVCEFVT 319 (608)
Q Consensus 244 ~~~~LG~G~fg~Vy~~~~~~g~~-vavK~~~~~~~~~--~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~-~~~lV~E~~~ 319 (608)
..+.||.|+||+||+|.+ .|+. ||||++....... .+.|.+|+.+|.+|+|||||+|+|+|.+.. .++||||||+
T Consensus 45 ~~~~iG~G~~g~V~~~~~-~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKW-RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhcccCCceeEEEEEe-CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 345699999999999999 4555 9999998654322 568999999999999999999999999887 7999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeeccCCCcEEEccCC-ceEEEEeeccccccCcccc
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK-IIHRDIKAANILLDFKF-EAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~-iiHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~~~~ 397 (608)
+|+|.++|+...+..++|..+++||.+||+||.|||++ + |||||||++||||+.++ .+||+|||+++...... .
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~ 199 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T 199 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence 99999999985455799999999999999999999998 6 99999999999999997 99999999998765432 2
Q ss_pred eeeeeecccCccChhhhh--cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 398 VSTRVMGTFGYLAPEYAS--SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~--~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
..+...||+.|||||++. ...|++|+|||||||+||||+||+.||..... . .........+.
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~------~~~~~v~~~~~--------- 263 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V------QVASAVVVGGL--------- 263 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H------HHHHHHHhcCC---------
Confidence 233467999999999999 66899999999999999999999999975443 1 11112222222
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+...+......+..++.+||+.||.+||++.+|+..|+...
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 22223335667888999999999999999999999998653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=387.65 Aligned_cols=250 Identities=30% Similarity=0.452 Sum_probs=207.7
Q ss_pred CcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-eeEEEEeecc
Q 046502 243 SDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS-QRMLVCEFVT 319 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~-~~~lV~E~~~ 319 (608)
...+.||+|..|+|||+.. .+++.+|+|++.... ....+++.+|++++++.+|||||++||.|...+ ...|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 4468899999999999995 468889999996543 344578999999999999999999999999988 5999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+|+|++++...+ .+++....+|+.+|++||.|||+.. +||||||||+||||+.+|++||||||.++..-+. ..
T Consensus 162 gGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~a 234 (364)
T KOG0581|consen 162 GGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---IA 234 (364)
T ss_pred CCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---hc
Confidence 999999997654 4899999999999999999999731 8999999999999999999999999999876553 44
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchh-hHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL-ARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l-~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
...+||..|||||.+.+..|+.++||||||+.|+||.+|+.||..... ... ...++ .++-++....+.+ +
T Consensus 235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~~~Ll-~~Iv~~ppP~lP~-----~ 305 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDIFELL-CAIVDEPPPRLPE-----G 305 (364)
T ss_pred ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCHHHHH-HHHhcCCCCCCCc-----c
Confidence 567899999999999999999999999999999999999999876411 111 11122 2333333322222 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....++.+++..||++||.+||++.|++++
T Consensus 306 ---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 ---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 245678899999999999999999999875
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=402.79 Aligned_cols=252 Identities=31% Similarity=0.450 Sum_probs=215.6
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCc
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNT 322 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gs 322 (608)
..++.||+|-||.||.|.++....||||.++... ...+.|.+|+++|++|+|+|||+|+|+|..++.+|||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3457899999999999999777799999998763 445678899999999999999999999999889999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeee
Q 046502 323 LEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRV 402 (608)
Q Consensus 323 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 402 (608)
|.++|....+..+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+||||||...++........
T Consensus 288 Ll~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~ 364 (468)
T KOG0197|consen 288 LLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGG 364 (468)
T ss_pred HHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCC
Confidence 99999986667899999999999999999999999 999999999999999999999999999997776655555555
Q ss_pred ecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCH
Q 046502 403 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481 (608)
Q Consensus 403 ~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 481 (608)
.-...|.|||.+..++++.|+|||||||+||||+| |+.|+..... ..++. .++.| .+-..+.
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-------~ev~~-~le~G---------yRlp~P~ 427 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-------EEVLE-LLERG---------YRLPRPE 427 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-------HHHHH-HHhcc---------CcCCCCC
Confidence 56789999999999999999999999999999997 8888764322 11222 22222 2223345
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 482 NEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 482 ~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+...+.+|+..||+.+|++|||+..+...|+..
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 5777899999999999999999999999888753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=379.60 Aligned_cols=201 Identities=29% Similarity=0.463 Sum_probs=181.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
..+|...+.||+|.|++||+|+. +++.+||||.+... .....+-+..|+.+|+.++|+|||+|++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 46788888899999999999994 56899999999766 4445567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC------CceEEEEeeccc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK------FEAKVADFGLAK 389 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~------~~~kl~DFGla~ 389 (608)
|||.||+|.++|+.++ .+++.....++.|||.||++||++ +||||||||.||||+.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999876 599999999999999999999999 99999999999999765 458999999999
Q ss_pred cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~ 446 (608)
.+.. .......+|++.|||||+++.++|+.|+|+||+|+|||+|++|+.||+...
T Consensus 164 ~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 164 FLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 8875 334556899999999999999999999999999999999999999998543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-46 Score=386.27 Aligned_cols=262 Identities=26% Similarity=0.407 Sum_probs=214.6
Q ss_pred CCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchh-HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQG-ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
...+.++||+|-||.|+++....+..||||+++.+.... ..+|.+|+++|.+|+|||||+|+|+|..++.+++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 445678999999999999999788999999999876554 4789999999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc-cccCcccce
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHV 398 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~-~~~~~~~~~ 398 (608)
+|+|..+|.....+.+.-....+|+.||+.||+||.+. ++|||||.++|+|+|.++++||+|||+++ +...++.+.
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999999887655556667788999999999999998 99999999999999999999999999998 445556666
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHH--hCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI--IGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ell--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
..+.+-...|||+|.+.-++++.++|||+|||.|||++ +...||..... +...+. ....+..+... ..
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven-~~~~~~~~~~~------~~ 765 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVEN-AGEFFRDQGRQ------VV 765 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHh-hhhhcCCCCcc------ee
Confidence 66777889999999999999999999999999999986 57778754321 111110 00111111111 11
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
-..+.-+...+++++..||+.|-.+||++.+|...|...
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 122344566788999999999999999999999998754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=390.39 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=209.9
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
..|...++||+|||+.||+++. ..|+.||+|++... .....+.+.+||+|.+.|+|||||+|++||++.+.+|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999996 88999999999653 3344567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|+|.+++|..++.. +..+++.+.+.++.||+.||.|||++ +|||||||..||||+++.++||+|||||..+..+.
T Consensus 98 ELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 99999999999873 44799999999999999999999999 99999999999999999999999999999877543
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
. .....+||+.|.|||++.....+..+||||+|||||-||+|++||+...- ... . ..++..++..
T Consensus 173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------ket-y-~~Ik~~~Y~~------ 237 (592)
T KOG0575|consen 173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------KET-Y-NKIKLNEYSM------ 237 (592)
T ss_pred c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------HHH-H-HHHHhcCccc------
Confidence 3 33447899999999999998999999999999999999999999975421 111 1 1233333211
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+......-.+|+..+|+.+|.+||++.+|+++
T Consensus 238 ----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 238 ----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11233445678899999999999999999975
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=380.25 Aligned_cols=254 Identities=26% Similarity=0.360 Sum_probs=208.9
Q ss_pred HhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCch-------hHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQ-------GERVFQAEVEIISRVHHKHLVSLVGYYTAGS 309 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~-------~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~ 309 (608)
..+.|...+.||+|+||.|-+|. ..+|+.||||+++..... ....+++|+++|++|+|||||+++++|++.+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 34668888999999999999998 567999999999653211 2234679999999999999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC---CceEEEEee
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVADFG 386 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~---~~~kl~DFG 386 (608)
..|||||||+||.|.+++-.++ .+.+..-..++.|++.||.|||+. +|+||||||+||||..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999988765 367777788999999999999999 99999999999999766 779999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
+|+..+. ...+...+||+.|+|||++.++. +..|+|+||+|||||-+|+|.+||...... . -+...+.
T Consensus 325 lAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~-----sl~eQI~ 395 (475)
T KOG0615|consen 325 LAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--P-----SLKEQIL 395 (475)
T ss_pred hhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--c-----cHHHHHh
Confidence 9998874 33455689999999999997765 345889999999999999999999754331 1 1333344
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.|.+... ..+..+..++.++++.++|..||+.||++.|++++
T Consensus 396 ~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 KGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 4544321 22334556778899999999999999999999875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=400.14 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=216.0
Q ss_pred CcCCccccCCceEEEEEEecC------CcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 243 SDANLLGQGGFGYVHKGVLPN------GKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
...+.||+|.||.||+|...+ .+.||||.++..... ...+|++|+++|..|+|+|||+|+|+|.+++.++||+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 445789999999999998533 457999999987655 6789999999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEE
Q 046502 316 EFVTSNTLEFHLHGKG------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 383 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~ 383 (608)
|||..|+|..+|.... ...|+..+.+.||.|||.||+||-++ ++|||||..+|+||.++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEec
Confidence 9999999999998531 12388899999999999999999999 99999999999999999999999
Q ss_pred Eeeccccc-cCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHH
Q 046502 384 DFGLAKLA-SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRA 461 (608)
Q Consensus 384 DFGla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 461 (608)
||||+|.. ..++.+...+..-...||+||.|+.++|+.++|||||||||||+++ |+-|+..... +-+...
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------~EVIe~ 717 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------QEVIEC 717 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------HHHHHH
Confidence 99999843 4445555545556889999999999999999999999999999995 8888754322 123344
Q ss_pred HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 462 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 462 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+.+|++ -..+++++.+++.|+..||+.+|.+||+++||-..|+.-.
T Consensus 718 i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 718 IRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred HHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 555554 2356678889999999999999999999999999998543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=360.83 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=214.4
Q ss_pred CCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceee-EEEeCCe-eEEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVG-YYTAGSQ-RMLVC 315 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g-~~~~~~~-~~lV~ 315 (608)
+|.+.++||+|.||.|||+. +.+|+.||.|.++-+ +.+....+..|+.+|++|+|||||++++ -+.++.+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46677899999999999998 678999999998743 4455677899999999999999999998 4555555 89999
Q ss_pred eeccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 316 EFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK--IIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 316 E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
|||..|+|..++.. +.+..+++..+++++.|+++||..+|.... + |+||||||.||+|+.+|.+||+||||++++
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999998875 345678999999999999999999999432 4 999999999999999999999999999988
Q ss_pred cCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
.... ......+||+.||+||.+....|+.|+||||+|||+|||..-+.||.... + .-+.+.+++|++..+.
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~--~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------L--LSLCKKIEQGDYPPLP 249 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------H--HHHHHHHHcCCCCCCc
Confidence 7643 33455789999999999999999999999999999999999999997542 2 1355667888775554
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
| ......+..++..|+..|++.||+...++..+..
T Consensus 250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 3 3455678889999999999999996666655543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=364.04 Aligned_cols=243 Identities=26% Similarity=0.368 Sum_probs=201.8
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|+||.||.++. ++++.||+|++++.. ....+...+|..||.+++||+||+|+.-|.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46789999999999999999984 568999999997653 23345678899999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
+||+.||.|..+|...+ .+++....-++..|+.||.|||+. +||||||||+|||||.+|+++|+||||++.....
T Consensus 104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999998766 488888888999999999999999 9999999999999999999999999999955443
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.. ....++||+.|||||++....|+..+|.|||||++||||+|.+||...+. ..+. +.+..++..
T Consensus 179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-------~~~~-~~I~~~k~~------ 243 (357)
T KOG0598|consen 179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-------KKMY-DKILKGKLP------ 243 (357)
T ss_pred CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-------HHHH-HHHhcCcCC------
Confidence 22 33447999999999999999999999999999999999999999975442 1122 222233211
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPR 504 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs 504 (608)
..+.-...+..+++...|+.||++|--
T Consensus 244 ---~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 244 ---LPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ---CCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 111112345678889999999999963
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=378.08 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=214.0
Q ss_pred cCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
..|....+||+|..|.||.+. ..+++.||||++.......++-+.+|+.+|+.++|+|||++++-|..++++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 468888999999999999998 5678999999998887777888999999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++|+|.+.+... .|++.++..|+.++++||+|||.+ +|||||||.+||||+.+|++||+|||+|..+......
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K- 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK- 425 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-
Confidence 999999998654 499999999999999999999999 9999999999999999999999999999877665443
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....+||+.|||||++....|..|.||||||+|++||+-|++||-.... +...++ ...+|.. ++ .
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lrAlyL--Ia~ng~P-~l-------k 490 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYL--IATNGTP-KL-------K 490 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HHHHHH--HhhcCCC-Cc-------C
Confidence 3457899999999999999999999999999999999999999854322 211111 1123322 11 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+|+.+||+.|+++|+++.|+|++
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 223445678899999999999999999999975
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=352.88 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=206.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
+.|....++|+|+||+|||++. ++|+.||||++.... ..-.+...+||.+|++|+|+|||.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4567778999999999999995 459999999996543 3334567889999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
||+..-|+++-+... .++.+...+++.|+++|+.|+|++ +||||||||+||||+.++.+||||||+|+.... ..
T Consensus 82 ~~dhTvL~eLe~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDHTVLHELERYPN--GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecchHHHHHHHhccC--CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 999876665543322 588899999999999999999999 999999999999999999999999999997764 34
Q ss_pred ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhh--HHHH-------HHHH-hcC
Q 046502 397 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLA--RPLL-------NRAI-EDG 465 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~--~~~~-------~~~~-~~~ 465 (608)
..++..+.|.+|+|||.+.+ ..|...+|||++|||+.||++|.+-|....+ .+.+. +..+ ...+ .+.
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD--iDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD--IDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch--HHHHHHHHHHHcccCHHHHHHhccCC
Confidence 56778889999999999876 6899999999999999999999988865433 12221 0000 0111 122
Q ss_pred CCCcccCcc------ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 NFDTLVDPK------LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~~~~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.|.-+.-|. |...| .....-++++++.||+.||++|++-.|++.+
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 222221111 11112 2233468899999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=357.67 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=215.2
Q ss_pred hcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchh-HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQG-ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~-~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.+.|...++||.|..++||+|+ .+.++.||||++..+..+. ...+++|+..|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3568888999999999999998 6778999999998665444 4789999999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
||.+|++.+++...-...|++..+..|+.++++||.|||.+ +.||||||+.||||+.+|.+||+|||....+.+...
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999987666799999999999999999999999 999999999999999999999999999765433222
Q ss_pred cee---eeeecccCccChhhhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 397 HVS---TRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 397 ~~~---~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
+.. ...+||++|||||+++. ..|+.|+|||||||..+||.+|..||....+. ..+...+ .+....+.
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-------kvLl~tL-qn~pp~~~ 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-------KVLLLTL-QNDPPTLL 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-------HHHHHHh-cCCCCCcc
Confidence 222 34689999999999643 35999999999999999999999999765431 1122222 23333332
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+..+........+.+++..||++||.+||++++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 2233333334445578899999999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=368.53 Aligned_cols=262 Identities=24% Similarity=0.296 Sum_probs=210.6
Q ss_pred hcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcC-CCCccceeeEEEeCC-eeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVH-HKHLVSLVGYYTAGS-QRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~-~~~lV 314 (608)
.++|..+++||.|+||.||+|+ ...|+.||||+++..-. ..+..-.+||..|++|+ |+|||+|.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4678888999999999999999 56789999999976532 33334567999999999 999999999999888 99999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
||||+ .+|.+++..+ +..+++..++.|+.||++||+|+|++ |+.||||||+|||+..+..+||+||||||....
T Consensus 89 fE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S- 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS- 162 (538)
T ss_pred HHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc-
Confidence 99997 4899988877 55899999999999999999999999 999999999999999999999999999997654
Q ss_pred ccceeeeeecccCccChhhh-hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHH-----------H-----
Q 046502 395 YTHVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARP-----------L----- 457 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~-----------~----- 457 (608)
....+..+.|.+|+|||++ ..+.|+.+.|||++|||++||.+-++-|.+.... |.+.+- |
T Consensus 163 -kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~--Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 -KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI--DQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred -CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH--HHHHHHHHHhCCCccccchhHHH
Confidence 3456778899999999986 5678999999999999999999999888765431 222110 0
Q ss_pred HHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 458 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 458 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+..+ .+-.+....--.+.. .-.....+.++++.+||.+||++|||+.|.+++
T Consensus 240 La~~-mnf~~P~~~~~~l~~-L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASA-MNFRFPQVKPSPLKD-LLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHH-hccCCCcCCCCChHH-hCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000 111222222222211 222366778899999999999999999999986
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=385.47 Aligned_cols=253 Identities=30% Similarity=0.464 Sum_probs=212.9
Q ss_pred CCcCCccccCCceEEEEEEecC----CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 242 FSDANLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
..+.++||.|.||.||+|+++- ...||||.|+... ....++|..|+.||.++.||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3467899999999999999743 3469999999874 4456789999999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
||+||+|+.+|+.+.. .+.|.++.-++.+||.||.||-+. ++|||||.++||||+.+..+||+||||+|...++..
T Consensus 711 yMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 9999999999998765 499999999999999999999998 999999999999999999999999999998766543
Q ss_pred ceeeeee--cccCccChhhhhcCCCCCcchhhhHHHHHHHHH-hCCCCCCCCcccccchhhHHHHHHHHhcC-CCCcccC
Q 046502 397 HVSTRVM--GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDNLARPLLNRAIEDG-NFDTLVD 472 (608)
Q Consensus 397 ~~~~~~~--gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~d 472 (608)
...+..- -...|.|||.+...++|.++|||||||||||.+ .|.+|+..... ...++ ++++| ++..
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-------QdVIk-aIe~gyRLPp--- 855 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------QDVIK-AIEQGYRLPP--- 855 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-------HHHHH-HHHhccCCCC---
Confidence 3333222 246899999999999999999999999999988 59999854322 12333 33332 3322
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+.++...|.+|++.|||+|-.+||.+.|||.+|+...
T Consensus 856 -------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 856 -------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred -------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 3456778999999999999999999999999998653
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=363.04 Aligned_cols=262 Identities=26% Similarity=0.357 Sum_probs=204.9
Q ss_pred hcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~l 313 (608)
.+.|..+++||+|+||.||+|+ +.+|+.||+|+++.+. ........+||.||++|+|||||+|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3456667889999999999999 6789999999998665 33345678899999999999999999998776 68999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
|+|||+. +|.-++...+ -.|+..++.-++.||+.||+|||.+ +|+|||||.+|||||.+|.+||+|||||+++..
T Consensus 196 VFeYMdh-DL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred EEecccc-hhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 9999986 5655555433 3689999999999999999999999 999999999999999999999999999998877
Q ss_pred cccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
......+..+-|.+|.|||++.+. .|+.++|+||.||||.||+.|++.|...... +.+.. +. + ..|...+-.-
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv--eQl~k-If-k--lcGSP~e~~W 344 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV--EQLHK-IF-K--LCGSPTEDYW 344 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH--HHHHH-HH-H--HhCCCChhcc
Confidence 666667778889999999998765 6999999999999999999999998765431 11110 11 0 1111111100
Q ss_pred c--cc--------cCcCCH-------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 P--KL--------HNEYNH-------NEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~--~l--------~~~~~~-------~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+ .| ...|.. ......++|+..+|..||.+|.|+.++++.
T Consensus 345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 00 011111 123346788999999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=364.27 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=211.1
Q ss_pred HHHhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~ 310 (608)
.+...+|...+.||+|.|++||+|+ ...+++||||++.+.- ....+.+..|-++|.+| +||.||+|+.-|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3445778899999999999999999 5579999999996532 22234677899999999 79999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
+|+|+||++||.|.++|+..+ .|++...+.++.+|+.||+|||.+ +||||||||+|||||.|+++||+|||.|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999998776 589999999999999999999999 999999999999999999999999999998
Q ss_pred ccCcccc----------ee--eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHH
Q 046502 391 ASDVYTH----------VS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLL 458 (608)
Q Consensus 391 ~~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~ 458 (608)
+...... .. ..++||..|++||++.++..+..+|||+|||+||+||.|.+||.....+ + .+
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney----l---iF 296 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY----L---IF 296 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH----H---HH
Confidence 7542211 11 3489999999999999999999999999999999999999999865431 1 11
Q ss_pred HHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 459 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 459 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
.++++ +| -++.........+|+.+.|..||.+|.+..||-++.
T Consensus 297 qkI~~-------l~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 297 QKIQA-------LD----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HHHHH-------hc----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 22211 01 122223335677899999999999999999998874
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=367.53 Aligned_cols=258 Identities=27% Similarity=0.418 Sum_probs=203.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeC-C
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAG-S 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~-~ 309 (608)
.++|...++||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +|+||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35788899999999999999973 2356799999975432 3345788999999999 899999999998764 4
Q ss_pred eeEEEEeeccCCcHHHHhhcCC----------------------------------------------------------
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKG---------------------------------------------------------- 331 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 331 (608)
.+++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5899999999999999987532
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc-eeeeeecccCc
Q 046502 332 --RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH-VSTRVMGTFGY 408 (608)
Q Consensus 332 --~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y 408 (608)
...+++..++.++.||++||+|||+. +|+||||||+||||+.++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 12478889999999999999999998 9999999999999999999999999999865332111 12223467889
Q ss_pred cChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHH
Q 046502 409 LAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARM 487 (608)
Q Consensus 409 ~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 487 (608)
+|||++.+..++.++|||||||+||||++ |..||..... .. .+...+.++..... .......+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~--~~-----~~~~~~~~~~~~~~---------~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--NE-----EFCQRLKDGTRMRA---------PENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc--cH-----HHHHHHhcCCCCCC---------CCCCCHHH
Confidence 99999999999999999999999999997 9999875432 11 11122233322111 11233468
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 488 VACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 488 ~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+++.+||+.||++||+|.||++.|+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 8899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=357.26 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=205.2
Q ss_pred cCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--eeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS--QRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~--~~~lV~E 316 (608)
.+|...+.||+|.||.||++...+ |+.+|||.+........+.+.+|+.+|++|+|+|||+.+|.....+ .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456677899999999999999644 8999999997664344667899999999999999999999855444 6899999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-CCceEEEEeeccccccC--
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKLASD-- 393 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-~~~~kl~DFGla~~~~~-- 393 (608)
|+.+|+|.+++.+.+. .|++..+.++..||++||+|||++ +|||||||++||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred ccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999998776 799999999999999999999999 9999999999999999 79999999999987663
Q ss_pred cccceeeeeecccCccChhhhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
........+.||+.|||||++..+... .++|||||||+++||+||+.||..... .. .++-.....+..
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-----~~-~~~~~ig~~~~~----- 241 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-----EA-EALLLIGREDSL----- 241 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-----hH-HHHHHHhccCCC-----
Confidence 222234457899999999999964433 499999999999999999999864200 00 111111222211
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
| ..+........+++..|++.+|++||++.+++++.-
T Consensus 242 P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 242 P----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred C----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 1 223334456778999999999999999999998754
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=393.39 Aligned_cols=255 Identities=31% Similarity=0.470 Sum_probs=214.1
Q ss_pred CCCcCCccccCCceEEEEEEecC--Cc----EEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPN--GK----EVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
+....+.||+|.||.||.|.+.+ |. .||||.++.. +.+...+|.+|..+|+.++|||||+|+|+|.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34556789999999999999543 33 4999999766 45566889999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 314 VCEFVTSNTLEFHLHGK-----GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~-----~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
++|||++|+|..+|+.. ....|.....+.|+.|||+|+.||+++ ++|||||.++|+||+....+||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999875 234689999999999999999999999 9999999999999999999999999999
Q ss_pred c-cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCC
Q 046502 389 K-LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGN 466 (608)
Q Consensus 389 ~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 466 (608)
+ ....++.....+.+-...|||||.+..+.++.|+|||||||+|||++| |..||...+. ..++..+.+.|+
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------~~v~~~~~~ggR 922 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------FEVLLDVLEGGR 922 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------HHHHHHHHhCCc
Confidence 9 334444444444445679999999999999999999999999999997 8889875443 223444556663
Q ss_pred CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 467 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
+. .+..+...+.+|++.||+.+|++||++..|++.++..
T Consensus 923 L~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 923 LD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred cC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 32 3445677889999999999999999999999977654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=405.85 Aligned_cols=267 Identities=26% Similarity=0.496 Sum_probs=216.6
Q ss_pred cCHHHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 046502 230 FTYEELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG 308 (608)
Q Consensus 230 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~ 308 (608)
++++++. ..|...++||+|+||.||+|.. .+++.||||+++..... ...|++++++++|||||+++|+|.+.
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4455543 4577888999999999999996 57899999998754322 23468899999999999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
+..++||||+++|+|.++++ .++|..+.+|+.|+++||+|||..|.++|+||||||+|||++.++..++. ||..
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 99999999999999999996 38999999999999999999998777799999999999999999988876 7765
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
...... ....++.+|||||++.+..++.|+|||||||++|||++|+.||+..... ... ...|...........
T Consensus 830 ~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~-~~~~~~~~~~~~~~~ 902 (968)
T PLN00113 830 GLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGS-IVEWARYCYSDCHLD 902 (968)
T ss_pred cccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCc-HHHHHHHhcCccchh
Confidence 543221 2236789999999999999999999999999999999999999643221 111 222333334445556
Q ss_pred cccCccccC--cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 469 TLVDPKLHN--EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 469 ~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.++|+.+.. ....+++.++.+++.+||+.||++||+|.||+++|+...
T Consensus 903 ~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred heeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 667776644 345677888999999999999999999999999998654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=363.93 Aligned_cols=248 Identities=29% Similarity=0.444 Sum_probs=206.6
Q ss_pred ccCHHHHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 046502 229 TFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG 308 (608)
Q Consensus 229 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~ 308 (608)
.+.|++| ...+-||.|+.|.||+|++ .++.||||+++... ..+|..|++|+|+||+.|.|+|...
T Consensus 120 eiPFe~I-------sELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqs 184 (904)
T KOG4721|consen 120 EIPFEEI-------SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQS 184 (904)
T ss_pred cCCHHHh-------hhhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCC
Confidence 3456665 4467899999999999999 56889999987422 3478899999999999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
-.+|||||||..|-|...|+... .+.-.....|..+||.||.|||.+ +|||||||.=||||..+..+||+|||.+
T Consensus 185 PcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS 259 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTS 259 (904)
T ss_pred ceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccch
Confidence 99999999999999999997654 578888899999999999999999 9999999999999999999999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
+...+..+. ..+.||..|||||++.....++|+|||||||||||||||..||...+... |--|-
T Consensus 260 ~e~~~~STk--MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------------IIwGV-- 323 (904)
T KOG4721|consen 260 KELSDKSTK--MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------------IIWGV-- 323 (904)
T ss_pred Hhhhhhhhh--hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------------eEEec--
Confidence 977765333 23689999999999999999999999999999999999999986543211 00000
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
-...|.--.+..+..-+.-|+++||+..|+.||+++||+.+|+-
T Consensus 324 --GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 324 --GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred --cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 01112222344566678889999999999999999999999974
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=361.30 Aligned_cols=246 Identities=25% Similarity=0.385 Sum_probs=193.0
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
|...++||+|+||.||+|+. .+|+.||||++..... .....|.+|++++++++|+||++++++|..++.+++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 45568899999999999985 4689999999865432 334678899999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.... .+.+..+..|+.||+.||.|||+. +|+|||||++||||+.++.+||+|||+++....... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 225 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PC 225 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-cc
Confidence 99986532 356778889999999999999998 899999999999999999999999999987643221 12
Q ss_pred eeeecccCccChhhhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 400 TRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
....|+..|+|||++.. ...+.++|||||||+||||++|+.||...... .+. .+... +.....
T Consensus 226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~---~~~-~~~~~-~~~~~~------- 293 (353)
T PLN00034 226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG---DWA-SLMCA-ICMSQP------- 293 (353)
T ss_pred cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc---cHH-HHHHH-HhccCC-------
Confidence 33568999999998743 23456899999999999999999999733221 111 11111 111111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..........+.+|+..||+.||++||++.||+++
T Consensus 294 --~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 294 --PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112234568899999999999999999999975
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=351.99 Aligned_cols=248 Identities=21% Similarity=0.333 Sum_probs=200.4
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCCchh---HHHHHHHHHHHHhcCCCCccceeeEEEe----CCeeEEEE
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQG---ERVFQAEVEIISRVHHKHLVSLVGYYTA----GSQRMLVC 315 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~Ev~~l~~l~Hpniv~l~g~~~~----~~~~~lV~ 315 (608)
.....||+|++|.||+|.+ +|+.||||+++...... .+.|.+|+.+|.+++|+|||+++|+|.+ ....++||
T Consensus 23 ~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 23 YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence 3346799999999999998 78999999997653333 3668899999999999999999999876 34689999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++|+|.+++.... .++|...++++.+++.||.|||... +++||||||+|||++.++.+||+|||+++.....
T Consensus 102 Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 102 EYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP- 176 (283)
T ss_pred EeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhccc-
Confidence 9999999999997643 5899999999999999999999743 6889999999999999999999999999865432
Q ss_pred cceeeeeecccCccChhhhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 396 THVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... . .+.......+ ...
T Consensus 177 ---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~----~~~~~i~~~~-~~~---- 241 (283)
T PHA02988 177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---K----EIYDLIINKN-NSL---- 241 (283)
T ss_pred ---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---H----HHHHHHHhcC-CCC----
Confidence 123457899999999976 6899999999999999999999999975432 1 1222222211 111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. .+......+.+++.+||+.||++||+|.||++.|+..
T Consensus 242 ~----~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 242 K----LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C----CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1 1112345688899999999999999999999998743
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=352.08 Aligned_cols=252 Identities=26% Similarity=0.417 Sum_probs=203.6
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.|...++||+|+||.||++.. .+|+.||||++.... ......+.+|+.++.+++|+||++++++|.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999985 578999999986432 2234467889999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+++|+|.+++.......+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888765545689999999999999999999998 99999999999999999999999999998754321
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
......|+..|+|||++.+..++.++|||||||+||||++|+.||......... . .+...+....
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~-~~~~~~~~~~---------- 221 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---E-EVDRRVKEDQ---------- 221 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---H-HHHHHhhccc----------
Confidence 223456899999999999999999999999999999999999999754321111 1 1111111111
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPR-----ISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~~ 511 (608)
..+.......+.+|+..||+.||++||+ +.+++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1112223346788999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=331.03 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=205.1
Q ss_pred cCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchh--HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQG--ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~--~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|...++||+|.||.||+|+ ..+|+.||||+++.....+ .....+||.+|+.++|+||+.|+++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 456777899999999999999 5679999999998653322 3456789999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
||+ .+|+..++.+.. .+.-..+..++.++++||+|||.+ .|+||||||.|+||+.+|.+||+|||+|+.+.....
T Consensus 82 fm~-tdLe~vIkd~~i-~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNI-ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred ecc-ccHHHHhccccc-ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 998 589988887654 688889999999999999999999 899999999999999999999999999998876543
Q ss_pred ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC------CCc
Q 046502 397 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN------FDT 469 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~~ 469 (608)
.. +..+-|.+|+|||.+.+ ..|+...||||.|||+.||+-|.+-|....+ -+.+.. +-+++-.-. +..
T Consensus 157 ~~-~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~--If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 157 IQ-THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSK--IFRALGTPTPDQWPEMTS 231 (318)
T ss_pred cc-ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHH--HHHHcCCCCcccCccccc
Confidence 33 33367999999999876 4699999999999999999998877765433 122211 111111101 111
Q ss_pred cc---------CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 LV---------DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ~~---------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+. .+.+.. .-..+....++++..+|..||.+|.+++|++++
T Consensus 232 lpdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 111111 122334456899999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=366.95 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=206.3
Q ss_pred CCCcCCccccCCceEEEEEEecC--C--cE-EEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPN--G--KE-VAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~--g--~~-vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
+....++||+|+||.||+|.+.. + .. ||||..+.. ......+|.+|+++|++++|+|||+|||++.....+|
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 33445899999999999999643 2 23 899999853 3455678999999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
||||+|.||+|+++|..+.. .+++.++++++.++|+||+|||.+ ++|||||.++|+|++.++.+||+||||++...
T Consensus 238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 99999999999999987665 699999999999999999999999 99999999999999999999999999988654
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHH-hcCCCCcc
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAI-EDGNFDTL 470 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~-~~~~~~~~ 470 (608)
.. ........-...|+|||.+..+.|+.++|||||||++||+++ |..||...... .+...+ .++....
T Consensus 314 ~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r~~- 383 (474)
T KOG0194|consen 314 QY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYRMP- 383 (474)
T ss_pred ce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCccCC-
Confidence 21 111111234679999999999999999999999999999998 88888654431 122223 2222111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.+......+..++.+||..+|++||+|.+|.+.|+...
T Consensus 384 --------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~ 421 (474)
T KOG0194|consen 384 --------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE 421 (474)
T ss_pred --------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence 12234556677788999999999999999999998644
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=361.30 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=205.3
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.+.+.....||+|.||+||+|.+.. .||||+++.+... ..+.|++||.++++-+|.||+=|.|||..... .||..
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 3445677899999999999999733 5999999876543 45789999999999999999999999998776 99999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc-c
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-Y 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~-~ 395 (608)
+|+|.+|..|||... ..|+..+.+.||.|||+|+.|||.+ +|||||||..||||++++.|||+||||+...... .
T Consensus 468 wCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999999755 4689999999999999999999999 9999999999999999999999999998633221 1
Q ss_pred cceeeeeecccCccChhhhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 396 THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
.......-|...|||||+++. ..|+..+||||||||+|||++|..||..... +.+. +.-|+=.-..|
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqIi-------fmVGrG~l~pd 613 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQII-------FMVGRGYLMPD 613 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hheE-------EEecccccCcc
Confidence 111222347789999999964 4689999999999999999999999973221 1110 01111111112
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.. ....+..++|.+|+..||..++++||.+.+|+..|+...
T Consensus 614 ~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 614 LS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred ch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 11 122355667888999999999999999999999887554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=357.52 Aligned_cols=247 Identities=27% Similarity=0.414 Sum_probs=211.3
Q ss_pred cCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|...+.||+|.||+||||+ ..+.+.||||.+.+... ...+.+++|++|++.|+|||||.++++|+...++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 567888899999999999999 45688999999865432 344678999999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.| +|..+|...+ .|.++.+..|+.+++.||.|||++ +|+|||+||.||||+.++.+|+||||+|+.... .+
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9987 9999997765 599999999999999999999999 999999999999999999999999999997765 46
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
.+.+.+.||+.|||||++.++.|+..+|+||+|||||||+.|++||..... ..+++.+.. |+.
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-------~~Lv~~I~~--------d~v-- 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-------TQLVKSILK--------DPV-- 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-------HHHHHHHhc--------CCC--
Confidence 677889999999999999999999999999999999999999999953321 112322222 111
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.++......++.++...|.+||.+|-+..+++.+
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1223555678899999999999999999999865
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=351.29 Aligned_cols=261 Identities=25% Similarity=0.362 Sum_probs=201.5
Q ss_pred cCCCcCCccccCCceEEEEEEecC-----------------CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccce
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-----------------GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSL 301 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l 301 (608)
++|...++||+|+||.||++.+.+ +..||||++.... ......|.+|+++|.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 567888999999999999998532 3369999987653 3334678999999999999999999
Q ss_pred eeEEEeCCeeEEEEeeccCCcHHHHhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 046502 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKG-----------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364 (608)
Q Consensus 302 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiH 364 (608)
+++|.+.+..++||||+.+++|.+++.... ...++|..+++|+.||+.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 999999999999999999999999886431 12478899999999999999999998 8999
Q ss_pred eccCCCcEEEccCCceEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhC--CCC
Q 046502 365 RDIKAANILLDFKFEAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIG--CRP 441 (608)
Q Consensus 365 rDIk~~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG--~~p 441 (608)
|||||+||||+.++.+||+|||+++...... ........++..|+|||++..+.++.++|||||||++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998654321 1122334567899999999989999999999999999999974 456
Q ss_pred CCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 442 VDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 442 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
|..... ..... .....+........ ..........+.+++.+||+.||++||+|.||++.|+
T Consensus 242 ~~~~~~---~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD---EQVIE-NAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH---HHHHH-HHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 653321 11111 11111111110000 0011123456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.03 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=207.4
Q ss_pred HHhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccC----Cc-hhHHHHHHHHHHHHhcC-CCCccceeeEEEeCC
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAG----SG-QGERVFQAEVEIISRVH-HKHLVSLVGYYTAGS 309 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~----~~-~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~ 309 (608)
...++|...+.||+|.||.|++|. ..+|+.||||++... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345788999999999999999997 456899999977653 12 23456778999999999 999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEeecc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLA 388 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFGla 388 (608)
..++||||+.+|.|.+++...+ .+.+....+++.|++.||+|||++ +|+|||||++|||||.+ +++||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999998844 588899999999999999999999 99999999999999999 99999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCC-CC-CcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGK-LT-EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 466 (608)
.... .........+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... .. +.+.+..+.
T Consensus 169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~-----l~~ki~~~~ 239 (370)
T KOG0583|consen 169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PN-----LYRKIRKGE 239 (370)
T ss_pred cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HH-----HHHHHhcCC
Confidence 9774 1123455678999999999999877 75 789999999999999999999986322 11 112233333
Q ss_pred CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 467 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
+.-- .... ...+..++.+||+.||.+|+++.+|+.
T Consensus 240 ~~~p------~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 FKIP------SYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ccCC------CCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 3211 1110 456788999999999999999999994
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=364.58 Aligned_cols=256 Identities=27% Similarity=0.417 Sum_probs=202.9
Q ss_pred cCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~ 311 (608)
++|...++||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.+|..+ +|+||++++++|..++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4578889999999999999973 235689999997543 33446788999999999 899999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCC------------------------------------------------------------
Q 046502 312 MLVCEFVTSNTLEFHLHGKG------------------------------------------------------------ 331 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 331 (608)
++||||+++|+|.++++...
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 99999999999999886432
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc-
Q 046502 332 -------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH- 397 (608)
Q Consensus 332 -------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 397 (608)
...++|..+++|+.||++||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 12478999999999999999999998 9999999999999999999999999999865432211
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
......++..|+|||++.+..++.++|||||||+||||++ |..||..... ... +...+..+.... .+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~-----~~~~~~~~~~~~--~~--- 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSK-----FYKMIKEGYRML--SP--- 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHH-----HHHHHHhCccCC--CC---
Confidence 1122335678999999999999999999999999999998 8888864321 111 111222221110 01
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.....++.+|+.+||+.||++||+|.||+++|+.
T Consensus 340 ----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1123468899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=343.13 Aligned_cols=254 Identities=28% Similarity=0.446 Sum_probs=208.8
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 56888999999999999999988888999999875432 35678899999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.++++......+++..++.++.+++.||+|||+. +++||||||+|||++.++.+||+|||+++...+......
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999875555789999999999999999999998 899999999999999999999999999987654322222
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....++..|+|||++..+.++.++|||||||++|||++ |+.||..... . ... ..+..+... + ...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~----~~~-~~~~~~~~~----~-~~~- 227 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---S----DVM-SALQRGYRM----P-RME- 227 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---H----HHH-HHHHcCCCC----C-CCC-
Confidence 23346778999999998899999999999999999998 9999864321 1 111 112222110 0 111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.....+.+++.+||+.+|++||+|.+|++.|+.
T Consensus 228 ---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 ---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 223467889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=358.80 Aligned_cols=261 Identities=21% Similarity=0.278 Sum_probs=195.7
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.+|.+.++||+|+||.||++... .++.||||.... ..+.+|+++|++|+|+|||++++++..++..+||||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 46889999999999999999964 478899996432 23568999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc-c
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-H 397 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~-~ 397 (608)
. ++|..++..... .++|..++.|+.||++||.|||+. +||||||||+||||+.++.+||+|||+++....... .
T Consensus 243 ~-~~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 243 R-SDLYTYLGARLR-PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred C-CCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 6 677777764332 699999999999999999999998 899999999999999999999999999986643221 1
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC-----CcccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF-----DTLVD 472 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-----~~~~d 472 (608)
......||..|+|||++.+..++.++|||||||+||||++|..++-..............+.+.+....+ .....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2234579999999999999999999999999999999999887653221111110000111111111111 10000
Q ss_pred ccc------------cCcCC----H---HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKL------------HNEYN----H---NEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l------------~~~~~----~---~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+ ...+. . .....+.+|+.+||+.||++||++.||+++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00000 0 111257789999999999999999999975
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=343.79 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=204.2
Q ss_pred cCCCcCCccccCCceEEEEEEec----CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP----NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...+.||+|+||.||+|++. .+..||+|+++.... ...+.|.+|+.++.+++|+||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999853 356899999986532 3345788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++.... ..++|..++.++.|++.||+|||+. +|+||||||+||||+.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999987643 3689999999999999999999998 8999999999999999999999999987654322
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.........++..|+|||++.++.++.++|||||||++|||++ |+.||..... . .++ ..++++....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~----~~~-~~~~~~~~~~---- 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---Q----DVI-KAVEDGFRLP---- 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---H----HHH-HHHHCCCCCC----
Confidence 1111112335678999999999999999999999999999875 9999864322 1 111 2222221110
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++..||+.+|.+||++.||++.|+.
T Consensus 229 -----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 229 -----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 112234568889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=344.29 Aligned_cols=265 Identities=22% Similarity=0.274 Sum_probs=203.9
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|...+.||+|+||.||+++.. +++.||||+++... ....+.+.+|++++++++|+||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999964 57889999987542 2234567889999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.++.|..+.... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99998877665432 3589999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhh----------HHHHHHHHhcCC
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLA----------RPLLNRAIEDGN 466 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~----------~~~~~~~~~~~~ 466 (608)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||...... +.+. ...+.....+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI--DQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhhCCCCHHHHHhhhccch
Confidence 2333457899999999999889999999999999999999999999754321 1110 000111111111
Q ss_pred CCcccCccccC------cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 467 FDTLVDPKLHN------EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 467 ~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.....+.... .+.......+.+++.+||+.||++||++.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111111100 1111233468899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=340.94 Aligned_cols=255 Identities=28% Similarity=0.440 Sum_probs=208.2
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.++|...+.||+|+||.||+|...+++.||||.++... ...+.|.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999998788899999997644 33567889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+++|.+++.......++|..+..++.+++.||.|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA 160 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence 999999999775545689999999999999999999998 89999999999999999999999999998765322111
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......+..|+|||++.+..++.++||||||+++|||++ |+.||..... .. .+. .+..+ ...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~----~~~-~~~~~-~~~-------- 223 (261)
T cd05068 161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AE----VLQ-QVDQG-YRM-------- 223 (261)
T ss_pred cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HH----HHH-HHHcC-CCC--------
Confidence 111223458999999998899999999999999999999 9999864322 11 111 11111 110
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.........+.+++.+||+.+|++||+|.+|++.|+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1112234568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=352.13 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=208.7
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.|...++||+|.||.||+|.+ ..++.||||++..+... ..+.+++|+.+|.+++++||.+.||.|..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 466678999999999999994 46889999999866433 3478899999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.||++.+.|.... .+++..+.-|+.+++.||.|||.+ +.+|||||+.||||..+|.+||+|||++..........
T Consensus 94 ~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred cCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999997654 457788888999999999999999 89999999999999999999999999998776654443
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
..++||+.|||||++....|+.|+||||||+.++||.+|.+|+...++...-.+ +.+-.-|.|.+
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------------Ipk~~PP~L~~- 233 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------------IPKSAPPRLDG- 233 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------------ccCCCCCcccc-
Confidence 567899999999999988999999999999999999999999977665111000 01111223333
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.....|.+|+..||+.||+.||++.+++++
T Consensus 234 ---~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 ---DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 444568899999999999999999999975
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=354.09 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=204.5
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|... +++.||||+++... ....+.+.+|++++.+++|+||+++++++.+++..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 58899999997532 223456888999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999997644 588999999999999999999998 899999999999999999999999999986543
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
......|++.|+|||++.+..++.++|||||||+||||++|+.||...... .. ........ ..+....
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~----~~~i~~~~---~~~~~~~ 221 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ET----WENLKYWK---ETLQRPV 221 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HH----HHHHHhcc---ccccCCC
Confidence 223456899999999999999999999999999999999999999754321 11 11111100 0011000
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...........+.+++..||+.+|.+||++.||+++
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 010011234567889999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=327.34 Aligned_cols=236 Identities=28% Similarity=0.379 Sum_probs=199.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch---hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ---GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||.|+||.|.+++. .+|..+|+|++....-. ..+...+|..+|+.+.||++++|++-|.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 5678889999999999999995 45888999999765332 2345678999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||++||.|..+|+..++ ++....+.+|.+|+.||+|||.. .|++|||||+|||||.+|.+||+|||+|+...+
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 99999999999987664 89999999999999999999999 999999999999999999999999999998765
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....+||+.|+|||++....|..++|.|+|||++|||+.|..||...... .+-..+-++++
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--------~iY~KI~~~~v-------- 258 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--------QIYEKILEGKV-------- 258 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH--------HHHHHHHhCcc--------
Confidence 245689999999999999999999999999999999999999999765541 11122222322
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCC
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRR 502 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~R 502 (608)
.++.-....+.+|+...|+.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1222333456778888888888887
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.64 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=204.5
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...+.||+|+||.||++.+.++..+|+|.++... .....|.+|++++++++|+||++++++|...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577788999999999999998888899999987543 334578889999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.++++.... .++|..++.++.+++.||.|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 83 NGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 9999999875432 589999999999999999999998 899999999999999999999999999986543222222
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....++..|+|||++....++.++||||||+++|||++ |+.||...... ..+.. +..+.. ...+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~~~~~-i~~~~~--~~~~~---- 224 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------EVVEM-ISRGFR--LYRPK---- 224 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH-HHCCCC--CCCCC----
Confidence 22335678999999998889999999999999999999 89998643321 11111 222211 11111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.....+.+++.+||+.+|++||+|.+|++.|.
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12346789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=342.11 Aligned_cols=256 Identities=30% Similarity=0.467 Sum_probs=212.7
Q ss_pred HhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
...+|...++||.|+||.||+|...+++.+|+|++..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999888999999999877665667789999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++.......+++..+++++.+++.||.|||+. +|+|||||++||||+.++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999876556789999999999999999999998 8999999999999999999999999999876543221
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
.....++..|++||++..+.++.++||||||+++|+|++ |+.||..... .. .+.... .+ +.
T Consensus 161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~----~~~~~~-~~-~~-------- 222 (261)
T cd05148 161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HE----VYDQIT-AG-YR-------- 222 (261)
T ss_pred -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HH----HHHHHH-hC-Cc--------
Confidence 123345778999999998899999999999999999998 8999864331 11 111111 11 10
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
..........+.+++.+||+.+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 01112334568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=340.11 Aligned_cols=254 Identities=27% Similarity=0.402 Sum_probs=206.9
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.+|...++||+|+||.||+|... +++.||+|++.... .....+.+|++++++++|+||++++++|..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34777889999999999999954 58899999987543 34567889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++.......+++..++.++.|+++||+|||.. +|+||||||+|||+++++.+||+|||+++.........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999999876656789999999999999999999998 89999999999999999999999999998765432222
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++.+..++.++|||||||++|||++ |..||..... +.+ ...+..+ +. .
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~-----~~~~~~~-~~--------~ 224 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQV-----YELLEKG-YR--------M 224 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH-----HHHHHCC-CC--------C
Confidence 222334668999999999999999999999999999998 8999865322 111 1112211 10 1
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.........+.+++.+||+.+|++||+|.+|+++|+.
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 1112234568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=360.72 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=202.4
Q ss_pred cCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~ 311 (608)
++|...++||+|+||.||+|+. .+++.||||+++.... .....+.+|+++++.+ +|+|||+++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4688899999999999999873 2245799999975433 3345688999999999 899999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCC------------------------------------------------------------
Q 046502 312 MLVCEFVTSNTLEFHLHGKG------------------------------------------------------------ 331 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 331 (608)
++||||+.+|+|.++++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999886421
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc-eeeee
Q 046502 332 --------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH-VSTRV 402 (608)
Q Consensus 332 --------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~ 402 (608)
...++|..+++|+.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 12478899999999999999999998 9999999999999999999999999999765432111 11223
Q ss_pred ecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCH
Q 046502 403 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481 (608)
Q Consensus 403 ~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 481 (608)
.++..|||||++....++.++|||||||+||||++ |+.||..... .. .+...+..+ +.. ..+ .
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~--~~-----~~~~~~~~~-~~~-~~~-------~ 338 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV--NS-----KFYKMVKRG-YQM-SRP-------D 338 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--cH-----HHHHHHHcc-cCc-cCC-------C
Confidence 35678999999999999999999999999999997 9999865322 11 111112221 100 011 1
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 482 NEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 482 ~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.....+.+++.+||+.||++||++.+|+++|+..
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1235678899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=350.78 Aligned_cols=242 Identities=24% Similarity=0.324 Sum_probs=197.2
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
++||+|+||.||++.. .+|+.||||+++... ......+.+|+.++++++|+||++++++|..++..+|||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 568999999997532 223356778999999999999999999999999999999999999
Q ss_pred cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeee
Q 046502 322 TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR 401 (608)
Q Consensus 322 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 401 (608)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...... .....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence 9999887643 589999999999999999999998 99999999999999999999999999997543221 12234
Q ss_pred eecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCH
Q 046502 402 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481 (608)
Q Consensus 402 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 481 (608)
..||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. +. ..+..+.. .++.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~----~~-~~~~~~~~----------~~p~ 216 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EK----LF-ELILMEEI----------RFPR 216 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HH----HH-HHHHcCCC----------CCCC
Confidence 5799999999999999999999999999999999999999964321 11 11 11111211 1112
Q ss_pred HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 482 NEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 482 ~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
.....+.+++..||+.||++|| ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2345678899999999999999 78988864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=346.07 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=201.5
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999964 68999999986432 233456889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+++|.+++...+ .+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999987654 588999999999999999999998 9999999999999999999999999999866432
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....|++.|+|||++.+..++.++|||||||+||||++|+.||..... .. +. ..+..+...
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~~----~~-~~i~~~~~~------- 216 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---FG----IY-EKILAGKLE------- 216 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HH----HH-HHHHhCCcC-------
Confidence 2235689999999999988899999999999999999999999975432 11 11 112222211
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPR-----ISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~~ 511 (608)
++......+.+++.+||+.||.+|++ +.+++++
T Consensus 217 ---~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 ---FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11112345788999999999999995 7777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=341.27 Aligned_cols=249 Identities=30% Similarity=0.511 Sum_probs=196.3
Q ss_pred cCCccccCCceEEEEEEec-----CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 244 DANLLGQGGFGYVHKGVLP-----NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 244 ~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
..+.||.|.||.||+|.+. .+..|+||.++.... ...+.|.+|++++++++|+||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999976 257899999976433 3467899999999999999999999999988889999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc-cc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-YT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~-~~ 396 (608)
+++|+|.++|+......+++..++.|+.||++||.|||++ +|+|+||+++||||+.++.+||+|||+++..... ..
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999988556799999999999999999999998 8999999999999999999999999999876321 12
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
...........|+|||++....++.++||||||+++|||++ |+.||..... ..+.... .++....
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-------~~~~~~~-~~~~~~~------ 225 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-------EEIIEKL-KQGQRLP------ 225 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-------HHHHHHH-HTTEETT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccc-cccccce------
Confidence 22233457789999999999999999999999999999999 6788754321 1122222 2222111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
........+.+++..||+.+|++||+|.+|++.|
T Consensus 226 ---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 ---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112345678899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=352.03 Aligned_cols=245 Identities=27% Similarity=0.371 Sum_probs=201.6
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++|+||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888999999999999999964 58899999987532 223456889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+++|.+++...+ .+++.....++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999987654 578889999999999999999998 9999999999999999999999999999866442
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....|++.|+|||++.+..++.++|||||||+||||++|+.||...... ... ..+..+.+. +
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~-~~i~~~~~~------~ 234 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-------RIY-EKILAGRLK------F 234 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-------HHH-HHHhcCCcC------C
Confidence 22357899999999999999999999999999999999999999643321 111 122233221 1
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPR-----ISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~~ 511 (608)
+.....++.+++..||+.||.+|++ +.+++.+
T Consensus 235 ----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 235 ----PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1112245778999999999999996 6777654
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=342.51 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=206.5
Q ss_pred cCCCcCCccccCCceEEEEEEecC-C-----cEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-G-----KEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|...+.||+|+||.||+|.... + +.||+|.++... ......|.+|+.++.+++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357788999999999999998533 2 579999987543 233467899999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC
Q 046502 313 LVCEFVTSNTLEFHLHGKGR--------------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF 378 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~ 378 (608)
++|||+++++|.+++..... ..+++..++.++.|++.||.|||+. +|+||||||+||||++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999875321 4588999999999999999999998 899999999999999999
Q ss_pred ceEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHH
Q 046502 379 EAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARP 456 (608)
Q Consensus 379 ~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 456 (608)
.+||+|||+++...... ........++..|+|||++..+.++.++|||||||+||||++ |..||..... ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~---- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QE---- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HH----
Confidence 99999999998653321 122233456889999999998899999999999999999998 9999864322 11
Q ss_pred HHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 457 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 457 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
+...+..+.... .......++.+|+.+||+.||++||++.||+++|+.
T Consensus 235 -~~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 -VIEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 112222222211 122345678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=350.57 Aligned_cols=200 Identities=27% Similarity=0.414 Sum_probs=176.2
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...+.||+|+||.||++... +|..||+|++.... ......+.+|+++|++++|+||++++++|..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367899999999999999999964 58889999987643 2334678999999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+++++|.+++.... .+++..+..++.+++.||.|||+.. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999997644 5889999999999999999999852 5999999999999999999999999999765432
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDST 445 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~ 445 (608)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 223356899999999999989999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=355.68 Aligned_cols=253 Identities=28% Similarity=0.379 Sum_probs=212.2
Q ss_pred cCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
+-|..++-||.|+.|.|-+|+ ..+|+.+|||++.... ......+.+||.||+.+.|||+++||+++.+..++|||+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 457778899999999999998 5689999999997652 122345788999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++|.|.++|-.++ .|.+.+..+++.||+.|+.|+|.. +|+||||||+|+|||.++++||+|||+|.+...+
T Consensus 92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 9999999999998877 488899999999999999999999 9999999999999999999999999999875542
Q ss_pred cceeeeeecccCccChhhhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.....-+|.+.|.+||++++..|. .++||||+|||||.||+|+.|||+.. .+.++.. +..|.|+.-
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------ir~LLlK-V~~G~f~MP---- 232 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------IRVLLLK-VQRGVFEMP---- 232 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------HHHHHHH-HHcCcccCC----
Confidence 344557899999999999999885 69999999999999999999998432 2333332 345655432
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcCcc
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT--LEGDAS 517 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~--L~~~~~ 517 (608)
.+...+..+|+.+||..||.+|-++.||+++ |.+...
T Consensus 233 ------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 233 ------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 2334456788999999999999999999986 444433
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=335.51 Aligned_cols=253 Identities=29% Similarity=0.447 Sum_probs=205.6
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...++||+|+||.||+|...++..||+|.++.... ..+.|.+|+.++++++|+||+++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999988888999999976443 3456899999999999999999999885 456899999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.++++......+++..++.++.+++.||.|||+. +|+||||||+|||+++++.+||+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999875555689999999999999999999998 899999999999999999999999999986644322222
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....++..|+|||++....++.++||||||+++|||++ |..||..... . ..+.. +..+.. ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~----~~~~~-~~~~~~---------~~ 223 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---R----EVLEQ-VERGYR---------MP 223 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---H----HHHHH-HHcCCC---------CC
Confidence 23345678999999998899999999999999999999 8888864321 1 11111 111110 11
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.+|++||+|.++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112334568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.81 Aligned_cols=252 Identities=28% Similarity=0.421 Sum_probs=204.5
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...+.||+|+||.||+|...++..||||.++... .....|.+|+.++.+++|+||++++++|.+.+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3567788999999999999998777789999987543 334678899999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++..... .++|..++.++.+|+.||.|||+. +|+|+||||+|||++.++.+||+|||+++..........
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 9999999876443 689999999999999999999998 999999999999999999999999999986544322112
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....++..|++||++.+..++.++|||||||++|||++ |+.||..... .. .... +..+.....
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~----~~~~-~~~~~~~~~-------- 222 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SE----TVEK-VSQGLRLYR-------- 222 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HH----HHHH-HhcCCCCCC--------
Confidence 22345678999999998889999999999999999998 9999864332 11 1111 122211100
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.......+.+++..||+.+|.+||++.+|++.|+
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1112457888999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=354.00 Aligned_cols=261 Identities=21% Similarity=0.271 Sum_probs=198.1
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...++||+|+||.||++.. .+++.||||+... ..+.+|+++|++|+|+|||+++++|..+...++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 36799999999999999999995 4688999997542 3467899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+. ++|..++..+. .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++........
T Consensus 165 ~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 96 67777776543 589999999999999999999998 9999999999999999999999999999764432222
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh-cCCCC--------
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE-DGNFD-------- 468 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~-------- 468 (608)
......||+.|+|||++.+..++.++|||||||+||||++|+.||-..............+...+. .|...
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 334467999999999999999999999999999999999999886432211100000000000000 00000
Q ss_pred ----cc---------cCccccCc--CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 ----TL---------VDPKLHNE--YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ----~~---------~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+ ..+..... ........+.+++.+||+.||++||++.|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00 00000000 001234568889999999999999999999864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=318.96 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=209.6
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|.+.+.||+|.||.||.|+. +++-.||+|++.+.. .+..+++.+|++|.+.|+||||+++|+||.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35789999999999999999994 456789999986542 33457899999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
+||..+|.|...|.......++......++.|+|.||.|+|.. +||||||||+|+|++.++..||+|||.+...+..
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 9999999999999976666788889999999999999999998 8999999999999999999999999998766532
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.....+||+.|++||.+.+..++.++|+|++||+.||+|.|.+||.... .+...+.+..- ++.+
T Consensus 178 ---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~--------~~~~-- 241 (281)
T KOG0580|consen 178 ---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKV--------DLKF-- 241 (281)
T ss_pred ---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHc--------cccC--
Confidence 3345789999999999999999999999999999999999999997543 22222212111 1112
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+........+++..|+..+|.+|....||+++
T Consensus 242 -----p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 -----PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 22334457789999999999999999999875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=356.09 Aligned_cols=258 Identities=24% Similarity=0.359 Sum_probs=204.8
Q ss_pred hcCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~ 310 (608)
.++|.+.++||+|+||.||+|+.. .+..||||+++.... ...+.|.+|+++|+++. |||||+++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888899999999999999842 134799999975433 33457889999999996 9999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCC-----------------------------------------------------------
Q 046502 311 RMLVCEFVTSNTLEFHLHGKG----------------------------------------------------------- 331 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 331 (608)
.+||||||++|+|.++|+...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999886431
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc
Q 046502 332 -----------------------------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF 376 (608)
Q Consensus 332 -----------------------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~ 376 (608)
...++|..++.++.||++||.|||.. +|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 12478889999999999999999998 8999999999999999
Q ss_pred CCceEEEEeeccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhh
Q 046502 377 KFEAKVADFGLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLA 454 (608)
Q Consensus 377 ~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~ 454 (608)
++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |..||..... ..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~--~~--- 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV--DS--- 347 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch--hH---
Confidence 999999999999865432211 1223446788999999999899999999999999999997 9899864321 11
Q ss_pred HHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 455 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 455 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+...+..+... .........+.+++.+||+.+|++||++.+|+++|+..
T Consensus 348 --~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 348 --TFYNKIKSGYRM---------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred --HHHHHHhcCCCC---------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 111122222110 11122345688999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.33 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=202.6
Q ss_pred CCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
+|...+.||+|+||.||++...+++.+|||.+..... ....|.+|++++++++|+||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677889999999999999987778899999865432 345678899999999999999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|.+++..... .++|..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...+.......
T Consensus 84 ~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 84 GCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 999999876443 689999999999999999999998 8999999999999999999999999999865432221112
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
...++..|+|||++.+..++.++|||||||++|||++ |+.||+.... .. ... .+..+. . ...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~----~~~-~~~~~~-----~----~~~ 222 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SE----VVE-SVSAGY-----R----LYR 222 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HH----HHH-HHHcCC-----c----CCC
Confidence 2224467999999998999999999999999999998 8888864332 11 111 111111 0 011
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
.......+.+++.+||+.+|++||+|.||++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 112345788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=345.73 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=202.3
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCc----EEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGK----EVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
.+|...++||+|+||.||+|.+. +++ .||||+++... ....+.|.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999853 343 38999997543 34456788999999999999999999999764 5789
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
|+||+.+|+|.+++.... ..+++..+++++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999998653 3588999999999999999999998 899999999999999999999999999987654
Q ss_pred ccccee-eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
...... ....++..|+|||++....++.++|||||||+||||++ |+.||+..... . +...+..+.. +.
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~-----~~~~~~~~~~--~~ 231 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E-----ISSILEKGER--LP 231 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H-----HHHHHhCCCC--CC
Confidence 322211 12234678999999999999999999999999999997 99998643220 1 1122222211 11
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+ ......+.+++..||+.+|.+||++.+|+..|...
T Consensus 232 ~~-------~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 232 QP-------PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CC-------CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 11234578899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.07 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=199.3
Q ss_pred CCCcCCccccCCceEEEEEEe----cCCcEEEEEEcccCC----chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL----PNGKEVAIKQLKAGS----GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~ 311 (608)
+|...++||+|+||.||++.. .+++.||||+++... ....+.+..|+.++.++ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999875 357899999986432 22235678899999999 599999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+.+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999987543 589999999999999999999998 8999999999999999999999999999865
Q ss_pred cCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
............||..|||||++.+. .++.++|||||||+||||++|+.||....... ....+... +...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~~~~~-~~~~----- 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN---TQSEVSRR-ILKC----- 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC---CHHHHHHH-HhcC-----
Confidence 43323333346799999999999765 47889999999999999999999996432211 11111111 1111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
++.+.. .....+.+++.+||+.||++|| ++.+++++
T Consensus 227 -~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 -DPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -CCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111 2234577899999999999999 67777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.02 Aligned_cols=242 Identities=26% Similarity=0.343 Sum_probs=196.9
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
++||+|+||.||++.. .+|+.||||+++... ......+.+|+.++++++|+||+++++++..++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999997542 233456788999999999999999999999999999999999999
Q ss_pred cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeee
Q 046502 322 TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR 401 (608)
Q Consensus 322 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 401 (608)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~ 154 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMKT 154 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-cccc
Confidence 9998886543 589999999999999999999998 999999999999999999999999999875432211 2234
Q ss_pred eecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCH
Q 046502 402 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481 (608)
Q Consensus 402 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 481 (608)
..|++.|+|||++.+..++.++|||||||+||||++|+.||..... .. +.. .+..+.+ .+ +.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~----~~~-~~~~~~~------~~----p~ 216 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EK----LFE-LILMEDI------KF----PR 216 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HH----HHH-HhccCCc------cC----CC
Confidence 5799999999999988999999999999999999999999964322 11 111 1111111 11 11
Q ss_pred HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 482 NEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 482 ~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
.....+.+++.+||+.||++|+ ++.|++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2234578899999999999997 89999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=346.14 Aligned_cols=242 Identities=23% Similarity=0.325 Sum_probs=196.0
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
++||+|+||.||++.. .+|+.||+|+++... ......+.+|+.++++++|+||++++++|...+..+|||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999985 468999999997532 223456778999999999999999999999999999999999999
Q ss_pred cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeee
Q 046502 322 TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR 401 (608)
Q Consensus 322 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 401 (608)
+|..++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cccc
Confidence 9998886543 589999999999999999999998 999999999999999999999999999875422211 1233
Q ss_pred eecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCH
Q 046502 402 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481 (608)
Q Consensus 402 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 481 (608)
..|++.|+|||++.++.++.++|||||||+||||++|+.||..... .. .... +..+.. .+ +.
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~----~~~~-~~~~~~------~~----p~ 216 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ER----LFEL-ILMEEI------RF----PR 216 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HH----HHHH-HhcCCC------CC----CC
Confidence 5689999999999999999999999999999999999999964332 11 1111 111111 11 11
Q ss_pred HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 482 NEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 482 ~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
.....+.+++..||+.||++|+ ++.+++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2234577899999999999998 88888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=334.46 Aligned_cols=254 Identities=30% Similarity=0.441 Sum_probs=205.5
Q ss_pred cCCCcCCccccCCceEEEEEEecC----CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++||+|+||.||+|.+.. ...||||+++... ......|.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998643 3579999987543 33346788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++..... .++|..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999876443 689999999999999999999998 8999999999999999999999999999877522
Q ss_pred ccce-eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 395 YTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 395 ~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
.... .....++..|+|||++.+..++.++||||||+++|||++ |..||..... .. +...+..+....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~-----~~~~~~~~~~~~--- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QD-----VIKAVEDGYRLP--- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HH-----HHHHHHcCCCCC---
Confidence 1111 122334678999999998899999999999999999998 9999854321 11 112222221100
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.+|++||+|.||+++|+.
T Consensus 229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 111234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.78 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=206.7
Q ss_pred cCCCcCCccccCCceEEEEEEecC------CcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN------GKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|...+.||+|+||.||+|...+ ++.||||.++..... ....|.+|+++|.+++|+||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998633 478999999765444 4578999999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 313 LVCEFVTSNTLEFHLHGKG------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
+||||+++++|.+++...+ ...+++..+..++.+++.||.|||.. +|+||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997542 23578999999999999999999998 89999999999999999999
Q ss_pred EEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHH
Q 046502 381 KVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLL 458 (608)
Q Consensus 381 kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 458 (608)
||+|||+++...... ........++..|+|||++.++.++.++|||||||++|||++ |..||..... .. .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~----~- 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EE----V- 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HH----H-
Confidence 999999997543221 112233446788999999999999999999999999999998 9999864332 11 1
Q ss_pred HHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 459 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 459 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
...+..+.+... .......+.+++.+||+.+|++||++.||++.|+
T Consensus 234 ~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 IECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 112223332211 1123456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=365.24 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=208.4
Q ss_pred cCCCcCCccccCCceEEEEEEecCC-cEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceee-EEE---e---CCe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNG-KEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVG-YYT---A---GSQ 310 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g-~~~---~---~~~ 310 (608)
.+.++.++|.+|||+.||++.+..+ .+||+|++-..+....+.+.+||++|++|. |+|||.+++ ... . .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4567788999999999999997666 999999998888888899999999999997 999999999 322 1 236
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
++|+||||.||.|-+++..+....|++.++++|+.++++|+++||.. .++|||||||.+||||..++..||||||.|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 79999999999999999876555699999999999999999999985 77899999999999999999999999999863
Q ss_pred ccCcc-c--ce-----eeeeecccCccChhhh---hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 046502 391 ASDVY-T--HV-----STRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 391 ~~~~~-~--~~-----~~~~~gt~~y~aPE~~---~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 459 (608)
.-... . .+ .-...-|+.|++||.+ .+..+++|+|||+|||+||-|+....||+.....
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----------- 264 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----------- 264 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----------
Confidence 21111 0 00 0113458999999986 5667999999999999999999999999865321
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
+|-+++|.-- -...+..+|.+||..||+.||++||++.||+..+-..
T Consensus 265 -aIlng~Y~~P--------~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 265 -AILNGNYSFP--------PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred -eEEeccccCC--------CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 1223333211 1146778899999999999999999999999887543
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=343.56 Aligned_cols=240 Identities=24% Similarity=0.338 Sum_probs=193.8
Q ss_pred cccCCceEEEEEEec-CCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 248 LGQGGFGYVHKGVLP-NGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 248 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
||+|+||.||++... +++.||||+++.. .......+.+|+.++.+++|+||++++++|...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999964 5789999998643 233345678899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeee
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 403 (608)
.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC 154 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence 99987654 589999999999999999999998 89999999999999999999999999998543221 2233457
Q ss_pred cccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHH
Q 046502 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483 (608)
Q Consensus 404 gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 483 (608)
||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+....+ .+.+ .+....
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~-~~~~----------~~~~~~ 216 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKIL-QEPL----------RFPDGF 216 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHH-cCCC----------CCCCcC
Confidence 99999999999999999999999999999999999999964322 11111111 1111 111122
Q ss_pred HHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 046502 484 MARMVACAAACVRHSARRRPR---ISQIVRT 511 (608)
Q Consensus 484 ~~~l~~l~~~Cl~~dp~~RPs---m~evv~~ 511 (608)
...+.+++.+||+.||.+||+ +.|++.+
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 345778999999999999986 4555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=361.40 Aligned_cols=250 Identities=22% Similarity=0.315 Sum_probs=204.5
Q ss_pred CCcCCccccCCceEEEEEEec-C-CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 242 FSDANLLGQGGFGYVHKGVLP-N-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
|...++||+|+||.||+|... + ++.||+|.+..........+++|+.+|+.++|+|||+++++|..++.++|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 778899999999999999843 3 67899998876655556678899999999999999999999999999999999999
Q ss_pred CCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc-
Q 046502 320 SNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT- 396 (608)
Q Consensus 320 ~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~- 396 (608)
+|+|.++|+.. ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 99999988642 234688999999999999999999998 999999999999999999999999999987654321
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
.......||++|+|||++.+..++.++|||||||++|||++|+.||..... ..++... ..+....+
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~-~~~~~~~~------ 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQV-LYGKYDPF------ 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHH-HhCCCCCC------
Confidence 223446799999999999999999999999999999999999999964322 1112221 12222111
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++..||+.+|++||++.+++.+
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11223468889999999999999999998753
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=338.04 Aligned_cols=262 Identities=22% Similarity=0.322 Sum_probs=199.5
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||+|... +++.||||+++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999854 68899999987543 22345677899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+ +|.+++...+. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDNCGN-LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 985 88888765432 578999999999999999999998 999999999999999999999999999976543211
Q ss_pred eeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH------------hc
Q 046502 398 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI------------ED 464 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~------------~~ 464 (608)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+.. +.+.+ ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~--~~~~~--~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK--EELHL--IFRLLGTPTEETWPGITSN 234 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH--HHHHhCCCChHHhhccccc
Confidence 1233468999999999865 56899999999999999999999999754321 11100 00000 00
Q ss_pred CCCCcccCccccCcC----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 465 GNFDTLVDPKLHNEY----NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 465 ~~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+.....+...... .......+++++..||+.||.+||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111111111110000 01123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=345.78 Aligned_cols=200 Identities=27% Similarity=0.429 Sum_probs=175.3
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...++||+|+||.||++... +++.+|+|+++... ......+.+|++++++++|+||++++++|.+++..+||||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367899999999999999999964 57889999887643 2334678899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.+++|.+++.... .+++.....++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 999999999997643 4889999999999999999999752 6999999999999999999999999999765432
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDST 445 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~ 445 (608)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123356899999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=333.21 Aligned_cols=253 Identities=30% Similarity=0.442 Sum_probs=204.9
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...++||+|+||.||+|.+.+...||||+++.... ..+.|.+|++++++++|+||+++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 46888999999999999999987777899999985432 3457889999999999999999999875 456899999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++.......++|..++.++.++++||.|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999865445689999999999999999999998 899999999999999999999999999986654322222
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....++..|++||++.++.++.++|||||||++|||++ |..||..... . .... .+..+.. ..
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~----~~~~-~~~~~~~---------~~ 223 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---R----EVLD-QVERGYR---------MP 223 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---H----HHHH-HHhcCCC---------CC
Confidence 23446778999999998899999999999999999999 7888864321 1 1111 1111110 01
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.+|++||++.++++.|+.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 122345568899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.87 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=209.6
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
.+|...+.||+|+||.||+|... ++..+++|.++.......+.+.+|++++++++|+||++++++|..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999742 356799999987766666789999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc
Q 046502 314 VCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE 379 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~ 379 (608)
||||+++++|.+++.... ...++|..++.++.+|+.||+|||++ +|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 999999999999987532 13489999999999999999999999 8999999999999999999
Q ss_pred eEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHH
Q 046502 380 AKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPL 457 (608)
Q Consensus 380 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 457 (608)
+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-------~- 233 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-------E- 233 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H-
Confidence 9999999997554321 112233456788999999999999999999999999999998 99998643321 1
Q ss_pred HHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 458 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 458 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+...+..+..... .......+.+++.+||+.+|++||++.+|+++|+...
T Consensus 234 ~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 234 VIECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HHHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1122233332221 1123456889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=332.96 Aligned_cols=254 Identities=28% Similarity=0.425 Sum_probs=206.9
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.++|...++||+|+||.||+|...+++.||+|.+..... ....|.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 356888899999999999999988899999999876543 3457889999999999999999999874 45789999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+++|.+++.......+++.+++.++.+++.||+|||+. +|+||||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 999999998776556789999999999999999999998 89999999999999999999999999998665322222
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++....++.++|||||||++|||++ |+.||..... .. ... .+..+....
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~----~~~-~~~~~~~~~-------- 223 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PE----VIQ-NLERGYRMP-------- 223 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HH----HHH-HHHcCCCCC--------
Confidence 223446778999999998899999999999999999999 9999864322 11 111 112111101
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.......++.+++.+||+.+|++||++.+|+..|+.
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111223568899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=337.31 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=196.4
Q ss_pred cCCCcCCccccCCceEEEEEEe--cCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhc---CCCCccceeeEEE-----e
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL--PNGKEVAIKQLKAGSG--QGERVFQAEVEIISRV---HHKHLVSLVGYYT-----A 307 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l---~Hpniv~l~g~~~-----~ 307 (608)
++|...+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.+++++ +|+||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999985 2468899999865432 2233556788777766 6999999999985 2
Q ss_pred CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeec
Q 046502 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL 387 (608)
Q Consensus 308 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGl 387 (608)
....++||||+. ++|.+++.......+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999997 5888888765555689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH--hcC
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI--EDG 465 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~ 465 (608)
++..... .......|+..|+|||++....++.++|||||||++|||++|+.||...... + .....+.... ...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~--~-~~~~i~~~~~~~~~~ 231 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV--D-QLGKILDVIGLPGEE 231 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH--H-HHHHHHHHhCCCChh
Confidence 9865432 2233456899999999999889999999999999999999999999754321 1 1111111000 000
Q ss_pred CCC-------cccCcccc---CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 NFD-------TLVDPKLH---NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~~~-------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+. ..+...-. ..........+.+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 00000000 00011123456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=337.16 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=203.4
Q ss_pred cCCCcCCccccCCceEEEEEEe-----cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-----PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|+..++||+|+||.||+|.+ .+++.||+|.++... .+....|.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577789999999999999984 245789999997543 3334678899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC
Q 046502 314 VCEFVTSNTLEFHLHGKG---------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF 378 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~ 378 (608)
||||+.+++|.+++.... ...+++...+.++.+++.||.|||+. +|+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999985321 23578999999999999999999998 899999999999999999
Q ss_pred ceEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHH
Q 046502 379 EAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARP 456 (608)
Q Consensus 379 ~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 456 (608)
.+||+|||+++...... ........++..|+|||++.++.++.++|||||||+||||++ |..||..... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~----- 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---Q----- 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---H-----
Confidence 99999999998653321 112223345778999999998899999999999999999998 8888864321 1
Q ss_pred HHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 457 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 457 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.+...+..+.... .......++.+++.+||+.+|.+||++.+|+++|++
T Consensus 234 ~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMVRKRQLLP---------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111222222111 111233567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=333.60 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=212.5
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.+|.+.+.||+|.||.|-++.. ..|+.||||.++.+.. ++...+++||+||+.|+||||+.+|.+|++.+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4566778899999999999984 6799999999987643 44456889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||..+|.|.+++...+ .|++.....++.||..|+.|+|.+ +++|||||.+|||||.|+++||+||||+.++.+.
T Consensus 133 EYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 9999999999998765 599999999999999999999999 9999999999999999999999999999987663
Q ss_pred cceeeeeecccCccChhhhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
...+.++|++-|.+||++.+..|. ..+|-|||||+||-|+.|..|||..+. . .+.+.+..|.+.+--.+.
T Consensus 207 -kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k-----~lvrQIs~GaYrEP~~PS 277 (668)
T KOG0611|consen 207 -KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---K-----RLVRQISRGAYREPETPS 277 (668)
T ss_pred -cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---H-----HHHHHhhcccccCCCCCc
Confidence 344568999999999999998885 689999999999999999999986542 1 234455666665543322
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
...-|+.+||..+|++|-|+.+|..+.
T Consensus 278 -----------dA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 278 -----------DASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----------hHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 234588999999999999999999875
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=347.20 Aligned_cols=257 Identities=27% Similarity=0.424 Sum_probs=202.8
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEe-CCe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTA-GSQ 310 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~-~~~ 310 (608)
++|.+.++||+|+||.||+|... .++.||+|+++.... .....+.+|++++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888999999999999999732 247899999975432 2335677899999999 89999999998864 456
Q ss_pred eEEEEeeccCCcHHHHhhcCC-----------------------------------------------------------
Q 046502 311 RMLVCEFVTSNTLEFHLHGKG----------------------------------------------------------- 331 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 331 (608)
+++||||+++++|.+++....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 889999999999999886432
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce-eeeeecccCccC
Q 046502 332 RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV-STRVMGTFGYLA 410 (608)
Q Consensus 332 ~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~a 410 (608)
...++|..+.+++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 12589999999999999999999998 99999999999999999999999999998654322111 223446778999
Q ss_pred hhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHH
Q 046502 411 PEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVA 489 (608)
Q Consensus 411 PE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 489 (608)
||++.+..++.++|||||||+||||++ |+.||..... .+ .+...+..+.... ........+.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~--~~-----~~~~~~~~~~~~~---------~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI--DE-----EFCRRLKEGTRMR---------APEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc--cH-----HHHHHHhccCCCC---------CCccCCHHHHH
Confidence 999999999999999999999999998 9999865322 11 1222222222111 11123456889
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 490 CAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 490 l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
++.+||+.+|++||++.||+++|+..
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=346.64 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=200.8
Q ss_pred cCCCcCCccccCCceEEEEEEecC--CcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN--GKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...+.||+|+||.||+|...+ +..||||++.... ......+.+|+.++..++||||++++++|.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999998543 3689999986432 22345678899999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.+|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999997654 589999999999999999999998 9999999999999999999999999999865432
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...... .+...+..+...
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~------ 246 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEGIIY------ 246 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCCC------
Confidence 23457999999999999888999999999999999999999999754321 111122222211
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
++......+.+++..||+.||.+|+ ++.+++++
T Consensus 247 ----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 ----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111223467899999999999995 88888865
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=352.39 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=218.7
Q ss_pred HHHHHHhcCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 233 EELARATDGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 233 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
++.+-...+....++||-|-||.||.|.++. .-.||||.++.+. ...++|..|..+|+.++|||+|+|+|+|..+-.+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3333344556677899999999999999754 4569999998654 5567899999999999999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
|||.|||.+|+|.++|+..++..++-...+.+|.||+.||+||..+ ++|||||.++|+||.++-.+||+||||++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999998888888889999999999999999999 9999999999999999999999999999988
Q ss_pred cCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
..+...........+.|.|||-+....++.|+|||+|||||||+.| |..||...+. .... ..+
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----SqVY----~LL-------- 479 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVY----GLL-------- 479 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----HHHH----HHH--------
Confidence 7643322233345789999999999999999999999999999996 8888765432 1111 112
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
....+.+.+..+...+++|+++||+++|.+||++.|+-+.||.
T Consensus 480 -EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 480 -EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred -hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 2223344456677889999999999999999999999998875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=349.97 Aligned_cols=252 Identities=23% Similarity=0.289 Sum_probs=199.3
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||++.. .+|+.||||+++... ......+.+|+.+|..++|+||++++++|.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4788999999999999999995 468999999997532 233456788999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999997654 589999999999999999999998 89999999999999999999999999987543211
Q ss_pred cc-------------------------------------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhC
Q 046502 396 TH-------------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIG 438 (608)
Q Consensus 396 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG 438 (608)
.. .....+||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 046502 439 CRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR---ISQIVRT 511 (608)
Q Consensus 439 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---m~evv~~ 511 (608)
+.||...... ......+.......+. . .......+.+++..|+. +|.+|++ +.|++++
T Consensus 236 ~~Pf~~~~~~-------~~~~~i~~~~~~~~~~-----~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNPQ-------ETYRKIINWKETLQFP-----D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCHH-------HHHHHHHcCCCccCCC-----C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9999754321 1111111111000000 0 00122356678888886 8999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=337.14 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=203.2
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
+|...++||+|+||.||++.. .+++.||||++..... .....+.+|+.++++++|+||++++++|..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999995 4689999999865322 223457789999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.+++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+|||+++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999988765555689999999999999999999998 89999999999999999999999999998654321
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .... .+...+..+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~-~~~~~~~~~~---------- 221 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKRE-EVERRVKEDQ---------- 221 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHH-HHHHHhhhcc----------
Confidence 122346899999999999889999999999999999999999999753321 1111 1111111111
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
..+.......+.+++..||+.||.+|| ++.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112223445678899999999999999 77788654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=327.75 Aligned_cols=247 Identities=28% Similarity=0.402 Sum_probs=200.7
Q ss_pred CccccCCceEEEEEEecCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcHH
Q 046502 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLE 324 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~ 324 (608)
++||+|+||.||+|...+++.||+|+++.... .....|.+|++++++++|+||++++++|...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46999999999999988899999999876543 33456889999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeeec
Q 046502 325 FHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMG 404 (608)
Q Consensus 325 ~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 404 (608)
+++.... ..++|..++.++.+++.+|.|||.. +++||||||+|||++.++.+||+|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9887543 3589999999999999999999998 89999999999999999999999999997554322211222234
Q ss_pred ccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHH
Q 046502 405 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483 (608)
Q Consensus 405 t~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 483 (608)
+..|+|||++..+.++.++|||||||++|||++ |..||...... . ....+..+... ......
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~-----~~~~~~~~~~~---------~~~~~~ 219 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---Q-----AREQVEKGYRM---------SCPQKC 219 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---H-----HHHHHHcCCCC---------CCCCCC
Confidence 678999999999999999999999999999998 99998643221 0 11112222111 111223
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 484 MARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 484 ~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
...+.+++.+||+.+|++||++.+|++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=330.66 Aligned_cols=253 Identities=31% Similarity=0.450 Sum_probs=204.5
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...++||+|+||.||++.+..+..||+|.+..... ..+.+.+|++++++++|+||+++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 45778889999999999999987777899999875432 3456888999999999999999999885 456899999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.++++......++|..+..++.+++.||.|||+. +|+|||||++||||++++.+||+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999875555689999999999999999999998 899999999999999999999999999986643222222
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....++..|+|||++.++.++.++|||||||++|||++ |+.||..... .. .. ..+..+ +.. .
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~----~~-~~~~~~-~~~--------~ 223 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---RE----VL-EQVERG-YRM--------P 223 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HH----HH-HHHHcC-CCC--------C
Confidence 22346778999999998999999999999999999999 8889864322 11 11 112211 110 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112334568889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=352.38 Aligned_cols=251 Identities=25% Similarity=0.301 Sum_probs=203.9
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|... +|+.||||+++... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999964 68999999997532 233457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+++|.+++... ..+++..++.++.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 3589999999999999999999998 99999999999999999999999999998654432
Q ss_pred ----------------------------cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc
Q 046502 396 ----------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHT 447 (608)
Q Consensus 396 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~ 447 (608)
........||..|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1122345689999999999999999999999999999999999999975432
Q ss_pred cccchhhHHHHHHHHhc-CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 046502 448 FMEDNLARPLLNRAIED-GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-ISQIVRT 511 (608)
Q Consensus 448 ~~~~~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-m~evv~~ 511 (608)
. . ........ ..+.. +. .......+.+++..||+ +|.+||+ +.+|+++
T Consensus 236 ~---~----~~~~i~~~~~~~~~---p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 Q---E----TYNKIINWKESLRF---PP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H---H----HHHHHhccCCcccC---CC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 0 11111110 11100 00 00134567788999997 9999999 9999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=340.08 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=203.6
Q ss_pred HHHHHhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCc--------------hhHHHHHHHHHHHHhcCCCCc
Q 046502 234 ELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSG--------------QGERVFQAEVEIISRVHHKHL 298 (608)
Q Consensus 234 el~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~--------------~~~~~~~~Ev~~l~~l~Hpni 298 (608)
+-....++|.+.+.||+|.||.|-+|+ ..+++.||||++.+... ...+.+++||.+|++|+|+||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 334456889999999999999999999 45789999999964321 113578899999999999999
Q ss_pred cceeeEEEe--CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc
Q 046502 299 VSLVGYYTA--GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF 376 (608)
Q Consensus 299 v~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~ 376 (608)
|+|+++..+ .+.+|||+|||..|.+...-- ....|...+.++++.+++.||+|||.+ +||||||||+|+||++
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 999999865 568999999999998864322 222389999999999999999999999 9999999999999999
Q ss_pred CCceEEEEeeccccccCc----ccceeeeeecccCccChhhhhcCC----CCCcchhhhHHHHHHHHHhCCCCCCCCccc
Q 046502 377 KFEAKVADFGLAKLASDV----YTHVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELIIGCRPVDSTHTF 448 (608)
Q Consensus 377 ~~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~Gvll~elltG~~p~~~~~~~ 448 (608)
+|++||+|||.+..+... ......+.+||+.|||||.+..+. .+.+.||||+||.||.||.|+.||.....
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~- 324 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE- 324 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-
Confidence 999999999999866221 112233478999999999997743 35689999999999999999999964322
Q ss_pred ccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 449 MEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 449 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.. +.. .++...|.-....++-+++.+|++++|++||++|-+..+|..+.-
T Consensus 325 --~~----l~~---------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 325 --LE----LFD---------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred --HH----HHH---------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 11 111 122222222222345667889999999999999999999988753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.37 Aligned_cols=243 Identities=28% Similarity=0.410 Sum_probs=202.0
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG---QGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~ 312 (608)
..++|...++||+|.||.|+++.++ +++.||||+++++.. .+.+....|..|+...+ ||.|++|+.+|...+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3468999999999999999999964 578999999998743 33456778888888875 999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+.||++..+.+. ..+++.....++..|+.||.|||++ +|||||||.+|||||.+|.+||+||||++...
T Consensus 446 fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 99999999995444332 3699999999999999999999999 99999999999999999999999999998654
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
... .....++||+.|||||++....|+..+|.|+|||||||||.|..||...+. +++.. .++. |
T Consensus 520 ~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee~Fd----sI~~--------d 583 (694)
T KOG0694|consen 520 GQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EEVFD----SIVN--------D 583 (694)
T ss_pred CCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHH----HHhc--------C
Confidence 322 245668999999999999999999999999999999999999999976442 22211 1111 1
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRI 505 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm 505 (608)
. ..|+.....+.+.++.+.|..+|++|.-+
T Consensus 584 ~---~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 E---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred C---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1 22455566677889999999999999877
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=347.16 Aligned_cols=253 Identities=22% Similarity=0.270 Sum_probs=203.2
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||++.. .+|+.||||+++... ....+.+.+|+.+++.++|+||+++++++.+.+..+|||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999985 468999999997542 234466889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999997652 3689999999999999999999999 99999999999999999999999999998765433
Q ss_pred cceeeeeecccCccChhhhh------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 396 THVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
........||+.|+|||++. ...++.++|||||||+||||++|+.||...... ..+...+.......
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~ 229 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQRFLK 229 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCCccC
Confidence 33334457899999999986 456789999999999999999999999653321 11122222111111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+ .......+.+++..||+ +|.+||++.+++.+
T Consensus 230 ~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 FPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 111 11223457788899998 99999999998864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=335.91 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=203.8
Q ss_pred HhcCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~ 310 (608)
..++|+..+.||+|+||.||+|... .+..||||++.... ......|.+|+.++++++|+||++++++|.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999998753 24679999986543 2334568899999999999999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEE
Q 046502 311 RMLVCEFVTSNTLEFHLHGKG--------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl 382 (608)
.++||||+.+++|.+++.... ...++|..++.++.|++.||.|||+. +++||||||+||||+.++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999987532 12468889999999999999999998 8999999999999999999999
Q ss_pred EEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHH
Q 046502 383 ADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 383 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++ |..||..... . ..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~----~~~~- 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---E----QVLR- 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---H----HHHH-
Confidence 99999975543211 11122345778999999998899999999999999999999 6888864322 1 1111
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.+.++.+..+ .......+.+++.+||+.+|++||++.|++++|+
T Consensus 233 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 233 FVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1122222111 1123346888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=325.01 Aligned_cols=250 Identities=27% Similarity=0.421 Sum_probs=206.6
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...+.||+|+||.||++.. .+++.|++|.+... .......+.+|++++++++|+||++++++|.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477788999999999999996 46899999998643 334456788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.++++......+++..++.++.+++.||.|||+. +|+|||||++|||++.++.+||+|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999876455789999999999999999999998 9999999999999999999999999999866543221
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....|+..|+|||++.++.++.++|||||||++|||++|+.||..... .. .. ..+..+.+..+
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~----~~-~~~~~~~~~~~------- 221 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ---GA----LI-LKIIRGVFPPV------- 221 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---HH----HH-HHHHcCCCCCC-------
Confidence 2234688999999999999999999999999999999999999975431 11 11 11222222211
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++.+||+.+|++||+|.+|+++
T Consensus 222 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 222 --SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred --ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.94 Aligned_cols=249 Identities=22% Similarity=0.337 Sum_probs=195.1
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||++.. .+++.||+|+++.. .......+..|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 45789999999753 223345677899988877 799999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|..++.... .+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence 99998886543 589999999999999999999998 999999999999999999999999999975432111 223
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCccccc-chhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME-DNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
...||..|+|||++.+..++.++|||||||++|||++|+.||+....... ......++...+..+... +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----------~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----------I 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----------C
Confidence 45789999999999999999999999999999999999999964221111 111111222222222211 1
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCC------HHHHHH
Q 046502 480 NHNEMARMVACAAACVRHSARRRPR------ISQIVR 510 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPs------m~evv~ 510 (608)
+......+.+++.+||+.||++|++ +.++++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 1223345778999999999999998 456654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=333.06 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=208.3
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...+.||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||++++++|..++..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57888899999999999999842 345689999987666666789999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEE
Q 046502 314 VCEFVTSNTLEFHLHGKG-----------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl 382 (608)
||||+++++|.+++.... ...++|..++.++.|++.||+|||.. +|+||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999987432 13489999999999999999999998 8999999999999999999999
Q ss_pred EEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHH
Q 046502 383 ADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 383 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... . ..+ .
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~----~~~-~ 233 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---N----EVI-E 233 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---H----HHH-H
Confidence 99999986543211 11223345778999999998899999999999999999998 8998864432 1 111 2
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.+..+.+.... . .....+.+++.+||+.+|.+||++.+|+..|+...
T Consensus 234 ~i~~~~~~~~~-----~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 234 CITQGRVLQRP-----R----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHHcCCcCCCC-----C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 22333322111 1 12345889999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.38 Aligned_cols=242 Identities=26% Similarity=0.393 Sum_probs=195.7
Q ss_pred CccccCCceEEEEEEe----cCCcEEEEEEcccCC----chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 246 NLLGQGGFGYVHKGVL----PNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++||+|+||.||++.. .+++.||||+++... ......+.+|+++|++++|+||++++++|..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999987532 22334577899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+++|.+++...+ .+.+..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999987654 478888899999999999999998 899999999999999999999999999875432211
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...... ..+.. +..+.+. +
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~~~~~-~~~~~~~------~-- 219 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------KTIDK-ILKGKLN------L-- 219 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-------HHHHH-HHcCCCC------C--
Confidence 223356899999999999888999999999999999999999999754321 11111 1222211 1
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
+......+.+++.+||+.+|++|| ++.+++++
T Consensus 220 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 220 --PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 111234578899999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=340.30 Aligned_cols=247 Identities=23% Similarity=0.281 Sum_probs=197.8
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch---hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ---GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
..++|..+.+||+|+||.||+++. .+|+.+|+|++++..-. ..+-++.|-.+|....+++||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 357899999999999999999994 56999999999875432 33457789999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||++||++.-+|...+ .|++.....++.+++.||.-||.. +||||||||+|+|||..|++||+||||+.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999998765 588888888999999999999999 999999999999999999999999999852110
Q ss_pred -----------------------ccc----cee-------------------eeeecccCccChhhhhcCCCCCcchhhh
Q 046502 394 -----------------------VYT----HVS-------------------TRVMGTFGYLAPEYASSGKLTEKSDVFS 427 (608)
Q Consensus 394 -----------------------~~~----~~~-------------------~~~~gt~~y~aPE~~~~~~~t~ksDVwS 427 (608)
+.. ... ...+||+.|||||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 000 000 1157999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 046502 428 FGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR 504 (608)
Q Consensus 428 ~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs 504 (608)
||||+||||.|.+||....+ ....+.++++... +....+. ....+-.+||.+||. ||++|--
T Consensus 374 LG~ImyEmLvGyPPF~s~tp---~~T~rkI~nwr~~---l~fP~~~--------~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETP---QETYRKIVNWRET---LKFPEEV--------DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhhh---ccCCCcC--------cccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999987654 2223333322211 1111111 111456678888888 9999986
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=334.44 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=203.2
Q ss_pred hcCCCcCCccccCCceEEEEEEecC------CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPN------GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
.++|...+.||+|+||.||+|.+.+ +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678899999999999999998643 5679999987543 33446788999999999999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC---ceEEE
Q 046502 312 MLVCEFVTSNTLEFHLHGKGR-----PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVA 383 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~---~~kl~ 383 (608)
++||||+++++|.+++..... ..++|..+++++.||+.||.|||+. +++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999876432 3589999999999999999999998 899999999999998754 59999
Q ss_pred EeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHH
Q 046502 384 DFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRA 461 (608)
Q Consensus 384 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 461 (608)
|||+++....... ........+..|+|||++.++.++.++|||||||++|||++ |+.||+..... . +....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~----~~~~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---E----VMEFV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHH
Confidence 9999986633211 11122234568999999999999999999999999999997 99998753321 1 11111
Q ss_pred HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 462 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 462 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
...... .........+.+++.+||+.+|++||++.+|+++|+
T Consensus 235 ~~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111 111223456888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=335.62 Aligned_cols=264 Identities=21% Similarity=0.306 Sum_probs=197.5
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...++||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999964 688999999875432 223457789999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+. ++|.+++.... ..+.+..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 996 56666665432 3588899999999999999999998 89999999999999999999999999997543221
Q ss_pred ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC---------C
Q 046502 397 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG---------N 466 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~ 466 (608)
.......+++.|+|||++.+ ..++.++|||||||+||||++|+.||...... .+.+.+ .. ..+... .
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~-~~-~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI-QDQLER-IF-LVLGTPNEDTWPGVHS 234 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHH-HH-HHhCCCChhhccchhh
Confidence 12233568999999999865 45889999999999999999999999754321 111111 00 000000 0
Q ss_pred CCcccCccccCcCC---H------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 467 FDTLVDPKLHNEYN---H------NEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 467 ~~~~~d~~l~~~~~---~------~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+....+..... . .....+.+++..||+.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000000000000 0 012456789999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=350.49 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=195.7
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.|..+++||+|+||.||+|.. .+++.||||++.... ......+.+|++++.+++|+||++++++|.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578889999999999999985 568899999997532 2334568899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc-
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY- 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~- 395 (608)
|+++|+|.+++.... .+++.....++.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999987654 588889999999999999999998 99999999999999999999999999986432100
Q ss_pred ---------------------------------------------cceeeeeecccCccChhhhhcCCCCCcchhhhHHH
Q 046502 396 ---------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 430 (608)
Q Consensus 396 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gv 430 (608)
.......+||..|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012357999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCcccccchhhHHHHHHHHh-cCCCCcccCccccCcCCHHHHHHHHHHHHH--hhhcCCCCCCCHHH
Q 046502 431 MLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE-DGNFDTLVDPKLHNEYNHNEMARMVACAAA--CVRHSARRRPRISQ 507 (608)
Q Consensus 431 ll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dp~~RPsm~e 507 (608)
+||||++|+.||...... . .....+. ...+. + +. ...+ ...+.+++.+ |+..++..|+++.+
T Consensus 237 il~elltG~~Pf~~~~~~--~-----~~~~i~~~~~~~~-~--~~-~~~~----s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPT--E-----TQLKVINWENTLH-I--PP-QVKL----SPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHHhCCCCCcCCCHH--H-----HHHHHHccccccC-C--CC-CCCC----CHHHHHHHHHHccCcccccCCCCHHH
Confidence 999999999999754321 0 1111111 11111 0 00 0111 2345566655 66667777999999
Q ss_pred HHHH
Q 046502 508 IVRT 511 (608)
Q Consensus 508 vv~~ 511 (608)
|+.+
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=343.40 Aligned_cols=242 Identities=23% Similarity=0.326 Sum_probs=195.6
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
++||+|+||.||++.. .+|+.||||+++... ......+.+|++++..++|+||++++++|...+..+|||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 568999999997532 223456778999999999999999999999999999999999999
Q ss_pred cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 322 TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 322 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
+|..++.... .+++..+..++.||+.||.|||+ . +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK 154 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence 9998886543 58999999999999999999997 5 899999999999999999999999999875432211 123
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... +. ... .+..+.+ .+ +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~----~~~-~i~~~~~------~~----p 216 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EK----LFE-LILMEEI------RF----P 216 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HH----HHH-HHhcCCC------CC----C
Confidence 35699999999999999999999999999999999999999964322 11 111 1111111 11 1
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 481 HNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
......+.+++.+||+.||++|+ ++.+++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 12234577899999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.41 Aligned_cols=255 Identities=25% Similarity=0.406 Sum_probs=202.9
Q ss_pred CCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
+|...++||+|+||.||+|+.. ....+++|.+..... ...+.+.+|+.+++.++|+||++++++|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999852 235789999875543 334678899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCc
Q 046502 314 VCEFVTSNTLEFHLHGKG----------------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAAN 371 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~N 371 (608)
||||+.+++|.+++.... ...++|..++.++.|++.||.|||+. +|+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999876421 13578999999999999999999998 89999999999
Q ss_pred EEEccCCceEEEEeeccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccc
Q 046502 372 ILLDFKFEAKVADFGLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFM 449 (608)
Q Consensus 372 ILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 449 (608)
|||++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999865332211 1222345778999999988889999999999999999998 9999864322
Q ss_pred cchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 450 EDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 450 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.. +. ..+..+ +. ..........+.+++..||+.+|++||++.||++.|+..
T Consensus 236 -~~----~~-~~~~~~-~~--------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 236 -ER----LF-NLLKTG-YR--------MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred -HH----HH-HHHhCC-CC--------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 11 11 112211 10 111122335688999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=328.31 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=197.4
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
++||+|+||.||+|.+ .+++.||+|.+.... ......|.+|++++++++|+||++++++|...+..++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999986 478999999886543 33456789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce-eeee
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV-STRV 402 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~~ 402 (608)
.+++.... ..++|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...+..... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99987543 3589999999999999999999998 89999999999999999999999999987544321111 0111
Q ss_pred ecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCH
Q 046502 403 MGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481 (608)
Q Consensus 403 ~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 481 (608)
..+..|+|||++.++.++.++|||||||++|||++ |..||..... .. ....+..+.. .....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~-----~~~~~~~~~~---------~~~~~ 219 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQ-----TREAIEQGVR---------LPCPE 219 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HH-----HHHHHHcCCC---------CCCcc
Confidence 23457999999999999999999999999999997 8888854321 10 1111111111 11112
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 482 NEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 482 ~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.....+.+++.+||+.+|++||++.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23456888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.30 Aligned_cols=201 Identities=26% Similarity=0.364 Sum_probs=174.9
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||++.. .+++.||||+++... ......+.+|+.++.+++|+||+++++++.+++..+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4788899999999999999985 458899999997532 223356788999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++|+|.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999997654 589999999999999999999998 99999999999999999999999999997543210
Q ss_pred c----------------------------------ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCC
Q 046502 396 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441 (608)
Q Consensus 396 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p 441 (608)
. .......||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 011235799999999999999999999999999999999999999
Q ss_pred CCCC
Q 046502 442 VDST 445 (608)
Q Consensus 442 ~~~~ 445 (608)
|...
T Consensus 236 f~~~ 239 (363)
T cd05628 236 FCSE 239 (363)
T ss_pred CCCC
Confidence 9754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=329.09 Aligned_cols=255 Identities=29% Similarity=0.449 Sum_probs=208.8
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.++|...++||+|+||.||+|.+.+++.||||.+..... ....+.+|+.++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467888999999999999999988888999999885433 3467889999999999999999999999989999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++.......+++..+..++.+++.||.|||++ +|+|+||||+||||+.++.+||+|||+++.........
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTA 160 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhh
Confidence 999999999876555799999999999999999999998 89999999999999999999999999998765422212
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||..... . ..+... ..+ +...
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~----~~~~~~-~~~-~~~~------- 224 (261)
T cd05034 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---R----EVLEQV-ERG-YRMP------- 224 (261)
T ss_pred hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H----HHHHHH-HcC-CCCC-------
Confidence 222334678999999998899999999999999999998 9999864321 1 112111 111 1100
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 225 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 -RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011124568899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=341.49 Aligned_cols=264 Identities=19% Similarity=0.314 Sum_probs=195.3
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----CeeE
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG-----SQRM 312 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~-----~~~~ 312 (608)
+|...++||+|+||.||+|+. .+|+.||||+++.. .......+.+|++++++++|+||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999995 46899999998743 223345688999999999999999999988643 2479
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+. ++|.+++.... .+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999996 57888876543 589999999999999999999998 89999999999999999999999999998543
Q ss_pred Ccc--cceeeeeecccCccChhhhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHH-------HHHH
Q 046502 393 DVY--THVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL-------LNRA 461 (608)
Q Consensus 393 ~~~--~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~-------~~~~ 461 (608)
... ........|+..|+|||++.+ ..++.++|||||||++|||++|+.||............... ....
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 221 112234578999999999876 67899999999999999999999999654321000000000 0000
Q ss_pred HhcCCCCcccC-------ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 462 IEDGNFDTLVD-------PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 462 ~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+........++ ..+...+ ......+.+++..||+.||++||++.||+++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 0000000 0122456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=352.39 Aligned_cols=254 Identities=21% Similarity=0.260 Sum_probs=201.4
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
..++|...++||+|+||.||++.. .+++.||||++... .......+.+|+.+++.++|+||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 356789999999999999999985 46889999998643 22334557889999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+++|+|.+++... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998653 477888889999999999999998 999999999999999999999999999986643
Q ss_pred cccceeeeeecccCccChhhhhcC----CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
..........||+.|+|||++... .++.++|||||||+||||++|+.||..... .. .............
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~-~~~~i~~~~~~~~ 267 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VG-TYSKIMDHKNSLT 267 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HH-HHHHHHcCCCcCC
Confidence 322222345799999999998653 478999999999999999999999975432 10 1111111111000
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRISQIVRT 511 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPsm~evv~~ 511 (608)
+. . .......+.+++..||+.+|++ |+++.|++++
T Consensus 268 ~~-----~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 FP-----D--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC-----C--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 0 1122356778999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=350.67 Aligned_cols=254 Identities=20% Similarity=0.260 Sum_probs=199.0
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
..++|...++||+|+||.||++... +++.||+|++... .......+.+|+.+++.++|+||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3578999999999999999999964 5789999998642 22234568889999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999998653 478889999999999999999998 999999999999999999999999999987643
Q ss_pred cccceeeeeecccCccChhhhhcC----CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
..........||..|||||++... .++.++|||||||+||||++|+.||...... ..............
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~ 267 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------GTYSKIMDHKNSLN 267 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------HHHHHHHhCCcccC
Confidence 322222346799999999999754 3788999999999999999999999653320 01111111111000
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRISQIVRT 511 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPsm~evv~~ 511 (608)
+ .........+.+++..||+.++.+ |+++.|++++
T Consensus 268 ~-------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 F-------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 001122345667788888755544 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=340.33 Aligned_cols=250 Identities=22% Similarity=0.331 Sum_probs=196.9
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||++.. .+++.||||+++... ......+..|+.++.++ +|+||++++++|...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999985 468899999997532 22345678899999998 799999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|.+++...+ .+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence 99998886543 589999999999999999999998 99999999999999999999999999987532211 1223
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCccccc-chhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME-DNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
...||..|+|||++.+..++.++|||||||++|||++|+.||+....... ......++...+..+.+. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~---- 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I---- 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C----
Confidence 46799999999999999999999999999999999999999974322110 111111222223222221 1
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 046502 480 NHNEMARMVACAAACVRHSARRRPR------ISQIVRT 511 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPs------m~evv~~ 511 (608)
+......+.+++..||+.||.+|++ +.+|+++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1122345788999999999999997 6677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.66 Aligned_cols=256 Identities=27% Similarity=0.395 Sum_probs=205.3
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~ 311 (608)
++|...++||+|+||.||++... .+..||||+++.... ...+.+.+|+++++++ +|+||++++++|...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 46888999999999999999741 345799999876532 3345788999999999 799999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+.+++|.++++......+++.+++.++.+++.||.|||+. +|+|+||||+|||++.++.+||+|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccc
Confidence 9999999999999999865544589999999999999999999998 8999999999999999999999999999865
Q ss_pred cCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 392 SDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 392 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
...... ......++..|+|||++..+.++.++|||||||++|||++ |..||..... .. .+...+..+...
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~-----~~~~~~~~~~~~- 263 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DS-----KFYKLIKEGYRM- 263 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hH-----HHHHHHHcCCcC-
Confidence 432211 1122345678999999999999999999999999999998 9999864332 11 111122222110
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.........+.+++.+||+.+|++||++.||++.|+.
T Consensus 264 --------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 264 --------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0111123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.80 Aligned_cols=266 Identities=27% Similarity=0.380 Sum_probs=202.3
Q ss_pred CCcCCccccCCceEEEEEEe-----cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEE
Q 046502 242 FSDANLLGQGGFGYVHKGVL-----PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRML 313 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~l 313 (608)
|...+.||+|+||.||++.. .+++.||+|.++.... .....|.+|+++|++++|+||++++++|... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47789999999999988652 3578899999976532 3456788999999999999999999998753 45899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+++|.+++... .++|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999998753 489999999999999999999998 899999999999999999999999999986643
Q ss_pred cccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
.... ......++..|++||++....++.++|||||||++|||++|+.|+........+.+... ........+.+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 237 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPK--QGQMTVVRLIELL 237 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccc--ccccchhhhhhhh
Confidence 2211 11223356679999999988999999999999999999999999864332111100000 0000000111111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
+..............+.+++.+||+.+|++||+|.+|++.|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111112223446788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=329.36 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=197.6
Q ss_pred cccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 248 LGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 248 LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
||+|+||.||++.. .+|+.||+|++.... ......+..|++++++++|+||+++++++..+...++||||+.+++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 458999999986432 12234556799999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeee
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 403 (608)
.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9988766656799999999999999999999998 99999999999999999999999999998665422 223356
Q ss_pred cccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHH
Q 046502 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483 (608)
Q Consensus 404 gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 483 (608)
|+..|+|||++.+..++.++|||||||++|||++|+.||........ ...+. .....+.+.. ... ..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~---~~~~~-~~~~~~~~~~-----~~~----~~ 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA---KEELK-RRTLEDEVKF-----EHQ----NF 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh---HHHHH-HHhhcccccc-----ccc----cC
Confidence 89999999999988999999999999999999999999865322111 01111 1111111110 001 22
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 484 MARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 484 ~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
...+.+++..||+.||++||++.|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 345788999999999999999988775544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.90 Aligned_cols=245 Identities=27% Similarity=0.430 Sum_probs=193.9
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHH---HhcCCCCccceeeEEEeCCeeEEE
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEII---SRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l---~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
|...++||+|+||.||+|.. .+|+.||||+++... ....+.+..|+.++ ++++|+||+++++++..++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56778999999999999985 468999999997532 22234566666655 566799999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.+++|..+++.. .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999888643 589999999999999999999998 9999999999999999999999999998754322
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
. .......|++.|||||++.+..++.++|||||||+||||++|+.||..... . .++.. +..+...
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~----~~~~~-i~~~~~~------ 219 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---E----EVFDS-IVNDEVR------ 219 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---H----HHHHH-HHhCCCC------
Confidence 1 122346799999999999999999999999999999999999999975432 1 11111 1122111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
++......+.+++.+||+.||.+|| ++.+++++
T Consensus 220 ----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 220 ----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1112234577899999999999999 45666543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.20 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=200.9
Q ss_pred cCCCcCCccccCCceEEEEEEecC---------------CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN---------------GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVG 303 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g 303 (608)
++|...++||+|+||.||++...+ ...||||+++... ......|.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987532 2358999997653 334457899999999999999999999
Q ss_pred EEEeCCeeEEEEeeccCCcHHHHhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEE
Q 046502 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKG----------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANIL 373 (608)
Q Consensus 304 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NIL 373 (608)
+|...+..++||||+.+++|.+++.... ...++|..+++++.+++.||.|||+. +|+||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 9999999999999999999999986532 12478999999999999999999998 8999999999999
Q ss_pred EccCCceEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh--CCCCCCCCccccc
Q 046502 374 LDFKFEAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII--GCRPVDSTHTFME 450 (608)
Q Consensus 374 l~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt--G~~p~~~~~~~~~ 450 (608)
|+.++.+||+|||+++...... ........++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 9999999999999997653321 112223345778999999998999999999999999999998 5556654321
Q ss_pred chhhHHHHHHHHhc-CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 451 DNLARPLLNRAIED-GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 451 ~~l~~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
+........ .... +..... .........+.+++.+||+.+|++||+|.+|++.|+
T Consensus 239 ~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGE-FFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHH-hhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111 0111 110000 011122357899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=328.19 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=203.2
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
++|...+.||+|+||.||+|.. .+++.||||++..........+.+|+.++++++|+||++++++|..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688899999999999999995 568899999997655555567889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.++++... .+++..+..++.|++.||.|||+. +|+|||||++|||++.++.+||+|||+++....... .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 89 GGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999999987543 589999999999999999999998 999999999999999999999999999986543211 1
Q ss_pred eeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 399 STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....|+..|+|||++. ...++.++|||||||++|||++|+.||........ .. .+....+. .+.+
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~------~~~~~~~~---~~~~ 231 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LF------LMSKSNFQ---PPKL 231 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--he------eeecCCCC---CCCC
Confidence 22346889999999984 44578899999999999999999999854322100 00 00111111 1111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
.. .......+.+++.+||+.+|++||++.+|+++|
T Consensus 232 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11 112345788999999999999999999999765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=332.39 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=201.1
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCc----EEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGK----EVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...+.||+|+||.||+|.+ .+++ .|++|.+..... .....+..|+.++++++|+||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 4577789999999999999985 3444 478888864432 23356788899999999999999999885 456789
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
++||+++|+|.+++..... .++|..++.|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 9999999999999976443 689999999999999999999998 899999999999999999999999999986543
Q ss_pred ccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
... .......++..|++||++.++.++.++|||||||++|||++ |+.||...... .+...+..+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~-- 231 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------EVPDLLEKGERLA-- 231 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcCC--
Confidence 222 12233457789999999999999999999999999999998 99998654321 1122233332211
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+.+ ....+.+++.+||..+|++||++.||++.|+..
T Consensus 232 ~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~ 268 (279)
T cd05111 232 QPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268 (279)
T ss_pred CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111 123567789999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=330.78 Aligned_cols=261 Identities=26% Similarity=0.355 Sum_probs=202.4
Q ss_pred cCCCcCCccccCCceEEEEEEe-----cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-----PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA--GSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~~ 312 (608)
++|...+.||+|+||.||++.. .+++.||||+++.......+.|.+|++++++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 2578999999987766666789999999999999999999998754 34689
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+++++|.+++.... ..++|..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999987543 3589999999999999999999998 99999999999999999999999999998764
Q ss_pred Ccccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc---------hhhHHHHHHH
Q 046502 393 DVYTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED---------NLARPLLNRA 461 (608)
Q Consensus 393 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~---------~l~~~~~~~~ 461 (608)
..... ......++..|+|||++.+..++.++|||||||++|||++|..++......... .+... +...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 238 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH-LIEL 238 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH-HHHH
Confidence 42211 111122345699999999889999999999999999999988765432110000 00000 1111
Q ss_pred HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 462 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 462 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
+..+.. ..........+.+++.+||+.+|++||+|.||++.|+.
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 239 LKNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HhcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 111110 00112234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.94 Aligned_cols=254 Identities=24% Similarity=0.360 Sum_probs=202.4
Q ss_pred CCCcCCccccCCceEEEEEEecC------CcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPN------GKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
+|...+.||+|+||.||+|...+ ++.||||+++..... ..+.|.+|+.++.+++|+||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 35667889999999999998532 478999999865433 34668899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc
Q 046502 314 VCEFVTSNTLEFHLHGK--------------GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE 379 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~ 379 (608)
++||+.+++|.+++... ....+++..+++++.|++.||.|||+. +|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999998532 123588999999999999999999998 8999999999999999999
Q ss_pred eEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHH
Q 046502 380 AKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPL 457 (608)
Q Consensus 380 ~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 457 (608)
+||+|||+++...... ........+++.|+|||++..+.++.++|||||||++|||++ |..||..... . .+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~----~~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q----DV 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---H----HH
Confidence 9999999988654321 112223446789999999998899999999999999999998 8778754321 1 11
Q ss_pred HHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 458 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 458 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
+ ..+..+.... +.......+.+++..||+.+|++||++.+|+..|+.
T Consensus 236 ~-~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 I-EMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-HHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 2222222211 112334557889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=332.05 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=204.5
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...++||+|+||.||++... ++..+|+|.++.........|.+|++++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999999742 356899999887666667789999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 314 VCEFVTSNTLEFHLHGKGR-------------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
||||+.+++|.+++..... ..++|..++.++.|++.||+|||+. +|+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999875421 3589999999999999999999998 99999999999999999999
Q ss_pred EEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHH
Q 046502 381 KVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLL 458 (608)
Q Consensus 381 kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 458 (608)
||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..+
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------EAI 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------HHH
Confidence 9999999975532211 11222345788999999999999999999999999999998 89998543221 011
Q ss_pred HHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 459 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 459 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
. .+..+.... ........+.+++.+||+.||.+||++.+|++.|+
T Consensus 235 ~-~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 E-CITQGRELE---------RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H-HHHcCccCC---------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1 111221111 11122345788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=326.41 Aligned_cols=245 Identities=27% Similarity=0.386 Sum_probs=196.5
Q ss_pred ccccCCceEEEEEEe---cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCC
Q 046502 247 LLGQGGFGYVHKGVL---PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++++++|+||+++++++. ++..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 599999999999974 357889999987543 234567899999999999999999999985 45679999999999
Q ss_pred cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce--e
Q 046502 322 TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV--S 399 (608)
Q Consensus 322 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~--~ 399 (608)
+|.+++.... .+++..+++++.|++.||.|||+. +|+||||||.|||++.++.+||+|||+++......... .
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999987543 589999999999999999999998 89999999999999999999999999998664432211 1
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....++..|+|||++....++.++|||||||++|||++ |+.||..... .. +...++.+....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~-----~~~~i~~~~~~~--------- 218 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NE-----VTQMIESGERME--------- 218 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HH-----HHHHHHCCCCCC---------
Confidence 12234578999999988889999999999999999998 9999865432 11 112223322111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.||++||+|.+|++.|+.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111233567889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.00 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=196.5
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||++.. .+|+.||||++.... ......+.+|++++.+++|+||++++++|.+.+..||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999984 568999999986432 223456888999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++|+|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999987543 588889999999999999999998 99999999999999999999999999996332100
Q ss_pred cc----------------------------------------------eeeeeecccCccChhhhhcCCCCCcchhhhHH
Q 046502 396 TH----------------------------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFG 429 (608)
Q Consensus 396 ~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~G 429 (608)
.. .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124699999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCC---CCHH
Q 046502 430 VMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRR---PRIS 506 (608)
Q Consensus 430 vll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Psm~ 506 (608)
|+||||++|+.||...... . .............+ + .. ......+.+++..||+ +|.+| +++.
T Consensus 236 vil~elltG~~Pf~~~~~~---~----~~~~i~~~~~~~~~--p---~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 236 AIMFECLIGWPPFCSENSH---E----TYRKIINWRETLYF--P---DD--IHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred hhhhhhhcCCCCCCCCCHH---H----HHHHHHccCCccCC--C---CC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999654321 1 11111111000001 0 00 0122456788899997 66665 6999
Q ss_pred HHHHH
Q 046502 507 QIVRT 511 (608)
Q Consensus 507 evv~~ 511 (608)
|++.+
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=330.74 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=204.3
Q ss_pred hcCCCcCCccccCCceEEEEEEecC-----------------CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccc
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPN-----------------GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVS 300 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~ 300 (608)
.++|...+.||+|+||.||++...+ +..||+|++.... ......|.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999988542 2458999987653 334567889999999999999999
Q ss_pred eeeEEEeCCeeEEEEeeccCCcHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCc
Q 046502 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKG---------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAAN 371 (608)
Q Consensus 301 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~N 371 (608)
++++|..++..++||||+.+++|..++.... ...+++..++.++.|++.||.|||+. +|+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999987643 12589999999999999999999998 89999999999
Q ss_pred EEEccCCceEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh--CCCCCCCCccc
Q 046502 372 ILLDFKFEAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII--GCRPVDSTHTF 448 (608)
Q Consensus 372 ILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt--G~~p~~~~~~~ 448 (608)
||++.++.++|+|||+++...... ........++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 999999999999999997654321 122334456789999999998899999999999999999998 6667653221
Q ss_pred ccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 449 MEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 449 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
..... .+...+..+..... ..........+.+++.+||+.||.+||+|.||++.|+
T Consensus 240 --~~~~~-~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIE-NAGHFFRDDGRQIY------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHH-HHHhcccccccccc------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111 01111111111111 1111223357899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=325.40 Aligned_cols=258 Identities=20% Similarity=0.335 Sum_probs=207.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|+. .+++.||||.++.. .......+.+|++++++++|+||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788899999999999999995 47899999987542 2333456889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 316 EFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 316 E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||+++++|.+++.. .....+++..++.++.++++||.|||+. +|+||||||+||||+.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 2234588999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.... .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ..+. ..+....+...
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~~~-~~~~~~~~~~~--- 228 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----FSLC-QKIEQCDYPPL--- 228 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-----HHHH-HHHhcCCCCCC---
Confidence 2211 123458889999999998889999999999999999999999985432210 1111 12222221111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
........+.+++.+||+.+|.+||++.+|++.|++.
T Consensus 229 -----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 -----PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -----ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1123345688999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.04 Aligned_cols=249 Identities=30% Similarity=0.461 Sum_probs=206.8
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...+.||.|+||.||+|.. .|+.||||+++.... ..+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 4678889999999999999987 478999999986654 55678899999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++.......++|..++.++.|++.||.|||.. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 99999999876655799999999999999999999998 999999999999999999999999999987643211
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....+..|+|||++..+.++.++||||||+++|||++ |+.||..... .. +. ..+..+... .
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~----~~-~~~~~~~~~---------~ 219 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KD----VV-PHVEKGYRM---------E 219 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HH----HH-HHHhcCCCC---------C
Confidence 2335678999999998899999999999999999997 9999864321 11 11 111111110 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.+|.+||++.+|+.+|+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=327.45 Aligned_cols=254 Identities=28% Similarity=0.435 Sum_probs=206.7
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.++|...++||+|+||.||++.+.++..+|+|.++... ...+.|.+|++++++++|+||+++++++.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35788899999999999999998778889999987543 345678899999999999999999999887 7789999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++.......++|..++.++.+++.||.|||+. +++||||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 999999999875555689999999999999999999998 89999999999999999999999999998664422222
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++..+.++.++|||||||++|+|++ |+.||..... . -+...+..+....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~-----~~~~~~~~~~~~~-------- 223 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---P-----EVIRALERGYRMP-------- 223 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---H-----HHHHHHhCCCCCC--------
Confidence 222345678999999998889999999999999999998 8989864321 0 1112222221111
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 224 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111233568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=336.63 Aligned_cols=241 Identities=28% Similarity=0.427 Sum_probs=190.8
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|.. .+++.||||+++... ....+.+..|..++..+ +|+||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 457889999997532 22234455677777654 899999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999987654 488999999999999999999998 89999999999999999999999999998543322 2233
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...||..|+|||++.+..++.++|||||||++|||++|+.||..... .. ++.. +.... ..++
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~----~~~~-i~~~~----------~~~~ 216 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DE----LFDS-ILNDR----------PHFP 216 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HH----HHHH-HHcCC----------CCCC
Confidence 45799999999999988999999999999999999999999975432 11 1111 11111 0111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRIS-QIVR 510 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~-evv~ 510 (608)
......+.+++..||+.+|.+||++. ++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12234567899999999999999986 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=337.86 Aligned_cols=242 Identities=26% Similarity=0.363 Sum_probs=194.4
Q ss_pred CccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|... +++.||||+++... ....+.+..|++++..+ +|+||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999864 57899999987532 23335577789998876 799999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|..++.... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT 154 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence 99998887543 589999999999999999999998 899999999999999999999999999875432211 223
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...|+..|+|||++.+..++.++|||||||++|||++|+.||..... .. .+.. +..+.. .. +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~----~~~~-i~~~~~---~~-------p 216 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DD----LFES-ILHDDV---LY-------P 216 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HH----HHHH-HHcCCC---CC-------C
Confidence 45689999999999998999999999999999999999999975432 11 1211 212211 01 1
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCC-------CHHHHHHH
Q 046502 481 HNEMARMVACAAACVRHSARRRP-------RISQIVRT 511 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RP-------sm~evv~~ 511 (608)
......+.+++..||+.||++|+ ++.+++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11234578899999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=345.16 Aligned_cols=264 Identities=20% Similarity=0.266 Sum_probs=198.3
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----eeE
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS-----QRM 312 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~-----~~~ 312 (608)
+|+..++||+|+||.||++.. .+|+.||||++... .....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999995 57899999998653 2233456889999999999999999999998776 789
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+. ++|..++.... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999997 46777665433 589999999999999999999998 89999999999999999999999999998654
Q ss_pred CcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH---------HH-----
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR---------PL----- 457 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~---------~~----- 457 (608)
...........++..|+|||++.+. .++.++|||||||++|||++|+.||............. .+
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 3322233345678999999998764 47999999999999999999999997654311000000 00
Q ss_pred -HHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 458 -LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 458 -~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+............+ ..........+.+++.+||+.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000000000000 00111224567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.07 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=201.4
Q ss_pred HHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEeC------
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAG------ 308 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~------ 308 (608)
.+.+.|...+.||+|+||.||+|.. .+++.||||++.... .....+..|+.++.++ +|+||++++++|...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3556788889999999999999985 457889999987543 3445788899999998 699999999998753
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
...++||||+.+++|.+++.......+.|..+..++.|++.||.|||+. +|+|||||++|||+++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999999875555789999999999999999999998 8999999999999999999999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
+....... ......|+..|+|||++. ...++.++|||||||++|||++|+.||+...... . .. ...
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~-~~--~~~ 229 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----A-LF--LIP 229 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----H-HH--HHh
Confidence 86543222 223456899999999986 3458889999999999999999999986433210 0 00 011
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+.+ ......+.+++.+||+.+|.+||++.+|+++
T Consensus 230 ~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 RNPAPRLKS--------KKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred cCCCCCCCC--------CCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 111111111 1223467889999999999999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=335.80 Aligned_cols=258 Identities=27% Similarity=0.416 Sum_probs=205.2
Q ss_pred HhcCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGS 309 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~ 309 (608)
..++|...+.||+|+||.||++... ....||+|.+.... ......+.+|++++.++ +|+||++++++|..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 3456888899999999999999853 23679999987542 23345688999999999 7999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGK--------------GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD 375 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~ 375 (608)
..++||||+.+++|..+++.. ....++|..+++++.|++.||.|||+. +|+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999998642 234689999999999999999999998 999999999999999
Q ss_pred cCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchh
Q 046502 376 FKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNL 453 (608)
Q Consensus 376 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l 453 (608)
.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ..
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~- 242 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EE- 242 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HH-
Confidence 999999999999986543221 11222335678999999998899999999999999999997 8888864321 01
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.. ..+..+.. ...+......+.+++.+||+.+|++||+|.||++.|+..
T Consensus 243 ---~~-~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ---LF-KLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HH-HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11 11111111 111223345688999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=328.40 Aligned_cols=255 Identities=29% Similarity=0.465 Sum_probs=204.0
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCc---EEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGK---EVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~---~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++||+|+||.||+|.+. +++ .+|||.++... ......+.+|++++.+++|+||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999964 333 79999987653 33456788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.+++|.+++..+. ..++|..+..++.+++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999987643 3589999999999999999999998 8999999999999999999999999999866432
Q ss_pred ccceee--eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 395 YTHVST--RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 395 ~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
...... ....+..|+|||++..+.++.++|||||||++|||++ |+.||..... . .+.. .+..+.. .
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~----~~~~-~i~~~~~--~- 229 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---H----EVMK-AINDGFR--L- 229 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---H----HHHH-HHhcCCC--C-
Confidence 221111 1223457999999998899999999999999999997 9999864321 1 1111 1222110 0
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.........+.+++.+||+.+|++||+|.+|++.|+..
T Consensus 230 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112345678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.60 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=203.2
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCch-hHHHHHHHHHHHHhcC-CCCccceeeEEEeCCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~ 311 (608)
++|...++||+|+||.||+|++. .++.||||+++..... ..+.+.+|+.+|.++. |+|||+++++|...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 35677899999999999999853 3468999999865332 2356889999999997 99999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCC------------------------------------------------------------
Q 046502 312 MLVCEFVTSNTLEFHLHGKG------------------------------------------------------------ 331 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~------------------------------------------------------------ 331 (608)
++||||+.+|+|.++++...
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 99999999999999997532
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc
Q 046502 332 ------------------------------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD 375 (608)
Q Consensus 332 ------------------------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~ 375 (608)
...++|..+++|+.|++.||.|||+. +|+|||||++|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEe
Confidence 12468888999999999999999998 899999999999999
Q ss_pred cCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchh
Q 046502 376 FKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNL 453 (608)
Q Consensus 376 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l 453 (608)
+++.+||+|||+++....... .......++..|+|||++....++.++|||||||+||||++ |+.||..... .+
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--~~-- 349 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--NE-- 349 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--hH--
Confidence 999999999999986533211 11122356788999999998889999999999999999998 8888864321 11
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+...+..+.. + .........+.+++..||+.+|.+||+|++|++.|+..
T Consensus 350 ---~~~~~~~~~~~--~-------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 350 ---QFYNAIKRGYR--M-------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---HHHHHHHcCCC--C-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11112222210 0 01112235688899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=341.86 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=213.1
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe-eEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ-RMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~-~~lV~ 315 (608)
++|..+++||+|+||.++..+. .+++.|++|++.... ....+...+|+.++++++|||||.+.+.|.+++. ++|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5678889999999999999873 467899999997543 3334567889999999999999999999999888 99999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
+||+||+|.+.|.......++++.+++++.|++.|+.|||++ +|+|||||+.|||++.+..+||+|||+|+......
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999887767899999999999999999999988 99999999999999999999999999999887654
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
. ....++||+.||.||.+.+..|..|+|||||||++|||++-+++|...+. ..++.+... +. +
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ki~~-~~----~---- 223 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILKINR-GL----Y---- 223 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-------HHHHHHHhh-cc----C----
Confidence 2 34558899999999999999999999999999999999999999976543 112332222 11 1
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.-.+..+...+..++..||+.+|+.||++.+++.+
T Consensus 224 -~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 -SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12233455678889999999999999999999986
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=331.21 Aligned_cols=246 Identities=26% Similarity=0.379 Sum_probs=195.2
Q ss_pred cccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 248 LGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 248 LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
||+|+||.||++.. .+|+.||||++..... ...+.+..|+.++++++|+||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 4688999999864322 2234677899999999999999999999999999999999999999
Q ss_pred HHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeee
Q 046502 324 EFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR 401 (608)
Q Consensus 324 ~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 401 (608)
.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887542 234689999999999999999999998 999999999999999999999999999976544222 2233
Q ss_pred eecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCH
Q 046502 402 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481 (608)
Q Consensus 402 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 481 (608)
..|+..|+|||++.+..++.++|||||||++|||++|+.||........ ......... .+. ..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~-~~~----------~~~~~ 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRIL-NDS----------VTYPD 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHhhc-ccC----------CCCcc
Confidence 5689999999999999999999999999999999999999975432111 011111111 110 01122
Q ss_pred HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 482 NEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 482 ~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
.....+.+++..||+.||++|| ++.+++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 3445678899999999999999 66777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=326.41 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=202.3
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc-----hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG-----QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...++||+|+||.||++.. .+++.||||.+..... .....+.+|++++++++|+||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788999999999999999985 4689999999864321 123568889999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+++++|.+++.... .+++..+..++.+++.||.|||+. +|+||||||+|||++.++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999887643 588899999999999999999998 999999999999999999999999999976543
Q ss_pred ccccee--eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
...... ....++..|+|||++.+..++.++|||||||++|||++|+.||...... . ...........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~-~~~~~~~~~~~---- 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------A-AIFKIATQPTN---- 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------H-HHHHHhccCCC----
Confidence 211111 2345788999999999988999999999999999999999998643221 0 01111111110
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..........+.+++..||+.+|++||++.||+++
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 -----PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -----CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11122233457889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=325.28 Aligned_cols=257 Identities=21% Similarity=0.351 Sum_probs=206.5
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||++.. .+++.||||.+.... ......+.+|+.+++.++|+||++++++|..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999994 578999999886432 233457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 316 EFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 316 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||+++++|.+++... ....++|..++.++.+|+.||.|||+. +|+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988642 234689999999999999999999998 999999999999999999999999999886643
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
... ......++..|+|||++.+..++.++||||||+++|||++|..||....... . .+. ..+....+ +
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~----~~~-~~~~~~~~-----~ 226 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-Y----SLC-KKIEQCDY-----P 226 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-H----HHh-hhhhcCCC-----C
Confidence 221 1223468899999999998889999999999999999999999986432210 0 111 11111111 1
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.+. .......+.+++.+||+.+|.+||+|.+|++.|+.
T Consensus 227 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 111 11234568889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=325.61 Aligned_cols=248 Identities=28% Similarity=0.424 Sum_probs=201.8
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEE-eCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT-AGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~-~~~~~~lV~E~~ 318 (608)
++|...+.||+|+||.||++.. .|+.||+|.++... ..+.|.+|+.++++++|+||+++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999987 47889999987543 3456889999999999999999999764 456789999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++.......++|..++.++.+++.||+|||.. +|+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 999999999876655689999999999999999999998 89999999999999999999999999987554321
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
....++..|+|||++....++.++|||||||++|||++ |+.||..... ..+. ..+..+....
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~~~-~~~~~~~~~~-------- 219 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVV-PRVEKGYKMD-------- 219 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHH-HHHhcCCCCC--------
Confidence 22334678999999998889999999999999999997 9988864321 1111 1122221111
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.+|++||++.++++.|+.
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112234568889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=334.28 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=200.4
Q ss_pred cCCCcCCccccCCceEEEEEEecC-Cc--EEEEEEcccC-CchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-GK--EVAIKQLKAG-SGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|+..++||+|+||.||+|.+.+ +. .+++|.++.. .....+.|.+|++++.++ +|+||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578888999999999999998643 33 4788988753 333456788999999999 799999999999999999999
Q ss_pred EeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 315 CEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
|||+++++|.++++... ...+++..++.|+.|++.||+|||+. +|+||||||+||||+.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 99999999999997532 12488999999999999999999998 99999999999999999999
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHH
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~ 459 (608)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||..... .. +..
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~----~~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AE----LYE 229 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HH----HHH
Confidence 9999999864322111 111123567999999998899999999999999999997 9999864332 11 111
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. +..+.. ..........+.+++.+||+.+|.+||++.+|++.|+..
T Consensus 230 ~-~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 275 (297)
T cd05089 230 K-LPQGYR---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM 275 (297)
T ss_pred H-HhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 111110 011112334678899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=337.19 Aligned_cols=237 Identities=28% Similarity=0.383 Sum_probs=191.0
Q ss_pred CccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|... +++.||||+++... ....+.+..|+.++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 58899999987532 22345667788888876 699999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS 154 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence 99999887654 589999999999999999999998 99999999999999999999999999987543211 1223
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... . .++. .+..+... +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~----~~~~-~i~~~~~~----------~~ 216 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---D----DLFE-AILNDEVV----------YP 216 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---H----HHHH-HHhcCCCC----------CC
Confidence 45799999999999988999999999999999999999999975432 1 1111 12222111 11
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRIS 506 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~ 506 (608)
......+.+++.+||+.||++|+++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 11234578899999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=330.56 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=201.0
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
|...++||+|+||.||++.. .+++.||||.+.... ......+.+|+.++++++|+||+.+++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999985 468899999986532 22234577899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999998765555689999999999999999999998 999999999999999999999999999876543221
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .......... .
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~----~~~~~~~~~~----------~ 222 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EVERLVKEVQ----------E 222 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH----HHHhhhhhhh----------h
Confidence 123468999999999999999999999999999999999999997543211111 1111111000 0
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPR-----ISQIVRT 511 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~~ 511 (608)
.+.......+.+++..||+.||++||+ +.|++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 111122345788999999999999999 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=336.94 Aligned_cols=241 Identities=27% Similarity=0.379 Sum_probs=193.6
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCC-CCccceeeEEEeCCeeEEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHH-KHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~H-pniv~l~g~~~~~~~~~lV~ 315 (608)
+|...+.||+|+||.||+|... +++.||||+++... ....+.+..|++++..++| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999854 57889999987532 2334567789999999976 56888999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999887654 488999999999999999999998 99999999999999999999999999987432211
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. .+.. +.....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~----~~~~-i~~~~~-------- 218 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DE----LFQS-IMEHNV-------- 218 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HH----HHHH-HHcCCC--------
Confidence 1 22345699999999999999999999999999999999999999975432 11 1111 111111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRI 505 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm 505 (608)
.++......+.+++.+||+.||.+|++.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 --SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111223457889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=326.76 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=200.4
Q ss_pred CCcCCccccCCceEEEEEEecC----CcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe-----
Q 046502 242 FSDANLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ----- 310 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~----- 310 (608)
|.+.++||+|+||.||+|.+.. +..||||+++... ......+.+|+++++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998642 3679999987542 2334678999999999999999999999876554
Q ss_pred -eEEEEeeccCCcHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 311 -RMLVCEFVTSNTLEFHLHGK----GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 311 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
.++||||+++++|..++... ....+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 79999999999999888543 234689999999999999999999998 8999999999999999999999999
Q ss_pred eccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHh
Q 046502 386 GLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 386 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
|+++........ ......++..|+|||++....++.++|||||||++|||++ |..||..... . .++. .+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~----~~~~-~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---H----EIYD-YLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---H----HHHH-HHH
Confidence 999865432211 1112234678999999988889999999999999999999 8888864332 1 1122 222
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.+.... ........+.+++.+||+.||++||++.||++.|+.
T Consensus 230 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 230 HGNRLK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred cCCCCC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 222111 112334578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=320.78 Aligned_cols=264 Identities=22% Similarity=0.277 Sum_probs=200.1
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhH--HHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGE--RVFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~~lV 314 (608)
+.|...+.|++|+||.||+|+. .+++.||+|+++.+..... ---.+||.+|.+++|+|||.+-.+... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 4467779999999999999995 4688999999987542221 124679999999999999999888653 4579999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
||||+. +|..+++.-. ..+...+..-++.|+++||+|||.+ -|+|||||++|+|+.+.|.+||+|||||+.+...
T Consensus 156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 999985 7888887654 4688889999999999999999999 7999999999999999999999999999988765
Q ss_pred ccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHH--HHH---H-HH-----
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARP--LLN---R-AI----- 462 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~--~~~---~-~~----- 462 (608)
. ...+..+-|.+|+|||++.+. .|++..|+||+|||+.|||++++-|...... +.+.+- ++. . .+
T Consensus 231 ~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~--dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 231 L-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI--DQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred c-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH--HHHHHHHHHhCCCccccCCCccc
Confidence 3 235667789999999998765 5999999999999999999999988754431 111111 100 0 00
Q ss_pred ----hcCCCCcccCccccCcCCHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 463 ----EDGNFDTLVDPKLHNEYNHN-EMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 463 ----~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..-.+..-.-..++..+... ..+.-++|+...|..||.+|-|+.|.+++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00011111111222222222 23456678899999999999999998865
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=336.79 Aligned_cols=241 Identities=26% Similarity=0.370 Sum_probs=194.2
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
+|...++||+|+||.||+|... +++.||||+++... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999854 57899999987542 22234566788888877 5899999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999887654 488999999999999999999998 99999999999999999999999999997543211
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. ++.. +..+.+
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~----~~~~-i~~~~~-------- 218 (323)
T cd05616 156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DE----LFQS-IMEHNV-------- 218 (323)
T ss_pred -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HH----HHHH-HHhCCC--------
Confidence 122345789999999999999999999999999999999999999975432 11 1111 222211
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRI 505 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm 505 (608)
.++......+.+++.+||+.+|.+|++.
T Consensus 219 --~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 --AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1112234567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=356.21 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=206.5
Q ss_pred HHHHHhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-
Q 046502 234 ELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS- 309 (608)
Q Consensus 234 el~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~- 309 (608)
++....++|...++||+|+||.||++. ..+|+.||||++... .......+.+|+.++..++|+||+++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 334456789999999999999999998 457899999998654 2334567889999999999999999988775432
Q ss_pred -------eeEEEEeeccCCcHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 310 -------QRMLVCEFVTSNTLEFHLHGKG--RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 310 -------~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
.+++||||+.+|+|.++|+... ...+++..+..|+.|++.||.|||+. +|+||||||+||||+.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 3689999999999999987532 34688999999999999999999998 99999999999999999999
Q ss_pred EEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 046502 381 KVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 381 kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 459 (608)
||+|||+++...... ........||..|+|||++.+..++.++|||||||+||||++|+.||..... ..++.
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~ 255 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMH 255 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHH
Confidence 999999998654321 1223346799999999999999999999999999999999999999975322 11122
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. ..+.... .+......+.+++..||+.+|.+||++.+|+++
T Consensus 256 ~~-~~~~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KT-LAGRYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HH-hcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 21 1222211 112233568889999999999999999999875
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=347.48 Aligned_cols=201 Identities=24% Similarity=0.309 Sum_probs=172.7
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.|..+++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++|+|||+++++|.+++.++||||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999985 568899999987532 2234568899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc-
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY- 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~- 395 (608)
|+++|+|.+++...+ .+++.....++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999987653 578888999999999999999998 89999999999999999999999999975321000
Q ss_pred ---------------------------------------------cceeeeeecccCccChhhhhcCCCCCcchhhhHHH
Q 046502 396 ---------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 430 (608)
Q Consensus 396 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gv 430 (608)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCc
Q 046502 431 MLLELIIGCRPVDSTH 446 (608)
Q Consensus 431 ll~elltG~~p~~~~~ 446 (608)
+||||++|+.||....
T Consensus 237 il~elltG~~Pf~~~~ 252 (382)
T cd05625 237 ILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHhCCCCCCCCC
Confidence 9999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.27 Aligned_cols=258 Identities=22% Similarity=0.371 Sum_probs=209.1
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|... +|+.||+|.++.. .......+.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999965 7899999988642 2233567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 316 EFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 316 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||+++++|..++... ....+++.+++.++.++++||.|||+. +|+||||||+|||++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988642 234589999999999999999999998 999999999999999999999999999886543
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
... ......++..|+|||++.+..++.++|||||||++|+|++|+.||..... .+.. +...+..+.+..+.
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~--~~~~~~~~~~~~~~-- 229 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYS--LCKKIEKCDYPPLP-- 229 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHH--HHhhhhcCCCCCCC--
Confidence 221 12234688999999999988899999999999999999999999864321 1110 11112222221111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.......+.+++.+||+.+|.+||++.+|+++|+..
T Consensus 230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 113345688899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=336.06 Aligned_cols=255 Identities=19% Similarity=0.233 Sum_probs=196.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||++.. .+++.||||++... .....+.|.+|+.++..++|+||++++++|.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999995 45899999998642 2223456888999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999987533 3588999999999999999999999 89999999999999999999999999997654433
Q ss_pred cceeeeeecccCccChhhhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
........||+.|||||++.. +.++.++|||||||+||||++|+.||..... . ......+.......+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~-~~~~~i~~~~~~~~~ 229 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------V-ETYGKIMNHKEHFQF 229 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------H-HHHHHHHcCCCcccC
Confidence 323333569999999999863 4578899999999999999999999964322 1 111111111111111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhc--CCCCCCCHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRH--SARRRPRISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~--dp~~RPsm~evv~~ 511 (608)
.. ... .....+.+++.+||.. ++..|+++.+++.+
T Consensus 230 ~~--~~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 PP--DVT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CC--ccC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 001 1233456666666644 44448899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=325.37 Aligned_cols=254 Identities=26% Similarity=0.434 Sum_probs=204.8
Q ss_pred cCCCcCCccccCCceEEEEEEecC------CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN------GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|...+.||+|+||.||+|...+ ++.||+|.+.... ......+.+|+.++..++|+||+++++++..+...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 578888999999999999998643 3689999987553 233457889999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEE
Q 046502 313 LVCEFVTSNTLEFHLHGKG--------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD 384 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~D 384 (608)
+||||+.+++|.+++.... ...++|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 9999999999999987532 22478999999999999999999998 999999999999999999999999
Q ss_pred eeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHH
Q 046502 385 FGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 385 FGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
||+++...... ........++..|+|||++..+.++.++|||||||++|||++ |..||..... .. ... .+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~----~~~-~~ 234 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EE----VLK-FV 234 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HH----HHH-HH
Confidence 99998654321 112233456789999999998899999999999999999998 8888864322 11 111 12
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
..+....+ .......+.+++.+||+.+|++||++.+|+..|+
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 22221111 1122457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=325.02 Aligned_cols=252 Identities=29% Similarity=0.455 Sum_probs=204.1
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
.+|...+.||+|+||.||++.+.+++.+|||.+..... ....|.+|++++++++|+||+++++++......++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677889999999999999987788999999875433 34568899999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++..+.. .+.|..++.++.+++.+|.|||+. +|+|||||++|||++.++.+||+|||+++..........
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 83 HGCLSDYLRAQRG-KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999999876433 588999999999999999999998 899999999999999999999999999986543222112
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....++.+|+|||++.++.++.++|||||||++|||++ |+.||..... . .++.. +..+. ....+.+
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~----~~~~~-~~~~~--~~~~~~~--- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---S----EVVET-INAGF--RLYKPRL--- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---H----HHHHH-HhCCC--CCCCCCC---
Confidence 22335678999999998899999999999999999998 9999864321 1 11111 12111 1111211
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
....+.+++.+||+.+|++||+|.+|+++|.
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=326.07 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=204.3
Q ss_pred HHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 235 LARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 235 l~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++.+++++....+||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++|+||++++++|..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 445677788888999999999999995 4578899999887766667789999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-CCceEEEEeecccc
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTM--DWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKL 390 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l--~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-~~~~kl~DFGla~~ 390 (608)
||||+++++|.+++..... .+ ++..+..++.||+.||.|||+. +|+||||||+||||+. ++.+||+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 9999999999999976432 34 7888999999999999999998 9999999999999976 67999999999876
Q ss_pred ccCcccceeeeeecccCccChhhhhcCC--CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
...... ......|+..|+|||++.... ++.++|||||||++|+|++|+.||......... ...... ..
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-----~~~~~~-~~--- 228 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-----MFKVGM-FK--- 228 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-----Hhhhhh-hc---
Confidence 543221 122345789999999986644 788999999999999999999998643221000 000000 00
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.....+......+.+++.+||+.+|.+||++.||+++
T Consensus 229 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0011222334567889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=330.19 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=200.0
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
|...++||+|+||.||++.. .+++.||||.+..... .....+.+|+++|++++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999985 4688999999865422 2234577899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+++|.+++.......+++..+..++.|++.||.|||+. +|+|||||++|||++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999988765555799999999999999999999998 89999999999999999999999999997654321
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......|+..|+|||++.+..++.++|||||||++|||++|+.||........ .. .+...+..+..
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~-~~~~~~~~~~~---------- 222 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---RE-EVDRRVLETEE---------- 222 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH-HHHHhhhcccc----------
Confidence 12335689999999999988999999999999999999999999975432110 01 11111111110
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPR-----ISQIVR 510 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~ 510 (608)
.+.......+.+++..||+.||++||+ +.+++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 111222345678999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.44 Aligned_cols=269 Identities=19% Similarity=0.268 Sum_probs=195.2
Q ss_pred HHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCC------CccceeeEE
Q 046502 233 EELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHK------HLVSLVGYY 305 (608)
Q Consensus 233 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hp------niv~l~g~~ 305 (608)
+++...+++|.+.++||+|+||.||+|.. ..++.||||+++... ...+.+..|++++.+++|. +|++++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 44555678899999999999999999985 457889999997532 2334556688888777654 588899988
Q ss_pred EeC-CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC------
Q 046502 306 TAG-SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF------ 378 (608)
Q Consensus 306 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~------ 378 (608)
..+ .+.+||||++ +++|.+++...+ .+++..+..|+.||+.||.|||.++ +||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~ 275 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPV 275 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccc
Confidence 764 4788999988 567877776543 5899999999999999999999743 899999999999998765
Q ss_pred ----------ceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCccc
Q 046502 379 ----------EAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTF 448 (608)
Q Consensus 379 ----------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~ 448 (608)
.+||+|||++..... ......||..|+|||++.+..++.++|||||||+||||++|+.||+.....
T Consensus 276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998864322 234467999999999999999999999999999999999999999764431
Q ss_pred ccchhhH--------HHHHH--------HH-hcCCCCcccCccc----cC-c--CCHHHHHHHHHHHHHhhhcCCCCCCC
Q 046502 449 MEDNLAR--------PLLNR--------AI-EDGNFDTLVDPKL----HN-E--YNHNEMARMVACAAACVRHSARRRPR 504 (608)
Q Consensus 449 ~~~~l~~--------~~~~~--------~~-~~~~~~~~~d~~l----~~-~--~~~~~~~~l~~l~~~Cl~~dp~~RPs 504 (608)
....+.. .|... .+ ..+.+....++.. .. . ........+++|+..||+.||++||+
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 1100000 00000 00 0011110111000 00 0 00011245779999999999999999
Q ss_pred HHHHHHH
Q 046502 505 ISQIVRT 511 (608)
Q Consensus 505 m~evv~~ 511 (608)
+.|++++
T Consensus 432 a~e~L~H 438 (467)
T PTZ00284 432 ARQMTTH 438 (467)
T ss_pred HHHHhcC
Confidence 9999974
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.61 Aligned_cols=252 Identities=22% Similarity=0.248 Sum_probs=195.3
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.+|...+.||+|+||.||++.. .+++.||||++.... ......+.+|+++|++++|+||++++++|.+++.++|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688899999999999999985 458999999986432 123456788999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++|+|.+++...+ .+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999997654 578888899999999999999998 99999999999999999999999999985321000
Q ss_pred ------------------------------------------cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHH
Q 046502 396 ------------------------------------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL 433 (608)
Q Consensus 396 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ 433 (608)
........||+.|||||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00012357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCC---CHHHHHH
Q 046502 434 ELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP---RISQIVR 510 (608)
Q Consensus 434 elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP---sm~evv~ 510 (608)
||++|+.||....... ....... ... .+..+. ... ....+.+++.+|+ .+|.+|+ ++.|++.
T Consensus 236 ell~G~~Pf~~~~~~~-------~~~~i~~-~~~-~~~~~~-~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 236 EMLVGQPPFLADTPAE-------TQLKVIN-WET-TLHIPS-QAK----LSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred ehhhCCCCCCCCCHHH-------HHHHHhc-cCc-cccCCC-CCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999997543211 1111111 000 000000 011 2234556666665 4999999 8888886
Q ss_pred H
Q 046502 511 T 511 (608)
Q Consensus 511 ~ 511 (608)
+
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=329.28 Aligned_cols=257 Identities=24% Similarity=0.388 Sum_probs=206.1
Q ss_pred hcCCCcCCccccCCceEEEEEEecC-----CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEe-CCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPN-----GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTA-GSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-~~~~ 311 (608)
.++|...++||+|+||.||+|...+ ++.|++|+++... ......+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999755 6889999987543 3345678899999999999999999999876 4678
Q ss_pred EEEEeeccCCcHHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 312 MLVCEFVTSNTLEFHLHGKGR------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
++++||+.+++|.+++..... ..+++..++.++.+++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999875422 4689999999999999999999998 8999999999999999999999999
Q ss_pred eccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHh
Q 046502 386 GLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 386 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
|+++.+.....+ ......++..|+|||++.+..++.++|||||||++|||++ |+.||+..... . +. ..+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~----~~-~~~~ 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---E----MA-AYLK 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---H----HH-HHHH
Confidence 999865432222 2223446778999999998889999999999999999998 99998754321 1 11 1122
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+.. +. ........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 234 ~~~~--~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 234 DGYR--LA-------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred cCCC--CC-------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 2210 00 0112235688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.92 Aligned_cols=250 Identities=27% Similarity=0.400 Sum_probs=204.7
Q ss_pred cCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
++|...++||+|+||.||+|...+ ++.|++|.+..... ...+.+|++++++++|+||+++++++..+...+++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999654 78999999876533 568999999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+++|.+++.... ..++|..++.++.++++||.|||.. +|+||||+++||+++.++.+||+|||++........ .
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999987543 3689999999999999999999998 899999999999999999999999999987654321 2
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
.....++..|++||++.+..++.++|||||||++|+|++|+.||....... ... .+..... ..+ .
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------~~~--~~~~~~~-----~~~--~ 220 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR------AIF--MIPNKPP-----PTL--S 220 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh------hhh--hhccCCC-----CCC--C
Confidence 233558899999999998899999999999999999999999987533210 000 0000000 001 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+......+.+++.+||+.+|++||++.||+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 122233568889999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=322.22 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=197.4
Q ss_pred CCcCCccccCCceEEEEEEecCC-c--EEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC------Ce
Q 046502 242 FSDANLLGQGGFGYVHKGVLPNG-K--EVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG------SQ 310 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~g-~--~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~------~~ 310 (608)
|...++||+|+||.||+|.+.+. . .||||.++.. .....+.|.+|++++++++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34568899999999999996543 2 5899998754 233456788999999999999999999987532 24
Q ss_pred eEEEEeeccCCcHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 311 RMLVCEFVTSNTLEFHLHGK----GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
.++||||+.+++|..++... ....++|...+.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887432 223589999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhc
Q 046502 387 LAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIED 464 (608)
Q Consensus 387 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 464 (608)
+++........ ......++..|++||++....++.++|||||||++|||++ |+.||..... . .+. ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~----~~~-~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---S----EIY-DYLRQ 229 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---H----HHH-HHHHc
Confidence 99876432211 1122345678999999999899999999999999999999 7888864322 1 111 22223
Q ss_pred CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 465 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 465 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
+..... .......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 230 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 230 GNRLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 221111 11233457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=335.87 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=192.1
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||++.. .+++.||||+++... ......+.+|+.++.++ +|+||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 457899999997542 22335678899999888 699999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|..++.... .+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS 154 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence 99998886543 589999999999999999999998 89999999999999999999999999997532211 1223
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...||+.|+|||++.+..++.++|||||||+||||++|+.||+.......... ...+...+....+. .+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~----------~p 223 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT-EDYLFQVILEKPIR----------IP 223 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc-HHHHHHHHHhCCCC----------CC
Confidence 46799999999999999999999999999999999999999964322111111 11222222222111 11
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRI 505 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm 505 (608)
......+.+++..||+.||++|+++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1223456789999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=323.92 Aligned_cols=246 Identities=26% Similarity=0.396 Sum_probs=195.5
Q ss_pred ccccCCceEEEEEEec---CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCc
Q 046502 247 LLGQGGFGYVHKGVLP---NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNT 322 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gs 322 (608)
.||+|+||.||+|.+. .+..||||++..... ...+.|.+|+.++++++|+||++++++|. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 355799999976543 33466889999999999999999999985 457899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee--e
Q 046502 323 LEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS--T 400 (608)
Q Consensus 323 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~--~ 400 (608)
|.+++.... ..+++..+++++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.......... .
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999987543 3689999999999999999999998 899999999999999999999999999986543222111 1
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
...++..|+|||++....++.++|||||||++|||++ |..||...... .+. ..+..+.. ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~-~~~~~~~~---------~~~ 219 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVM-SFIEQGKR---------LDC 219 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHH-HHHHCCCC---------CCC
Confidence 1223578999999988889999999999999999996 99998654321 111 12222211 111
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
+......+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 22334567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=330.94 Aligned_cols=258 Identities=25% Similarity=0.433 Sum_probs=201.3
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||++.. .+++.||+|.++... ......+.+|++++.+++|+||++++++|..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 4688999999999999999985 467889999987543 23345688999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++.... .+++..+..++.|+++||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 99999999997653 5889999999999999999999743 7999999999999999999999999998765432
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC---------
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD--------- 468 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--------- 468 (608)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....... +.. ++..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEA-MFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHH-hhcCccccccccCCcccccCC
Confidence 1233568899999999988889999999999999999999999986432110 000 000000000000
Q ss_pred -----------c----cc---CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 -----------T----LV---DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 -----------~----~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+ ++ .+.+.. ......+.+++.+||+.+|++||++.||+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 000000 0123457899999999999999999999976
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.75 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=199.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||+|.. .+++.||||++... .......|.+|++++++++|+||++++++|...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3577889999999999999984 56889999998654 233446788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997553 378889999999999999999998 9999999999999999999999999999765432
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||..............+. ..+..... +.+..
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~ 222 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDEDP-----PVLPV 222 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhccCC-----CCCCC
Confidence 1233568999999999998899999999999999999999999986532211111111111 11111111 11111
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+.+++.+||+.+|++||++.+|+++
T Consensus 223 ---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 ---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1123457889999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=334.84 Aligned_cols=240 Identities=28% Similarity=0.406 Sum_probs=191.3
Q ss_pred CccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|... +|+.||||+++... ......+..|..++..+ +|+||+++++++.+++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999964 58899999997532 22334566788888764 899999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|..++..+. .+++..+..++.|+++||+|||+. +|+||||||+||||+.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCcee
Confidence 99999887643 488999999999999999999998 9999999999999999999999999998743221 11234
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. +.. .+..+. +.+ .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~----~~~-~~~~~~------~~~----~ 216 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DE----LFE-SIRVDT------PHY----P 216 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HH----HHH-HHHhCC------CCC----C
Confidence 46799999999999999999999999999999999999999964332 11 111 111111 111 1
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRIS-QIV 509 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~-evv 509 (608)
......+.+++..||+.||++|+++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11234577899999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=320.62 Aligned_cols=247 Identities=28% Similarity=0.413 Sum_probs=200.1
Q ss_pred CccccCCceEEEEEEecCCcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcHH
Q 046502 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLE 324 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~ 324 (608)
++||+|+||.||++.+.+++.||+|++...... ....|.+|++++++++|+||+++++++...+..++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998765443 4567899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee-eeee
Q 046502 325 FHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS-TRVM 403 (608)
Q Consensus 325 ~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~-~~~~ 403 (608)
+++..... .+++..++.++.+++.+|.|||++ +|+||||||+||||+.++.+||+|||+++.......... ....
T Consensus 81 ~~l~~~~~-~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKKN-RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 99876433 588999999999999999999998 899999999999999999999999999986543211111 1122
Q ss_pred cccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHH
Q 046502 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHN 482 (608)
Q Consensus 404 gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 482 (608)
++..|+|||++.++.++.++|||||||++|||++ |..||..... .. ....+..+. .+ .....
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~---~~-----~~~~~~~~~--~~-------~~~~~ 219 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN---QQ-----TRERIESGY--RM-------PAPQL 219 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH---HH-----HHHHHhcCC--CC-------CCCcc
Confidence 3567999999998899999999999999999999 8888854332 11 111111111 00 11122
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 483 EMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 483 ~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
....+.+++.+||+.+|.+||++.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3456888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=311.16 Aligned_cols=261 Identities=23% Similarity=0.314 Sum_probs=209.3
Q ss_pred hcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----eeE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS-----QRM 312 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~-----~~~ 312 (608)
.++|.+.++||+|||..||++. +.+++.||+|++.....++.+..++|++..++++||||+++++++..+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4679999999999999999998 7789999999998877777888899999999999999999999875443 489
Q ss_pred EEEeeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 313 LVCEFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
|++.|...|+|.+.+... ++..+++.+.+.|+.+|++||++||+. .+.+.||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999988753 234689999999999999999999998 44599999999999999999999999999875
Q ss_pred ccCccc-----c---eeeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 046502 391 ASDVYT-----H---VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 391 ~~~~~~-----~---~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 459 (608)
..-... . .-.....|.-|.|||.+. +...++++|||||||+||+|+.|..||+..-. ...+++..
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaLA--- 254 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLALA--- 254 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEEe---
Confidence 432100 0 011234689999999985 34578999999999999999999999975433 12222211
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
+.++.+... -.....+.|.+++++||+.||.+||++.+++..++.
T Consensus 255 --v~n~q~s~P--------~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 255 --VQNAQISIP--------NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred --eeccccccC--------CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 111121111 111256778999999999999999999999998874
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=323.06 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=201.1
Q ss_pred CccccCCceEEEEEEecC--C--cEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLPN--G--KEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|.+.+ + ..||||.+..... ...+.|.+|+.++++++|+||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 469999999999998643 3 3689999987665 556789999999999999999999999988 889999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc--e
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH--V 398 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~--~ 398 (608)
++|.+++.......++|..++.++.|++.||+|||.. +|+||||||+|||++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999775434689999999999999999999998 9999999999999999999999999999876442211 1
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|++||++.+..++.++|||||||++|||++ |+.||..... .. .+......+. .+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~----~~~~~~~~~~--~~~------ 221 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQ----ILKKIDKEGE--RLE------ 221 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HH----HHHHHHhcCC--cCC------
Confidence 123457789999999999899999999999999999998 9999864322 11 1111111111 111
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
........+.+++.+||+.+|++||++.+|++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123456888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=330.83 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=204.7
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.+|...+.||+|+||.||+|.. .+++.||||.+........+.+.+|+.+++.++|+||++++++|..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788889999999999999984 568999999998766555677889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++... .+++.+++.++.|++.||.|||.. +|+||||||+||||+.++.+||+|||++........ .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 999999998643 478999999999999999999998 899999999999999999999999999876543211 1
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...... . .+. .....+. ..+ .
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~----~~~-~~~~~~~-~~~-------~ 237 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--R----ALY-LIATNGT-PEL-------Q 237 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--H----hHH-HHhcCCC-CCC-------C
Confidence 22346889999999999888999999999999999999999999654321 1 011 1111111 011 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||..+|++||++.+|+++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 112233567889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=342.84 Aligned_cols=260 Identities=22% Similarity=0.269 Sum_probs=202.9
Q ss_pred HHHHHHhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 046502 233 EELARATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG 308 (608)
Q Consensus 233 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~ 308 (608)
.++....++|...+.||+|+||.||++... +++.||+|++... .......+.+|+.+++.++|+||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344555689999999999999999999954 5789999998642 222345678899999999999999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
+..++||||+++|+|.+++... .++...+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999999998653 478888899999999999999999 9999999999999999999999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcC----CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhc
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIED 464 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 464 (608)
+..............||+.|||||++... .++.++|||||||+||||++|+.||...... .........
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~ 262 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNH 262 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------HHHHHHHcC
Confidence 87654322233446799999999999753 3789999999999999999999999754321 011122211
Q ss_pred CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHh
Q 046502 465 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRISQIVRTL 512 (608)
Q Consensus 465 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPsm~evv~~L 512 (608)
.....+.+ .......+.+++..||+.++.+ |+++.+|+++.
T Consensus 263 ~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11111111 1123345677889999844443 78999998865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=334.46 Aligned_cols=242 Identities=27% Similarity=0.397 Sum_probs=195.4
Q ss_pred CccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||++... +++.||||+++... ......+..|+.++..+ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999864 57899999997542 22345567889999888 699999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS 154 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence 99999887654 589999999999999999999998 999999999999999999999999999875322111 223
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...|+..|+|||++.+..++.++|||||||++|||++|+.||..... .. +.. .+..+... ++
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~----~~~-~i~~~~~~----------~~ 216 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DE----LFQ-SILEDEVR----------YP 216 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HH----HHH-HHHcCCCC----------CC
Confidence 35689999999999999999999999999999999999999965332 11 111 12222111 11
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRI-----SQIVRT 511 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm-----~evv~~ 511 (608)
......+.+++.+||+.||.+||++ .+++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1223467889999999999999999 777754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.06 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=201.1
Q ss_pred cCCCcCCccccCCceEEEEEEec-----------------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccce
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-----------------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSL 301 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l 301 (608)
++|+..++||+|+||.||++... ++..||||+++... ......|.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999998532 23468999997643 3345678999999999999999999
Q ss_pred eeEEEeCCeeEEEEeeccCCcHHHHhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcE
Q 046502 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGR---------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANI 372 (608)
Q Consensus 302 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NI 372 (608)
++++..++..++||||+.+++|.+++..... ..+++.+++.++.|++.||+|||+. +|+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999875321 2478889999999999999999998 899999999999
Q ss_pred EEccCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh--CCCCCCCCcccc
Q 046502 373 LLDFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII--GCRPVDSTHTFM 449 (608)
Q Consensus 373 Ll~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt--G~~p~~~~~~~~ 449 (608)
|++.++.+||+|||+++....... .......++..|++||+...+.++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 999999999999999986533211 11222345678999999988899999999999999999998 6677753321
Q ss_pred cchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 450 EDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 450 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.+ .... ....+..... ....+ ........+.+++.+||+.||++||+|.+|++.|+
T Consensus 240 ~~-~~~~-~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQ-VIEN-TGEFFRDQGR-QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH-HHHH-HHHHHhhccc-cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11 1110 0011111100 00000 01123367889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=334.50 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=203.6
Q ss_pred cCCCcCCccccCCceEEEEEEec--------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP--------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGS 309 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~ 309 (608)
++|...+.||+|+||.||++... ++..||+|.++... ......+.+|++++.++ +|+||++++++|..++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888999999999999999742 23579999998643 23345688899999999 7999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD 375 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~ 375 (608)
..++||||+.+++|.+++.... ...++|.++++++.|++.||+|||+. +|+||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 9999999999999999997642 13589999999999999999999998 999999999999999
Q ss_pred cCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchh
Q 046502 376 FKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNL 453 (608)
Q Consensus 376 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l 453 (608)
.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... +.
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~- 250 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE- 250 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HH-
Confidence 999999999999976543211 11112234568999999998899999999999999999998 8888854321 11
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+. ..+..+... .........+.+++.+||+.+|.+||+|.+|++.|+...
T Consensus 251 ---~~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 251 ---LF-KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred ---HH-HHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11 112222111 111223456788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=337.81 Aligned_cols=238 Identities=26% Similarity=0.320 Sum_probs=193.0
Q ss_pred CccccCCceEEEEEEe----cCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 246 NLLGQGGFGYVHKGVL----PNGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++||+|+||.||++.. .+|+.||||+++.... .....+..|+++|++++|+||++++++|..++..|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 3578999999975322 223456789999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++.... .+++..++.++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++....... ..
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA 155 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence 999999986543 589999999999999999999998 899999999999999999999999999986543221 22
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
....|+..|+|||++.+..++.++|||||||+||||++|+.||..... . ..+.. +....+. .
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~----~~~~~-i~~~~~~----------~ 217 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---K----ETMTM-ILKAKLG----------M 217 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---H----HHHHH-HHcCCCC----------C
Confidence 345789999999999988899999999999999999999999975332 1 11111 1111111 1
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQ 507 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~e 507 (608)
+......+.+++..||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1122345778999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=333.81 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=205.3
Q ss_pred hcCCCcCCccccCCceEEEEEEec--------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeC
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP--------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAG 308 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~ 308 (608)
.++|...+.||+|+||.||++... ++..||+|.++... ....+.+.+|+.+++.+ +|+||++++++|...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356788899999999999999731 24579999987543 33456788999999999 799999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL 374 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl 374 (608)
...++||||+.+++|.+++.... ...++|..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999987532 23578899999999999999999998 99999999999999
Q ss_pred ccCCceEEEEeeccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccch
Q 046502 375 DFKFEAKVADFGLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDN 452 (608)
Q Consensus 375 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 452 (608)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |..||..... .
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~- 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---E- 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---H-
Confidence 99999999999999876542221 1222345678999999998889999999999999999998 7788754321 1
Q ss_pred hhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 046502 453 LARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDAS 517 (608)
Q Consensus 453 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~~ 517 (608)
.+.. .+..+... .........+.+++.+||+.+|.+||+|.||++.|+....
T Consensus 247 ---~~~~-~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 247 ---ELFK-LLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ---HHHH-HHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1111 12222111 0112334568889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.60 Aligned_cols=241 Identities=28% Similarity=0.374 Sum_probs=191.6
Q ss_pred CccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHh-cCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISR-VHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~-l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|... +++.||||+++... ......+..|..++.. ++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 57899999997542 2233456667888876 4899999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
|+|..++.... .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 99999987543 588999999999999999999998 99999999999999999999999999987532211 1223
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...||..|+|||++.+..++.++|||||||++|||++|+.||..... .. ++.. +..+.. .+ +
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~----~~~~-i~~~~~------~~----~ 216 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EE----LFQS-IRMDNP------CY----P 216 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HH----HHHH-HHhCCC------CC----C
Confidence 45789999999999998999999999999999999999999975432 11 1111 111111 11 1
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRIS-QIVR 510 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~-evv~ 510 (608)
......+.+++..||+.||++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11234577899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=330.07 Aligned_cols=258 Identities=26% Similarity=0.444 Sum_probs=204.2
Q ss_pred HhcCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~ 310 (608)
..++|.+.++||+|+||.||+|... .+..||||.++.... .....+.+|+.++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567899999999999999999743 245799999875432 334567889999999999999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEE
Q 046502 311 RMLVCEFVTSNTLEFHLHGKG--------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl 382 (608)
.++||||+.+|+|.+++.... ...+.+..+.+++.|++.||.|||+. +|+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997532 23457788899999999999999998 8999999999999999999999
Q ss_pred EEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHH
Q 046502 383 ADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 383 ~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
+|||+++...... ........++..|+|||++.++.++.++|||||||++|||++ |..||..... ..+...
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLKF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH
Confidence 9999998553321 111222345678999999998899999999999999999998 7888864321 112222
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.. .+..... .......+.+++.+||+.+|++||+|.++++.|+..
T Consensus 234 ~~-~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 VM-DGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HH-cCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11 2221111 112235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=321.26 Aligned_cols=240 Identities=25% Similarity=0.389 Sum_probs=190.5
Q ss_pred CccccCCceEEEEEEecC-------------CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 246 NLLGQGGFGYVHKGVLPN-------------GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
+.||+|+||.||+|++.. ...|++|.+..........|.+|+.+++.++||||++++++|......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999998532 2358999987655555567888999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc-------eEEEEe
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE-------AKVADF 385 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~-------~kl~DF 385 (608)
+||||+++++|..++.... ..+++..+++|+.||++||+|||+. +|+||||||+||||+.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999998887543 3589999999999999999999998 9999999999999987664 899999
Q ss_pred eccccccCcccceeeeeecccCccChhhhh-cCCCCCcchhhhHHHHHHHHH-hCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 386 GLAKLASDVYTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 386 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvll~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
|++...... ....++..|+|||++. ...++.++|||||||+||||+ .|+.|+....... .. .+.
T Consensus 157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--------~~-~~~ 222 (262)
T cd05077 157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--------KE-RFY 222 (262)
T ss_pred CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--------HH-HHH
Confidence 998754321 2245788999999986 466899999999999999998 5777775432110 00 111
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.+.+. .. . .....+.+++..||+.||++||++.+|++.|+
T Consensus 223 ~~~~~-~~-----~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 EGQCM-LV-----T----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred hcCcc-CC-----C----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 11111 11 1 11345788999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=335.35 Aligned_cols=238 Identities=27% Similarity=0.389 Sum_probs=189.0
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHH-HHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVE-IISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~-~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|.. .+|+.||||++.... ......+..|.. +++.++|+||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999996 468999999986432 122234444544 56789999999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|..++.... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS 154 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence 99999887643 588999999999999999999998 99999999999999999999999999987543221 1233
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...|++.|+|||++.+..++.++|||||||+||||++|+.||..... .. +... +..+.+. +..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~----~~~~-i~~~~~~------~~~--- 217 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AE----MYDN-ILNKPLR------LKP--- 217 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HH----HHHH-HHcCCCC------CCC---
Confidence 45789999999999999999999999999999999999999965321 11 1111 1122111 111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRISQ 507 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~e 507 (608)
.....+.+++.+||+.||.+||++.+
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 12446788999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.80 Aligned_cols=247 Identities=29% Similarity=0.443 Sum_probs=197.6
Q ss_pred CccccCCceEEEEEEecC----CcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|.+.. +..||+|.+..... ...+.+.+|+.+++++.|+||+++++++. ++..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997422 26899999986544 34567899999999999999999999876 5568999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee-
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS- 399 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 399 (608)
++|.+++.... .++|..++.++.|++.||.|||.. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997654 689999999999999999999998 899999999999999999999999999986643322211
Q ss_pred -eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 400 -TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 400 -~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
....++..|+|||++.+..++.++|||||||++|||++ |+.||+.... .. +. ..+..+....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~----~~-~~~~~~~~~~-------- 218 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AE----VI-AMLESGERLP-------- 218 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HH----HH-HHHHcCCcCC--------
Confidence 11223567999999998999999999999999999998 9999865432 11 11 1222221111
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1112335678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=319.91 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=193.2
Q ss_pred CccccCCceEEEEEEecC---CcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCC
Q 046502 246 NLLGQGGFGYVHKGVLPN---GKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
+.||+|+||.||+|.+.+ +..+|+|.++.... .....|.+|+.++++++|+||++++++|.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 45799999876543 33457889999999999999999999999999999999999999
Q ss_pred cHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc-
Q 046502 322 TLEFHLHGKG---RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH- 397 (608)
Q Consensus 322 sL~~~l~~~~---~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 397 (608)
+|.++++... ....++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987532 23467888889999999999999998 8999999999999999999999999999754332211
Q ss_pred eeeeeecccCccChhhhhcC-------CCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 398 VSTRVMGTFGYLAPEYASSG-------KLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
......++..|+|||++... .++.++|||||||++|||++ |+.||...... + .....+. +....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~-----~~~~~~~-~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--Q-----VLTYTVR-EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--H-----HHHHHhh-cccCC
Confidence 12234577889999998642 35789999999999999996 99999643321 1 1111111 11122
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
+.++.+... ....+.+++..|+ .+|++||++.||++.|+
T Consensus 230 ~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 223322221 2234677888998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=350.87 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=192.5
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeC--------C
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG--------S 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--------~ 309 (608)
.++|...++||+|+||.||+|.. .+++.||||++.... ....+|+.+|++++|+|||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999995 468899999986432 2345799999999999999999886432 2
Q ss_pred eeEEEEeeccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-ceEEEEee
Q 046502 310 QRMLVCEFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFG 386 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-~~kl~DFG 386 (608)
.+++||||+++ +|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+||||+.++ .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccc
Confidence 46799999986 56555542 2334689999999999999999999998 899999999999998664 69999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH-----
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR----- 460 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~----- 460 (608)
+++...... ......|++.|+|||++.+. .++.++|||||||+||||++|+.||...... +.+.+ .+..
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~-i~~~~~~p~ 291 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVR-IIQVLGTPT 291 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHH-HHHHhCCCC
Confidence 998654322 22335689999999998654 6899999999999999999999999754321 11111 0000
Q ss_pred --HH--hcCCC-----CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 --AI--EDGNF-----DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 --~~--~~~~~-----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+ ....+ ..+....+...++......+++|+..||+.||.+||++.|++++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 00111 11111111111222234568899999999999999999999865
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=324.80 Aligned_cols=254 Identities=30% Similarity=0.448 Sum_probs=203.6
Q ss_pred cCCCcCCccccCCceEEEEEEec-C---CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-N---GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.+|...+.||+|+||.||+|.+. + +..+|+|.++... ....+.|.+|+.++.+++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999853 2 3379999987543 23346789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++..... .+++.+++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 999999999999976543 589999999999999999999998 9999999999999999999999999999876543
Q ss_pred ccceee--eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 395 YTHVST--RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 395 ~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
...... ...++..|++||++.++.++.++|||||||++|||++ |..||..... . .... .+.++. ..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~----~~~~-~~~~~~--~~- 228 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---Q----DVIK-AIEEGY--RL- 228 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---H----HHHH-HHhCCC--cC-
Confidence 222221 1223567999999998899999999999999999886 9999864322 1 1111 122221 00
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
. ........+.+++.+||+.+|.+||+|.+|++.|+.
T Consensus 229 --~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 --P----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred --C----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0 011234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.80 Aligned_cols=192 Identities=24% Similarity=0.357 Sum_probs=164.6
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
...+|...+.||+|+||.||+|... +++.||+|+.... .+..|+.++++++|+||++++++|..++..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999964 4678999985432 23468999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+. ++|.+++.... ..++|..++.|+.||+.||.|||.. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 138 HYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred ccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 996 57777776543 3689999999999999999999998 8999999999999999999999999999754321
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCC
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPV 442 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~ 442 (608)
.......||..|+|||++.+..++.++|||||||+||||+++..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999866554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=327.87 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=196.0
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----eeEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS-----QRMLV 314 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~-----~~~lV 314 (608)
.|...++||.|.||.||+|.+ .+++.||||++..+.. .-.+|+++|+++.|||||+|+.+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466678999999999999995 4578999999876543 2346999999999999999999886422 34689
Q ss_pred EeeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEeeccccc
Q 046502 315 CEFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLA 391 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFGla~~~ 391 (608)
||||+. +|.+.++.. .+..++...+.-+..||++||.|||+. +|+||||||.|||||.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 777777642 234577777888999999999999998 99999999999999987 89999999999977
Q ss_pred cCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH-------HHHh
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN-------RAIE 463 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-------~~~~ 463 (608)
..... +.....+..|+|||.+.+. .|+.+.||||.|||+.||+-|+.-|.+... .+.+.. +++ +.+.
T Consensus 177 ~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~e-Iik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVE-IIKVLGTPTREDIK 251 (364)
T ss_pred ccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHH-HHHHhCCCCHHHHh
Confidence 55332 3445679999999998764 699999999999999999999999976432 122211 110 1111
Q ss_pred --cCCCCcccCccccC-----cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 --DGNFDTLVDPKLHN-----EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 --~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+..+...+.+.. -+......+.++|+.+||+.+|.+|-++.|++.+
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11222222222222 1334455678899999999999999999999864
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=326.93 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=201.9
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCc----EEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGK----EVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...++||+|+||.||+|.+ .+|+ .||||+++... ....+.+.+|+.++..++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 5678889999999999999984 4554 48999987543 3345678899999999999999999999975 45789
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
+|||+++|+|.++++... ..+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999987643 3589999999999999999999998 999999999999999999999999999987653
Q ss_pred cccce-eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
..... .....++..|++||.+.+..++.++|||||||++|||++ |..||+.... .. +...+..+.....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~-----~~~~~~~~~~~~~- 232 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---RE-----IPDLLEKGERLPQ- 232 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HH-----HHHHHHCCCcCCC-
Confidence 22211 112234678999999998899999999999999999998 8899864322 11 1122222221111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.......+.+++.+||+.||++||++.++++.|+..
T Consensus 233 --------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 233 --------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred --------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 112334678899999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=326.01 Aligned_cols=253 Identities=29% Similarity=0.444 Sum_probs=201.2
Q ss_pred CCCcCCccccCCceEEEEEEecC-C---cEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPN-G---KEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
+|...+.||+|+||.||+|.+.. + ..||||.++.. .......|..|+.++++++|+||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46778999999999999999643 3 36999998764 3334567999999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+++|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||||+.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999987653 3689999999999999999999998 99999999999999999999999999987654322
Q ss_pred cce-eee-ee--cccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 396 THV-STR-VM--GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 396 ~~~-~~~-~~--gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
... ... .. .+..|+|||++..+.++.++|||||||++|||++ |..||..... . ...........+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~----~~~~~i~~~~~~~-- 231 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---Q----DVINAIEQDYRLP-- 231 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---H----HHHHHHHcCCcCC--
Confidence 111 111 11 2457999999999999999999999999999886 9999864332 1 1111111111110
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
...+....+.+++..||+.+|.+||+|.+|+..|+.
T Consensus 232 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 232 --------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred --------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 011233557889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=338.63 Aligned_cols=257 Identities=28% Similarity=0.419 Sum_probs=200.5
Q ss_pred cCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeC-Ce
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAG-SQ 310 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~-~~ 310 (608)
++|...++||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688899999999999999973 3468899999976433 2345688899999999 689999999988654 46
Q ss_pred eEEEEeeccCCcHHHHhhcCC-----------------------------------------------------------
Q 046502 311 RMLVCEFVTSNTLEFHLHGKG----------------------------------------------------------- 331 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 331 (608)
.++||||+++|+|.++++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 789999999999999987532
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc-ceeeeeec
Q 046502 332 ------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-HVSTRVMG 404 (608)
Q Consensus 332 ------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~g 404 (608)
...++|..+.+++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 12368889999999999999999998 999999999999999999999999999986533211 11122345
Q ss_pred ccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHH
Q 046502 405 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483 (608)
Q Consensus 405 t~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 483 (608)
+..|+|||++.+..++.++|||||||++|||++ |..||...... . . +...+.++..... + . ..
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~----~-~~~~~~~~~~~~~--~---~----~~ 307 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E----E-FCRRLKEGTRMRA--P---D----YT 307 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--H----H-HHHHHhccCCCCC--C---C----CC
Confidence 678999999998899999999999999999997 88888643221 1 1 1122222221111 1 1 11
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 484 MARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 484 ~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
...+.+++..||+.+|++||++.||+++|+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 23578899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=318.51 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=204.5
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+|...++||+|+||.||++.. .+++.||+|.++.. .....+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477789999999999999985 46889999998643 2334567888999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++.......+++...+.++.+++.||.|||+. +|+|+||||+|||++.++.++|+|||+++....... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 999999988765445688999999999999999999998 999999999999999999999999999976643221 2
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||..... .... ..+..+.+..+
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~-~~~~~~~~~~~-------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLI-LKVCQGSYKPL-------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHH-HHHhcCCCCCC--------
Confidence 2345688999999999988899999999999999999999999975321 0111 11223332221
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++.+||+.||++||++.+|+..
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=332.52 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=199.8
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCc--EEEEEEcccC-CchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGK--EVAIKQLKAG-SGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|+..+.||+|+||.||+|.+. ++. .+++|.++.. .......|.+|++++.++ +|+||++++++|..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56788899999999999999964 454 4588877643 234456788999999999 899999999999999999999
Q ss_pred EeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 315 CEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
|||+++++|.++++... ...+++..++.++.|++.||+|||+. +|+||||||+||||+.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999997542 23578999999999999999999998 99999999999999999999
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHH
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~ 459 (608)
||+|||+++...... ......++..|+|||++....++.++|||||||+||||++ |..||..... .. +..
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~----~~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE----LYE 234 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HH----HHH
Confidence 999999986432111 1111224668999999988889999999999999999998 9999864322 11 111
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+..+.. ..........+.+++.+||+.+|++||++.+++.+|+..
T Consensus 235 -~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 -KLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -HHhcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111100 001112234578899999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=316.09 Aligned_cols=248 Identities=30% Similarity=0.447 Sum_probs=203.7
Q ss_pred CccccCCceEEEEEEecC----CcEEEEEEcccCCchh-HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGSGQG-ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~-~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|.... +..|+||+++...... .+.+.+|++++.+++|+||+++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999643 7889999998654433 57889999999999999999999999999999999999999
Q ss_pred CcHHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 321 NTLEFHLHGKG-------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 321 gsL~~~l~~~~-------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
++|.+++.... ...+++..++.++.++++||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998652 24689999999999999999999998 999999999999999999999999999987654
Q ss_pred cc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
.. ........++..|+|||.+....++.++|||||||++|||++ |+.||..... .. +...+..+...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~-----~~~~~~~~~~~--- 226 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EE-----VLEYLRKGYRL--- 226 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HH-----HHHHHHcCCCC---
Confidence 32 112233457889999999998899999999999999999999 6999875422 11 11122222111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.........+.+++.+||+.+|.+||++.||+++|+
T Consensus 227 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 ------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 111222467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=324.72 Aligned_cols=255 Identities=27% Similarity=0.409 Sum_probs=204.5
Q ss_pred hcCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
.++|...+.||+|+||.||++... ++..||||++.... ......|.+|+.++++++|+||++++++|.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 46789999987543 33456789999999999999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCc
Q 046502 312 MLVCEFVTSNTLEFHLHGKG--------------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAAN 371 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~N 371 (608)
++||||+++++|.+++.... ...+++..++.++.|++.||.|||.. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999986421 13478899999999999999999998 89999999999
Q ss_pred EEEccCCceEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccc
Q 046502 372 ILLDFKFEAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFM 449 (608)
Q Consensus 372 ILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 449 (608)
||++.++.+||+|||+++...... .........+..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999999987543221 111222334678999999998899999999999999999997 8888753321
Q ss_pred cchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 450 EDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 450 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
. .++ ..+..++.... ......++.+++.+||+.+|.+||++.||++.|+
T Consensus 239 -~----~~~-~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 -E----EVI-YYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred -H----HHH-HHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 111 22333332111 1123456888999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.15 Aligned_cols=255 Identities=20% Similarity=0.264 Sum_probs=197.5
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+++.. +++.||||++... .......+.+|+.++..++|+||+++++++.+.+..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999954 5788999998642 2223355888999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+|+|..++.... ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997633 2588999999999999999999998 99999999999999999999999999998665433
Q ss_pred cceeeeeecccCccChhhhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
........|++.|+|||++.. +.++.++|||||||+||||++|+.||...... ........... ..-
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~i~~~~~-~~~ 228 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHEE-RFQ 228 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------HHHHHHHcCCC-ccc
Confidence 323334579999999999875 56889999999999999999999999643321 11111111110 000
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPsm~evv~~ 511 (608)
+...+ ......+.+++.+|+..++++ |+++.+++++
T Consensus 229 ~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 11111 122356777888888765544 4678777755
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=330.91 Aligned_cols=257 Identities=19% Similarity=0.281 Sum_probs=195.7
Q ss_pred cCCccccC--CceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 244 DANLLGQG--GFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 244 ~~~~LG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
..++||+| +|++||++.. .+|+.||||+++... ....+.+.+|+++++.++|+||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999985 578999999997542 233457888999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc--
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-- 396 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~-- 396 (608)
++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||||+.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998765444689999999999999999999998 899999999999999999999999987543221100
Q ss_pred ----ceeeeeecccCccChhhhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 397 ----HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 397 ----~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .. .... ..+....+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~-----~~~~-~~~~~~~~ 230 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QM-----LLEK-LNGTVPCL 230 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HH-----HHHH-hcCCcccc
Confidence 01112346778999999976 45899999999999999999999999643210 00 0000 01111111
Q ss_pred cC-------------------c-----------------cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 VD-------------------P-----------------KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ~d-------------------~-----------------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+ . .....+.......+.+++.+||+.||++||++.||+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 0 00001122234568899999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=337.35 Aligned_cols=264 Identities=23% Similarity=0.305 Sum_probs=198.3
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeC------
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG------ 308 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~------ 308 (608)
..++|...+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999985 458899999997532 23345677899999999999999999988643
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
...++||||+++ +|...+.. .+++..+..++.|+++||.|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999986 55555542 488899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccch-hh-------------
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDN-LA------------- 454 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~-l~------------- 454 (608)
+...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||.......... ..
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 8654321 2233568999999999998899999999999999999999999997543211000 00
Q ss_pred -HHHHHHHHhc-CCCCcccCccc--------cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 455 -RPLLNRAIED-GNFDTLVDPKL--------HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 455 -~~~~~~~~~~-~~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+...++. ..+..+..+.+ ...........+.+++.+||+.||++||++.||+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000011110 11111110000 001112234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.19 Aligned_cols=262 Identities=23% Similarity=0.295 Sum_probs=195.0
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhc---CCCCccceeeEEEe-----CC
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG--QGERVFQAEVEIISRV---HHKHLVSLVGYYTA-----GS 309 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l---~Hpniv~l~g~~~~-----~~ 309 (608)
+|...+.||+|+||.||+|.. .+|+.||||.++.... .....+.+|+++++++ +|+||++++++|.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477889999999999999985 4688999999875322 1223456677777765 69999999998864 34
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
..++||||+.+ +|..++.......+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57999999985 788888765555689999999999999999999999 89999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH--hcCCC
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI--EDGNF 467 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~ 467 (608)
...... ......|+..|+|||++.+..++.++|||||||++|||++|+.+|...... +.+.+ ...... ....+
T Consensus 157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~--~~~~~-~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA--DQLGK-IFDLIGLPPEDDW 231 (288)
T ss_pred cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH--HHHHH-HHHHhCCCChhhC
Confidence 664321 223356899999999999889999999999999999999999998654321 11111 111000 00000
Q ss_pred Cc-------ccCccc---cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DT-------LVDPKL---HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~-------~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .+.+.. ...........+.+++.+||+.||++||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000 001111234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.07 Aligned_cols=239 Identities=26% Similarity=0.369 Sum_probs=188.3
Q ss_pred ccccCCceEEEEEEecC-------------------------CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccce
Q 046502 247 LLGQGGFGYVHKGVLPN-------------------------GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l 301 (608)
+||+|+||.||+|.+.. ...|++|++..........|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876554455678889999999999999999
Q ss_pred eeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC---
Q 046502 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF--- 378 (608)
Q Consensus 302 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~--- 378 (608)
+++|..+...++||||+++++|..++.... ..+++..+++++.||++||+|||+. +|+||||||+||||+.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999886543 3689999999999999999999998 899999999999997653
Q ss_pred ----ceEEEEeeccccccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHH-hCCCCCCCCcccccch
Q 046502 379 ----EAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDN 452 (608)
Q Consensus 379 ----~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~ell-tG~~p~~~~~~~~~~~ 452 (608)
.+||+|||++...... ....++..|+|||++.. ..++.++|||||||++|||+ +|+.||.......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE--- 229 (274)
T ss_pred CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---
Confidence 3799999998644321 12347788999998865 56899999999999999995 6888886432211
Q ss_pred hhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 453 LARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 453 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
. ...+.... .+.. .....+.+++.+||+.+|++||+|.+|++.|.
T Consensus 230 ~-----~~~~~~~~-------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 K-----ERFYEKKH-------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H-----HHHHHhcc-------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 11111100 0101 11235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.96 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=205.1
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
..+|...+.||+|+||.||++.. .+++.||||.+........+.+.+|+.+++.++|+||++++++|..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36788999999999999999995 57899999999866555667788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++... .+++..+..++.+++.||.|||+. +|+||||||+||||+.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred cCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 9999999998643 488999999999999999999998 899999999999999999999999999876543221
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......++..|++||++.+..++.++|||||||++|+|++|+.||....... .+. .....+ ...+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~--~~~-----~~~~~~-~~~~------- 235 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY-----LIATNG-TPEL------- 235 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch--hee-----eeccCC-CCCC-------
Confidence 1223468899999999998889999999999999999999999996533210 000 000011 0000
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.........+.+++.+||+.+|++||++.+|+++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112233457789999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=335.54 Aligned_cols=244 Identities=26% Similarity=0.365 Sum_probs=191.8
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHH-HHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVE-IISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~-~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||++.. .+|+.||||++.... ......+..|.. +++.++|+||++++++|...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999985 468999999986431 223344555554 56779999999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|..++.... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT 154 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence 99998886543 589999999999999999999998 8999999999999999999999999998754321 11233
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. +... +..+.+. +..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~----~~~~-~~~~~~~------~~~--- 217 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---AE----MYDN-ILHKPLV------LRP--- 217 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---HH----HHHH-HHcCCcc------CCC---
Confidence 46799999999999999999999999999999999999999965332 11 1111 1111110 111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 481 HNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.....+.+++..||+.+|.+||++.+.++.+.
T Consensus 218 -~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~ 249 (325)
T cd05604 218 -GASLTAWSILEELLEKDRQRRLGAKEDFLEIQ 249 (325)
T ss_pred -CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHh
Confidence 12345778999999999999999875444443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=322.43 Aligned_cols=253 Identities=28% Similarity=0.445 Sum_probs=200.0
Q ss_pred CCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHH--HHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 242 FSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGER--VFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
|...++||+|+||+||++... +++.||+|++......... ...+|+.++++++|+||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999965 4668999999876544332 3456999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+++|.+++... ..+++..++.++.|+++||.|||+. +|+|+||||+|||++.++.++|+|||++...... ...
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-NEN 154 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-TSE
T ss_pred cccccccccccc--ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-ccc
Confidence 999999999832 3589999999999999999999998 9999999999999999999999999999764221 223
Q ss_pred eeeeecccCccChhhhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++. ...++.++||||||+++|+|++|..||...............+....... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~-- 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS---------S-- 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH---------T--
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc---------c--
Confidence 34467899999999998 88899999999999999999999999976521111111111111000000 0
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.........+.+++..||+.||++||++.+|+++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112678899999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.97 Aligned_cols=245 Identities=24% Similarity=0.334 Sum_probs=191.2
Q ss_pred CccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHH-HHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEV-EIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev-~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
+.||+|+||.||++... +++.||+|++.... ......+..|. .+++.++|+||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999954 57889999986432 12223344444 457789999999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|.+++.... .+.+.....++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~ 154 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS 154 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence 99999987643 477888889999999999999998 99999999999999999999999999997543221 1233
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... .. ++... ..+... +.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~----~~~~i-~~~~~~----------~~ 216 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AE----MYDNI-LNKPLQ----------LK 216 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HH----HHHHH-HhCCcC----------CC
Confidence 46799999999999999999999999999999999999999964332 11 11111 111111 11
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 481 HNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
......+.+++..||+.+|.+|+++.+.+..+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 1223457789999999999999998765544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.22 Aligned_cols=248 Identities=28% Similarity=0.424 Sum_probs=194.8
Q ss_pred CccccCCceEEEEEEecC-Cc--EEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLPN-GK--EVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|.+.+ +. .+++|.++... ......+.+|++++.++ +|+||++++++|...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999644 43 46889887533 34456788999999999 799999999999999999999999999
Q ss_pred CcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 321 NTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 321 gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 12478999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
+++....... ......+..|+|||++....++.++|||||||++|||++ |..||..... .. +... +..+
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~----~~~~-~~~~ 227 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE----LYEK-LPQG 227 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HH----HHHH-HhCC
Confidence 9864322111 111223567999999998899999999999999999997 9999854321 11 1111 1111
Q ss_pred CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 466 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 466 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.... ........+.+++.+||+.+|.+||++.+|+..|+..
T Consensus 228 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 YRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1100 1112234678999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.39 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=196.0
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||++... +++.||||++.... ......|.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999964 47789999986421 222345888999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++|+|.+++..... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFED-RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999976332 589999999999999999999998 99999999999999999999999999997654333
Q ss_pred cceeeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 396 THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
........||+.|+|||++. .+.++.++|||||||+||||++|+.||..... .. .......... .+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~-~~~~i~~~~~--~~ 227 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VE-TYGKIMNHKE--RF 227 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HH-HHHHHhCCCc--cc
Confidence 32333457999999999986 34688999999999999999999999964322 11 1111111110 00
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCC--CCCCHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSAR--RRPRISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~--~RPsm~evv~~ 511 (608)
.-+.. .......+.+++.+|+..+++ .|+++.|++++
T Consensus 228 ~~p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00000 112234566777777754443 47889998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=322.01 Aligned_cols=247 Identities=29% Similarity=0.473 Sum_probs=201.3
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...+.||+|+||.||++.. +++.||+|+++... ....+.+|+.++++++|+||+++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999985 67889999987543 345788999999999999999999998764 5799999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++.......+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999876655689999999999999999999998 99999999999999999999999999987643321
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
.....+..|+|||++.++.++.++|||||||++|||++ |+.||...... . +...+..+....
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~-----~~~~~~~~~~~~--------- 217 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---E-----VKECVEKGYRME--------- 217 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---H-----HHHHHhCCCCCC---------
Confidence 12234578999999998899999999999999999997 99998644321 1 111222221111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.+|++||++.+|+..|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112234567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.84 Aligned_cols=241 Identities=26% Similarity=0.374 Sum_probs=193.3
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ 315 (608)
+|...++||+|+||.||++.. .+|+.||||+++... ....+.+..|+.++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367789999999999999985 468899999987532 223355778899998885 577888999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++|+|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999987654 489999999999999999999998 89999999999999999999999999987543221
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.......|+..|+|||++.+..++.++|||||||+||||++|+.||..... .. .... +..+...
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~----~~~~-i~~~~~~------- 219 (323)
T cd05615 156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DE----LFQS-IMEHNVS------- 219 (323)
T ss_pred -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HH----HHHH-HHhCCCC-------
Confidence 122335689999999999998999999999999999999999999975432 11 1111 1122111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRI 505 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm 505 (608)
++......+.+++.+||+.+|.+|++.
T Consensus 220 ---~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 ---YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111223457889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.13 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=202.9
Q ss_pred cCCCcCCccccCCceEEEEEEe-----cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Cee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-----PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~ 311 (608)
+.|...++||+|+||.||++.+ .+++.||||.++... ......+.+|++++++++|+||++++++|... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999974 357889999997553 33446789999999999999999999998875 568
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+++++|.+++.... ..++|..++.++.+++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999986543 2589999999999999999999998 9999999999999999999999999999866
Q ss_pred cCcccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCccccc-------chhhHHHHHHHH
Q 046502 392 SDVYTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME-------DNLARPLLNRAI 462 (608)
Q Consensus 392 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~-------~~l~~~~~~~~~ 462 (608)
...... ......++..|+|||++.+..++.++|||||||++|||++++.+......... ...........+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 432211 11234467789999999888899999999999999999998776432111000 000000111112
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
..+.... ........+.+++.+||+.+|++||++.+|++.|+.
T Consensus 240 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 240 EEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 2221111 111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=323.34 Aligned_cols=265 Identities=29% Similarity=0.454 Sum_probs=198.9
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhc--CCCCccceeeEEEeCC----eeEEEEe
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV--HHKHLVSLVGYYTAGS----QRMLVCE 316 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l--~Hpniv~l~g~~~~~~----~~~lV~E 316 (608)
...++||+|.||.||||.+ +++.||||++.. +....|++|-+|.+.. +|+||++|+++-..+. +++||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 3446799999999999999 559999999974 4566788888887764 7999999999876665 8899999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC------HPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~------~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
|.+.|+|.++|..+ .++|....+|+..+++||+|||+.. .+.|+|||||.+||||..|+.+.|+|||||..
T Consensus 289 fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred eccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999999875 6999999999999999999999863 34699999999999999999999999999987
Q ss_pred ccCcccc-eeeeeecccCccChhhhhcCC-CC-----CcchhhhHHHHHHHHHhCCCCCCC--Ccc---cccchh-----
Q 046502 391 ASDVYTH-VSTRVMGTFGYLAPEYASSGK-LT-----EKSDVFSFGVMLLELIIGCRPVDS--THT---FMEDNL----- 453 (608)
Q Consensus 391 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~t-----~ksDVwS~Gvll~elltG~~p~~~--~~~---~~~~~l----- 453 (608)
+...... .....+||..|||||++.+.. +. .+.||||+|.|||||++....++. ... ..+..+
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 6543221 123378999999999996532 22 368999999999999998776642 111 011111
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcC-CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcccc
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEY-NHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLA 519 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~~~~ 519 (608)
...+...+..+.. .|.+.... ....+.-+.+.+..||+.|++.|.|+.=|-+++.....+.
T Consensus 446 ~e~mq~~VV~kK~-----RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 446 LEEMQELVVRKKQ-----RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HHHHHHHHHhhcc-----CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 0001111111111 12221111 1245667889999999999999999998888876554433
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=329.99 Aligned_cols=266 Identities=21% Similarity=0.297 Sum_probs=197.7
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||+|+.. +++.||||+++.... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999854 578899999875432 2334677899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+ +|..++...+ ..+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 986 7777765543 3588999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHH--------HHHHHhcCCCC
Q 046502 398 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL--------LNRAIEDGNFD 468 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~~~~ 468 (608)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||............... .........+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1223457899999999865 46899999999999999999999999754321110000000 00000000000
Q ss_pred cccCccccC----cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHN----EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+.... .........+.+++.+||+.||++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000 0001123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=316.59 Aligned_cols=251 Identities=23% Similarity=0.379 Sum_probs=206.6
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|+..++||+|+||.||.+.. .+++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999884 56889999998654 234456788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++.......+++..+..++.+++.+|.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999876455689999999999999999999998 899999999999999999999999999986654332
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......++..|+|||++.+..++.++||||||+++|||++|+.||+.... ...... +..+.+....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~-~~~~~~~~~~------ 222 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVK-IVQGNYTPVV------ 222 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHH-HHcCCCCCCc------
Confidence 22335689999999999888899999999999999999999999865332 111111 1223322211
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
......+.+++.+||+.+|++||++.++++++
T Consensus 223 ---~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 ---SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 22345678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=310.81 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=211.2
Q ss_pred HHHhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCc-----h---hHHHHHHHHHHHHhc-CCCCccceeeEE
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSG-----Q---GERVFQAEVEIISRV-HHKHLVSLVGYY 305 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-----~---~~~~~~~Ev~~l~~l-~Hpniv~l~g~~ 305 (608)
...-++|...+.||.|..+.|-++. ..+|+++|+|++..... . -.+.-..|+.||+++ .||||++|.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 4445678888999999999999887 46789999999854321 1 124566799999998 599999999999
Q ss_pred EeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 306 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
..+..+++|+|.|+.|.|.|+|..+. .++++...+|+.|+.+|++|||.+ +||||||||+|||+|++.++||+||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999997764 689999999999999999999999 9999999999999999999999999
Q ss_pred eccccccCcccceeeeeecccCccChhhhhcC------CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 046502 386 GLAKLASDVYTHVSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 386 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 459 (608)
|+++..... ......+||++|+|||.+... .|+...|+|++||++|.||.|..||...+. -++.
T Consensus 168 GFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------mlML 237 (411)
T KOG0599|consen 168 GFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------MLML 237 (411)
T ss_pred ceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HHHH
Confidence 999877653 234568999999999998543 578899999999999999999999954332 1345
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+.+|++. +-.+. ..+......+|+.+||+.||.+|-|..|++++
T Consensus 238 R~ImeGkyq-F~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 238 RMIMEGKYQ-FRSPE-----WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHhcccc-cCCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 666777763 22222 23445567889999999999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=323.36 Aligned_cols=255 Identities=23% Similarity=0.396 Sum_probs=204.3
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|.....||+|+||.||+|+.. +.+.|++|.+...... ....+.+|++++++++|+||++++++|.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999853 2467999998765443 3467899999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 313 LVCEFVTSNTLEFHLHGKGR-------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
+||||+++++|.+++..... ..++|..++.++.|++.||.|||+. +|+||||||+||||+.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999976541 2589999999999999999999998 8999999999999999999999999
Q ss_pred eccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhc
Q 046502 386 GLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIED 464 (608)
Q Consensus 386 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 464 (608)
|+++..............++..|++||.+.+..++.++|||||||++|+|++ |..||..... .. ++ .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~----~~-~~~~~ 233 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EE----VL-NRLQA 233 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HH----HH-HHHHc
Confidence 9987543221112223356778999999988889999999999999999998 7788854321 11 11 12222
Q ss_pred CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 465 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 465 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
+.+.... .......+.+++.+||+.+|.+||++.||+.+|.
T Consensus 234 ~~~~~~~--------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELPV--------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCCC--------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 3222111 1123356888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=316.69 Aligned_cols=238 Identities=28% Similarity=0.421 Sum_probs=190.9
Q ss_pred CccccCCceEEEEEEecCCc-----------EEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 246 NLLGQGGFGYVHKGVLPNGK-----------EVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++||+|+||.||+|.+.+.. .|++|.+...... ...|.+|+.++++++|+||++++++|.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999975433 5788887755433 6778899999999999999999999988 778999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-------ceEEEEeec
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-------EAKVADFGL 387 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-------~~kl~DFGl 387 (608)
|||+.+++|.+++..... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976543 689999999999999999999998 999999999999999887 799999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcC--CCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhc
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIED 464 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~ 464 (608)
++.... .....++..|+|||++... .++.++|||||||++|||++ |..||...... . .. ..+..
T Consensus 155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~----~~-~~~~~ 221 (259)
T cd05037 155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---E----KE-RFYQD 221 (259)
T ss_pred cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---h----HH-HHHhc
Confidence 986543 1223467789999999876 78999999999999999999 56676543211 0 00 01111
Q ss_pred CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 465 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 465 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
... +.. .....+.+++.+||..+|.+||++.+|++.|+
T Consensus 222 ~~~--~~~---------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHR--LPM---------PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC--CCC---------CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 110 000 01167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=333.18 Aligned_cols=252 Identities=26% Similarity=0.343 Sum_probs=212.2
Q ss_pred HhcCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCch---hHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQ---GERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~ 312 (608)
....|...+.||+|.||.||+++... |+.+|+|.+...... ....+.+|+.+|+++. |||||.|++.|+..+.++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34567788999999999999999654 999999999765433 3468899999999998 999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC----CceEEEEeecc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK----FEAKVADFGLA 388 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~----~~~kl~DFGla 388 (608)
+|||++.||.|.+.+... .+++.....++.|++.++.|||.. +|+||||||+|||+... +.+|++|||++
T Consensus 113 lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999998776 389999999999999999999998 99999999999999543 47999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
..... .......+||++|+|||++....|+..+||||+||++|.|++|..||...... .....+..+++
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--------~~~~~i~~~~~- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--------EIFLAILRGDF- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh--------HHHHHHHcCCC-
Confidence 98876 34556689999999999999999999999999999999999999999754321 11123445554
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
++ ...+.........+++..|+..||.+|+++.+++++
T Consensus 256 ~f-----~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DF-----TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CC-----CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11 122233445667789999999999999999999985
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.39 Aligned_cols=250 Identities=26% Similarity=0.445 Sum_probs=201.4
Q ss_pred CCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCc------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG------QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
+|...++||+|+||.||+|...+|+.+|||+++.... .....+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999999864321 2234688999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999997643 478999999999999999999998 8999999999999999999999999998754321
Q ss_pred -----ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 395 -----YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 395 -----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
.........|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ... ........+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~-~~~~~~~~~~~-- 227 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAA-MFYIGAHRGLM-- 227 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHH-HHHhhhccCCC--
Confidence 11122335689999999999988899999999999999999999999964322 100 11000000111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
+.+ .......+.+++.+||+.+|.+||++.||+.
T Consensus 228 ---~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 ---PRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 1223456788999999999999999999985
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=332.09 Aligned_cols=237 Identities=25% Similarity=0.367 Sum_probs=187.6
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHH-HHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEV-EIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev-~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|+. .+|+.||||++.... ......+..|+ .+++.++|+||++++++|.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999996 468899999986432 12233444555 467889999999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|..++.... .+.+..+..++.||++||.|||.. +|+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS 154 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence 99998886543 578888899999999999999998 89999999999999999999999999987543221 1233
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...|++.|+|||++.+..++.++|||||||+||||++|+.||..... . .+... +..+.. ..+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~----~~~~~-i~~~~~----------~~~ 216 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---S----QMYDN-ILHKPL----------QLP 216 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---H----HHHHH-HhcCCC----------CCC
Confidence 45789999999999988999999999999999999999999965421 1 11111 111111 111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRIS 506 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~ 506 (608)
......+.+++.+||+.||.+|++..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 22334678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.67 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=202.9
Q ss_pred cCCCcCCccccCCceEEEEEEecCC----cEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNG----KEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++||+|+||.||+|...+. ..||||...... ....+.|.+|+.++++++|+||++++++|.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577889999999999999985432 468999987654 4455678999999999999999999999875 567899
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++..... .++|..++.++.+++.||.|||+. +++||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999976443 589999999999999999999998 8999999999999999999999999999866543
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.........++..|+|||++....++.++|||||||++|||++ |..||...... . .+. .+..+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~----~~~-~~~~~~~~~---- 228 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---D----VIG-RIENGERLP---- 228 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---H----HHH-HHHcCCcCC----
Confidence 2222222334568999999988889999999999999999996 99998654321 1 111 122221111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. .......+.+++.+||..+|++||++.++++.|+..
T Consensus 229 -~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 229 -M----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred -C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 112234688899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.26 Aligned_cols=263 Identities=22% Similarity=0.300 Sum_probs=201.1
Q ss_pred cCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCC-ccceeeEEEeCC------
Q 046502 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKH-LVSLVGYYTAGS------ 309 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpn-iv~l~g~~~~~~------ 309 (608)
..|..+++||+|+||+||+|+ ..+|+.||+|+++..... ......+|+.+|++|+|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 445666789999999999999 557899999999865442 2234578999999999999 999999998877
Q ss_pred eeEEEEeeccCCcHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeec
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGR--PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL 387 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGl 387 (608)
.++|||||++ .+|..++..... ..++...+..++.||++||+|||++ +|+||||||.||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 7899999997 478888876543 3577788999999999999999999 999999999999999999999999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh---
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE--- 463 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--- 463 (608)
|+.+.-. ....+..++|.+|.|||++.+. .|+...||||+||+++||++++.-|..... .+.+.+-+ +.+-
T Consensus 167 Ara~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If--~~lGtP~ 241 (323)
T KOG0594|consen 167 ARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIF--RLLGTPN 241 (323)
T ss_pred HHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHH--HHcCCCC
Confidence 9965532 2235567789999999999876 799999999999999999999988875443 12121111 0110
Q ss_pred cCCCCccc---C--ccccC-----cCCH---HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 DGNFDTLV---D--PKLHN-----EYNH---NEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 ~~~~~~~~---d--~~l~~-----~~~~---~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+..+..+. | ..... .+.. .......+++.+||+.+|.+|.++...+.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 01111110 1 00000 0001 111367889999999999999999999976
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.62 Aligned_cols=249 Identities=27% Similarity=0.391 Sum_probs=204.3
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...+.||.|+||.||+|... +++.||||++.... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788899999999999999954 68899999987543 33446788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+++|.+++... .+++..++.++.|++.||.|||.. +|+||||+|+|||++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999998754 689999999999999999999998 899999999999999999999999999987654322
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......++..|++||++.+..++.++|||||||++|+|++|+.||...... ..+ ..+..+....+. .
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~-~~~~~~~~~~~~-----~ 220 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVL-FLIPKNNPPSLE-----G 220 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHH-HHhhhcCCCCCc-----c
Confidence 223356888999999999888999999999999999999999999654321 011 111122111111 1
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .....+.+++.+||..+|++||++.+|+++
T Consensus 221 ~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 N---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred c---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 033457889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=330.51 Aligned_cols=256 Identities=25% Similarity=0.406 Sum_probs=202.2
Q ss_pred cCCCcCCccccCCceEEEEEEec--------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP--------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGS 309 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~ 309 (608)
++|.+.++||+|+||.||++... ....||+|+++... ......+.+|+++++++ +|+||++++++|..++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56788899999999999999742 24578999987543 23345688999999999 6999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD 375 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~ 375 (608)
..++||||+.+++|.+++.... ...++|..+.+++.|++.||.|||+. +|+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 9999999999999999986532 23589999999999999999999998 999999999999999
Q ss_pred cCCceEEEEeeccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchh
Q 046502 376 FKFEAKVADFGLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNL 453 (608)
Q Consensus 376 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l 453 (608)
.++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||..... ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~- 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EE- 244 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HH-
Confidence 9999999999999866432111 1112234567999999998899999999999999999999 8888854321 11
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
+.. .+..+... .........+.+++.+||+.+|++||++.+|++.|+..
T Consensus 245 ---~~~-~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 245 ---LFK-LLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred ---HHH-HHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111 11222111 11122334677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=320.35 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=201.4
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
++|...++||+|+||.||+|.. .+++.||||+++.........+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677778999999999999985 468899999998665555567889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++...+ .+++.+++.++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||++........ .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA-K 162 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCccc-c
Confidence 9999999987654 589999999999999999999998 899999999999999999999999999876543221 2
Q ss_pred eeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 399 STRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||...... .. +. ......+. .+.+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--~~-----~~-~~~~~~~~---~~~~ 231 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RA-----LF-LMTKSNFQ---PPKL 231 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--hh-----HH-hhhccCCC---CCcc
Confidence 23356899999999984 456889999999999999999999998543321 00 00 01111111 1111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... ......+.+++.+||+.+|++||++.+|+++
T Consensus 232 ~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 KDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 110 0122457889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=318.64 Aligned_cols=249 Identities=25% Similarity=0.433 Sum_probs=200.3
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch---------hHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ---------GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~ 310 (608)
+|.....||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.++++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999985 45789999988654221 12468889999999999999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.++||||+++++|..++.... .+++..+..++.+++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999997643 588999999999999999999998 899999999999999999999999999986
Q ss_pred ccCcccc-----eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 391 ASDVYTH-----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 391 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
....... ......|+..|+|||++.++.++.++|||||||++|+|++|+.||..... . . .+.. +...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~-~-~~~~-~~~~ 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----L-Q-AIFK-IGEN 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----H-H-HHHH-Hhcc
Confidence 6532111 11224578899999999988899999999999999999999999975322 1 0 0111 1111
Q ss_pred CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .+ .........+.+++.+||+.+|.+||++.||+++
T Consensus 228 ~-----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 228 A-----SP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred C-----CC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 1 11 1122334567889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=326.75 Aligned_cols=195 Identities=23% Similarity=0.345 Sum_probs=160.0
Q ss_pred CCccccCCceEEEEEEec---CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEEEEeecc
Q 046502 245 ANLLGQGGFGYVHKGVLP---NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLVCEFVT 319 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~~lV~E~~~ 319 (608)
.++||+|+||.||+|... +++.||||++.... ....+.+|+.+|++++|+||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999987542 23456789999999999999999998854 456899999997
Q ss_pred CCcHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE----ccCCceEEEEeecc
Q 046502 320 SNTLEFHLHGK-------GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL----DFKFEAKVADFGLA 388 (608)
Q Consensus 320 ~gsL~~~l~~~-------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl----~~~~~~kl~DFGla 388 (608)
+ +|.+++... ....+++..+..|+.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 676665421 123588999999999999999999998 89999999999999 45678999999999
Q ss_pred ccccCcccc--eeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 046502 389 KLASDVYTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDST 445 (608)
Q Consensus 389 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~ 445 (608)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876543221 2234678999999999876 45899999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=313.97 Aligned_cols=251 Identities=30% Similarity=0.440 Sum_probs=203.4
Q ss_pred CCcCCccccCCceEEEEEEecC-----CcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 242 FSDANLLGQGGFGYVHKGVLPN-----GKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
|...+.||.|+||.||++...+ +..||+|+++..... ....+..|+.++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999644 378999999766543 5678899999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++.......+++..++.++.|++.||+|||+. +++|||||++|||++.++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765543389999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
........++..|+|||.+....++.++||||||+++|+|++ |+.||..... ..+. ..+..+.....
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~-~~~~~~~~~~~---- 225 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVL-EYLKKGYRLPK---- 225 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHH-HHHhcCCCCCC----
Confidence 211112336789999999988889999999999999999998 7888764221 1111 12222221111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
......++.+++.+||+.+|++||++.|+++.|
T Consensus 226 -----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 -----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 112345688899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=323.21 Aligned_cols=240 Identities=24% Similarity=0.384 Sum_probs=190.8
Q ss_pred CccccCCceEEEEEEecC--------CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 246 NLLGQGGFGYVHKGVLPN--------GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998532 234888988765555556788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc--------eEEEEeeccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE--------AKVADFGLAK 389 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~--------~kl~DFGla~ 389 (608)
+.+|+|..+++.... .++|..++.++.||+.||.|||+. +|+||||||+|||++.++. ++|+|||++.
T Consensus 81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 999999999976543 689999999999999999999998 9999999999999988765 5999999886
Q ss_pred cccCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCC-CCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGC-RPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
.... .....++..|+|||++.+. .++.++|||||||++|||++|. .|+....... .. .... ...
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-------~~-~~~~-~~~ 222 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KL-QFYE-DRH 222 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------HH-HHHH-ccc
Confidence 5432 1224578899999999764 5899999999999999999995 5554322110 00 0111 110
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.++......+.+++..||+.+|++||++.+|++.|+
T Consensus 223 ----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 ----------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111112245789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=315.11 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=202.5
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEe-CCeeEEEEe
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTA-GSQRMLVCE 316 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-~~~~~lV~E 316 (608)
+|...+.||+|+||.||++... +++.||||++.... ....+.+.+|++++++++|+||+++++.+.. +..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999954 57889999986543 2344568899999999999999999998764 446799999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+++++|.+++.......+++.+++.++.+++.||.|||+. +|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999865445689999999999999999999998 899999999999999999999999999986643222
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
......++..|+|||++.+..++.++|||||||++|+|++|+.||+.... .. ... .+..+.+..
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~~----~~~-~~~~~~~~~------- 221 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---NS----LVY-RIIEGKLPP------- 221 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HH----HHH-HHHhcCCCC-------
Confidence 22345688999999999999999999999999999999999999874321 11 111 112222211
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||+.+|++||++.+|+++
T Consensus 222 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 --MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 122334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=335.60 Aligned_cols=264 Identities=23% Similarity=0.311 Sum_probs=196.9
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS----- 309 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~----- 309 (608)
..++|...+.||+|+||.||++.. .+|+.||||++... .......+.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999985 45899999998643 2233456788999999999999999999986543
Q ss_pred -eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 310 -QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 310 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
..++||||+.++ |...++. .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 579999999864 5555542 378889999999999999999998 9999999999999999999999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc-hh-------hHHH---
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED-NL-------ARPL--- 457 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~-~l-------~~~~--- 457 (608)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........- .+ ...+
T Consensus 171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 754332 1223456899999999999999999999999999999999999999754321000 00 0000
Q ss_pred ----HHHHHh-cCCCC-----cccCccc---cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 458 ----LNRAIE-DGNFD-----TLVDPKL---HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 458 ----~~~~~~-~~~~~-----~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+..... ...+. ++...-+ ...........+.+++.+||+.||++||++.|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 00000 0000000 000111223457889999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=315.39 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=190.9
Q ss_pred CccccCCceEEEEEEecC---CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCC
Q 046502 246 NLLGQGGFGYVHKGVLPN---GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
+.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+.+++.++|+||++++++|...+..++||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468889876543 233467889999999999999999999999999999999999999
Q ss_pred cHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc-cc
Q 046502 322 TLEFHLHGKGR---PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY-TH 397 (608)
Q Consensus 322 sL~~~l~~~~~---~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~-~~ 397 (608)
+|.+++..... ...++...+.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 2357888899999999999999998 89999999999999999999999999987543211 11
Q ss_pred eeeeeecccCccChhhhhc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 398 VSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
......++..|+|||++.. ..++.++|||||||++|||++ |..||..... . ..+...+..+. ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~----~~~~~~~~~~~-~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---E----QVLKQVVREQD-IK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---H----HHHHHHhhccC-cc
Confidence 1122345678999999753 356889999999999999999 7778754322 1 11222222222 12
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
+.++.+... ....+.+++..|+ .||++||++.+|++.|.
T Consensus 230 ~~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 223332222 3345566778888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=319.15 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=205.6
Q ss_pred cCCCcCCccccCCceEEEEEEec-----CCcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEe--CCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-----NGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTA--GSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~ 311 (608)
+.|...+.||+|+||.||++.+. +++.||||+++..... ....|.+|++++++++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999853 3688999999865443 46789999999999999999999999987 5578
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+++++|.+++..... .++|..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999976543 589999999999999999999998 8999999999999999999999999999876
Q ss_pred cCcccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc-------hhhHHHHHHHH
Q 046502 392 SDVYTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED-------NLARPLLNRAI 462 (608)
Q Consensus 392 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~-------~l~~~~~~~~~ 462 (608)
...... ......++..|++||++....++.++||||||+++|||++|+.|+......... ......+...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 532111 111233456799999999889999999999999999999999997643221100 00011111112
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..+. ...........+.+++.+||+.+|++||+|.||+++|+..
T Consensus 240 ~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111 0011112336788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=323.91 Aligned_cols=247 Identities=27% Similarity=0.409 Sum_probs=200.5
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.|+..+.||+|+||.||+|.+ .+++.||||.+.... ....+.+.+|++++++++|+||++++++|..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 355667899999999999985 457889999987543 334467889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++... .+.+..+..++.++++||.|||+. +|+|+||+|+||++++++.+||+|||+++....... .
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06642 85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence 999999988642 589999999999999999999998 899999999999999999999999999976543221 1
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
.....++..|+|||++.+..++.++|||||||++|||++|+.|+....... .. ..+..+. .+ .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~-~~~~~~~-----~~----~ 220 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VL-FLIPKNS-----PP----T 220 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HH-hhhhcCC-----CC----C
Confidence 223457889999999998889999999999999999999999986432210 11 1111111 11 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||+.+|++||+|.+|+++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 122344568899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.15 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=191.9
Q ss_pred CccccCCceEEEEEEecCC---cEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCC
Q 046502 246 NLLGQGGFGYVHKGVLPNG---KEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
+.||+|+||.||+|...++ ..+++|.++... ....+.|.+|+.+++.++|+||++++++|......++||||++++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985443 346677776543 334568899999999999999999999999999999999999999
Q ss_pred cHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC-cccce
Q 046502 322 TLEFHLHGKG--RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD-VYTHV 398 (608)
Q Consensus 322 sL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~-~~~~~ 398 (608)
+|.++++... ...+.+..++.++.||++||.|||+. +|+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997642 23467778889999999999999998 899999999999999999999999999864321 11122
Q ss_pred eeeeecccCccChhhhhc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 399 STRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||..... . ..+...+.+ ....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~----~~~~~~~~~-~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---R----EVLNHVIKD-QQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---H----HHHHHHHhh-ccccc
Confidence 234567889999999853 245789999999999999997 4667754321 1 122222222 22334
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.++.+...+. .++.+++..|| .+|++||+|.||++.|-
T Consensus 230 ~~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 4444443333 45677888999 67999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=319.52 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=200.1
Q ss_pred CCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 242 FSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
|...+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|+||++++++|..++..++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456688999999999999964 4778899998766656667788999999999999999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|..++.... ..++|..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||++........ ...
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 161 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence 99998886533 3689999999999999999999998 999999999999999999999999999976543221 223
Q ss_pred eeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 401 RVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... .. ...... ......+..
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~-~~~~~~-~~~~~~~~~--- 230 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MR-VLLKIA-KSEPPTLAQ--- 230 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HH-HHHHHh-hcCCCCCCC---
Confidence 356899999999984 34578899999999999999999999864321 01 111111 111111111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+......+.+++.+||+.+|.+||++.+|+++
T Consensus 231 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 231 ----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223567889999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=334.90 Aligned_cols=253 Identities=27% Similarity=0.421 Sum_probs=209.8
Q ss_pred CCcCCccccCCceEEEEEEecC---Cc--EEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 242 FSDANLLGQGGFGYVHKGVLPN---GK--EVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~---g~--~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
....++||+|-||.||+|++.+ |+ .||||..+.+ .....+.|..|..+|++++|||||+|+|+|.+ ...||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 4456789999999999999533 33 5899999875 44456789999999999999999999999976 5689999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|+++.|.|..+|..+.. .|+......++.||+.+|+|||+. ++|||||.++||||...-.+||+||||++...+..
T Consensus 470 EL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred ecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999999987644 688889999999999999999999 99999999999999999999999999999887653
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHH-hCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.-..+...-...|||||.+.-.+++.++|||-|||.+||+| .|..||.+...... + ..+++|+
T Consensus 546 yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--I------~~iEnGe-------- 609 (974)
T KOG4257|consen 546 YYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--I------GHIENGE-------- 609 (974)
T ss_pred hhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--E------EEecCCC--------
Confidence 33333455678999999999999999999999999999998 59999976443110 0 1122222
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+--++.++...|..++.+||..+|.+||++.|+...|....
T Consensus 610 -RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 610 -RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred -CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 12245567788999999999999999999999999987543
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=322.22 Aligned_cols=252 Identities=24% Similarity=0.346 Sum_probs=202.5
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+.|.+.++||+|+||.||+|... +++.|++|++........+.+.+|+.++++++|+||++++++|..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888899999999999999964 58899999998776666778899999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|..++.... ..+++..++.++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 166 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-R 166 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc-c
Confidence 9999988876543 3589999999999999999999998 999999999999999999999999999875433211 1
Q ss_pred eeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 399 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.....++..|+|||++. ...++.++|||||||++|||++|+.||..... .. ..... .......+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~-~~~~~-~~~~~~~~~-- 236 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MR-VLLKI-AKSEPPTLS-- 236 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HH-HHHHH-hcCCCccCC--
Confidence 23356889999999984 34578899999999999999999999864321 01 11111 111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||+.+|++||++.+|+++
T Consensus 237 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 -----QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -----CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111233467889999999999999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=337.06 Aligned_cols=202 Identities=26% Similarity=0.371 Sum_probs=174.7
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||++.. .+++.||||+++... ......+.+|+.++.+++|+||+++++++.+++.++|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999985 468999999996432 223456788999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999987644 589999999999999999999998 99999999999999999999999999987543210
Q ss_pred c----------------------------------ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCC
Q 046502 396 T----------------------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441 (608)
Q Consensus 396 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p 441 (608)
. ......+||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 011235699999999999999999999999999999999999999
Q ss_pred CCCCc
Q 046502 442 VDSTH 446 (608)
Q Consensus 442 ~~~~~ 446 (608)
|....
T Consensus 236 f~~~~ 240 (360)
T cd05627 236 FCSET 240 (360)
T ss_pred CCCCC
Confidence 97543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=321.57 Aligned_cols=248 Identities=29% Similarity=0.463 Sum_probs=197.1
Q ss_pred CccccCCceEEEEEEecC-------CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 246 NLLGQGGFGYVHKGVLPN-------GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+.||+|+||.||+|...+ ++.||||.+.... ......|.+|++++++++|+||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998643 2579999886543 23456788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-----ceEEEEeec
Q 046502 318 VTSNTLEFHLHGK-----GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-----EAKVADFGL 387 (608)
Q Consensus 318 ~~~gsL~~~l~~~-----~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-----~~kl~DFGl 387 (608)
+++++|.+++... ....++|..++.++.+++.||.|||+. +|+|+||||+|||++.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998753 223478999999999999999999998 899999999999999887 899999999
Q ss_pred cccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 388 AKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 388 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
++...... ........++..|+|||++.++.++.++|||||||++|||++ |+.||...... .... .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~~~~-~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------EVLQ-HVTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------HHHH-HHhcC
Confidence 97553321 111222345788999999999999999999999999999998 99998643220 1111 11111
Q ss_pred CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 466 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 466 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.. ..........+.+++.+||+.+|.+||++.+|++.|+
T Consensus 230 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GR---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred Cc---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 10 0111223456789999999999999999999999986
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=321.79 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=204.5
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+++++.++|+||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4577788999999999999985 468899999886543 33456788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++...+ .+++..+..++.+++.+|.|||+.. +|+||||||+|||++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999887643 5899999999999999999999742 79999999999999999999999999987543321
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccch-h---hHHHHHHHHhcCCCCcccCc
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDN-L---ARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~-l---~~~~~~~~~~~~~~~~~~d~ 473 (608)
.....|+..|+|||++.++.++.++|||||||++|+|++|+.||+......... . ...++...+.. .. +
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----~ 231 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PP-----P 231 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cC-----C
Confidence 123568999999999988899999999999999999999999997543211100 0 01112111111 11 1
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.+.. ......+.+++.+||+.||++||++.||++++.
T Consensus 232 ~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 232 RLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1111 113456888999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=319.65 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=201.5
Q ss_pred CCCcCCccccCCceEEEEEEecC--CcEEEEEEcccC----------CchhHHHHHHHHHHHHh-cCCCCccceeeEEEe
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPN--GKEVAIKQLKAG----------SGQGERVFQAEVEIISR-VHHKHLVSLVGYYTA 307 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~Ev~~l~~-l~Hpniv~l~g~~~~ 307 (608)
+|+..+.||+|+||.||+|.... ++.+|||.+... .......+.+|+.++.+ ++|+||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999755 688999988532 12223457778888875 799999999999999
Q ss_pred CCeeEEEEeeccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 308 GSQRMLVCEFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 308 ~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
++..++||||+++++|.+++.. .....+++..+++++.|++.||.|||... +|+|+|||++|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 9999999999999999988754 22346899999999999999999999632 7999999999999999999999999
Q ss_pred eccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 386 GLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 386 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
|++....... ......|+..|++||++.++.++.++||||||+++|||++|+.||...... .....+.++
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~~~~~~ 228 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLATKIVEA 228 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHHHHhhc
Confidence 9998655432 233456899999999999888999999999999999999999998643221 011112222
Q ss_pred CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 466 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 466 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.+..... ......+.+++.+||+.||++||+|.||..+|+
T Consensus 229 ~~~~~~~--------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYEPLPE--------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCCcCCc--------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 2211111 112356788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=317.49 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=206.4
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
++|...+.||.|+||.||+|.. .+++.+++|++........+.+.+|++++++++|+||+++++++..++..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5788889999999999999985 457889999998765556678899999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+++|.+++.... ..+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 83 GGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 9999999887642 3589999999999999999999998 899999999999999999999999999986543221 1
Q ss_pred eeeeecccCccChhhhhcC---CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 399 STRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....++..|+|||++... .++.++|||||||++|||++|+.||....... . .. .+....+. ...+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~----~~--~~~~~~~~---~~~~ 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--A----LF--LISKSNFP---PPKL 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--H----HH--HHHhccCC---Cccc
Confidence 2335688899999999776 88999999999999999999999986543210 0 00 01111111 1111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.........+.+++.+||+.+|.+||++.+|+.+
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1122345678899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=320.99 Aligned_cols=269 Identities=20% Similarity=0.321 Sum_probs=203.2
Q ss_pred HHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEccc--CCchhHHHHHHHHHHHHhcCCCCccceeeEEEe---
Q 046502 234 ELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKA--GSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA--- 307 (608)
Q Consensus 234 el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~--~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--- 307 (608)
+.......|...+.||+|+||.|+.+.. .+|+.||||++.. ......+...+|+.+|++++|+||+.+++.+..
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 3444556777789999999999999984 5689999999972 333444566789999999999999999998764
Q ss_pred --CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 308 --GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 308 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
.+.+|+|+|+| +.+|...++... .|+......++.|+++||.|+|+. +|+||||||+|+|++.+..+||+||
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 45789999999 468888887653 488899999999999999999999 9999999999999999999999999
Q ss_pred eccccccCc-ccceeeeeecccCccChhhhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHH-------
Q 046502 386 GLAKLASDV-YTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARP------- 456 (608)
Q Consensus 386 Gla~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~------- 456 (608)
|||+..... .....+..+.|.+|.|||++. ...|+.+.||||.||+|.|||+|+.-|.+.+....-.+...
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 999977432 122346678899999999875 45799999999999999999999999876553211111000
Q ss_pred -HHH--------HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 457 -LLN--------RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 457 -~~~--------~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+. ..++ .+.......+...+. ..-...++|+.+||..||.+|.|+.|.+++
T Consensus 250 e~l~~i~s~~ar~yi~--slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIK--SLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHhccHHHHHHHH--hCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 0111 000000001111111 222346789999999999999999999975
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=324.11 Aligned_cols=263 Identities=26% Similarity=0.404 Sum_probs=205.5
Q ss_pred cCHHHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEE-
Q 046502 230 FTYEELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYT- 306 (608)
Q Consensus 230 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~- 306 (608)
+.++.+..+.++|...+.||+|+||.||++.. .+++.||||+++... .....+.+|+.++.++ +|+||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 45567778889999999999999999999985 457899999986532 2345678899999999 6999999999884
Q ss_pred ----eCCeeEEEEeeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 307 ----AGSQRMLVCEFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 307 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
.++..++||||+++++|.++++.. ....+++..+..++.|+++||.|||.. +|+|||||++|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 345689999999999999887642 234688999999999999999999998 89999999999999999999
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR 455 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~ 455 (608)
||+|||+++....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... .
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~------~ 236 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM------R 236 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh------H
Confidence 9999999986543221 1223468999999999853 45788999999999999999999998654321 0
Q ss_pred HHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 456 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 456 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
.+. . +..+....+.++. .....+.+++.+||+.+|++||++.||++++
T Consensus 237 ~~~-~-~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 237 ALF-K-IPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred HHh-h-ccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 011 0 1111111111111 1234588899999999999999999999764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=318.27 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=193.0
Q ss_pred CccccCCceEEEEEEecC----CcEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEE-eCCeeEEEEeecc
Q 046502 246 NLLGQGGFGYVHKGVLPN----GKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYT-AGSQRMLVCEFVT 319 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~-~~~~~~lV~E~~~ 319 (608)
++||+|+||.||+|.+.+ +..||||++... .....+.+.+|+.+++.++|+||++++++|. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 469999999999998532 357999998643 3344567889999999999999999999876 4556899999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc---
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT--- 396 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~--- 396 (608)
+++|.+++..... .+.+..++.++.+++.||.|||+. +|+|||||++|||++.++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 9999999976433 467888899999999999999998 899999999999999999999999999975543211
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIG-CRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.......++..|+|||++....++.++|||||||++|||++| ..||..... . .+... +..+.....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~----~~~~~-~~~~~~~~~----- 223 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---F----DITVY-LLQGRRLLQ----- 223 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---H----HHHHH-HhcCCCCCC-----
Confidence 011233457789999999888999999999999999999995 455543221 1 11111 222211100
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.......+.+++..||+.+|++||++.+|++.|+..
T Consensus 224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111234688999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.87 Aligned_cols=252 Identities=22% Similarity=0.282 Sum_probs=202.0
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCch---hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQ---GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||++... +++.||||.+...... ..+.+.+|++++++++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888899999999999999964 4899999999765332 3456889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+++|.+++.......+++..+..++.|+++||.|||.. +|+||||||+||||+.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998865555789999999999999999999998 89999999999999999999999999987543211
Q ss_pred cc----------------------------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc
Q 046502 396 TH----------------------------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHT 447 (608)
Q Consensus 396 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~ 447 (608)
.. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 00 11124688999999999988899999999999999999999999964432
Q ss_pred cccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 046502 448 FMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR----ISQIVR 510 (608)
Q Consensus 448 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs----m~evv~ 510 (608)
.. .+ .... ..... + .........+.+++.+||+.+|++||+ +.||+.
T Consensus 238 --~~----~~-~~~~-~~~~~------~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 --DE----TF-SNIL-KKEVT------F--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred --HH----HH-HHHh-cCCcc------C--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 11 1111 11110 0 001114567889999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.53 Aligned_cols=265 Identities=23% Similarity=0.335 Sum_probs=203.9
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|...++||+|+||.||+|... +++.||||+++... ......+.+|++++++++|+||++++++|..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999964 58899999987532 2334678899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|++++.|..++... ..+++..++.++.+|+.||.|||+. +|+||||+++||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99998887666543 2489999999999999999999998 899999999999999999999999999987655433
Q ss_pred ceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH--H--------HHHHHHhcC
Q 046502 397 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR--P--------LLNRAIEDG 465 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~--~--------~~~~~~~~~ 465 (608)
.......++..|+|||++... .++.++||||||++||+|++|+.||...... +.+.. . .......+.
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI--DQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHhhhcccCc
Confidence 233446688999999999888 8899999999999999999999998643221 11100 0 000000000
Q ss_pred CCC-----cccCcc-ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 NFD-----TLVDPK-LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~~~-----~~~d~~-l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+. ...+.. +...+.......+.+++.+||+.+|++||++.+|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 010 000000 0011222235678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=324.38 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=200.7
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|...++||+|+||.||+|... +++.||+|++..... ...+.+.+|++++++++|+||++++++|..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999975 589999999864322 234568889999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|++++.|..+..... .++|..++.++.||++||.|||+. +|+||||+++||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999988776543 489999999999999999999998 89999999999999999999999999998654432
Q ss_pred ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC-------
Q 046502 397 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD------- 468 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------- 468 (608)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.+|...... +.+ .... .+. +.+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~--~~~-~~~~-~~~--~~~~~~~~~~~ 228 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI--DQL-YHII-KCL--GNLIPRHQEIF 228 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH--HHH-HHHH-HHh--CCCchhhHHHh
Confidence 22233567899999999875 45788999999999999999999998644321 110 0000 000 0000
Q ss_pred -------cccCccccC-----cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 -------TLVDPKLHN-----EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 -------~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+..+.... .........+.+++.+||+.+|++||+|.+|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000 0011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.41 Aligned_cols=197 Identities=29% Similarity=0.364 Sum_probs=173.8
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-C-----CCccceeeEEEeCCeeEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-H-----KHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-H-----pniv~l~g~~~~~~~~~l 313 (608)
+|.+.++||+|.||.|.+|++ .+++.||||++++... ..++-+.||.+|.+|+ | -|+|++++||...+++||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788899999999999999994 5699999999987543 3345567999999997 4 389999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC--CceEEEEeeccccc
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK--FEAKVADFGLAKLA 391 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~--~~~kl~DFGla~~~ 391 (608)
|+|.+. .+|.++|..+....|+...++.|+.||+.||.+||+. +|||+||||+||||.+- .++||+|||.+...
T Consensus 266 VfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999996 5899999998888899999999999999999999998 99999999999999654 36999999999877
Q ss_pred cCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~ 446 (608)
... .. ..+.+..|+|||++.+.+|+.+.||||||||+.||++|.+-|....
T Consensus 342 ~q~---vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 342 SQR---VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred CCc---ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 652 22 4667899999999999999999999999999999999988776544
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=358.19 Aligned_cols=257 Identities=20% Similarity=0.298 Sum_probs=200.9
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|... +|+.||||+++... ....+.|.+|++++++++||||++++++|.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999954 58999999997542 223457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 316 EFVTSNTLEFHLHGKG---------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
||+++++|.+++.... ...+++..++.|+.||++||+|||+. +|+||||||+||||+.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 12467788899999999999999998 99999999999999999999999999
Q ss_pred ccccccCccc-----------------ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccc
Q 046502 387 LAKLASDVYT-----------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM 449 (608)
Q Consensus 387 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~ 449 (608)
+++....... ......+||+.|||||++.+..++.++|||||||++|||++|+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9986521100 0112356999999999999999999999999999999999999999653220
Q ss_pred cchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhc
Q 046502 450 EDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-RISQIVRTLEG 514 (608)
Q Consensus 450 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-sm~evv~~L~~ 514 (608)
.. .... . +.++.-.. ........+.+++.+||+.||++|+ ++.++++.|+.
T Consensus 238 --ki---~~~~-----~---i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 238 --KI---SYRD-----V---ILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred --hh---hhhh-----h---ccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 0000 0 00100000 0012234577899999999999996 56667776654
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=314.59 Aligned_cols=250 Identities=21% Similarity=0.373 Sum_probs=204.6
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|+..++||+|+||.||++.. .+|+.||||++... .......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999985 46899999998643 233445788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+++|.+++.......+++..+++++.|++.||.|||+. +++|+||+++|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999998765544689999999999999999999998 899999999999999999999999999986544221
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......|+..|+|||++.++.++.++|||||||++|+|++|+.||..... .......+ .+.....
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~-~~~~~~~------- 221 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKII-RGSYPPV------- 221 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHh-cCCCCCC-------
Confidence 12234588899999999988999999999999999999999999864322 11111111 2222111
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++.+||+.+|.+||+|.+|+++
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 222 --SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 12234568889999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=333.56 Aligned_cols=264 Identities=23% Similarity=0.305 Sum_probs=197.5
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeC------
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG------ 308 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~------ 308 (608)
..++|...++||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 357899999999999999999985 458899999997532 23345677899999999999999999987543
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
...++||||+.+ +|..++.. .+++..+..++.|+++||.|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999986 56666542 478899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchh-h-------------
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL-A------------- 454 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l-~------------- 454 (608)
+...... ......|+..|+|||++.+..++.++|||||||+||||++|+.||........... .
T Consensus 174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 8654321 22335689999999999999999999999999999999999999975432110000 0
Q ss_pred -HHHHHHHHhc-CCCC-----cccCccc---cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 455 -RPLLNRAIED-GNFD-----TLVDPKL---HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 455 -~~~~~~~~~~-~~~~-----~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+....++ ..+. .+....+ ...........+.+++.+||+.||.+||++.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000 0000 0000000 001111123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=337.21 Aligned_cols=260 Identities=21% Similarity=0.249 Sum_probs=196.9
Q ss_pred cCCCcCCccccCCceEEEEEEec---CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP---NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.+|...+.||+|+||.||++... .++.||||.+... ..+.+|+++|++++|+|||++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 57899999999999999999743 3578999988643 234679999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+. ++|..++... ..++|..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 167 ~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 167 KYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 997 5777777433 3689999999999999999999998 899999999999999999999999999976543221
Q ss_pred -ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC--cc---
Q 046502 397 -HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD--TL--- 470 (608)
Q Consensus 397 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~--- 470 (608)
.......||..|+|||++....++.++|||||||+||||++|+.||............+..+. .+...... ..
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQNGST 319 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCccch
Confidence 222346799999999999999999999999999999999999999865432111111111111 00000000 00
Q ss_pred --------cCccccCcCC-------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 --------VDPKLHNEYN-------HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 --------~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+....+..+. ......+.+++..||+.||++||++.|++.+
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 0112356788999999999999999999976
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=327.12 Aligned_cols=250 Identities=21% Similarity=0.373 Sum_probs=204.7
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.+|+..+.||.|+||.||+|.. .+|+.|+||.+........+.+.+|+.+++.++|+||++++++|..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999984 578999999997665555677889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+++|..++... .++|.++..++.+++.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 171 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K 171 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence 999999988643 489999999999999999999999 999999999999999999999999999876543221 1
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||....... . +..... .....+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--~-----~~~~~~-~~~~~~~------- 236 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--A-----LYLIAT-NGTPELQ------- 236 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H-----HHHHHh-cCCcccC-------
Confidence 223468899999999998889999999999999999999999997543211 0 111111 1111111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||+.+|.+||++.+|+.+
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111223457789999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=319.66 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=201.2
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|+..++||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+||++++++|......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999965 58999999986432 2234567899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|++++.|..++.... .++|..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999988775433 589999999999999999999998 999999999999999999999999999987654321
Q ss_pred ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHH-------HHHHhcCCC-
Q 046502 397 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLL-------NRAIEDGNF- 467 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~-------~~~~~~~~~- 467 (608)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...............+ ...+..+.+
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF 234 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence 1223457889999999876 457899999999999999999999997543211100000000 000000000
Q ss_pred CcccCccccCcCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DTLVDPKLHNEYN-----HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+..+....... ......+.+++.+||+.+|++||++.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0111111100000 1123568899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=318.27 Aligned_cols=250 Identities=24% Similarity=0.402 Sum_probs=195.1
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-----chhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-----GQGERVFQAEVEIISRVHHKHLVSLVGYYTA--GSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~ 311 (608)
.+|...++||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++|+||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4788899999999999999985 458999999986432 1233568889999999999999999998875 3578
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
+++|||+++++|.+++.... .+++..++.++.|++.||.|||+. +|+|||||++|||++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999987644 488999999999999999999988 8999999999999999999999999999765
Q ss_pred cCcc--cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 392 SDVY--THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 392 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
.... ........++..|+|||++.+..++.++|||||||++|||++|+.||...... . .+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~-~~~~~~~~~---- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------A-AIFKIATQP---- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------H-HHHHHhcCC----
Confidence 3211 11112345889999999999888999999999999999999999999643220 0 111111111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+. ++......+.+++ .||..+|++||+|.||+++
T Consensus 226 -~~~~----~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 -TNPQ----LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -CCCC----CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0111 1222223344455 6888999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.65 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=201.8
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-----chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-----GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
+|...+.||+|+||.||+|... +++.|+||.+.... ....+.+.+|+.++++++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677789999999999999975 78999999986533 22446788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++.... .+++..+..++.+++.||.|||.. +|+|+||+++||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999987653 488999999999999999999998 8999999999999999999999999998865442
Q ss_pred ccceeeeeecccCccChhhhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
. ......++..|++||.+.... ++.++|||||||++|+|++|+.||+.... ...+...........
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~---- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPP---- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCCC----
Confidence 2 223456889999999997776 89999999999999999999999865431 111111111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||+.+|.+||++.+++++
T Consensus 223 -----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 -----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111233567789999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=331.22 Aligned_cols=261 Identities=20% Similarity=0.327 Sum_probs=196.2
Q ss_pred HHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeC----
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG---- 308 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~---- 308 (608)
....++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+|++++|+||++++++|...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34567899999999999999999985 567899999987532 22335577899999999999999999987543
Q ss_pred --CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 309 --SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 309 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
...++++|++ +++|.+++... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCc
Confidence 3568999988 67888877542 589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH-----
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR----- 460 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~----- 460 (608)
+++..... .....|+..|+|||++.+ ..++.++|||||||+||||++|+.||...... +.+ ..+...
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~-~~~~~~~~~~~ 236 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQL-KRIMEVVGTPS 236 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHH-HHHHHHhCCCC
Confidence 99865432 233568999999999876 56899999999999999999999999654321 100 000000
Q ss_pred -----HHhcC-------CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 -----AIEDG-------NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 -----~~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+... .+.......+...+ ......+.+++.+||+.||++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 00000000000000 0112246789999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=320.21 Aligned_cols=262 Identities=22% Similarity=0.292 Sum_probs=197.0
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999964 68999999986532 22345688899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 318 VTSNTLEFHLHGKG-RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
+. ++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 98 57877776532 24689999999999999999999998 99999999999999999999999999997654321
Q ss_pred ceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH-------H----hc
Q 046502 397 HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRA-------I----ED 464 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~-------~----~~ 464 (608)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||...... +.+.. .+... + ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFR-IFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-HHHHhCCCChhhhhcchhh
Confidence 122334578899999988654 5788999999999999999999999754321 11100 00000 0 00
Q ss_pred C----CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 465 G----NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 465 ~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .+.......+ .........++.+++.+||+.||.+||++.+|+.+
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0 0000000000 00011123456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=341.25 Aligned_cols=246 Identities=27% Similarity=0.405 Sum_probs=203.9
Q ss_pred CCccccCCceEEEEEEecC--Cc--EEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 245 ANLLGQGGFGYVHKGVLPN--GK--EVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~--g~--~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
.++||+|.||.|++|.+.. |+ .||||.++.+... ....|.+|+.+|-+|+|+|+|+|||+..+ ...+||||+++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 4789999999999999743 54 5899999987655 56789999999999999999999999877 77899999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc--cc
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY--TH 397 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~--~~ 397 (608)
.|+|.+.|+...+..|-......++.|||.||.||..+ ++|||||.++||||-....+||+||||.+.+.... ..
T Consensus 194 lGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yv 270 (1039)
T KOG0199|consen 194 LGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYV 270 (1039)
T ss_pred cchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceE
Confidence 99999999986666788889999999999999999999 99999999999999999999999999999775432 22
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
+.....-.+.|+|||.+..+.++.++|||+|||.||||++ |..||-.... .+++. .+++|. +
T Consensus 271 m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------~qIL~-~iD~~e---------r 333 (1039)
T KOG0199|consen 271 MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------IQILK-NIDAGE---------R 333 (1039)
T ss_pred ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------HHHHH-hccccc---------c
Confidence 2223345789999999999999999999999999999996 7778755432 11222 222211 1
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
-.-+..+.++++++++.||..+|.+||++..|++.
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 12345678899999999999999999999999844
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=317.60 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=203.5
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.|+..++||.|+||.||+|... +++.||||++.... ......+.+|+.++++++|+||++++++|.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4667789999999999999964 58899999987543 344567889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++... .+++.....++.+++.||.|||.. +++|+||+|+|||++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-c
Confidence 999999998643 488899999999999999999998 999999999999999999999999999976544221 2
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
.....++..|+|||++.+..++.++|||||||++|||++|..||....... .. ..+..+. ...
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~-~~~~~~~---------~~~ 220 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-------VL-FLIPKNN---------PPT 220 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-------Hh-hhhhcCC---------CCC
Confidence 233467889999999998889999999999999999999999986433210 01 0111111 122
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++..||+.+|++||++.+|+.+
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 333456678899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.09 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=203.0
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...+.||+|+||.||++.. .+++.+|||++.... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999985 468899999986542 33456788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEeeccccccCccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFGla~~~~~~~~ 396 (608)
+++++|.+++.......+++..+++++.+++++|.|||++ +|+|||||++|||++.+ +.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999876555689999999999999999999998 99999999999999865 468999999998665421
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
......++..|+|||++.+..++.++|||||||++|+|++|+.||+.... .. ..... ..+....+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~----~~~~~-~~~~~~~~~----- 222 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PA----LVLKI-MSGTFAPIS----- 222 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HH----HHHHH-HhcCCCCCC-----
Confidence 12235688999999999988899999999999999999999999865432 11 11111 112222111
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+.+++..||+.+|++||++.||+.+
T Consensus 223 ----~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 223 ----DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ----CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1233457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=321.91 Aligned_cols=259 Identities=25% Similarity=0.402 Sum_probs=204.2
Q ss_pred CHHHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEe-
Q 046502 231 TYEELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTA- 307 (608)
Q Consensus 231 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~- 307 (608)
+..++....+.|...++||.|+||.||+|.. .+++.||+|++.... .....+..|+.++.++ +|+||++++++|..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4556666778899999999999999999995 568899999986543 2345678899999998 69999999999853
Q ss_pred -----CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEE
Q 046502 308 -----GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382 (608)
Q Consensus 308 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl 382 (608)
++..++||||+.+++|.+++.......+++..++.++.||+.||.|||+. +|+|||||++|||++.++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 46789999999999999998765555688999999999999999999998 8999999999999999999999
Q ss_pred EEeeccccccCcccceeeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHH
Q 046502 383 ADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL 457 (608)
Q Consensus 383 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 457 (608)
+|||+++....... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ .
T Consensus 163 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~------~ 235 (282)
T cd06636 163 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA------L 235 (282)
T ss_pred eeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh------h
Confidence 99999876543211 123356899999999985 34688899999999999999999999964332100 0
Q ss_pred HHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 458 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 458 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
... .... ...+. .......+.+++.+||+.||.+||++.||++
T Consensus 236 -~~~-~~~~-----~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -FLI-PRNP-----PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hhH-hhCC-----CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 0010 11111 1123356888999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=330.79 Aligned_cols=257 Identities=26% Similarity=0.389 Sum_probs=202.9
Q ss_pred cCCCcCCccccCCceEEEEEEecC--------CcEEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN--------GKEVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGS 309 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~ 309 (608)
.+|...+.||+|+||.||++.... +..||+|.++... ....+.+.+|++++.++ +|+||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 357888999999999999997421 2368999987543 33456788999999999 7999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD 375 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~ 375 (608)
..++||||+.+++|.+++.... ...+.|..++.++.|++.||.|||+. +|+||||||+||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999987532 23588999999999999999999998 999999999999999
Q ss_pred cCCceEEEEeeccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchh
Q 046502 376 FKFEAKVADFGLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNL 453 (608)
Q Consensus 376 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l 453 (608)
.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |..||..... +.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~- 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EE- 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH---HH-
Confidence 9999999999999865432111 1122234567999999999999999999999999999998 8888864321 11
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+.. .+..+.... ........+.+++.+||+.+|++||+|.||++.|+...
T Consensus 245 ---~~~-~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 245 ---LFK-LLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ---HHH-HHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 111 122221111 11123346888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.81 Aligned_cols=254 Identities=24% Similarity=0.438 Sum_probs=200.1
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc----------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG----------QGERVFQAEVEIISRVHHKHLVSLVGYYTAGS 309 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~----------~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~ 309 (608)
+|...+.||+|+||.||+|.. .+|+.||||.++.... ...+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999984 4689999998853211 11245788999999999999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
..++||||+++++|.+++...+ .+++..+..++.|++.||.|||+. +++||||+++||+++.++.+||+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999997653 589999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcccc-eeeeeecccCccChhhhhcCC--CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC
Q 046502 390 LASDVYTH-VSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466 (608)
Q Consensus 390 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 466 (608)
........ ......|+..|+|||++.... ++.++||||||+++|||++|..||..... ... +. ... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~-~~-~~~-~~~ 228 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAA-MF-KLG-NKR 228 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHH-HH-Hhh-ccc
Confidence 65432221 123356889999999987655 88999999999999999999999864322 100 11 111 111
Q ss_pred CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 467 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+.. .........+.+++..||+.+|++||+|.+|+++
T Consensus 229 ~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 1111111 1112234578889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.51 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=211.0
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
|.++++||+|.||.|||+.. ..|+.+|||++..+. +.+++..|+.||+++..+++|++||.|-....+|+|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 55678899999999999984 569999999998653 456788999999999999999999999889999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
|++.++++-+++ .|.+..+..|+...++||+|||.. +-||||||+.||||+.+|.+||+|||.|..+.+..... .
T Consensus 113 GSiSDI~R~R~K-~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR-N 187 (502)
T KOG0574|consen 113 GSISDIMRARRK-PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR-N 187 (502)
T ss_pred CcHHHHHHHhcC-CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh-C
Confidence 999999986654 799999999999999999999998 78999999999999999999999999998776654433 3
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
.+.||+.|||||++..-.|+.++||||||+...||..|++||...++.... |..-..+.-.-..+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI---------------FMIPT~PPPTF~KP 252 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI---------------FMIPTKPPPTFKKP 252 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee---------------EeccCCCCCCCCCh
Confidence 478999999999999999999999999999999999999999877652111 11111111112334
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.....+-++++.||-..|++|-++-+++++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 5667789999999999999999999998876
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=317.05 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=203.8
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
++|.+.+.||.|+||.||++.. .+++.||+|++........+.|.+|++++++++|+||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 5688889999999999999996 468899999998766666678899999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++..... .+++..++.++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++........ .
T Consensus 85 ~~~~L~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 85 DGGALDSIMLELER-GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred CCCcHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 99999999876433 589999999999999999999999 899999999999999999999999999876543222 2
Q ss_pred eeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 399 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.....++..|++||++. ...++.++|||||||++|||++|+.||...... . .+.. +..+....+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~-~~~~-~~~~~~~~~~~- 230 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------R-VLLK-ILKSEPPTLDQ- 230 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------H-HHHH-HhcCCCCCcCC-
Confidence 23356899999999985 334678999999999999999999998653221 1 1111 11221111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++..||+.+|.+||++.+|+++
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 231 ------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11223457789999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=319.42 Aligned_cols=254 Identities=27% Similarity=0.405 Sum_probs=202.7
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCc----EEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGK----EVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
.+|...++||+|+||.||+|.+. +|+ .||+|.+..... .....+.+|+.++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45778899999999999999853 333 589999876543 344678899999999999999999999987 78899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 9999999999999976543 489999999999999999999998 999999999999999999999999999987653
Q ss_pred ccccee-eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYTHVS-TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
...... ....++..|++||.+....++.++|||||||++|||++ |+.||+.... .. +...+..+.. +.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~-----~~~~~~~~~~--~~ 231 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VE-----IPDLLEKGER--LP 231 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HH-----HHHHHhCCCC--CC
Confidence 222111 11223568999999988899999999999999999998 9999875432 11 1122222211 10
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. +......+.+++.+||..+|.+||++.++++.|+..
T Consensus 232 ~-------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 232 Q-------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1 111224577899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=324.60 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=199.7
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCc----EEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGK----EVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~----~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...+.||+|+||.||+|.+ .+|+ .||+|.+..... .....+.+|+.++++++|+||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4677889999999999999985 3444 479998875533 2344688999999999999999999998754 5789
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
|+||+++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD-NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 9999999999999876432 589999999999999999999998 999999999999999999999999999986643
Q ss_pred cccce-eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYTHV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
..... .....++..|++||++.+..++.++|||||||++|||++ |+.||..... .. +...+..+.. +.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---~~-----~~~~~~~~~~--~~ 231 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---RE-----IPDLLEKGER--LP 231 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HH-----HHHHHHCCCC--CC
Confidence 22211 122345678999999998899999999999999999997 8999864321 11 1111222211 10
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. .......+.+++..||..+|++||+|.+|++.|+..
T Consensus 232 ~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 232 Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 111234678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.53 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=205.7
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|+..+.||.|+||.||+|.. .++..+++|++.... ......+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4788899999999999999995 467899999986543 23456789999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 318 VTSNTLEFHLHGKGR-PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
+++++|.+++..... ..+++.....++.|++.||.|||+. +|+|||||++||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976432 4689999999999999999999998 899999999999999999999999999876544222
Q ss_pred c---eeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 397 H---VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 397 ~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
. ......|+..|++||++... .++.++|||||||++|||++|+.||...... . .+...+.. ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~-----~~~~~~~~-~~----- 224 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--K-----VLMLTLQN-DP----- 224 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--h-----hHHHHhcC-CC-----
Confidence 1 22335689999999999877 7899999999999999999999999654321 0 11111111 11
Q ss_pred ccccCcC-CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEY-NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+.... .......+.+++..||+.||++||++.+|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111111 12334667899999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=323.56 Aligned_cols=266 Identities=20% Similarity=0.299 Sum_probs=198.3
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999854 57899999987543 22334677899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+. ++|..++.... ..+++..+..++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 98 57888776543 3588999999999999999999998 999999999999999999999999999976433211
Q ss_pred eeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH--------HHHHHHHhcCCCC
Q 046502 398 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR--------PLLNRAIEDGNFD 468 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~~~~~ 468 (608)
......++..|+|||++.+. .++.++|||||||++|||++|+.||............. ......+....+.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 12234578899999998654 57889999999999999999999997543210000000 0000000111111
Q ss_pred cccCccccCc----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNE----YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+....+ ........+.+++.+||+.||.+||++.||+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1101111110 011223457789999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=319.80 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=200.8
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|+..+.||+|+||.||++... +|+.||+|.++.. .......+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999964 6899999998754 223346788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 318 VTSNTLEFHLHGKG-RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
+++++|..++.... ...+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 99999998887532 236899999999999999999999743 79999999999999999999999999997654321
Q ss_pred ceeeeeecccCccChhhhhcCC------CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~------~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
.....++..|+|||++.+.. ++.++|||||||++|||++|+.||..... ..... .+ ..+..+....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~-~~-~~~~~~~~~~- 229 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFA-QL-SAIVDGDPPT- 229 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHH-HH-HHHhhcCCCC-
Confidence 22345788999999985543 58899999999999999999999964321 11110 01 1111222111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||+.+|++||++.+++.+
T Consensus 230 --------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 --------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --------CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 122345667889999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=321.70 Aligned_cols=263 Identities=25% Similarity=0.366 Sum_probs=207.0
Q ss_pred ccCHHHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEE
Q 046502 229 TFTYEELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYT 306 (608)
Q Consensus 229 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~ 306 (608)
.++..++..++++|...+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++.++ +|+||++++++|.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 456677888899999999999999999999996 568899999986543 2345677899999999 7999999999987
Q ss_pred eC-----CeeEEEEeeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc
Q 046502 307 AG-----SQRMLVCEFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE 379 (608)
Q Consensus 307 ~~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~ 379 (608)
.. +..++||||+++++|.++++.. ....+.|..++.++.|++.||.|||+. +|+|||||++|||++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 53 3589999999999999988642 234689999999999999999999998 8999999999999999999
Q ss_pred eEEEEeeccccccCcccceeeeeecccCccChhhhhcCC-----CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhh
Q 046502 380 AKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK-----LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLA 454 (608)
Q Consensus 380 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~ 454 (608)
+||+|||+++....... ......|+..|+|||++.... ++.++|||||||++|||++|+.||...... ..
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~-- 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KT-- 241 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HH--
Confidence 99999999886543221 122346889999999986443 688999999999999999999998643221 11
Q ss_pred HHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 455 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 455 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.. +..+....+.+ .......+.+++.+||+.+|++||++.|++++
T Consensus 242 ---~~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 ---LFK-IPRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---HHH-HhcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 11122211111 11233468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=319.03 Aligned_cols=262 Identities=23% Similarity=0.295 Sum_probs=200.5
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCch-----hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQ-----GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
+|...++||+|+||.||+|... +|+.||||+++..... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999954 6899999999765432 245577899999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+ +++|..++.... ..+++..++.++.||++||.|||.. +|+|||||++|||++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999997654 3689999999999999999999998 8999999999999999999999999999876543
Q ss_pred ccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH-------H-hcC
Q 046502 395 YTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRA-------I-EDG 465 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~-------~-~~~ 465 (608)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|..+|...... +.+.+ ..... + ...
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI--DQLGK-IFEALGTPTEENWPGVT 231 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH--HHHHH-HHHHcCCCchhhhhhcc
Confidence 21 1223356788999999854 45789999999999999999998777643321 11111 10000 0 000
Q ss_pred CCCcccCccccCc-----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 NFDTLVDPKLHNE-----YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
............. ........+.+++.+||+.+|++||++.||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000011 112234678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=322.89 Aligned_cols=195 Identities=23% Similarity=0.346 Sum_probs=159.4
Q ss_pred CCccccCCceEEEEEEec---CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEEEEeecc
Q 046502 245 ANLLGQGGFGYVHKGVLP---NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLVCEFVT 319 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~~lV~E~~~ 319 (608)
..+||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++|+||++++++|.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999964 35789999987543 23457789999999999999999999854 557899999998
Q ss_pred CCcHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE----ccCCceEEEEeecc
Q 046502 320 SNTLEFHLHGK-------GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL----DFKFEAKVADFGLA 388 (608)
Q Consensus 320 ~gsL~~~l~~~-------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl----~~~~~~kl~DFGla 388 (608)
+ +|.+++... ....+++..+..|+.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 565555321 123588999999999999999999998 89999999999999 56678999999999
Q ss_pred ccccCcccc--eeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 046502 389 KLASDVYTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDST 445 (608)
Q Consensus 389 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~ 445 (608)
+........ ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 1234568999999999876 45899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=356.05 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=198.2
Q ss_pred HHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCee
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTA--GSQR 311 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~ 311 (608)
...++|.+.++||+|+||.||++.. ..++.||+|++... .......|..|+.+|.+|+|+|||+++++|.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3457899999999999999999995 45778999998653 22334678899999999999999999998854 4568
Q ss_pred EEEEeeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeeeeccCCCcEEEccC--------
Q 046502 312 MLVCEFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCH----PKIIHRDIKAANILLDFK-------- 377 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~----~~iiHrDIk~~NILl~~~-------- 377 (608)
||||||+.+++|.++|... ....+++..++.|+.||+.||.|||..+. .+||||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999998753 22368999999999999999999998531 259999999999999643
Q ss_pred ---------CceEEEEeeccccccCcccceeeeeecccCccChhhhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 046502 378 ---------FEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446 (608)
Q Consensus 378 ---------~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvll~elltG~~p~~~~~ 446 (608)
+.+||+|||+++...... ......||+.|+|||++.. ..++.++||||||||||||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999998664321 2234579999999999864 458899999999999999999999996533
Q ss_pred ccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 447 TFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 447 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
.. ..++. .+..+.. + .+ . .....+.+|+..||+.+|.+||++.|++.
T Consensus 248 ~~------~qli~-~lk~~p~--l---pi-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NF------SQLIS-ELKRGPD--L---PI-K----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cH------HHHHH-HHhcCCC--C---Cc-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 11111 1221110 0 00 1 12345788999999999999999999984
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=320.39 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=195.8
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...++||+|+||.||+|.. .+|+.||+|+++.... .....+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477789999999999999996 4689999999865322 2234677899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+ +|.+++.... ..+++..++.++.||++||.|||+. +|+|||||++|||++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CDQ-DLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 985 6777665433 2589999999999999999999998 899999999999999999999999999986543221
Q ss_pred eeeeeecccCccChhhhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC------CCcc
Q 046502 398 VSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN------FDTL 470 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~~~ 470 (608)
......++..|+|||++.+.. ++.++|||||||++|||++|+.|+...... .+.+ .... ..+.... ...+
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~-~~~~-~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQL-KRIF-RLLGTPTEESWPGVSKL 231 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHH-HHHH-HHhCCCChHHhHHhhhc
Confidence 122345788999999987654 789999999999999999999986433221 1111 0000 0000000 0000
Q ss_pred cCc----ccc-----CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 VDP----KLH-----NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ~d~----~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+. ... ..........+.+++.+||+.||.+||++.||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 000 01111234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=329.60 Aligned_cols=240 Identities=24% Similarity=0.312 Sum_probs=186.3
Q ss_pred cccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhc---CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 248 LGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRV---HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 248 LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l---~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
||+|+||.||+|.. .+|+.||||++..... .....+..|..++.++ +|+||+++++++...+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999985 4589999999864321 1223345567777665 699999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|.+++..+. .+++..+..++.||++||+|||+. +|+||||||+||||+.++.+||+|||+++....... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~ 154 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN 154 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence 99999887644 589999999999999999999998 999999999999999999999999999975432211 223
Q ss_pred eeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 401 RVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
...||..|+|||++.+. .++.++|||||||+||||++|+.||..... . .+. ..+..+... +.. .
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~----~~~-~~i~~~~~~-~~~----~-- 219 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---Q----QMY-RNIAFGKVR-FPK----N-- 219 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---H----HHH-HHHHcCCCC-CCC----c--
Confidence 45799999999998764 489999999999999999999999965322 1 111 122222211 111 0
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 046502 480 NHNEMARMVACAAACVRHSARRRPR----ISQIVR 510 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPs----m~evv~ 510 (608)
.....+.+++.+||+.||.+||+ +.++++
T Consensus 220 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 --VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 12345678999999999999985 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.07 Aligned_cols=248 Identities=22% Similarity=0.353 Sum_probs=200.5
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
|.....||+|+||.||++.. .+++.||||++........+.+.+|+.++..++|+||++++++|..++..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44456799999999999985 46899999999765555566788999999999999999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|..++... .+++..++.++.|++.||.|||+. +|+|||||++|||++.++.+||+|||+++....... ...
T Consensus 103 ~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 103 GALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred CCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 9999887542 489999999999999999999998 899999999999999999999999999976543322 123
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...|+..|+|||++.+..++.++|||||||++|||++|+.||...... . .+. .+......... ..
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~-----~~~-~~~~~~~~~~~-------~~ 240 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--Q-----AMK-RLRDSPPPKLK-------NA 240 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H-----HHH-HHhccCCCCcc-------cc
Confidence 356899999999999889999999999999999999999998643321 0 111 11111111110 01
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+.+++..||+.+|.+||++.+|+++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1123457789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=313.03 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=204.2
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...+.||.|+||.||++... +++.||+|++.... ......+.+|++++++++|+||++++++|..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999965 58899999987653 34456788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
+.+++|.+++.... ..+++..+..++.+++.||.|||. . +|+|+|||++||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999987643 468899999999999999999999 7 899999999999999999999999999876543222
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
. ...++..|++||++.+..++.++||||||+++|+|++|+.||........ . ....+..... +.... +.
T Consensus 157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~-~~~~~~~~~~-~~~~~-----~~ 225 (265)
T cd06605 157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-G-IFELLQYIVN-EPPPR-----LP 225 (265)
T ss_pred h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-c-HHHHHHHHhc-CCCCC-----CC
Confidence 1 15688999999999998999999999999999999999999865432111 1 1112222111 11111 11
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .....+.+++..||..+|++||++.||+.+
T Consensus 226 ~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 SG---KFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11 134557889999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=318.80 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=201.8
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477889999999999999995 468999999987653 23346788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+ +++|.+++.... ..+++..++.++.||++||.|||+. +|+|+|||++||+++.++.++|+|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999987644 4689999999999999999999998 8999999999999999999999999999876543222
Q ss_pred eeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH-------Hhc-C---
Q 046502 398 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRA-------IED-G--- 465 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~-------~~~-~--- 465 (608)
......++..|+|||++... .++.++|||||||++|||++|+.+|...... ..+ ...+... +.+ .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQL-AIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHH-HHHHHHcCCCChHHHhhccCcc
Confidence 23345689999999998654 4689999999999999999998877543321 111 1011000 000 0
Q ss_pred CCCcccCcccc----CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 NFDTLVDPKLH----NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+...+..+... .....+....+.+++.+||+.+|++||++.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00111233678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=320.60 Aligned_cols=245 Identities=25% Similarity=0.413 Sum_probs=199.0
Q ss_pred CCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 245 ANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
...||+|+||.||++.. .+++.||||++........+.+.+|+.++++++|+||++++++|..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 45799999999999985 46889999998766555667789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeee
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 403 (608)
.+++... .+++..++.++.+|+.||.|||+. +|+||||||+|||++.++.+||+|||++........ ......
T Consensus 107 ~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~ 179 (292)
T cd06658 107 TDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKSLV 179 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCceee
Confidence 9988543 488999999999999999999998 899999999999999999999999999876543222 223356
Q ss_pred cccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHH
Q 046502 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483 (608)
Q Consensus 404 gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 483 (608)
|+..|+|||++.+..++.++|||||||++|||++|+.||...... . .+.. +... + ...+.. ....
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~-----~~~~-~~~~-~----~~~~~~--~~~~ 244 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--Q-----AMRR-IRDN-L----PPRVKD--SHKV 244 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H-----HHHH-HHhc-C----CCcccc--cccc
Confidence 899999999999888999999999999999999999998643321 0 1111 1111 1 111111 1122
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 484 MARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 484 ~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+.+++..||+.||.+||++.||+++
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3457788999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.70 Aligned_cols=251 Identities=26% Similarity=0.429 Sum_probs=202.0
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...+.||+|+||.||+|.. .+++.|+||.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477889999999999999985 46889999998765443 567889999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++.... .+++..+..|+.+++.||.|||+. +|+|+||+++|||++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999997643 478999999999999999999998 8999999999999999999999999999876543222
Q ss_pred eee---eeecccCccChhhhhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 398 VST---RVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 398 ~~~---~~~gt~~y~aPE~~~~~~---~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
... ...++..|++||++.... ++.++||||||+++|||++|+.||..... ... .. ..+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----~~~--~~-~~~~~~~~~~-- 226 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQ--IM-FHVGAGHKPP-- 226 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----hHH--HH-HHHhcCCCCC--
Confidence 211 346788999999998766 88999999999999999999999964321 010 11 1111111111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
+... ......+.+++.+||+.+|.+||++.+++.
T Consensus 227 ---~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 ---IPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---CCcc--cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111 112445678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=313.07 Aligned_cols=253 Identities=23% Similarity=0.363 Sum_probs=203.0
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLVC 315 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~~lV~ 315 (608)
+|...+.||.|+||.||++.. .+++.||+|++... .....+.+.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999984 56789999998643 23344678899999999999999999998764 45679999
Q ss_pred eeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 316 EFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDC--HPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 316 E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~--~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
||+++++|.+++... ....+++..++.++.+++.||.|||..+ ..+|+|+||||+|||++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998653 2346899999999999999999999332 228999999999999999999999999999876
Q ss_pred cCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
..... ......++..|++||++....++.++||||||+++|+|++|+.||..... . .+...+..+.+..
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~-----~~~~~~~~~~~~~-- 229 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---L-----QLASKIKEGKFRR-- 229 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---H-----HHHHHHhcCCCCC--
Confidence 54322 12234689999999999988899999999999999999999999975431 1 1122233333221
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||+.+|++||++.+|+++
T Consensus 230 -------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 230 -------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 222345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.74 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=197.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-----chhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Cee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-----GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~ 311 (608)
.+|...++||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++|+||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788899999999999999985 458999999885321 22345788899999999999999999998763 467
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+++++|.+++.... .+++...++++.+++.||.|||+. +|+|+||||+|||++.++.+||+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999987543 478888999999999999999998 8999999999999999999999999999765
Q ss_pred cCccc--ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 392 SDVYT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 392 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .. . +.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~-~-~~~~~~~~---- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MA-A-IFKIATQP---- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HH-H-HHHHhcCC----
Confidence 32111 112234688999999999888899999999999999999999999864321 10 0 11111111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. ...+......+.+++..|+. +|++||++.+|+++
T Consensus 226 -~~----~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 -TN----PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -CC----CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 01 11233444567788888985 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.32 Aligned_cols=255 Identities=27% Similarity=0.382 Sum_probs=202.2
Q ss_pred HHhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC-----
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGS----- 309 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~----- 309 (608)
..+++|...+.||+|+||.||+|... +++.|++|++..... ....+.+|+.+++++ +|+||++++++|....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999964 578899999876543 346789999999999 6999999999997644
Q ss_pred -eeEEEEeeccCCcHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 310 -QRMLVCEFVTSNTLEFHLHGKG--RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 310 -~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+. +|+|+||+++||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999887533 34689999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRA 461 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 461 (608)
++........ ......|+..|+|||++.. ..++.++|||||||+||+|++|+.||...... . .+...
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~-----~~~~~ 230 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--R-----ALFKI 230 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--H-----HHHHh
Confidence 9876543222 1233568899999999854 34678999999999999999999999643210 0 11111
Q ss_pred HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 462 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 462 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+....+. ........+.+++.+||..||.+||++.||+++
T Consensus 231 -~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 231 -PRNPPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -hccCCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111111 112244578899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=311.50 Aligned_cols=253 Identities=22% Similarity=0.394 Sum_probs=201.6
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC------chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS------GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
+|+..++||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++|+||++++++|.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999984 678999999986432 1124678899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-ceEEEEeecccccc
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKLAS 392 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-~~kl~DFGla~~~~ 392 (608)
||||+.+++|.+++.... .+++..++.++.|++.||.|||+. +|+|+|||++|||++.++ .+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999987643 588999999999999999999998 999999999999998776 59999999997664
Q ss_pred Ccccc---eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 393 DVYTH---VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 393 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
..... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...... ... . .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~-~-~~~~~~~~~---- 227 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS--NHL-A-LIFKIASAT---- 227 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc--chH-H-HHHHHhccC----
Confidence 32111 122346889999999998888999999999999999999999998643221 100 0 111111100
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.....+......+.+++.+||+.+|.+||++.+++.+
T Consensus 228 -----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 -----TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -----CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0112233344668889999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.00 Aligned_cols=260 Identities=27% Similarity=0.309 Sum_probs=202.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~lV~ 315 (608)
++|...+.||.|+||.||++.. .+++.||+|.+..... .....+.+|++++++++|+||++++++|... +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4678889999999999999996 4578999999875433 3456788999999999999999999998653 4689999
Q ss_pred eeccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 316 EFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 316 E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||+++++|.+++.. .....+++..+..|+.|++.||.|||.. +++|+||+++||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999988754 2234588999999999999999999998 999999999999999999999999999875543
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.. .....++..|++||.+.+..++.++|||+|||++|+|++|+.||+......... ..+. ..+.......+.+.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~ 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP--IELL-SYIVNMPNPELKDE 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh--HHHH-HHHhcCCchhhccC
Confidence 21 123457889999999999999999999999999999999999997553211111 1111 11111111111111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .........+.+++.+||+.+|.+||+|.||+++
T Consensus 232 -~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 232 -P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred -C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1 1111235678899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.52 Aligned_cols=251 Identities=23% Similarity=0.380 Sum_probs=204.6
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++|+||++++++|...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36788899999999999999985 46889999998765555567788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++... .+++..+..++.+++.||.|||+. +++|||||++||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 98 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 9999999998653 478999999999999999999998 899999999999999999999999999876543222
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......++..|++||++..+.++.++|||||||++|+|++|+.||....... .+ ......+. . . .
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~--~~-----~~~~~~~~-~-----~--~ 235 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--AL-----YLIATNGT-P-----E--L 235 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh--he-----eehhcCCC-C-----C--C
Confidence 1223468889999999988889999999999999999999999997543211 00 00001110 0 0 0
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.........+.+++..||+.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112234467889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.34 Aligned_cols=253 Identities=23% Similarity=0.251 Sum_probs=205.2
Q ss_pred cCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCch---hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQ---GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~---~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
+.|..+++||.|.-|+||++.+.+ +..+|+|++.+.... .....+.|-+||+.+.||.|..||..|+.++..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345667889999999999999754 588999999765432 3345677999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC--
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD-- 393 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~-- 393 (608)
|||+||+|..+++......+++..+..++..|+-||+|||.. +||+|||||+||||.++|++.|+||.|+..+..
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999988888899999999999999999999999 999999999999999999999999998743210
Q ss_pred -------------------------------ccc----------------------ceeeeeecccCccChhhhhcCCCC
Q 046502 394 -------------------------------VYT----------------------HVSTRVMGTFGYLAPEYASSGKLT 420 (608)
Q Consensus 394 -------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~t 420 (608)
... ..+..++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 112236799999999999999999
Q ss_pred CcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCC
Q 046502 421 EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSAR 500 (608)
Q Consensus 421 ~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~ 500 (608)
.++|.|.|||+|||||.|+.||..... ++. +.+- +...+.--........+.+||...|.+||.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~--~~T----l~NI----------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNN--KET----LRNI----------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCc--hhh----HHHH----------hcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999986543 111 1111 111111111124556788999999999999
Q ss_pred CCCC----HHHHHHH
Q 046502 501 RRPR----ISQIVRT 511 (608)
Q Consensus 501 ~RPs----m~evv~~ 511 (608)
+|-. +.||-++
T Consensus 378 kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhccccchHHhhcC
Confidence 9998 7777664
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=313.80 Aligned_cols=248 Identities=25% Similarity=0.439 Sum_probs=200.1
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcC---CCCccceeeEEEeCCeeEEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVH---HKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~---Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.|+..++||+|+||.||+|.. .+++.||||.++... ......+.+|+.++++++ |+||++++++|..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467788999999999999995 568999999987542 334467889999999997 999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++... .+++...+.++.+++.||.|||+. +|+||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999988653 589999999999999999999998 89999999999999999999999999998765432
Q ss_pred cceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
. ......|+..|+|||++..+ .++.++|||||||++|+|++|+.||....... .. ..+.... .+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~-~~~~~~~-----~~~ 221 (277)
T cd06917 156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AM-MLIPKSK-----PPR 221 (277)
T ss_pred c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hh-hccccCC-----CCC
Confidence 2 22334688999999998754 46889999999999999999999996533210 00 0011111 111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+..+ .....+.+++..||+.||++||++.+++++
T Consensus 222 ~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111 134568889999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=318.43 Aligned_cols=265 Identities=20% Similarity=0.331 Sum_probs=197.3
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||+|... +++.||||.+...... ....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888999999999999999964 6889999998754322 234567899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+ +|.+++..... .+++...+.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 ~~~-~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred CCC-CHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 985 89888875543 689999999999999999999998 89999999999999999999999999987543211 1
Q ss_pred eeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHH----------HHHHHhcCC
Q 046502 398 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL----------LNRAIEDGN 466 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~----------~~~~~~~~~ 466 (608)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... .+.+...+ .........
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV-EDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH-HHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122346889999999865 45889999999999999999999999654321 11110000 000000000
Q ss_pred CCc-----ccCccccCcC-CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 467 FDT-----LVDPKLHNEY-NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 467 ~~~-----~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.. .....+.... .......+.+++..||+.+|++||++.|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000 0000000000 00112567789999999999999999998853
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.78 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=207.4
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||++... +++.|+||++..... .....+.+|+.++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888899999999999999965 489999999876544 4457789999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
+++++|.+++... ..+++..+++++.|+++||.|||. . +++||||+++||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999765 368999999999999999999999 8 899999999999999999999999999986654322
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
. .....++..|+|||++....++.++|||+||+++|+|++|+.||...... .. ........ ..... .
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~-~~~~~~~~-~~~~~-----~-- 222 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SF-FELMQAIC-DGPPP-----S-- 222 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CH-HHHHHHHh-cCCCC-----C--
Confidence 2 22456889999999999989999999999999999999999998755320 11 11111111 11111 1
Q ss_pred CcCCHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHN-EMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~-~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.... ....+.+++.+||+.+|++||++.||+++
T Consensus 223 --~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 --LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1112 44678899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=317.38 Aligned_cols=262 Identities=20% Similarity=0.308 Sum_probs=198.7
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|+..+.||.|+||.||+|+. .+|+.||||+++.... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999985 4689999999875432 2235688899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+. ++|..++.......+++..++.++.+++.||+|||+. +|+||||+|+|||++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 5788888765556789999999999999999999998 899999999999999999999999999876543221
Q ss_pred eeeeeecccCccChhhhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH-------------H-
Q 046502 398 VSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRA-------------I- 462 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~-------------~- 462 (608)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||..... .+.+.+ .+... +
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFR-IFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHH-HHHHhCCCChhhhhhhhHHH
Confidence 122345688999999886544 68899999999999999999999865432 111111 00000 0
Q ss_pred -hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 463 -EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 463 -~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+.......+. .........+.+++.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00011111110000 0001122456789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=310.78 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=197.1
Q ss_pred CCcCCccccCCceEEEEEEec----CCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC------
Q 046502 242 FSDANLLGQGGFGYVHKGVLP----NGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS------ 309 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~------ 309 (608)
|...++||+|+||.||+|.+. +++.||||+++.. .....+.+.+|++++++++|+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999853 3688999998754 2334567889999999999999999999886532
Q ss_pred eeEEEEeeccCCcHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 310 QRMLVCEFVTSNTLEFHLHGK----GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
..++++||+.+++|.+++... ....+++...++++.|++.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 247899999999998887532 223578999999999999999999998 8999999999999999999999999
Q ss_pred eccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHh
Q 046502 386 GLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 386 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
|+++....... .......++..|++||.+....++.++|||||||++|||++ |+.||..... .. +......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~----~~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SE----IYNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HH----HHHHHHc
Confidence 99986543211 11122345678999999998899999999999999999999 8888764322 11 1111111
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
...+.. .......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 231 ~~~~~~----------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 231 GNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CCcCCC----------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 111110 11233578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=326.57 Aligned_cols=251 Identities=22% Similarity=0.373 Sum_probs=203.2
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEccc--CCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKA--GSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E 316 (608)
..|+++++||.||.+.||++...+.+.||+|++.. .+.+...-|.+|+.+|.+|+ |.+||+|++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45778899999999999999987888899988753 34555678999999999996 9999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|=+ .+|..+|..+.....+| .++.+..|++.++.++|.+ +|||.||||.|+||- .|.+||+|||+|..+..+.+
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred ccc-ccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCcccc
Confidence 864 68999998877766667 6778899999999999999 999999999999995 46899999999998876544
Q ss_pred ce-eeeeecccCccChhhhhcCC-----------CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhc
Q 046502 397 HV-STRVMGTFGYLAPEYASSGK-----------LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIED 464 (608)
Q Consensus 397 ~~-~~~~~gt~~y~aPE~~~~~~-----------~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 464 (608)
.. ....+||+.||+||.+.... .+.++|||||||+||+|+.|+.||..... +..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------~~a----- 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------QIA----- 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH---------HHH-----
Confidence 43 45678999999999985432 55799999999999999999999964321 111
Q ss_pred CCCCcccCccccCcCCHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 465 GNFDTLVDPKLHNEYNHN-EMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 465 ~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
++..+.|+...-+|+.- .-.+++++++.||.+||++||+..+|+++
T Consensus 581 -Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 13344455333233211 11228999999999999999999999975
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=315.86 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=194.1
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHH-HHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEI-ISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~-l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|...+.||+|+||.||++... +|+.||||+++... ......+..|+.+ ++.++|+||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999964 68999999987543 2233455556665 666789999999999999999999999
Q ss_pred eccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 317 FVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 317 ~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|++ ++|..++... ....+++..++.++.||+.||.|||+++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 5777776542 2346899999999999999999999864 7999999999999999999999999999865432
Q ss_pred ccceeeeeecccCccChhhhhc----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... + .+..... +....+
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~-----~~~~~~~-~~~~~~ 228 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-Q-----QLKQVVE-EPSPQL 228 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-H-----HHHHHHh-cCCCCC
Confidence 1 1233468899999998864 456889999999999999999999986432110 0 1111111 111111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. ......+.+++..||..+|++||++.+|+.+
T Consensus 229 ~~--------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 229 PA--------EKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred Cc--------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1123468889999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=315.01 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=202.5
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
.|...++||+|+||.||++.. .+++.|+||++........+.+.+|+.++++++|+||+++++++..++..++|+||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 355567999999999999985 4688999999876655556678899999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++.. ..+++..+..++.+++.||+|||+. +|+||||+|+|||++.++.++|+|||++........ ..
T Consensus 100 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 100 GGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 9999999876 2589999999999999999999998 899999999999999999999999999876543221 22
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+. .+..+....+. .
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~~~~-~~~~~~~~~~~-----~-- 237 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------QAMK-RIRDNLPPKLK-----N-- 237 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------HHHH-HHHhcCCCCCc-----c--
Confidence 3356899999999999888999999999999999999999998653321 0111 11111111111 0
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++.+||+.+|++||++.+++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 11133568899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=309.21 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=202.8
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++|+||++++++|..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999964 58899999986542 23445788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-ceEEEEeeccccccCccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKLASDVYT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~~~ 396 (608)
+.+++|.+++.......++|..++.++.+++.||.|||.. +|+|+|||++|||+++++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999776555689999999999999999999998 899999999999998885 469999999986654322
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .. .+.... .+.+..+
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~-~~~~~~~------ 222 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQ-LVLKIC-QGYFAPI------ 222 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HH-HHHHHh-cccCCCC------
Confidence 22334688999999999888899999999999999999999999864321 11 111111 1222111
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++.+||+.+|++||++.+|+++
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 ---SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223468889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=302.82 Aligned_cols=250 Identities=31% Similarity=0.462 Sum_probs=206.1
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
.|...+.||+|+||.||++... +++.|++|++..........+.+|++++++++|+||+++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999975 688999999987655566789999999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++.... ..+++..+..++.+++.+|.|||.. +++||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 999999987653 3689999999999999999999998 999999999999999999999999999987654321 3
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
....++..|++||++....++.++||||||+++|+|++|+.||...... . .+.. ........+.+.
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~-~~~~-~~~~~~~~~~~~------ 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------K-ALFK-IATNGPPGLRNP------ 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------H-HHHH-HHhcCCCCcCcc------
Confidence 3456889999999999888999999999999999999999998654210 0 0111 111111111111
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+.+++.+||+.||.+||++.||+++
T Consensus 221 -~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 -EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1124568889999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=304.94 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=202.4
Q ss_pred hcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.+.|+.-++||+|.|+.||++. ...|+.+|+|+++.. ...+-+++.+|+.|.+.|+|||||+|++-+.+...+|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4567777899999999999987 567999999988543 3345678899999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---CCceEEEEeecccccc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGLAKLAS 392 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---~~~~kl~DFGla~~~~ 392 (608)
|+|.|+.|..-+-.+ ..+++...-..+.||+++|.|+|.+ +|||||+||+|+||.. .--+||+|||+|....
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999996554332 3467777888999999999999999 9999999999999954 3458999999999877
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
+ .......+||++|||||++...+|+..+|||+.||+||-||.|+.||..... . -+-+.+..|.++- +
T Consensus 165 ~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~-----rlye~I~~g~yd~--~ 232 (355)
T KOG0033|consen 165 D--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---H-----RLYEQIKAGAYDY--P 232 (355)
T ss_pred C--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---H-----HHHHHHhccccCC--C
Confidence 3 3344557899999999999999999999999999999999999999965221 1 1222334444321 1
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+ .+.....+.-.+|+.+||..||.+|-|+.|.+.+
T Consensus 233 ~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 233 S----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred C----cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1 1112233456678899999999999999998864
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=313.97 Aligned_cols=247 Identities=28% Similarity=0.405 Sum_probs=201.1
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
-|...++||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++.+++|+||++++++|..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778999999999999985 468899999986443 233467889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+++|..++... .+++..+..++.+++.+|.|||+. +|+|+|||++||+++.++.++|+|||++........ .
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 157 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence 999999988643 589999999999999999999998 999999999999999999999999999876543221 1
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
.....++..|++||++....++.++|||||||++|+|++|..||...... ... ..+..+... .
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~-~~~~~~~~~---------~ 220 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVL-FLIPKNNPP---------T 220 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHH-HHHhcCCCC---------C
Confidence 22346788999999998888999999999999999999999998643210 011 111112111 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||+.+|.+||+|.+++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 112234567889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=314.82 Aligned_cols=245 Identities=27% Similarity=0.349 Sum_probs=200.9
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||++... +++.||||++.... ......+.+|++++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999954 68999999986532 233456889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||+|+||||+.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999987653 589999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||..... . ... ..+..+... +
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~----~~~-~~~~~~~~~------~ 217 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---I----QIY-EKILEGKVR------F 217 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---H----HHH-HHHhcCCcc------C
Confidence 2334688999999999888899999999999999999999999865431 1 111 111122211 1
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
+......+.+++.+||+.+|.+|+ ++.|++++
T Consensus 218 ----~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 218 ----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ----CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 112235678899999999999999 66666643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=316.26 Aligned_cols=263 Identities=20% Similarity=0.287 Sum_probs=200.1
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~lV 314 (608)
++|...+.||+|+||.||+|... +++.||||.++..... ....+.+|+.++.+++|+||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888899999999999999965 5889999999754322 223567899999999999999999999877 889999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.+ +|.+++..... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999985 88888875443 689999999999999999999998 8999999999999999999999999999876543
Q ss_pred ccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH-------------
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR------------- 460 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~------------- 460 (608)
.. ......++..|+|||++.+. .++.++|||||||++|||++|+.||....... .+.+ ....
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID--QLNK-IFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHhCCCchHHHHHhh
Confidence 21 12334578899999998754 46899999999999999999999997543211 1100 0000
Q ss_pred ---HHhcCCCCcccCccccCcCCHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 ---AIEDGNFDTLVDPKLHNEYNHN-EMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ---~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+.......+...+... ....+.+++..||+.+|++||++.||+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000111111111122222222 34567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=316.01 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=195.8
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...++||+|+||.||++.. .+++.||||++.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 445567899999999999985 458999999987543 334567889999999996 99999999999999999999999
Q ss_pred ccCCcHHH---HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 318 VTSNTLEF---HLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 318 ~~~gsL~~---~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
+.. +|.+ ++.......+++.....++.+++.||+|||+.+ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 874 4433 333333346899999999999999999999743 7999999999999999999999999999765432
Q ss_pred ccceeeeeecccCccChhhhhcC---CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSG---KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
.. .....|+..|+|||++... .++.++|||||||++|||++|+.||..... ... .+... ..+..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~-~~~~~---- 228 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFD-QLTQV-VKGDP---- 228 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHH-HHhhh-cCCCC----
Confidence 21 1234588999999999776 689999999999999999999999864321 100 11111 11111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+...........+.+++.+||+.+|++||++.+|+++
T Consensus 229 -~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 -PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122222222345578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.96 Aligned_cols=255 Identities=20% Similarity=0.310 Sum_probs=201.3
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||++.. ..++.|+||.+.... ......+.+|++++++++|+||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4688899999999999999995 457899999987543 223456889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++...+ .+++..+..++.+++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997653 589999999999999999999998 89999999999999999999999999987421100
Q ss_pred --------------cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 046502 396 --------------THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRA 461 (608)
Q Consensus 396 --------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 461 (608)
........++..|+|||++....++.++|||||||++|||++|+.||..... .. ++...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~----~~~~~ 228 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EE----LFGQV 228 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HH----HHHHH
Confidence 0011124578899999999888899999999999999999999999864321 11 12111
Q ss_pred HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 462 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 462 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
..+... .+.... .....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 -~~~~~~---~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 -ISDDIE---WPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -HhcccC---CCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111111 111111 233457889999999999999997766666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=329.26 Aligned_cols=244 Identities=29% Similarity=0.413 Sum_probs=199.5
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhH---HHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGE---RVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~---~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
|...+.||.|.||.||-+++ .+.+.||||++.-...+.. ..+..||.+|.+|+|||+|.+.|||..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 67778899999999999994 5678899999975544443 4678899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
|- |+-.|+|....+ .|-+..+..|+.+.+.||+|||+. +.||||||+.||||.+.|.+||+|||.|.....
T Consensus 108 Cl-GSAsDlleVhkK-plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKK-PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred Hh-ccHHHHHHHHhc-cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 96 566777765433 688899999999999999999999 899999999999999999999999999976654
Q ss_pred eeeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 398 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
...++||+.|||||++. .|.|+-|+|||||||.+.||...++|+-.-.. + . .+- -+..++. |.
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-M----S--ALY-HIAQNes-----Pt 244 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-M----S--ALY-HIAQNES-----PT 244 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-H----H--HHH-HHHhcCC-----CC
Confidence 34478999999999984 57899999999999999999999998642211 0 0 011 1112221 22
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
|. ..+....++.|+..||+.-|.+||+..+++++
T Consensus 245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22 34566778999999999999999999998875
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=313.93 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=207.4
Q ss_pred HHhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
..+++|...+.||+|+||.||+|... +++.|++|++..... ....+.+|++++++++|+||++++++|...+..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888899999999999999975 688999999986554 5567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++.... ..+++..+..++.+++.||.|||.. +|+|+||+|+||+++.++.++|+|||++.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999998754 3699999999999999999999998 99999999999999999999999999987554322
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
. ......++..|++||++.+..++.++|||||||++|+|++|+.||....... .... +..+....+.+
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-------~~~~-~~~~~~~~~~~--- 238 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-------ALFL-ITTKGIPPLKN--- 238 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH-HHhcCCCCCcc---
Confidence 1 1223457889999999998889999999999999999999999986433210 0111 11111111111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++.+||+.+|.+||++.+|+++
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 ----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ----hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11133567889999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=318.23 Aligned_cols=267 Identities=22% Similarity=0.302 Sum_probs=196.5
Q ss_pred CCCcCCccccCCceEEEEEEec---CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP---NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRM 312 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~ 312 (608)
+|...++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++|+||++++++|.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999964 47899999998633 23335677899999999999999999999988 7899
Q ss_pred EEEeeccCCcHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc----CCceEEEEe
Q 046502 313 LVCEFVTSNTLEFHLHGK---GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF----KFEAKVADF 385 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~----~~~~kl~DF 385 (608)
+||||+++ +|..++... ....+++..++.|+.|++.||.|||+. +|+|||||++|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 555555322 123688999999999999999999998 8999999999999999 899999999
Q ss_pred eccccccCccc--ceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccch--hhHHHHHH
Q 046502 386 GLAKLASDVYT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDN--LARPLLNR 460 (608)
Q Consensus 386 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~--l~~~~~~~ 460 (608)
|+++....... .......++..|+|||++.+. .++.++|||||||+||||++|+.||.......... .....+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986644322 112335678999999988764 57899999999999999999999997544321000 00000000
Q ss_pred HH---------------hcCCCCcccCccccCcCC---------H--HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 AI---------------EDGNFDTLVDPKLHNEYN---------H--NEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ~~---------------~~~~~~~~~d~~l~~~~~---------~--~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+ +...+..+.+......+. . ....++.+++.+||+.||++||++.||+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00 000111100000001111 0 233468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=314.04 Aligned_cols=262 Identities=20% Similarity=0.294 Sum_probs=195.9
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++++|...+.||+|+||.||+|.. .+|+.||||++...... ....+.+|++++++++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999985 46889999998754322 2346778999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+. ++|..++.... ..+.+..+..++.|++.||.|||.. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9997 56655554332 3578888999999999999999998 89999999999999999999999999997543321
Q ss_pred cceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh-cC--------
Q 046502 396 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE-DG-------- 465 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-~~-------- 465 (608)
. ......++..|+|||++.+. .++.++|||||||+||||++|+.||+...... +. +...+. .+
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~-----~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQ-----LEKIWTVLGVPTEDTWP 230 (291)
T ss_pred C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HH-----HHHHHHHcCCCChhhhh
Confidence 1 12234578999999998753 57889999999999999999999997543211 11 111100 00
Q ss_pred ------CC-CcccC----ccccCc-CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 ------NF-DTLVD----PKLHNE-YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ------~~-~~~~d----~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+ ..+.. ..+... ........+.+++.+|++.||.+||++.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 00000 000000 000113457789999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=337.75 Aligned_cols=268 Identities=18% Similarity=0.243 Sum_probs=187.3
Q ss_pred HhcCCCcCCccccCCceEEEEEEecC--CcEEEEE------------------EcccCCchhHHHHHHHHHHHHhcCCCC
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLPN--GKEVAIK------------------QLKAGSGQGERVFQAEVEIISRVHHKH 297 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK------------------~~~~~~~~~~~~~~~Ev~~l~~l~Hpn 297 (608)
..++|..+++||+|+||.||++.+.. +..+++| .++. .......|.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987532 2222222 1111 1223456889999999999999
Q ss_pred ccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE
Q 046502 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKG---RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL 374 (608)
Q Consensus 298 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl 374 (608)
||++++++...+..|+|+|++.+ +|..++.... .....+.....|+.||+.||.|||+. +||||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 99999999999999999999965 5555554321 11233556778999999999999998 89999999999999
Q ss_pred ccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCC-CCCCcccccchh
Q 046502 375 DFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP-VDSTHTFMEDNL 453 (608)
Q Consensus 375 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p-~~~~~~~~~~~l 453 (608)
+.++.+||+|||+++.+............|+..|+|||++.+..++.++|||||||+||||++|..+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987655433333446799999999999999999999999999999999998754 432221111111
Q ss_pred hHHHHHHH-HhcCCCCc-------ccCc-ccc--CcCCH------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 454 ARPLLNRA-IEDGNFDT-------LVDP-KLH--NEYNH------NEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 454 ~~~~~~~~-~~~~~~~~-------~~d~-~l~--~~~~~------~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .+... .....+.. .++. .+. ..... .....+.+++.+||+.||.+||++.|++.+
T Consensus 381 ~~-~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LK-IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HH-HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11 00000 00000000 0000 000 00000 012346678899999999999999999875
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=317.20 Aligned_cols=246 Identities=28% Similarity=0.374 Sum_probs=195.6
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
+.|...++||+|+||.||+|... +|+.||||++..... .....+.+|+++++.++|+||++++++|..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999854 689999999864322 23356889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+ +|.+++.... ..+++..+..++.|++.||.|||.. +|+||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~g-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCLG-SASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhCC-CHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99984 6666655433 2589999999999999999999998 8999999999999999999999999998765432
Q ss_pred cceeeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 396 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
....++..|+|||++. .+.++.++|||||||++|||++|+.||....... .+.. +..+....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~-~~~~~~~~--- 233 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH-IAQNDSPT--- 233 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHH-HhcCCCCC---
Confidence 2345788999999874 4568899999999999999999999986433210 0111 11111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+ ........+.+++.+||+.+|++||+|.+|+.+
T Consensus 234 --~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 --L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1 111234568899999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.27 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=198.3
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
|+..++||.|++|.||+|.. .+|+.||||++..... .....+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999985 4789999999875432 22356788999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
. ++|..++.......+++..++.++.|+++||.|||+. +++||||+|+|||++.++.++|+|||+++....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 6899888765545689999999999999999999998 899999999999999999999999999976543211 1
Q ss_pred eeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH-----------HHhc--
Q 046502 399 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR-----------AIED-- 464 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-----------~~~~-- 464 (608)
.....++..|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+.. .... ....
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFR-IFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHHHhCCCChHHhhhhhhchh
Confidence 1223568899999988654 5788999999999999999999999654321 11100 0000 0000
Q ss_pred --CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 465 --GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 465 --~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+.......+ ..........+.+++.+||+.+|.+||++.||+++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 01112223568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=330.23 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=204.4
Q ss_pred ccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcHHH
Q 046502 247 LLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEF 325 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~ 325 (608)
+||+|.||+||-|++. +...+|||.+.....+..+-+.+||.+.++|+|+|||+.+|.|.+++.+.|.||.++||+|..
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999954 456799999987777777788999999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc-cCCceEEEEeeccccccCcccceeeee
Q 046502 326 HLHGKGRPTM--DWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKLASDVYTHVSTRV 402 (608)
Q Consensus 326 ~l~~~~~~~l--~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~ 402 (608)
+|+.+=+ +| ++.+.-.+-.||++||.|||++ .|||||||-+||||+ ..|.+||+|||.++....- ......+
T Consensus 662 LLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 662 LLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred HHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 9987533 34 6778888999999999999999 999999999999995 5799999999999877543 3345567
Q ss_pred ecccCccChhhhhcCC--CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 403 MGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 403 ~gt~~y~aPE~~~~~~--~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
.||..|||||++..|. |..++|||||||.+.||.||++||-...... + ..++-|-+ ..+...+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----A-----AMFkVGmy------KvHP~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----A-----AMFKVGMY------KVHPPIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----H-----hhhhhcce------ecCCCCc
Confidence 8999999999997764 8899999999999999999999995432210 0 11122221 2234567
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 481 HNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
.+..++...++++|+..||.+||++++++.
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 777888899999999999999999999985
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.07 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=206.0
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRMLVC 315 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~lV~ 315 (608)
+|...+.||+|+||.||+|... +++.|+||++..... ...+.+.+|+.++++++|+||+++++++... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999965 689999999876543 4467789999999999999999999999988 8899999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+++|.+++.... .++|..++.++.+++++|.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999987654 689999999999999999999998 89999999999999999999999999998765532
Q ss_pred cc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 TH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.. ......++..|++||++....++.++||||||+++|+|++|+.||..... ... .+......+..
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~-~~~~~~~~~~~------- 222 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-----PMA-ALYKIGSSGEP------- 222 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----hHH-HHHhccccCCC-------
Confidence 21 12335688999999999988899999999999999999999999975441 000 11111110111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..........+.+++.+||+.+|++||++.+++.+
T Consensus 223 --~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 --PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11222335678889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=312.12 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=198.8
Q ss_pred CCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEEEe
Q 046502 242 FSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRMLVCE 316 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~lV~E 316 (608)
|...++||+|+||.||+|... +++.||||++.... ......+.+|++++++++|+||+++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999964 58899999998653 23345688899999999999999999999988 88999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+++ +|..++.... ..+++..++.++.+|++||+|||.. +++|+||||+|||+++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9985 7888776543 3689999999999999999999998 899999999999999999999999999986654332
Q ss_pred ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH--hcCCCCcc---
Q 046502 397 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI--EDGNFDTL--- 470 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~--- 470 (608)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ........... ....+..+
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL---EQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchhhccccccc
Confidence 22333457889999997764 45789999999999999999999998754321 11111111000 00000000
Q ss_pred -----------cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 -----------VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 -----------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+...+...+...+++++..||+.+|.+||++.+|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00001111111125678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.86 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=205.7
Q ss_pred cCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+.|.++..||.|+||.||++..++ +-..|.|++...+....+.|.-||+||..+.||+||+|++.|..++.++|+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 346677889999999999999654 3445788888777778889999999999999999999999988889999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.||-++.++-.-++ .|...++..++.+++.||.|||++ +|||||||+.|||++-+|.++|+|||.+...... ...
T Consensus 112 ~GGAVDaimlEL~r-~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR-VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK 186 (1187)
T ss_pred CCchHhHHHHHhcc-ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence 99999988876554 799999999999999999999999 9999999999999999999999999997543321 123
Q ss_pred eeeeecccCccChhhhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 399 STRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
...++||+.|||||++++ ..|+.++|||||||.|.||..+.+|-..... .+.+++ +......-++.|
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllK--iaKSePPTLlqP 258 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLK--IAKSEPPTLLQP 258 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHH--HhhcCCCcccCc
Confidence 345789999999998754 5799999999999999999999998532221 222222 122223333332
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+.+++..||..||+.||++.|++++
T Consensus 259 -------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 -------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2445668899999999999999999999875
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=316.75 Aligned_cols=247 Identities=28% Similarity=0.383 Sum_probs=196.2
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
|...+.||+|+||.||++.. .+++.||||++..... .....+.+|++++++++|+|+++++++|.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66778999999999999995 4688999999864322 2335688899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+ +|.+++.... ..++|..+..++.+++.||.|||+. +|+||||+|+|||++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 107 CLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCC-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 975 6766665433 3589999999999999999999998 8999999999999999999999999998754432
Q ss_pred eeeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 398 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||..... ...+......+. ...
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~---- 244 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNES-PTL---- 244 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhccC-CCC----
Confidence 2346888999999984 45689999999999999999999999854321 011111111111 111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+++.+||+.+|.+||++.+|++++..
T Consensus 245 ----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 245 ----QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ----CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 111233457889999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.54 Aligned_cols=261 Identities=21% Similarity=0.227 Sum_probs=193.1
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcC-CCCccceeeEEEeC--CeeEEEEe
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVH-HKHLVSLVGYYTAG--SQRMLVCE 316 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~--~~~~lV~E 316 (608)
|...++||+|+||.||+|.. .+++.||||+++... ........+|+.++.++. |+||++++++|.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678999999999999985 468899999987542 222234457899999985 99999999999987 88999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.+ +|.+++.... ..++|..++.++.|++.||.|||.. +|+||||||+|||++. +.+||+|||+++.......
T Consensus 81 ~~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMDM-NLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCCc-cHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 9975 6777766533 3689999999999999999999998 8999999999999999 9999999999986643221
Q ss_pred ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccch-h-------hHHHHHHHHhcCCC
Q 046502 397 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDN-L-------ARPLLNRAIEDGNF 467 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~-l-------~~~~~~~~~~~~~~ 467 (608)
.....++..|+|||++.. +.++.++|||||||++|||++|..||.......... . ...+ .........
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 231 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRH 231 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHH-HHhhccccc
Confidence 223457889999998754 557889999999999999999999996543211000 0 0000 001100000
Q ss_pred CcccCccccC----cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DTLVDPKLHN----EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.....+.... .........+.+++.+||+.+|++||++.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0110000000 0112335778999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.37 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=197.1
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|...+.||+|+||.||+|... +|+.||||++..... ...+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999964 688999999865432 234568889999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-CCceEEEEeeccccccCcc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-~~~~kl~DFGla~~~~~~~ 395 (608)
|+. ++|..++.......+++.....++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 4777777655444578888999999999999999998 8999999999999985 5679999999997654321
Q ss_pred cceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc---
Q 046502 396 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV--- 471 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~--- 471 (608)
.......++..|+|||++.+. .++.++|||||||++|+|++|+.||...... +.+.. .+ ..+. .......
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~--~~~~~-~~-~~~~-~~~~~~~~~~ 231 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI--DELFK-IF-RILG-TPNEETWPGV 231 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HH-HHhC-CCChhhcccc
Confidence 122334578899999998664 5789999999999999999999999654321 11110 00 0000 0000000
Q ss_pred ----C-----ccccC----cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 472 ----D-----PKLHN----EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 472 ----d-----~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+ +.... .........+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000 0111223457889999999999999999999863
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.39 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=198.6
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC------
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG------ 308 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~------ 308 (608)
..++|...+.||+|+||.||+|.. .+|+.||||++... .......+.+|+.++++++|+||++++++|...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 357899999999999999999995 46899999998643 223345677899999999999999999988643
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
...++||||+.+ +|.+.+... +++..+..++.|++.||+|||.. +|+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 357999999975 777776532 88899999999999999999998 8999999999999999999999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc------------hhhH-
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED------------NLAR- 455 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~------------~l~~- 455 (608)
+....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||......... .+..
T Consensus 166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 86644221 22345789999999999999999999999999999999999999654321100 0000
Q ss_pred --HHHHHHHhcC------CCCcccCccc----cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 456 --PLLNRAIEDG------NFDTLVDPKL----HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 456 --~~~~~~~~~~------~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+....... .+.+++...+ ...........+.+++.+||+.||++||++.|++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 0111111111 011112345567899999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=310.36 Aligned_cols=263 Identities=20% Similarity=0.262 Sum_probs=194.8
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCe-----
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--QGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQ----- 310 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~----- 310 (608)
++|...+.||+|+||.||+|... +|+.||||+++.... .....+.+|+.+++++. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999954 689999999865432 22356788999999995 6999999999887665
Q ss_pred eEEEEeeccCCcHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-CCceEEEEee
Q 046502 311 RMLVCEFVTSNTLEFHLHGKG---RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFG 386 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-~~~~kl~DFG 386 (608)
.++||||+.+ +|.+++.... ...+++..++.++.||++||.|||.. +|+|||||++|||++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999996 7877776432 23689999999999999999999998 9999999999999998 8999999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....... .+. ... ..+...
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~-~~~-~~~~~~ 231 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLL-HIF-KLLGTP 231 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHH-HHH-HHhCCC
Confidence 9985533211 1223356889999998865 457899999999999999999999986533211 000 000 000000
Q ss_pred C---CCcccC-------cccc----CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 N---FDTLVD-------PKLH----NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~---~~~~~d-------~~l~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. +....+ +... ..........+.+++..||+.+|.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 000000 0000 00011234567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.80 Aligned_cols=261 Identities=23% Similarity=0.360 Sum_probs=198.2
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+|+..++||+|+||.||+|+.. +|+.||||+++..... ....+.+|+.++++++|+||++++++|...+..+|||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999964 6889999998765332 3456778999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 319 TSNTLEFHLHGKG-RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 319 ~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
.+ +|.+++.... ...+++..+..++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 7777776543 34689999999999999999999998 899999999999999999999999999976543221
Q ss_pred eeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH----------HHhc--
Q 046502 398 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR----------AIED-- 464 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~----------~~~~-- 464 (608)
......++..|++||++.+. .++.++|||+|||++|+|++|+.||..... .+.+ ...+.. .+..
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN--EDQL-LKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHH-HHHHHHhCCCChhhHHHHhcCc
Confidence 12234578899999998654 578899999999999999999999875432 1111 111100 0000
Q ss_pred ---CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 465 ---GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 465 ---~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
..+....+..+ ..........+.+++..||+.||.+||++.||++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000 0111122456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=307.99 Aligned_cols=247 Identities=24% Similarity=0.309 Sum_probs=202.0
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
+|...++||.|+||.||++... +++.||+|++.... ....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999964 58999999997542 2345678899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.+++|.+++... ..+++..+..|+.++++||.|||.. +|+|+||+|+|||+++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999998765 3689999999999999999999998 89999999999999999999999999998665432
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
......|+..|++||++....++.++||||||+++|+|++|+.||........ . .+...... . .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~-~~~~~~~~--~--------~ 218 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----D-QIRAKQET--A--------D 218 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----H-HHHHHhcc--c--------c
Confidence 22335688899999999988899999999999999999999999975432101 1 11111111 0 0
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCH--HHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRI--SQIV 509 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm--~evv 509 (608)
...+......+.+++.+||+.||.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11222234678899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=315.85 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=206.2
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.+.|..-++||+||||.||-+.. .+|+-||.|++.+. ..+++..-.+|-.||.+++.+.||.|-..|+..+.++||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 35688899999999999999984 56999999988543 344556677899999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|..|+||+|.+||.+.+...+++...+.++.+|+.||++||+. +||+|||||+|||||+.|+++|+|+|||..+.+.
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 9999999999999998888999999999999999999999999 9999999999999999999999999999988765
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
... ...+||.||||||++.++.|+...|.|+|||+|||||.|+.||........ +.-+.+.+.+.
T Consensus 341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----~eEvdrr~~~~--------- 405 (591)
T KOG0986|consen 341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----REEVDRRTLED--------- 405 (591)
T ss_pred Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----HHHHHHHHhcc---------
Confidence 433 223799999999999999999999999999999999999999975433111 11122222111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPR 504 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs 504 (608)
..+|+....++...+....|+.||.+|.-
T Consensus 406 -~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 406 -PEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred -hhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 12344455566777888899999999964
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=307.48 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=198.2
Q ss_pred cccCCceEEEEEEec-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 248 LGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 248 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
||.|+||.||++... +|+.|++|++..... ...+.+.+|++++++++|+||+++++++..+...++||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999975 489999999875543 3456788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc-------
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT------- 396 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~------- 396 (608)
.+++.... .+++..+..++.||++||.|||+. +|+||||+++|||++.++.+||+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997654 589999999999999999999998 899999999999999999999999999875433211
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
.......++..|++||++....++.++||||||+++|||++|+.||..... . ..... +..+.+...
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~----~~~~~-~~~~~~~~~------ 221 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---E----EIFQN-ILNGKIEWP------ 221 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---H----HHHHH-HhcCCcCCC------
Confidence 122335678899999999888899999999999999999999999975432 1 11111 112222111
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.. ......+.+++.+||+.+|++||++.+|.+.|+
T Consensus 222 ~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 222 ED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 012456789999999999999999977776665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=308.55 Aligned_cols=241 Identities=27% Similarity=0.390 Sum_probs=191.9
Q ss_pred cccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 248 LGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 248 LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
||+|+||.||++.. .+|+.||+|.+.... ......+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 79999999999984 468899999986432 22345667899999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeee
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 403 (608)
.+++.......+++..++.++.|++.||.|||.. +|+||||+++|||++.++.+||+|||++...... .......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC--Ccccccc
Confidence 9999876655789999999999999999999998 8999999999999999999999999998765431 1122345
Q ss_pred cccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHH
Q 046502 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483 (608)
Q Consensus 404 gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 483 (608)
++..|++||++.++.++.++|||||||++|+|++|+.||........ ...+.... ... ...+....
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~----~~~------~~~~~~~~ 221 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRRT----LEM------AVEYPDKF 221 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhcc----ccc------cccCCccC
Confidence 78899999999888899999999999999999999999965432111 00111111 100 01112223
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHH
Q 046502 484 MARMVACAAACVRHSARRRPRISQ 507 (608)
Q Consensus 484 ~~~l~~l~~~Cl~~dp~~RPsm~e 507 (608)
...+.+++.+||+.+|.+||+..+
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 456788999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.96 Aligned_cols=265 Identities=23% Similarity=0.306 Sum_probs=199.2
Q ss_pred HHhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGS---- 309 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~---- 309 (608)
...++|...++||+|+||.||+|... +|+.||||+++.... .....+.+|++++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999964 588999999975432 23356778999999999999999999987654
Q ss_pred ------eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEE
Q 046502 310 ------QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 383 (608)
Q Consensus 310 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~ 383 (608)
..++|+||+++ .|..++... ...+++..++.|+.|++.||+|||+. +|+|||||++|||+++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999987 566666544 33689999999999999999999998 99999999999999999999999
Q ss_pred EeeccccccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 046502 384 DFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 384 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
|||++...............++..|++||++.+ ..++.++|||||||++|||++|+.||...... +.+ ..+ ....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~-~~~-~~~~ 234 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQL-ELI-SRLC 234 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHH-HHH-HHHh
Confidence 999998765433222233456888999998864 35788999999999999999999999754321 111 111 1111
Q ss_pred hcC---CCCccc--------C------ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 463 EDG---NFDTLV--------D------PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 463 ~~~---~~~~~~--------d------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... .+..+. + ..+...+ ......+.+++..||+.+|.+||++.+|+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 000000 0 0000001 0124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.71 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=204.6
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...++||+|+||.||++.. .+++.+|||.+.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999984 468899999987542 23345678899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 318 VTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
+++++|..++... ....+++..++.++.++++||.|||+. +++|+||+++||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999988652 234689999999999999999999998 9999999999999999999999999999876553
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
......++..|++||++.+..++.++||||||+++|||++|+.||...... . +...+..+.+..+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~-----~~~~~~~~~~~~~----- 221 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ---D-----LRYKVQRGKYPPI----- 221 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H-----HHHHHhcCCCCCC-----
Confidence 122245788999999999988999999999999999999999999754321 1 1122223333222
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++.+||+.+|++||++.+|+++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 ----PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 22345668999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.39 Aligned_cols=248 Identities=20% Similarity=0.281 Sum_probs=206.1
Q ss_pred cCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.-|...+.||+|.|..|-+++ .-.|..||||++.+.... ....+..||..|+.++|||||+||++......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346667789999999999998 458999999999765332 23456779999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE-ccCCceEEEEeeccccccCcc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL-DFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl-~~~~~~kl~DFGla~~~~~~~ 395 (608)
+=++|+|.++|..... .+.+....+++.||+.|+.|+|.. .+|||||||+||.+ ..-|-+||.|||++..+....
T Consensus 98 LGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999876543 689999999999999999999998 89999999999876 556889999999998776532
Q ss_pred cceeeeeecccCccChhhhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
..+..+|...|-|||++.+..|+ .++||||||||||-|++|+.||....+.+ .+..++|-.
T Consensus 174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------------TLTmImDCK 235 (864)
T KOG4717|consen 174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------------TLTMIMDCK 235 (864)
T ss_pred --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----------------hhhhhhccc
Confidence 34557899999999999988876 58999999999999999999998654411 112233321
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
-..+.....++.+||..||..||.+|-+..+|+..
T Consensus 236 --YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 236 --YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred --ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 12345667789999999999999999999999853
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=304.86 Aligned_cols=260 Identities=22% Similarity=0.304 Sum_probs=196.4
Q ss_pred CCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHhc---CCCCccceeeEEEeCCe-----
Q 046502 242 FSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--QGERVFQAEVEIISRV---HHKHLVSLVGYYTAGSQ----- 310 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l---~Hpniv~l~g~~~~~~~----- 310 (608)
|...++||+|+||.||+|... +++.||||+++.... .....+.+|+.++.++ +|+||++++++|...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999975 489999999974322 2234566788887776 59999999999988776
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.+++|||+.+ +|.+++.......++|..++.++.|+++||.|||+. +|+|+||+++|||++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999985 788888765444699999999999999999999998 899999999999999999999999999976
Q ss_pred ccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC----
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN---- 466 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---- 466 (608)
...... .....++..|+|||++.+..++.++|||||||++|||++|+.||..... .+.+ ..++......+.
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE--ADQL-DKIFDVIGLPSEEEWP 231 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh--HHHH-HHHHHHcCCCChHhcC
Confidence 643211 1233578899999999998999999999999999999999999865332 1111 111110000000
Q ss_pred ---------CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 467 ---------FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 467 ---------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+........ ..........+.+++.+||+.||.+||++.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 11112234567889999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=310.30 Aligned_cols=255 Identities=19% Similarity=0.250 Sum_probs=194.3
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCc
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNT 322 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gs 322 (608)
.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34456666666666665 7899999998754 33445679999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc------
Q 046502 323 LEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT------ 396 (608)
Q Consensus 323 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~------ 396 (608)
|.+++.......+++.....++.|+++||.|||+. +|+|||||++|||++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99999865445688999999999999999999999 899999999999999999999999999864432111
Q ss_pred ceeeeeecccCccChhhhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc-----
Q 046502 397 HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT----- 469 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~----- 469 (608)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... . .+.. + .+....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~----~~~~-~-~~~~~~~~~~~ 234 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--M----LLEK-V-RGTVPCLLDKS 234 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--H----HHHH-H-hccCccccccC
Confidence 11123457788999999876 358899999999999999999999997543210 0 0100 0 000000
Q ss_pred ---------------ccCccc----cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 ---------------LVDPKL----HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ---------------~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..++.. ...........+.+++.+||+.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 235 TYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred chhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 001100 011222334578889999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=307.86 Aligned_cols=242 Identities=25% Similarity=0.346 Sum_probs=187.8
Q ss_pred ccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHh---cCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 247 LLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISR---VHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~---l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
+||+|+||.||++.. .+++.||||.+.... ......+.+|..++.. .+|+||+.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999996 458899999986532 1222334455544443 479999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++...+ .++|..+..|+.|++.||.|||.. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~ 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence 999999887554 589999999999999999999998 89999999999999999999999999987554321 1
Q ss_pred eeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....|+..|+|||.+.. ..++.++|||||||++|||++|+.||......... .+...... .. ..
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~~~~------~~----~~ 217 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTLT------VN----VE 217 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-----HHHHHhhc------CC----cC
Confidence 23468999999999864 45889999999999999999999999653321111 11111100 01 11
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
.+......+.+++..||+.||.+|| ++.+++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2223345678899999999999999 59998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.47 Aligned_cols=263 Identities=24% Similarity=0.355 Sum_probs=197.0
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC--CchhHHHHHHHHHHHHhc-CCCCccceeeEEEeC--Cee
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG--SGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAG--SQR 311 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~--~~~ 311 (608)
..++|...+.||+|+||.||+|... +|+.||||++... .......+.+|+.+++++ +|+||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999964 5889999988542 223334577899999999 999999999998653 368
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+. ++|..++... .++|..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999998 4888888654 689999999999999999999998 9999999999999999999999999999865
Q ss_pred cCccc----ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH------
Q 046502 392 SDVYT----HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR------ 460 (608)
Q Consensus 392 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~------ 460 (608)
..... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+.+ ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~--~~~~-~~~~~~~~~~ 234 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN--QLEK-IIEVIGPPSA 234 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHhCCCCH
Confidence 43221 12234568999999998754 457889999999999999999999986543211 0000 0000
Q ss_pred ----HHhcCCCCcccC-------ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 ----AIEDGNFDTLVD-------PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ----~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+.......+++ ..+ ..........+.+++.+||+.+|.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPL-DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccch-hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000 000 00111134568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=302.12 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=205.9
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...+.||.|+||.||++... +++.|++|++..... .....+.+|++++++++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999964 588999999976533 4556788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 318 VTSNTLEFHLHGKG--RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
+++++|.+++.... ...+++..+..++.+++.||.|||+. +++|+||+++|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 35689999999999999999999998 99999999999999999999999999998765432
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.......|+..|+|||++....++.++||||||+++|+|++|+.||+.... ..+.... ....+..+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~-~~~~~~~~----- 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKI-LKGQYPPI----- 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHH-hcCCCCCC-----
Confidence 123335688999999999988899999999999999999999999865431 1111111 12222111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++.+||..+|++||++.+|+++
T Consensus 224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11233567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=289.28 Aligned_cols=249 Identities=26% Similarity=0.440 Sum_probs=197.8
Q ss_pred CcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEeecc
Q 046502 243 SDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
..+..||.|.-|.||+++. ..|..+|||.+.... ....+.+...+.++..-+ +|+||+.+|||..+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 4457799999999999995 458999999997654 444567788888888776 8999999999999999999999985
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
..++.+|..-. ..+++...-++...+++||.||.++- +||||||||+|||||+.|++||||||++.+.-+. ...
T Consensus 175 -~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--kAh 248 (391)
T KOG0983|consen 175 -TCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--KAH 248 (391)
T ss_pred -HHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--ccc
Confidence 35666665433 35788788899999999999999873 8999999999999999999999999999876653 334
Q ss_pred eeeecccCccChhhhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 400 TRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
++..|.+.|||||.+.- ..|+.++|||||||.|+||.||+-||...+...+ .+...+.+. . +.|.
T Consensus 249 trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~e--P----P~L~ 316 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNEE--P----PLLP 316 (391)
T ss_pred ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhcC--C----CCCC
Confidence 56779999999999853 4688999999999999999999999987554221 233333311 1 2332
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... .....+.+++..||+.|+.+||...+++++
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 221 134567889999999999999999999864
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=314.21 Aligned_cols=261 Identities=20% Similarity=0.269 Sum_probs=194.7
Q ss_pred CccccC--CceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQG--GFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
..||+| +||+||++.. .+|+.||||++.... ....+.+.+|+.+++.++|+||++++++|..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 357776 9999999985 478999999987543 22346788999999999999999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce--
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV-- 398 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 398 (608)
++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998876555689999999999999999999998 89999999999999999999999998654322111000
Q ss_pred ----eeeeecccCccChhhhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHH--------------
Q 046502 399 ----STRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLL-------------- 458 (608)
Q Consensus 399 ----~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~-------------- 458 (608)
.....++..|++||++.+. .++.++|||||||++|||++|+.||...... ..+...+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccch
Confidence 0112345679999999764 4789999999999999999999999654221 00000000
Q ss_pred -HHH----------------HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 459 -NRA----------------IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 459 -~~~----------------~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... +..+....+.+..+...........+.+|+.+||+.||++||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00000001111122222233456678999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=305.34 Aligned_cols=259 Identities=21% Similarity=0.299 Sum_probs=200.0
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
|...+.||+|++|.||++.. .+++.+++|+++..... ....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 55678899999999999986 46889999998754332 3467888999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+ +|.+++..+. ..+++..++.++.+++.||.|||.. +|+|+|||++|||++.++.+||+|||++....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 86 7777776543 3689999999999999999999998 89999999999999999999999999998765432 12
Q ss_pred eeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC---CCCcc----
Q 046502 399 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG---NFDTL---- 470 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~---- 470 (608)
.....++..|++||.+.+. .++.++||||||+++|+|++|+.+|....... .+.+ .. ..+... .+..+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~-~~-~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFK-IF-RTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HH-HHcCCCchHhcccchhhh
Confidence 2334578899999998776 78999999999999999999999986543211 1100 00 000000 00000
Q ss_pred ----------cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 ----------VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ----------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+..+ ..........+.+++..||+.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 231 RNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 11112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.10 Aligned_cols=250 Identities=22% Similarity=0.342 Sum_probs=198.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC-----CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Cee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG-----SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~ 311 (608)
.+|...++||+|+||.||+|.. .+++.||+|++... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788899999999999999985 46899999987532 123345788999999999999999999998764 468
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+++++|.+++...+ .+++...+.++.+++.||.|||+. +|+|+||||+|||++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999987544 488999999999999999999998 8999999999999999999999999999865
Q ss_pred cCccc--ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 392 SDVYT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 392 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
..... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... . .+....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~-~-- 226 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM------A-AIFKIATQP-T-- 226 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH------H-HHHHHHcCC-C--
Confidence 33111 1122356889999999999888999999999999999999999998643211 0 111111111 1
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+......+.+++..||+ ++.+||+..+++.+
T Consensus 227 ------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 227 ------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 111223344568889999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=321.13 Aligned_cols=262 Identities=21% Similarity=0.360 Sum_probs=195.8
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----Cee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG-----SQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~-----~~~ 311 (608)
.++|...++||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999984 568999999986432 23345678899999999999999999987654 357
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+.+ +|..++... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999975 777776543 589999999999999999999998 8999999999999999999999999999865
Q ss_pred cCccc--ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC---
Q 046502 392 SDVYT--HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG--- 465 (608)
Q Consensus 392 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--- 465 (608)
..... .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+ . .+...+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~-~-~~~~~~~~~~~~ 232 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QL-N-LILGVLGTPSQE 232 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HH-H-HHHHHcCCCCHH
Confidence 43211 11233568999999998754 468999999999999999999999996543210 00 0 000000000
Q ss_pred CCCcccC-------------cccc-CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 NFDTLVD-------------PKLH-NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~~~~~~d-------------~~l~-~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+..+.+ +... ..........+.+++.+||+.+|++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000 00001124568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.48 Aligned_cols=266 Identities=25% Similarity=0.363 Sum_probs=199.4
Q ss_pred HhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHh--cCCCCccceeeEEEeCC----ee
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISR--VHHKHLVSLVGYYTAGS----QR 311 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~--l~Hpniv~l~g~~~~~~----~~ 311 (608)
..+.....+.||+|.||.||+|.+ .|+.||||+|.. .+++.+.+|.+|.+. |+|+||+.|++.-..++ ++
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 345667789999999999999999 789999999975 345567778888776 48999999998754432 68
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED-----CHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~-----~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
+||.+|.++|+|.|+|... .++-...+++++.+|.||++||.. ..|.|.|||||+.||||..++.+.|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999999763 689999999999999999999964 56789999999999999999999999999
Q ss_pred ccccccCcc---cceeeeeecccCccChhhhhcCC----C--CCcchhhhHHHHHHHHHhCC----------CCCCCCcc
Q 046502 387 LAKLASDVY---THVSTRVMGTFGYLAPEYASSGK----L--TEKSDVFSFGVMLLELIIGC----------RPVDSTHT 447 (608)
Q Consensus 387 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~--t~ksDVwS~Gvll~elltG~----------~p~~~~~~ 447 (608)
||....... .......+||..|||||++...- + -..+||||||+|+||+.... .||...-+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 997654431 11234467999999999995432 1 13699999999999997532 34432111
Q ss_pred cccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 448 FMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 448 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
. +. ....+...+-..++...+..++ .+...+..|.++++.||..+|.-|-++-.|-+.|....
T Consensus 442 ~--DP-s~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 442 S--DP-SFEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred C--CC-CHHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 0 00 0001111111122222222222 34577888999999999999999999988888876544
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=309.74 Aligned_cols=244 Identities=25% Similarity=0.394 Sum_probs=197.5
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcHH
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLE 324 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~ 324 (608)
.+||+|+||.||++.. .+++.||||++..........+.+|+.++++++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 568999999987655556677899999999999999999999999999999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeeec
Q 046502 325 FHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMG 404 (608)
Q Consensus 325 ~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~g 404 (608)
+++... .+++.....++.|++.||+|||+. +|+|||||++|||++.++.++|+|||++........ ......|
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~ 178 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVG 178 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccccc
Confidence 987543 489999999999999999999998 899999999999999999999999999876543221 1233568
Q ss_pred ccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHH
Q 046502 405 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEM 484 (608)
Q Consensus 405 t~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 484 (608)
+.+|++||++.+..++.++|||||||++|+|++|..||...... .. + ..+..+.. ..+.. .....
T Consensus 179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~----~-~~~~~~~~-----~~~~~--~~~~~ 243 (292)
T cd06657 179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KA----M-KMIRDNLP-----PKLKN--LHKVS 243 (292)
T ss_pred CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HH----H-HHHHhhCC-----cccCC--cccCC
Confidence 89999999998888999999999999999999999998643221 00 1 11111110 01100 01123
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 485 ARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 485 ~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+.+++.+||+.+|.+||++.+|+++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 457788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=307.74 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=196.4
Q ss_pred CCCcCCccccCCceEEEEEEe----cCCcEEEEEEcccCCc----hhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL----PNGKEVAIKQLKAGSG----QGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~ 311 (608)
+|+..+.||+|+||.||++.. .+|+.||+|+++.... ...+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999985 3688999999875322 2345678899999999 599999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+++++|.+++.... .+.+.....++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999987653 588899999999999999999998 8999999999999999999999999999866
Q ss_pred cCcccceeeeeecccCccChhhhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
............|+..|+|||++... .++.++||||||+++|+|++|+.||...... .....+...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~~~-~~--- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK---NSQAEISRRILK-SE--- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc---ccHHHHHHHhhc-cC---
Confidence 44322223345689999999998753 4788999999999999999999998643221 011111111111 11
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVR 510 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~ 510 (608)
+ .++......+.+++.+||+.+|++|| ++.+++.
T Consensus 229 ---~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 ---P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0 11122335678899999999999997 5565554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=303.88 Aligned_cols=242 Identities=26% Similarity=0.331 Sum_probs=195.1
Q ss_pred cccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 248 LGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 248 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
||.|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++|+||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999964 48999999986532 23346789999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeee
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 403 (608)
.+++.... .+++..+..++.+++.||.|||+. +++|+|||++|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 99997653 489999999999999999999998 99999999999999999999999999998765432 223346
Q ss_pred cccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHH
Q 046502 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483 (608)
Q Consensus 404 gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 483 (608)
++..|++||++....++.++|||+||+++|+|++|..||..... + . ..+..... .+. ....++...
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~-~-~~~~~~~~-~~~--------~~~~~~~~~ 219 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---D-P-MEIYNDIL-KGN--------GKLEFPNYI 219 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC---C-H-HHHHHHHh-ccC--------CCCCCCccc
Confidence 78999999999888899999999999999999999999975432 0 0 01111111 111 011122222
Q ss_pred HHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 046502 484 MARMVACAAACVRHSARRRPR-----ISQIVR 510 (608)
Q Consensus 484 ~~~l~~l~~~Cl~~dp~~RPs-----m~evv~ 510 (608)
...+.+++..||+.+|++||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 457889999999999999999 566554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=296.22 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=203.3
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...++||+|+||.||++... +++.|+||.+..... .....+.+|++++.+++|+|++++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4777899999999999999854 578999999976654 3456789999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++... ..+++..+..++.+++.||.|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999998765 3589999999999999999999998 9999999999999999999999999999876543221
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|++||++....++.++|||+||+++|+|++|+.||..... .. .... ........
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~--~~~~-~~~~~~~~-------- 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MA--ALFR-IVQDDHPP-------- 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HH--HHHH-HhccCCCC--------
Confidence 2335688999999999888889999999999999999999999864321 11 1111 11111111
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
........+.+++.+||+.+|++||++.+++.
T Consensus 219 -~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 -LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11223456788999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=308.00 Aligned_cols=264 Identities=21% Similarity=0.247 Sum_probs=198.0
Q ss_pred CCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEeec
Q 046502 242 FSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
|...+.||+|+||.||+|+.. +++.|+||++..... .......+|+..+.+++ |+||++++++|..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999975 478899999875432 22334567999999999 999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
+++|.+++.......++|..++.++.|++.+|.|||+. +|+|+||+++|||++.++.++|+|||+++...... .
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~ 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence 78898888776545689999999999999999999998 89999999999999999999999999998654321 1
Q ss_pred eeeeecccCccChhhhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccch---------hhHHHHHHHHhcCCCC
Q 046502 399 STRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDN---------LARPLLNRAIEDGNFD 468 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~---------l~~~~~~~~~~~~~~~ 468 (608)
.....++..|+|||++. ...++.++||||||+++|||++|+.||.......... ....+.........+.
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23345788999999874 4457899999999999999999999986543211000 0000111000001111
Q ss_pred cccCccc---cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKL---HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+.... ...........+.+++.+||+.+|++||++.||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 001111124568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=307.72 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=195.0
Q ss_pred cCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCc-hhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSG-QGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|...+.||+|+||.||+|...+ ++.||||+++.... .....+..|+.++.++. |+||++++++|..+...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999754 89999999975432 23445667887777775 9999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.+ +|..++..... .+++..+..|+.++++||.|||..+ +|+||||+++|||++.++.+||+|||++........
T Consensus 95 ~~~~-~l~~l~~~~~~-~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 95 LMST-CLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred ccCc-CHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9864 66666654332 6899999999999999999999742 799999999999999999999999999976543222
Q ss_pred ceeeeeecccCccChhhhhcCC----CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 397 HVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
.....++..|+|||++.... ++.++||||||+++|||++|+.||...... ...+...+... ...+..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~~~~~ 241 (296)
T cd06618 171 --KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEE-PPSLPP 241 (296)
T ss_pred --ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCC-CCCCCC
Confidence 22335788999999987553 788999999999999999999998643210 11122222211 111110
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......++.+++.+||+.||.+||++.+|+++
T Consensus 242 -------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 -------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01234568889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=309.61 Aligned_cols=264 Identities=22% Similarity=0.252 Sum_probs=195.8
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~l 313 (608)
.++|...++||+|+||.||+|.. .+|+.||+|+++..... ....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 46789999999999999999996 45899999998754322 123456799999999999999999998754 56899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+ +|.+++.... ..+++..++.++.|+++||.|||.. +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999975 7777776532 3689999999999999999999998 899999999999999999999999999987654
Q ss_pred cccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH-------H---H
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR-------A---I 462 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-------~---~ 462 (608)
... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ........ . +
T Consensus 161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchhh
Confidence 221 1223345788999999865 457899999999999999999999997543211 11101100 0 0
Q ss_pred hcCCCCccc--CccccCcC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 463 EDGNFDTLV--DPKLHNEY---NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 463 ~~~~~~~~~--d~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+ ........ .......+.+++..||+.||++||++.||+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 00000000 00124456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=306.53 Aligned_cols=255 Identities=24% Similarity=0.300 Sum_probs=200.0
Q ss_pred CCCcCCccccCCceEEEEEEe----cCCcEEEEEEcccCC----chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 046502 241 GFSDANLLGQGGFGYVHKGVL----PNGKEVAIKQLKAGS----GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~ 311 (608)
+|...+.||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +|+||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999884 356889999987432 22335678899999999 599999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+.+++|.+++.... .+++..+..++.|++++|.|||.. +++||||||+|||++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999887543 588999999999999999999998 8999999999999999999999999999865
Q ss_pred cCcccceeeeeecccCccChhhhhcCC--CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
............|+..|++||++.+.. .+.++||||||+++|||++|..||...... .....+...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~-~~--- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ---NSQSEISRRILK-SK--- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc---chHHHHHHHHHc-cC---
Confidence 443222223356889999999987665 788999999999999999999998643211 111111111111 11
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
... .......+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 229 ---~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 ---PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111 11122457789999999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=308.87 Aligned_cols=262 Identities=23% Similarity=0.263 Sum_probs=193.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCC------
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGS------ 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~------ 309 (608)
.++|...++||+|+||.||+|.. .+++.||||++..... .....+.+|++++++++|+||++++++|...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45789999999999999999995 4689999999864322 22345668999999999999999999987654
Q ss_pred --eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeec
Q 046502 310 --QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL 387 (608)
Q Consensus 310 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGl 387 (608)
..++||||+.+ +|.+++.... ..+++..++.++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999975 6777775443 3589999999999999999999998 899999999999999999999999999
Q ss_pred cccccCccc---ceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 388 AKLASDVYT---HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 388 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
+........ .......++..|+|||++.+. .++.++||||||+++|||++|+.||......... ..+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~----~~~~~~~- 240 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL----TLISQLC- 240 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHh-
Confidence 986543211 112234578899999998664 3788999999999999999999998654321100 0111110
Q ss_pred cCCCCccc----------Cc-cccCcC---------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 DGNFDTLV----------DP-KLHNEY---------NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 ~~~~~~~~----------d~-~l~~~~---------~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+...+ +. .+.... .......+.+++.+||+.||.+||++.|++++
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 241 -GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred -CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 1100000 00 000000 00012346789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=330.53 Aligned_cols=250 Identities=27% Similarity=0.393 Sum_probs=203.6
Q ss_pred CcCCccccCCceEEEEEE-ecCCc----EEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 243 SDANLLGQGGFGYVHKGV-LPNGK----EVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~-~~~g~----~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
...++||.|+||+||+|. .+.|+ .||||++.... .+...+|.+|+-+|.+|.|+||++|+|+|.... +.||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 345789999999999998 45554 58999987654 344578999999999999999999999998765 899999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
||+.|+|.++++... ..+--+..+.|+.|||+||.|||++ +++||||.++||||..-..+||.|||++++...+..
T Consensus 778 ~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred hcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999998744 3677888999999999999999999 999999999999999999999999999998765544
Q ss_pred ceeee-eecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 397 HVSTR-VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 397 ~~~~~-~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
..... ..-.+.|||-|.+....|+.++|||||||.+||||| |..|++..... -+...++.|+- +
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--------eI~dlle~geR--L---- 919 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--------EIPDLLEKGER--L---- 919 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--------HhhHHHhcccc--C----
Confidence 33322 234678999999999999999999999999999996 99998764431 12223333321 2
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
..+......+.-++.+||..|++.||+++++...+..
T Consensus 920 ---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 920 ---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred ---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 2233455667888999999999999999999887653
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.45 Aligned_cols=254 Identities=19% Similarity=0.213 Sum_probs=183.0
Q ss_pred cCCCcCCccccCCceEEEEEEecC----CcEEEEEEcccCCchh--H---------HHHHHHHHHHHhcCCCCccceeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGSGQG--E---------RVFQAEVEIISRVHHKHLVSLVGY 304 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~--~---------~~~~~Ev~~l~~l~Hpniv~l~g~ 304 (608)
++|.+.++||+|+||.||+|...+ +..+|+|+........ + .....++..+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578899999999999999999644 3456777643322111 1 112223344556789999999998
Q ss_pred EEeCC----eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 305 YTAGS----QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 305 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
+.... ..++++|++.. ++.+.+.... ..++..+..|+.|+++||.|||+. +|+||||||+||||+.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 76543 34677887654 5555554322 357888899999999999999998 89999999999999999999
Q ss_pred EEEEeeccccccCcccc------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhh
Q 046502 381 KVADFGLAKLASDVYTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLA 454 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~ 454 (608)
||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... ...+.
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~--~~~~~ 243 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH--NGNLI 243 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc--chHHH
Confidence 99999999865422111 11224699999999999999999999999999999999999999975422 11111
Q ss_pred H----HHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 455 R----PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 455 ~----~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
. .++.+ +..+.+. .......+.+++..|++.+|++||++.+|++.|+
T Consensus 244 ~~~~~~~~~~-~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKR-LHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHH-hhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 1 11111 1111110 0112356888999999999999999999998774
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=300.30 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=214.8
Q ss_pred HHHHHHHhcCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeE
Q 046502 232 YEELARATDGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGY 304 (608)
Q Consensus 232 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~ 304 (608)
..||.....+|+...++-+|.||.||.|.+. +.+.|.||.++.. +......|..|..++..+.|+|+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3466666777999999999999999999653 3456778888754 33445678889999999999999999999
Q ss_pred EEeC-CeeEEEEeeccCCcHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC
Q 046502 305 YTAG-SQRMLVCEFVTSNTLEFHLHG------KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK 377 (608)
Q Consensus 305 ~~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~ 377 (608)
+.++ +..+++|.++.-|+|..+|.. +..+.+.-.+...++.|++.|++|||++ +|||.||.++|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8764 467899999999999999982 2335677788899999999999999999 99999999999999999
Q ss_pred CceEEEEeeccc-cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhH
Q 046502 378 FEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLAR 455 (608)
Q Consensus 378 ~~~kl~DFGla~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~ 455 (608)
.++||+|-.|+| ++..++.+...+......||++|.+....|+.++|||||||+||||+| |+.|+-..++++
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------ 506 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------ 506 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence 999999999998 556666666666777889999999999999999999999999999996 888987655522
Q ss_pred HHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 456 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 456 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
+...+++|. +-..+.+++.+++.+++-||...|++||++.|++.-|.
T Consensus 507 --m~~ylkdGy---------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 507 --MEHYLKDGY---------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred --HHHHHhccc---------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 222233331 11223467778999999999999999999999998875
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=325.30 Aligned_cols=241 Identities=25% Similarity=0.407 Sum_probs=193.9
Q ss_pred CCccccCCceEEEEEEe-cCCcEEEEEEccc----CCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe--eEEEEee
Q 046502 245 ANLLGQGGFGYVHKGVL-PNGKEVAIKQLKA----GSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ--RMLVCEF 317 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~----~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~--~~lV~E~ 317 (608)
..+||+|+|-+||||.+ .+|.+||--.++. ......+.|..|+.+|+.|+|+|||+||.+|.+... ..+|.|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 35799999999999995 3578887433322 123344789999999999999999999999987665 7899999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEeeccccccCccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFGla~~~~~~~~ 396 (608)
|..|+|..++...++ ++...+..|+.||++||.|||.+ +|+|||||||.+||+|+.+ |.+||+|+|||......
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-- 199 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc--
Confidence 999999999987654 88889999999999999999998 7899999999999999764 89999999999977653
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC---CCCcccCc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG---NFDTLVDP 473 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~d~ 473 (608)
....++||+.|||||... ..|++.+||||||+.++||+|+.-||..-.. ..++.++.+..- .|..+-|
T Consensus 200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n------~AQIYKKV~SGiKP~sl~kV~d- 270 (632)
T KOG0584|consen 200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN------PAQIYKKVTSGIKPAALSKVKD- 270 (632)
T ss_pred -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC------HHHHHHHHHcCCCHHHhhccCC-
Confidence 233489999999999988 7899999999999999999999999864332 112222222211 1222222
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.++.++|..||.. ...|+++.|++..
T Consensus 271 -----------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 271 -----------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2467789999999 9999999999964
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=315.48 Aligned_cols=267 Identities=19% Similarity=0.290 Sum_probs=198.3
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTA----GSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~----~~~~ 311 (608)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+|++++|+||++++++|.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36888999999999999999995 468999999987542 2334567789999999999999999998753 3568
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+. ++|.+++.... .+++..+..++.||+.||.|||.. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999996 58888886543 489999999999999999999998 8999999999999999999999999999765
Q ss_pred cCccc---ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHH-------HHH
Q 046502 392 SDVYT---HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL-------LNR 460 (608)
Q Consensus 392 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~-------~~~ 460 (608)
..... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||........-...... +..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 43211 11233568899999999865 46889999999999999999999999654321000000000 000
Q ss_pred HHhcCCCCcccCc-ccc-----CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 AIEDGNFDTLVDP-KLH-----NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ~~~~~~~~~~~d~-~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+....+. ... .+........+.+++..||+.+|++||++.+++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000 000 00112235678899999999999999999999975
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=315.95 Aligned_cols=274 Identities=22% Similarity=0.359 Sum_probs=200.6
Q ss_pred cCHHHHHHH----hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCcccee
Q 046502 230 FTYEELARA----TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLV 302 (608)
Q Consensus 230 ~~~~el~~~----~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~ 302 (608)
|..+|+..+ .++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++|+||++++
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 80 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence 344555555 37899999999999999999995 468999999986432 22235678899999999999999999
Q ss_pred eEEEeC------CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc
Q 046502 303 GYYTAG------SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF 376 (608)
Q Consensus 303 g~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~ 376 (608)
++|... ...++|+||+.. +|..++. ..+++..+..++.|+++||.|||.. +|+||||||+|||++.
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~ 152 (342)
T cd07879 81 DVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNE 152 (342)
T ss_pred heecccccCCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECC
Confidence 998754 346999999974 6766542 2488999999999999999999998 8999999999999999
Q ss_pred CCceEEEEeeccccccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH
Q 046502 377 KFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR 455 (608)
Q Consensus 377 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~ 455 (608)
++.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..
T Consensus 153 ~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~--~~~~~ 226 (342)
T cd07879 153 DCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQ 226 (342)
T ss_pred CCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 999999999999865332 223467889999999876 46889999999999999999999999754321 10100
Q ss_pred HH---------HHHHHhcCCCCcccC--cc-ccCcC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcCcc
Q 046502 456 PL---------LNRAIEDGNFDTLVD--PK-LHNEY---NHNEMARMVACAAACVRHSARRRPRISQIVRT--LEGDAS 517 (608)
Q Consensus 456 ~~---------~~~~~~~~~~~~~~d--~~-l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~--L~~~~~ 517 (608)
.+ +...+........++ +. ..... .......+.+++.+||+.||.+||++.+|+.+ +++...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 227 ILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00 000000000000000 00 00000 01123457899999999999999999999965 655443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=298.35 Aligned_cols=244 Identities=23% Similarity=0.279 Sum_probs=190.4
Q ss_pred CccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHH-HhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEII-SRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l-~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
+.||+|+||.||+|.. .+|+.||||++..... .....+..|..++ ..++|+||++++++|..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999985 4689999999875432 1223344555444 455899999999999999999999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
++|..++.... .+++..+..++.|++.||.|||.. +|+||||+|+|||++.++.+||+|||+++.... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999997643 588999999999999999999998 899999999999999999999999999875443 22
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
...++..|++||.+.+..++.++||||||+++|||++|..||..... .. ... .+..+.... .....
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~----~~~-~~~~~~~~~------~~~~~ 217 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DA----VFD-NILSRRINW------PEEVK 217 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HH----HHH-HHHhcccCC------CCccc
Confidence 34578899999999888899999999999999999999999965332 11 111 111111110 01111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 481 HNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 481 ~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
......+.+++.+||+.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 123456889999999999999998876665553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=302.28 Aligned_cols=242 Identities=25% Similarity=0.357 Sum_probs=187.7
Q ss_pred ccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHH---HHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 247 LLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVE---IISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~---~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
+||+|+||.||++.. .+++.||||.+.... ......+..|.. +++..+|+||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 458899999986532 122233444444 4444579999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++...+ .++|..++.|+.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 999999886543 599999999999999999999998 89999999999999999999999999987554321 1
Q ss_pred eeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....|+..|+|||++.++ .++.++|||||||++|||++|+.||.......... ........ +..+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~------~~~~--- 218 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----IDRMTLTM------AVEL--- 218 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-----HHHHhhcc------CCCC---
Confidence 234689999999999755 58999999999999999999999997543211111 11111111 1111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
.......+.+++.+||+.+|.+|| ++.+++++
T Consensus 219 -~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 -PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112245688899999999999999 89999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=299.22 Aligned_cols=249 Identities=25% Similarity=0.347 Sum_probs=200.6
Q ss_pred hcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchhHHH---HHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV---FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~---~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|.||.|.+++ ...|+.||||++++.....+.+ -..|-++|+..+||.+..|...|...+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4678888999999999999998 4579999999998765444333 34688999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.||.|..||.... .+++.....+-..|+.||.|||++ +||+||||.+|+|||.+|++||+||||++..-..
T Consensus 247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 99999999999997643 688888888899999999999998 9999999999999999999999999999853322
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
......++||+.|+|||++....|..++|.|.+|||+|||++|+.||...+. +.+...++. ++-+
T Consensus 322 -g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~---ed~k-------- 386 (516)
T KOG0690|consen 322 -GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILM---EDLK-------- 386 (516)
T ss_pred -cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHh---hhcc--------
Confidence 2344568999999999999999999999999999999999999999964332 122211111 1111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
++.....+-..|+...|..||.+|. .+.||.++
T Consensus 387 ----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 387 ----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred ----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 2222233445677889999999996 46666654
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=317.85 Aligned_cols=248 Identities=25% Similarity=0.360 Sum_probs=207.8
Q ss_pred HHhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
.....|.+...||+|.|+.|.+|+ ...+.+||||.+.+.... ..+.+.+|+++|..|+|||||+|+.+.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345778999999999999999998 456899999999765332 23458889999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+|.++++|...++ +.......++.|+.++++|||.+ .|||||||++||||+.+.++||+|||++..+..
T Consensus 133 V~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999988775 55578888999999999999999 899999999999999999999999999988763
Q ss_pred cccceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
.......+|++.|.|||++.+..| .+.+|+||+||+||-|+.|..||+.... .++-+
T Consensus 208 --~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------------------k~Lr~ 265 (596)
T KOG0586|consen 208 --GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------------------KELRP 265 (596)
T ss_pred --cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------------------ccccc
Confidence 445667899999999999998776 5799999999999999999999985432 11112
Q ss_pred ccccCcCC--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYN--HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~--~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+.+.+. .-....+-++++++|-.+|.+|+++.++.+.
T Consensus 266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 22222221 1223457788899999999999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.53 Aligned_cols=267 Identities=20% Similarity=0.300 Sum_probs=201.0
Q ss_pred cCHHHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEE
Q 046502 230 FTYEELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYT 306 (608)
Q Consensus 230 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~ 306 (608)
....++...+++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34467778889999999999999999999984 568999999987532 223456788999999999999999999886
Q ss_pred eC------CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 307 AG------SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 307 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
.. ...+++++++ +++|.+++... .+++..++.++.|+++||.|||+. +|+|||||++||+++.++.+
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 43 3467888877 67898877643 489999999999999999999998 89999999999999999999
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 459 (608)
||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+ ...+.
T Consensus 160 kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~-~~~~~ 232 (345)
T cd07877 160 KILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QL-KLILR 232 (345)
T ss_pred EEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH-HHHHH
Confidence 99999998865432 233467899999999866 568899999999999999999999986533211 00 00000
Q ss_pred HH----------HhcC-------CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 460 RA----------IEDG-------NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 460 ~~----------~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. +... .+.......+. +........+.+++..||+.||.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 0000 00000000000 0000123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=303.49 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=202.5
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC---CchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG---SGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...+.||+|+||.||++... +|+.||||++... .....+.+.+|++++++++ |+||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999964 6899999998653 2233467888999999998 99999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.+++|.+++.... .+++..++.|+.|++.||.|||+. +++|+|||++||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997654 599999999999999999999998 8999999999999999999999999999866442
Q ss_pred cc-------------------ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH
Q 046502 395 YT-------------------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR 455 (608)
Q Consensus 395 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~ 455 (608)
.. .......++..|++||.+....++.++||||||+++|+|++|+.||.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------ 229 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------ 229 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------
Confidence 21 11223457899999999998889999999999999999999999997543210
Q ss_pred HHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCH----HHHHH
Q 046502 456 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRI----SQIVR 510 (608)
Q Consensus 456 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm----~evv~ 510 (608)
.+.... ... ..+.......+.+++..||+.+|.+||++ .++++
T Consensus 230 -~~~~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 -TFQKIL-KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -HHHHHH-hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 111111 111 11122224568899999999999999999 66664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.56 Aligned_cols=247 Identities=26% Similarity=0.354 Sum_probs=194.5
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.|...+.||+|+||.||+|.. .+++.||||.+... .....+.+.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 366678899999999999995 45788999998642 22233567789999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+. ++|.+++.... ..+++..+..++.+++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 997 57777665433 3589999999999999999999998 8999999999999999999999999998765432
Q ss_pred ceeeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 397 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
....++..|+|||++. .+.++.++|||||||++|||++|+.||...... ..+... ..+......
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~-~~~~~~~~~-- 235 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHI-AQNESPALQ-- 235 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHHHH-hhcCCCCcC--
Confidence 2345788999999985 356888999999999999999999998543210 011111 111111110
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.......+.+++.+||+.+|++||++.+|+++..
T Consensus 236 ------~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 236 ------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred ------cccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 1123455788999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=315.04 Aligned_cols=268 Identities=19% Similarity=0.290 Sum_probs=198.6
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----Ce
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG-----SQ 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~-----~~ 310 (608)
.++|...+.||+|+||.||++.. .+++.||||++... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788999999999999999985 46899999998653 222344567899999999999999999988654 34
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999997 67888776543 589999999999999999999998 899999999999999999999999999986
Q ss_pred ccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH-------HHH
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN-------RAI 462 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-------~~~ 462 (608)
..... .......++..|+|||++.. ..++.++|||||||++|+|++|+.||...............+. ..+
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 64322 12233457889999998865 4688999999999999999999999965321100000000000 000
Q ss_pred hcCCC-------CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhc
Q 046502 463 EDGNF-------DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT--LEG 514 (608)
Q Consensus 463 ~~~~~-------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~--L~~ 514 (608)
..... ....+..+.. ........+.+++.+||+.+|++||++.||+++ |+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 237 RNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred CchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00000 0000000000 011234567899999999999999999999987 554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=306.61 Aligned_cols=244 Identities=27% Similarity=0.381 Sum_probs=192.8
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
|...+.||+|+||.||+|.. .+|+.|+||++..... .....+.+|++++++++|+|+++++++|.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66677899999999999985 4688999999864322 2335678899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+ +|.+++.... ..++|..++.++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 103 ~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CLG-SASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 974 6666665433 3589999999999999999999998 899999999999999999999999999864332
Q ss_pred eeeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 398 VSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.....|+..|+|||++. .+.++.++|||||||++|||++|..||...... ..+..... ........
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~-~~~~~~~~-- 242 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQ-NDSPTLQS-- 242 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHh-cCCCCCCc--
Confidence 12356889999999984 456888999999999999999999998654321 01111111 11111111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+.+++.+||+.+|.+||++.+++++
T Consensus 243 ------~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 ------NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122457889999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=296.81 Aligned_cols=250 Identities=22% Similarity=0.275 Sum_probs=194.0
Q ss_pred HHHHHHHhcCCCcCCcc--ccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEe
Q 046502 232 YEELARATDGFSDANLL--GQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTA 307 (608)
Q Consensus 232 ~~el~~~~~~f~~~~~L--G~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~ 307 (608)
..++....++|...+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +|+||++++++|..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34555666788887777 9999999999985 468889999986532211 123222222 69999999999999
Q ss_pred CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-ceEEEEee
Q 046502 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFG 386 (608)
Q Consensus 308 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-~~kl~DFG 386 (608)
.+..++||||+++++|.+++.... .++|..++.++.|+++||.|||+. +|+||||||+|||++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999997654 699999999999999999999998 899999999999999998 99999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 466 (608)
+++..... ....++..|+|||++.+..++.++|||||||++|||++|+.||..... +.+....+.... ...
T Consensus 156 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~-~~~ 226 (267)
T PHA03390 156 LCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED---EELDLESLLKRQ-QKK 226 (267)
T ss_pred cceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc---chhhHHHHHHhh-ccc
Confidence 98765432 123578999999999988999999999999999999999999974322 111111111111 000
Q ss_pred CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 046502 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-ISQIVR 510 (608)
Q Consensus 467 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-m~evv~ 510 (608)
. .........+.+++.+||+.+|.+|++ +.|+++
T Consensus 227 ~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 L----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred C----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 111134456788999999999999995 688874
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=309.16 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=197.2
Q ss_pred HHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--
Q 046502 235 LARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS-- 309 (608)
Q Consensus 235 l~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~-- 309 (608)
+....++|...+.||+|+||.||++.. .+|+.||||++.... ......+.+|+++|++++|+||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 344577899999999999999999984 568999999986432 223456788999999999999999999987543
Q ss_pred ----eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 310 ----QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 310 ----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
..++||||+ +++|.+++... .+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 67888887642 589999999999999999999998 8999999999999999999999999
Q ss_pred eccccccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH-----
Q 046502 386 GLAKLASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN----- 459 (608)
Q Consensus 386 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~----- 459 (608)
|+++..... .....++..|++||++.+ ..++.++|||||||++|+|++|+.||...... ..+ ...+.
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~-~~~~~~~~~~ 235 (343)
T cd07880 163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQL-MEIMKVTGTP 235 (343)
T ss_pred ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHHhcCCC
Confidence 999865432 223457889999999876 45889999999999999999999999754321 000 00000
Q ss_pred -----HHHhcCC-------CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 460 -----RAIEDGN-------FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 460 -----~~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+.... +..+....+ ..........+.+++.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000000000 00111223357899999999999999999999953
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=301.18 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=198.8
Q ss_pred CCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 242 FSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
|+..+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++++++|+||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999964 58999999998653 223456778999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
. ++|.+++.... ..+++..++.++.++++||.|||+. +|+||||+++||++++++.+||+|||+++....... .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 8 48999887653 3589999999999999999999998 899999999999999999999999999986654322 1
Q ss_pred eeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH-------HHH--------
Q 046502 399 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN-------RAI-------- 462 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~-------~~~-------- 462 (608)
.....++..|+|||++... .++.++|||||||++|||++|+.||...... +.+ ..... ..+
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI--DQL-FKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH--HHH-HHHHHHhCCCcHHHHHhhccccc
Confidence 2234467889999998776 7899999999999999999999998654321 000 00000 000
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+.......+...+ ......+.+++..||+.+|++||++.+|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00011111000000000 1124568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=306.64 Aligned_cols=264 Identities=21% Similarity=0.267 Sum_probs=194.2
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeC-------
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAG------- 308 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~------- 308 (608)
.++|...++||+|+||.||+|.. .+++.||||++...... ....+.+|++++++++|+||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999995 46899999998654322 234567899999999999999999987543
Q ss_pred -CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeec
Q 046502 309 -SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL 387 (608)
Q Consensus 309 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGl 387 (608)
..+++||||+.+ +|...+.... ..+++..+..++.|+++||.|||.. +|+|||||++|||+++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 346999999986 5666665432 3699999999999999999999998 899999999999999999999999999
Q ss_pred cccccCccc----------ceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHH
Q 046502 388 AKLASDVYT----------HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARP 456 (608)
Q Consensus 388 a~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~ 456 (608)
++....... ...+...++..|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~---~~~~ 238 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID---QLHL 238 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence 976543211 112335678899999988654 58899999999999999999999987543211 1111
Q ss_pred HHHHHH--hc------CCCCccc----C----ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 457 LLNRAI--ED------GNFDTLV----D----PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 457 ~~~~~~--~~------~~~~~~~----d----~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+..... .. ..+.... . +.+...+ ......+.+++.+||+.+|++||++.||+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 110000 00 0000000 0 0010000 1122568899999999999999999999853
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=312.30 Aligned_cols=262 Identities=20% Similarity=0.289 Sum_probs=200.4
Q ss_pred CCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-----eeE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS-----QRM 312 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~-----~~~ 312 (608)
+|...+.||.|+||.||+|... +++.||||++.... ....+.+.+|+.++++++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999964 48999999987643 334467889999999999999999999988775 789
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+.+ +|..++.... .+++..++.++.+++.||.|||.. +|+||||||+||||+.++.++|+|||++....
T Consensus 81 lv~e~~~~-~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchhh-hHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 99999984 7888886544 699999999999999999999998 89999999999999999999999999998765
Q ss_pred Cccc--ceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH-------H-
Q 046502 393 DVYT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR-------A- 461 (608)
Q Consensus 393 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-------~- 461 (608)
.... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||....... ........ .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChhHh
Confidence 4321 122334678899999999887 78999999999999999999999997543210 00000000 0
Q ss_pred --HhcCCCCcccC---ccc---cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 462 --IEDGNFDTLVD---PKL---HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 462 --~~~~~~~~~~d---~~l---~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.........+. ... ...........+.+++.+||+.+|++||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000000000 000 000111134567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=309.34 Aligned_cols=267 Identities=19% Similarity=0.309 Sum_probs=198.7
Q ss_pred HHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEe-CC
Q 046502 234 ELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTA-GS 309 (608)
Q Consensus 234 el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-~~ 309 (608)
++...+++|...++||+|+||.||++.. .+++.||||++... .....+.+.+|++++++++|+||++++++|.. +.
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3445788999999999999999999985 47899999988542 22334567789999999999999999998865 56
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
..++||||+. ++|..++... .+.+.....++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 ~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELLG-TDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehhc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 7899999994 6888887643 478888899999999999999998 89999999999999999999999999987
Q ss_pred cccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH--------HHHHH
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR--------PLLNR 460 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~--------~~~~~ 460 (608)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||............. .+...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54331 123457889999998866 568999999999999999999999996543211000000 00000
Q ss_pred HHhcCCCCcccCccccCcCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 AIEDGNFDTLVDPKLHNEYN-----HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.........+..-....... ......+.+++.+||+.+|++||++.+|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000001111 1123578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=289.87 Aligned_cols=265 Identities=23% Similarity=0.396 Sum_probs=206.7
Q ss_pred CHHHHHHHhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeC
Q 046502 231 TYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAG 308 (608)
Q Consensus 231 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~ 308 (608)
+|+++.+.|+ ++||+|+|+.|-.++ +.+|++||||++.+........+.+||+++.+.+ |+||+.|++||+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 4666666553 679999999999988 7899999999998887777778889999999996 99999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC---ceEEEEe
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVADF 385 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~---~~kl~DF 385 (608)
..+|||||.|.||.|..+|+... .+++.+..++..+|+.||.|||.+ +|.||||||+|||..+-. -+|||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999998654 589999999999999999999999 999999999999996544 4899999
Q ss_pred eccccc--cCcc----cceeeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc----ccc
Q 046502 386 GLAKLA--SDVY----THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHT----FME 450 (608)
Q Consensus 386 Gla~~~--~~~~----~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~----~~~ 450 (608)
.|..-. +.+- +......+|+..|||||++. ...|+.++|.||||||||-||+|..||-..-. +.+
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 887432 1111 12223467899999999862 34688999999999999999999999964321 111
Q ss_pred chh---hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 451 DNL---ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 451 ~~l---~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... ....+-..+.+|.++ +.|..+ .....+-.+++...|..|+.+|-++.+|+.+
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYe-FPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYE-FPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred CCccHHHHHHHHHHHhccCCc-CChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 111 222333445566652 333322 1223344567778888999999999999873
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=295.04 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=195.0
Q ss_pred CCCcCCccccCCceEEEEEEecC-CcEEEEEEcccC-----CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAG-----SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
+|...++||+|+||.||++.... +..+++|.++.. .......+..|+.++++++|+||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47778999999999999998543 445666665432 122334567799999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 315 CEFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
|||+++++|.+++.. .....+++..++.++.|++.||.|||+. +|+|+|||++|||++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998864 2334689999999999999999999998 9999999999999976 469999999997654
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
.... ......|+..|+|||++....++.++||||||+++|+|++|..||..... .. .... +..+....
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~-~~~~-~~~~~~~~--- 224 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LS-VVLR-IVEGPTPS--- 224 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HH-HHHH-HHcCCCCC---
Confidence 3221 22234578899999999888889999999999999999999999864321 10 1111 11222111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||+.+|++||++.|++++
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 ------LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 122344578889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=343.46 Aligned_cols=256 Identities=27% Similarity=0.378 Sum_probs=204.4
Q ss_pred HhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.+-+|....+||.|.||.||.|. .++|+-.|+|.++..... ....+.+|+.+|..|+|||||+.+|+-.+.+..+|-
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 35578889999999999999999 667888999998754332 335678899999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
||||.+|+|.+.+...+ .+++.....+-.|++.||.|||+. +|||||||+.||||+.+|.+|++|||.|+.+...
T Consensus 1313 MEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999987543 466667777889999999999999 9999999999999999999999999999877654
Q ss_pred ccc---eeeeeecccCccChhhhhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 395 YTH---VSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 395 ~~~---~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
... .....+||+.|||||++.+.. -..+.||||+|||++||+||++||..-+. ++ .+......|.-
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e~---aIMy~V~~gh~- 1459 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----EW---AIMYHVAAGHK- 1459 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----hh---HHHhHHhccCC-
Confidence 211 123578999999999996533 44589999999999999999999853221 11 12222223332
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
...+.....+=.+++..||+.||++|.++.|++++=-+
T Consensus 1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 22333455566789999999999999999988876433
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=308.21 Aligned_cols=261 Identities=24% Similarity=0.309 Sum_probs=194.4
Q ss_pred cCCCc-CCccccCCceEEEEEEec-CCcEEEEEEcccCCchh--------------HHHHHHHHHHHHhcCCCCccceee
Q 046502 240 DGFSD-ANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQG--------------ERVFQAEVEIISRVHHKHLVSLVG 303 (608)
Q Consensus 240 ~~f~~-~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~Ev~~l~~l~Hpniv~l~g 303 (608)
++|.. .++||+|+||.||+|... +++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34543 467999999999999954 68999999986543221 124678999999999999999999
Q ss_pred EEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEE
Q 046502 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 383 (608)
Q Consensus 304 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~ 383 (608)
+|..++..++||||+. ++|.+++.... .+++.....++.|++.||.|||+. +|+|||||++|||++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999997 58888886543 488999999999999999999998 89999999999999999999999
Q ss_pred EeeccccccCcc-------------cceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccc
Q 046502 384 DFGLAKLASDVY-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM 449 (608)
Q Consensus 384 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~ 449 (608)
|||+++...... ........++..|+|||++.+. .++.++|||||||++|||++|+.||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 999997654110 1111223468899999998764 4689999999999999999999999754321
Q ss_pred cchhhHHHHHHHHhcC---CCCccc------------CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 450 EDNLARPLLNRAIEDG---NFDTLV------------DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 450 ~~~l~~~~~~~~~~~~---~~~~~~------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+ .... ..+... .+.... ...+. .........+.+++..||+.+|++||++.||+.+
T Consensus 241 -~~~-~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 -DQL-GRIF-ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred -HHH-HHHH-HHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 111 0000 000000 000000 00000 0011224567899999999999999999999975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.55 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=194.4
Q ss_pred HHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeC------
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG------ 308 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~------ 308 (608)
+-..+|...++||+||||.|||++. -||+.||||++.... ...-..+.+|+.+|++|+|||||+++..|.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3445677778999999999999993 489999999997653 33345678899999999999999988543210
Q ss_pred --------------------------------------------------------------------------------
Q 046502 309 -------------------------------------------------------------------------------- 308 (608)
Q Consensus 309 -------------------------------------------------------------------------------- 308 (608)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 046502 309 ---------------------------------SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH 355 (608)
Q Consensus 309 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH 355 (608)
..+||-||||+..+|.++++.+.... .-...++++.+|++||.|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 12478899999999998888764211 35678899999999999999
Q ss_pred hcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc------C-----------cccceeeeeecccCccChhhhhcC-
Q 046502 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS------D-----------VYTHVSTRVMGTFGYLAPEYASSG- 417 (608)
Q Consensus 356 ~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~- 417 (608)
+. +||||||||.||+||.+..+||+|||+|+... + ......+..+||.-|+|||++.+.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 89999999999999999999999999998611 0 011123557899999999999654
Q ss_pred --CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhh
Q 046502 418 --KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACV 495 (608)
Q Consensus 418 --~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl 495 (608)
.|+.|+|+|||||||+||+. ||... |+ |-.....++.|.+... .++....+..=..++.+++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---ME----Ra~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTS---ME----RASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCch---HH----HHHHHHhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999986 35432 22 2223334456665544 2223344444567899999
Q ss_pred hcCCCCCCCHHHHHH
Q 046502 496 RHSARRRPRISQIVR 510 (608)
Q Consensus 496 ~~dp~~RPsm~evv~ 510 (608)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999985
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.16 Aligned_cols=262 Identities=20% Similarity=0.300 Sum_probs=194.1
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeC----------
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG---------- 308 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~---------- 308 (608)
.+|...+.||+|+||.||+|.. .+|+.||||++........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6788899999999999999995 46899999999776656667788999999999999999999776543
Q ss_pred ----CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-CCceEEE
Q 046502 309 ----SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVA 383 (608)
Q Consensus 309 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-~~~~kl~ 383 (608)
...++||||+. ++|..++... .+.+...+.++.||+.||.|||+. +|+|||||++|||++. ++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 4888777532 488999999999999999999998 8999999999999974 5678999
Q ss_pred EeeccccccCcccce--eeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 046502 384 DFGLAKLASDVYTHV--STRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 384 DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
|||+++......... .....++..|+|||++.. ..++.++|||||||++|||++|+.||........ . ...+..
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~-~~~~~~ 234 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--M-QLILES 234 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHh
Confidence 999997654322111 122457889999998754 4578899999999999999999999975432111 0 000000
Q ss_pred ----------HHhcCCCCcccCccccC-----cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 ----------AIEDGNFDTLVDPKLHN-----EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ----------~~~~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.........+....... .........+.+++..||+.||++||++.||+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000000000000000 0001123467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=330.43 Aligned_cols=254 Identities=27% Similarity=0.392 Sum_probs=203.8
Q ss_pred CCcCCccccCCceEEEEEEecC--------CcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 046502 242 FSDANLLGQGGFGYVHKGVLPN--------GKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~ 311 (608)
..+.+.||+|.||.|++|.+.. ...||||.++.... ...+.+..|+++|+.+ +|+||+.|+|+|...+..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 3445599999999999998431 35699999986543 4557899999999999 599999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCC------C--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC
Q 046502 312 MLVCEFVTSNTLEFHLHGKG------R--------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK 377 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~------~--------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~ 377 (608)
++|+||+..|+|..+|+.+. . ..+.....+.++.|||+|++||++. ++|||||.++||||..+
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCC
Confidence 99999999999999998765 0 1388899999999999999999999 89999999999999999
Q ss_pred CceEEEEeeccccccCcccceeeeee--cccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhh
Q 046502 378 FEAKVADFGLAKLASDVYTHVSTRVM--GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLA 454 (608)
Q Consensus 378 ~~~kl~DFGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~ 454 (608)
..+||+|||||+.......-....-. -...|||||.+....|+.|+|||||||+||||++ |..|+..... .
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~---- 528 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--T---- 528 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--H----
Confidence 99999999999965432211111111 2456999999999999999999999999999997 7788764221 1
Q ss_pred HHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 455 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 455 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
..++ ..+++|.- .+.+..+..++.++++.||+.+|++||++.|+++.|+.
T Consensus 529 ~~l~-~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 529 EELL-EFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HHHH-HHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1122 23444432 22233456678899999999999999999999999987
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=285.95 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=204.2
Q ss_pred HhcCCCcC-CccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEe----CCe
Q 046502 238 ATDGFSDA-NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTA----GSQ 310 (608)
Q Consensus 238 ~~~~f~~~-~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~----~~~ 310 (608)
.+++|++. ++||-|-.|.|-.+.. ..++.+|+|++... . ..++||++.-+. .|+|||.++++|.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-P----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-H----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666653 5799999999999884 56889999998743 2 235678776555 59999999998754 456
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---CCceEEEEeec
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGL 387 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---~~~~kl~DFGl 387 (608)
+++|||+|+||.|...+..++...+++.+...|+.||+.|+.|||.. +|.||||||+|+|... |-.+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 78999999999999999999888899999999999999999999999 9999999999999965 45689999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
|+...... .....+.|+.|.|||++...+|+..+|+||+||++|-||+|.+||...+.. . ..+-+++.++.|.+
T Consensus 211 AK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---a-ispgMk~rI~~gqy 284 (400)
T KOG0604|consen 211 AKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---A-ISPGMKRRIRTGQY 284 (400)
T ss_pred ccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---c-CChhHHhHhhccCc
Confidence 99765422 223356799999999999999999999999999999999999999766541 1 22345556666665
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. +-++.+ ....+...++++..|+.+|.+|-++.|++.+
T Consensus 285 ~-FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 285 E-FPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-CCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 2 222222 2345566778999999999999999999875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=328.96 Aligned_cols=146 Identities=29% Similarity=0.374 Sum_probs=131.5
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|.+.++||+|+||.||+|... +++.||||+++... ......+..|+.++..++|+||+++++++...+.+|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367889999999999999999964 68999999997542 22346788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
|||+.+++|.+++...+ .+++..++.|+.||+.||.|||.. +||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997643 488899999999999999999998 89999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=315.61 Aligned_cols=267 Identities=25% Similarity=0.354 Sum_probs=202.1
Q ss_pred CCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeC------CeeEE
Q 046502 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAG------SQRML 313 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~------~~~~l 313 (608)
|...+.||+|+||.||+|+ ...|+.||||.++.... ...+...+|+++|++|+|+|||++++.-+.. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3445789999999999999 66799999999987542 3345677899999999999999999875443 35689
Q ss_pred EEeeccCCcHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc--cCC--ceEEEEeecc
Q 046502 314 VCEFVTSNTLEFHLHGK-GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD--FKF--EAKVADFGLA 388 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~-~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~--~~~--~~kl~DFGla 388 (608)
|||||.+|+|...|..- +-..|++.+.+.++.+++.||.|||++ +||||||||.||++- .+| -.||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999999873 345799999999999999999999998 999999999999983 233 3799999999
Q ss_pred ccccCcccceeeeeecccCccChhhhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccc-cchhhHHHHHHH-----
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM-EDNLARPLLNRA----- 461 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~----- 461 (608)
|-..++. ..+.++||..|++||.+. .+.|+..+|.|||||++||++||..||....... ........+.+.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9887643 566789999999999998 4889999999999999999999999997543311 111111111110
Q ss_pred -----HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCC--CHHHHHHHhh
Q 046502 462 -----IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP--RISQIVRTLE 513 (608)
Q Consensus 462 -----~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP--sm~evv~~L~ 513 (608)
-++|.+..-.+-............++-.++..+|..++++|- ...+....+.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~ 308 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD 308 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence 011222111111112234455667777888889999999998 5444444443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.54 Aligned_cols=262 Identities=21% Similarity=0.259 Sum_probs=190.8
Q ss_pred CCCcCCccccCCceEEEEEEec-C--CcEEEEEEcccCC--chhHHHHHHHHHHHHhc-CCCCccceeeEEEeC----Ce
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-N--GKEVAIKQLKAGS--GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAG----SQ 310 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~--g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~----~~ 310 (608)
+|...+.||+|+||.||++... . ++.||||++.... ....+.+.+|+.+++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999954 3 7789999986432 22345678899999999 599999999976433 45
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
+++++||+. ++|..++.... .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788899886 57888876433 589999999999999999999998 899999999999999999999999999986
Q ss_pred ccCcccc---eeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH----------H
Q 046502 391 ASDVYTH---VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR----------P 456 (608)
Q Consensus 391 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~----------~ 456 (608)
....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ..+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV--DQLNQILQVLGTPDEE 232 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH--HHHHHHHHHhCCCCHH
Confidence 5432111 1233568999999998865 46899999999999999999999998754321 00000 0
Q ss_pred HHHHHHhcC------CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 457 LLNRAIEDG------NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 457 ~~~~~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+....... .+...-...+ ..........+.+++.+||+.||.+||++.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0000000000 00001123468889999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=318.45 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=215.8
Q ss_pred cCHHHHHHHhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEE-
Q 046502 230 FTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYT- 306 (608)
Q Consensus 230 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~- 306 (608)
..++.+..-++.|.+.+.||.|.+|.||+++ .++++.+|||++..+.. .++++..|.+||+.+ +|||++.++|+|.
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3445555667889999999999999999999 67889999999876543 345677899999888 6999999999986
Q ss_pred ----eCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEE
Q 046502 307 ----AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382 (608)
Q Consensus 307 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl 382 (608)
.++++|||||||.+|+..|++.+.....|.|..+..|+..+++||.+||.+ .+||||||-.||||+.++.+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 367999999999999999999886667899999999999999999999999 8999999999999999999999
Q ss_pred EEeeccccccCcccceeeeeecccCccChhhhhcC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHH
Q 046502 383 ADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL 457 (608)
Q Consensus 383 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 457 (608)
+|||++........ .....+||+.|||||++... .|+..+|+||||++..||--|.+|+..-++. +.+
T Consensus 165 vDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------raL 237 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------RAL 237 (953)
T ss_pred eeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------hhh
Confidence 99999876654332 23446799999999999654 4778999999999999999999998765541 101
Q ss_pred HHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 458 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 458 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
|...-.|...-.-+....+++.+++..||..|-++||++.+++++
T Consensus 238 ---------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 238 ---------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111112222223356778889999999999999999999999865
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.56 Aligned_cols=261 Identities=21% Similarity=0.353 Sum_probs=197.1
Q ss_pred HHhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe---
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ--- 310 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~--- 310 (608)
...++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 44678999999999999999999964 57899999986532 2233567789999999999999999998766554
Q ss_pred ---eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeec
Q 046502 311 ---RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL 387 (608)
Q Consensus 311 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGl 387 (608)
.++|+||+ +++|.+++... .+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999999 56898888652 589999999999999999999998 899999999999999999999999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH------
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR------ 460 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~------ 460 (608)
+...... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||...... ..+ ..++..
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~-~~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQL-KRIMNLVGTPDE 237 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHH-HHHHHhcCCCCH
Confidence 9865432 223457889999999865 36789999999999999999999999654321 000 000000
Q ss_pred ----HHhcCCCCcccC---ccccCcC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 ----AIEDGNFDTLVD---PKLHNEY---NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ----~~~~~~~~~~~d---~~l~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+.......++. ......+ .......+.+++.+||+.+|.+||++.+|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000000000000 0000000 01124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=292.34 Aligned_cols=260 Identities=26% Similarity=0.383 Sum_probs=201.4
Q ss_pred ccCHHHHHHHhcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEE
Q 046502 229 TFTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYY 305 (608)
Q Consensus 229 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~ 305 (608)
.|+-++|. ....||.|.||+|+|-. .+.|+..|||+++.... ....+|..|++...+- ++||||+++|.+
T Consensus 60 ~F~~~~Lq-------dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 60 TFTSDNLQ-------DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccchHH-------HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 45555553 35679999999999987 45799999999987654 4456788888876554 699999999999
Q ss_pred EeCCeeEEEEeeccCCcHHH---HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEE
Q 046502 306 TAGSQRMLVCEFVTSNTLEF---HLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382 (608)
Q Consensus 306 ~~~~~~~lV~E~~~~gsL~~---~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl 382 (608)
-.++..|+.||+|.- +|+. +++...+..+++...-+|..-.++||.||.+.. +||||||||+|||||..|.+||
T Consensus 133 F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEee
Confidence 999999999999963 5543 333334456888888899999999999999875 8999999999999999999999
Q ss_pred EEeeccccccCcccceeeeeecccCccChhhhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 046502 383 ADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 383 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
||||++..+.+.. ..+.-.|...|||||.+.. ..|+-++||||||+.|||+.||+.|+..+...++ ++ .
T Consensus 210 CDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe-----ql-~- 280 (361)
T KOG1006|consen 210 CDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE-----QL-C- 280 (361)
T ss_pred ecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH-----HH-H-
Confidence 9999997665432 2344578999999999853 3489999999999999999999999976544221 11 1
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+-.|++..+..+ ....+....|+.++..||.+|-.+||...++..+
T Consensus 281 ~Vv~gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 QVVIGDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHcCCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1234555444321 1123455678999999999999999999998754
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=284.69 Aligned_cols=236 Identities=28% Similarity=0.334 Sum_probs=193.1
Q ss_pred cccCCceEEEEEEec-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 248 LGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 248 LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
||+|+||.||++... +++.||+|++..... .....+..|+.++++++|+||+++++.+..++..++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999964 589999999875432 2345788999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeee
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 403 (608)
.+++.... .+++..+..++.|++.||.|||.. +++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99987654 589999999999999999999998 99999999999999999999999999998654421 1223456
Q ss_pred cccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHH
Q 046502 404 GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483 (608)
Q Consensus 404 gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 483 (608)
++..|++||.+.+...+.++|||+||+++|+|++|+.||..... . ........ +.+ .++...
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~----~~~~~~~~-~~~----------~~~~~~ 216 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---K----EIYEKILK-DPL----------RFPEFL 216 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---H----HHHHHHhc-CCC----------CCCCCC
Confidence 78899999999888899999999999999999999999965432 1 11111111 111 111122
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHH
Q 046502 484 MARMVACAAACVRHSARRRPRISQ 507 (608)
Q Consensus 484 ~~~l~~l~~~Cl~~dp~~RPsm~e 507 (608)
...+.+++..||..||++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 456788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=282.27 Aligned_cols=272 Identities=22% Similarity=0.318 Sum_probs=197.9
Q ss_pred HHhcCCCcCCccccCCceEEEEEEecC-----CcEEEEEEcccCCchh--HHHHHHHHHHHHhcCCCCccceeeEEEe-C
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVLPN-----GKEVAIKQLKAGSGQG--ERVFQAEVEIISRVHHKHLVSLVGYYTA-G 308 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~--~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-~ 308 (608)
+....|..+.+||+|+||.||||.-.+ .+.+|||+++...... -....+|+.+++.|+|+|||.|+.+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 344678889999999999999996322 3479999998653221 2345679999999999999999999887 7
Q ss_pred CeeEEEEeeccCCcHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC----CceE
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGK---GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK----FEAK 381 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~----~~~k 381 (608)
..++|++||.+.. |..+|+.. ....++-.....|+.||+.|+.|||++ =|+||||||.||||..+ |++|
T Consensus 101 ~~v~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 7899999999875 44444421 224678888899999999999999999 49999999999999877 8999
Q ss_pred EEEeeccccccCcccce--eeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccch--hhHH
Q 046502 382 VADFGLAKLASDVYTHV--STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDN--LARP 456 (608)
Q Consensus 382 l~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~--l~~~ 456 (608)
|+|||+++++.+..... ...++-|++|.|||++.+. .||.+.|||+.|||+.|||+-++-|.......... +...
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999999987754443 3457889999999998765 59999999999999999999888876443322221 1222
Q ss_pred HHHHHHhc-C-----CCCcccC-cc-------cc-CcCCHH----H-------HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 457 LLNRAIED-G-----NFDTLVD-PK-------LH-NEYNHN----E-------MARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 457 ~~~~~~~~-~-----~~~~~~d-~~-------l~-~~~~~~----~-------~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
.+.+.++- | ++..+.. |. .. ..++.. . ...-++|+..+|+.||.+|-++.|.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 22222221 1 1110000 00 00 000000 0 011567889999999999999999887
Q ss_pred Hh
Q 046502 511 TL 512 (608)
Q Consensus 511 ~L 512 (608)
+.
T Consensus 337 h~ 338 (438)
T KOG0666|consen 337 HP 338 (438)
T ss_pred cc
Confidence 64
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=296.54 Aligned_cols=255 Identities=29% Similarity=0.422 Sum_probs=193.3
Q ss_pred cCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchhH-------HHHHHHHHHHHhcCCCCccceeeEEE-eCCe
Q 046502 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-------RVFQAEVEIISRVHHKHLVSLVGYYT-AGSQ 310 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~-------~~~~~Ev~~l~~l~Hpniv~l~g~~~-~~~~ 310 (608)
++|-..++||+|||+.|||+. +...+.||||+-..+....+ +-..+|..|.+.|.|+.||++|+||. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 346668899999999999999 55678899998643322211 22457999999999999999999986 4566
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---CCceEEEEeec
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGL 387 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---~~~~kl~DFGl 387 (608)
+|-|+|||+|.+|+++|.... .+++.....|+.||+.||.||.+. .++|||-||||.||||-. -|.+||.||||
T Consensus 543 FCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 899999999999999997654 589999999999999999999987 678999999999999954 47899999999
Q ss_pred cccccCccc------ceeeeeecccCccChhhhhcC----CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHH
Q 046502 388 AKLASDVYT------HVSTRVMGTFGYLAPEYASSG----KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL 457 (608)
Q Consensus 388 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 457 (608)
++.+.++.. .......||++|++||.+.-+ +++.|+||||+|||+|+.|.|++||....... +-|..
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ-dILqe-- 696 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ-DILQE-- 696 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-HHHhh--
Confidence 998865422 234456899999999987544 57889999999999999999999998654311 11100
Q ss_pred HHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 046502 458 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIV 509 (608)
Q Consensus 458 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv 509 (608)
+.+++.....--..| ....+..++|.+||++.-++|-...|+.
T Consensus 697 -NTIlkAtEVqFP~KP--------vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 697 -NTILKATEVQFPPKP--------VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -hchhcceeccCCCCC--------ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 011111111111111 1223456788999999999998777665
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=299.62 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=200.2
Q ss_pred CCccccCCceEEEEEE-ecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCC
Q 046502 245 ANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
.++||.|-||+||-|+ .++|+.||||++.+. ....+..+++|+.||.+++||.||.|-..|+..+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 5789999999999998 567999999999653 3455678999999999999999999999999999999999999988
Q ss_pred cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC---CceEEEEeeccccccCcccce
Q 046502 322 TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 322 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~---~~~kl~DFGla~~~~~~~~~~ 398 (608)
-|+-+|.... ..|++.....++.||+.||.|||.+ +|+|+||||+||||... -++||||||+|+++++.. .
T Consensus 649 MLEMILSsEk-gRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F 722 (888)
T KOG4236|consen 649 MLEMILSSEK-GRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F 722 (888)
T ss_pred HHHHHHHhhc-ccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence 8887776543 3588888888999999999999999 99999999999999654 469999999999988742 3
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
...++||+.|+|||++..+.|...-|+||.||++|--|+|..||+...+ ++..+.+..|.-- .+
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd----------IndQIQNAaFMyP------p~ 786 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED----------INDQIQNAAFMYP------PN 786 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc----------hhHHhhccccccC------CC
Confidence 3458899999999999999999999999999999999999999975433 2222333222211 11
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
-..+....-++|+...||..=++|-+..+-+.+
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 122334456788888889888889888776653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.28 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=183.1
Q ss_pred hcCCCcCCccccCCceEEEEEEe-----------------cCCcEEEEEEcccCCchhHHH--------------HHHHH
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-----------------PNGKEVAIKQLKAGSGQGERV--------------FQAEV 287 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~--------------~~~Ev 287 (608)
.++|.+.++||+|+||.||+|.+ .+++.||||+++.......+. +..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999964 235689999997654332223 33477
Q ss_pred HHHHhcCCCCc-----cceeeEEEe--------CCeeEEEEeeccCCcHHHHhhcCCC----------------------
Q 046502 288 EIISRVHHKHL-----VSLVGYYTA--------GSQRMLVCEFVTSNTLEFHLHGKGR---------------------- 332 (608)
Q Consensus 288 ~~l~~l~Hpni-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~---------------------- 332 (608)
.++.+++|.++ +++++||.. .+..+|||||+.+++|.++|+....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 78888876654 678888753 3568999999999999999875321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeeecccCccChh
Q 046502 333 PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE 412 (608)
Q Consensus 333 ~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE 412 (608)
..++|..+..|+.|++.+|.|||.. +|+||||||+|||++.++.+||+|||+++..............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2347888999999999999999998 8999999999999999999999999999755432211112234578999999
Q ss_pred hhhcCC----------------------CCCcchhhhHHHHHHHHHhCCC-CCCCCcccccchhh--HHHHH--HHHhcC
Q 046502 413 YASSGK----------------------LTEKSDVFSFGVMLLELIIGCR-PVDSTHTFMEDNLA--RPLLN--RAIEDG 465 (608)
Q Consensus 413 ~~~~~~----------------------~t~ksDVwS~Gvll~elltG~~-p~~~~~~~~~~~l~--~~~~~--~~~~~~ 465 (608)
.+.... ...+.||||+|||||||++|.. ||.....+. ..+. ...+. +.+...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~-~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFN-TELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhh-hHHhhccchHHHHHhhccc
Confidence 875432 1235799999999999999875 664322111 1110 00011 111111
Q ss_pred CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCC---CCCCCHHHHHHH
Q 046502 466 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSA---RRRPRISQIVRT 511 (608)
Q Consensus 466 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp---~~RPsm~evv~~ 511 (608)
.+ +-.. .........+++..||..++ .+|+++.|++++
T Consensus 460 ~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 460 KY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 1001 11223456778888998765 789999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=282.78 Aligned_cols=220 Identities=20% Similarity=0.175 Sum_probs=176.5
Q ss_pred CCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcHHHHhhc
Q 046502 251 GGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHG 329 (608)
Q Consensus 251 G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 329 (608)
|.||.||++.. .+++.||+|+++... .+..|...+....|+||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999995 568999999997543 233455556666799999999999999999999999999999998875
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeeecccCcc
Q 046502 330 KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL 409 (608)
Q Consensus 330 ~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 409 (608)
.. .+++..+..++.|+++||.|||+. +|+||||||+|||++.++.++|+|||++...... .....++..|+
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~ 149 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC 149 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence 43 489999999999999999999998 8999999999999999999999999988655432 12234577899
Q ss_pred ChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHH
Q 046502 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVA 489 (608)
Q Consensus 410 aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 489 (608)
|||++....++.++|||||||++|||++|+.+++...... .. . ....+ +......+.+
T Consensus 150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~--~---~~~~~----~~~~~~~~~~ 207 (237)
T cd05576 150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NT--H---TTLNI----PEWVSEEARS 207 (237)
T ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------cc--c---cccCC----cccCCHHHHH
Confidence 9999988889999999999999999999998865321100 00 0 00011 1122345778
Q ss_pred HHHHhhhcCCCCCCCHH
Q 046502 490 CAAACVRHSARRRPRIS 506 (608)
Q Consensus 490 l~~~Cl~~dp~~RPsm~ 506 (608)
++.+||+.||++|+++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=301.50 Aligned_cols=240 Identities=23% Similarity=0.289 Sum_probs=194.7
Q ss_pred hcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++.|.....||.|+|+.|..+. ..+++..+||++.... ....+|+.++.+. +|+||+++++.|.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5667777889999999999988 5678999999997652 2334577666665 69999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE-ccCCceEEEEeeccccccCcc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL-DFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl-~~~~~~kl~DFGla~~~~~~~ 395 (608)
++.++.|.+.+..+.. +. ..+..|+.+|+.++.|||++ +||||||||+|||+ +..++++|+|||.++.....
T Consensus 397 ~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999999888776542 22 67778999999999999998 99999999999999 58899999999999877654
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
....+-|..|.|||++....|++++|+||||||||+||+|+.||...... . .+...+..+.+.
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~-ei~~~i~~~~~s------- 532 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------I-EIHTRIQMPKFS------- 532 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------H-HHHHhhcCCccc-------
Confidence 22234588999999999999999999999999999999999999754331 1 122223333332
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......-.+|+.+||+.||.+|++|.|+..+
T Consensus 533 -----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 -----ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -----cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 3334456789999999999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=273.95 Aligned_cols=238 Identities=27% Similarity=0.320 Sum_probs=194.8
Q ss_pred CceEEEEEEec-CCcEEEEEEcccCCchh-HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcHHHHhhc
Q 046502 252 GFGYVHKGVLP-NGKEVAIKQLKAGSGQG-ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHG 329 (608)
Q Consensus 252 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 329 (608)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+||+++++++......+++|||+.+++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 48999999998765544 67899999999999999999999999999999999999999999999876
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeeecccCcc
Q 046502 330 KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL 409 (608)
Q Consensus 330 ~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~ 409 (608)
... +++..++.++.+++++|.|||.. +|+|+||+++||+++.++.++|+|||++....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 543 89999999999999999999998 99999999999999999999999999998765432 223456888999
Q ss_pred ChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHH
Q 046502 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVA 489 (608)
Q Consensus 410 aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 489 (608)
+||.+....++.++|||+||+++|+|++|..||..... .. .+...+..+...... ........+.+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~-----~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 219 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LL-----ELFKKIGKPKPPFPP-------PEWKISPEAKD 219 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HH-----HHHHHHhccCCCCcc-------ccccCCHHHHH
Confidence 99999988899999999999999999999999865321 01 111112222111100 00003457888
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 046502 490 CAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 490 l~~~Cl~~dp~~RPsm~evv~ 510 (608)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.79 Aligned_cols=258 Identities=22% Similarity=0.271 Sum_probs=171.9
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-C----CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeE------EE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-N----GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGY------YT 306 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~------~~ 306 (608)
..++|...++||+|+||.||+|++. + ++.||||++..... .+.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999964 4 68999999864321 1111111 1222223333322221 24
Q ss_pred eCCeeEEEEeeccCCcHHHHhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccC
Q 046502 307 AGSQRMLVCEFVTSNTLEFHLHGKGRP------------------TMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIK 368 (608)
Q Consensus 307 ~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk 368 (608)
.+...+|||||+.+++|.+++...... ...+..+..|+.||+.||.|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 567899999999999999988754311 012234567999999999999998 89999999
Q ss_pred CCcEEEcc-CCceEEEEeeccccccCcccceeeeeecccCccChhhhhcC----------------------CCCCcchh
Q 046502 369 AANILLDF-KFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG----------------------KLTEKSDV 425 (608)
Q Consensus 369 ~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDV 425 (608)
|+||||+. ++.+||+|||+++..............+++.|||||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986644333334556789999999965322 24567799
Q ss_pred hhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC-----cccCcc----ccCcC--CHHHHHHHHHHHHHh
Q 046502 426 FSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD-----TLVDPK----LHNEY--NHNEMARMVACAAAC 494 (608)
Q Consensus 426 wS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-----~~~d~~----l~~~~--~~~~~~~l~~l~~~C 494 (608)
|||||+||||+++..+++..... +...+...... ..+.+. +...+ .........+|+.+|
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~---------~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQ---------FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHH---------HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence 99999999999987765432110 01111111000 001110 00000 000112345799999
Q ss_pred hhcCCCCCCCHHHHHHH
Q 046502 495 VRHSARRRPRISQIVRT 511 (608)
Q Consensus 495 l~~dp~~RPsm~evv~~ 511 (608)
|+.||++||++.|++++
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=285.43 Aligned_cols=240 Identities=28% Similarity=0.384 Sum_probs=192.2
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhH---HHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGE---RVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV 314 (608)
.+|..+.+||+|.||.|.++..+ ..+.||||+++.+..... +--..|-++|... +-|.++.|+.+|..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 45777899999999999999854 356799999987643222 2234466777666 468999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.||+|-++++.-++ +.+.....+|..||-||-|||++ +||+||||.+|||||.+|++||+|||+++.---.
T Consensus 429 MEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccC
Confidence 999999999999987664 77778889999999999999999 9999999999999999999999999999842211
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
......++||+.|+|||++....|...+|.|+|||+|||||.|+.||+..+. +.+.+ ++.+.+
T Consensus 504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~elF~-----aI~ehn-------- 566 (683)
T KOG0696|consen 504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQ-----AIMEHN-------- 566 (683)
T ss_pred -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHH-----HHHHcc--------
Confidence 1223457899999999999999999999999999999999999999987543 33322 222222
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCC
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRP 503 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 503 (608)
..|+.....+-+.+.+..|..+|.+|.
T Consensus 567 --vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 --VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 224444455566777888899999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=284.73 Aligned_cols=264 Identities=22% Similarity=0.317 Sum_probs=203.4
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCC--CC----ccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH--KH----LVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~H--pn----iv~l~g~~~~~~~~ 311 (608)
+++|.+..+||+|.||.|-++++. .+..||||+++.-... .+.-+-|+++|.++.+ |+ +|.+.+||.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 788999999999999999999853 4688999999865433 3344569999999942 22 67888899999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---------------
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF--------------- 376 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~--------------- 376 (608)
|||+|.+ |.++.++|..++...++...+..|+.|++++++|||+. +++|.||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999998 45899999988888899999999999999999999999 9999999999999832
Q ss_pred -----CCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCccc---
Q 046502 377 -----KFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTF--- 448 (608)
Q Consensus 377 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~--- 448 (608)
+..+||+|||.|++..+.. ..++.|..|.|||++.+-.++..+||||+||||+||.+|..-|......
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL 318 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL 318 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence 2458999999998765532 4467899999999999999999999999999999999999988654421
Q ss_pred --ccchh---hHHHHHH-----HHhcCCCC-----------cccCcc--c--cCcCCHHHHHHHHHHHHHhhhcCCCCCC
Q 046502 449 --MEDNL---ARPLLNR-----AIEDGNFD-----------TLVDPK--L--HNEYNHNEMARMVACAAACVRHSARRRP 503 (608)
Q Consensus 449 --~~~~l---~~~~~~~-----~~~~~~~~-----------~~~d~~--l--~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 503 (608)
|+.-+ ....+.+ ....|.++ ...++. | .......+..+|++|+..+|..||.+|.
T Consensus 319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri 398 (415)
T KOG0671|consen 319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI 398 (415)
T ss_pred HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence 11111 0011111 11112111 001100 0 0112345677899999999999999999
Q ss_pred CHHHHHHH
Q 046502 504 RISQIVRT 511 (608)
Q Consensus 504 sm~evv~~ 511 (608)
|++|++.+
T Consensus 399 Tl~EAL~H 406 (415)
T KOG0671|consen 399 TLREALSH 406 (415)
T ss_pred cHHHHhcC
Confidence 99999864
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=254.65 Aligned_cols=199 Identities=24% Similarity=0.359 Sum_probs=168.4
Q ss_pred CCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchh--HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQG--ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~--~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...++||+|.||+||||+ ...++.||+|+++.++..+ .....+||.+|+.|+|+|||+|+++...+..+-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999 4567889999997654322 34567899999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
|.. .|..+...-+. .++.+....++.|+++||.|+|.+ +++||||||.|+||+.+|+.||+|||+++.++-...+
T Consensus 83 cdq-dlkkyfdslng-~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred hhH-HHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 974 67777665443 589999999999999999999999 9999999999999999999999999999988765444
Q ss_pred eeeeeecccCccChhhhhcCC-CCCcchhhhHHHHHHHHHh-CCCCCCCC
Q 046502 398 VSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELII-GCRPVDST 445 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~Gvll~ellt-G~~p~~~~ 445 (608)
.+. .+-|.+|.+|.++.+.+ |+...|+||-||++.||.. |++-|...
T Consensus 158 ysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 158 YSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred eec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 433 45699999999998765 8899999999999999996 55555443
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.78 Aligned_cols=259 Identities=23% Similarity=0.256 Sum_probs=205.0
Q ss_pred HHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 046502 233 EELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG 308 (608)
Q Consensus 233 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~ 308 (608)
.++.-..++|.++++||+|+||.|..++. ..++.||+|++++. .......|..|-.+|..-+.+-||+|+..|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 45555678999999999999999999995 45889999999864 233446789999999999999999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
.++|||||||+||+|..+|...+ .+++.....++..|+-||.-||+. |+|||||||+|||||..|++||+|||.|
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 99999999999999999998766 577777888889999999999999 9999999999999999999999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhh----c-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYAS----S-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
-....+..-.+...+||+.|.+||++. + +.|...+|.||+||++||||.|..||. .+++...+-+ ++.
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY------adslveTY~K-Im~ 295 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY------ADSLVETYGK-IMN 295 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch------HHHHHHHHHH-Hhc
Confidence 888766666667788999999999984 2 679999999999999999999999985 3444333221 111
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR---ISQIVRT 511 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs---m~evv~~ 511 (608)
..+.-.+.|. .+......+||.+.+. ++++|-. +.++-.+
T Consensus 296 hk~~l~FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 296 HKESLSFPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hhhhcCCCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 1111111111 1122334445444443 6778877 7777765
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=292.99 Aligned_cols=202 Identities=24% Similarity=0.321 Sum_probs=171.8
Q ss_pred CCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 241 GFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
-|..++.||-|+||.|.++. .++...||+|.|++.+- ....-++.|-.||..-..+-||+||.-|.+.+.+|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 37778899999999999998 45567899999976532 223346789999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc--
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-- 394 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~-- 394 (608)
|++||++-.+|...+ .+.+.....++..+.+|+++.|.. ++|||||||+|||||.+|++||.|||||.-+...
T Consensus 710 YIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred ccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 999999999988765 578888888888999999999999 9999999999999999999999999998533210
Q ss_pred ------ccce---------------------------------eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHH
Q 046502 395 ------YTHV---------------------------------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435 (608)
Q Consensus 395 ------~~~~---------------------------------~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~el 435 (608)
..|. ....+||..|+|||++....|+.-+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 0000 0115799999999999999999999999999999999
Q ss_pred HhCCCCCCCCcc
Q 046502 436 IIGCRPVDSTHT 447 (608)
Q Consensus 436 ltG~~p~~~~~~ 447 (608)
+.|+.||-....
T Consensus 865 ~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 865 LVGQPPFLADTP 876 (1034)
T ss_pred hhCCCCccCCCC
Confidence 999999976544
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=267.96 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=190.5
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEe--------CC
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTA--------GS 309 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--------~~ 309 (608)
.|....+||+|.||.||+|+. +.|+.||+|++..+... ....-.+|+.+|..|+|+|+++|++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 345557899999999999995 45788999876432211 12334579999999999999999998853 23
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
.+||||++|+. +|.-+|... ...++..++.+++.++..||.|+|+. .|+|||+|+.|+||+.++.+||+|||+++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 57999999985 566666543 23588899999999999999999999 89999999999999999999999999997
Q ss_pred cccC---cccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 390 LASD---VYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 390 ~~~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
.+.. ......++.+-|.+|++||.+.+ ..|+.+.|||.-|||+.||.+|.+-+..+.....-.+...++ |
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~Lc------G 246 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLC------G 246 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHh------c
Confidence 6532 22233556677999999998865 469999999999999999999998876543321111111111 1
Q ss_pred CCCcccCcc--------------cc-CcCC--HHHHH------HHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 466 NFDTLVDPK--------------LH-NEYN--HNEMA------RMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 466 ~~~~~~d~~--------------l~-~~~~--~~~~~------~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
.+..-+-|. +. +.+. .+.+. .-++|+..++..||.+|+...+++.+-
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 111111110 10 1110 11111 356788999999999999999998763
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-33 Score=286.12 Aligned_cols=249 Identities=24% Similarity=0.333 Sum_probs=199.3
Q ss_pred cCCCcCCccccCCceEEEEEEecCCc-EEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGK-EVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~-~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.++..+..||-||||.|-+......+ .+|+|.+++. +....+-+..|-+||...+.+.||+||.-|.+...+|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34556677999999999999874433 3888888653 2333445667999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|-|-||.|-.+|+.++ .++..+...++..+++|++|||++ +||+|||||+|+|||.+|-+||.|||+|+......
T Consensus 500 EaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 9999999999998766 488888888999999999999999 99999999999999999999999999999887632
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.+-.++||+.|.|||++.+...+.++|.|+||+++||||+|.+||...++....++ + ++ | ++.
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~----I---Lk-G-id~------ 637 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL----I---LK-G-IDK------ 637 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH----H---Hh-h-hhh------
Confidence 34457999999999999999999999999999999999999999987765322221 1 11 1 111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPR-----ISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~~ 511 (608)
-+++......-.++++..++.+|..|.- +.+|-++
T Consensus 638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 638 -IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1233334445567788888999998875 4555543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=262.35 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=197.2
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~l 313 (608)
.++|...++||+|.|+.|.++.+ ++.+.||+|++++.- .....-++.|-.+..+- +||.+|.|+.+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46799999999999999999985 457889999997642 22334456677777665 79999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
|.||++||+|-.++.... .|+++....+...|.-||.|||++ +||+||||..|||||.+|++||.|+|+++..-.
T Consensus 329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999998887654 588888888999999999999999 999999999999999999999999999985433
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
. ......++||+.|.|||++.+..|....|.|+|||+++||+.|+.||+.......+.....++-+.+-+..+.
T Consensus 404 ~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir----- 477 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR----- 477 (593)
T ss_pred C-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-----
Confidence 2 2234568999999999999999999999999999999999999999986553333322333333333322221
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCC
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRP 503 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 503 (608)
.+.....+...+++.-|.+||..|.
T Consensus 478 -----iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 478 -----IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -----ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1112223345677888899998885
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=274.27 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=198.8
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-----C---CCccceeeEEE----
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-----H---KHLVSLVGYYT---- 306 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-----H---pniv~l~g~~~---- 306 (608)
.+|-..++||.|.|++||++++ .+.+.||+|+.+... .-.+.-..||.+|++++ | .+||+|+++|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 5788899999999999999995 457889999998543 33445678999999985 2 36999999986
Q ss_pred eCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC---------
Q 046502 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK--------- 377 (608)
Q Consensus 307 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~--------- 377 (608)
.+.++|||+|++. .+|..+|.....+.++...+.+|+.||+.||.|||++| +|||.||||+||||..+
T Consensus 157 NG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~ 233 (590)
T KOG1290|consen 157 NGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAR 233 (590)
T ss_pred CCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhh
Confidence 4668999999995 56667776666668999999999999999999999999 99999999999999400
Q ss_pred --------------------------------------------------------------------------------
Q 046502 378 -------------------------------------------------------------------------------- 377 (608)
Q Consensus 378 -------------------------------------------------------------------------------- 377 (608)
T Consensus 234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~ 313 (590)
T KOG1290|consen 234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE 313 (590)
T ss_pred hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence
Q ss_pred -----------------------------------------------------------------------------Cce
Q 046502 378 -----------------------------------------------------------------------------FEA 380 (608)
Q Consensus 378 -----------------------------------------------------------------------------~~~ 380 (608)
.++
T Consensus 314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v 393 (590)
T KOG1290|consen 314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV 393 (590)
T ss_pred cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence 024
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc--c--ccchhhH-
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHT--F--MEDNLAR- 455 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~--~--~~~~l~~- 455 (608)
||+|||-|..+.. ..+.-+.|..|+|||++.+..|...+|||||+|++|||+||..-|+.... + .++.++.
T Consensus 394 KIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i 469 (590)
T KOG1290|consen 394 KIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI 469 (590)
T ss_pred EEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence 6666666665432 12334568999999999999999999999999999999999998874321 1 1222211
Q ss_pred -HHHH----HHHhc-----------CCCCcccC-------ccccC--cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 456 -PLLN----RAIED-----------GNFDTLVD-------PKLHN--EYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 456 -~~~~----~~~~~-----------~~~~~~~d-------~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
.++. ..+.. |.+..+-. ..|.. ++..++...+.+++.-||+.+|++||++.+.++
T Consensus 470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhc
Confidence 1111 11122 22222211 11111 467788999999999999999999999999996
Q ss_pred H
Q 046502 511 T 511 (608)
Q Consensus 511 ~ 511 (608)
+
T Consensus 550 h 550 (590)
T KOG1290|consen 550 H 550 (590)
T ss_pred C
Confidence 4
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=252.36 Aligned_cols=202 Identities=28% Similarity=0.428 Sum_probs=166.5
Q ss_pred CCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
....+..||+|++|.|-+-+ ..+|+..|+|++.... .+..+.+.+|+++..+. .+|.+|.|+|.+......++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 33445779999999998887 4679999999997653 34456678899987765 699999999998888999999999
Q ss_pred ccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 318 VTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|.. +|+.+-.. +....+++..+-+|+..|..||.|||++. .|||||+||+||||+.+|++|+||||++-.+.+..
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 974 66654332 23346888999999999999999999986 89999999999999999999999999998766532
Q ss_pred cceeeeeecccCccChhhhhc----CCCCCcchhhhHHHHHHHHHhCCCCCCCCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASS----GKLTEKSDVFSFGVMLLELIIGCRPVDSTHT 447 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwS~Gvll~elltG~~p~~~~~~ 447 (608)
. .+-..|...|||||.+.. ..|+-|+||||||+.+.||.+++.|++.+..
T Consensus 204 A--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 204 A--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred H--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 1 222458889999999843 3689999999999999999999999987665
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=246.62 Aligned_cols=211 Identities=35% Similarity=0.538 Sum_probs=185.0
Q ss_pred cccCCceEEEEEEecC-CcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcHHH
Q 046502 248 LGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEF 325 (608)
Q Consensus 248 LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~ 325 (608)
||+|.+|.||++...+ ++.++||++...... ....+.+|+++++++.|++|+++++++......+++|||+.+++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 7899999999999754 899999999866443 34678899999999999999999999999999999999999999999
Q ss_pred HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-CCceEEEEeeccccccCcccceeeeeec
Q 046502 326 HLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKLASDVYTHVSTRVMG 404 (608)
Q Consensus 326 ~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~g 404 (608)
++.... ..+++..++.++.+++++|.|||+. +++|+||++.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 987653 3589999999999999999999999 9999999999999999 89999999999986654321 1233557
Q ss_pred ccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHH
Q 046502 405 TFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483 (608)
Q Consensus 405 t~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 483 (608)
...|++||.+... .++.+.|+|+||+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999999887 888999999999999998
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 484 MARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 484 ~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
..+.+++..|++.+|.+||++.++++.|
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4577899999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=290.59 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=186.2
Q ss_pred CcCCccccCCceE-EEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 243 SDANLLGQGGFGY-VHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 243 ~~~~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
...+++|.|..|+ ||+|.. +|++||||++-.. .....++||..|+.- .|+|||++++.-.+...+||+.|.|.
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 3345699999875 799998 7899999998643 234567899999988 59999999998888889999999996
Q ss_pred CcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-----CCceEEEEeeccccccC
Q 046502 321 NTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-----KFEAKVADFGLAKLASD 393 (608)
Q Consensus 321 gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-----~~~~kl~DFGla~~~~~ 393 (608)
.+|.+++... ......-...+.++.|++.||++||.. +||||||||.||||+. ..+++|+|||+++....
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 6999999874 111111134567889999999999996 9999999999999966 25799999999998765
Q ss_pred cccce--eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 394 VYTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIG-CRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 394 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
..... .....||-||+|||.+....-+.++||||||||+|..++| ..||..... ++ ..+..|++.-+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-------R~---~NIl~~~~~L~ 733 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-------RQ---ANILTGNYTLV 733 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-------hh---hhhhcCcccee
Confidence 43322 3457799999999999988888899999999999999986 889865322 11 11222222111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. |... .++ .-.+||.+|++.+|..||++.+|+.+
T Consensus 734 ~---L~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 H---LEPL--PDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred e---eccC--chH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1 1111 111 55679999999999999999999854
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=257.14 Aligned_cols=266 Identities=21% Similarity=0.263 Sum_probs=192.3
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEe-----CCeeEE
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTA-----GSQRML 313 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-----~~~~~l 313 (608)
.+..+-||.|+||.||..++ .+|+.||+|++.+-- ...-+.+.+|+.+|+.++|.|++.+++...- -+++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 45568899999999999985 469999999986432 2223456689999999999999998876532 235688
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
|.|+|.. +|..++-.. ..|+-..+.-++.||++||.|||.. +|+||||||.|+|++.|..+|||||||++....
T Consensus 135 ~TELmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 8888863 666666443 3577778888999999999999999 999999999999999999999999999997765
Q ss_pred cccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHH--------HHHHHhc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL--------LNRAIED 464 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~ 464 (608)
+.....+..+-|-.|.|||++++. .|+.+.||||.||++.|||..+.-|....+...-++...+ +..+.+.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 555555556679999999999875 5999999999999999999888777655442221221111 1222222
Q ss_pred CCCCcccC-------ccccCcC-CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 465 GNFDTLVD-------PKLHNEY-NHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 465 ~~~~~~~d-------~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.+-..+-. +.|..-. ....-.+-+.+...++..||++|-+..+.+.++.
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 11111111 1111100 1122233456778889999999999998887763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-29 Score=245.88 Aligned_cols=199 Identities=32% Similarity=0.449 Sum_probs=174.0
Q ss_pred CCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 242 FSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
|...+.||.|+||.||++...+ ++.++||.+...... ....+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567889999999999999765 889999999876554 56788999999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++..... .+++..+..++.+++.+|.|||.. +++|+||++.||+++.++.++|+|||++...........
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 9999999876542 288999999999999999999998 999999999999999999999999999987654321122
Q ss_pred eeeecccCccChhhh-hcCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 046502 400 TRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELIIGCRPVDS 444 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~Gvll~elltG~~p~~~ 444 (608)
....+...|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 345678899999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=266.79 Aligned_cols=196 Identities=25% Similarity=0.385 Sum_probs=167.9
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchh-----H---HHHHHHHHHHHhcC---CCCccceeeEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQG-----E---RVFQAEVEIISRVH---HKHLVSLVGYYTA 307 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----~---~~~~~Ev~~l~~l~---Hpniv~l~g~~~~ 307 (608)
..|...+.||+|+||.|++|+.+ +..+|+||.+.+...-. . -.+-.||+||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999954 56789999987542111 1 12456999999998 9999999999999
Q ss_pred CCeeEEEEeec-cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 308 GSQRMLVCEFV-TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 308 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
++.+||+||-. ++-+|.+++..+. .+++.....|+.||+.|+++||.. +|||||||-+||.||.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeecc
Confidence 99999999976 5668888887654 599999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCC
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVD 443 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~ 443 (608)
.+.+.... ....++||.+|.|||++.+.+| ...-|||++||+||.++....||.
T Consensus 716 saa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99876543 2345789999999999998876 456899999999999998888863
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=237.90 Aligned_cols=257 Identities=20% Similarity=0.315 Sum_probs=193.6
Q ss_pred hcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeC--CeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAG--SQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~--~~~~lV 314 (608)
.++|++.+++|+|.|+.||.|. ..+++.++||+++.- ..+.+.+|+.||..|. |+||++|++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678899999999999999998 567899999999853 4567889999999997 99999999988654 356799
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEeeccccccC
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLASD 393 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFGla~~~~~ 393 (608)
+||+++.+...+.. .|....+...+.++++||.|+|+. +|+|||+||.|++||.. ..++|+|+|||.+...
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999987765542 466677888999999999999999 99999999999999875 5699999999987654
Q ss_pred cccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH-------HHHHHHHhcC
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR-------PLLNRAIEDG 465 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~-------~~~~~~~~~~ 465 (608)
.. ...-.+.+..|--||++.. ..|+..-|+|||||+|..|+..+.||-..+... +.+.+ .-+...+..
T Consensus 186 ~~--eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIakVLGt~el~~Yl~K- 261 (338)
T KOG0668|consen 186 GK--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAKVLGTDELYAYLNK- 261 (338)
T ss_pred Cc--eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHHHhChHHHHHHHHH-
Confidence 21 1222346788999998855 458889999999999999999999997654322 22211 111111111
Q ss_pred CCCcccCccccC---cC------------C-HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 NFDTLVDPKLHN---EY------------N-HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~~~~~~d~~l~~---~~------------~-~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+...+|+.+.+ .. + .-...+.++++...|+.|-.+|+|++|...+
T Consensus 262 -Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 -YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred -HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11112222211 00 0 1112467789999999999999999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=271.63 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=203.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|.....+|.|.||.|||++. ..++..|||+++.........++.|+-+++..+|+|||.++|-+...+.++++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46788889999999999999994 56889999999988777777888999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
|.+|+|+++-|..+ .+++.++..+++..++||.|||.. +=+|||||-.|||+++.+.+|++|||.+..+.....
T Consensus 94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhh-
Confidence 99999999887765 589999999999999999999999 789999999999999999999999999865543211
Q ss_pred eeeeeecccCccChhhh---hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 398 VSTRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~---~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
....+.||+.|||||+. ..+.|..++|||++|+...||-.-+.|....++.. ..++ ...- .+++.
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-----~l~L---mTkS----~~qpp 235 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-----ALFL---MTKS----GFQPP 235 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-----HHHH---hhcc----CCCCC
Confidence 23457899999999986 56779999999999999999987777754333310 0011 1111 12221
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
-..+ .......+-+|++.|+..+|++||++..++.
T Consensus 236 ~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 1233445778999999999999999987765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=241.21 Aligned_cols=261 Identities=24% Similarity=0.301 Sum_probs=190.6
Q ss_pred cCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEe------CCe
Q 046502 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTA------GSQ 310 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~------~~~ 310 (608)
.+|.....+|.|.- .|..+. .-.++.||+|++... ....-+.-.+|+.++..++|+||++++.+|.- ..+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888888 555555 235789999988532 22223455679999999999999999999863 346
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.|+|||||. .+|...++- .++-.+..+|..|++.|+.|||+. +|+||||||+||+|..+..+||.|||+|+.
T Consensus 96 ~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 799999997 477766662 367778899999999999999999 999999999999999999999999999986
Q ss_pred ccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccc-----cchh---hHHHHHHHH
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM-----EDNL---ARPLLNRAI 462 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~-----~~~l---~~~~~~~~~ 462 (608)
.... -..+..+.+..|.|||++.+..|.+.+||||+||++.||++|+--|.+..... .+.+ ...+..+..
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 6543 35677888999999999998889999999999999999999998876432110 0000 000111100
Q ss_pred -------h------cCCCCcc-cCccccC--cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 463 -------E------DGNFDTL-VDPKLHN--EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 463 -------~------~~~~~~~-~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+ .-.+.++ -|..+.. +.+........+++..||-.+|++|-++++++++
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 0111111 1211111 1112233445679999999999999999999986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=252.49 Aligned_cols=265 Identities=23% Similarity=0.255 Sum_probs=198.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCC------CCccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH------KHLVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~H------pniv~l~g~~~~~~~~ 311 (608)
-..|......|+|-|++|..|.. ..|+.||||++.++..... .=+.|++||++|+. -|+++|+-.|...+++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K-tGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK-TGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh-hhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 35677778899999999999995 4488999999987644333 23469999999973 4789999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEeeccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGR-PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAK 389 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFGla~ 389 (608)
|||+|-+. .+|.++|...++ -.|....+..++.|+.-||..|... +|+|.||||.||||++. ..+||||||.|-
T Consensus 510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccc
Confidence 99999885 588888886543 4578888999999999999999875 99999999999999876 458999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcc-cccch---hhHHHHHHHHhcC
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHT-FMEDN---LARPLLNRAIEDG 465 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~-~~~~~---l~~~~~~~~~~~~ 465 (608)
...+.. .+.+.-+..|.|||++.+..|+...|+||.||.||||.||+.-|..... .|..- +.-.+-+..+..|
T Consensus 586 ~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 586 FASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred cccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 776532 2334457789999999999999999999999999999999998865322 11100 0000111222222
Q ss_pred CCCc-cc-----------C---------------c------ccc-----CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 046502 466 NFDT-LV-----------D---------------P------KLH-----NEYNHNEMARMVACAAACVRHSARRRPRISQ 507 (608)
Q Consensus 466 ~~~~-~~-----------d---------------~------~l~-----~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~e 507 (608)
.|.+ -+ | | .|. .+-....+..|.+|+..||..||.+|-+..|
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 2210 01 1 1 011 1122345667888999999999999999999
Q ss_pred HHHH
Q 046502 508 IVRT 511 (608)
Q Consensus 508 vv~~ 511 (608)
.+.+
T Consensus 743 AL~H 746 (752)
T KOG0670|consen 743 ALKH 746 (752)
T ss_pred HhcC
Confidence 8864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=244.04 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=196.9
Q ss_pred HHHHhcCCCcCCccccCCceEEEEEEec----CCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCC
Q 046502 235 LARATDGFSDANLLGQGGFGYVHKGVLP----NGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGS 309 (608)
Q Consensus 235 l~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~ 309 (608)
+....+.|..+++||+|.|+.||++++. ..+.||+|.+...+. ...+.+|+++|.++. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344577999999999999999999853 367899999976543 345789999999995 999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEeecc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLA 388 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFGla 388 (608)
...+||||++.....+++.. ++...+...+..+++||.++|.+ +||||||||+|+|.+.. ++-.|+|||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhH
Confidence 99999999999998888764 67788899999999999999999 99999999999999764 67899999999
Q ss_pred ccccC-----------------------------------ccc--------ceeeeeecccCccChhhhhc-CCCCCcch
Q 046502 389 KLASD-----------------------------------VYT--------HVSTRVMGTFGYLAPEYASS-GKLTEKSD 424 (608)
Q Consensus 389 ~~~~~-----------------------------------~~~--------~~~~~~~gt~~y~aPE~~~~-~~~t~ksD 424 (608)
..... .+. .......||+||.|||++.. ..-+.++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 72100 000 01112569999999999864 45788999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCcccccchhh--------HHHHHHHHhcCC------------------CCcccCcccc--
Q 046502 425 VFSFGVMLLELIIGCRPVDSTHTFMEDNLA--------RPLLNRAIEDGN------------------FDTLVDPKLH-- 476 (608)
Q Consensus 425 VwS~Gvll~elltG~~p~~~~~~~~~~~l~--------~~~~~~~~~~~~------------------~~~~~d~~l~-- 476 (608)
|||.|||++-+++++.||-...... +.+. ..+.+-+...|. ++.+.-..+.
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred eeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999985443211 1110 011111111222 1111000000
Q ss_pred -------CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 -------NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 -------~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..........+++++.+|+..||.+|-++.+.+++
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 01111123367899999999999999999999865
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-28 Score=281.74 Aligned_cols=196 Identities=14% Similarity=0.196 Sum_probs=140.2
Q ss_pred hcCC-CCccceeeEE-------EeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 046502 292 RVHH-KHLVSLVGYY-------TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363 (608)
Q Consensus 292 ~l~H-pniv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ii 363 (608)
.++| .||++++++| .+.+.++++|||+ +++|.++|.... ..+++..++.|+.||++||.|||++ +|+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 4456 6888888887 3334677889987 569999997543 3599999999999999999999998 999
Q ss_pred eeccCCCcEEEccC-------------------CceEEEEeeccccccCcc---------------cceeeeeecccCcc
Q 046502 364 HRDIKAANILLDFK-------------------FEAKVADFGLAKLASDVY---------------THVSTRVMGTFGYL 409 (608)
Q Consensus 364 HrDIk~~NILl~~~-------------------~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~y~ 409 (608)
||||||+||||+.. +.+||+|||+++...... .......+||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 99999999999654 455666666665321100 00011245888999
Q ss_pred ChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHH
Q 046502 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVA 489 (608)
Q Consensus 410 aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 489 (608)
|||++.+..|+.++|||||||+||||++|..|+..... . +. .+.... +.+.. ......+..
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~----~~-~~~~~~----~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----T----MS-SLRHRV----LPPQI-----LLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----H----HH-HHHHhh----cChhh-----hhcCHHHHH
Confidence 99999999999999999999999999999887642111 0 10 011110 11111 111234567
Q ss_pred HHHHhhhcCCCCCCCHHHHHHH
Q 046502 490 CAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 490 l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
++.+||+.+|.+||+|.||+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8889999999999999999874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=228.37 Aligned_cols=252 Identities=18% Similarity=0.299 Sum_probs=182.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeE-EEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGY-YTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~-~~~~~~~~lV~ 315 (608)
.+.|.+.+.||+|.||.+-++.. ...+.+++|-+... ....++|.+|...--.| .|.||+.-|++ |...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 45688899999999999999985 45778999988653 34457888898876666 49999988765 66677888999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE-cc-CCceEEEEeeccccccC
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL-DF-KFEAKVADFGLAKLASD 393 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl-~~-~~~~kl~DFGla~~~~~ 393 (608)
||++.|+|...+... .+-+....+++.|++.||.|||++ ++||||||.+|||| +. ..++||||||+.+..+.
T Consensus 102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999998877654 366778889999999999999999 99999999999999 33 34799999999886553
Q ss_pred cccceeeeeecccCccChhhhhcC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
. .....-+..|.+||..... .....+|||.||||+|.+|||+.|+.... .+....++ |+ .+..+...
T Consensus 176 t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~-~~--~w~~rk~~ 247 (378)
T KOG1345|consen 176 T----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWE-WE--QWLKRKNP 247 (378)
T ss_pred e----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHH-HH--HHhcccCc
Confidence 2 1223346679999987432 24668999999999999999999987332 12222222 22 22333222
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+ ...+.. ...+..++-++-|..++++|=...++.++
T Consensus 248 ~~-----P~~F~~-fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 AL-----PKKFNP-FSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cC-----chhhcc-cCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 22 122211 12334456677888899998555555444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=215.03 Aligned_cols=166 Identities=20% Similarity=0.245 Sum_probs=125.7
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceee
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 400 (608)
|+|.++++..+ ..++|.+++.|+.||++||.|||+. + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 68999997643 3699999999999999999999998 4 999999999999999 99998765421
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~ 480 (608)
..|++.|||||++.+..++.++|||||||++|||++|+.||...... ......++... ... ++.. ....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~-----~~~--~~~~-~~~~ 132 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGM-----PAD--DPRD-RSNL 132 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHh-----ccC--Cccc-cccH
Confidence 25899999999999999999999999999999999999998643221 11111111111 000 0000 0011
Q ss_pred HHHH--HHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 481 HNEM--ARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 481 ~~~~--~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.... ..+.+++.+||+.+|++||++.||++++..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 1222 268999999999999999999999998864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=232.99 Aligned_cols=174 Identities=18% Similarity=0.195 Sum_probs=133.7
Q ss_pred HhcCCCcCCccccCCceEEEEEEec--CCcEEEEEEcccC-----CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP--NGKEVAIKQLKAG-----SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~ 310 (608)
..++|...++||+|+||.||+|... +++.||||++... .....+.|.+|+++|++++|+|++..+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3467899999999999999999854 5777899987533 12235668999999999999999864332 246
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecc-CCCcEEEccCCceEEEEeeccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI-KAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDI-k~~NILl~~~~~~kl~DFGla~ 389 (608)
.+|||||+++++|... ... . ...++.+++++|.|||+. +|+|||| ||+|||++.++.+||+|||+++
T Consensus 93 ~~LVmE~~~G~~L~~~-~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred cEEEEEccCCCCHHHh-Ccc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 7999999999999632 111 1 146788999999999998 9999999 9999999999999999999998
Q ss_pred cccCcccc-------eeeeeecccCccChhhhhcCC------CCCcchhh
Q 046502 390 LASDVYTH-------VSTRVMGTFGYLAPEYASSGK------LTEKSDVF 426 (608)
Q Consensus 390 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~------~t~ksDVw 426 (608)
.+...... ..+..++++.|+|||++.... .+...|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 66543211 113567899999999985432 22346767
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=220.40 Aligned_cols=258 Identities=21% Similarity=0.239 Sum_probs=192.2
Q ss_pred CCCcCCccccCCceEEEEEEecCC--cEEEEEEcccCCchhHHHHHHHHHHHHhcCC----CCccceeeEE-EeCCeeEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPNG--KEVAIKQLKAGSGQGERVFQAEVEIISRVHH----KHLVSLVGYY-TAGSQRML 313 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~H----pniv~l~g~~-~~~~~~~l 313 (608)
+|...++||+|+||.||++..... +.+|+|............+..|+.++..+.. .++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996553 4789988766533333367789999999873 5888999888 47778899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-----CceEEEEeecc
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-----FEAKVADFGLA 388 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-----~~~kl~DFGla 388 (608)
||+.+ |.+|.++........++..+.++|+.|++.+|++||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99988 67899987655556799999999999999999999999 99999999999999765 46999999999
Q ss_pred c--cccCccc----ce---eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 046502 389 K--LASDVYT----HV---STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 389 ~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 459 (608)
+ ....... .. .....||..|+++....+...+.+.|+||++.++.||+.|..|+......... ..+.
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~----~~~~ 250 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK----SKFE 250 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH----HHHH
Confidence 8 3222111 11 12355999999999999999999999999999999999999998543321111 1111
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..... ..... .... ....+..+...+-..+...+|....+...|+..
T Consensus 251 ~~~~~----~~~~~--~~~~---~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 251 KDPRK----LLTDR--FGDL---KPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHhhh----hcccc--ccCC---ChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 11111 11110 1112 223344455555558999999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-23 Score=209.84 Aligned_cols=260 Identities=28% Similarity=0.366 Sum_probs=198.3
Q ss_pred CCcCCccccCCceEEEEEEecCCcEEEEEEcccCCch---hHHHHHHHHHHHHhcCCC-CccceeeEEEeCCeeEEEEee
Q 046502 242 FSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQ---GERVFQAEVEIISRVHHK-HLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~Ev~~l~~l~Hp-niv~l~g~~~~~~~~~lV~E~ 317 (608)
|...+.||.|+||.||++... ..+++|.+...... ....|.+|+.++..+.|+ +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999975 78999998765333 367789999999999988 799999999777778999999
Q ss_pred ccCCcHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-ceEEEEeeccccccCcc
Q 046502 318 VTSNTLEFHLHGKGR-PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKLASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~~ 395 (608)
+.+++|.+++..... ..+.......++.+++.+|.|+|.. +++||||||+|||++... .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999976654432 2588889999999999999999999 899999999999999988 79999999998655432
Q ss_pred cc-----eeeeeecccCccChhhhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 396 TH-----VSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 396 ~~-----~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
.. ......|+..|++||.+.. ..+....|+|++|++++++++|..||...... ........ .+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~-~~~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLK-IILELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHH-HHHhcCC
Confidence 22 2355789999999999987 57889999999999999999999997654321 00111111 1111111
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .....+...........+.+++..|+..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1 000011111112233567788999999999999999987764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=209.46 Aligned_cols=244 Identities=19% Similarity=0.315 Sum_probs=191.5
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCc
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNT 322 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gs 322 (608)
.-+|.+...|..|+|++ .|..+++|+++.. .....+.|..|.-.|+-+.||||+.++|.|....++.++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 34688899999999999 5556777887643 23334689999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEE--EeeccccccCcccceee
Q 046502 323 LEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA--DFGLAKLASDVYTHVST 400 (608)
Q Consensus 323 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~--DFGla~~~~~~~~~~~~ 400 (608)
|...||.......+-.+..++++++|+|++|||.. .+-|.---|....++||++..++|. |--++... .
T Consensus 274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe--------~ 344 (448)
T KOG0195|consen 274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE--------V 344 (448)
T ss_pred HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec--------c
Confidence 99999988777778889999999999999999997 4445555789999999999988873 32221111 1
Q ss_pred eeecccCccChhhhhcCCCC---CcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 401 RVMGTFGYLAPEYASSGKLT---EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t---~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
..+-.+.||+||.+....-+ .++|+|||.|+||||.|...||....+. +-. ++-+ -..|+.
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspm-ecg-----mkia----------leglrv 408 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM-ECG-----MKIA----------LEGLRV 408 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch-hhh-----hhhh----------hccccc
Confidence 12346889999999876533 4799999999999999999999765431 111 1111 123444
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
..+......|.+++.-|+..||.+||.+..|+-.||.
T Consensus 409 ~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 409 HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 5555666778899999999999999999999999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=199.68 Aligned_cols=179 Identities=13% Similarity=0.155 Sum_probs=139.3
Q ss_pred cCHHHHHHH--hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHH---------HHHHHHHHHhcCCCCc
Q 046502 230 FTYEELARA--TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERV---------FQAEVEIISRVHHKHL 298 (608)
Q Consensus 230 ~~~~el~~~--~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~---------~~~Ev~~l~~l~Hpni 298 (608)
..|.++... .++|...++||.|+||.||+... +++.+|||++........+. +.+|+..+.+++|++|
T Consensus 19 ~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI 97 (232)
T PRK10359 19 NKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGL 97 (232)
T ss_pred ccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCC
Confidence 345555544 57899999999999999999665 67789999997543333322 6899999999999999
Q ss_pred cceeeEEEeC--------CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCC
Q 046502 299 VSLVGYYTAG--------SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAA 370 (608)
Q Consensus 299 v~l~g~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~ 370 (608)
..+..++... ...+|||||++|.+|.++.. ++. .++.+++.+|..||+. +|+||||||+
T Consensus 98 ~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~ 164 (232)
T PRK10359 98 ASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKG 164 (232)
T ss_pred CcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChH
Confidence 9999886543 35789999999999988732 222 3456899999999999 9999999999
Q ss_pred cEEEccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHH
Q 046502 371 NILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 436 (608)
Q Consensus 371 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ell 436 (608)
|||++.++ ++|+|||..+........ -.++....|..++|||+||+.+..+.
T Consensus 165 Nili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 165 NFIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HEEEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988 999999988755321110 11455556778999999999987664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-23 Score=231.82 Aligned_cols=253 Identities=20% Similarity=0.225 Sum_probs=187.7
Q ss_pred CcCCccccCCceEEEEEEe-cCCcEEEEEEcc----cCC-ch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 243 SDANLLGQGGFGYVHKGVL-PNGKEVAIKQLK----AGS-GQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~----~~~-~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
...+++|.|.+|.|+.... ...+.++.|.+. ... .. ....+..|+.+-..|+|+|++..+..+.+....+.+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999998887763 334444444432 111 11 1122667888888999999988888777776666779
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|||++ +|..++...+ .+....+..++.|++.||.|||.. +|.|||||++|+|++.++.+||+|||.+..+.-..
T Consensus 401 E~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 9988887653 477778889999999999999999 89999999999999999999999999997665332
Q ss_pred c---ceeeeeecccCccChhhhhcCCCCC-cchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 396 T---HVSTRVMGTFGYLAPEYASSGKLTE-KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 396 ~---~~~~~~~gt~~y~aPE~~~~~~~t~-ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
. +....++|+-.|+|||++....|.. ..||||.||++..|++|+.||......... + .......+..
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~-~--------~~~~~~~~~~ 545 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS-F--------KTNNYSDQRN 545 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc-h--------hhhccccccc
Confidence 2 5566788999999999999888875 689999999999999999998765432111 0 0000000110
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
+..-..........+...++.++|+.+|.+|-+|.+|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 100111223445667788999999999999999999985
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-22 Score=191.74 Aligned_cols=140 Identities=16% Similarity=0.154 Sum_probs=109.5
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCch--h------------------------HHHHHHHHHHHHhcCCCCc
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQ--G------------------------ERVFQAEVEIISRVHHKHL 298 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~Ev~~l~~l~Hpni 298 (608)
...||+|+||.||+|...+|+.||||+++..... . ......|+.+|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999878999999999754211 0 1122349999999988877
Q ss_pred cceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeeccCCCcEEEccC
Q 046502 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL-HEDCHPKIIHRDIKAANILLDFK 377 (608)
Q Consensus 299 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yL-H~~~~~~iiHrDIk~~NILl~~~ 377 (608)
.....+.. ...+|||||+++++|...+... ..+++.....++.|++.+|.|| |.. +|+||||||+|||++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 54333322 2348999999998776543222 2588999999999999999999 677 899999999999998 4
Q ss_pred CceEEEEeecccccc
Q 046502 378 FEAKVADFGLAKLAS 392 (608)
Q Consensus 378 ~~~kl~DFGla~~~~ 392 (608)
+.++|+|||++....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.1e-22 Score=187.43 Aligned_cols=257 Identities=21% Similarity=0.280 Sum_probs=191.7
Q ss_pred hcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCC-CCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH-KHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~H-pniv~l~g~~~~~~~~~lV~E 316 (608)
.++|..+++||.|.||.+|.|. +.+|.+||||+-..... .-++.-|..+...|+| ..|..+..|..+.+.-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4678999999999999999998 78899999998664432 2356678999999975 567778888888888999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC---CceEEEEeeccccccC
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVADFGLAKLASD 393 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~---~~~kl~DFGla~~~~~ 393 (608)
++ |-+|++++.-..+ .++..+.+-++-|++.-|+|+|.+ ++|||||||+|+|+.-+ ..+.|+||||++.+.+
T Consensus 92 LL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 98 5799998876544 588999999999999999999999 79999999999999654 4589999999997765
Q ss_pred cccc------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 394 VYTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 394 ~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
..+. ...+..||..|.+=-...+..-+.+.|+=|+|.||..+.-|..||..........-. ..+.+.+.
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy-----EkI~EkK~ 241 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY-----EKISEKKM 241 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH-----HHHHHhhc
Confidence 3221 234467999999877777777788999999999999999999998765432111111 11112222
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
.-.+. .|.. ..+.++.-.+.-|-...-++-|...-+.+.+
T Consensus 242 s~~ie-~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF 281 (341)
T KOG1163|consen 242 STPIE-VLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF 281 (341)
T ss_pred CCCHH-HHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence 11111 1112 2234555667778888888888866555444
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=185.16 Aligned_cols=141 Identities=15% Similarity=0.121 Sum_probs=112.0
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCch---------------------h-----HHHHHHHHHHHHhcCCCCc
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQ---------------------G-----ERVFQAEVEIISRVHHKHL 298 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------------------~-----~~~~~~Ev~~l~~l~Hpni 298 (608)
...||+|+||.||+|...+|+.||||+++..... . ...+..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999999764211 0 1224678999999999988
Q ss_pred cceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeeccCCCcEEEccC
Q 046502 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE-DCHPKIIHRDIKAANILLDFK 377 (608)
Q Consensus 299 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~iiHrDIk~~NILl~~~ 377 (608)
.....+... ..+|||||++++++...+... ..++......++.+++.+|.|||. . +|+||||||+||||+ +
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 655444333 248999999988654432222 246778889999999999999999 7 999999999999999 8
Q ss_pred CceEEEEeeccccccC
Q 046502 378 FEAKVADFGLAKLASD 393 (608)
Q Consensus 378 ~~~kl~DFGla~~~~~ 393 (608)
+.++|+|||+++....
T Consensus 154 ~~~~liDFG~a~~~~~ 169 (190)
T cd05145 154 GKPYIIDVSQAVELDH 169 (190)
T ss_pred CCEEEEEcccceecCC
Confidence 8999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.3e-21 Score=188.92 Aligned_cols=199 Identities=24% Similarity=0.321 Sum_probs=168.8
Q ss_pred CCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEeec
Q 046502 241 GFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+|...++||+|.||.++.|+ +-+++.||||.-...+ ..-++..|....+.|. .++|..++.|-.++-+-.||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 67889999999999999999 6789999999854332 2235777888888885 789999998888888889999998
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-----CceEEEEeeccccccC
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-----FEAKVADFGLAKLASD 393 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-----~~~kl~DFGla~~~~~ 393 (608)
|-+|+|++.-.++ .++.++.+.||.|++.-++|+|++ .+|+|||||+|+||..- ..+.|+|||+|+...+
T Consensus 107 -GPSLEDLFD~CgR-~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR-RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhcC-cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 5799998876665 699999999999999999999999 89999999999999653 3489999999998766
Q ss_pred cccce------eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 046502 394 VYTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446 (608)
Q Consensus 394 ~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~ 446 (608)
..+.. ....-||..||+=....+..-+.+-|+=+||-|+..+|-|..||...+
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 44322 233569999999888888889999999999999999999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=181.15 Aligned_cols=184 Identities=16% Similarity=0.080 Sum_probs=140.7
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhH----HHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEee
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGE----RVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~----~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.....|+.|+||+||.+.. .+..++.+.+........ ..|.+|+++|++|+ |++|.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997765 678888888876543222 25789999999995 5889999886 447999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeecc-CCCcEEEccCCceEEEEeeccccccCccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI-KAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDI-k~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
+.|.+|...+.. ....++.+++++|.+||.. +|+|||| |++|||++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998754321 1235778999999999999 9999999 79999999999999999999985543221
Q ss_pred c-----------e-eeeeecccCccChhhhhcC-CCC-CcchhhhHHHHHHHHHhCCCCCC
Q 046502 397 H-----------V-STRVMGTFGYLAPEYASSG-KLT-EKSDVFSFGVMLLELIIGCRPVD 443 (608)
Q Consensus 397 ~-----------~-~~~~~gt~~y~aPE~~~~~-~~t-~ksDVwS~Gvll~elltG~~p~~ 443 (608)
. . ......++.|+.|+...-. ..+ ...+.++-|..+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 1123468889999865322 223 45788899999999999988753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8e-21 Score=203.23 Aligned_cols=216 Identities=24% Similarity=0.412 Sum_probs=164.7
Q ss_pred HHhcCCCCccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-eeeccC
Q 046502 290 ISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI-IHRDIK 368 (608)
Q Consensus 290 l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~i-iHrDIk 368 (608)
|+.+.|.|+.+|+|.|.++...++|.+||..|+|.+.+... ...++|.....++.+|+.||.|||.. .| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 35678999999999999999999999999999999999873 34799999999999999999999987 44 999999
Q ss_pred CCcEEEccCCceEEEEeeccccccCc-ccceeeeeecccCccChhhhhcC-------CCCCcchhhhHHHHHHHHHhCCC
Q 046502 369 AANILLDFKFEAKVADFGLAKLASDV-YTHVSTRVMGTFGYLAPEYASSG-------KLTEKSDVFSFGVMLLELIIGCR 440 (608)
Q Consensus 369 ~~NILl~~~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwS~Gvll~elltG~~ 440 (608)
..|+++|..+.+||+|||+..+..+. .........-..-|.|||.+... ..+.+.||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998766421 01111122245679999998763 14678999999999999999999
Q ss_pred CCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 441 PVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 441 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
||+........ ..++.+ +++ .-...+.|.+.... +....++.++..||..+|..||++.+|-..++...
T Consensus 157 ~~~~~~~~~~~---~eii~~-~~~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDP---DEIILR-VKK-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCCh---HHHHHH-HHh-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 99865432221 111222 222 11222233332111 33347899999999999999999999998887543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=217.00 Aligned_cols=251 Identities=22% Similarity=0.216 Sum_probs=180.1
Q ss_pred CCCcCCccccCCceEEEEEEecCCcEEEEEEcccCC-chhHHHHHHHHHH--HHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS-GQGERVFQAEVEI--ISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~Ev~~--l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+|...+.||.+.|=.|.+|+.+.|. |+||++-+.. ....+.|.++++- ...++|||++.+..+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666788999999999999987777 8999985433 3344445444433 4455899999988887777777899999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc--ccCcc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL--ASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~--~~~~~ 395 (608)
+.+ +|.|.|.. ++.|...+.+-|+.|++.||..+|+. +|+|||||.+||||+.=.-+.|+||.--+. ..++.
T Consensus 103 vkh-nLyDRlST--RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLST--RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhcc--chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 875 77777743 45678888889999999999999999 999999999999999988899999987652 23222
Q ss_pred cceeeee----ecccCccChhhhhcC-----------CCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHH
Q 046502 396 THVSTRV----MGTFGYLAPEYASSG-----------KLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 396 ~~~~~~~----~gt~~y~aPE~~~~~-----------~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~ 459 (608)
....+-+ ..-.+|+|||.+... .++.+-||||+||+++||++ |+++|+.... +.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----------~a 246 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----------LA 246 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----------Hh
Confidence 1111111 123479999987542 26788999999999999997 6777763321 11
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
++.|. .......| .+. +-..+.++++.|++.||.+|-++.++++.-.|.
T Consensus 247 --Yr~~~-~~~~e~~L-e~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 --YRSGN-ADDPEQLL-EKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred --HhccC-ccCHHHHH-HhC---cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11221 00000001 000 011467899999999999999999999986664
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=177.54 Aligned_cols=137 Identities=18% Similarity=0.191 Sum_probs=108.0
Q ss_pred CCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-----CCCCccceeeEEEeCC---e-eE
Q 046502 242 FSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-----HHKHLVSLVGYYTAGS---Q-RM 312 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-----~Hpniv~l~g~~~~~~---~-~~ 312 (608)
....++||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ .|+||++++|++..+. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 3234444 79998765555667899999999999 5799999999998763 3 33
Q ss_pred EEEee--ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeeccCCCcEEEcc----CCceEEEEe
Q 046502 313 LVCEF--VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGL-AYLHEDCHPKIIHRDIKAANILLDF----KFEAKVADF 385 (608)
Q Consensus 313 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L-~yLH~~~~~~iiHrDIk~~NILl~~----~~~~kl~DF 385 (608)
+|+|| +.+++|.+++... .+++. ..++.+++.++ +|||++ +|+||||||+|||++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5689999999653 25554 35677888887 999999 9999999999999974 347999995
Q ss_pred ecc
Q 046502 386 GLA 388 (608)
Q Consensus 386 Gla 388 (608)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.5e-21 Score=204.40 Aligned_cols=225 Identities=27% Similarity=0.307 Sum_probs=174.0
Q ss_pred ccccCCceEEEEEE----ecCCcEEEEEEcccCCchh--HHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEeecc
Q 046502 247 LLGQGGFGYVHKGV----LPNGKEVAIKQLKAGSGQG--ERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~~--~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
.+|+|.||.|+++. .+.|+.+|+|+++...... ......|-.++..++ |+.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999765 2357789999987543211 113455788888887 9999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+|.|..++.... .+++.........++-++++||.. +|+|||+|++||+++.+|++|+.|||+.+..-+....
T Consensus 81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-- 153 (612)
T ss_pred cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--
Confidence 999987775443 466667777788899999999999 9999999999999999999999999999866543221
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
+||..|||||++. .....+|.||||++++||++|..||.. +. +.++++. .-.+
T Consensus 154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~----~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DT----MKRILKA-----------ELEM 206 (612)
T ss_pred ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HH----HHHHhhh-----------ccCC
Confidence 7999999999998 456789999999999999999999864 11 1111110 0122
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCH
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRI 505 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm 505 (608)
+.+......+++..++..+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 33444455567777778888888655
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=183.30 Aligned_cols=231 Identities=19% Similarity=0.271 Sum_probs=148.7
Q ss_pred CCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCC----------CCccceeeE---
Q 046502 242 FSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHH----------KHLVSLVGY--- 304 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~H----------pniv~l~g~--- 304 (608)
+...+.||.|+|+.||.+++. +|+++|||++.... ....+.+++|.-.+..+.+ -.++.-++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999964 48999999985432 2234566666655555332 112211121
Q ss_pred ------EEeCC--------eeEEEEeeccCCcHHHHhh---cCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeee
Q 046502 305 ------YTAGS--------QRMLVCEFVTSNTLEFHLH---GKGR--PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365 (608)
Q Consensus 305 ------~~~~~--------~~~lV~E~~~~gsL~~~l~---~~~~--~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHr 365 (608)
+.... ..+++|+-+. ++|.+++. .... ..+....++.+..|+++.+++||.. +|+|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11111 2356777774 57776643 2221 1244566777889999999999999 99999
Q ss_pred ccCCCcEEEccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcC--------CCCCcchhhhHHHHHHHHHh
Q 046502 366 DIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG--------KLTEKSDVFSFGVMLLELII 437 (608)
Q Consensus 366 DIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~t~ksDVwS~Gvll~ellt 437 (608)
|||++|+|++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||++||.|.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999988766543221 2346789999987542 47889999999999999999
Q ss_pred CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCC
Q 046502 438 GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRR 502 (608)
Q Consensus 438 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R 502 (608)
|+.||+.......... .-..+. +..+.+..++..+|+.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999986533111100 113344 677788889999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.3e-19 Score=201.44 Aligned_cols=193 Identities=23% Similarity=0.229 Sum_probs=155.7
Q ss_pred HHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC---CCCccceeeEEEeCCeeEE
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH---HKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~---Hpniv~l~g~~~~~~~~~l 313 (608)
.-.+.|.+.+.||+|+||.||+|...+|+.||||+-+...... |--=.+++.||+ -+.|..+..++.-.+.-+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3345688889999999999999998789999999987654332 111234445555 3445556666666777899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-------CCceEEEEee
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-------KFEAKVADFG 386 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-------~~~~kl~DFG 386 (608)
|+||.+.|+|.+++. ....++|...+.++.++++-++.||.. +|||+||||+|+||.. +.-++|+|||
T Consensus 772 v~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 999999999999997 344799999999999999999999998 9999999999999943 3458999999
Q ss_pred ccc---cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCC
Q 046502 387 LAK---LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGC 439 (608)
Q Consensus 387 la~---~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~ 439 (608)
.+- ++.+. .....+.+|-++-.+|...+..++..+|.|.|..+++-||.|+
T Consensus 847 ~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 847 RSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 985 33332 2334467899999999999999999999999999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.1e-19 Score=171.65 Aligned_cols=134 Identities=22% Similarity=0.327 Sum_probs=114.9
Q ss_pred CccccCCceEEEEEEecCCcEEEEEEcccCCch--------hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQ--------GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++||+|++|.||+|.. +|..|+||+....... ....+.+|+.++.+++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7788999986543211 124577899999999999998888887777889999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
++|++|.+++.... + .+..++.+++.+|.+||.. +++||||+|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886432 2 7889999999999999998 899999999999999 78999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.5e-19 Score=176.39 Aligned_cols=144 Identities=15% Similarity=0.150 Sum_probs=112.8
Q ss_pred cCCCcCCccccCCceEEEEEE--ecCCcEEEEEEcccCCch------------------------hHHHHHHHHHHHHhc
Q 046502 240 DGFSDANLLGQGGFGYVHKGV--LPNGKEVAIKQLKAGSGQ------------------------GERVFQAEVEIISRV 293 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~Ev~~l~~l 293 (608)
..|.+.+.||+|+||.||+|. ..+|+.||||+++..... ....+..|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358889999999999999998 568999999998754210 112357899999999
Q ss_pred CCCC--ccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeeccCCC
Q 046502 294 HHKH--LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK-IIHRDIKAA 370 (608)
Q Consensus 294 ~Hpn--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~-iiHrDIk~~ 370 (608)
.+.+ +.+++++ ...+|||||+.+.+|...+.... .+.......++.+++.+|.|||.. + |+||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChh
Confidence 7633 3344433 23589999999988876543222 355556788999999999999999 8 999999999
Q ss_pred cEEEccCCceEEEEeeccccccC
Q 046502 371 NILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 371 NILl~~~~~~kl~DFGla~~~~~ 393 (608)
|||++ +++++|+|||++.....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccCC
Confidence 99999 88999999999875543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=168.60 Aligned_cols=131 Identities=21% Similarity=0.301 Sum_probs=108.8
Q ss_pred ccccCCceEEEEEEecCCcEEEEEEcccCCc--------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 247 LLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG--------QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+||+|+||.||+|.+ +|+.|+||+...... .....+.+|++++..++|.++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 678899998654321 11255778999999999988766666666677789999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
+|++|.+++.... ..++.+++.+|.+||.. +++||||+|.|||++ ++.++|+|||+++..
T Consensus 80 ~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN---------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH---------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875421 17899999999999999 999999999999999 889999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.6e-18 Score=167.04 Aligned_cols=146 Identities=18% Similarity=0.153 Sum_probs=114.2
Q ss_pred HHHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCc----------------------hhHHHHHHHHHHH
Q 046502 233 EELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG----------------------QGERVFQAEVEII 290 (608)
Q Consensus 233 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~Ev~~l 290 (608)
.++...-..|...+.||+|+||.||++...+|+.||||++..... .....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 344444445788899999999999999988899999998764321 0112366789999
Q ss_pred HhcCCCC--ccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccC
Q 046502 291 SRVHHKH--LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIK 368 (608)
Q Consensus 291 ~~l~Hpn--iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk 368 (608)
..+.|.+ +..+++. ...++||||+++++|..+... .....++.+++.++.+||.. +|+|||||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 9998874 4444432 456899999999999765431 23567889999999999998 99999999
Q ss_pred CCcEEEccCCceEEEEeeccccccC
Q 046502 369 AANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 369 ~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
|+||||+.++.++|+|||++.....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCC
Confidence 9999999999999999999965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.8e-19 Score=178.59 Aligned_cols=196 Identities=22% Similarity=0.280 Sum_probs=136.2
Q ss_pred CCCCccceeeEEEe---------------------------CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHH
Q 046502 294 HHKHLVSLVGYYTA---------------------------GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG 346 (608)
Q Consensus 294 ~Hpniv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ 346 (608)
+|||||+++++|.+ ...+||||...+ .+|..+|..+. .+...+.-|+.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 49999999987653 235688888776 48888887653 455566778899
Q ss_pred HHHHHHHHHhcCCCCeeeeccCCCcEEE--ccCC--ceEEEEeeccccccC-----cccceeeeeecccCccChhhhhcC
Q 046502 347 FAKGLAYLHEDCHPKIIHRDIKAANILL--DFKF--EAKVADFGLAKLASD-----VYTHVSTRVMGTFGYLAPEYASSG 417 (608)
Q Consensus 347 ia~~L~yLH~~~~~~iiHrDIk~~NILl--~~~~--~~kl~DFGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~ 417 (608)
+++|+.|||.+ +|.|||+|.+|||| |+|. .+.|+|||++--... .+.......-|.-.-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999999 4443 368899999753322 111112234577889999998543
Q ss_pred C------CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHH
Q 046502 418 K------LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACA 491 (608)
Q Consensus 418 ~------~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 491 (608)
. .-.|+|.|+.|.+.||++....||.......-+ .+.+.+..+ +.+.. ....-+.+++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-------~r~Yqe~qL-----Palp~----~vpp~~rqlV 490 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-------TRTYQESQL-----PALPS----RVPPVARQLV 490 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-------hhhhhhhhC-----CCCcc----cCChHHHHHH
Confidence 2 235899999999999999999999753221100 011122222 22222 2334467788
Q ss_pred HHhhhcCCCCCCCHHHHHHHh
Q 046502 492 AACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 492 ~~Cl~~dp~~RPsm~evv~~L 512 (608)
...|+.||.+|++..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999876554444
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=2e-18 Score=192.91 Aligned_cols=145 Identities=20% Similarity=0.285 Sum_probs=116.2
Q ss_pred HHHHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEc-ccC-C------chhHHHHHHHHHHHHhcCCCCccceee
Q 046502 232 YEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQL-KAG-S------GQGERVFQAEVEIISRVHHKHLVSLVG 303 (608)
Q Consensus 232 ~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~-~~~-~------~~~~~~~~~Ev~~l~~l~Hpniv~l~g 303 (608)
+.........|...++||+|+||.||+|.+.+. .+++|+. ... . ....+.+.+|++++.+++|++|+..+.
T Consensus 325 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~ 403 (535)
T PRK09605 325 WIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI 403 (535)
T ss_pred eccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence 333334445567789999999999999987444 3444432 211 1 112346889999999999999999888
Q ss_pred EEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEE
Q 046502 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 383 (608)
Q Consensus 304 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~ 383 (608)
++...+..++||||+++++|.+++. .+..++.+++++|.|||+. +|+||||||+|||| .++.++|+
T Consensus 404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEE
Confidence 8888788899999999999998875 3578999999999999998 89999999999999 67899999
Q ss_pred Eeeccccc
Q 046502 384 DFGLAKLA 391 (608)
Q Consensus 384 DFGla~~~ 391 (608)
|||+++..
T Consensus 470 DFGla~~~ 477 (535)
T PRK09605 470 DFGLGKYS 477 (535)
T ss_pred eCcccccC
Confidence 99999754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-19 Score=189.89 Aligned_cols=173 Identities=24% Similarity=0.374 Sum_probs=129.5
Q ss_pred eeEEEEeeccCCcHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGK-GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
.+|+.|++|...+|.+||.++ .....+|...+.++.|++.|+.| + +.+|||+||.||+...+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999743 34467888999999999999999 5 7999999999999999999999999998
Q ss_pred ccccCcc-----cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcccccchhhHHHHHHHH
Q 046502 389 KLASDVY-----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIG-CRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 389 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
....... ....+...||..||+||.+.+..|+.|+|||+||+||+||+.- ...++ +.-....+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----------r~~t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----------RIATLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----------HHHhhhhh
Confidence 7655433 2234557899999999999999999999999999999999861 11111 11111222
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQI 508 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~ev 508 (608)
++|.+.. ....+++ .+ ..|+.+++...|.+||+..++
T Consensus 473 r~g~ip~----~~~~d~p----~e-~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGIIPP----EFLQDYP----EE-YTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCCh----HHhhcCc----HH-HHHHHHhcCCCcccCchHHHH
Confidence 3333321 1111222 22 357889999999999944433
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=8e-17 Score=147.52 Aligned_cols=136 Identities=20% Similarity=0.134 Sum_probs=116.1
Q ss_pred cCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCC--CCccceeeEEEeCCeeEEEEeeccCC
Q 046502 244 DANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH--KHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 244 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~H--pniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
+.+.||+|.++.||++...+ +.++||.+..... ...+.+|+.++..++| .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999844 7899999876543 5578899999999976 58999999988888899999999988
Q ss_pred cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 322 TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 322 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
.+..+ ++.....++.+++++|.+||.....+++|+||+++|||++.++.++|+|||+++..
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77543 55677888999999999999864447999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.8e-18 Score=187.99 Aligned_cols=208 Identities=23% Similarity=0.352 Sum_probs=141.2
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.+|..+++|-.|+||.||..+.+ ..+.+|+|+ +++.. .+++ ++.....+.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCccee-------------------
Confidence 57888999999999999999854 467788844 32211 1111 22222333333
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc---
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY--- 395 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~--- 395 (608)
|+=...+..-+. ++. +++.+++|||+. +|+|||+|++|+||+.-|++|+.|||+.+......
T Consensus 136 --gDc~tllk~~g~--lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP--LPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred --chhhhhcccCCC--Ccc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 222233332222 221 227889999999 99999999999999999999999999987432110
Q ss_pred ---------cc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhc
Q 046502 396 ---------TH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIED 464 (608)
Q Consensus 396 ---------~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~ 464 (608)
++ ....++||+.|.|||++....|...+|.|++|+|+||.+-|+.||+..-+ +.|...++...+
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd~i-- 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDDI-- 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhhhc--
Confidence 11 12336899999999999999999999999999999999999999986543 233333332211
Q ss_pred CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 046502 465 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR 504 (608)
Q Consensus 465 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs 504 (608)
.+.+ .+.....+..+++.+.|+.+|.+|--
T Consensus 276 -~wpE---------~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 276 -EWPE---------EDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred -cccc---------cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 1111 12333445677888899999999953
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=153.91 Aligned_cols=136 Identities=18% Similarity=0.207 Sum_probs=99.3
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCchh---HHH---------------------HHHHHHHHHhcCCCC--c
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQG---ERV---------------------FQAEVEIISRVHHKH--L 298 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~---------------------~~~Ev~~l~~l~Hpn--i 298 (608)
.+.||+|+||.||+|...+|+.||||+++...... ... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46899999999999998789999999987542211 111 135666666665443 4
Q ss_pred cceeeEEEeCCeeEEEEeeccCCcHHHH-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeeccCCCcEEEcc
Q 046502 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFH-LHGKGRPTMDWPTRLKIALGFAKGLAYLHE-DCHPKIIHRDIKAANILLDF 376 (608)
Q Consensus 299 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~iiHrDIk~~NILl~~ 376 (608)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.+||. . +|+||||||+|||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 444443 246899999999544321 11110 11 5678899999999999999 6 899999999999999
Q ss_pred CCceEEEEeecccccc
Q 046502 377 KFEAKVADFGLAKLAS 392 (608)
Q Consensus 377 ~~~~kl~DFGla~~~~ 392 (608)
++.++|+|||++....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-15 Score=153.20 Aligned_cols=136 Identities=19% Similarity=0.211 Sum_probs=106.1
Q ss_pred CCccc-cCCceEEEEEEecCCcEEEEEEcccCC-------------chhHHHHHHHHHHHHhcCCCCc--cceeeEEEeC
Q 046502 245 ANLLG-QGGFGYVHKGVLPNGKEVAIKQLKAGS-------------GQGERVFQAEVEIISRVHHKHL--VSLVGYYTAG 308 (608)
Q Consensus 245 ~~~LG-~G~fg~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~Ev~~l~~l~Hpni--v~l~g~~~~~ 308 (608)
...|| .||.|+||+... ++..++||.++... ......+.+|++++.+|+|.+| ++.++++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35688 899999999987 47789999885321 1223457889999999998875 6777775443
Q ss_pred Ce----eEEEEeeccC-CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEE
Q 046502 309 SQ----RMLVCEFVTS-NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 383 (608)
Q Consensus 309 ~~----~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~ 383 (608)
.. .+|||||+++ .+|.+++... .++.. .+.+|+.+|.+||.. +|+||||||.||||+.++.++|+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 22 2599999997 6898887542 24432 367899999999999 99999999999999999999999
Q ss_pred Eeeccccc
Q 046502 384 DFGLAKLA 391 (608)
Q Consensus 384 DFGla~~~ 391 (608)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.6e-17 Score=179.87 Aligned_cols=251 Identities=20% Similarity=0.240 Sum_probs=182.8
Q ss_pred CCcCCccccCCceEEEEEEecC--CcEEEEEEcccCC--chhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEe
Q 046502 242 FSDANLLGQGGFGYVHKGVLPN--GKEVAIKQLKAGS--GQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E 316 (608)
|...+.||+|.|+.|-...... ...+|+|.+.... .........|..+-..+. |.|++.+++...+.+..++++|
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 4445669999999998887533 3456667665443 222234455888888887 9999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeeccCCCcEEEccCC-ceEEEEeeccccccC-
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH-EDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKLASD- 393 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH-~~~~~~iiHrDIk~~NILl~~~~-~~kl~DFGla~~~~~- 393 (608)
|..++++.+.+.......++.......+.|+..+|.|+| +. ++.||||||+|.+++..+ ..|++|||+|..+..
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999988883222223555667788999999999999 66 899999999999999999 999999999986655
Q ss_pred -cccceeeeeec-ccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 394 -VYTHVSTRVMG-TFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 394 -~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
.........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++....... .+..+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~---------------~~~~~ 243 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG---------------RYSSW 243 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc---------------cceee
Confidence 22233344667 9999999998874 556789999999999999999999875443211 11111
Q ss_pred cCcccc--CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 471 VDPKLH--NEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 471 ~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
.+.... ............++...|+..++..|.+..++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 244 KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 111100 1111122234556677788889999998887754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=2e-14 Score=155.92 Aligned_cols=142 Identities=25% Similarity=0.286 Sum_probs=102.0
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCchh----------------------------------------HHHHH
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQG----------------------------------------ERVFQ 284 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~ 284 (608)
.+.||.|++|.||+|++.+|+.||||+.+.+.... +-.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999987542110 01245
Q ss_pred HHHHHHHhcC----CCCccceeeEE-EeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 046502 285 AEVEIISRVH----HKHLVSLVGYY-TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK-GLAYLHEDC 358 (608)
Q Consensus 285 ~Ev~~l~~l~----Hpniv~l~g~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~-~L~yLH~~~ 358 (608)
+|+..+.++. |.+-+.+-.+| ......+|||||++|++|.+++..... .+ .+.+++..+++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC-
Confidence 5666666553 33333332232 224457999999999999887653211 12 24566666666 46788887
Q ss_pred CCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 359 ~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
+++|+|+||.|||++.+++++|+|||++.....
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999876653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.4e-14 Score=144.08 Aligned_cols=202 Identities=21% Similarity=0.347 Sum_probs=140.3
Q ss_pred HHHHHhcCCCCccceeeEEEeC-----CeeEEEEeeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 046502 287 VEIISRVHHKHLVSLVGYYTAG-----SQRMLVCEFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCH 359 (608)
Q Consensus 287 v~~l~~l~Hpniv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~ 359 (608)
+.-|-++.|-|||+++.|+.+. .+..++.|||..|+|..+|+.. ....+......+|+.||+.||.|||. |.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445566799999999998653 3568999999999999999863 33457778888999999999999998 68
Q ss_pred CCeeeeccCCCcEEEccCCceEEEEeecccc---ccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHH
Q 046502 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELI 436 (608)
Q Consensus 360 ~~iiHrDIk~~NILl~~~~~~kl~DFGla~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ell 436 (608)
|.|+|+++..+.|++..++-+|+.---.... +............+-++|.+||+-.....+.++|||+||+..+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999999988842111100 0000011112234678999999988778888999999999999998
Q ss_pred hCCCCCCCC-ccc-ccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 437 IGCRPVDST-HTF-MEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 437 tG~~p~~~~-~~~-~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+..--... ... .+...+. .+ . .+... .-..++..|++..|..||+|++++.+
T Consensus 277 ilEiq~tnseS~~~~ee~ia~-----~i------~----~len~-------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIAN-----VI------I----GLENG-------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeehhhhhhh-----he------e----eccCc-------cccCcCcccccCCCCCCcchhhhhcC
Confidence 765431111 000 0011110 00 0 00010 11245678999999999999998875
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=4e-13 Score=144.46 Aligned_cols=248 Identities=21% Similarity=0.239 Sum_probs=177.9
Q ss_pred cCCCcCCcccc--CCceEEEEEEe---cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCee
Q 046502 240 DGFSDANLLGQ--GGFGYVHKGVL---PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~--G~fg~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~ 311 (608)
..|.....+|. |.+|.||.+.. .++..+|+|+-+..- ......=.+|+....+++ |.|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34667788999 99999999986 357889999844321 122222245777777775 99999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEee
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK----GLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFG 386 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~----~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFG 386 (608)
++-.|++. .+|..+.+.... .+.....+.+..+..+ ||..+|.. +|+|-|+|+.||++..+ ...+++|||
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeecccc-chhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence 99999997 577776665432 3566667777777777 99999998 99999999999999999 889999999
Q ss_pred ccccccCccc----ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 046502 387 LAKLASDVYT----HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 387 la~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
+...+.+..- ....+..|...|++||.+. +.++.+.|||+||.++++..+|......... ..+. .
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---~~W~------~- 337 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN---SSWS------Q- 337 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC---CCcc------c-
Confidence 9987765431 1223346888999999987 4778899999999999999988766433211 0000 0
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
++... +..++...-..++..++..+++.++..|++.+.+..
T Consensus 338 ----~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ----LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000 111222122233444888999999999998776653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.2e-13 Score=126.53 Aligned_cols=131 Identities=18% Similarity=0.099 Sum_probs=98.0
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCcc-ceeeEEEeCCeeEEEEeeccCCcH
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLV-SLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv-~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
++.|+.|.++.||++.. .++.|+||+...... ....+..|+.++..+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 45789999999999987 478899999865432 223467899999998765554 455443 3345899999999887
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC--HPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~--~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.... + ....++.+++++|+.||... ...++|+|+++.|||++ ++.++|+|||.+..
T Consensus 79 ~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 1 12345678999999999873 22369999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.4e-13 Score=149.55 Aligned_cols=145 Identities=21% Similarity=0.247 Sum_probs=94.6
Q ss_pred hcCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCch----------------------------------hHH--
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQ----------------------------------GER-- 281 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~-- 281 (608)
...|+. +.||.|++|.||+|++.+ |+.||||+++.+-.. ..+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999877 999999999754211 011
Q ss_pred ----HHHHHHHHHHhcC----CCCccceeeEEEe-CCeeEEEEeeccCCcHHHH--hhcCCCCCCCHHHHHHHHHHHHH-
Q 046502 282 ----VFQAEVEIISRVH----HKHLVSLVGYYTA-GSQRMLVCEFVTSNTLEFH--LHGKGRPTMDWPTRLKIALGFAK- 349 (608)
Q Consensus 282 ----~~~~Ev~~l~~l~----Hpniv~l~g~~~~-~~~~~lV~E~~~~gsL~~~--l~~~~~~~l~~~~~~~ia~~ia~- 349 (608)
.|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+.|.++ +...+ .+. ..++...++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d~---~~la~~~v~~ 271 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TDM---KLLAERGVEV 271 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CCH---HHHHHHHHHH
Confidence 2344554444442 3333333333322 4567899999999999774 22221 221 222222222
Q ss_pred HHHHHHhcCCCCeeeeccCCCcEEEccCC----ceEEEEeeccccccC
Q 046502 350 GLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGLAKLASD 393 (608)
Q Consensus 350 ~L~yLH~~~~~~iiHrDIk~~NILl~~~~----~~kl~DFGla~~~~~ 393 (608)
-+..++.. +++|+|+||.||||+.++ +++++|||++.....
T Consensus 272 ~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 272 FFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 12233445 899999999999999988 999999999976654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.4e-11 Score=133.75 Aligned_cols=166 Identities=19% Similarity=0.267 Sum_probs=127.3
Q ss_pred ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHH
Q 046502 261 LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTR 340 (608)
Q Consensus 261 ~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~ 340 (608)
..++.+|.|+..+...........+-++.|+.|+||||++++..++..+..|||.|-+. .|..++...+ ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HHHH
Confidence 55788899988877665334556778889999999999999999999999999999985 4665665432 4456
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCC
Q 046502 341 LKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420 (608)
Q Consensus 341 ~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t 420 (608)
...+.||+.||.|||+.| +++|++|.-..|+|+..|+.||++|-++........ ......---.|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--
Confidence 677889999999999888 899999999999999999999999988765443211 011111122466666554322
Q ss_pred CcchhhhHHHHHHHHHhC
Q 046502 421 EKSDVFSFGVMLLELIIG 438 (608)
Q Consensus 421 ~ksDVwS~Gvll~elltG 438 (608)
-..|.|-|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 246999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-11 Score=121.52 Aligned_cols=143 Identities=20% Similarity=0.238 Sum_probs=112.0
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCC--CccceeeEEEeCC---eeEEEEeec
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHK--HLVSLVGYYTAGS---QRMLVCEFV 318 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hp--niv~l~g~~~~~~---~~~lV~E~~ 318 (608)
.+.|+.|.++.||++...+|+.++||+...... .....+..|++++..+.+. ++.+++.++.... ..++||||+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 357899999999999987778999999865432 1345678899999999764 4577888776543 568999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC---------------------------------------- 358 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~---------------------------------------- 358 (608)
++.+|.+.+.. ..++...+..++.++++.|.+||+..
T Consensus 83 ~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 83 DGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 99988775532 24777788888899999999998531
Q ss_pred -------------CCCeeeeccCCCcEEEcc--CCceEEEEeecccc
Q 046502 359 -------------HPKIIHRDIKAANILLDF--KFEAKVADFGLAKL 390 (608)
Q Consensus 359 -------------~~~iiHrDIk~~NILl~~--~~~~kl~DFGla~~ 390 (608)
...++|+|+++.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.2e-11 Score=116.10 Aligned_cols=135 Identities=16% Similarity=0.161 Sum_probs=98.6
Q ss_pred CccccCCceEEEEEEecC-------CcEEEEEEcccCC----------------------chhHHHHH----HHHHHHHh
Q 046502 246 NLLGQGGFGYVHKGVLPN-------GKEVAIKQLKAGS----------------------GQGERVFQ----AEVEIISR 292 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~----------------------~~~~~~~~----~Ev~~l~~ 292 (608)
..||.|.-+.||.|...+ +..+|||+.+... ......+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 469999999999998543 4799999985311 00122333 79999999
Q ss_pred cCC--CCccceeeEEEeCCeeEEEEeeccCCcHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeeccC
Q 046502 293 VHH--KHLVSLVGYYTAGSQRMLVCEFVTSNTLEF-HLHGKGRPTMDWPTRLKIALGFAKGLAYL-HEDCHPKIIHRDIK 368 (608)
Q Consensus 293 l~H--pniv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~ia~~ia~~L~yL-H~~~~~~iiHrDIk 368 (608)
+.. -++.+++++ ...+|||||+.+..+.. .|.. ..++......+..+++.+|.+| |.. +|||+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 864 355666654 45689999998754422 2221 1244456677889999999999 776 89999999
Q ss_pred CCcEEEccCCceEEEEeeccccc
Q 046502 369 AANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 369 ~~NILl~~~~~~kl~DFGla~~~ 391 (608)
+.|||++ ++.++|+|||.+...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 468999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.3e-12 Score=137.46 Aligned_cols=251 Identities=20% Similarity=0.187 Sum_probs=176.7
Q ss_pred HHHHhcCCCcCCccccCCceEEEEEEe--cCCcEEEEEEcccCCchhHH--HHHHHHHHHHhcC-CCCccceeeEEEeCC
Q 046502 235 LARATDGFSDANLLGQGGFGYVHKGVL--PNGKEVAIKQLKAGSGQGER--VFQAEVEIISRVH-HKHLVSLVGYYTAGS 309 (608)
Q Consensus 235 l~~~~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~--~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~ 309 (608)
...-..+|..+..||.|.|+.||+... .++..|++|.+......... .=..|+.+...+. |.++++.+..|....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 334456899999999999999999874 45778999998765433222 2234666666664 889999888888888
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEeecc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLA 388 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFGla 388 (608)
+.|+-.|||.++++...+. -...++...++++..+++.++.++|+. .++|+|+|++||++..+ +..++.|||++
T Consensus 340 ~~~ip~e~~~~~s~~l~~~--~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV--TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cccCchhhhcCcchhhhhH--HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 8899999999999887662 223577788999999999999999988 89999999999999886 88899999998
Q ss_pred ccccCcccceeeeeecccCc-cChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGY-LAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
..+.-. .....-.+..| .+++......+-.+.|+|+||+-+.|.++|..--..... | ..+..+.+
T Consensus 415 t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------~--~~i~~~~~ 480 (524)
T KOG0601|consen 415 TRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------S--LTIRSGDT 480 (524)
T ss_pred ccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---------c--eeeecccc
Confidence 642211 01111123334 355555666788899999999999999988654221111 0 01112221
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.. +.. . ...+..+++.++..++..||.+.++..+.+-
T Consensus 481 p~-----~~~----~-~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 481 PN-----LPG----L-KLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cC-----CCc----h-HHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 11 111 1 1334456677888999999998888766553
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.6e-11 Score=109.10 Aligned_cols=143 Identities=19% Similarity=0.258 Sum_probs=108.2
Q ss_pred cCCccccCCceEEEEEEecCCcEEEEEEcccC--------CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 244 DANLLGQGGFGYVHKGVLPNGKEVAIKQLKAG--------SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 244 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--------~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
...+|-+|+-+.|+++.+ .|+.+.||.-... ..-..+...+|+.+|.+++--.|..-.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999998 6788788764321 1223456778999999987656655445566666778999
Q ss_pred eeccC-CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC---ceEEEEeecccc
Q 046502 316 EFVTS-NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVADFGLAKL 390 (608)
Q Consensus 316 E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~---~~kl~DFGla~~ 390 (608)
||+++ .++.+++...............++..|-+.|.-||.+ .|||+||..+||||..++ .+.|+|||+...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4777777765443333344478899999999999999 999999999999996554 358999999753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-10 Score=107.79 Aligned_cols=132 Identities=19% Similarity=0.270 Sum_probs=100.7
Q ss_pred CccccCCceEEEEEEecCCcEEEEEEcccCC--------chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS--------GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.+|++|+-+.+|.+.+. |..+++|.--... .-..+...+|+.+|.+++--.|..-+=|..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46899999999999763 4446666542211 11123467799999998765555444455667778899999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++|-.|.+.+... +..++..|-+-+.-||.. +|||+||.++||+|..+. +.++||||+...
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888654 356778888888999999 999999999999997764 999999998743
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.2e-09 Score=110.84 Aligned_cols=142 Identities=17% Similarity=0.113 Sum_probs=104.7
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCchh-----------HHHHHHHHHHHHhcCCCCc--cceeeEEEe----
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQG-----------ERVFQAEVEIISRVHHKHL--VSLVGYYTA---- 307 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------~~~~~~Ev~~l~~l~Hpni--v~l~g~~~~---- 307 (608)
.+++-+-....|++..+ +|+.|.||+........ ...+.+|...+.+|...+| ..+++|.+.
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 35555555566778766 77899999875433111 1136789999998864443 455666543
Q ss_pred -CCeeEEEEeeccCC-cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-------CC
Q 046502 308 -GSQRMLVCEFVTSN-TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-------KF 378 (608)
Q Consensus 308 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-------~~ 378 (608)
...-+||+|++++. +|.+++........+...+..++.+++..+.-||.. +|+|+|++++||||+. ++
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23568999999986 898887543223455667789999999999999999 9999999999999975 47
Q ss_pred ceEEEEeecccc
Q 046502 379 EAKVADFGLAKL 390 (608)
Q Consensus 379 ~~kl~DFGla~~ 390 (608)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.7e-09 Score=112.89 Aligned_cols=168 Identities=17% Similarity=0.204 Sum_probs=127.3
Q ss_pred ceEEEEEE-ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEE----eCCeeEEEEeeccC-CcHHHH
Q 046502 253 FGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT----AGSQRMLVCEFVTS-NTLEFH 326 (608)
Q Consensus 253 fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~ 326 (608)
-.+.||++ ..||..|++|+++.+..+.......-+++++++.|.|||+|.++|. .+.-++|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35779998 5689999999996544443333445688999999999999998876 34567999999986 455544
Q ss_pred hhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 327 LHGK-------------GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 327 l~~~-------------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
-... ....+.+..+|.++.|+..||.++|+. ++.-+-|.+.+||++.+.+++|..+|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 3321 123467788999999999999999999 888899999999999999999998887765544
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCC
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p 441 (608)
+.. |-+.. -.+-|.=.||.||+.|.||+..
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 320 11111 2357888999999999999654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.7e-10 Score=105.36 Aligned_cols=126 Identities=21% Similarity=0.273 Sum_probs=84.6
Q ss_pred EEEEEEecCCcEEEEEEcccCCc--------------------------hhHHHHHHHHHHHHhcCCC--CccceeeEEE
Q 046502 255 YVHKGVLPNGKEVAIKQLKAGSG--------------------------QGERVFQAEVEIISRVHHK--HLVSLVGYYT 306 (608)
Q Consensus 255 ~Vy~~~~~~g~~vavK~~~~~~~--------------------------~~~~~~~~Ev~~l~~l~Hp--niv~l~g~~~ 306 (608)
.||.|...+|..+|||+.+.... ......++|++.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999999853210 0123467799999999866 456666542
Q ss_pred eCCeeEEEEeecc--CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeeccCCCcEEEccCCceEEE
Q 046502 307 AGSQRMLVCEFVT--SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL-HEDCHPKIIHRDIKAANILLDFKFEAKVA 383 (608)
Q Consensus 307 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yL-H~~~~~~iiHrDIk~~NILl~~~~~~kl~ 383 (608)
..+|||||++ |..+..+.... ++......++.+++..+..+ |.. +|+|+||...|||++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3479999999 66665443321 11344567788888866665 566 99999999999999888 99999
Q ss_pred Eeecccccc
Q 046502 384 DFGLAKLAS 392 (608)
Q Consensus 384 DFGla~~~~ 392 (608)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.5e-11 Score=134.98 Aligned_cols=247 Identities=19% Similarity=0.216 Sum_probs=162.3
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|.+.+-+-.|.|+.++.+.- ..|...++|+..... .+..+....+-.++-..+||.+++..--+.-....+||+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 4566666778888888887662 234444444443221 111222333334444445676666655555667889999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc-
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV- 394 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~- 394 (608)
+|+.+++|...||.-+ ..+..-.......+..+++|||.. .++|||+++.|+|+..++..++.|||+.......
T Consensus 884 ~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred HHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999999998755 344444445556688899999998 7999999999999999999999999844321100
Q ss_pred -------------------------c----cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 046502 395 -------------------------Y----THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDST 445 (608)
Q Consensus 395 -------------------------~----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~ 445 (608)
. ........||..|++||.+.+......+|.|++|++++|.++|..||+..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 01122357899999999999999999999999999999999999999765
Q ss_pred cccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 046502 446 HTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRIS 506 (608)
Q Consensus 446 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~ 506 (608)
... ...+ .+-.+..... ....+...+..+++...+..++.+|-.|.
T Consensus 1039 tpq---~~f~-----ni~~~~~~~p-------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQ---QIFE-----NILNRDIPWP-------EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chh---hhhh-----ccccCCCCCC-------CCccccChhhhhhhhhhhccCchhccCcc
Confidence 431 1111 1111111111 11222233444566667788888887766
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.4e-08 Score=100.48 Aligned_cols=135 Identities=19% Similarity=0.201 Sum_probs=98.3
Q ss_pred CCcCCccccCCceEEEEEEecCCcEEEEEEcccCCc----------------------hhHHHHHHHHHHHHhcCCC--C
Q 046502 242 FSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG----------------------QGERVFQAEVEIISRVHHK--H 297 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~Ev~~l~~l~Hp--n 297 (608)
..+.+.||.|.-+.||.|....|.++|||.=+.... ......++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 445689999999999999999999999996532210 0122356799999998754 5
Q ss_pred ccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC
Q 046502 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK 377 (608)
Q Consensus 298 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~ 377 (608)
+.+.+++ +...+||||++|-.|...- ++-.....|+..|++-+.-+-+. +|||+|+..-||||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 6666654 5668999999997775432 12223344555555555555555 89999999999999999
Q ss_pred CceEEEEeecccc
Q 046502 378 FEAKVADFGLAKL 390 (608)
Q Consensus 378 ~~~kl~DFGla~~ 390 (608)
|.+.|+||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976553
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=6.7e-10 Score=121.38 Aligned_cols=153 Identities=21% Similarity=0.300 Sum_probs=108.1
Q ss_pred HHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc--------ccceeeeeecccCccChhhhh
Q 046502 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV--------YTHVSTRVMGTFGYLAPEYAS 415 (608)
Q Consensus 344 a~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~--------~~~~~~~~~gt~~y~aPE~~~ 415 (608)
+.+++.||.|||... ++||++|.|++|.++.++..||+.|+++...... .....--..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999874 8999999999999999999999999998654431 011111123466899999999
Q ss_pred cCCCCCcchhhhHHHHHHHHH-hCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHh
Q 046502 416 SGKLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAAC 494 (608)
Q Consensus 416 ~~~~t~ksDVwS~Gvll~ell-tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~C 494 (608)
....+.++|+|||||++|.+. .|+.-+..........+ ....+..-...+..+...++++.+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--------------~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--------------SRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh--------------hhcccccccccccccCcHHHHHHHHHH
Confidence 988899999999999999998 44444443322111111 111111111233455667888899999
Q ss_pred hhcCCCCCCCHHHHHHHh
Q 046502 495 VRHSARRRPRISQIVRTL 512 (608)
Q Consensus 495 l~~dp~~RPsm~evv~~L 512 (608)
+..+...||++.++....
T Consensus 249 l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred hcCCcccCcchhhhhccc
Confidence 999999999888887653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=7.5e-08 Score=93.12 Aligned_cols=152 Identities=14% Similarity=0.120 Sum_probs=110.0
Q ss_pred HHHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCC------chhHHHHHHHHHHHHhcCCCC--ccceeeE
Q 046502 233 EELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS------GQGERVFQAEVEIISRVHHKH--LVSLVGY 304 (608)
Q Consensus 233 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~Ev~~l~~l~Hpn--iv~l~g~ 304 (608)
+.+-.....+-+.-=-|+||.+-|++-.+ +|+.+-||+-...- ..+...|.+|+..|.+|..-+ +.+++ +
T Consensus 11 ~~~w~~~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f 88 (216)
T PRK09902 11 NHWWATEGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-F 88 (216)
T ss_pred HHHHhCCCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-e
Confidence 33333333333333357799999999777 55578899875211 335678999999999996433 44444 3
Q ss_pred EE-e----CCeeEEEEeeccC-CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC
Q 046502 305 YT-A----GSQRMLVCEFVTS-NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF 378 (608)
Q Consensus 305 ~~-~----~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~ 378 (608)
+. . .-.-+||+|-+.+ .+|.+++........+...+..++.+|+..|.-||.. ++.|+|+.+.|||++.++
T Consensus 89 ~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g 165 (216)
T PRK09902 89 GEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEG 165 (216)
T ss_pred eeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCC
Confidence 32 1 1235899997764 5888888665444567788899999999999999999 999999999999998666
Q ss_pred c--eEEEEeeccc
Q 046502 379 E--AKVADFGLAK 389 (608)
Q Consensus 379 ~--~kl~DFGla~ 389 (608)
. ++++||--++
T Consensus 166 ~~~v~lIDlEk~r 178 (216)
T PRK09902 166 KAEAGFLDLEKSR 178 (216)
T ss_pred CeeEEEEEhhccc
Confidence 6 9999997655
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=5e-08 Score=95.46 Aligned_cols=124 Identities=20% Similarity=0.195 Sum_probs=92.4
Q ss_pred CCcEEEEEEcccCC-------chhHHHHHHHHHHHHhcCCCC--ccceeeEEEeCC----eeEEEEeeccCC-cHHHHhh
Q 046502 263 NGKEVAIKQLKAGS-------GQGERVFQAEVEIISRVHHKH--LVSLVGYYTAGS----QRMLVCEFVTSN-TLEFHLH 328 (608)
Q Consensus 263 ~g~~vavK~~~~~~-------~~~~~~~~~Ev~~l~~l~Hpn--iv~l~g~~~~~~----~~~lV~E~~~~g-sL~~~l~ 328 (608)
.++.+.+|.+...- ........+|...+.+|.... ..+.+++..... .-+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 45666676543211 112345678888888886443 456677765532 348999999984 7998887
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC---ceEEEEeeccccc
Q 046502 329 GKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVADFGLAKLA 391 (608)
Q Consensus 329 ~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~---~~kl~DFGla~~~ 391 (608)
.... ++...+..++.++++.+.-||.. +|+|+|+++.||||+.+. .+.|+||+-++..
T Consensus 111 ~~~~--~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQ--LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcc--cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 6332 55667889999999999999999 999999999999998887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.4e-07 Score=94.19 Aligned_cols=259 Identities=18% Similarity=0.215 Sum_probs=155.3
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeE------E-EeCCeeEEE
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGY------Y-TAGSQRMLV 314 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~------~-~~~~~~~lV 314 (608)
...+-||+|+-+.+|..-- -...+.|+...-......+ -+..|... .||-+-.-+.| . ..+...-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecch--hhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3456799999999996431 1223557765433322222 23334443 45543321111 0 112225677
Q ss_pred EeeccCCc-HHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 315 CEFVTSNT-LEFHLHG----KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 315 ~E~~~~gs-L~~~l~~----~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
|..+.+.- +..++.- ..-...+|...++++..+|.+.+-||+. +.+-+|+..+||||.+++.+.|.|-.--.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 88777652 2222221 2234579999999999999999999999 88999999999999999999998854332
Q ss_pred cccCcccceeeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcccccchhhHHHHHHHHh
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIG-CRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
...+ .....-.+|...|.+||.-. +..-+...|.|.|||++++||.| +.||..........- -....|.
T Consensus 166 i~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~---p~E~~Ia 240 (637)
T COG4248 166 INAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPN---PLETDIA 240 (637)
T ss_pred eccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCC---cchhhhh
Confidence 2211 11223356889999999764 33456789999999999999987 899875432111100 1112233
Q ss_pred cCCCCcccCcccc-----CcCCHHH-HHHHHHHHHHhhhcC--CCCCCCHHHHHHHhhc
Q 046502 464 DGNFDTLVDPKLH-----NEYNHNE-MARMVACAAACVRHS--ARRRPRISQIVRTLEG 514 (608)
Q Consensus 464 ~~~~~~~~d~~l~-----~~~~~~~-~~~l~~l~~~Cl~~d--p~~RPsm~evv~~L~~ 514 (608)
.|.|..--|.... ...+-.. ...+-.+-.+|+... +.-||+.+..+..|..
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 4444333331111 0111111 123334556777643 5689999998887754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=5e-08 Score=107.06 Aligned_cols=141 Identities=22% Similarity=0.302 Sum_probs=95.5
Q ss_pred CccccCCceEEEEEEecCCcEEEEEEcccCCchh----------------------------------------HHHHHH
Q 046502 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQG----------------------------------------ERVFQA 285 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~~ 285 (608)
+-|+.++-|.||+|++.+|+.||||+.+.+-... +-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999997542110 112445
Q ss_pred HHHHHHhcC-----CCCccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCC
Q 046502 286 EVEIISRVH-----HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGL-AYLHEDCH 359 (608)
Q Consensus 286 Ev~~l~~l~-----Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L-~yLH~~~~ 359 (608)
|..-+.+++ .++|.--.=|+.-.....|+|||++|-.+.++..-+. ..++ +..|+..++++. ..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhc--
Confidence 655555553 2332211112233466799999999999988743222 2345 334444444432 223334
Q ss_pred CCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 360 ~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
+++|.|.+|.||+++.++++.+.|||+......
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999876654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.7e-07 Score=90.58 Aligned_cols=138 Identities=17% Similarity=0.194 Sum_probs=87.2
Q ss_pred CccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC--ccceeeEEEeCCeeEEEEeeccCCc-
Q 046502 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH--LVSLVGYYTAGSQRMLVCEFVTSNT- 322 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn--iv~l~g~~~~~~~~~lV~E~~~~gs- 322 (608)
..||+|..+.||+. .|..+++|...... ....+.+|.++++.+..-. +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999984 25568889887533 2345688999999987544 4677888888888899999999863
Q ss_pred HHHH---------------------hhcCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCeeeeccC
Q 046502 323 LEFH---------------------LHGKGRPTMDWPTRLK-IAL----------GFAK-GLAYLHED-CHPKIIHRDIK 368 (608)
Q Consensus 323 L~~~---------------------l~~~~~~~l~~~~~~~-ia~----------~ia~-~L~yLH~~-~~~~iiHrDIk 368 (608)
+... ||.-.........+.. +.. .+.. ...+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 2211001111111110 000 0111 12222211 12357999999
Q ss_pred CCcEEEccCCceEEEEeeccc
Q 046502 369 AANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 369 ~~NILl~~~~~~kl~DFGla~ 389 (608)
+.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.2e-06 Score=86.15 Aligned_cols=154 Identities=19% Similarity=0.203 Sum_probs=102.6
Q ss_pred ccCHHHHHHHhcCCCcCCcc---ccCCceEEEEEEecCCcEEEEEEcccCCchhHH------------------------
Q 046502 229 TFTYEELARATDGFSDANLL---GQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGER------------------------ 281 (608)
Q Consensus 229 ~~~~~el~~~~~~f~~~~~L---G~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------ 281 (608)
..+++.|.....+..+.++. ..|.-+.||+|...++..+|||+++......++
T Consensus 34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 34566676666666665554 466677899999878999999999754321111
Q ss_pred HHHHHHHHHHhcC--CCCccceeeEEEeCCeeEEEEeeccCCcHH-HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 046502 282 VFQAEVEIISRVH--HKHLVSLVGYYTAGSQRMLVCEFVTSNTLE-FHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358 (608)
Q Consensus 282 ~~~~Ev~~l~~l~--Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~-~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~ 358 (608)
-..+|+.-|.++. +=.+.+-+++. .-.|||||+....+- -.|..- .+.......+..++++.+.-|-..+
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~~a 186 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYKEA 186 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHHhc
Confidence 1234666666664 33344445443 237999999764211 111111 1222256677788888888887744
Q ss_pred CCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 359 ~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
++||+||..-|||+. ++.+.|+|||-|....
T Consensus 187 --~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 --GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 899999999999999 8899999999886443
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.9e-07 Score=88.11 Aligned_cols=142 Identities=17% Similarity=0.169 Sum_probs=86.9
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC--ccceeeEEEe---CCeeEEEEeecc
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH--LVSLVGYYTA---GSQRMLVCEFVT 319 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn--iv~l~g~~~~---~~~~~lV~E~~~ 319 (608)
++.|+.|..+.||+....+ +.+++|..... .....+..|+.++..|.... +.+++.++.. ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999867 68999997654 45567888999999886433 5577765533 334689999999
Q ss_pred CCcHHH----------------H---hhcC--CCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh
Q 046502 320 SNTLEF----------------H---LHGK--GRPTMDWPTR---------LKI------------ALGFAK-GLAYLHE 356 (608)
Q Consensus 320 ~gsL~~----------------~---l~~~--~~~~l~~~~~---------~~i------------a~~ia~-~L~yLH~ 356 (608)
+..+.. . ||.. ....+.+... ... ...+.+ .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988777 1 1111 1111111110 000 112222 3444443
Q ss_pred c----CCCCeeeeccCCCcEEEc-cCCceEEEEeeccc
Q 046502 357 D----CHPKIIHRDIKAANILLD-FKFEAKVADFGLAK 389 (608)
Q Consensus 357 ~----~~~~iiHrDIk~~NILl~-~~~~~kl~DFGla~ 389 (608)
. ....++|+|+.+.|||++ .++.+.|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 233699999999999999 66677899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.5e-07 Score=86.20 Aligned_cols=144 Identities=17% Similarity=0.216 Sum_probs=97.7
Q ss_pred CHHHHHHH--hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHH---------HHHHHHHHhcCC---C
Q 046502 231 TYEELARA--TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVF---------QAEVEIISRVHH---K 296 (608)
Q Consensus 231 ~~~el~~~--~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~Ev~~l~~l~H---p 296 (608)
.|.+|... .++|...+++-......|.+-.. +|+.+++|..+......++.| .+++..+.++.. -
T Consensus 20 ~y~~l~~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~ 98 (229)
T PF06176_consen 20 KYLELGEKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFT 98 (229)
T ss_pred HHHHHHHHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence 34444443 46788888888888888888777 678899999876554433333 234444444432 2
Q ss_pred CccceeeEEE-----eCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCc
Q 046502 297 HLVSLVGYYT-----AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAAN 371 (608)
Q Consensus 297 niv~l~g~~~-----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~N 371 (608)
.+..++-++. .....+|||||++|..|.++.. ++. .++..+.++|.-||.. +++|+|++|.|
T Consensus 99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgN 165 (229)
T PF06176_consen 99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGN 165 (229)
T ss_pred ccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCc
Confidence 3333333322 1234578999999988866532 221 3456677889999999 99999999999
Q ss_pred EEEccCCceEEEEeeccc
Q 046502 372 ILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 372 ILl~~~~~~kl~DFGla~ 389 (608)
++++.+ .++++||+.-+
T Consensus 166 Flv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 166 FLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred EEEECC-cEEEEECcccc
Confidence 999865 59999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.42 E-value=3e-06 Score=84.98 Aligned_cols=138 Identities=17% Similarity=0.101 Sum_probs=85.7
Q ss_pred cccCCc-eEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEeeccCCcHHH
Q 046502 248 LGQGGF-GYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEF 325 (608)
Q Consensus 248 LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~ 325 (608)
|-.|.. ..||+.... +..+.||+..... ...+.+|+++++.+. +--+.++++++..++..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 889999864 4788899876543 335677999998885 4345577887777667899999999987764
Q ss_pred Hh-------------------hcCC--CCCCC--HHHHHHHHH--------------------HHHHHHHHHHhc----C
Q 046502 326 HL-------------------HGKG--RPTMD--WPTRLKIAL--------------------GFAKGLAYLHED----C 358 (608)
Q Consensus 326 ~l-------------------~~~~--~~~l~--~~~~~~ia~--------------------~ia~~L~yLH~~----~ 358 (608)
.. |.-. ...+. +..++.... .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 1111 00111 001110000 011112222111 1
Q ss_pred CCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 359 ~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
.+.++|+|+.+.|||++.+..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2359999999999999998778899998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.7e-06 Score=94.89 Aligned_cols=140 Identities=20% Similarity=0.198 Sum_probs=90.9
Q ss_pred CccccCCceEEEEEEecCCcEEEEEEcccCCchh-------------------------------------HHHHHHHHH
Q 046502 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQG-------------------------------------ERVFQAEVE 288 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-------------------------------------~~~~~~Ev~ 288 (608)
+-||.-..|.||+|++++|+.||||+-+.+-... +-.|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999987542111 112444544
Q ss_pred HHHhc----CCCC------ccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 046502 289 IISRV----HHKH------LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358 (608)
Q Consensus 289 ~l~~l----~Hpn------iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~ 358 (608)
-..++ .|-+ |.+++- .-...+.|+||||+|.-+.+...-.. ..++-. .|+..+.++... ...
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~---~i~~~l~~~~~~--qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDK-RGISPH---DILNKLVEAYLE--QIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHH-cCCCHH---HHHHHHHHHHHH--HHH
Confidence 33333 3545 223332 22356799999999987765432211 124433 444444443332 222
Q ss_pred CCCeeeeccCCCcEEEcc----CCceEEEEeeccccccC
Q 046502 359 HPKIIHRDIKAANILLDF----KFEAKVADFGLAKLASD 393 (608)
Q Consensus 359 ~~~iiHrDIk~~NILl~~----~~~~kl~DFGla~~~~~ 393 (608)
..+++|+|=+|-|||++. ++++.+.|||+......
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 228999999999999983 67899999999876554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.8e-08 Score=107.68 Aligned_cols=183 Identities=17% Similarity=0.154 Sum_probs=132.7
Q ss_pred cCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCCeeEEEEeeccCC-
Q 046502 244 DANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH-LVSLVGYYTAGSQRMLVCEFVTSN- 321 (608)
Q Consensus 244 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn-iv~l~g~~~~~~~~~lV~E~~~~g- 321 (608)
..+-+++|+++.+||.+-.-.+....|.+... ....-++++|.+++||| .+..++-+..++..+++++++..+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34568899999999988433344445555432 34456899999999999 677777777778889999999877
Q ss_pred cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeee
Q 046502 322 TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR 401 (608)
Q Consensus 322 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 401 (608)
+....... ....+...+...++..-+++|+|||+. .=+||| |||..+ ...|..||+....+.... ....
T Consensus 321 s~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 321 SSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred cccccCCh-hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 22211110 111233344556777788899999987 458998 887765 688999999987666543 2234
Q ss_pred eecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCC
Q 046502 402 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPV 442 (608)
Q Consensus 402 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~ 442 (608)
..++..|+|||+...+.+..+-|+|++|+-..+|--|..|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 57899999999999999999999999998777777676653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.35 E-value=6.5e-06 Score=79.15 Aligned_cols=125 Identities=28% Similarity=0.450 Sum_probs=92.3
Q ss_pred cCCCcCCccccCCc-eEEEEEEecCCcEEEEEEcccCC------------c---------hhHHHHHHHHHHHHhcC---
Q 046502 240 DGFSDANLLGQGGF-GYVHKGVLPNGKEVAIKQLKAGS------------G---------QGERVFQAEVEIISRVH--- 294 (608)
Q Consensus 240 ~~f~~~~~LG~G~f-g~Vy~~~~~~g~~vavK~~~~~~------------~---------~~~~~~~~Ev~~l~~l~--- 294 (608)
..|+.++.||.|.- |.||++.+ +|+.||||+++... . .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999998 77899999943210 0 01124788999888885
Q ss_pred CCCc--cceeeEEEeC------------------CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 046502 295 HKHL--VSLVGYYTAG------------------SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354 (608)
Q Consensus 295 Hpni--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yL 354 (608)
+.++ |+.+||..-. -.+.||.||++... ....+-+.++.+-|..|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------~~~~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------PLQIRDIPQMLRDLKIL 180 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------------ccchhHHHHHHHHHHHH
Confidence 4566 8999997422 12357888776543 11233456778888999
Q ss_pred HhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 355 H~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
|.. +|+-+|+|+.|.. .-||+|||.+
T Consensus 181 ~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHC---CeeeccCcccccc-----CCEEEecccC
Confidence 998 9999999999987 5689999864
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.8e-06 Score=81.72 Aligned_cols=103 Identities=19% Similarity=0.163 Sum_probs=81.4
Q ss_pred HHHHHHHHhcCC-CCccceeeEEEeCCeeEEEEeeccCCcHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 046502 284 QAEVEIISRVHH-KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHG-KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361 (608)
Q Consensus 284 ~~Ev~~l~~l~H-pniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~ 361 (608)
..|..+|+.+++ +++.+++|+|- .++|.||+..+++...-.. ..-...+|..|.+||.++++.+.+|+..-...
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458889999976 69999999993 4789999987755321000 01124689999999999999999999853335
Q ss_pred eeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 362 IIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 362 iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
+.-.|++++|+-|++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.29 E-value=6.8e-06 Score=96.80 Aligned_cols=147 Identities=16% Similarity=0.242 Sum_probs=94.2
Q ss_pred CCccccCCceEEEEEEecCC---cEEEEEEcccCC-chhHHHHHHHHHHHHhcC-CCCc--cceeeEEEeC---CeeEEE
Q 046502 245 ANLLGQGGFGYVHKGVLPNG---KEVAIKQLKAGS-GQGERVFQAEVEIISRVH-HKHL--VSLVGYYTAG---SQRMLV 314 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~-Hpni--v~l~g~~~~~---~~~~lV 314 (608)
++.|+.|.+..+|+....++ ..+++|+..... ......+.+|+++|+.|. |.+| .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999886554 468888765432 123456889999999996 6665 7888888764 467899
Q ss_pred EeeccCCcHHH-----------------------HhhcCCC---------CCCCHH--HHHHHH---------------H
Q 046502 315 CEFVTSNTLEF-----------------------HLHGKGR---------PTMDWP--TRLKIA---------------L 345 (608)
Q Consensus 315 ~E~~~~gsL~~-----------------------~l~~~~~---------~~l~~~--~~~~ia---------------~ 345 (608)
|||++|..+.+ .||.-.. ....+. ++..+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999864321 1222110 011111 111110 1
Q ss_pred HHHHHHHHHHhcCC--------CCeeeeccCCCcEEEcc-CCc-eEEEEeeccccc
Q 046502 346 GFAKGLAYLHEDCH--------PKIIHRDIKAANILLDF-KFE-AKVADFGLAKLA 391 (608)
Q Consensus 346 ~ia~~L~yLH~~~~--------~~iiHrDIk~~NILl~~-~~~-~kl~DFGla~~~ 391 (608)
.+.+.+.+|..+.. +.+||+|+++.|||++. +.+ +-|.||.++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 23344667754322 24999999999999985 334 579999998654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.23 E-value=9.5e-06 Score=75.69 Aligned_cols=125 Identities=22% Similarity=0.243 Sum_probs=88.2
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccc-eeeEEEeCCeeEEEEeeccCCcH
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVS-LVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~-l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
.+.|++|+++.||+|.+ .|..+|+|+-+.++. ...+..|+++|..+.--++.. ++.|-. -++.|||+.|-.|
T Consensus 27 ~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L 99 (201)
T COG2112 27 EKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPL 99 (201)
T ss_pred hhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcch
Confidence 46799999999999998 556899999876543 457888999999998766654 444432 2456999999888
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCC--CcEEEccCCceEEEEeeccc
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKA--ANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~--~NILl~~~~~~kl~DFGla~ 389 (608)
..+-... + .+-...+++.-.-|-.. +|-|+.|.- .||++.+ ..+.|+||.-|.
T Consensus 100 ~~~~~~~-----~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~-~~~~iIDFd~At 154 (201)
T COG2112 100 GKLEIGG-----D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVND-RDVYIIDFDSAT 154 (201)
T ss_pred hhhhhcc-----c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecC-CcEEEEEccchh
Confidence 7654321 1 22234455554445555 899988864 4565554 499999998876
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.22 E-value=3.5e-05 Score=74.62 Aligned_cols=130 Identities=22% Similarity=0.318 Sum_probs=94.2
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCC----------------chhHHHHHHHHHHHHhcC------CCCccc
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS----------------GQGERVFQAEVEIISRVH------HKHLVS 300 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~Ev~~l~~l~------Hpniv~ 300 (608)
+....||+|+.-.||.- ++.....||++.... ....+++.+|+....++. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 34568999999999974 345567889887655 223456777887777776 788999
Q ss_pred eeeEEEeCCeeEEEEeeccC------CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE
Q 046502 301 LVGYYTAGSQRMLVCEFVTS------NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL 374 (608)
Q Consensus 301 l~g~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl 374 (608)
++|+...+...-+|+|.+.+ -+|.+++.... ++. . +...+-+-..||-++ +|+.+||++.||++
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 99999999999999998754 35777775432 443 2 333334455677776 89999999999999
Q ss_pred ccCC----ceEEEE
Q 046502 375 DFKF----EAKVAD 384 (608)
Q Consensus 375 ~~~~----~~kl~D 384 (608)
..+. .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 5432 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.2e-05 Score=80.12 Aligned_cols=74 Identities=14% Similarity=0.173 Sum_probs=47.5
Q ss_pred CCccccCCce-EEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCC---CccceeeEEEeC---CeeEEEEee
Q 046502 245 ANLLGQGGFG-YVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHK---HLVSLVGYYTAG---SQRMLVCEF 317 (608)
Q Consensus 245 ~~~LG~G~fg-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hp---niv~l~g~~~~~---~~~~lV~E~ 317 (608)
++.|+.||.. .||+. +..+++|..+.. .....+.+|+++|..|... -+.++++.+... ...++|||+
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3567877776 48975 245778876542 2345788899999988632 234444443322 234889999
Q ss_pred ccCCcHH
Q 046502 318 VTSNTLE 324 (608)
Q Consensus 318 ~~~gsL~ 324 (608)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.2e-05 Score=80.07 Aligned_cols=78 Identities=13% Similarity=0.075 Sum_probs=58.3
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCC---CCccceeeEEEeC---CeeEEEEe
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH---KHLVSLVGYYTAG---SQRMLVCE 316 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~H---pniv~l~g~~~~~---~~~~lV~E 316 (608)
...+.||.|..+.||+....+++ +++|..+.. .....|..|.+.|+.|.- -.+.+++++|..+ +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 44567999999999999865664 677775431 123578899999999963 3577889888643 56899999
Q ss_pred eccCCcH
Q 046502 317 FVTSNTL 323 (608)
Q Consensus 317 ~~~~gsL 323 (608)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >PF01102 Glycophorin_A: Glycophorin A; InterPro: IPR001195 Proteins in this group are responsible for the molecular basis of the blood group antigens, surface markers on the outside of the red blood cell membrane | Back alignment and domain information |
|---|
Probab=98.10 E-value=9.7e-07 Score=77.33 Aligned_cols=38 Identities=26% Similarity=0.450 Sum_probs=24.6
Q ss_pred CCCcccccEEEehHHHHHHHHHHHHHHhhhhccccccC
Q 046502 88 GGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRR 125 (608)
Q Consensus 88 ~~~~~~g~~vgi~v~~~~~~~~~~~~~~~~~~~~~~~~ 125 (608)
..+++.++|+||++|+++++++++++++||.||+||+.
T Consensus 58 ~h~fs~~~i~~Ii~gv~aGvIg~Illi~y~irR~~Kk~ 95 (122)
T PF01102_consen 58 VHRFSEPAIIGIIFGVMAGVIGIILLISYCIRRLRKKS 95 (122)
T ss_dssp SSSSS-TCHHHHHHHHHHHHHHHHHHHHHHHHHHS---
T ss_pred ccCccccceeehhHHHHHHHHHHHHHHHHHHHHHhccC
Confidence 56788889999999998777666666555555555443
|
Most of these markers are proteins, but some are carbohydrates attached to lipids or proteins [Reid M.E., Lomas-Francis C. The Blood Group Antigen FactsBook Academic Press, London / San Diego, (1997)]. Glycophorin A (PAS-2) and glycophorin B (PAS-3) belong to the MNS blood group system and are associated with antigens that include M/N, S/s, U, He, Mi(a), M(c), Vw, Mur, M(g), Vr, M(e), Mt(a), St(a), Ri(a), Cl(a), Ny(a), Hut, Hil, M(v), Far, Mit, Dantu, Hop, Nob, En(a), ENKT, amongst others. Glycophorin A is the major sialoglycoprotein of the erythrocyte membrane []. Structurally, glycophorin A consists of an N-terminal extracellular domain, heavily glycosylated on serine and threonine residues, followed by a transmembrane region and a C-terminal cytoplasmic domain. Other glycophorins in this entry such as Glycophorin B and Glycophorin E represent minor sialoglycoproteins in the erythrocyte membrane.; GO: 0016021 integral to membrane; PDB: 2KPF_B 1AFO_B 2KPE_A. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.06 E-value=2.4e-05 Score=80.82 Aligned_cols=142 Identities=15% Similarity=0.117 Sum_probs=88.1
Q ss_pred cCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC--ccceeeE------EEeCCeeEEEE
Q 046502 244 DANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH--LVSLVGY------YTAGSQRMLVC 315 (608)
Q Consensus 244 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn--iv~l~g~------~~~~~~~~lV~ 315 (608)
..+.|..|....+|+....+ ..+++|+... .....+..|++++..|.+.+ +.+++.. ...++..++||
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred heecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 35667788888999987644 4688998764 23345667888888885433 3444431 23345678999
Q ss_pred eeccCCcHHH--------------HhhcC----C-----CCCCCHHHHHH----------HHHHHHHHHHHHHh----cC
Q 046502 316 EFVTSNTLEF--------------HLHGK----G-----RPTMDWPTRLK----------IALGFAKGLAYLHE----DC 358 (608)
Q Consensus 316 E~~~~gsL~~--------------~l~~~----~-----~~~l~~~~~~~----------ia~~ia~~L~yLH~----~~ 358 (608)
+|++|..+.. .||.. . .....|..... ....+...+.+|.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876421 11110 0 01123332211 11223344555553 12
Q ss_pred CCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 359 ~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
...+||+|+.+.|||++.+..+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3369999999999999998777899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.3e-05 Score=75.38 Aligned_cols=140 Identities=21% Similarity=0.209 Sum_probs=82.4
Q ss_pred CCccccCCceEEEEEEecC--CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEeeccCC
Q 046502 245 ANLLGQGGFGYVHKGVLPN--GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~g 321 (608)
++.|..|-...+|+....+ ++.|++|+....... .-...+|+.++..+...++ .++++++. -.+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence 3567788889999998764 678999987643221 1123468889998864444 45554432 24899999987
Q ss_pred cHHHH-----------------hhcCCC---------CCC-CHHHHHHHHH----------------------HHHHHHH
Q 046502 322 TLEFH-----------------LHGKGR---------PTM-DWPTRLKIAL----------------------GFAKGLA 352 (608)
Q Consensus 322 sL~~~-----------------l~~~~~---------~~l-~~~~~~~ia~----------------------~ia~~L~ 352 (608)
++... +|.... ... -|..+..+.. .+...+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 65311 111111 011 1222212111 1111112
Q ss_pred HHH----hc-CCCCeeeeccCCCcEEEcc-CCceEEEEeeccc
Q 046502 353 YLH----ED-CHPKIIHRDIKAANILLDF-KFEAKVADFGLAK 389 (608)
Q Consensus 353 yLH----~~-~~~~iiHrDIk~~NILl~~-~~~~kl~DFGla~ 389 (608)
.|- .. ....++|+|+.+.|||++. +..+.|+||-.|.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 221 11 1236999999999999998 5789999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.8e-05 Score=77.67 Aligned_cols=138 Identities=14% Similarity=0.096 Sum_probs=80.6
Q ss_pred ccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEeeccCCcHHH
Q 046502 247 LLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVCEFVTSNTLEF 325 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~gsL~~ 325 (608)
.+..|-.+.+|+... +++.+++|........-.-...+|..+++.+....+ .++++++. -++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 356678889998874 677888998654322211134678999999865444 34454432 368999999876532
Q ss_pred -----------------HhhcCC--CCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCeeeeccCCCc
Q 046502 326 -----------------HLHGKG--RPTMDWPTR-LKIALG---------FAKGLAYLHED-----CHPKIIHRDIKAAN 371 (608)
Q Consensus 326 -----------------~l~~~~--~~~l~~~~~-~~ia~~---------ia~~L~yLH~~-----~~~~iiHrDIk~~N 371 (608)
.||... ...++...+ .....+ +.+.+..+-.. ....++|+|+.+.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 122211 112222211 111111 11112222111 12358999999999
Q ss_pred EEEccCCceEEEEeecccc
Q 046502 372 ILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 372 ILl~~~~~~kl~DFGla~~ 390 (608)
||++.++ ++|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00022 Score=74.56 Aligned_cols=156 Identities=15% Similarity=0.141 Sum_probs=86.4
Q ss_pred cCHHHHHHHhcCCCc-----CCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC--cccee
Q 046502 230 FTYEELARATDGFSD-----ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH--LVSLV 302 (608)
Q Consensus 230 ~~~~el~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn--iv~l~ 302 (608)
.+.+++......|.. .+.|+.|....+|+....+| .+++|++... ....+..|+.++..|...+ +.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 344555555555543 35566777789999887555 6889987621 2233444666666664222 23333
Q ss_pred e------EEEeCCeeEEEEeeccCCcHH--------------HHhhcCC---------CCCCCH-HHHHH----------
Q 046502 303 G------YYTAGSQRMLVCEFVTSNTLE--------------FHLHGKG---------RPTMDW-PTRLK---------- 342 (608)
Q Consensus 303 g------~~~~~~~~~lV~E~~~~gsL~--------------~~l~~~~---------~~~l~~-~~~~~---------- 342 (608)
. +...++..+++|||++|..+. ..+|... ...+.| .....
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 2 123356678999999987431 1112110 011222 22111
Q ss_pred --HHHH-HHHHHHHHHhc----CCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 343 --IALG-FAKGLAYLHED----CHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 343 --ia~~-ia~~L~yLH~~----~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
.+.+ +...+..+... ...++||+|+++.|||++.+...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122333211 23479999999999999876556899998765
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00029 Score=73.32 Aligned_cols=156 Identities=18% Similarity=0.192 Sum_probs=91.2
Q ss_pred CHHHHHHHhcCCCc-----CCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC--ccceee
Q 046502 231 TYEELARATDGFSD-----ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH--LVSLVG 303 (608)
Q Consensus 231 ~~~el~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn--iv~l~g 303 (608)
+-++|....+.|.. ++.|+.|-...+|+....+| .+++|+..... ....+..|++++..|.... +.+++.
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~ 84 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVK 84 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCcccc
Confidence 34556555555543 45677777789999876555 57889875432 1334556778887774322 344443
Q ss_pred E------EEeCCeeEEEEeeccCCcHH--------------HHhhcCCC----------CCCCHHHHHH-----------
Q 046502 304 Y------YTAGSQRMLVCEFVTSNTLE--------------FHLHGKGR----------PTMDWPTRLK----------- 342 (608)
Q Consensus 304 ~------~~~~~~~~lV~E~~~~gsL~--------------~~l~~~~~----------~~l~~~~~~~----------- 342 (608)
. ...++..++||||++|..+. ..+|.... ..-.|.....
T Consensus 85 t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~ 164 (307)
T TIGR00938 85 SRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA 164 (307)
T ss_pred CCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH
Confidence 2 12345678999999885432 11221100 0112322111
Q ss_pred -HHHHHHHHHHHHHh----cCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 343 -IALGFAKGLAYLHE----DCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 343 -ia~~ia~~L~yLH~----~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
....+.+.+++|.. .....+||+|+++.|||++.++...|+||+.+.
T Consensus 165 ~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 165 HMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 11223345555543 223479999999999999988777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00015 Score=75.22 Aligned_cols=139 Identities=24% Similarity=0.258 Sum_probs=84.2
Q ss_pred CccccCCceEEEEEEecC-------CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEee
Q 046502 246 NLLGQGGFGYVHKGVLPN-------GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~ 317 (608)
+.|..|-...||+....+ ++.|++|+...... ......+|++++..+....+ .++++++.. .+||||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667778999988655 57899999765432 22345678888888864334 356665542 368999
Q ss_pred ccCCcHHHH-----------------hhcCCCC-------CC--CHHHHHH--------------------------HHH
Q 046502 318 VTSNTLEFH-----------------LHGKGRP-------TM--DWPTRLK--------------------------IAL 345 (608)
Q Consensus 318 ~~~gsL~~~-----------------l~~~~~~-------~l--~~~~~~~--------------------------ia~ 345 (608)
++|..+... ||..... .. -|..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998766321 1221111 00 1111111 111
Q ss_pred HHHHHHHHHHh------cCCCCeeeeccCCCcEEEccC----CceEEEEeeccc
Q 046502 346 GFAKGLAYLHE------DCHPKIIHRDIKAANILLDFK----FEAKVADFGLAK 389 (608)
Q Consensus 346 ~ia~~L~yLH~------~~~~~iiHrDIk~~NILl~~~----~~~kl~DFGla~ 389 (608)
.+..-+.+|.. .....++|+|+.+.|||++.+ +.++|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 134469999999999999985 889999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.79 E-value=9e-05 Score=86.12 Aligned_cols=196 Identities=19% Similarity=0.209 Sum_probs=135.7
Q ss_pred HHHHHHHHHhcCCCCccceeeEEEeCCeeE----EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 046502 283 FQAEVEIISRVHHKHLVSLVGYYTAGSQRM----LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358 (608)
Q Consensus 283 ~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~ 358 (608)
...|+..+.++.|+|++.++.|-.+....- +.-|++...++..++...+ .++..+.+.+..++.+||.|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSL- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHh-
Confidence 445777888889999999999876544333 4456787788887776654 477788888999999999999998
Q ss_pred CCCeeeeccCCC---cEEEccCCceEEE--EeeccccccCcccceeeeeecccCccChhhhhcCCCCC--cchhhhHHHH
Q 046502 359 HPKIIHRDIKAA---NILLDFKFEAKVA--DFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE--KSDVFSFGVM 431 (608)
Q Consensus 359 ~~~iiHrDIk~~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--ksDVwS~Gvl 431 (608)
...|.-|..+ +-.++.++.+.+. ||+..+...+.... ....-...|.++|......+.. ..|+|.+|.+
T Consensus 306 --~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 306 --SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred --ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 6666666555 5555666777776 89888776653222 1223455677888776655544 4799999999
Q ss_pred HHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 432 LLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 432 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+..++.|...-..... .. .+++ ... ...+.+....|+..+.++|+...+++.+
T Consensus 382 ~~~~~~~~~i~~~~~~------~~-------------~~l~----~~~----~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------PV-------------SLLD----VLS----TSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HhhhhhcCcccccccc------hh-------------hhhc----ccc----chhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999988765321110 00 0111 111 1145667789999999999999999976
Q ss_pred h
Q 046502 512 L 512 (608)
Q Consensus 512 L 512 (608)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00048 Score=73.77 Aligned_cols=76 Identities=18% Similarity=0.157 Sum_probs=54.1
Q ss_pred CCccccCCceEEEEEEecCC-cEEEEEEcccC-----C--chhHHHHHHHHHHHHhcC---CCCccceeeEEEeCCeeEE
Q 046502 245 ANLLGQGGFGYVHKGVLPNG-KEVAIKQLKAG-----S--GQGERVFQAEVEIISRVH---HKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~-----~--~~~~~~~~~Ev~~l~~l~---Hpniv~l~g~~~~~~~~~l 313 (608)
.+.||.|.+..||++...+| +.|+||+-... . ....+.+..|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35799999999999998777 58999985421 1 123345667888888763 2456677766 3355789
Q ss_pred EEeeccCCc
Q 046502 314 VCEFVTSNT 322 (608)
Q Consensus 314 V~E~~~~gs 322 (608)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >PF04478 Mid2: Mid2 like cell wall stress sensor; InterPro: IPR007567 This family represents a region near the C terminus of Mid2, which contains a transmembrane region | Back alignment and domain information |
|---|
Probab=97.67 E-value=2.4e-05 Score=70.33 Aligned_cols=34 Identities=21% Similarity=0.533 Sum_probs=19.5
Q ss_pred ccEEEehHHH--HHHHHHHHHHHhhhhccccccCCC
Q 046502 94 GLVVGLAIGG--LAVIVVVSLLILRCRRKRRRRRDD 127 (608)
Q Consensus 94 g~~vgi~v~~--~~~~~~~~~~~~~~~~~~~~~~~~ 127 (608)
.+|||++||+ .++|++++++||||+|+||....+
T Consensus 49 nIVIGvVVGVGg~ill~il~lvf~~c~r~kktdfid 84 (154)
T PF04478_consen 49 NIVIGVVVGVGGPILLGILALVFIFCIRRKKTDFID 84 (154)
T ss_pred cEEEEEEecccHHHHHHHHHhheeEEEecccCcccc
Confidence 4666666654 444555566666666666654443
|
The remainder of the protein sequence is serine-rich and of low complexity, and is therefore impossible to align accurately. Mid2 is thought to act as a mechanosensor of cell wall stress. The C-terminal cytoplasmic region of Mid2 is known to interact with Rom2, a guanine nucleotide exchange factor (GEF) for Rho1, which is part of the cell wall integrity signalling pathway []. |
| >PTZ00382 Variant-specific surface protein (VSP); Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=2.6e-05 Score=66.01 Aligned_cols=35 Identities=26% Similarity=0.426 Sum_probs=23.4
Q ss_pred CCCCcccccEEEehHHHHHHH-HHHHHHHhhhhccc
Q 046502 87 GGGGVSTGLVVGLAIGGLAVI-VVVSLLILRCRRKR 121 (608)
Q Consensus 87 ~~~~~~~g~~vgi~v~~~~~~-~~~~~~~~~~~~~~ 121 (608)
+++++++|+|+||+||+++++ +|+++++||+++||
T Consensus 59 ~~~~ls~gaiagi~vg~~~~v~~lv~~l~w~f~~r~ 94 (96)
T PTZ00382 59 NRSGLSTGAIAGISVAVVAVVGGLVGFLCWWFVCRG 94 (96)
T ss_pred CCCCcccccEEEEEeehhhHHHHHHHHHhheeEEee
Confidence 456889999999999877555 44445544444443
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=8.2e-05 Score=75.64 Aligned_cols=134 Identities=19% Similarity=0.129 Sum_probs=93.9
Q ss_pred CCcCCccccCCceEEEEEEecCCcEEEEEEcccCC--------------------ch--hHHHHHHHHHHHHhcC-CCC-
Q 046502 242 FSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS--------------------GQ--GERVFQAEVEIISRVH-HKH- 297 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------------------~~--~~~~~~~Ev~~l~~l~-Hpn- 297 (608)
++..+.||-|.-+.||.+...+|+..++|.=+... .. ..-...+|+..|+.|. |..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 56788999999999999999899999988643211 00 0112456888888885 332
Q ss_pred ccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC
Q 046502 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK 377 (608)
Q Consensus 298 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~ 377 (608)
+.+.+++ +..++|||++.+-.|...-+- .+..++ ...+..-+.-|-.+ ++||+|..-=||+|+++
T Consensus 174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~l---y~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd 238 (465)
T KOG2268|consen 174 VPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTL---YDDLMGLIVRLANH---GLIHGDFNEFNIMVKDD 238 (465)
T ss_pred CCCcccc----cceeeHHHhhcccceeeeeec-----CChHHH---HHHHHHHHHHHHHc---CceecccchheeEEecC
Confidence 3344443 467899999999888654332 222333 33333444556566 89999999999999999
Q ss_pred CceEEEEeecccc
Q 046502 378 FEAKVADFGLAKL 390 (608)
Q Consensus 378 ~~~kl~DFGla~~ 390 (608)
+.++++||--+..
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 9999999976543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0006 Score=69.82 Aligned_cols=31 Identities=26% Similarity=0.456 Sum_probs=25.8
Q ss_pred CeeeeccCCCcEEEccCCc-eEEEEeeccccc
Q 046502 361 KIIHRDIKAANILLDFKFE-AKVADFGLAKLA 391 (608)
Q Consensus 361 ~iiHrDIk~~NILl~~~~~-~kl~DFGla~~~ 391 (608)
.++|+|+++.|||++.+++ .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 5899999999999997555 469999987643
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00069 Score=70.18 Aligned_cols=136 Identities=16% Similarity=0.228 Sum_probs=93.9
Q ss_pred CccccCCceEEEEEEecCCcEEEEEEcccCC---------------------ch-hHH----HHHHHHHHHHhcCCCCcc
Q 046502 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS---------------------GQ-GER----VFQAEVEIISRVHHKHLV 299 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~---------------------~~-~~~----~~~~Ev~~l~~l~Hpniv 299 (608)
..|..|.-+.||.++-.+|..+|||+++-.- .. ..+ -...|+.-|.+|+.-.|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4688899999999999999999999985310 00 001 123477777777654433
Q ss_pred ceeeEEEeCCeeEEEEeeccCCcHHH-HhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC
Q 046502 300 SLVGYYTAGSQRMLVCEFVTSNTLEF-HLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF 378 (608)
Q Consensus 300 ~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~ 378 (608)
.---... ....|||+|+....... .|. ...|+......+-.+++.-|.-|...| ++||.||.--|+|+ .+|
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG 301 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDG 301 (520)
T ss_pred CCCceee--ecceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECC
Confidence 2111111 23479999997443321 121 124566677788889999999999999 89999999999998 567
Q ss_pred ceEEEEeeccc
Q 046502 379 EAKVADFGLAK 389 (608)
Q Consensus 379 ~~kl~DFGla~ 389 (608)
.+.|+|.+-+.
T Consensus 302 ~lyiIDVSQSV 312 (520)
T KOG2270|consen 302 KLYIIDVSQSV 312 (520)
T ss_pred EEEEEEccccc
Confidence 89999988765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0025 Score=66.02 Aligned_cols=147 Identities=18% Similarity=0.242 Sum_probs=85.2
Q ss_pred cCCccccCCceEEEEEEecCCcEEEEEEcc--cCCchhHHHHHHHHHHHHhcCC--CCccceeeEEEeCC--eeEEEEee
Q 046502 244 DANLLGQGGFGYVHKGVLPNGKEVAIKQLK--AGSGQGERVFQAEVEIISRVHH--KHLVSLVGYYTAGS--QRMLVCEF 317 (608)
Q Consensus 244 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~--~~~~~~~~~~~~Ev~~l~~l~H--pniv~l~g~~~~~~--~~~lV~E~ 317 (608)
+.+.+-.|---.+|.... .++.++|. .. ...........+|..+|+.+.- --+-+.+++|.++. ..+.||+|
T Consensus 29 ~v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 334443333333444443 37888888 33 1222334556778888888753 22345677787766 67999999
Q ss_pred ccCCcHH------------------HHh---hc---------------CCCCCCCHHHHHHHHH--------HHHHHHHH
Q 046502 318 VTSNTLE------------------FHL---HG---------------KGRPTMDWPTRLKIAL--------GFAKGLAY 353 (608)
Q Consensus 318 ~~~gsL~------------------~~l---~~---------------~~~~~l~~~~~~~ia~--------~ia~~L~y 353 (608)
++|..+. ++| |. ..++...|....+.+. ....-..|
T Consensus 107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 9983221 111 11 0011112322221111 22334556
Q ss_pred HHhcCC-----CCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 354 LHEDCH-----PKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 354 LH~~~~-----~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
|+.+.. +.++|+|+++.||||+.+..+=|.||+++.+..
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD 230 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence 655422 359999999999999999889999999987543
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0033 Score=65.25 Aligned_cols=64 Identities=8% Similarity=0.101 Sum_probs=40.2
Q ss_pred EEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCC--CccceeeE------EEeCCeeEEEEeeccCCcH
Q 046502 255 YVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHK--HLVSLVGY------YTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 255 ~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hp--niv~l~g~------~~~~~~~~lV~E~~~~gsL 323 (608)
.||+....+| .+++|++... ...+..|+.++..|... .+.+++.. ...++..++|+||++|..+
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~ 82 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC 82 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence 4898886555 5889988532 23355577777777433 33333321 2335678999999998554
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.00022 Score=49.15 Aligned_cols=28 Identities=18% Similarity=0.382 Sum_probs=11.8
Q ss_pred cccEEEehHHHHHHHHHHHHHHhhhhcc
Q 046502 93 TGLVVGLAIGGLAVIVVVSLLILRCRRK 120 (608)
Q Consensus 93 ~g~~vgi~v~~~~~~~~~~~~~~~~~~~ 120 (608)
..+.+|++|.++++++++++++|++|||
T Consensus 11 vaIa~~VvVPV~vI~~vl~~~l~~~~rR 38 (40)
T PF08693_consen 11 VAIAVGVVVPVGVIIIVLGAFLFFWYRR 38 (40)
T ss_pred EEEEEEEEechHHHHHHHHHHhheEEec
Confidence 3444555554444433333333333333
|
This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis []. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0028 Score=66.30 Aligned_cols=139 Identities=21% Similarity=0.289 Sum_probs=85.8
Q ss_pred ccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC------ccceeeEE--EeCC--eeEEEEe
Q 046502 247 LLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH------LVSLVGYY--TAGS--QRMLVCE 316 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn------iv~l~g~~--~~~~--~~~lV~E 316 (608)
.|.+ .-..||+....+|+. ++|+.+.. ....++..|+.+|..|.-.+ |..+-|-. .-.. ..+.|++
T Consensus 33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 3444 556789998877776 88988765 44556677888888874222 22222211 1223 6788999
Q ss_pred eccCCcHHH---------------Hhhc--CC--------CCCCCHHH---H----------HHHHHHHHHHHHHHHhcC
Q 046502 317 FVTSNTLEF---------------HLHG--KG--------RPTMDWPT---R----------LKIALGFAKGLAYLHEDC 358 (608)
Q Consensus 317 ~~~~gsL~~---------------~l~~--~~--------~~~l~~~~---~----------~~ia~~ia~~L~yLH~~~ 358 (608)
|++|..+.. .||. ++ .....|.. + .....++...+..+.+..
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999988772 1111 11 11345541 0 123334444555555432
Q ss_pred ----CCC---eeeeccCCCcEEEccCCc-eEEEEeeccc
Q 046502 359 ----HPK---IIHRDIKAANILLDFKFE-AKVADFGLAK 389 (608)
Q Consensus 359 ----~~~---iiHrDIk~~NILl~~~~~-~kl~DFGla~ 389 (608)
... +||+|+.+.|||++.+.. +.++||+-+.
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 223 999999999999999885 8999999764
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.00013 Score=86.50 Aligned_cols=160 Identities=12% Similarity=0.025 Sum_probs=111.5
Q ss_pred HHHHHHHHHHhcCCCCccceeeEEE--eCCeeEEEEeeccCCcHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhc
Q 046502 282 VFQAEVEIISRVHHKHLVSLVGYYT--AGSQRMLVCEFVTSNTLEFHLHGKG--RPTMDWPTRLKIALGFAKGLAYLHED 357 (608)
Q Consensus 282 ~~~~Ev~~l~~l~Hpniv~l~g~~~--~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~ 357 (608)
....|.+.++...|.++.....-.. +..+.+.+++|+.+|.+...|...- ...++..-......+......-.|..
T Consensus 1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence 3445666666778888776554332 3446689999999999998876532 23333333333333334444444433
Q ss_pred CC--CCeeeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHH
Q 046502 358 CH--PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLEL 435 (608)
Q Consensus 358 ~~--~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~el 435 (608)
.+ .-.+|+++|.-|.+|..+.++|++++|+.+...... .......+++.|+.++....-.++.++|+|..|+.+|++
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 21 137899999999999999999999999999443322 222335678899999999988999999999999999998
Q ss_pred HhCCCCC
Q 046502 436 IIGCRPV 442 (608)
Q Consensus 436 ltG~~p~ 442 (608)
--|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 7766553
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0059 Score=64.63 Aligned_cols=139 Identities=19% Similarity=0.226 Sum_probs=83.0
Q ss_pred CccccCCceEEEEEEecC-----CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCcc-ceeeEEEeCCeeEEEEeecc
Q 046502 246 NLLGQGGFGYVHKGVLPN-----GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLV-SLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv-~l~g~~~~~~~~~lV~E~~~ 319 (608)
..|-.|-...+|+....+ ++.|++|+......... ...+|+.++..+..-++. ++++++..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 445567888999987543 36799998865432221 225688999888655444 666665432 5899998
Q ss_pred CCcHHHH-----------------hhcCC---CC-CCCHHHHHHHHHH-----------------HHHHHHHHHh-----
Q 046502 320 SNTLEFH-----------------LHGKG---RP-TMDWPTRLKIALG-----------------FAKGLAYLHE----- 356 (608)
Q Consensus 320 ~gsL~~~-----------------l~~~~---~~-~l~~~~~~~ia~~-----------------ia~~L~yLH~----- 356 (608)
+.+|... +|... .. ..-|....++..+ +...+..|..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776411 22211 11 1123333333211 1222222222
Q ss_pred cCCCCeeeeccCCCcEEEcc-CCceEEEEeeccc
Q 046502 357 DCHPKIIHRDIKAANILLDF-KFEAKVADFGLAK 389 (608)
Q Consensus 357 ~~~~~iiHrDIk~~NILl~~-~~~~kl~DFGla~ 389 (608)
.....++|+|+++.|||+++ ++.++|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11235899999999999986 4689999998765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0017 Score=66.76 Aligned_cols=139 Identities=18% Similarity=0.215 Sum_probs=74.8
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC---CCCccceeeEEEeCCeeEEEEeecc
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH---HKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~---Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
...+.|+.|....+|+.. .+++.+.||+-. ......|..|.+-|+.|. --.+.+++++...++..+|||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445678989999999988 578889999866 233456888999998884 3456788888877777899999998
Q ss_pred CCcH-----------HHHhhc-CCC-------------------CCCCHHHH-----HHHHHHHH-----------HHHH
Q 046502 320 SNTL-----------EFHLHG-KGR-------------------PTMDWPTR-----LKIALGFA-----------KGLA 352 (608)
Q Consensus 320 ~gsL-----------~~~l~~-~~~-------------------~~l~~~~~-----~~ia~~ia-----------~~L~ 352 (608)
.+.. ...||. ... -.-+|..- +....+.+ +.++
T Consensus 96 ~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~ 175 (288)
T PF03881_consen 96 MGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVE 175 (288)
T ss_dssp -----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHH
Confidence 7711 112333 110 11244321 11111111 1122
Q ss_pred HHHhc-----CCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 353 YLHED-----CHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 353 yLH~~-----~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
-|.+. ..|-++|+||-..|++++.++++.|.|=
T Consensus 176 ~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DP 213 (288)
T PF03881_consen 176 RLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDP 213 (288)
T ss_dssp HHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S-
T ss_pred HHHHHhcCCCCCceeeEcCccccceeecCCCCceeecc
Confidence 22221 2346999999999999999998999874
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.021 Score=59.94 Aligned_cols=94 Identities=13% Similarity=0.036 Sum_probs=56.2
Q ss_pred ccCHHHHHHHhcCCCc---CC-ccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC--ccc--
Q 046502 229 TFTYEELARATDGFSD---AN-LLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH--LVS-- 300 (608)
Q Consensus 229 ~~~~~el~~~~~~f~~---~~-~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn--iv~-- 300 (608)
.++-+.+..+...+-. .+ .+=.+.-..||+....+|+.+++|+.+... ....++..|++++..|.... ++.
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 3444555555544422 11 122345677999988788899999876432 34556777888887774211 222
Q ss_pred -eee--EEEeCCeeEEEEeeccCCcH
Q 046502 301 -LVG--YYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 301 -l~g--~~~~~~~~~lV~E~~~~gsL 323 (608)
.-| +...++..+.|+++++|..+
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 112 23335677899999987643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.01 Score=61.68 Aligned_cols=31 Identities=16% Similarity=0.262 Sum_probs=27.8
Q ss_pred CCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 360 ~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.++||+|+...|||++.++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3699999999999999999999999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0097 Score=71.72 Aligned_cols=142 Identities=15% Similarity=0.196 Sum_probs=81.2
Q ss_pred CccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-------CCCcccee-e----EEEe-CC--e
Q 046502 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-------HKHLVSLV-G----YYTA-GS--Q 310 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-------Hpniv~l~-g----~~~~-~~--~ 310 (608)
+.|+ |..-.+|+....+|+.+++|+.+.... ...+..|.++|..|. -|.+++.. | .+.. ++ .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 456888999888888999999986432 233444556665552 22323211 1 1111 22 4
Q ss_pred eEEEEeeccCCcHHHH-----------------hhc--------CCCCCCCHHH-----------------HHHHHHHHH
Q 046502 311 RMLVCEFVTSNTLEFH-----------------LHG--------KGRPTMDWPT-----------------RLKIALGFA 348 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~-----------------l~~--------~~~~~l~~~~-----------------~~~ia~~ia 348 (608)
.+.+|+|++|..|.+. ||. .....+.|.. +..++.+++
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5778999999877541 110 0112244432 112222333
Q ss_pred HHHHH----HHhcCCCCeeeeccCCCcEEEccCC--ceE-EEEeecccc
Q 046502 349 KGLAY----LHEDCHPKIIHRDIKAANILLDFKF--EAK-VADFGLAKL 390 (608)
Q Consensus 349 ~~L~y----LH~~~~~~iiHrDIk~~NILl~~~~--~~k-l~DFGla~~ 390 (608)
..+.- ........+||+|+.+.|||++.+. ++. |+|||-+..
T Consensus 188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 32221 1112334699999999999999875 555 999998764
|
|
| >PF03302 VSP: Giardia variant-specific surface protein; InterPro: IPR005127 During infection, the intestinal protozoan parasite Giardia lamblia virus undergoes continuous antigenic variation which is determined by diversification of the parasite's major surface antigen, named VSP (variant surface protein) | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.00061 Score=73.16 Aligned_cols=38 Identities=21% Similarity=0.396 Sum_probs=26.7
Q ss_pred CCCCCCcccccEEEehHHHHHHH-HHHHHHHhhhhcccc
Q 046502 85 DDGGGGVSTGLVVGLAIGGLAVI-VVVSLLILRCRRKRR 122 (608)
Q Consensus 85 ~~~~~~~~~g~~vgi~v~~~~~~-~~~~~~~~~~~~~~~ 122 (608)
+.+.++|++|+|+||+|+||+|| .||+||.||+.-|.|
T Consensus 358 ~~n~s~LstgaIaGIsvavvvvVgglvGfLcWwf~crgk 396 (397)
T PF03302_consen 358 STNKSGLSTGAIAGISVAVVVVVGGLVGFLCWWFICRGK 396 (397)
T ss_pred CcccccccccceeeeeehhHHHHHHHHHHHhhheeeccc
Confidence 34567899999999999987664 466666555544443
|
|
| >PF13908 Shisa: Wnt and FGF inhibitory regulator | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.013 Score=55.80 Aligned_cols=26 Identities=27% Similarity=0.464 Sum_probs=15.9
Q ss_pred CCcccccEEEehHHHHHHHHHHHHHH
Q 046502 89 GGVSTGLVVGLAIGGLAVIVVVSLLI 114 (608)
Q Consensus 89 ~~~~~g~~vgi~v~~~~~~~~~~~~~ 114 (608)
.+..+++|+||++++++++++|++++
T Consensus 74 ~~~~~~iivgvi~~Vi~Iv~~Iv~~~ 99 (179)
T PF13908_consen 74 IYFITGIIVGVICGVIAIVVLIVCFC 99 (179)
T ss_pred ccceeeeeeehhhHHHHHHHhHhhhe
Confidence 34566788888777766654444433
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.026 Score=59.54 Aligned_cols=73 Identities=15% Similarity=0.133 Sum_probs=47.0
Q ss_pred ccccCCceEEEEEEecCC-cEEEEEEcccCC-------chhHHHHHHHHHHHHhcC--CCC-ccceeeEEEeCCeeEEEE
Q 046502 247 LLGQGGFGYVHKGVLPNG-KEVAIKQLKAGS-------GQGERVFQAEVEIISRVH--HKH-LVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~~~g-~~vavK~~~~~~-------~~~~~~~~~Ev~~l~~l~--Hpn-iv~l~g~~~~~~~~~lV~ 315 (608)
.||.|....||++...+| +.|+||+-.... ....+...-|.+.|.... .|. +.+++.| +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999997655 689999853211 122233445777777664 343 4444443 345567999
Q ss_pred eeccCC
Q 046502 316 EFVTSN 321 (608)
Q Consensus 316 E~~~~g 321 (608)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.014 Score=61.32 Aligned_cols=139 Identities=16% Similarity=0.210 Sum_probs=80.9
Q ss_pred CccccCCceEEEEEEecC----CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~ 320 (608)
+.|-.|=...+|+....+ +..|++|+........ -.-.+|+.+++.+..-++ .++++++. ++ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 445557778899887543 2378999876543221 123568889988875555 46676663 22 58999987
Q ss_pred CcHHH-----------------HhhcCC---CC-CCCHHHHHHHHHH----------------------HHHHHHHHHhc
Q 046502 321 NTLEF-----------------HLHGKG---RP-TMDWPTRLKIALG----------------------FAKGLAYLHED 357 (608)
Q Consensus 321 gsL~~-----------------~l~~~~---~~-~l~~~~~~~ia~~----------------------ia~~L~yLH~~ 357 (608)
..|.. .||... .. .--|..+.++..+ +.+-+..|...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66521 122211 01 1123333222221 12222222221
Q ss_pred -----CCCCeeeeccCCCcEEEcc-CCceEEEEeeccc
Q 046502 358 -----CHPKIIHRDIKAANILLDF-KFEAKVADFGLAK 389 (608)
Q Consensus 358 -----~~~~iiHrDIk~~NILl~~-~~~~kl~DFGla~ 389 (608)
...-++|.|+.+.|||+++ ++.++|+||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1124899999999999975 5789999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.043 Score=58.90 Aligned_cols=73 Identities=12% Similarity=0.131 Sum_probs=49.4
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCc-------hhHHHHHHHHHHHHhcC---CCCccceeeEEEeCCeeEEE
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG-------QGERVFQAEVEIISRVH---HKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-------~~~~~~~~Ev~~l~~l~---Hpniv~l~g~~~~~~~~~lV 314 (608)
.+.||.|....||+... .++.|+||+-..... .....-..|++.|..+. ..++.+++.+|. +..++|
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 56789999999999886 456799998652111 11222233566666653 247788888887 446789
Q ss_pred EeeccC
Q 046502 315 CEFVTS 320 (608)
Q Consensus 315 ~E~~~~ 320 (608)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >COG3889 Predicted solute binding protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.0025 Score=70.96 Aligned_cols=15 Identities=27% Similarity=0.439 Sum_probs=7.2
Q ss_pred HHHHHHHHHHhhhhc
Q 046502 105 AVIVVVSLLILRCRR 119 (608)
Q Consensus 105 ~~~~~~~~~~~~~~~ 119 (608)
++++|+++.++++||
T Consensus 856 iiv~LaAla~lLrRR 870 (872)
T COG3889 856 IIVGLAALALLLRRR 870 (872)
T ss_pred HHHHHHHHHHHHHhh
Confidence 444455555554443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0085 Score=58.59 Aligned_cols=121 Identities=21% Similarity=0.227 Sum_probs=59.6
Q ss_pred CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEeeccCCcHHH-------H---------
Q 046502 264 GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVCEFVTSNTLEF-------H--------- 326 (608)
Q Consensus 264 g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~gsL~~-------~--------- 326 (608)
++.|+||+.......- -....|+.+++.+..-++ .++++++.+ .+|+||+++..|.. .
T Consensus 2 ~~~~~~Ri~g~~t~~~-idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENF-IDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCGCSH-HHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcccc-cCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 4678888887653222 234568888888864444 556665533 25779997766531 1
Q ss_pred -hhc--C---CCCCCCHHHHHHH----------------------HHHHHHHHHHHHh---c--CCCCeeeeccCCCcEE
Q 046502 327 -LHG--K---GRPTMDWPTRLKI----------------------ALGFAKGLAYLHE---D--CHPKIIHRDIKAANIL 373 (608)
Q Consensus 327 -l~~--~---~~~~l~~~~~~~i----------------------a~~ia~~L~yLH~---~--~~~~iiHrDIk~~NIL 373 (608)
+|. . .....-|.....+ ...+..-+..+.+ . ...-++|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 111 0 0111112222222 1112222222221 1 0125899999999999
Q ss_pred E-ccCCceEEEEeeccc
Q 046502 374 L-DFKFEAKVADFGLAK 389 (608)
Q Consensus 374 l-~~~~~~kl~DFGla~ 389 (608)
+ +.++.++|+||-.|.
T Consensus 157 ~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAG 173 (211)
T ss_dssp ETSSSSCEEE--GTT-E
T ss_pred eccCCCeEEEecHHHHh
Confidence 9 888999999998765
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 608 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-63 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-62 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-42 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-37 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-28 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-28 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-24 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-22 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-22 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-22 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-22 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-22 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-22 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-22 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-17 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-17 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 8e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 9e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 4e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 6e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-13 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 7e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-13 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 8e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 9e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 7e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 8e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 9e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 527 bits (1360), Expect = 0.0
Identities = 142/313 (45%), Positives = 196/313 (62%), Gaps = 13/313 (4%)
Query: 220 GLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQG 279
+ LG LK F+ EL A+D FS+ N+LG+GGFG V+KG L +G VA+K+LK QG
Sbjct: 11 EVHLGQLK-RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG 69
Query: 280 -ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGK--GRPTMD 336
E FQ EVE+IS H++L+ L G+ ++R+LV ++ + ++ L + +P +D
Sbjct: 70 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 337 WPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396
WP R +IALG A+GLAYLH+ C PKIIHRD+KAANILLD +FEA V DFGLAKL T
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189
Query: 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL--- 453
HV+T V GT G++APEY S+GK +EK+DVF +GVMLLELI G R D +D++
Sbjct: 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 454 --ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511
+ LL ++ + LVD L Y E+ +++ A C + S RP++S++VR
Sbjct: 250 DWVKGLL----KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 512 LEGDASLADLNEG 524
LEGD E
Sbjct: 306 LEGDGLAERWEEW 318
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 488 bits (1258), Expect = e-171
Identities = 114/324 (35%), Positives = 172/324 (53%), Gaps = 13/324 (4%)
Query: 203 SSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLP 262
S + + S + F +L AT+ F L+G G FG V+KGVL
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 263 NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNT 322
+G +VA+K+ S QG F+ E+E +S H HLVSL+G+ ++ +L+ +++ +
Sbjct: 62 DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGN 121
Query: 323 LEFHLHGKGRPT--MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380
L+ HL+G PT M W RL+I +G A+GL YLH IIHRD+K+ NILLD F
Sbjct: 122 LKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVP 178
Query: 381 KVADFGLAKLASDV-YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGC 439
K+ DFG++K +++ TH+ST V GT GY+ PEY G+LTEKSDV+SFGV+L E++
Sbjct: 179 KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 440 RPVDSTHTFMEDNL---ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVR 496
+ + NL A N G + +VDP L ++ + + A C+
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNN----GQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 497 HSARRRPRISQIVRTLEGDASLAD 520
S+ RP + ++ LE L +
Sbjct: 295 LSSEDRPSMGDVLWKLEYALRLQE 318
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 458 bits (1182), Expect = e-160
Identities = 101/304 (33%), Positives = 170/304 (55%), Gaps = 26/304 (8%)
Query: 229 TFTYEELARATDGFSD------ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAG----SGQ 278
+F++ EL T+ F + N +G+GGFG V+KG + N VA+K+L A + +
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 279 GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHG-KGRPTMDW 337
++ F E++++++ H++LV L+G+ + G LV ++ + +L L G P + W
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 338 PTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA-SDVYT 396
R KIA G A G+ +LHE+ IHRDIK+ANILLD F AK++DFGLA+ + T
Sbjct: 133 HMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL--- 453
+++R++GT Y+APE G++T KSD++SFGV+LLE+I G VD L
Sbjct: 190 VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLLDI 246
Query: 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+ + E+ + +D K+ N+ + + M + A+ C+ +RP I ++ + L+
Sbjct: 247 KEEIED---EEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 514 GDAS 517
+
Sbjct: 303 EMTA 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 6e-85
Identities = 74/320 (23%), Positives = 117/320 (36%), Gaps = 35/320 (10%)
Query: 228 STFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEV 287
E L + + +G FG V K + VA+K Q + + EV
Sbjct: 12 VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-NEYEV 69
Query: 288 EIISRVHHKHLVSLVGYYTAGS----QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKI 343
+ + H++++ +G G+ L+ F +L L + W I
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVVSWNELCHI 126
Query: 344 ALGFAKGLAYLHED-------CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396
A A+GLAYLHED P I HRDIK+ N+LL A +ADFGLA +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 397 HV-STRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
+ +GT Y+APE + D+++ G++L EL C D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV---- 242
Query: 451 DNLARPLLNRAIEDGNFDTL--------VDPKLHNEY-NHNEMARMVACAAACVRHSARR 501
D P + + + + P L + + H MA + C H A
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 502 RPRISQIVRTLEGDASLADL 521
R + + L ++
Sbjct: 303 RLSAGCVGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-64
Identities = 64/339 (18%), Positives = 123/339 (36%), Gaps = 46/339 (13%)
Query: 230 FTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEI 289
E + D L+G+G +G V+KG L + + VA+K + Q F E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQN---FINEKNI 58
Query: 290 --ISRVHHKHLVSLVGYYTAGS-----QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK 342
+ + H ++ + + + +LV E+ + +L +L T DW + +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSDWVSSCR 115
Query: 343 IALGFAKGLAYLHED------CHPKIIHRDIKAANILLDFKFEAKVADFGLAKL------ 390
+A +GLAYLH + P I HRD+ + N+L+ ++DFGL+
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 391 -ASDVYTHVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIIGCRPV 442
+ + +GT Y+APE ++ D+++ G++ E+ + C +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 443 DSTHTFMEDNLARPLLNRAIEDGNFDTLVD--------PKLHNEYNHNE--MARMVACAA 492
+ E + F+ + PK + N + +
Sbjct: 236 FPGESVPEYQM--AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 493 ACVRHSARRRPRISQIVRTLEGDASLADLNEGIRPGQSS 531
C A R + + + N+ + P
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-58
Identities = 75/197 (38%), Positives = 110/197 (55%), Gaps = 6/197 (3%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERV--FQAEVEIISRVHHKHLVSLVGYY 305
+G G FG VH+ +G +VA+K L ERV F EV I+ R+ H ++V +G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKG-RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
T +V E+++ +L LH G R +D RL +A AKG+ YLH +P I+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSD 424
R++K+ N+L+D K+ KV DFGL++L + + S GT ++APE EKSD
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 425 VFSFGVMLLELIIGCRP 441
V+SFGV+L EL +P
Sbjct: 222 VYSFGVILWELATLQQP 238
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-58
Identities = 85/281 (30%), Positives = 132/281 (46%), Gaps = 37/281 (13%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-------FQAEVEIISRVHHKHLV 299
+G+GGFG VHKG + + VAIK L G +GE FQ EV I+S ++H ++V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
L G + +V EFV L L K P + W +L++ L A G+ Y+ + +
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIALGIEYMQ-NQN 142
Query: 360 PKIIHRDIKAANILLD-----FKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE-- 412
P I+HRD+++ NI L AKVADFGL++ + H + ++G F ++APE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNFQWMAPETI 198
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472
A TEK+D +SF ++L ++ G P F E + + I +
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGP------FDEYSYGKIKFINMIREEGL-RPTI 251
Query: 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
P E + ++ C ++RP S IV+ L
Sbjct: 252 P----EDCPPRLRNVI---ELCWSGDPKKRPHFSYIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-57
Identities = 75/268 (27%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
+G+G FG V K K+VAIKQ+++ S + F E+ +SRV+H ++V L G
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACL- 71
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGR-PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
+ LV E+ +L LHG P + L ++G+AYLH +IHRD
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 367 IKAANILLDFKFE-AKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
+K N+LL K+ DFG A T G+ ++APE +EK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 426 FSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMA 485
FS+G++L E+I +P F E + A+ +G K +
Sbjct: 187 FSWGIILWEVITRRKP------FDEIGGPAFRIMWAVHNGT--RPPLIK----NLPKPIE 234
Query: 486 RMVACAAACVRHSARRRPRISQIVRTLE 513
++ C +RP + +IV+ +
Sbjct: 235 SLM---TRCWSKDPSQRPSMEEIVKIMT 259
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-55
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAG----SGQGERVFQAEVEIISRVHHKHLVSLVG 303
+G GGFG V++ G EVA+K + Q + E ++ + + H ++++L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
LV EF L L GK + + A+ A+G+ YLH++ II
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 364 HRDIKAANILLDFKFE--------AKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS 415
HRD+K++NIL+ K E K+ DFGLA+ G + ++APE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPEVIR 187
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRP 441
+ ++ SDV+S+GV+L EL+ G P
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-55
Identities = 44/201 (21%), Positives = 84/201 (41%), Gaps = 15/201 (7%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
L + G + KG G ++ +K LK S + R F E + H +++ ++G
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 306 TA--GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ L+ ++ +L LH +D +K AL A+G+A+LH P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE---YASSGKLT 420
+ + ++++D A+++ + + S M ++APE
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDTNR 189
Query: 421 EKSDVFSFGVMLLELIIGCRP 441
+D++SF V+L EL+ P
Sbjct: 190 RSADMWSFAVLLWELVTREVP 210
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-54
Identities = 71/284 (25%), Positives = 110/284 (38%), Gaps = 41/284 (14%)
Query: 248 LGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
LG+G FG K G+ + +K+L + +R F EV+++ + H +++ +G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
+ + E++ TL + W R+ A A G+AYLH IIHRD
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS---MNIIHRD 133
Query: 367 IKAANILLDFKFEAKVADFGLAKLASDVYTH-------------VSTRVMGTFGYLAPEY 413
+ + N L+ VADFGLA+L D T V+G ++APE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRP----VDSTHTFMEDNLARPLLNRAIEDGNFDT 469
+ EK DVFSFG++L E+I + T F + R L+R
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN--VRGFLDRYCPPN---- 247
Query: 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
P C +RP ++ LE
Sbjct: 248 -CPPSFFP------------ITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-53
Identities = 74/278 (26%), Positives = 127/278 (45%), Gaps = 37/278 (13%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERV--FQAEVEIISRVHHKHLVSLVGYY 305
+G G FG V+KG +G +VA+K L + +++ F+ EV ++ + H +++ +GY
Sbjct: 32 IGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
T Q +V ++ ++L HLH + + IA A+G+ YLH IIHR
Sbjct: 90 T-APQLAIVTQWCEGSSLYHHLH-ASETKFEMKKLIDIARQTARGMDYLHA---KSIIHR 144
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPE---YASSGKLTE 421
D+K+ NI L K+ DFGLA S +H ++ G+ ++APE S +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 422 KSDVFSFGVMLLELIIGCRP------VDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475
+SDV++FG++L EL+ G P D + P L++ + ++
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN------CPKRM 258
Query: 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
MA C++ RP +I+ +E
Sbjct: 259 -----KRLMAE-------CLKKKRDERPSFPRILAEIE 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 5e-53
Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 41/297 (13%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEI--ISRVHHKHLVSLVG 303
+G+G +G V +G G+ VA+K + + E+ + E E+ + H++++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 304 YYTAGS----QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED-- 357
Q L+ + +L +L T+D + L+I L A GLA+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 358 ---CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV---STRVMGTFGYLAP 411
P I HRD+K+ NIL+ + +AD GLA + S + + +GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 412 E------YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465
E ++ D+++FG++L E+ + P + D
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP-----PFYDVVPNDP 241
Query: 466 NFDTLVD--------PKLHNEY-NHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+F+ + P + N + + + + C + R +I +TL
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-52
Identities = 64/297 (21%), Positives = 120/297 (40%), Gaps = 41/297 (13%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEI--ISRVHHKHLVSLVG 303
+G+G +G V G G++VA+K E + E EI + H++++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 304 YYTAGS----QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED-- 357
G+ Q L+ ++ + +L +L T+D + LK+A GL +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK---STTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 358 ---CHPKIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTFGYLAP 411
P I HRD+K+ NIL+ +AD GLA ++ +GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 412 E------YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465
E + + +D++SFG++L E+ C + P + D
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ-----LPYHDLVPSDP 270
Query: 466 NFDTLVD--------PKLHNEY-NHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+++ + + P N + + + +M C H+ R ++ +TL
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-51
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 22/211 (10%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERV--FQAEVEIISRVHHKHLVSLVG 303
L+G+G FG V+ G +G EVAI+ + +++ F+ EV + H+++V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ ++ TL + + +D +IA KG+ YLH I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM----GTFGYLAPEYASSGKL 419
H+D+K+ N+ D + + DFGL ++ + + G +LAPE
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 420 ---------TEKSDVFSFGVMLLELIIGCRP 441
++ SDVF+ G + EL P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 5e-49
Identities = 69/297 (23%), Positives = 125/297 (42%), Gaps = 41/297 (13%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEI--ISRVHHKHLVSLVG 303
+G+G FG V +G G+EVA+K + + ER + E EI + H++++ +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 304 ----YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED-- 357
+Q LV ++ +L +L+ R T+ +K+AL A GLA+LH +
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 358 ---CHPKIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTFGYLAP 411
P I HRD+K+ NIL+ +AD GLA A+D +GT Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 412 E------YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465
E + +++D+++ G++ E+ C + ++ P + D
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG-----IHEDYQLPYYDLVPSDP 275
Query: 466 NFDTLVD--------PKLHNEY-NHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+ + + P + N + + + M C + R +I +TL
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 12/200 (6%)
Query: 248 LGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSLVGYY 305
+G+G FG V G L + VA+K + + F E I+ + H ++V L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
T +V E V L +G + T L++ A G+ YL IHR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLESK---CCIHR 237
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASD-VYTHVSTRVMGTFGY--LAPEYASSGKLTEK 422
D+ A N L+ K K++DFG+++ +D VY + APE + G+ + +
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG--LRQVPVKWTAPEALNYGRYSSE 295
Query: 423 SDVFSFGVMLLELI-IGCRP 441
SDV+SFG++L E +G P
Sbjct: 296 SDVWSFGILLWETFSLGASP 315
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 65/293 (22%), Positives = 117/293 (39%), Gaps = 50/293 (17%)
Query: 248 LGQGGFGYVHKGVLP-----NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLV 302
LG+G FG V G+ VA+K+L+ + + R F+ E+EI+ + H ++V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 303 GYYTAGSQR--MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
G + +R L+ E++ +L +L K + +D L+ KG+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 133
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTF--GYLAPEYAS 415
+ IHRD+ NIL++ + K+ DFGL K+ + + + G + APE +
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK---VKEPGESPIFWYAPESLT 190
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR----PLLNR----AIEDGNF 467
K + SDV+SFGV+L EL S + ++ +++
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN-- 248
Query: 468 DTLVDPKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRISQIVRTLE 513
+ R C C ++ +RP + ++
Sbjct: 249 --------------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 66/290 (22%), Positives = 115/290 (39%), Gaps = 44/290 (15%)
Query: 248 LGQGGFGYVHKGVLP-----NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLV 302
LG+G FG V G+ VA+K+L+ + + R F+ E+EI+ + H ++V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 303 GYYTAGSQR--MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
G + +R L+ E++ +L +L K + +D L+ KG+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLLQYTSQICKGMEYLGTK--- 164
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKL--ASDVYTHVSTRVMGTFGYLAPEYASSGK 418
+ IHRD+ NIL++ + K+ DFGL K+ Y V + APE + K
Sbjct: 165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224
Query: 419 LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR----PLLNR----AIEDGNFDTL 470
+ SDV+SFGV+L EL S + ++ +++
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN----- 279
Query: 471 VDPKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRISQIVRTLE 513
+ R C C ++ +RP + ++
Sbjct: 280 -----------GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 9e-40
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQ--LKAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
+G+G F V+KG+ EVA + + + + F+ E E++ + H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 304 YYTAGSQRM----LVCEFVTSNTLEFHL--HGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
+ + + LV E +TS TL+ +L M KGL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT- 147
Query: 358 CHPKIIHRDIKAANILLDFKF-EAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS 416
P IIHRD+K NI + K+ D GLA L + V+GT ++APE
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEE 204
Query: 417 GKLTEKSDVFSFGVMLLELIIGCRP 441
E DV++FG+ +LE+ P
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP 228
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-39
Identities = 71/293 (24%), Positives = 116/293 (39%), Gaps = 50/293 (17%)
Query: 248 LGQGGFGYVHKGVLP-----NGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSL 301
LG+G FG V G++VA+K LK SG + E+EI+ ++H+++V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 302 VG--YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
G G+ L+ EF+ S +L+ +L K + ++ +LK A+ KG+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQLKYAVQICKGMDYLGSR-- 145
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTF--GYLAPEYA 414
+ +HRD+ A N+L++ + + K+ DFGL K + YT + + APE
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT---VKDDRDSPVFWYAPECL 201
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL-------LNRAIEDGNF 467
K SDV+SFGV L EL+ C S + L +++G
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG-- 259
Query: 468 DTLVDPKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRISQIVRTLE 513
+ C C R ++ E
Sbjct: 260 --------------KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 67/198 (33%), Positives = 98/198 (49%), Gaps = 12/198 (6%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
+G G FG VH G N +VAIK ++ G+ E F E E++ ++ H LV L G
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
+ LV EF+ L +L R T L + L +G+AYL E+ +IHRD+
Sbjct: 75 QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIHRDL 130
Query: 368 KAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGY--LAPEYASSGKLTEKSD 424
A N L+ KV+DFG+ + + D YT + F +PE S + + KSD
Sbjct: 131 AARNCLVGENQVIKVSDFGMTRFVLDDQYT---SSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 425 VFSFGVMLLELI-IGCRP 441
V+SFGV++ E+ G P
Sbjct: 188 VWSFGVLMWEVFSEGKIP 205
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 80/290 (27%), Positives = 116/290 (40%), Gaps = 45/290 (15%)
Query: 248 LGQGGFGYVHKGVLP-----NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLV 302
LG+G FG V G VA+KQL+ +R FQ E++I+ +H +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 303 G--YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
G Y LV E++ S L L + R +D L + KG+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLLLYSSQICKGMEYLGSR--- 146
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTFGYLAPEYASSG 417
+ +HRD+ A NIL++ + K+ADFGLAKL D Y V + APE S
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV-VREPGQSPIFWYAPESLSDN 205
Query: 418 KLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDNLARPL------LNRAIEDGNFDTL 470
+ +SDV+SFGV+L EL + + F+ L +E+G
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG----- 260
Query: 471 VDPKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRISQIVRTLE 513
+ AC A C S + RP S + L+
Sbjct: 261 -----------QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-39
Identities = 58/198 (29%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG V G +VA+K +K GS + F E + + ++ H LV G +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE-FFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
+V E++++ L +L G ++ L++ +G+A+L + IHRD+
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDL 130
Query: 368 KAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGY--LAPEYASSGKLTEKSD 424
A N L+D KV+DFG+ + + D Y + V F APE K + KSD
Sbjct: 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQYV---SSVGTKFPVKWSAPEVFHYFKYSSKSD 187
Query: 425 VFSFGVMLLELI-IGCRP 441
V++FG+++ E+ +G P
Sbjct: 188 VWAFGILMWEVFSLGKMP 205
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-39
Identities = 81/336 (24%), Positives = 127/336 (37%), Gaps = 24/336 (7%)
Query: 122 RRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPP 181
+D YC + + + A P
Sbjct: 212 LISQDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLP 271
Query: 182 HSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDG 241
P P ++S G + + P P + F EEL
Sbjct: 272 AHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLF 331
Query: 242 FSDANL------LGQGGFGYVHKGVLPNGKE---VAIKQLKAGSGQGERV-FQAEVEIIS 291
NL LG G FG V +GV K+ VAIK LK G+ + + E +I+
Sbjct: 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMH 391
Query: 292 RVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGL 351
++ + ++V L+G MLV E L L GK R + ++ + G+
Sbjct: 392 QLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGM 449
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTFGY 408
YL E+ + +HR++ A N+LL + AK++DFGL+K YT R G +
Sbjct: 450 KYL-EEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT---ARSAGKWPL 503
Query: 409 --LAPEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
APE + K + +SDV+S+GV + E + G +P
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-39
Identities = 61/200 (30%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
+G+G FG V G G +VA+K +K + + F AE +++++ H +LV L+G
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 306 TAGSQR-MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
+V E++ +L +L +GR + LK +L + + YL + +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 140
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY--LAPEYASSGKLTEK 422
RD+ A N+L+ AKV+DFGL K + + T+ G APE K + K
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK---EASS---TQDTGKLPVKWTAPEALREKKFSTK 194
Query: 423 SDVFSFGVMLLELI-IGCRP 441
SDV+SFG++L E+ G P
Sbjct: 195 SDVWSFGILLWEIYSFGRVP 214
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-39
Identities = 67/203 (33%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 248 LGQGGFGYVHKGVL--PNGKE---VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSL 301
+G G FG V+KG+L +GK+ VAIK LKAG + +RV F E I+ + H +++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
G + M++ E++ + L+ L + + + G A G+ YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMKYL-ANMN-- 167
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY--LAPEYASSGKL 419
+HRD+ A NIL++ KV+DFGL+++ D T G APE S K
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 420 TEKSDVFSFGVMLLELI-IGCRP 441
T SDV+SFG+++ E++ G RP
Sbjct: 228 TSASDVWSFGIVMWEVMTYGERP 250
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 248 LGQGGFGYVHKGVLPNGKE-----VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSL 301
LG G FG V+KG+ E VAIK+L+ + E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+G S L+ + + L ++ + + + L + AKG+ YL + +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
++HRD+ A N+L+ K+ DFGLAK L ++ + + ++A E T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 421 EKSDVFSFGVMLLELI-IGCRP 441
+SDV+S+GV + EL+ G +P
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKP 219
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 8e-39
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 23/206 (11%)
Query: 248 LGQGGFGYVHKGVL--PNGKE--VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSLV 302
+G+G FG VH+G+ P VAIK K + R F E + + H H+V L+
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
G T + ++ E T L L + ++D + + A + LAYL +
Sbjct: 83 GVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTALAYLESK---RF 137
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKL--ASDVYTHVSTRV----MGTFGYLAPEYASS 416
+HRDI A N+L+ K+ DFGL++ S Y ++ M APE +
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------APESINF 191
Query: 417 GKLTEKSDVFSFGVMLLELI-IGCRP 441
+ T SDV+ FGV + E++ G +P
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG V G +VAIK +K GS + F E +++ + H+ LV L G T
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
++ E++ + L +L + R L++ + + YL E +HRD+
Sbjct: 91 QRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLHRDL 146
Query: 368 KAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGY--LAPEYASSGKLTEKSD 424
A N L++ + KV+DFGL++ + D YT + V F PE K + KSD
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYVLDDEYT---SSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 425 VFSFGVMLLELI-IGCRP 441
+++FGV++ E+ +G P
Sbjct: 204 IWAFGVLMWEIYSLGKMP 221
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 78/284 (27%), Positives = 114/284 (40%), Gaps = 34/284 (11%)
Query: 248 LGQGGFGYVHKGVLPNGKE-----VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSL 301
LG+G FG V + VA+K LKA +G R ++ E++I+ ++H+H++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 302 VG--YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
G + LV E+V +L +L R ++ L A +G+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKL--ASDVYTHVSTRVMGTFGYLAPEYASSG 417
IHRD+ A N+LLD K+ DFGLAK Y V + APE
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477
K SDV+SFGV L EL+ C S T + + + +L
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA----------QGQMTVLRLTE 262
Query: 478 EYNHNE-MARMVACAAA-------CVRHSARRRPRISQIVRTLE 513
E + R C A C A RP ++ L+
Sbjct: 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK 306
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 64/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 248 LGQGGFGYVHKGVLPNGKE---VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSLVG 303
LG G FG V +GV K+ VAIK LK G+ + + E +I+ ++ + ++V L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
MLV E L L GK + ++ + G+ YL E+ + +
Sbjct: 78 VCQ-AEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL-EEKN--FV 132
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTF--GYLAPEYASSGK 418
HRD+ A N+LL + AK++DFGL+K YT R G + + APE + K
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT---ARSAGKWPLKWYAPECINFRK 189
Query: 419 LTEKSDVFSFGVMLLELI-IGCRP 441
+ +SDV+S+GV + E + G +P
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 65/202 (32%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 248 LGQGGFGYVHKGVLPNGK-EVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
LG G +G V++GV VA+K LK + + E F E ++ + H +LV L+G T
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
++ EF+T L +L R + L +A + + YL + IHRD
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRD 136
Query: 367 IKAANILLDFKFEAKVADFGLAKL-ASDVYT-HVSTRV----MGTFGYLAPEYASSGKLT 420
+ A N L+ KVADFGL++L D YT H + APE + K +
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------APESLAYNKFS 190
Query: 421 EKSDVFSFGVMLLELI-IGCRP 441
KSDV++FGV+L E+ G P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 68/209 (32%), Positives = 97/209 (46%), Gaps = 20/209 (9%)
Query: 246 NLLGQGGFGYVHKGVL--PNGKE--VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
++G+G FG V+ G L +GK+ A+K L + GE F E I+ H +++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 301 LVGYYTAG-SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
L+G ++V ++ L + + L AKG+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKYLASK-- 147
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL------APEY 413
K +HRD+ A N +LD KF KVADFGLA+ D+Y V G A E
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLAR---DMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 414 ASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
+ K T KSDV+SFGV+L EL+ G P
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 69/197 (35%), Positives = 98/197 (49%), Gaps = 6/197 (3%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LGQG FG V G VAIK LK G+ E F E +++ ++ H+ LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVV 248
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
+ +V E+++ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 249 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 304
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
D++AANIL+ KVADFGLA+L D + APE A G+ T KSDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 426 FSFGVMLLELI-IGCRP 441
+SFG++L EL G P
Sbjct: 365 WSFGILLTELTTKGRVP 381
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 3e-38
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 248 LGQGGFGYVHKGVL--PNGKE--VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSLV 302
LG+G FG V++GV G++ VA+K K + F +E I+ + H H+V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
G ++ E L +L + + ++ T + +L K +AYL E +
Sbjct: 80 GIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLVLYSLQICKAMAYL-ESIN--C 134
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLA--SDVYTHVSTRV----MGTFGYLAPEYASS 416
+HRDI NIL+ K+ DFGL++ D Y TR+ M +PE +
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------SPESINF 188
Query: 417 GKLTEKSDVFSFGVMLLELI-IGCRP 441
+ T SDV+ F V + E++ G +P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 67/202 (33%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 248 LGQGGFGYVHKGVL--PNGKE--VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSLV 302
+G G FG V G L P+ KE VAIK LK G + +R F E I+ + H +++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
G T M+V E++ + +L+ L K + + G A G+ YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMKYL-SDMG--Y 168
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL--APEYASSGKLT 420
+HRD+ A NIL++ KV+DFGL ++ D T G +PE + K T
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 421 EKSDVFSFGVMLLELI-IGCRP 441
SDV+S+G++L E++ G RP
Sbjct: 229 SASDVWSYGIVLWEVMSYGERP 250
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-38
Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 16/198 (8%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
+G+G FG V G G +VA+K +K + + F AE +++++ H +LV L+G
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 308 GSQR-MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366
+V E++ +L +L +GR + LK +L + + YL + +HRD
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 314
Query: 367 IKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY--LAPEYASSGKLTEKSD 424
+ A N+L+ AKV+DFGL K + + T+ G APE K + KSD
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK---EASS---TQDTGKLPVKWTAPEALREKKFSTKSD 368
Query: 425 VFSFGVMLLELI-IGCRP 441
V+SFG++L E+ G P
Sbjct: 369 VWSFGILLWEIYSFGRVP 386
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 80/321 (24%), Positives = 124/321 (38%), Gaps = 49/321 (15%)
Query: 142 VDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSG 201
+DP G H + AA ++ P + + +Y + F ++
Sbjct: 4 IDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANT 63
Query: 202 GSSSNYSGS--------EAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGF 253
+ + I P SL + ++G+G F
Sbjct: 64 VHIDLSALNPELVQAVQHVVIGPSSLIVHFN---------------------EVIGRGHF 102
Query: 254 GYVHKGVL--PNGKE--VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSLVGYYT-A 307
G V+ G L +GK+ A+K L + GE F E I+ H +++SL+G +
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
++V ++ L + + L AKG+ +L K +HRD+
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDL 218
Query: 368 KAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL------APEYASSGKLTE 421
A N +LD KF KVADFGLA+ D+Y V G A E + K T
Sbjct: 219 AARNCMLDEKFTVKVADFGLAR---DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT 275
Query: 422 KSDVFSFGVMLLELI-IGCRP 441
KSDV+SFGV+L EL+ G P
Sbjct: 276 KSDVWSFGVLLWELMTRGAPP 296
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-37
Identities = 69/270 (25%), Positives = 108/270 (40%), Gaps = 15/270 (5%)
Query: 179 RPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARA 238
RP P G S S SE + + + E+ R
Sbjct: 331 RPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQR- 389
Query: 239 TDGFSDANLLGQGGFGYVHKGVL--PNGKE--VAIKQLKAGSGQGERV-FQAEVEIISRV 293
+ +G+G FG VH+G+ P VAIK K + R F E + +
Sbjct: 390 -ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF 448
Query: 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
H H+V L+G T + ++ E T L L + ++D + + A + LAY
Sbjct: 449 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAY 506
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPE 412
L + +HRDI A N+L+ K+ DFGL++ + Y S + APE
Sbjct: 507 LESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-APE 562
Query: 413 YASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
+ + T SDV+ FGV + E++ G +P
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 6/198 (3%)
Query: 246 NLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
+ LG G +G V++GV VA+K LK + + E F E ++ + H +LV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLGV 284
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
T ++ EF+T L +L R + L +A + + YL + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIH 341
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSD 424
R++ A N L+ KVADFGL++L + + APE + K + KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 425 VFSFGVMLLELI-IGCRP 441
V++FGV+L E+ G P
Sbjct: 402 VWAFGVLLWEIATYGMSP 419
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 67/198 (33%), Positives = 100/198 (50%), Gaps = 12/198 (6%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307
LG G FG V G +VA+K LK GS + F AE ++ ++ H+ LV L T
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVT- 78
Query: 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDI 367
++ E++ + +L L + L +A A+G+A++ E IHRD+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDL 135
Query: 368 KAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGY--LAPEYASSGKLTEKSD 424
+AANIL+ K+ADFGLA+ + + YT R F APE + G T KSD
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYT---AREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 425 VFSFGVMLLELI-IGCRP 441
V+SFG++L E++ G P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 61/207 (29%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 248 LGQGGFGYVHKGVL--PNGKE--VAIKQLKAGSGQGERV---FQAEVEIISRVHHKHLVS 300
LG G FG V +G P+GK VA+K LK F EV + + H++L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
L G +V E +L L K + T + A+ A+G+ YL E
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYL-ESKR- 141
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTFGY--LAPEYAS 415
IHRD+ A N+LL + K+ DFGL + D Y + + APE
Sbjct: 142 -FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV---MQEHRKVPFAWCAPESLK 197
Query: 416 SGKLTEKSDVFSFGVMLLELI-IGCRP 441
+ + SD + FGV L E+ G P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 248 LGQGGFGYVHKGVL--PNGKE--VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSLV 302
+G G G V G L P ++ VAIK LKAG + +R F +E I+ + H +++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
G T G M+V E++ + +L+ L + + G G+ YL D
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMRYL-SDLG--Y 172
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL--APEYASSGKLT 420
+HRD+ A N+L+D KV+DFGL+++ D T G APE + +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 421 EKSDVFSFGVMLLELI-IGCRP 441
SDV+SFGV++ E++ G RP
Sbjct: 233 SASDVWSFGVVMWEVLAYGERP 254
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 248 LGQGGFGYVHKGVLPNGK---EVAIKQLKAGSGQGERV--FQAEVEIISRVHHKHLVSLV 302
LG G FG V KG K VA+K LK + AE ++ ++ + ++V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
G MLV E L +L + + +++ + G+ YL E+ +
Sbjct: 85 GICE-AESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL-EESN--F 138
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF--GYLAPEYASSGKLT 420
+HRD+ A N+LL + AK++DFGL+K + + G + + APE + K +
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 421 EKSDVFSFGVMLLELI-IGCRP 441
KSDV+SFGV++ E G +P
Sbjct: 199 SKSDVWSFGVLMWEAFSYGQKP 220
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 65/291 (22%), Positives = 108/291 (37%), Gaps = 57/291 (19%)
Query: 246 NLLGQGGFGYVHKGVLPNGKE----VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
++G+G FG V+ G + + AIK L + + F E ++ ++H ++++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 301 LVGYYTAGS-QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
L+G ++ ++ L + + + L A+G+ YL E
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVARGMEYLAEQ-- 143
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL------APEY 413
K +HRD+ A N +LD F KVADFGLA+ D+ V A E
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLAR---DILDREYYSVQQHRHARLPVKWTALES 199
Query: 414 ASSGKLTEKSDVFSFGVMLLELI-IGCRP---VDSTHTFMEDNLARPLLNRAIEDGNFDT 469
+ + T KSDV+SFGV+L EL+ G P +D + G
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT-----------HFLAQG---- 244
Query: 470 LVDPKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRISQIVRTLE 513
+ + C + C RP +V +E
Sbjct: 245 ------------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-37
Identities = 63/194 (32%), Positives = 94/194 (48%), Gaps = 11/194 (5%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG G FG V +VA+K +K GS E F AE ++ + H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVV 252
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
T ++ EF+ +L L P + + A+G+A++ + IHR
Sbjct: 253 T-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHR 308
Query: 366 DIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGY--LAPEYASSGKLTEK 422
D++AANIL+ K+ADFGLA+ + + YT R F APE + G T K
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYT---AREGAKFPIKWTAPEAINFGSFTIK 365
Query: 423 SDVFSFGVMLLELI 436
SDV+SFG++L+E++
Sbjct: 366 SDVWSFGILLMEIV 379
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 29/213 (13%)
Query: 248 LGQGGFGYVHKGVL--------PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLV 299
LGQG F + KGV + EV +K L F ++S++ HKHLV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
G G + +LV EFV +L+ +L K + ++ +L++A A + +L E+
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMHFL-EENT 133
Query: 360 PKIIHRDIKAANILLDFKFE--------AKVADFGLAK-LASDVYTHVSTRVMGTFGYLA 410
+IH ++ A NILL + + K++D G++ + +
Sbjct: 134 --LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV------P 185
Query: 411 PEYASSGKL-TEKSDVFSFGVMLLELI-IGCRP 441
PE + K +D +SFG L E+ G +P
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-36
Identities = 60/304 (19%), Positives = 114/304 (37%), Gaps = 57/304 (18%)
Query: 237 RATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH 295
R F + +LGQG FG V K + + AIK+++ + + EV +++ ++H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNH 61
Query: 296 KHLVSLVGYYTAGSQRM-------------LVCEFVTSNTLEFHLHGKGRPTMDWPTRLK 342
+++V + + + E+ + TL +H + R +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ----QRDE 117
Query: 343 IALGFA---KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL--------- 390
F + L+Y+H IIHRD+K NI +D K+ DFGLAK
Sbjct: 118 YWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 391 -----ASDVYTHVSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELIIGCRPVDS 444
++++ + GT Y+A E +G EK D++S G++ E+I
Sbjct: 175 LDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF----- 228
Query: 445 THTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPR 504
L + + + + P + +++ + H +RP
Sbjct: 229 ---STGMERVNIL--KKLRSVSIE--FPPDFDDNK-MKVEKKII---RLLIDHDPNKRPG 277
Query: 505 ISQI 508
+
Sbjct: 278 ARTL 281
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 248 LGQGGFGYVHKGVLPNGKE-----VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSL 301
LG G FG VHKGV E V IK ++ SG+ + I + H H+V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+G GS LV +++ +L H+ + R + L + AKG+ YL E
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLEEH---G 135
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
++HR++ A N+LL + +VADFG+A L D + + ++A E GK T
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 421 EKSDVFSFGVMLLELI-IGCRP 441
+SDV+S+GV + EL+ G P
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEP 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 65/304 (21%), Positives = 108/304 (35%), Gaps = 54/304 (17%)
Query: 236 ARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQAEVEIISRV 293
R F LG+GGFG V + + AIK+++ + + R EV+ ++++
Sbjct: 1 GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 60
Query: 294 HHKHLVSLVGYYTA------------GSQRMLVC---EFVTSNTL-EFHLHGKGRPTMDW 337
H +V Y+ A S ++ + + L ++ +
Sbjct: 61 EHPGIV---RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 338 PTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-------- 389
L I L A+ + +LH ++HRD+K +NI KV DFGL
Sbjct: 118 SVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174
Query: 390 ---LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446
L T +GT Y++PE + K D+FS G++L EL P +
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---LYPFSTQM 231
Query: 447 TFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRIS 506
R + + F P L + + MV + S RP
Sbjct: 232 E-------RVRTLTDVRNLKF-----PPLFTQK-YPCEYVMV---QDMLSPSPMERPEAI 275
Query: 507 QIVR 510
I+
Sbjct: 276 NIIE 279
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 72/284 (25%), Positives = 119/284 (41%), Gaps = 48/284 (16%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
L+G GGFG V K +GK IK++K + E+ + EV+ ++++ H ++V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAER-EVKALAKLDHVNIVHYNGC 72
Query: 305 YTAGSQRM----------------LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA 348
+ + EF TLE + + +D L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY 408
KG+ Y+H K+I+RD+K +NI L + K+ DFGL + TR GT Y
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN--DGKRTRSKGTLRY 187
Query: 409 LAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
++PE SS ++ D+++ G++L EL+ C T F D + DG
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD----------LRDGIIS 237
Query: 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512
+ D K ++ + RP S+I+RTL
Sbjct: 238 DIFDKKEKT---------LL---QKLLSKKPEDRPNTSEILRTL 269
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 13/202 (6%)
Query: 248 LGQGGFGYVHKGVLPNGKE-----VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVSL 301
LG G FG V+KG+ E VAIK+L+ + E +++ V + H+ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+G S L+ + + L ++ + + + L + AKG+ YL + +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
++HRD+ A N+L+ K+ DFGLAK L ++ + + ++A E T
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 421 EKSDVFSFGVMLLELI-IGCRP 441
+SDV+S+GV + EL+ G +P
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKP 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 248 LGQGGFGYVHKGVLPNGKE------VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
LGQG FG V++GV + VAIK + + ER+ F E ++ + H+V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTR--------LKIALGFAKGLA 352
L+G + G +++ E +T L+ +L + P +++A A G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL--- 409
YL+ + K +HRD+ A N ++ F K+ DFG+ + D+Y R G G L
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---DIYETDYYR-KGGKGLLPVR 205
Query: 410 --APEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
+PE G T SDV+SFGV+L E+ + +P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 69/197 (35%), Positives = 98/197 (49%), Gaps = 6/197 (3%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LGQG FG V G VAIK LK G+ E F E +++ ++ H+ LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVV 331
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
+ +V E+++ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 332 S-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHR 387
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
D++AANIL+ KVADFGLA+L D + APE A G+ T KSDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 426 FSFGVMLLELI-IGCRP 441
+SFG++L EL G P
Sbjct: 448 WSFGILLTELTTKGRVP 464
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 15/82 (18%), Positives = 23/82 (28%)
Query: 10 PSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPP 69
P +S + PA + P + P S P + AP + P
Sbjct: 7 PKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGF 66
Query: 70 SSNPVARSPPSPPTGDDGGGGV 91
+S+ SP G
Sbjct: 67 NSSDTVTSPQRAGPLAGGVTTF 88
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-35
Identities = 71/299 (23%), Positives = 111/299 (37%), Gaps = 64/299 (21%)
Query: 248 LGQGGFGYVHKGVLPNGKE------VAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+G FG V N VA+K LK + + FQ E E+++ + H+H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 302 VGYYTAGSQRMLVCEFV--------------TSNTLEFHLHGKGRPTMDWPTRLKIALGF 347
G G ++V E++ + L + + + L IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFG 407
A G+ YL +HRD+ N L+ K+ DFG+++ DVY+ RV G
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSR---DVYSTDYYRVGGH-T 195
Query: 408 YL-----APEYASSGKLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDNLARPLLNRA 461
L PE K T +SDV+SFGV+L E+ G +P + +
Sbjct: 196 MLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----WFQLSNTEVI----EC 247
Query: 462 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRISQIVRTLE 513
I G + R C C + ++R I +I + L
Sbjct: 248 ITQG----------------RVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILH 290
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-35
Identities = 66/300 (22%), Positives = 111/300 (37%), Gaps = 65/300 (21%)
Query: 248 LGQGGFGYVHKGVLPNGKE------VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
LG+ FG V+KG L VAIK LK + R F+ E + +R+ H ++V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 301 LVGYYTAGSQRMLVCEFVT--------------SNTLEFHLHGKGRPTMDWPTRLKIALG 346
L+G T ++ + + S+ + ++ P + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
A G+ YL ++H+D+ N+L+ K K++D GL + +VY +++G
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR---EVYAADYYKLLGN- 189
Query: 407 GYL-----APEYASSGKLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDNLARPLLNR 460
L APE GK + SD++S+GV+L E+ G +P + +
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----YCGYSNQDVV----E 241
Query: 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAA-------CVRHSARRRPRISQIVRTLE 513
I + + C A C RRPR I L
Sbjct: 242 MIRNR----------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 59/285 (20%), Positives = 106/285 (37%), Gaps = 36/285 (12%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG+GGF YV L +G A+K++ Q Q E ++ +H +++ LV Y
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 306 TAGSQRM----LVCEFVTSNTLEFHL--HGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
L+ F TL + + L + LG +GL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM--------GTFGYLAP 411
HRD+K NILL + + + D G A + T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 412 E---YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
E S + E++DV+S G +L ++ G P + + A+++
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP------YDMVFQKGDSVALAVQNQ--- 263
Query: 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+ ++ + + +++ + + +RP I ++ LE
Sbjct: 264 --LSIPQSPRHS-SALWQLL---NSMMTVDPHQRPHIPLLLSQLE 302
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-35
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 9/199 (4%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV---FQAEVEIISRVHHKHLVSLV 302
LG GG V+ +VAIK + + E F+ EV S++ H+++VS++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
LV E++ TL ++ G + T + G+ + H+ +I
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEK 422
+HRDIK NIL+D K+ DFG+AK S+ + V+GT Y +PE A E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 423 SDVFSFGVMLLELIIGCRP 441
+D++S G++L E+++G P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 248 LGQGGFGYVHKGVLPNGK------EVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
LG G FG V++G + +VA+K L + + + F E IIS+ +H+++V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL------KIALGFAKGLAYL 354
+G R ++ E + L+ L + RP P+ L +A A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLR-ETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 355 HEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKLASDVYTHVSTRVMGTFGYL-- 409
E+ IHRDI A N LL AK+ DFG+A+ D+Y R G L
Sbjct: 157 EEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRASYYR-KGGCAMLPV 209
Query: 410 ---APEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
PE G T K+D +SFGV+L E+ +G P
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 61/219 (27%), Positives = 92/219 (42%), Gaps = 32/219 (14%)
Query: 248 LGQGGFGYVHKGVLPNGKE------VAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+G FG V N VA+K LK S + FQ E E+++ + H+H+V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 302 VGYYTAGSQRMLVCEFVT-------------SNTLEFHLHGKGRPTMDWPTRLKIALGFA 348
G T G ++V E++ L + L +A A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY 408
G+ YL +HRD+ N L+ K+ DFG+++ D+Y+ R +G
Sbjct: 169 AGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSR---DIYSTDYYR-VGGRTM 221
Query: 409 L-----APEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
L PE K T +SDV+SFGV+L E+ G +P
Sbjct: 222 LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 66/273 (24%), Positives = 113/273 (41%), Gaps = 27/273 (9%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQL-KAGSGQGERVF-QAEVEIISRVHHKHLVSLVG 303
+G G +G K +GK + K+L + E+ +EV ++ + H ++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 304 YYTAGSQRML--VCEFVTSNTLEFHL--HGKGRPTMDWPTRLKIALGFAKGLAYLHE--D 357
+ L V E+ L + K R +D L++ L H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
++HRD+K AN+ LD K K+ DFGLA++ + + T V GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477
EKSD++S G +L EL P F + L I +G F ++
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP------FTAFSQKE--LAGKIREGKF-----RRIPY 238
Query: 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
Y+ +E+ ++ + RP + +I+
Sbjct: 239 RYS-DELNEII---TRMLNLKDYHRPSVEEILE 267
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 58/216 (26%), Positives = 86/216 (39%), Gaps = 29/216 (13%)
Query: 248 LGQGGFGYVHKGVLPNGKE----VAIKQLKAGSGQGERV--FQAEVEIISRVHHKHLVSL 301
LG+G FG V + L VA+K LKA + F E + H H+ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 302 VG------YYTAGSQRMLVCEFVTS-NTLEF---HLHGKGRPTMDWPTRLKIALGFAKGL 351
VG M++ F+ + F G+ + T ++ + A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL-- 409
YL IHRD+ A N +L VADFGL++ +Y+ R G L
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR---KIYSGDYYRQ-GCASKLPV 203
Query: 410 ---APEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
A E + T SDV++FGV + E++ G P
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 22/227 (9%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLK----AGSGQGERVFQAEVEIISRVHHKHLVS 300
LG+G FG V+ + +A+K L +G ++ + EVEI S + H +++
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL-RREVEIQSHLRHPNILR 73
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
L GY+ ++ L+ E+ T+ L + D A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHSK--- 128
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
++IHRDIK N+LL E K+ADFG + A + GT YL PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRMHD 185
Query: 421 EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467
EK D++S GV+ E ++G P F + + I F
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP------FEANTY--QETYKRISRVEF 224
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 77/302 (25%), Positives = 114/302 (37%), Gaps = 48/302 (15%)
Query: 162 HVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGL 221
SP Y S M+ + NY + L
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDY---NPNYCFAGKTSSISDL-- 65
Query: 222 SLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGK------EVAIKQLKAG 275
+E+ R + LG G FG V++G + +VA+K L
Sbjct: 66 -----------KEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 112
Query: 276 SGQGERV-FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPT 334
+ + + F E IIS+ +H+++V +G R ++ E + L+ L + RP
Sbjct: 113 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLR-ETRPR 171
Query: 335 MDWPTRL------KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADF 385
P+ L +A A G YL E+ IHRDI A N LL AK+ DF
Sbjct: 172 PSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDF 228
Query: 386 GLAKLASDVYTHVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELI-IGC 439
G+A+ D+Y R G L PE G T K+D +SFGV+L E+ +G
Sbjct: 229 GMAR---DIYRAGYYR-KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 284
Query: 440 RP 441
P
Sbjct: 285 MP 286
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 57/267 (21%), Positives = 112/267 (41%), Gaps = 24/267 (8%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLK-AGSGQGERVF-QAEVEIISRVHHKHLVSLVG 303
+G+G FG +G++ IK++ + ER + EV +++ + H ++V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ +V ++ L ++ + L + L ++H+ KI+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKIL 147
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKS 423
HRDIK+ NI L ++ DFG+A++ + + GT YL+PE + KS
Sbjct: 148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPYNNKS 206
Query: 424 DVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483
D+++ G +L EL F ++ L I G+F P + Y+ +
Sbjct: 207 DIWALGCVLYELCTLKHA------FEAGSM--KNLVLKIISGSF-----PPVSLHYS-YD 252
Query: 484 MARMVACAAACVRHSARRRPRISQIVR 510
+ +V + + + R RP ++ I+
Sbjct: 253 LRSLV---SQLFKRNPRDRPSVNSILE 276
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 28/215 (13%)
Query: 248 LGQGGFGYVHKGVLPNGKE----VAIKQLKAGS-GQGERV-FQAEVEIISRVHHKHLVSL 301
LG+G FG V +G L VA+K +K + Q E F +E + H +++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 302 VG-----YYTAGSQRMLVCEFVTS-NTLEF---HLHGKGRPTMDWPTRLKIALGFAKGLA 352
+G + M++ F+ + + G + T LK + A G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYL--- 409
YL +HRD+ A N +L VADFGL+K +Y+ R G +
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSK---KIYSGDYYRQ-GRIAKMPVK 214
Query: 410 --APEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
A E + T KSDV++FGV + E+ G P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 35/221 (15%)
Query: 246 NLLGQGGFGYVHKGVLPNGKE---VAIKQLKAGSGQGERV-FQAEVEIISRV-HHKHLVS 300
+++G+G FG V K + AIK++K + + + F E+E++ ++ HH ++++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 301 LVGYYTAGSQRMLVCEFV--------------TSNTLEFHLHGKGRPTMDWPTRLKIALG 346
L+G L E+ F + T+ L A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
A+G+ YL + + IHRD+ A NIL+ + AK+ADFGL++ +VY V T
Sbjct: 151 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-GQEVY------VKKTM 200
Query: 407 GYL-----APEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
G L A E + T SDV+S+GV+L E++ +G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLK---AGSGQGERVFQAEVEIISRVHHKHLVSL- 301
+LG GG VH L + ++VA+K L+ A F+ E + + ++H +V++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 302 -VGYYTAGSQRM--LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
G + + +V E+V TL +H +G M +++ + L + H++
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQN- 135
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV--STRVMGTFGYLAPEYASS 416
IIHRD+K ANI++ KV DFG+A+ +D V + V+GT YL+PE A
Sbjct: 136 --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 417 GKLTEKSDVFSFGVMLLELIIGCRP 441
+ +SDV+S G +L E++ G P
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 53/217 (24%), Positives = 79/217 (36%), Gaps = 32/217 (14%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQL-KAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
+LGQG V +G G AIK + V E E++ +++HK++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 305 YTAGSQRM--LVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGF----AKGLAYLHE 356
+ R L+ EF +L L L L G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-----GLPESEFLIVLRDVVGGMNHLRE 130
Query: 357 DCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKLASDVYTHVSTRVMGTFGYLAPE 412
+ I+HR+IK NI+ + K+ DFG A+ D + GT YL P+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPD 185
Query: 413 --------YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
K D++S GV G P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 27/230 (11%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
LLG+G F V++ + G EVAIK + +G +RV EV+I ++ H ++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK-AGMVQRVQN-EVKIHCQLKHPSILE 75
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
L Y+ + LV E + + +L + +P + R + G+ YLH
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLHSH--- 131
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM---GTFGYLAPEYASSG 417
I+HRD+ +N+LL K+ADFGL + + GT Y++PE A+
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGL----ATQLKMPHEKHYTLCGTPNYISPEIATRS 187
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467
+SDV+S G M L+IG P F D + + ++
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPP------FDTDTV--KNTLNKVVLADY 229
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 59/275 (21%), Positives = 119/275 (43%), Gaps = 24/275 (8%)
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRVHH 295
F +G+G F V++ L +G VA+K+++ + E++++ +++H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHL--HGKGRPTMDWPTRLKIALGFAKGLAY 353
+++ + ++ +V E + L + K + + T K + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY 413
+H +++HRDIK AN+ + K+ D GL + S T + V GT Y++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473
KSD++S G +L E+ P F D + L + IE ++ P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLYSLCKKIEQCDY-----P 256
Query: 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQI 508
L +++ E+ ++V C+ +RP ++ +
Sbjct: 257 PLPSDHYSEELRQLV---NMCINPDPEKRPDVTYV 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 63/226 (27%), Positives = 98/226 (43%), Gaps = 22/226 (9%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLK----AGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+G FG V+ N +A+K L G ++ + E+EI S + H +++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL-RREIEIQSHLRHPNILRM 79
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
Y+ + L+ EF L L GR + + + A L Y HE K
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD-EQRSATFMEE-LADALHYCHER---K 134
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
+IHRDIK N+L+ +K E K+ADFG + A + GT YL PE E
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHDE 191
Query: 422 KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467
K D++ GV+ E ++G P F + +R I + +
Sbjct: 192 KVDLWCAGVLCYEFLVGMPP------FDSPSH--TETHRRIVNVDL 229
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 59/285 (20%), Positives = 103/285 (36%), Gaps = 26/285 (9%)
Query: 182 HSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDG 241
H + S P S ++ + P LG S+ E ++
Sbjct: 1 HHHHHHSSGLVPRG---SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI 57
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKEVAIKQ--LKAGSGQGERVFQAEVEIISRVHHK--H 297
+S +G GG V + + + AIK L+ Q ++ E+ ++++
Sbjct: 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
++ L Y +V E + L L K +D R + + +H+
Sbjct: 118 IIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH 174
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPE---- 412
I+H D+K AN L+ K+ DFG+A + D + V +G Y+ PE
Sbjct: 175 ---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 413 -------YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
S K++ KSDV+S G +L + G P +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 64/221 (28%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL--KAGSGQGERVFQAEVEIISRVHHKHLVSLV-- 302
LG GGFGYV + + G++VAIKQ + ER E++I+ +++H ++VS
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSAREV 80
Query: 303 ----GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGF----AKGLA 352
+L E+ L +L+ L + L
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC-----GLKEGPIRTLLSDISSALR 135
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYL 409
YLHE+ +IIHRD+K NI+L + K+ D G AK + T +GT YL
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYL 190
Query: 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
APE K T D +SFG + E I G RP ++
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 51/221 (23%), Positives = 87/221 (39%), Gaps = 23/221 (10%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQ--LKAGSGQGERVFQAEVEIISRV--HHKHLVSL 301
+G GG V + + + AIK L+ Q ++ E+ ++++ H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
Y +V E + L L K +D R + + +H+
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 128
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPE-------- 412
I+H D+K AN L+ K+ DFG+A + D + V +GT Y+ PE
Sbjct: 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 413 ---YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
S K++ KSDV+S G +L + G P +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 45/225 (20%)
Query: 248 LGQGGFGYVHKGVLPNGKE------VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
+G+G FG V + P VA+K LK + + FQ E +++ + ++V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 301 LVGYYTAGSQRMLVCEFV----------------------TSNTLEFHLHGKGRPTMDWP 338
L+G G L+ E++ + + + G P +
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 339 TRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK--LASDVYT 396
+L IA A G+AYL E K +HRD+ N L+ K+ADFGL++ ++D Y
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 397 HVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELI 436
+ PE + T +SDV+++GV+L E+
Sbjct: 232 ------ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 61/273 (22%), Positives = 91/273 (33%), Gaps = 30/273 (10%)
Query: 173 PHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTY 232
V + + P S + S P P S ++
Sbjct: 8 SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQ--------SF 59
Query: 233 EELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQL-KAGSGQGERV-FQAEVEI 289
+ L + LG G +G V K +G+ A+K+ G +R AEV
Sbjct: 60 QRL----------SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGS 109
Query: 290 ISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA 348
+V H V L + G L E +L+ H G +
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGAS-LPEAQVWGYLRDTL 167
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY 408
LA+LH ++H D+K ANI L + K+ DFGL + G Y
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQE-GDPRY 222
Query: 409 LAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+APE G +DVFS G+ +LE+
Sbjct: 223 MAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 45/225 (20%)
Query: 248 LGQGGFGYVHKGVLPNGKE------VAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
LG+G FG V K + K VA+K LK + E +E ++ +V+H H++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 301 LVGYYTAGSQRMLVCEFV----------------------TSNTLEFHLHGKGRPTMDWP 338
L G + +L+ E+ + L +
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 339 TRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL--ASDVYT 396
+ A ++G+ YL E K++HRD+ A NIL+ + K++DFGL++ D Y
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 397 HVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELI 436
+ G + A E T +SDV+SFGV+L E++
Sbjct: 208 ------KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 75/304 (24%), Positives = 120/304 (39%), Gaps = 69/304 (22%)
Query: 246 NLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGSGQGERV-FQAEVEIISRV-HHKH 297
LG G FG V + +VA+K LK+ + E+ +E++I+S + H++
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTR------------LKIAL 345
+V+L+G T G +++ E+ L L K R P L +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 346 GFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGT 405
A+G+A+L IHRD+ A N+LL AK+ DFGLA+ D+ S ++
Sbjct: 172 QVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLAR---DIMND-SNYIVKG 224
Query: 406 FGYL-----APEYASSGKLTEKSDVFSFGVMLLELI-IGCRP---VDSTHTFMEDNLARP 456
L APE T +SDV+S+G++L E+ +G P + F +
Sbjct: 225 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK------ 278
Query: 457 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAA-------ACVRHSARRRPRISQIV 509
++DG +MA+ AC RP QI
Sbjct: 279 ----LVKDG----------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQIC 318
Query: 510 RTLE 513
L+
Sbjct: 319 SFLQ 322
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 50/212 (23%), Positives = 85/212 (40%), Gaps = 23/212 (10%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQ--LKAGSGQGERVFQAEVEIISRVHHK--HLVSL 301
+G GG V + + + AIK L+ Q ++ E+ ++++ ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
Y +V E + L L K +D R + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKKKS--IDPWERKSYWKNMLEAVHTIHQH---G 147
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPE-------- 412
I+H D+K AN L+ K+ DFG+A + D + V +GT Y+ PE
Sbjct: 148 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 413 ---YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
S K++ KSDV+S G +L + G P
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
+LG+G +G V+ G L N +AIK++ + + E+ + + HK++V +G +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGK-GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
+ + E V +L L K G + T +GL YLH++ +I+H
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 365 RDIKAANILLDFKF-EAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE--YASSGKLTE 421
RDIK N+L++ K++DFG +K + + T GT Y+APE +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYGK 204
Query: 422 KSDVFSFGVMLLELIIGCRP 441
+D++S G ++E+ G P
Sbjct: 205 AADIWSLGCTIIEMATGKPP 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 53/217 (24%), Positives = 80/217 (36%), Gaps = 32/217 (14%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQL-KAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
+LGQG V +G G AIK + V E E++ +++HK++V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 305 YTAGSQRM--LVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAK----GLAYLHE 356
+ R L+ EF +L L L L + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY-----GLPESEFLIVLRDVVGGMNHLRE 130
Query: 357 DCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKLASDVYTHVSTRVMGTFGYLAPE 412
+ I+HR+IK NI+ + K+ DFG A+ D + GT YL P+
Sbjct: 131 N---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHPD 185
Query: 413 --------YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
K D++S GV G P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 49/200 (24%), Positives = 80/200 (40%), Gaps = 11/200 (5%)
Query: 247 LLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERV---FQAEVEIISRVHHKHLVSLV 302
L+G+GG G V++ + VA+K + Q E R+ H+V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
+ Q + + L L +G + P + I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDV-YTHVSTRVMGTFGYLAPEYASSGKLTE 421
HRD+K NIL+ A + DFG+A +D T + +GT Y+APE S T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHATY 214
Query: 422 KSDVFSFGVMLLELIIGCRP 441
++D+++ +L E + G P
Sbjct: 215 RADIYALTCVLYECLTGSPP 234
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 36/218 (16%)
Query: 248 LGQGGFGYVHKGVLPNGKE------VAIKQLKAGSGQGERV-FQAEVEIISRV-HHKHLV 299
LG G FG V + + VA+K LK + ER +E++++S + +H ++V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 300 SLVGYYTAGSQRMLVCEFV----------------TSNTLEFHLHGKGRPTMDWPTRLKI 343
+L+G T G +++ E+ + + +D L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403
+ AKG+A+L IHRD+ A NILL K+ DFGLA+ D+ + V
Sbjct: 151 SYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR---DIKNDSNYVVK 204
Query: 404 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELI 436
G L APE + T +SDV+S+G+ L EL
Sbjct: 205 GN-ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 37/224 (16%)
Query: 248 LGQGGFGYVHKGVLPNGKE--------VAIKQLKAGSGQGERV-FQAEVEIISRV-HHKH 297
LG+G FG V + VA+K LK + + + +E+E++ + HK+
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 298 LVSLVGYYTAGSQRMLVCEFV--------------TSNTLEFHLHGKGRPTMDWPTRLKI 343
+++L+G T ++ E+ + ++ M + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403
A+G+ YL K IHRD+ A N+L+ K+ADFGLA+ D+ +
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR---DINNIDYYKK- 215
Query: 404 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
T G L APE T +SDV+SFGV++ E+ +G P
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 72/331 (21%), Positives = 132/331 (39%), Gaps = 45/331 (13%)
Query: 216 PPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKA 274
P SLG + G +S F + + +L +GGF +V++ + +G+E A+K+L +
Sbjct: 4 PGSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS 63
Query: 275 GSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQR--------MLVCEFVTSNTLEF 325
+ R EV + ++ H ++V + G + +L+ E +EF
Sbjct: 64 NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEF 123
Query: 326 HLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385
+ R + T LKI + + ++H P IIHRD+K N+LL + K+ DF
Sbjct: 124 LKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 386 GLAKLASDVYTHVSTRVM-----------GTFGYLAPE---YASSGKLTEKSDVFSFGVM 431
G A S + + T Y PE S+ + EK D+++ G +
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242
Query: 432 LLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACA 491
L L P F + I +G + P +Y ++
Sbjct: 243 LYLLCFRQHP------FEDGAK------LRIVNGKYS---IPPHDTQY--TVFHSLIRA- 284
Query: 492 AACVRHSARRRPRISQIVRTLEGDASLADLN 522
++ + R I+++V L+ A+ ++N
Sbjct: 285 --MLQVNPEERLSIAEVVHQLQEIAAARNVN 313
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 7e-31
Identities = 43/230 (18%), Positives = 92/230 (40%), Gaps = 35/230 (15%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLK------------------AGSGQGERVFQAEVEI 289
L QG F + + K A+K+ + + + + E++I
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN-ELQI 96
Query: 290 ISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL------KI 343
I+ + +++ ++ G T + ++ E++ ++++ ++ + I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403
+Y+H I HRD+K +NIL+D K++DFG ++ D S
Sbjct: 157 IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211
Query: 404 GTFGYLAPEYASSGKLT---EKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
GT+ ++ PE S + + K D++S G+ L + P + +E
Sbjct: 212 GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 61/219 (27%), Positives = 91/219 (41%), Gaps = 39/219 (17%)
Query: 248 LGQGGFGYVHKGVLPNGKE------VAIKQLKAGSGQGERV-FQAEVEIISRV-HHKHLV 299
LG+G FG V + + VA+K LK G+ E +E++I+ + HH ++V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 300 SLVGYYT-AGSQRMLVCEFVT--------------SNTLEFHLHGKGRPTMDWPTRLKIA 344
+L+G T G M++ EF + + + + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 345 LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL--ASDVYTHVSTRV 402
AKG+ +L K IHRD+ A NILL K K+ DFGLA+ Y
Sbjct: 155 FQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV------ 205
Query: 403 MGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELI 436
L APE T +SDV+SFGV+L E+
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 41/226 (18%)
Query: 248 LGQGGFGYVHKGVLPNGKE--------VAIKQLKAGSGQGERV-FQAEVEIISRV-HHKH 297
LG+G FG V + VA+K LK + + + +E+E++ + HK+
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 298 LVSLVGYYTAGSQRMLVCEFV--------------TSNTLEFHLHGKGRPTMDWPTRLKI 343
+++L+G T ++ E+ + ++ M + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL--ASDVYTHVSTR 401
A+G+ YL K IHRD+ A N+L+ K+ADFGLA+ D Y
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK----- 260
Query: 402 VMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELI-IGCRP 441
T G L APE T +SDV+SFGV++ E+ +G P
Sbjct: 261 -KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 59/281 (20%), Positives = 94/281 (33%), Gaps = 35/281 (12%)
Query: 167 PPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFL 226
H +AS + P + G
Sbjct: 4 SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYR--------- 54
Query: 227 KSTFTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA 285
EE+ T +G+G FG VH+ G + A+K+++ E
Sbjct: 55 ------EEVHWMTHQ----PRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVE 99
Query: 286 EVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL 345
E+ + + +V L G G + E + +L + G + L
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLG 157
Query: 346 GFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLASDVYTHVSTR--- 401
+GL YLH +I+H D+KA N+LL A + DFG A S
Sbjct: 158 QALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214
Query: 402 -VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ GT ++APE K D++S M+L ++ GC P
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 60/230 (26%), Positives = 92/230 (40%), Gaps = 28/230 (12%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
LG+GGF + + A K L Q E++ E+ I + H+H+V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSM-EISIHRSLAHQHVVG 79
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
G++ +V E +L LH K R + P G YLH +
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSL-LELH-KRRKALTEPEARYYLRQIVLGCQYLHRN--- 134
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM---GTFGYLAPEYASSG 417
++IHRD+K N+ L+ E K+ DFGLA + R GT Y+APE S
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATK----VEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467
+ + DV+S G ++ L++G P F L I+ +
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPP------FETSCL--KETYLRIKKNEY 232
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 69/297 (23%), Positives = 104/297 (35%), Gaps = 50/297 (16%)
Query: 180 PPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARAT 239
P P P P + + A P L +S Y
Sbjct: 3 APADPGKAGVPGVAAP--------GAPAAAPPAKEIPEVLVDP----RSRRRYVRG---- 46
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQGERVFQAEVEIISRV 293
LG+GGF + + A K L Q E++ E+ I +
Sbjct: 47 ------RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSM-EISIHRSL 98
Query: 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
H+H+V G++ +V E +L LH K R + P G Y
Sbjct: 99 AHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELH-KRRKALTEPEARYYLRQIVLGCQY 156
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM---GTFGYLA 410
LH + ++IHRD+K N+ L+ E K+ DFGLA + R GT Y+A
Sbjct: 157 LHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK----VEYDGERKKVLCGTPNYIA 209
Query: 411 PEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467
PE S + + DV+S G ++ L++G P F L I+ +
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP------FETSCL--KETYLRIKKNEY 258
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 8/198 (4%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
++ +GQG G V+ + + G+EVAI+Q+ + + E+ ++ + ++V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
+ Y G + +V E++ +L + MD + + L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN--- 135
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
++IHRDIK+ NILL K+ DFG + + ST V GT ++APE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 421 EKSDVFSFGVMLLELIIG 438
K D++S G+M +E+I G
Sbjct: 195 PKVDIWSLGIMAIEMIEG 212
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 56/218 (25%), Positives = 95/218 (43%), Gaps = 36/218 (16%)
Query: 248 LGQGGFGYVHKGVLPNGK--------EVAIKQLKAGSGQGERV-FQAEVEIISRV-HHKH 297
LG+G FG V +VA+K LK+ + + + +E+E++ + HK+
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 298 LVSLVGYYTAGSQRMLVCEFVT--------------SNTLEFHLHGKGRPTMDWPTRLKI 343
+++L+G T ++ E+ + ++ + +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM 403
A A+G+ YL K IHRD+ A N+L+ K+ADFGLA+ D++ +
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR---DIHHIDYYKK- 249
Query: 404 GTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELI 436
T G L APE T +SDV+SFGV+L E+
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-30
Identities = 65/264 (24%), Positives = 116/264 (43%), Gaps = 27/264 (10%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGER-VFQAEVEIISR-VHHKHLVSLVGY 304
LG+G +G V K +P+G+ +A+K+++A E+ +++I R V V+ G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 305 YTAGSQRMLVCEFV-TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ E + TS + T+ KIA+ K L +LH +I
Sbjct: 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVI 132
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE----YASSGKL 419
HRD+K +N+L++ + K+ DFG++ D G Y+APE +
Sbjct: 133 HRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479
+ KSD++S G+ ++EL I P DS T + L + +E+ P+L +
Sbjct: 191 SVKSDIWSLGITMIELAILRFPYDSWGTPFQ------QLKQVVEEP------SPQLPADK 238
Query: 480 NHNEMARMVACAAACVRHSARRRP 503
E + C++ +++ RP
Sbjct: 239 FSAEFVDFTSQ---CLKKNSKERP 259
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 47/226 (20%)
Query: 248 LGQGGFGYVHKGVLPNGKE------VAIKQLKAGSGQGERV-FQAEVEIISRV-HHKHLV 299
LG G FG V + VA+K LK + ER +E+++++++ H+++V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 300 SLVGYYTAGSQRMLVCEFVTS-NTLEFHLHGKGRPTMDWPTR------------------ 340
+L+G T L+ E+ + L + L K +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNY-LRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 341 ---LKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL--ASDVY 395
L A AKG+ +L +HRD+ A N+L+ K+ DFGLA+ + Y
Sbjct: 172 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 396 THVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELI 436
+ L APE G T KSDV+S+G++L E+
Sbjct: 229 V------VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 9/207 (4%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-RVFQAEVEIISRVHHKHLV 299
F+ +G+G FG V KG+ K VAIK + + E Q E+ ++S+ ++
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
G Y ++ ++ E++ + L T L+ L KGL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHSE-- 138
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
K IHRDIKAAN+LL E K+ADFG+A +D +T +GT ++APE
Sbjct: 139 -KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAY 196
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTH 446
K+D++S G+ +EL G P H
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELH 223
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 59/251 (23%), Positives = 112/251 (44%), Gaps = 9/251 (3%)
Query: 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGER-VFQAEVEIISRVHHKH 297
D F + LG G G V K P+G +A K + R E++++ + +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
+V G + + + + E + +L+ L GR + K+++ KGL YL E
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLREK 150
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
KI+HRD+K +NIL++ + E K+ DFG++ D + ++ V GT Y++PE
Sbjct: 151 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFV-GTRSYMSPERLQGT 205
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477
+ +SD++S G+ L+E+ +G P+ + + + + + N
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265
Query: 478 EYNHNEMARMV 488
++ + M
Sbjct: 266 KFGMDSRPPMA 276
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 8/198 (4%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
+G+G G V +G++VA+K + Q + EV I+ H ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
+ Y G + ++ EF+ L + ++ + + LAYLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ--- 160
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
+IHRDIK+ +ILL K++DFG S + V GT ++APE S
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA 219
Query: 421 EKSDVFSFGVMLLELIIG 438
+ D++S G+M++E++ G
Sbjct: 220 TEVDIWSLGIMVIEMVDG 237
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 14/211 (6%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGER-VFQAEVEIISR-VHHKHLVSLVGY 304
+G G G V K G +A+KQ++ + E +++++ + ++V G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
+ + + E + + + +G + K+ + K L YL E +IH
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGP--IPERILGKMTVAIVKALYYLKEK--HGVIH 148
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE-----YASSGKL 419
RD+K +NILLD + + K+ DFG++ D R G Y+APE +
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
++DV+S G+ L+EL G P + T E
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCKTDFE 237
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 46/296 (15%), Positives = 88/296 (29%), Gaps = 49/296 (16%)
Query: 179 RPPHSPVYTPSPPPPPPF--------MSSSGGSSSNYSG-SEAPIPPPSLGLSLGFLKST 229
V P+ P+ +S S+Y E P++ F +
Sbjct: 5 MSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGS 64
Query: 230 FTYEELARATDGFSDANLLGQGGFGYVHKGV------LPNGKEVAIKQLKAGSGQGERVF 283
+LLG+G F V++ N ++ +K K + +
Sbjct: 65 KLVYVH----------HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 284 QAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPT---MDWPTR 340
+E + + + + +LV E + TL ++ M
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 341 LKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA-----------KVADFGLAK 389
+ A+ + +H+ +IIH DIK N +L F + D G +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 390 LASDVYTHVSTRVM----GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
D+ + T G+ E S+ + D F + ++ G
Sbjct: 232 ---DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-29
Identities = 69/353 (19%), Positives = 124/353 (35%), Gaps = 64/353 (18%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVS 300
F ++LG G G + + + ++VA+K++ + EV+++ H +++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIR 82
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
+ + E + TL+ ++ K + + GLA+LH
Sbjct: 83 YFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHSL--- 137
Query: 361 KIIHRDIKAANILLDFKFE-----AKVADFGLAKLASD---VYTHVSTRVMGTFGYLAPE 412
I+HRD+K NIL+ A ++DFGL K + ++ S GT G++APE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPE 196
Query: 413 Y---ASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469
T D+FS G + +I H F + + N + + D
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----HPFGKSLQRQ--ANILLGACSLDC 249
Query: 470 LVDPKLHNEYNHNEMARMVA-------CAAACVRH----------------SAR--RRPR 504
L K + + +M+A A ++H S R +
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESL 309
Query: 505 ISQIVRTLEGDASLADLNEGIRPGQSSVYGSLDYDTMQYNEDLKKFRKMALNS 557
IV+ LE + ++ DL+KFR S
Sbjct: 310 DGPIVKQLERGGRAVVKMDWRE--------NITVPLQ---TDLRKFRTYKGGS 351
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 13/212 (6%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQAEVEIISR-VHHKHLVSLVGY 304
+G+G +G V+K V P+G+ +A+K++++ + E+ +++++ R ++V G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAKGLAYLHEDCHPKI 362
+ E ++++ +F+ + P + KI L K L +L E+ KI
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE----YASSGK 418
IHRDIK +NILLD K+ DFG++ D + TR G Y+APE AS
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPYMAPERIDPSASRQG 205
Query: 419 LTEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
+SDV+S G+ L EL G P ++ +
Sbjct: 206 YDVRSDVWSLGITLYELATGRFPYPKWNSVFD 237
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 66/275 (24%), Positives = 109/275 (39%), Gaps = 30/275 (10%)
Query: 202 GSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGV- 260
+ SG E L + F + ++ + LG G +G V
Sbjct: 3 HHHHHSSGRENLYFQGDLQAT----PGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRD 58
Query: 261 LPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317
E AIK + + ++ + EV ++ + H +++ L ++ LV E
Sbjct: 59 KVTHVERAIKIIRKTSVSTSSNSKLLE-EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117
Query: 318 VTSNTLEFHLHGKGRPT-MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF 376
L + + + +D +K L G+ YLH+ I+HRD+K N+LL+
Sbjct: 118 YKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYLHKH---NIVHRDLKPENLLLES 171
Query: 377 KFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLL 433
K + K+ DFGL+ + + +GT Y+APE K EK DV+S GV+L
Sbjct: 172 KEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILF 228
Query: 434 ELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
L+ G P F L R +E G +
Sbjct: 229 ILLAGYPP------FGGQTDQEIL--RKVEKGKYT 255
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 20/227 (8%)
Query: 232 YEELARATD---GFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEV 287
YE + R D + LG G FG V+K G A K ++ S + + E+
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEI 67
Query: 288 EIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL-- 345
EI++ H ++V L+G Y + ++ EF ++ + R T +I +
Sbjct: 68 EILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGL----TEPQIQVVC 123
Query: 346 -GFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMG 404
+ L +LH +IIHRD+KA N+L+ + + ++ADFG++ + +G
Sbjct: 124 RQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIG 179
Query: 405 TFGYLAPEYASSGKLTE-----KSDVFSFGVMLLELIIGCRPVDSTH 446
T ++APE + + K+D++S G+ L+E+ P +
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 49/247 (19%), Positives = 85/247 (34%), Gaps = 34/247 (13%)
Query: 276 SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL-EFHLHGKGRPT 334
S ++ + K+ V + + + + L ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 335 MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK----- 389
+ L I + A+ + +LH ++HRD+K +NI KV DFGL
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 390 ------LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVD 443
L T +GT Y++PE + K D+FS G++L EL+
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS--- 274
Query: 444 STHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP 503
T ME R + + + F P L + + + MV + S RP
Sbjct: 275 ---TQME----RVRIITDVRNLKF-----PLLFTQK-YPQEHMMV---QDMLSPSPTERP 318
Query: 504 RISQIVR 510
+ I+
Sbjct: 319 EATDIIE 325
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 58/239 (24%), Positives = 103/239 (43%), Gaps = 46/239 (19%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
+LG G F V GK A+K +K + + E+ ++ ++ H+++V+L Y
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGF-------------AKGLA 352
+ + LV + V+ L F R+ + G +
Sbjct: 76 ESTTHYYLVMQLVSGGEL-FD-------------RI-LERGVYTEKDASLVIQQVLSAVK 120
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYL 409
YLHE+ I+HRD+K N+L E + DFGL+K+ + + + GT GY+
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTACGTPGYV 174
Query: 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
APE + ++ D +S GV+ L+ G P F E+ ++ L I++G ++
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPP------FYEETESK--LFEKIKEGYYE 225
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 63/229 (27%), Positives = 106/229 (46%), Gaps = 25/229 (10%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
LG+G FG V G+E A+K + + + EV+++ ++ H +++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPT-MDWPTRLKIALGFAKGLAYLHEDCHPKI 362
++ LV E T L + + R + +D ++ L G+ Y+H++ KI
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS---GITYMHKN---KI 147
Query: 363 IHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
+HRD+K N+LL+ K + ++ DFGL+ + +GT Y+APE G
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYYIAPE-VLHGTY 204
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
EK DV+S GV+L L+ GC P F N L + +E G +
Sbjct: 205 DEKCDVWSTGVILYILLSGCPP------FNGANEYDIL--KKVEKGKYT 245
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 8/198 (4%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
F LG+G +G V+K + G+ VAIKQ+ + E+ I+ + H+V
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
G Y + +V E+ + ++ + + + + I KGL YLH
Sbjct: 89 YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHFM--- 144
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
+ IHRDIKA NILL+ + AK+ADFG+A +D +T + GT ++APE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 203
Query: 421 EKSDVFSFGVMLLELIIG 438
+D++S G+ +E+ G
Sbjct: 204 CVADIWSLGITAIEMAEG 221
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 56/307 (18%), Positives = 99/307 (32%), Gaps = 68/307 (22%)
Query: 237 RATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLK---AGSGQGERVFQAEVEIISR 292
R T F + +G G FG V K V +G AIK+ K AGS + + EV +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALR-EVYAHAV 66
Query: 293 V-HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHL--HGKGRPTMDWPTRLKIALGFAK 349
+ H H+V + ++ E+ +L + + + + L +
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLD-------------------FKFEAKVADFGLAKL 390
GL Y+H ++H DIK +NI + K K+ D G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 391 ASDVYTHVSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELIIGCRPVD 443
S G +LA E + K+D+F+ + ++
Sbjct: 184 ISSPQVEE-----GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPLPR 232
Query: 444 STHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP 503
+ + I G P++ + E ++ + RRP
Sbjct: 233 NGDQW-----------HEIRQGRL-----PRIPQVLS-QEFTELLKV---MIHPDPERRP 272
Query: 504 RISQIVR 510
+V+
Sbjct: 273 SAMALVK 279
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 22/218 (10%)
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-RVFQAEVEIISRVHHKH 297
D + ++G G V P ++VAIK++ Q E++ +S+ HH +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK---IA------LGFA 348
+VS + + LV + ++ ++ + L IA L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL--- 131
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF-G 407
+GL YLH++ IHRD+KA NILL ++ADFG++ + +V TF G
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 408 ---YLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRP 441
++APE + K+D++SFG+ +EL G P
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-28
Identities = 65/229 (28%), Positives = 101/229 (44%), Gaps = 26/229 (11%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
LG+G FG V K +E A+K + A + + + EVE++ ++ H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFE 88
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPT-MDWPTRLKIALGFAKGLAYLHEDCHPKI 362
S +V E T L + + R + D +K G+ Y+H+ I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS---GITYMHKH---NI 142
Query: 363 IHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
+HRD+K NILL+ K + K+ DFGL+ +GT Y+APE G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPE-VLRGTY 199
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
EK DV+S GV+L L+ G P F N L + +E G +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP------FYGKNEYDIL--KRVETGKYA 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 22/208 (10%)
Query: 247 LLGQGGFGYVHKGV--LPNGKEVAIKQLK-AGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
+ GG G+++ + NG+ V +K L +G + + + AE + ++ V H +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 304 YYTAGSQRM-----LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
+ + +V E+V +L+ K + + L L+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLHSI- 201
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
+++ D+K NI+L + + K+ D G + + GT G+ APE
Sbjct: 202 --GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIVR-TG 252
Query: 419 LTEKSDVFSFGVMLLELIIGCRPVDSTH 446
T +D+++ G L L + + +
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRNGRY 280
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-27
Identities = 64/278 (23%), Positives = 105/278 (37%), Gaps = 37/278 (13%)
Query: 210 SEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVA 268
+ + + ++ + + + LG G +G V E A
Sbjct: 6 HHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKA 65
Query: 269 IKQLK--------------AGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314
IK +K E ++ E+ ++ + H +++ L + LV
Sbjct: 66 IKVIKKSQFDKGRYSDDNKNIEKFHEEIYN-EISLLKSLDHPNIIKLFDVFEDKKYFYLV 124
Query: 315 CEFVTSNTLEFHLHGKGRPT-MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANIL 373
EF L + + + D +K L G+ YLH+ I+HRDIK NIL
Sbjct: 125 TEFYEGGELFEQIINRHKFDECDAANIMKQILS---GICYLHKH---NIVHRDIKPENIL 178
Query: 374 LDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGV 430
L+ K K+ DFGL+ S + +GT Y+APE K EK DV+S GV
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSK--DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGV 235
Query: 431 MLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
++ L+ G P F N + + +E G +
Sbjct: 236 IMYILLCGYPP------FGGQNDQDII--KKVEKGKYY 265
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 64/271 (23%), Positives = 105/271 (38%), Gaps = 26/271 (9%)
Query: 186 YTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDA 245
Y + ++ + P + L + F ++ FSD
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDP---EKLFSDL 59
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE---RVFQAEVEIISRVHHKHLVSL 301
+G G FG V+ + N + VAIK++ Q + EV + ++ H + +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL---GFAKGLAYLHEDC 358
G Y LV E+ + + K IA G +GLAYLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAYLHSH- 173
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
+IHRD+KA NILL K+ DFG A + + + +GT ++APE +
Sbjct: 174 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMD 226
Query: 419 LTE---KSDVFSFGVMLLELIIGCRPVDSTH 446
+ K DV+S G+ +EL P+ + +
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMN 257
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 71/355 (20%), Positives = 127/355 (35%), Gaps = 62/355 (17%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGY 304
+LG G G V G+ VA+K++ + E+++++ H +++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCS 77
Query: 305 YTAGSQRMLVCEFVTSNTLEF----HLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
T + E N + ++ + + + A G+A+LH
Sbjct: 78 ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL--- 134
Query: 361 KIIHRDIKAANILLDFK-------------FEAKVADFGLAKL----ASDVYTHVSTRVM 403
KIIHRD+K NIL+ ++DFGL K S T+++
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS- 193
Query: 404 GTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELI-IGCRPVDSTHTFMEDNLAR 455
GT G+ APE + +LT D+FS G + ++ G P ++ E N
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS-RESN--- 249
Query: 456 PLLNRAIEDGNFDTLVDPKLHNE--------YNHNEMARMVACAAACVRH----SARRRP 503
++ L D L E +H+ + R A +RH ++
Sbjct: 250 -IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP--TAMKVLRHPLFWPKSKKL 306
Query: 504 RISQIV---RTLEGDASLADLNEGIRPGQSSVYGSLDYDTM---QYNEDLKKFRK 552
V +E + L G V S D+ + ++L+++RK
Sbjct: 307 EFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYRK 361
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 64/321 (19%), Positives = 113/321 (35%), Gaps = 36/321 (11%)
Query: 156 VPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIP 215
+ H ++P P P + + G SSNY I
Sbjct: 82 IIAENKHGQSKPCEPTAPVLIPGDERKRRR-GYDVDEQGKIVRGKGTVSSNYDNYVFDIW 140
Query: 216 PPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKA 274
+ D + LG G FG VH+ G A K +
Sbjct: 141 KQYYPQPVEIKHDHVL--------DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 275 GSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL-EFHLHGKGRP 333
+ + E++ +S + H LV+L + ++ +++ EF++ L E +
Sbjct: 193 PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM 252
Query: 334 TMDWPTRLKIALGFAK----GLAYLHEDCHPKIIHRDIKAANILLDFKFEA--KVADFGL 387
+ A+ + + GL ++HE+ +H D+K NI+ K K+ DFGL
Sbjct: 253 SE------DEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 303
Query: 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHT 447
GT + APE A + +D++S GV+ L+ G P
Sbjct: 304 TAHLDP--KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP------ 355
Query: 448 FMEDNLARPLLNRAIEDGNFD 468
F +N L N ++ +++
Sbjct: 356 FGGENDDETLRN--VKSCDWN 374
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 65/230 (28%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
LG+G FG V K +E A+K + A + + + EVE++ ++ H +++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFE 88
Query: 304 YYTAGSQRMLVCEFVTSNTLEFH-LHGKGRPT-MDWPTRLKIALGFAKGLAYLHEDCHPK 361
S +V E T L F + + R + D +K G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL-FDEIIKRKRFSEHDAARIIKQVFS---GITYMHKH---N 141
Query: 362 IIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
I+HRD+K NILL+ K + K+ DFGL+ +GT Y+APE G
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPEVL-RGT 198
Query: 419 LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
EK DV+S GV+L L+ G P F N + + +E G +
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPP------FYGKNEYD--ILKRVETGKYA 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 70/322 (21%), Positives = 126/322 (39%), Gaps = 36/322 (11%)
Query: 165 TQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLG 224
+ R P +R + S P ++ + + ++ S+G
Sbjct: 20 RRARREIRHLPNLNREQ-RRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG 78
Query: 225 FLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQ 278
+ + +++G+G V + V G E A+K + Q
Sbjct: 79 PEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ 138
Query: 279 GERV---FQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFH-LHGKGRP 333
E V + E I+ +V H H+++L+ Y + S LV + + L F L K
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-FDYLTEKVAL 197
Query: 334 T-MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392
+ + TR I + +++LH + I+HRD+K NILLD + +++DFG +
Sbjct: 198 SEKE--TR-SIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251
Query: 393 DVYTHVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446
+ GT GYLAPE + ++ D+++ GV+L L+ G P
Sbjct: 252 P--GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP----- 304
Query: 447 TFMEDNLARPLLNRAIEDGNFD 468
F + L+ R I +G +
Sbjct: 305 -FWHRR--QILMLRMIMEGQYQ 323
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 59/241 (24%), Positives = 92/241 (38%), Gaps = 35/241 (14%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL-KAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG G FG VH +G E IK + K S +AE+E++ + H +++ + +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 306 TAGSQRMLVCEFVTSNTLEFH-----LHGKGRPTMDWPTRLKIALGFAK----GLAYLHE 356
+V E L + K LAY H
Sbjct: 90 EDYHNMYIVMETCEGGEL-LERIVSAQARGKALSE------GYVAELMKQMMNALAYFHS 142
Query: 357 DCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY 413
++H+D+K NIL K+ DFGLA+L ST GT Y+APE
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALYMAPEV 197
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473
+T K D++S GV++ L+ GC P F +L + + + V+
Sbjct: 198 F-KRDVTFKCDIWSAGVVMYFLLTGCLP------FTGTSLEE--VQQKATYKEPNYAVEC 248
Query: 474 K 474
+
Sbjct: 249 R 249
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 74/343 (21%), Positives = 127/343 (37%), Gaps = 58/343 (16%)
Query: 146 GGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSS 205
G H V ++ Q + + SR H+ +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMKNSGDQD--SRSGHNEAKEVWSNADLTERMPVKSKRT 59
Query: 206 NYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSD------ANLLGQGGFGYVHKG 259
+ + P PP F + + + +LG G FG VHK
Sbjct: 60 SALAVDIPAPPAP-----------FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC 108
Query: 260 V-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318
G ++A K +K + + + E+ +++++ H +L+ L + + + +LV E+V
Sbjct: 109 EETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV 168
Query: 319 TSNTL-------EFHLHGKGRPTMDWPTRLKIALGFAK----GLAYLHEDCHPKIIHRDI 367
L ++L T L L F K G+ ++H+ I+H D+
Sbjct: 169 DGGELFDRIIDESYNL-----------TELDTIL-FMKQICEGIRHMHQM---YILHLDL 213
Query: 368 KAANILLDFKFEA--KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
K NIL + K+ DFGLA+ GT +LAPE + ++ +D+
Sbjct: 214 KPENILCVNRDAKQIKIIDFGLARRYKP--REKLKVNFGTPEFLAPEVVNYDFVSFPTDM 271
Query: 426 FSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
+S GV+ L+ G P F+ DN A L N I +D
Sbjct: 272 WSVGVIAYMLLSGLSP------FLGDNDAETLNN--ILACRWD 306
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 18/218 (8%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLV 299
F L+G G +G V+KG + G+ AIK + +G E + E+ ++ + HH+++
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 300 SLVGYYTAGSQRM------LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
+ G + + LV EF + ++ + T+ I +GL++
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 144
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY 413
LH+ K+IHRDIK N+LL E K+ DFG++ +T +GT ++APE
Sbjct: 145 LHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEV 200
Query: 414 ASSGKLTE-----KSDVFSFGVMLLELIIGCRPVDSTH 446
+ + + KSD++S G+ +E+ G P+ H
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 56/273 (20%), Positives = 90/273 (32%), Gaps = 64/273 (23%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
+GQG +G V + AIK +++ + + + EV ++ ++HH ++ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK------------ 349
Y LV E L L+ + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 350 --------------------------GLAYLHEDCHPKIIHRDIKAANILLDFKFEA--K 381
L YLH I HRDIK N L K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 382 VADFGLAKL----ASDVYTHVSTRVMGTFGYLAPE--YASSGKLTEKSDVFSFGVMLLEL 435
+ DFGL+K + Y ++T+ GT ++APE ++ K D +S GV+L L
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 436 IIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
++G P F N A + +
Sbjct: 270 LMGAVP------FPGVNDAD--TISQVLNKKLC 294
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 55/227 (24%), Positives = 89/227 (39%), Gaps = 24/227 (10%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
+G+G +G V V A K++ + F+ E+EI+ + H +++ L +
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 307 AGSQRMLVCEFVTSNTLEFH-LHGKGRPT-MDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
+ LV E T L F + K D +K L +AY H+ + H
Sbjct: 77 DNTDIYLVMELCTGGEL-FERVVHKRVFRESDAARIMKDVL---SAVAYCHKL---NVAH 129
Query: 365 RDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
RD+K N L K+ DFGLA + +GT Y++P+ G
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKP--GKMMRTKVGTPYYVSPQ-VLEGLYGP 186
Query: 422 KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
+ D +S GVM+ L+ G P F + + I +G F
Sbjct: 187 ECDEWSAGVMMYVLLCGYPP------FSAPTDSE--VMLKIREGTFT 225
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 43/220 (19%), Positives = 83/220 (37%), Gaps = 24/220 (10%)
Query: 239 TDGFSDANLLGQG--GFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV--FQAEVEIISRV 293
+ ++G+G V+ P G+ V ++++ + E V Q E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 294 HHKHLVSLVGYYTAGSQRMLVCEFVT----SNTLEFHLHGKGRPTMDWPTRLKIALGFAK 349
+H ++V + A ++ +V F+ + + H M+ I G K
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD----GMNELAIAYILQGVLK 139
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG-LAKLASD-----VYTHVSTRVM 403
L Y+H +HR +KA++IL+ + ++ + S V +
Sbjct: 140 ALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 404 GTFGYLAPEYASSGKL--TEKSDVFSFGVMLLELIIGCRP 441
+L+PE KSD++S G+ EL G P
Sbjct: 197 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL--KAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
LG+G F V + V G E A K + K S + + + E I ++ H ++V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK----GLAYLHEDCHP 360
S LV + VT L + + + A + +AY H +
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSE------ADASHCIQQILESIAYCHSN--- 124
Query: 361 KIIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
I+HR++K N+LL K + K+ADFGLA +D + GT GYL+PE
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLKKD 182
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
++ D+++ GV+L L++G P F +++ R L I+ G +D
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPP------FWDEDQHR--LYAQIKAGAYD 225
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 69/264 (26%), Positives = 113/264 (42%), Gaps = 23/264 (8%)
Query: 212 APIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIK 270
P G S F + +D + LG+G F V + V G E A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 271 QL--KAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLH 328
+ K S + + + E I ++ H ++V L S LV + VT L +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 329 GKGRPT-MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA---KVAD 384
+ + D ++ L + +AY H + I+HR++K N+LL K + K+AD
Sbjct: 121 AREFYSEADASHCIQQIL---ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLAD 174
Query: 385 FGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDS 444
FGLA +D + GT GYL+PE ++ D+++ GV+L L++G P
Sbjct: 175 FGLAIEVND--SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP--- 229
Query: 445 THTFMEDNLARPLLNRAIEDGNFD 468
F +++ R L I+ G +D
Sbjct: 230 ---FWDEDQHR--LYAQIKAGAYD 248
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 57/235 (24%), Positives = 97/235 (41%), Gaps = 30/235 (12%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
+G+G F V + + G++ A+K + + G + E I + H H+V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTR-----LKIALGFAKGLAYLHE 356
+ Y++ +V EF+ L F + + + ++ L + L Y H+
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EALRYCHD 148
Query: 357 DCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY 413
+ IIHRD+K +LL K + K+ FG+A + RV GT ++APE
Sbjct: 149 N---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEV 204
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
+ DV+ GV+L L+ GC P T ++ L I G +
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLF-----EGIIKGKYK 250
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 55/297 (18%), Positives = 113/297 (38%), Gaps = 47/297 (15%)
Query: 186 YTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDA 245
+ G ++Y I + + + + D +
Sbjct: 5 HHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVY--------DYYDIL 56
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
LG G FG VH+ V G+ K + + + E+ I++++HH L++L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 305 YTAGSQRMLVCEFVTSNTL-------EFHLHGKGRPTMDWPTRLKIALGFAK----GLAY 353
+ + +L+ EF++ L ++ + + ++ + + GL +
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKM-----------SEAEVIN-YMRQACEGLKH 164
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEA--KVADFGLAKLASDVYTHVSTRVMGTFGYLAP 411
+HE I+H DIK NI+ + K + K+ DFGLA + + T + AP
Sbjct: 165 MHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAP 219
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
E + +D+++ GV+ L+ G P F ++ L N ++ +++
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSP------FAGEDDLETLQN--VKRCDWE 268
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 40/240 (16%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
LLG+G +G V + + A+K +L+ V + E++++ R+ HK+++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQ 70
Query: 301 LVGYYTAGSQRM--LVCEFVTSNTLE-FHLHGKGRPTMDWPTRLKIALGF----AKGLAY 353
LV ++ +V E+ E + R + A G+ GL Y
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC------QAHGYFCQLIDGLEY 124
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL----ASDVYTHVSTRVMGTFGYL 409
LH I+H+DIK N+LL K++ G+A+ A+D S G+ +
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GSPAFQ 178
Query: 410 APEYASSGKLTE--KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467
PE A+ K D++S GV L + G P F DN+ L I G++
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP------FEGDNI--YKLFENIGKGSY 230
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 24/248 (9%), Positives = 54/248 (21%), Gaps = 43/248 (17%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKHLVSLV 302
L G V + ++ A+K S +R+ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 303 GYY--------------------------TAGSQRMLVCEFVTSNTLE----FHLHGKGR 332
A + +L+ + + R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 333 PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392
+ + A L ++H N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 393 DVYTHVSTRVMGTFGYLAPEYASSGKL--TEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
S Y E+ ++ T + + G+ + + P ++
Sbjct: 246 TRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 451 DNLARPLL 458
+ RP L
Sbjct: 302 GSWKRPSL 309
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 37/296 (12%)
Query: 179 RPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARA 238
S V + MSS S++ + S P G + L F E
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVP-DYWIDGSNRDALSDFFEVESE--- 60
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH 297
LG+G V++ K A+K LK +++ + E+ ++ R+ H +
Sbjct: 61 ---------LGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPN 109
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEF-HLHGKGRPT-MDWPTRLKIALGFAKGLAYLH 355
++ L + ++ LV E VT L F + KG + D +K L +AYLH
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL-FDRIVEKGYYSERDAADAVKQILE---AVAYLH 165
Query: 356 EDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPE 412
E+ I+HRD+K N+L K+ADFGL+K+ + V GT GY APE
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPE 220
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
+ D++S G++ L+ G P F ++ + + R I + +
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP------FYDERGDQFMF-RRILNCEYY 269
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 22/228 (9%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL--KAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
LG+G F V + V + G+E A + K S + + + E I + H ++V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPT-MDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ L+ + VT L + + + D ++ L + + H+ ++
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE---AVLHCHQM---GVV 132
Query: 364 HRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
HR++K N+LL K + K+ADFGLA GT GYL+PE
Sbjct: 133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDPYG 191
Query: 421 EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
+ D+++ GV+L L++G P F +++ R L + I+ G +D
Sbjct: 192 KPVDLWACGVILYILLVGYPP------FWDEDQHR--LYQQIKAGAYD 231
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 27/229 (11%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
+G+G F V + G+EVAIK + + +++F+ EV I+ ++H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79
Query: 304 YYTAGSQRM--LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ +++ L+ E+ + + +L GR M + Y H+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARSKFRQIVSAVQYCHQKR--- 134
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
I+HRD+KA N+LLD K+ADFG + + + G Y APE GK +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPELF-QGKKYD 191
Query: 422 --KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
+ DV+S GV+L L+ G P F NL L + G +
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP------FDGQNL--KELRERVLRGKYR 232
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 63/264 (23%), Positives = 104/264 (39%), Gaps = 36/264 (13%)
Query: 225 FLKSTFTYEELARATDGFSD----ANLLGQGGFGYVHKGV-LPNGKEVAIKQLK------ 273
F+ T ++ + D + LG G G V K+VAI+ +
Sbjct: 116 FVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAI 175
Query: 274 --AGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFH-LHGK 330
A + E+EI+ +++H ++ + ++ A +V E + L F + G
Sbjct: 176 GSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGEL-FDKVVGN 233
Query: 331 GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGL 387
R + + YLHE+ IIHRD+K N+LL + E K+ DFG
Sbjct: 234 KRLKEA-TCK-LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288
Query: 388 AKLASDVYTHVSTRVMGTFGYLAPE---YASSGKLTEKSDVFSFGVMLLELIIGCRPVDS 444
+K+ + T + + GT YLAPE + D +S GV+L + G P
Sbjct: 289 SKILGE--TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--- 343
Query: 445 THTFMEDNLARPLLNRAIEDGNFD 468
F E + L I G ++
Sbjct: 344 ---FSEHR-TQVSLKDQITSGKYN 363
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 64/254 (25%), Positives = 102/254 (40%), Gaps = 38/254 (14%)
Query: 237 RATDGFSDA----NLLGQGGFGYVHKGV-LPNGKEVAIK---------QLKAGSGQGERV 282
+T GF + +LG+G V + + P KE A+K +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 283 FQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFH-LHGKGRPTMDWPTR 340
EV+I+ +V H +++ L Y + LV + + L F L K + +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVTLSEKETRK 128
Query: 341 LKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVST 400
+ AL + + LH+ I+HRD+K NILLD K+ DFG +
Sbjct: 129 IMRAL--LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLR 181
Query: 401 RVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLA 454
V GT YLAPE + ++ D++S GV++ L+ G P F
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------FWHRK-- 233
Query: 455 RPLLNRAIEDGNFD 468
+ L+ R I GN+
Sbjct: 234 QMLMLRMIMSGNYQ 247
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 47/235 (20%), Positives = 93/235 (39%), Gaps = 40/235 (17%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT 306
LG+G FG VH+ V + K K +K V + E+ I++ H++++ L +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK-EISILNIARHRNILHLHESFE 71
Query: 307 AGSQRMLVCEFVTSNTL-------EFHLHGKGRPTMDWPTRLKIALGFAK----GLAYLH 355
+ + +++ EF++ + F L +I + L +LH
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFEL-----------NEREIV-SYVHQVCEALQFLH 119
Query: 356 EDCHPKIIHRDIKAANILLDFKFEA--KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY 413
I H DI+ NI+ + + K+ +FG A+ + Y APE
Sbjct: 120 SH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP--GDNFRLLFTAPEYYAPEV 174
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
++ +D++S G ++ L+ G P F+ + + + N I + +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINP------FLAETNQQIIEN--IMNAEYT 221
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 54/235 (22%), Positives = 97/235 (41%), Gaps = 34/235 (14%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL---KAGSGQGERVFQAEVEIISRV-HHKHLVSLV 302
LG+G F V + + G+E A K L + G + E+ ++ +++L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH-EIAVLELAKSCPRVINLH 95
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAK----GLAYLHE 356
Y S+ +L+ E+ + F + + + K G+ YLH+
Sbjct: 96 EVYENTSEIILILEYAAGGEI-FS-----LCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149
Query: 357 DCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEY 413
+ I+H D+K NILL + K+ DFG+++ +MGT YLAPE
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH--ACELREIMGTPEYLAPEI 204
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
+ +T +D+++ G++ L+ P F+ ++ LN I N D
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTHTSP------FVGEDNQETYLN--ISQVNVD 251
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 71/317 (22%), Positives = 118/317 (37%), Gaps = 43/317 (13%)
Query: 163 VVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLS 222
+++ +PP P + P+PPP PP + + P +
Sbjct: 1 MLSNSQGQSPPVPFPA---------PAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSG 51
Query: 223 LGFLKSTFT--YEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQG 279
L K+ Y+ ++ +LG G G V + ++ A+K L+
Sbjct: 52 LQIKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKMLQ----DC 98
Query: 280 ERVFQAEVEIISRV-HHKHLVSLVGYY-TAGSQRM---LVCEFVTSNTLEFHLHGKGRPT 334
+ + EVE+ R H+V +V Y + R +V E + L + +G
Sbjct: 99 PKARR-EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA 157
Query: 335 MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKLA 391
+I + + YLH I HRD+K N+L K K+ DFG AK
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214
Query: 392 SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED 451
+ + T T Y+APE K + D++S GV++ L+ G P S H
Sbjct: 215 TS--HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 272
Query: 452 NLARPLLNRAIEDGNFD 468
P + I G ++
Sbjct: 273 ----PGMKTRIRMGQYE 285
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 57/258 (22%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIK---------------------------QLKAGSGQ 278
+G+G +G V + A+K G
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 279 GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMD 336
E+V+Q E+ I+ ++ H ++V LV ++ L V E V + + + D
Sbjct: 80 IEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-MEVPTLKPLSED 137
Query: 337 WPTRLKIALGFAK----GLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392
A + + G+ YLH KIIHRDIK +N+L+ K+ADFG++
Sbjct: 138 ------QARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 393 DVYTHVSTRVMGTFGYLAPEYASSGKLT---EKSDVFSFGVMLLELIIGCRPVDSTHTFM 449
+S V GT ++APE S + + DV++ GV L + G P FM
Sbjct: 189 GSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP------FM 241
Query: 450 EDNLARPLLNRAIEDGNF 467
++ + L+ I+
Sbjct: 242 DERI--MCLHSKIKSQAL 257
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 4e-23
Identities = 65/237 (27%), Positives = 99/237 (41%), Gaps = 36/237 (15%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLK------AGSGQGERVFQAEVEIISRVHHKHLVS 300
LG G F V K GKE A K +K + G + EV I+ + H ++++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFH-LHGKGRPTMDWPTRLKIALGFAK----GLAYLH 355
L + + +L+ E V+ L F L K T A F K G+ YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGEL-FDFLAEKESLTE------DEATQFLKQILDGVHYLH 125
Query: 356 EDCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKLASDVYTHVSTRVMGTFGYLAP 411
+I H D+K NI+L K K+ DFG+A + + GT ++AP
Sbjct: 126 SK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEFKNIFGTPEFVAP 180
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
E + L ++D++S GV+ L+ G P F+ + L N I N+D
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP------FLGETKQETLTN--ISAVNYD 229
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 69/237 (29%), Positives = 100/237 (42%), Gaps = 36/237 (15%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQGER-VFQAEVEIISRVHHKHLVS 300
LG G F V K G E A K Q +A R + EV I+ +V H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEF-HLHGKGRPTMDWPTRLKIALGFAK----GLAYLH 355
L Y + +L+ E V+ L F L K + + A F K G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL-FDFLAQKESLSE------EEATSFIKQILDGVNYLH 132
Query: 356 EDCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKLASDVYTHVSTRVMGTFGYLAP 411
KI H D+K NI+L K K+ DFGLA D + GT ++AP
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAP 187
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
E + L ++D++S GV+ L+ G P F+ D L N I ++D
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP------FLGDTKQETLAN--ITSVSYD 236
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 61/242 (25%), Positives = 95/242 (39%), Gaps = 42/242 (17%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLK---------AGSGQGERVFQAEVEIISRVHHKH 297
LG G G V K+VAIK + + V E+EI+ +++H
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET-EIEILKKLNHPC 76
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFH-LHGKGRPTMDWPTRLKIALGFAK----GLA 352
++ + ++ A +V E + L F + G R + +
Sbjct: 77 IIKIKNFFDA-EDYYIVLELMEGGEL-FDKVVGNKRLKE------ATCKLYFYQMLLAVQ 128
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYL 409
YLHE+ IIHRD+K N+LL + E K+ DFG +K+ + T + + GT YL
Sbjct: 129 YLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTPTYL 183
Query: 410 APE---YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466
APE + D +S GV+L + G P F E L I G
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP------FSEHRTQVSLK-DQITSGK 236
Query: 467 FD 468
++
Sbjct: 237 YN 238
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-23
Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 16/230 (6%)
Query: 242 FSDANLLGQGGFGYV----HKGVLPNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVH 294
F +LG+GGFG V + GK A K+L+ +GE + E +I+ +V+
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN 242
Query: 295 HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354
+ +VSL Y LV + L+FH++ G+ + A GL L
Sbjct: 243 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
H + +I++RD+K NILLD +++D GLA + T + RV GT GY+APE
Sbjct: 303 HRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVV 357
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRP-VDSTHTFMEDNLARPLLNRAIE 463
+ + T D ++ G +L E+I G P + + R + E
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 68/237 (28%), Positives = 100/237 (42%), Gaps = 36/237 (15%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV------FQAEVEIISRVHHKHLVS 300
LG G F V K G E A K +K + R + EV I+ +V H ++++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEF-HLHGKGRPTMDWPTRLKIALGFAK----GLAYLH 355
L Y + +L+ E V+ L F L K + + A F K G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGEL-FDFLAQKESLSE------EEATSFIKQILDGVNYLH 132
Query: 356 EDCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKLASDVYTHVSTRVMGTFGYLAP 411
KI H D+K NI+L K K+ DFGLA D + GT ++AP
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAP 187
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
E + L ++D++S GV+ L+ G P F+ D L N I ++D
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP------FLGDTKQETLAN--ITAVSYD 236
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-22
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 240 DGFSDANLLGQGGFGYV----HKGVLPNGKEVAIKQLKAG---SGQGERVFQAEVEIISR 292
D F D +LG+GGFG V K GK A K+L +G + E +I+++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 293 VHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWP-TRLK-----IALG 346
VH + +VSL + + LV + + +H++ + R I G
Sbjct: 242 VHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
L +LH+ II+RD+K N+LLD +++D GLA T GT
Sbjct: 302 ----LEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTP 353
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIG 438
G++APE + D F+ GV L E+I
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAA 385
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 63/237 (26%), Positives = 98/237 (41%), Gaps = 36/237 (15%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLK------AGSGQGERVFQAEVEIISRVHHKHLVS 300
LG G F V K G + A K +K + G + EV I+ + H ++++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFH-LHGKGRPTMDWPTRLKIALGFAK----GLAYLH 355
L Y + +L+ E V L F L K T + A F K G+ YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGEL-FDFLAEKESLTE------EEATEFLKQILNGVYYLH 131
Query: 356 EDCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKLASDVYTHVSTRVMGTFGYLAP 411
+I H D+K NI+L + K+ DFGLA + + GT ++AP
Sbjct: 132 SL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAP 186
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
E + L ++D++S GV+ L+ G P F+ D L N + N++
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASP------FLGDTKQETLAN--VSAVNYE 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 72/318 (22%), Positives = 111/318 (34%), Gaps = 38/318 (11%)
Query: 141 KVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSS 200
K++ R ++ A HP + PP +
Sbjct: 94 KLETEEERLVCSREIFDTY-----IMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQP 148
Query: 201 GGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARAT-DGFSDANLLGQGGFGYV--- 256
+ E T + FS ++G+GGFG V
Sbjct: 149 YIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGC 208
Query: 257 -HKGVLPNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVH---HKHLVSLVGYYTAGS 309
GK A+K L QGE + E ++S V +V + +
Sbjct: 209 RKAD---TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265
Query: 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK-----IALGFAKGLAYLHEDCHPKIIH 364
+ + + + L +HL G + ++ I LG L ++H +++
Sbjct: 266 KLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILG----LEHMHNR---FVVY 315
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKS- 423
RD+K ANILLD +++D GLA S H V GT GY+APE G + S
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVAYDSSA 372
Query: 424 DVFSFGVMLLELIIGCRP 441
D FS G ML +L+ G P
Sbjct: 373 DWFSLGCMLFKLLRGHSP 390
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 64/231 (27%), Positives = 109/231 (47%), Gaps = 30/231 (12%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
LG G FG V G G +VA+K ++++ ++ + E++ + H H++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS-LDVVGKIKR-EIQNLKLFRHPHIIK 75
Query: 301 LVGYYTAGSQRM--LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
L Y + +V E+V+ L ++ GR ++ ++ + Y H
Sbjct: 76 L--YQVISTPTDFFMVMEYVSGGELFDYICKHGR--VEEMEARRLFQQILSAVDYCHRH- 130
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK 418
++HRD+K N+LLD AK+ADFGL+ + SD + T G+ Y APE SG+
Sbjct: 131 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPEVI-SGR 185
Query: 419 LTE--KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467
L + D++S GV+L L+ G P F ++++ P L + I G F
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLP------FDDEHV--PTLFKKIRGGVF 228
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 27/241 (11%), Positives = 62/241 (25%), Gaps = 54/241 (22%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV----------------------- 282
+LGQ + G+ +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 283 -----FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTL------EFHLHGKG 331
F +++ K ++ + + + H
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 332 RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391
++ RL++ L + LA LH H ++H ++ +I+LD + + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 392 SDVYTHVSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELIIGCR 440
+ G+ PE + +T D ++ G+++ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 441 P 441
P
Sbjct: 312 P 312
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 6e-22
Identities = 28/235 (11%), Positives = 61/235 (25%), Gaps = 43/235 (18%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE---RVFQAEVEIISR---------- 292
+LGQ + G+ + + + EV +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 293 ------------VHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHL---------HGKG 331
V ++ ++ F ++ +L H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 332 RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391
++ RL++ L + LA LH ++H ++ +I+LD + + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 392 SDVYTHVSTRVMGTFGYLAPE-----YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
R A +T D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 28/209 (13%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLK----AGSGQGERVFQAEVEIISRVHHKHL 298
+G+G FG V K A+K + + VF E++I+ + H L
Sbjct: 22 AIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVF-KELQIMQGLEHPFL 77
Query: 299 VSLVGYYT-AGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA-LGFAKGLAYLH 355
V+L +Y+ + M +V + + L +HL + +L I L A L YL
Sbjct: 78 VNL--WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-VKLFICELVMA--LDYLQ 132
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS 415
+IIHRD+K NILLD + DF +A + + + GT Y+APE S
Sbjct: 133 NQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFS 187
Query: 416 SGKLTE--KS-DVFSFGVMLLELIIGCRP 441
S K + D +S GV EL+ G RP
Sbjct: 188 SRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQL--KAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
LG+G +G V V + VA+K + K E + + E+ I ++H+++V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK----GLAYLHEDCH 359
+ G+ + L E+ + L + A F G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------DAQRFFHQLMAGVVYLHGI-- 124
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT--HVSTRVMGTFGYLAPEYASSG 417
I HRDIK N+LLD + K++DFGLA + ++ GT Y+APE
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KR 181
Query: 418 KL--TEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
+ E DV+S G++L ++ G P D +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 52/234 (22%), Positives = 93/234 (39%), Gaps = 31/234 (13%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQL-KAGSGQGERVFQAEVEIISRV-HHKHLVSLVGY 304
LG+G F K V + + A+K + K ++ E+ + H ++V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK----EITALKLCEGHPNIVKLHEV 74
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKG-------RPTMDWPTRLKIALGFAKGLAYLHED 357
+ LV E + L + K M K+ ++++H+
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM-----RKLV----SAVSHMHDV 125
Query: 358 CHPKIIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
++HRD+K N+L + + K+ DFG A+L + T T Y APE
Sbjct: 126 ---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELL 181
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
+ E D++S GV+L ++ G P S + A ++ + I+ G+F
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK-IKKGDFS 234
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 60/212 (28%), Positives = 84/212 (39%), Gaps = 28/212 (13%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLK---------AGSGQGERVFQAEVEIISRVHHKH 297
LG G FG+V V KEV +K +K + +V E+ I+SRV H +
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHAN 90
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEF-HLHGKGRPTMDWPTRLKIALGFAKGLAYLHE 356
++ ++ + LV E S F + R +D P I + YL
Sbjct: 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR--LDEPLASYIFRQLVSAVGYLRL 148
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD---VYTHVSTRVMGTFGYLAPEY 413
IIHRDIK NI++ F K+ DFG A YT GT Y APE
Sbjct: 149 K---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC-----GTIEYCAPEV 200
Query: 414 ASSGKLTE--KSDVFSFGVMLLELIIGCRPVD 443
G + +++S GV L L+ P
Sbjct: 201 L-MGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 62/259 (23%), Positives = 96/259 (37%), Gaps = 42/259 (16%)
Query: 197 MSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYV 256
M + +GS PP + F +LG+G F V
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRP--------------EDFKFGKILGEGSFSTV 46
Query: 257 ----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG 308
+E AIK L+ + V E +++SR+ H V L Y+T
Sbjct: 47 VLARELA---TSREYAIKILEKRHIIKENKVPYV-TRERDVMSRLDHPFFVKL--YFTFQ 100
Query: 309 SQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGLAYLHEDCHPKII 363
L + + L ++ G TR +I L YLH II
Sbjct: 101 DDEKLYFGLSYAKNGELLKYIRKIGSFDET-CTRFYTAEIVSA----LEYLHGK---GII 152
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYASSGKLTEK 422
HRD+K NILL+ ++ DFG AK+ S GT Y++PE + +
Sbjct: 153 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 212
Query: 423 SDVFSFGVMLLELIIGCRP 441
SD+++ G ++ +L+ G P
Sbjct: 213 SDLWALGCIIYQLVAGLPP 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 54/231 (23%), Positives = 88/231 (38%), Gaps = 24/231 (10%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGY 304
+LG G G V + G++ A+K L + Q EV+ + H+V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLY----DSPKARQ-EVDHHWQASGGPHIVCILDV 90
Query: 305 YTAGSQRM----LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
Y ++ E + L + +G +I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH--- 147
Query: 361 KIIHRDIKAANILLDFKFEA---KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
I HRD+K N+L K + K+ DFG AK + + T T Y+APE
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPC-YTPYYVAPEVLGPE 204
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
K + D++S GV++ L+ G P S P + R I G +
Sbjct: 205 KYDKSCDMWSLGVIMYILLCGFPPFYSNT----GQAISPGMKRRIRLGQYG 251
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 54/257 (21%), Positives = 102/257 (39%), Gaps = 52/257 (20%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGY 304
+LG+G V + L +E A+K ++ G EVE++ + H++++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGF------------AKGLA 352
+ + LV E + ++ H+H + F A L
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRH--------------FNELEASVVVQDVASALD 125
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEA---KVADFGLAKL--ASDVYTHVSTRVM---- 403
+LH I HRD+K NIL + + K+ DF L + + +ST +
Sbjct: 126 FLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 404 GTFGYLAPE-----YASSGKLTEKSDVFSFGVMLLELIIGCRP-------VDSTHTFMED 451
G+ Y+APE + ++ D++S GV+L L+ G P
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 452 NLARPLLNRAIEDGNFD 468
+ +L +I++G ++
Sbjct: 243 PACQNMLFESIQEGKYE 259
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQL--KAGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
LG+G +G V V + VA+K + K E + + E+ I ++H+++V G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG 72
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK----GLAYLHEDCH 359
+ G+ + L E+ + L + A F G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEP------DAQRFFHQLMAGVVYLHGI-- 124
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT--HVSTRVMGTFGYLAPEYASSG 417
I HRDIK N+LLD + K++DFGLA + ++ GT Y+APE
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELL-KR 181
Query: 418 KL--TEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
+ E DV+S G++L ++ G P D +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 39/235 (16%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
LG+G FG V ++VA+K LK S RV + E+ + + H H++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK-SDMHMRVER-EISYLKLLRHPHIIK 73
Query: 301 LVGYYTAGSQRM--LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK----GLAYL 354
L Y + +V E+ L ++ K R T D F + + Y
Sbjct: 74 L--YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTED------EGRRFFQQIICAIEYC 124
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
H KI+HRD+K N+LLD K+ADFGL+ + +D + T G+ Y APE
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSC-GSPNYAAPEVI 179
Query: 415 SSGKLTE--KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467
+GKL + DV+S G++L +++G P F ++ + P L + + +
Sbjct: 180 -NGKLYAGPEVDVWSCGIVLYVMLVGRLP------FDDEFI--PNLFKKVNSCVY 225
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 34/234 (14%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
+G G FG + VA+K ++ G+ E V Q E+ + H ++V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV-QREIINHRSLRHPNIVRF--KE 83
Query: 306 TAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGF----AKGLAYLHEDCH 359
+ L + E+ + L + GR + D A F G++Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSED------EARFFFQQLLSGVSYCHSM-- 135
Query: 360 PKIIHRDIKAANILLDFKFEA--KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
+I HRD+K N LLD K+ DFG +K + ++ + V GT Y+APE
Sbjct: 136 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV-GTPAYIAPEVL-LR 191
Query: 418 KLTE--KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL--LNRAIEDGNF 467
+ + +DV+S GV L +++G P F + R + I +
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYP------FEDPEEPRDYRKTIQRILSVKY 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 67/235 (28%), Positives = 109/235 (46%), Gaps = 38/235 (16%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIK-----QLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
LG G FG V G G +VA+K ++++ ++ + E++ + H H++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS-LDVVGKIRR-EIQNLKLFRHPHIIK 80
Query: 301 LVGYYTAGSQRM--LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAK----GLAYL 354
L Y + +V E+V+ L ++ GR + + G+ Y
Sbjct: 81 L--YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK------ESRRLFQQILSGVDYC 132
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
H ++HRD+K N+LLD AK+ADFGL+ + SD + T G+ Y APE
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPEVI 187
Query: 415 SSGKLTE--KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467
SG+L + D++S GV+L L+ G P F +D++ P L + I DG F
Sbjct: 188 -SGRLYAGPEVDIWSSGVILYALLCGTLP------FDDDHV--PTLFKKICDGIF 233
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 30/208 (14%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQA--EVEIISRVHHKHLVSLVG 303
+G+G +G V K + VA+K+++ E V A E+ ++ + HK++V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHD 68
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ + LV EF + L+ + +D KGL + H ++
Sbjct: 69 VLHSDKKLTLVFEFCDQD-LKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCHSR---NVL 123
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASD---VYTHVSTRVMGTFGYLAPE-------Y 413
HRD+K N+L++ E K+A+FGLA+ Y+ V+ T Y P+ Y
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPPDVLFGAKLY 179
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
++S D++S G + EL RP
Sbjct: 180 STS------IDMWSAGCIFAELANAGRP 201
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 52/254 (20%), Positives = 92/254 (36%), Gaps = 41/254 (16%)
Query: 233 EELARATDGFSDA----NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEV 287
++L R + F+D +G G + + + E A+K + E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EI 66
Query: 288 EIISR-VHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEF-HLHGKG-------RPTMDWP 338
EI+ R H ++++L Y G +V E + L + + +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-LDKILRQKFFSEREASAVL--- 122
Query: 339 TRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKLASDV 394
I K + YLH ++HRD+K +NIL + ++ DFG AK
Sbjct: 123 --FTIT----KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLA 454
+ T T ++APE D++S GV+L ++ G P + + +
Sbjct: 174 NGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232
Query: 455 RPLLNRAIEDGNFD 468
I G F
Sbjct: 233 -----ARIGSGKFS 241
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 52/213 (24%), Positives = 89/213 (41%), Gaps = 22/213 (10%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLK-------AGSGQGERVFQAEVEIISRVHHK-- 296
LLG GGFG V+ G+ + + VAIK ++ G RV EV ++ +V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFS 108
Query: 297 HLVSLVGYYTAGSQRMLVCEFVTSNTLEF-HLHGKGRPTMDWPTRLKIALGFAKGLAYLH 355
++ L+ ++ +L+ E F + +G + + + + H
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLEAVRHCH 166
Query: 356 EDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
++HRDIK NIL+D + E K+ DFG L D GT Y PE+
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWI 220
Query: 415 SSGKLT-EKSDVFSFGVMLLELIIGCRPVDSTH 446
+ + V+S G++L +++ G P +
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 234 ELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV---FQA--EV 287
++ + + LG+G F V+K + VAIK++K G + A E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 288 EIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGF 347
+++ + H +++ L+ + S LV +F+ ++ LE + + L
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLV-LTPSHIKAYMLMT 121
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD---VYTHVSTRVMG 404
+GL YLH+ I+HRD+K N+LLD K+ADFGLAK YTH +V+
Sbjct: 122 LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH---QVV- 174
Query: 405 TFGYLAPE 412
T Y APE
Sbjct: 175 TRWYRAPE 182
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 30/218 (13%)
Query: 237 RATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERV-FQA--EVEIISRV 293
+ + +G+G +G V+K G+ VA+K+++ + E + A E+ ++ +
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAED-EGIPSTAIREISLLKEL 76
Query: 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
HH ++VSL+ + LV EF+ + L+ L + +G+A+
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTG-LQDSQIKIYLYQLLRGVAH 134
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD---VYTHVSTRVMGTFGYLA 410
H+ +I+HRD+K N+L++ K+ADFGLA+ YTH V+ T Y A
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYRA 187
Query: 411 PE-------YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
P+ Y++S D++S G + E+I G +P
Sbjct: 188 PDVLMGSKKYSTS------VDIWSIGCIFAEMITG-KP 218
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 8e-19
Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 30/207 (14%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERV-FQA--EVEIISRVHHKHLVSLVGY 304
+G+G +G V+K G+ A+K+++ + E + E+ I+ + H ++V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
+ +LV E + + L+ L ++ T L G+AY H+ +++H
Sbjct: 69 IHTKKRLVLVFEHLDQD-LKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCHDR---RVLH 123
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASD---VYTHVSTRVMGTFGYLAPE-------YA 414
RD+K N+L++ + E K+ADFGLA+ YTH ++ T Y AP+ Y+
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYRAPDVLMGSKKYS 179
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRP 441
++ D++S G + E++ G P
Sbjct: 180 TT------IDIWSVGCIFAEMVNG-TP 199
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 74/321 (23%), Positives = 114/321 (35%), Gaps = 43/321 (13%)
Query: 132 CTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPP 191
C L P+ + + R W V HV T R + +
Sbjct: 60 CQLMKTERPRPNTFIIRCLQWT-TVIERTFHVETPEEREEWTTAIQTVADGLK---KQAA 115
Query: 192 PPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLG---FLKSTFTYEELARATDGFSDANLL 248
F S S +S E + P +++ +LK LL
Sbjct: 116 AEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK-------------------LL 156
Query: 249 GQGGFGYV----HKGVLPNGKEVAIKQL-KAGSGQGERV--FQAEVEIISRVHHKHLVSL 301
G+G FG V K G+ A+K L K + V E ++ H L +L
Sbjct: 157 GKGTFGKVILVKEKA---TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+ + V E+ L FHL + + D R A L YLH + +
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-ARFYGA-EIVSALDYLHSEKN-- 269
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYASSGKLT 420
+++RD+K N++LD K+ DFGL K + + + GT YLAPE
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGTPEYLAPEVLEDNDYG 327
Query: 421 EKSDVFSFGVMLLELIIGCRP 441
D + GV++ E++ G P
Sbjct: 328 RAVDWWGLGVVMYEMMCGRLP 348
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 240 DGFSDANLLGQGGFGYVHKG-VLPNGKEVAIKQLKAGSGQGE-----RVFQAEVEIISRV 293
+ + + LG+G + V+KG VA+K+++ +G R EV ++ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKDL 57
Query: 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
H ++V+L LV E++ + L+ +L G ++ +GLAY
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNI-INMHNVKLFLFQLLRGLAY 115
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD---VYTHVSTRVMGTFGYLA 410
H K++HRD+K N+L++ + E K+ADFGLA+ S Y + V+ T Y
Sbjct: 116 CH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRP 168
Query: 411 PE-------YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
P+ Y++ D++ G + E+ G RP
Sbjct: 169 PDILLGSTDYSTQ------IDMWGVGCIFYEMATG-RP 199
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 39/214 (18%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE-----RVFQAEVEIISRVHHKHLVSL 301
LG G + V+KG+ G VA+K++K S +G R E+ ++ + H+++V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRL 68
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA----KGLAYLHED 357
++ LV EF+ ++ L+ ++ + L + F +GLA+ HE+
Sbjct: 69 YDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD---VYTHVSTRVMGTFGYLAPE-- 412
KI+HRD+K N+L++ + + K+ DFGLA+ ++ V+ T Y AP+
Sbjct: 128 ---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYRAPDVL 180
Query: 413 -----YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
Y++S D++S G +L E+I G +P
Sbjct: 181 MGSRTYSTS------IDIWSCGCILAEMITG-KP 207
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 237 RATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQ-GERVFQA----EVEI- 289
AT + +G G +G V+K +G VA+K ++ +G G EV +
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 290 --ISRVHHKHLVSL----VGYYTAGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRLK 342
+ H ++V L T ++ LV E V + L +L P + T
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKD 124
Query: 343 IALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD--VYTHVST 400
+ F +GL +LH + I+HRD+K NIL+ K+ADFGLA++ S T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP--- 178
Query: 401 RVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELIIG 438
V+ T Y APE YA+ D++S G + E+
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATP------VDMWSVGCIFAEMFRR 215
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 55/212 (25%), Positives = 88/212 (41%), Gaps = 24/212 (11%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLK-------AGSGQGERVFQAEVEIISRVH---- 294
LLG+GGFG V G L + +VAIK + + EV ++ +V
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGG 96
Query: 295 HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEF-HLHGKGRPTMDWPTRLKIALGFAKGLAY 353
H ++ L+ ++ MLV E F ++ KG + + +
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQH 154
Query: 354 LHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE 412
H ++HRDIK NIL+D + AK+ DFG L D GT Y PE
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPE 208
Query: 413 YASSGKLT-EKSDVFSFGVMLLELIIGCRPVD 443
+ S + + V+S G++L +++ G P +
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 33/209 (15%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQA--EVEIISRVHHKHLVSLVG 303
+G+G +G V K G+ VAIK+ + A E+ ++ ++ H +LV+L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ + LV E+ + L R + I + + + H+ H I
Sbjct: 70 VFRRKRRLHLVFEYCDHT-VLHELDRYQRG-VPEHLVKSITWQTLQAVNFCHK--H-NCI 124
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLAS---DVYTH-VSTRVMGTFGYLAPE------- 412
HRD+K NIL+ K+ DFG A+L + D Y V+TR Y +PE
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPELLVGDTQ 179
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
Y DV++ G + EL+ G P
Sbjct: 180 YGPP------VDVWAIGCVFAELLSG-VP 201
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 58/221 (26%), Positives = 95/221 (42%), Gaps = 43/221 (19%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL 301
+++ ++G G FG V + L EVAIK++ R E++I+ V H ++V L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDL 97
Query: 302 VGYYTAGSQRM------LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA------- 348
++ + + LV E+V ++ +LK +
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPET-----VY----RASRHYAKLKQTMPMLLIKLYMY 148
Query: 349 ---KGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAK--LASDVYTH-VSTR 401
+ LAY+H I HRDIK N+LLD K+ DFG AK +A + + +R
Sbjct: 149 QLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205
Query: 402 VMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
Y APE + T D++S G ++ EL+ G +P
Sbjct: 206 Y-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QP 240
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 63/214 (29%), Positives = 88/214 (41%), Gaps = 29/214 (13%)
Query: 240 DGFSDANLLGQGGFGYV----HKGVLPNGKEVAIKQLK----AGSGQGERVFQAEVEIIS 291
D F LG G FG V HK +G A+K L Q E E I+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTL-NEKRILQ 96
Query: 292 RVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFA 348
V+ LV L + S +V E+V + HL GR + R +I L
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAAQIVLT-- 153
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-YTHVSTRVMGTFG 407
YLH +I+RD+K N+L+D + +V DFG AK +T + GT
Sbjct: 154 --FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPE 203
Query: 408 YLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
LAPE S + D ++ GV++ E+ G P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQL-KAGSGQGERV-FQAEVEIISRVHHKHLVS 300
+LGQG FG V + A+K L KA +RV + E +I+ V+H +V
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 301 LVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGLAYLH 355
L +Y ++ L + +F+ L L + T + + ++AL L +LH
Sbjct: 91 L--HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED-VKFYLAELALA----LDHLH 143
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYA 414
II+RD+K NILLD + K+ DFGL+K + GT Y+APE
Sbjct: 144 SL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEVV 198
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ T+ +D +SFGV++ E++ G P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 36/223 (16%)
Query: 237 RATDGFSDANLLGQGGFGYVHKG--VLPNGKEVAIKQLKAGSGQGERV-FQAEVEI---- 289
RA + +G+G +G V K + G+ VA+K+++ +G+ E + E+
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLR 66
Query: 290 -ISRVHHKHLVSL----VGYYTAGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKI 343
+ H ++V L T ++ LV E V + L +L P + T +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDM 125
Query: 344 ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD--VYTHVSTR 401
+GL +LH +++HRD+K NIL+ + K+ADFGLA++ S T
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---V 179
Query: 402 VMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELIIG 438
V+ T Y APE YA+ D++S G + E+
Sbjct: 180 VV-TLWYRAPEVLLQSSYATP------VDLWSVGCIFAEMFRR 215
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 60/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)
Query: 237 RATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQA--EVEIISR 292
++ + + + L+G+G +G V K G+ VAIK+ + V A E++++ +
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQ 80
Query: 293 VHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLA 352
+ H++LV+L+ + LV EFV + L +D+ K G+
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHT-ILDDLELFPNG-LDYQVVQKYLFQIINGIG 138
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS---DVYTH-VSTRVMGTFGY 408
+ H H IIHRDIK NIL+ K+ DFG A+ + +VY V+TR Y
Sbjct: 139 FCHS--H-NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WY 190
Query: 409 LAPE-------YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
APE Y + DV++ G ++ E+ +G P
Sbjct: 191 RAPELLVGDVKYGKA------VDVWAIGCLVTEMFMG-EP 223
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 55/282 (19%), Positives = 105/282 (37%), Gaps = 67/282 (23%)
Query: 176 VASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEEL 235
+A H + P MS S S+
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGSMSVSAAPSA------------------------------ 30
Query: 236 ARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQA--EVEIIS 291
+ D + LG+G +G V+K + + VAIK+++ + E V A EV ++
Sbjct: 31 -TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH-EEEGVPGTAIREVSLLK 88
Query: 292 RVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGL 351
+ H++++ L + L+ E+ ++ L+ ++ P + G+
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKN--PDVSMRVIKSFLYQLINGV 145
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEA-----KVADFGLAKLASD---VYTHVSTRVM 403
+ H + +HRD+K N+LL + K+ DFGLA+ +TH ++
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII 199
Query: 404 GTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELIIG 438
T Y PE Y++S D++S + E+++
Sbjct: 200 -TLWYRPPEILLGSRHYSTS------VDIWSIACIWAEMLMK 234
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 5e-17
Identities = 68/324 (20%), Positives = 110/324 (33%), Gaps = 24/324 (7%)
Query: 132 CTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPP 191
+ K W ++ V
Sbjct: 228 FRFQLKESDKDRRLSVEIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYF 287
Query: 192 PPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDAN----- 246
P S G+ E +T + + D +
Sbjct: 288 NVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLM 347
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQL-KAGSGQGERV--FQAEVEIISRV-HHKHL 298
+LG+G FG V KG + A+K L K Q + V E +++ L
Sbjct: 348 VLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 404
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
L + + V E+V L +H+ GR A A GL +L
Sbjct: 405 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAA-EIAIGLFFLQSK- 461
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYASSG 417
II+RD+K N++LD + K+ADFG+ K +++ V+T+ GT Y+APE +
Sbjct: 462 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 418 KLTEKSDVFSFGVMLLELIIGCRP 441
+ D ++FGV+L E++ G P
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 59/231 (25%), Positives = 89/231 (38%), Gaps = 50/231 (21%)
Query: 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQA------EVEII- 290
D F + GQG FG V G G VAIK +V Q E++I+
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK----------KVIQDPRFRNRELQIMQ 71
Query: 291 --SRVHHKHLVSLVGYYTAGSQR-------MLVCEFVTSNTLEFHLHGKGRPTMDWPTRL 341
+ +HH ++V L Y+ +R +V E+V LH R
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-----LHRCCRNYYRRQVAP 126
Query: 342 KIALG------FAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLAS-- 392
L + + LH + HRDIK N+L++ K+ DFG AK S
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185
Query: 393 DVYTH-VSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ + +R Y APE + T D++S G + E+++G P
Sbjct: 186 EPNVAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EP 230
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 8e-17
Identities = 63/247 (25%), Positives = 97/247 (39%), Gaps = 37/247 (14%)
Query: 277 GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMD 336
G R + V I + L S+ ++ S + + ++ E + +
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLT 191
Query: 337 WPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396
+ + AKG+ +L K IHRD+ A NILL K K+ DFGLA+ D+Y
Sbjct: 192 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR---DIYK 245
Query: 397 HVSTRVMGTFGYL-----APEYASSGKLTEKSDVFSFGVMLLELI-IGCRP---VDSTHT 447
V L APE T +SDV+SFGV+L E+ +G P V
Sbjct: 246 D-PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304
Query: 448 FMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMAR-MVACAAACVRHSARRRPRIS 506
F R +++G + P +Y EM + M+ C +RP S
Sbjct: 305 FC----------RRLKEGT--RMRAP----DYTTPEMYQTMLDCWH----GEPSQRPTFS 344
Query: 507 QIVRTLE 513
++V L
Sbjct: 345 ELVEHLG 351
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 57/271 (21%), Positives = 93/271 (34%), Gaps = 67/271 (24%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEI-------------ISR 292
LG G F V + N VA+K ++ E AE EI
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDS 82
Query: 293 VHHKHLVSLVGY-YTAGSQRM---LVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALG 346
+ H++ L+ + G + +V E + N L + R P +I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG---IPLIYVKQISKQ 139
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLD------FKFEAKVADFGLAKLASD-VYTHVS 399
GL Y+H C IIH DIK N+L++ + K+AD G A + +
Sbjct: 140 LLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459
TR Y +PE +D++S ++ ELI G L
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITG----------------DFL-- 234
Query: 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVAC 490
F+ + +H +A+++
Sbjct: 235 -------FEPDEGHSYTKDDDH--IAQIIEL 256
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 68/277 (24%), Positives = 114/277 (41%), Gaps = 54/277 (19%)
Query: 197 MSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDG----------FSDAN 246
MS ++S + P + G + AT G ++D
Sbjct: 1 MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK 60
Query: 247 LLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
++G G FG V++ L +G+ VAIK++ Q +R E++I+ ++ H ++V L ++
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 306 TAGSQRM------LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA----------K 349
+ ++ LV ++V ++ +R K L +
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPET-----VY----RVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 350 GLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKLAS--DVYTH-VSTRVMGT 405
LAY+H I HRDIK N+LLD K+ DFG AK + + +R
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY--- 221
Query: 406 FGYLAPEY-ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
Y APE + T DV+S G +L EL++G +P
Sbjct: 222 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QP 255
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 55/207 (26%), Positives = 83/207 (40%), Gaps = 26/207 (12%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHHKHL 298
LLG+G FG V K G+ A+K L+ + E ++ H L
Sbjct: 12 LLGKGTFGKVILVREKA---TGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFL 67
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGLAYLH 355
+L + + V E+ L FHL + T + R +I L YLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-ARFYGAEIVSA----LEYLH 122
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYA 414
+++RDIK N++LD K+ DFGL K + + + GT YLAPE
Sbjct: 123 SR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVL 177
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRP 441
D + GV++ E++ G P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 58/212 (27%), Positives = 93/212 (43%), Gaps = 32/212 (15%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLK-----AGSGQGERVFQAEVEIISRVHHKH 297
+LG+GG+G V GK A+K LK + +AE I+ V H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPF 82
Query: 298 LVSLVGYY---TAGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKG 350
+V L Y T G ++ L+ E+++ L L +G D +I++
Sbjct: 83 IVDL--IYAFQTGG--KLYLILEYLSGGELFMQLEREGIFMEDT-ACFYLAEISMA---- 133
Query: 351 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYL 409
L +LH+ II+RD+K NI+L+ + K+ DFGL K ++ T GT Y+
Sbjct: 134 LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGTIEYM 188
Query: 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
APE D +S G ++ +++ G P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 53/213 (24%), Positives = 84/213 (39%), Gaps = 29/213 (13%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQL-KAGSGQGERV--FQAEVEIISRVHHKHLV 299
++G+G F V K G+ A+K + K + V F+ E +++ + +
Sbjct: 68 VIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 300 SLVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA-LGFAKGLAYLHE 356
L ++ + L V E+ L L G R +A + A + +H
Sbjct: 125 QL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA--IDSVHR 180
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPE--- 412
+HRDIK NILLD ++ADFG L +D V GT YL+PE
Sbjct: 181 L---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQ 236
Query: 413 ----YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+G + D ++ GV E+ G P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 23/209 (11%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQL-KAGSGQGERV--FQAEVEIISRVHHKHLV 299
++G+G FG V K K A+K L K + F+ E +++ K +
Sbjct: 81 VIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLH-GKGRPTMDWPTRLKIA-LGFAKGLAYLHED 357
+L + + LV ++ L L + R + R +A + A + +H+
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLAEMVIA--IDSVHQL 194
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE----- 412
+HRDIK NIL+D ++ADFG + T S+ +GT Y++PE
Sbjct: 195 ---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 251
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
G+ + D +S GV + E++ G P
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.7 bits (195), Expect = 4e-16
Identities = 62/209 (29%), Positives = 90/209 (43%), Gaps = 33/209 (15%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHHKHL 298
LG G FG V + NG+ A+K LK Q E E ++S V H +
Sbjct: 13 TLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTN-DERLMLSIVTHPFI 68
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK-----IALGFAKGLAY 353
+ + G + Q ++ +++ L L R K + L L Y
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEVCLA----LEY 121
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPE 412
LH II+RD+K NILLD K+ DFG AK DV T + GT Y+APE
Sbjct: 122 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPE 173
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
S+ + D +SFG+++ E++ G P
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 237 RATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQA--EVEIISR 292
+ +GQG FG V K G++VA+K++ + + E A E++I+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQL 72
Query: 293 VHHKHLVSLVG--------YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA 344
+ H+++V+L+ Y LV +F + L L ++
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVK-FTLSEIKRVM 130
Query: 345 LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-------KLASDVYTH 397
GL Y+H + KI+HRD+KAAN+L+ K+ADFGLA + YT+
Sbjct: 131 QMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 398 VSTRVMGTFGYLAPE-------YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
RV+ T Y PE Y D++ G ++ E+ P
Sbjct: 188 ---RVV-TLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTR-SP 227
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 7e-16
Identities = 61/225 (27%), Positives = 88/225 (39%), Gaps = 36/225 (16%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLK----AGSGQGERVFQAEVEIISRVHHKHL 298
++G+G FG V HK K A+K L F E +I++ + +
Sbjct: 76 VIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWV 131
Query: 299 VSLVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA-LGFAKGLAYLH 355
V L +Y R L V E++ L +L W R A + A L +H
Sbjct: 132 VQL--FYAFQDDRYLYMVMEYMPGGDL-VNLMSNYDVPEKW-ARFYTAEVVLA--LDAIH 185
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPE-- 412
IHRD+K N+LLD K+ADFG + V GT Y++PE
Sbjct: 186 SM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM-KMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 413 --YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR 455
G + D +S GV L E+++G P F D+L
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP------FYADSLVG 280
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 43/183 (23%), Positives = 83/183 (45%), Gaps = 24/183 (13%)
Query: 248 LGQGGFGYVHKGV---LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
+G+G +G+V+K + K+ A+KQ++ E+ ++ + H +++SL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC--REIALLRELKHPNVISLQKV 86
Query: 305 YTAGSQR--MLVCEFVTS---NTLEFHLHGKGRPT---MDWPTRLKIALGFAKGLAYLHE 356
+ + + R L+ ++ + ++FH K + + G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 357 DCHPKIIHRDIKAANILLDFKFEA----KVADFGLAKLASD---VYTHVSTRVMGTFGYL 409
+ ++HRD+K ANIL+ + K+AD G A+L + + V+ TF Y
Sbjct: 147 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 202
Query: 410 APE 412
APE
Sbjct: 203 APE 205
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 69/301 (22%), Positives = 117/301 (38%), Gaps = 42/301 (13%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRVHHK------ 296
++G+G FG V K + VA+K ++ +R + E+ I+ + +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 297 HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAKGLAYL 354
+++ ++ +T + + E ++ N E K + + L K A + L L
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG---FSLPLVRKFAHSILQCLDAL 216
Query: 355 HEDCHPKIIHRDIKAANILL--DFKFEAKVADFGLAKLASD-VYTHVSTRVMGTFGYLAP 411
H+ +IIH D+K NILL + KV DFG + VYT++ +R F Y AP
Sbjct: 217 HK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR----F-YRAP 268
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHT------FMEDNLARP---LLNRAI 462
E + D++S G +L EL+ G P+ M + L P LL+ +
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGDQLACMIELLGMPSQKLLDASK 327
Query: 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG--DASLAD 520
NF + + +V R R P + L+G D D
Sbjct: 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD 387
Query: 521 L 521
Sbjct: 388 F 388
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 32/214 (14%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLK-----AGSGQGERVFQAEVEIISRV-HHK 296
+LG G +G V GK A+K LK + E + E +++ +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEHIRQSP 119
Query: 297 HLVSLVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGL 351
LV+L +Y ++ L + +++ L HL + R T ++ +I L L
Sbjct: 120 FLVTL--HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-VQIYVGEIVLA----L 172
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAP 411
+LH+ II+RDIK NILLD + DFGL+K T + GT Y+AP
Sbjct: 173 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 412 E---YASSGKLTEKS-DVFSFGVMLLELIIGCRP 441
+ SG +K+ D +S GV++ EL+ G P
Sbjct: 230 DIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 50/224 (22%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVE 288
+ +G G +G V + +G++VAIK+L R FQ+ E+
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-------SRPFQSEIFAKRAYRELL 75
Query: 289 IISRVHHKHLVSLVGYYTAGSQRM------LVCEFVTSNTLEFHLHG--KGRPTMDWPTR 340
++ + H++++ L+ +T S LV F+ ++ L + + + +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD-----LQKIMGLKFSEE---K 127
Query: 341 LKIALGFA----KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396
++ KGL Y+H ++HRD+K N+ ++ E K+ DFGLA+ A T
Sbjct: 128 IQY---LVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 181
Query: 397 H-VSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELIIG 438
V TR Y APE S + D++S G ++ E++ G
Sbjct: 182 GYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 25/207 (12%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQL-KAGSGQGERVF--QAEVEIISRV-HHKHL 298
+LG+G FG V KG + A+K L K Q + V E +++ L
Sbjct: 27 VLGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL 83
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGLAYLH 355
L + + V E+V L +H+ GR +IA+G L +L
Sbjct: 84 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH-AVFYAAEIAIG----LFFLQ 138
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYA 414
II+RD+K N++LD + K+ADFG+ K +++ V+T+ GT Y+APE
Sbjct: 139 SK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEII 193
Query: 415 SSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ + D ++FGV+L E++ G P
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 33/287 (11%), Positives = 79/287 (27%), Gaps = 55/287 (19%)
Query: 247 LLGQGGFGYVHKG---VLPNGKEVAIKQLKAGSGQGERV---FQAEVEIISRVHHKHLVS 300
G + L ++VA+ + + V + +SR+ +
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
++ + ++V E++ +L+ P ++ A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA--- 148
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
+ + + V+ G LA +
Sbjct: 149 GVALSIDHPSRVR--------VSIDGDVVLA-------------YPATMPDA-------N 180
Query: 421 EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480
+ D+ G L L++ P E + L E ++P +
Sbjct: 181 PQDDIRGIGASLYALLVNRWP------LPEAGVRSGL--APAERDTAGQPIEPADIDRDI 232
Query: 481 HNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLADLNEGIRP 527
+++ + A + R S ++ ++ ++AD E + P
Sbjct: 233 PFQISAVAARSVQ--GDGGIRSA--STLLNLMQQATAVADRTEVLGP 275
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-15
Identities = 64/303 (21%), Positives = 113/303 (37%), Gaps = 39/303 (12%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRV------HH 295
+L+G+G FG V K + VAIK +K + EV ++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAKGLAY 353
++V L ++ + LV E ++ N + + R L K A L +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG---VSLNLTRKFAQQMCTALLF 172
Query: 354 LHEDCHPKIIHRDIKAANILL--DFKFEAKVADFGLAKLASD-VYTHVSTRVMGTFGYLA 410
L IIH D+K NILL + K+ DFG + +Y ++ +R F Y +
Sbjct: 173 LATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR----F-YRS 226
Query: 411 PEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHT------FMEDNLARP---LLNRA 461
PE D++S G +L+E+ G P+ S + + L P +L++A
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGANEVDQMNKIVEVLGIPPAHILDQA 285
Query: 462 IEDGN-FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLAD 520
+ F+ L D + + + + + R E ++AD
Sbjct: 286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVAD 345
Query: 521 LNE 523
+
Sbjct: 346 YLK 348
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 9e-15
Identities = 60/215 (27%), Positives = 85/215 (39%), Gaps = 41/215 (19%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLK---------AGSGQGER-VFQAEVEIISR 292
+LG+G FG V K + AIK LK E+ V
Sbjct: 24 MLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW----- 75
Query: 293 VHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLK-----IALGF 347
H L + + V E++ L +H+ + + R I LG
Sbjct: 76 -EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILG- 130
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTF 406
L +LH I++RD+K NILLD K+ADFG+ K ++ T GT
Sbjct: 131 ---LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNTFCGTP 182
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
Y+APE K D +SFGV+L E++IG P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 48/227 (21%), Positives = 83/227 (36%), Gaps = 39/227 (17%)
Query: 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQL--KAGSGQGERVFQA---------EV 287
++ + G +G V GV G VAIK++ G+ + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 288 EIISRVHHKHLVSLVGYYTAGSQRM-----LVCEFVTSNTLEFHLHGKGRPTMDWPTRLK 342
+++ HH +++ L + + LV E + L +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVISPQH 135
Query: 343 IALGFA----KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-- 396
I F GL LHE ++HRD+ NILL + + DF LA+ +
Sbjct: 136 IQY-FMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKT 191
Query: 397 -HVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+V+ R Y APE T+ D++S G ++ E+ +
Sbjct: 192 HYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KA 232
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 27/208 (12%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISRV-HHKH 297
++G+G + V K + A+K +K + V Q E + + +H
Sbjct: 16 VIGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWV-QTEKHVFEQASNHPF 71
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGLAYL 354
LV L + S+ V E+V L FH+ + + + R +I+L L YL
Sbjct: 72 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISLA----LNYL 126
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEY 413
HE II+RD+K N+LLD + K+ D+G+ K + +T GT Y+APE
Sbjct: 127 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEI 181
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
D ++ GV++ E++ G P
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 62/264 (23%), Positives = 106/264 (40%), Gaps = 32/264 (12%)
Query: 196 FMSSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFS--DANLL---GQ 250
+ + +E ++G + K E +A+ D +LL G+
Sbjct: 3 YYHHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGR 62
Query: 251 GGFGYV----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISRV-HHKHLVSL 301
G + V K + A++ +K + V Q E + + +H LV L
Sbjct: 63 GSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWV-QTEKHVFEQASNHPFLVGL 118
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGLAYLHEDC 358
+ S+ V E+V L FH+ + + + R +I+L L YLHE
Sbjct: 119 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAEISLA----LNYLHER- 172
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEYASSG 417
II+RD+K N+LLD + K+ D+G+ K + +T GT Y+APE
Sbjct: 173 --GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 418 KLTEKSDVFSFGVMLLELIIGCRP 441
D ++ GV++ E++ G P
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 65/271 (23%), Positives = 105/271 (38%), Gaps = 53/271 (19%)
Query: 189 SPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLSLG---FLKSTFTYEELARATDGFSDA 245
S P P M+++ S P + FLK
Sbjct: 3 SQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLK------------------ 44
Query: 246 NLLGQGGFGYV----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISR-VHHK 296
++G+G FG V HK A+K L+ + + + + +E ++ + V H
Sbjct: 45 -VIGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHI-MSERNVLLKNVKHP 99
Query: 297 HLVSLVGYYTAGSQRML--VCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGL 351
LV L +++ + L V +++ L +HL + R +IA L
Sbjct: 100 FLVGL--HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIASA----L 152
Query: 352 AYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLA 410
YLH I++RD+K NILLD + + DFGL K ++ + +T GT YLA
Sbjct: 153 GYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTTSTFCGTPEYLA 207
Query: 411 PEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
PE D + G +L E++ G P
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 45/219 (20%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVEIIS 291
+ D +G G +G V V G +VAIK+L R FQ+ E+ ++
Sbjct: 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-------YRPFQSELFAKRAYRELRLLK 79
Query: 292 RVHHKHLVSLVGYYTAGSQRM------LVCEFVTSNTLEFHLHG--KGRPTMDWPTRLKI 343
+ H++++ L+ +T LV F+ ++ L K + + +
Sbjct: 80 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTD-----LGKLMKHEKLGEDRIQFLV 134
Query: 344 --ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-HVST 400
L KGL Y+H IIHRD+K N+ ++ E K+ DFGLA+ A T +V T
Sbjct: 135 YQML---KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT 188
Query: 401 RVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELIIG 438
R Y APE + + T+ D++S G ++ E+I G
Sbjct: 189 RW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 41/217 (18%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVEIIS 291
+ + +G G G V + VAIK+L R FQ E+ ++
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-------SRPFQNQTHAKRAYRELVLMK 79
Query: 292 RVHHKHLVSLVGYYTAGSQRM------LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL 345
V+HK+++ L+ +T +V E + +N L + +D R+ L
Sbjct: 80 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELD-HERMSYLL 133
Query: 346 -GFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT---HVSTR 401
G+ +LH IIHRD+K +NI++ K+ DFGLA+ A + +V TR
Sbjct: 134 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
Query: 402 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIG 438
Y APE E D++S G ++ E+I G
Sbjct: 191 Y-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 55/266 (20%), Positives = 89/266 (33%), Gaps = 79/266 (29%)
Query: 224 GFLKSTFTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV 282
G S+ Y LG G FG V + + +GK A+K +V
Sbjct: 1 GLETSSKKYSLG----------KTLGTGSFGIVCEVFDIESGKRFALK----------KV 40
Query: 283 FQA------EVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMD 336
Q E++I+ + H +++ LV Y+ + + G
Sbjct: 41 LQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHH 100
Query: 337 W-------------------PTRL-KIALGFAK-------------------GLAYLHED 357
P L K+ F + + ++H
Sbjct: 101 KSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-- 158
Query: 358 CHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLAS--DVYTH-VSTRVMGTFGYLAPE- 412
I HRDIK N+L++ K K+ DFG AK + + +R Y APE
Sbjct: 159 -SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL 212
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIG 438
+ + T D++S G + ELI+G
Sbjct: 213 MLGATEYTPSIDLWSIGCVFGELILG 238
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 62/208 (29%), Positives = 87/208 (41%), Gaps = 27/208 (12%)
Query: 247 LLGQGGFGYV----HKGVLPNGKEVAIKQLKAGS----GQGERVFQAEVEIISRV-HHKH 297
+LG+G FG V K G A+K LK E E I+S +H
Sbjct: 30 VLGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQDDDVECT-MTEKRILSLARNHPF 85
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL---KIALGFAKGLAYL 354
L L + + V EFV L FH+ R R +I L +L
Sbjct: 86 LTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR-ARFYAAEIISA----LMFL 140
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVM-GTFGYLAPEY 413
H+ II+RD+K N+LLD + K+ADFG+ K + V+T GT Y+APE
Sbjct: 141 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDYIAPEI 195
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
D ++ GV+L E++ G P
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 39/219 (17%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVE 288
+ + +G G G V + VAIK+L R FQ E+
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELV 113
Query: 289 IISRVHHKHLVSLVGYYTAGSQRM------LVCEFVTSNTLEFHLHGKGRPTMDWPTRLK 342
++ V+HK+++SL+ +T LV E + +N L + +D
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSY 168
Query: 343 IALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT---HVS 399
+ G+ +LH IIHRD+K +NI++ K+ DFGLA+ A + +V
Sbjct: 169 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 225
Query: 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIG 438
TR Y APE E D++S G ++ E++
Sbjct: 226 TRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 49/229 (21%), Positives = 92/229 (40%), Gaps = 44/229 (19%)
Query: 247 LLGQGGFGYVHKGVLPNGK------EVAIKQLKAGSGQ---GERVFQ--AEVEIISRVHH 295
+GQGGFG ++ + + + +K + +G + +Q A+ E I +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 296 KHLVSLVG---YYTAGSQ-------RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIAL 345
+ +G Y+ +G R ++ + S+ L+ + T L+++L
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD-LQKIYEANAK-RFSRKTVLQLSL 159
Query: 346 GFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV--ADFGLAKLASDVYTHV----- 398
L Y+HE +H DIKA+N+LL++K +V D+GLA H
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 399 -STRVMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELIIGCRP 441
GT E+ S +G + + D+ G +++ + G P
Sbjct: 217 PKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 45/222 (20%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVE 288
+ + + + +G G +G V G VA+K+L R FQ+ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 289 IISRVHHKHLVSLVGYYTAGSQRM------LVCEFVTSNTLEFHLHG--KGRPTMDWPTR 340
++ + H++++ L+ +T LV + ++ L+ K + D +
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-----LNNIVKCQKLTDDHVQ 135
Query: 341 LKI--ALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-H 397
I L +GL Y+H IIHRD+K +N+ ++ E K+ DFGLA+ +D T +
Sbjct: 136 FLIYQIL---RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 398 VSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELIIG 438
V+TR Y APE + + D++S G ++ EL+ G
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 43/227 (18%), Positives = 86/227 (37%), Gaps = 42/227 (18%)
Query: 248 LGQGGFGYVHKGV---------LPNGKEVAIK-QLKAGSGQGERVF------QAEVEIIS 291
+ G +++ P ++ ++K K G E+ F +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 292 RVHHKHLVSLVGYYTAGSQ----RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGF 347
+++ L+++ G R LV + + L+ L + + + L++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS-LQSALDVSPKHVLSERSVLQVACRL 168
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV--ADFGLAKLASDVYTHVSTR---- 401
L +LHE+ +H ++ A NI +D + +++V A +G A HV+
Sbjct: 169 LDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR 225
Query: 402 --VMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELIIGCRP 441
G E+ S G + +SD+ S G +L+ + G P
Sbjct: 226 SPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 53/219 (24%), Positives = 101/219 (46%), Gaps = 41/219 (18%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE--RVFQAEVEIISRVHHKHL 298
+++ + +G+G +G V N VAIK++ Q R + E++I+ R H+++
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENI 87
Query: 299 VSLVGYYTAGSQRM-----LVCEFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFA--- 348
+ + A + +V + + ++ L+ K + + F
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMETD-----LYKLLKTQHLSNDHICY-----FLYQI 137
Query: 349 -KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH-------VST 400
+GL Y+H ++HRD+K +N+LL+ + K+ DFGLA++A + H V+T
Sbjct: 138 LRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 194
Query: 401 RVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELIIG 438
R Y APE +S T+ D++S G +L E++
Sbjct: 195 R-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 56/266 (21%), Positives = 94/266 (35%), Gaps = 61/266 (22%)
Query: 217 PSLGLSLGFLKSTFT--YEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLK 273
P + L K+ Y+ ++ +LG G G V + ++ A+K L+
Sbjct: 2 PHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGINGKVLQIFNKRTQEKFALKMLQ 52
Query: 274 AGSGQGERVFQAEVEIISRV-HHKHLVSLVGYY-TAGSQRM---LVCEFVTSNTLEFH-L 327
+ EVE+ R H+V +V Y + R +V E + L F +
Sbjct: 53 D-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL-FSRI 106
Query: 328 HGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA---KVAD 384
+G +I + + YLH I HRD+K N+L K K+ D
Sbjct: 107 QDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163
Query: 385 FGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDS 444
FG AK + Y + D++S GV++ L+ G P
Sbjct: 164 FGFAK-------ETTGE-----KY-----------DKSCDMWSLGVIMYILLCGYPP--- 197
Query: 445 THTFMEDNLAR--PLLNRAIEDGNFD 468
F ++ P + I G ++
Sbjct: 198 ---FYSNHGLAISPGMKTRIRMGQYE 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHK 296
D + LG+G + V + + + N ++V +K LK + +++ + E++I+ +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKR-EIKILENLRGGP 91
Query: 297 HLVSL--VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354
++++L + LV E V N +F + D + L K L Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHV--NNTDFKQLYQTLTDYDIRFYMYEIL---KALDY- 145
Query: 355 HEDCHPK-IIHRDIKAANILLDFKF-EAKVADFGLAKLAS--DVYTH-VSTRVMGTFGYL 409
CH I+HRD+K N+++D + + ++ D+GLA+ Y V++R +
Sbjct: 146 ---CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FK 197
Query: 410 APEYASSGKLTEKS-DVFSFGVMLLELIIGCRP 441
PE ++ + S D++S G ML +I P
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 52/234 (22%), Positives = 92/234 (39%), Gaps = 57/234 (24%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVEIIS 291
+ D LG GG G V V K VAIK++ V E++II
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---------VLTDPQSVKHALREIKIIR 63
Query: 292 RVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFH---------LHG--KGRPTMDWPTR 340
R+ H ++V + ++ + + L + P ++ R
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR 123
Query: 341 LKIALGFA----KGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKLASDVY 395
L F +GL Y+H ++HRD+K AN+ ++ + K+ DFGLA++ Y
Sbjct: 124 L-----FMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
Query: 396 TH-------VSTRVMGTFGYLAPE-YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+H + T+ Y +P S T+ D+++ G + E++ G +
Sbjct: 176 SHKGHLSEGLVTK-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KT 223
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 54/229 (23%), Positives = 92/229 (40%), Gaps = 47/229 (20%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLK---AGSGQGE---RVFQ--AEVEIISRVHHKH 297
+G GGFG ++ ++ A +K +G + +Q A+ + I + +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 298 LVSLVG---YYTAGSQ-------RMLVCEFVTSNTLE--FHLHGKGRPTMDWPTRLKIAL 345
+ +G +Y +G R +V E + + L+ +G T L++ +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID-LQKISGQNGT----FKKSTVLQLGI 158
Query: 346 GFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV--ADFGLAKLASDVYTHV----- 398
L Y+HE+ +H DIKAAN+LL +K +V AD+GL+ H
Sbjct: 159 RMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 399 -STRVMGTFGYLAPEYAS----SGK-LTEKSDVFSFGVMLLELIIGCRP 441
GT E+ S G L+ +SDV G +L + G P
Sbjct: 216 PRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 63/239 (26%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVE 288
+ F +LLG+G +G V P G+ VAIK++ F E++
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDKPLFALRTLREIK 61
Query: 289 IISRVHHKHLVSLVGYYTAGSQRM-----LVCEFVTSNTLEFHLHG--KGRPTMDWPTRL 341
I+ H++++++ S ++ E + ++ LH + D +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD-----LHRVISTQMLSDDHIQY 116
Query: 342 KIALGFA----KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT- 396
F + + LH +IHRD+K +N+L++ + KV DFGLA++ +
Sbjct: 117 -----FIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 397 -------------HVSTRVMGTFGYLAPEY-ASSGKLTEKSDVFSFGVMLLELIIGCRP 441
V+TR Y APE +S K + DV+S G +L EL + RP
Sbjct: 169 NSEPTGQQSGMVEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RP 221
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 49/212 (23%), Positives = 82/212 (38%), Gaps = 30/212 (14%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH-KHLVSLVGYY 305
+G+G FG + +G L N ++VAIK S + E + + ++ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
G +LV + + + LE L GR T A + +HE +++R
Sbjct: 76 QEGLHNVLVIDLLGPS-LEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEKS---LVYR 130
Query: 366 DIKAANILLDFKFEAK-----VADFGLAKLASDVYT--HVSTR----VMGTFGYLAPEYA 414
DIK N L+ V DFG+ K D T H+ R + GT Y
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT-----ARYM 185
Query: 415 S----SGK-LTEKSDVFSFGVMLLELIIGCRP 441
S G+ + + D+ + G + + + G P
Sbjct: 186 SINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 49/212 (23%), Positives = 79/212 (37%), Gaps = 55/212 (25%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVE 288
D + +L+G+G +GYV+ K VAIK++ R+F+ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-------NRMFEDLIDCKRILREIT 77
Query: 289 IISRVHHKHLVSLVGYYTAGSQRM-----LVCEFVTSNTLEFHLHGKGRPTMDWPTRL-- 341
I++R+ +++ L +V E S+ L +L
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSD-----LK-----------KLFK 121
Query: 342 -KIALGFA----------KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA-K 389
I L G ++HE IIHRD+K AN LL+ KV DFGLA
Sbjct: 122 TPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178
Query: 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
+ S+ T++ + +LT
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 62/286 (21%), Positives = 100/286 (34%), Gaps = 99/286 (34%)
Query: 247 LLGQGGFGYV-----HKGVLPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRVHHK-- 296
LG+G FG V HK G+ VA+K +K +R +A E++++ ++
Sbjct: 21 TLGEGAFGKVVECIDHKA---GGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDP 73
Query: 297 ----HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAKG 350
V ++ ++ +V E + +T +F P + K+A K
Sbjct: 74 NSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLP---FRLDHIRKMAYQICKS 130
Query: 351 LAYLHEDCHPKIIHRDIKAANILLD-------------------FKFEAKVADFGLAKLA 391
+ +LH K+ H D+K NIL + KV DFG A
Sbjct: 131 VNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 392 SD-VYTHVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELIIGCRPVDS 444
+ T VSTR Y APE + ++ DV+S G +L+E +G
Sbjct: 188 DEHHSTLVSTRH-----YRAPEVILALGW------SQPCDVWSIGCILIEYYLG------ 230
Query: 445 THTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVAC 490
+ F T H+ H +A M
Sbjct: 231 ----------FTV---------FPT------HDSKEH--LAMMERI 249
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 52/212 (24%), Positives = 80/212 (37%), Gaps = 30/212 (14%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH-KHLVSLVGYY 305
+G G FG + G L + VAIK S E ++ + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYFG 74
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
G +V E + + LE R T T L IA+ + Y+H +I+R
Sbjct: 75 PCGKYNAMVLELLGPS-LEDLFDLCDR-TFSLKTVLMIAIQLISRMEYVHSKN---LIYR 129
Query: 366 DIKAANILL---DFKFEAKV--ADFGLAKLASDVYT--HVSTR----VMGTFGYLAPEYA 414
D+K N L+ K + + DF LAK D T H+ R + GT Y
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT-----ARYM 184
Query: 415 S----SGK-LTEKSDVFSFGVMLLELIIGCRP 441
S GK + + D+ + G M + + G P
Sbjct: 185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 59/280 (21%), Positives = 97/280 (34%), Gaps = 70/280 (25%)
Query: 247 LLGQGGFGYVHKGV--LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRVHHK----- 296
LG+G FG V + + +VA+K ++ + +A E+ ++ ++ K
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENK 81
Query: 297 -HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAKGLAY 353
V + ++ + E + NT EF +P +P +A L +
Sbjct: 82 FLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQP---YPLPHVRHMAYQLCHALRF 138
Query: 354 LHEDCHPKIIHRDIKAANILL-------------------DFKFEAKVADFGLAKLASD- 393
LHE ++ H D+K NIL +VADFG A +
Sbjct: 139 LHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH 195
Query: 394 VYTHVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHT 447
T V+TR Y PE + + DV+S G +L E G + TH
Sbjct: 196 HTTIVATRH-----YRPPEVILELGW------AQPCDVWSIGCILFEYYRG-FTLFQTHE 243
Query: 448 ------FMEDNLARP---LLNRAIEDGNFDTLVDPKLHNE 478
ME L +++R + F N
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS 283
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 56/287 (19%), Positives = 92/287 (32%), Gaps = 97/287 (33%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---EVEIISRV-----HHKH 297
+G G FG V + N K A+K ++ ++ ++ E +I+ ++ ++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNN 97
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRL--KIALGFAKGLAYLH 355
+V G + L+ E + + E + + K L YL
Sbjct: 98 IVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNG---FHIEDIKLYCIEILKALNYLR 154
Query: 356 EDCHPKIIHRDIKAANILL-------------------------DFKFEAKVADFGLAKL 390
+ + H D+K NILL K+ DFG A
Sbjct: 155 KM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF 211
Query: 391 ASD-VYTHVSTRVMGTFGYLAPE------YASSGKLTEKSDVFSFGVMLLELIIGCRPVD 443
SD + ++TR Y APE + SD++SFG +L EL G
Sbjct: 212 KSDYHGSIINTR----Q-YRAPEVILNLGW------DVSSDMWSFGCVLAELYTG----- 255
Query: 444 STHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVAC 490
L F T H H +A M +
Sbjct: 256 -----------SLL---------FRT------HEHMEH--LAMMESI 274
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 1e-10
Identities = 35/204 (17%), Positives = 52/204 (25%), Gaps = 48/204 (23%)
Query: 238 ATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQL------KAGSGQGERVFQAEVEIIS 291
T+ +G+G FG V + + + VAIK + + + EII
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 292 RVHHKHLVSLVGYYTAGSQRMLVCEFVTSNT----------------------------- 322
L V T G + V +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 323 ----LEFHLHGK-----GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANIL 373
LEF G T I LA HRD+ N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVL 194
Query: 374 LDFKFEAKVADFGLAKLASDVYTH 397
L K+ K +S + +
Sbjct: 195 LKKTSLKKLHYTLNGK-SSTIPSC 217
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 20/206 (9%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH-KHLVSLVGYY 305
+G G FG ++ G + G+EVAIK + E +I + + ++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
G ++V E + + LE + R T L +A + Y+H IHR
Sbjct: 75 AEGDYNVMVMELLGPS-LEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN---FIHR 129
Query: 366 DIKAANILLDFKFEAK---VADFGLAKLASDVYT--HVSTR----VMGTFGYLAPEYASS 416
D+K N L+ + + DFGLAK D T H+ R + GT Y A
Sbjct: 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASINTHL 188
Query: 417 GK-LTEKSDVFSFGVMLLELIIGCRP 441
G + + D+ S G +L+ +G P
Sbjct: 189 GIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 48/215 (22%), Positives = 78/215 (36%), Gaps = 46/215 (21%)
Query: 198 SSSGGSSSNYSGSEAPIPPPSLGLSLGFLKSTFTYEELARATDGFSDANLLGQGGFGYVH 257
+ G+ SGS+ S S + D + +L+G G +G+V
Sbjct: 11 QHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVC 70
Query: 258 KGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVEIISRVHHKHLVSLVGYYTA 307
+ + VAIK++ RVF+ E+ I++R++H H+V ++
Sbjct: 71 EAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123
Query: 308 GSQRM-----LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA---------LGFAKGLAY 353
+V E + P L L G+ Y
Sbjct: 124 KDVEKFDELYVVLEI-----ADSDFKK----LFRTPVYLTELHIKTLLYNLL---VGVKY 171
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388
+H I+HRD+K AN L++ KV DFGLA
Sbjct: 172 VHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 46/205 (22%), Positives = 84/205 (40%), Gaps = 51/205 (24%)
Query: 242 FSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQA---------EVEIIS 291
+ LG+G +G V K + G+ VA+K++ FQ E+ I++
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILT 63
Query: 292 RVH-HKHLVSLVGYYTAGSQR--MLVCEF--------VTSNTLEFHLHGKGRPTMDWPTR 340
+ H+++V+L+ A + R LV ++ + +N LE +H +
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE-PVHKQY--------- 113
Query: 341 LKIALGFA----KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396
K + YLH ++HRD+K +NILL+ + KVADFGL++ ++
Sbjct: 114 ------VVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 397 HVSTRVMGTFGYLAPEYASSGKLTE 421
+ + LT+
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTD 189
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 39/225 (17%), Positives = 58/225 (25%), Gaps = 43/225 (19%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
+ L +P + + + + + PTS
Sbjct: 1478 GLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGV 1537
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRK 120
S+P S P+S SP SP T
Sbjct: 1538 SSPGFS--PTSP--TYSPTSPAYSPTSPSYSPTS-------------------------- 1567
Query: 121 RRRRRDDEAGYCTLPP---PLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVA 177
Y P P +P P + P++ P +P P
Sbjct: 1568 --------PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY 1619
Query: 178 SRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLS 222
S P SP Y+P+ P P S +S +YS + P S S
Sbjct: 1620 S--PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYS 1662
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 42/222 (18%), Positives = 63/222 (28%), Gaps = 33/222 (14%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
+ + + +S ++P SP +S T PTS A P
Sbjct: 1502 DAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSP---TSPTYSPTSPAYSP 1558
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRK 120
++PS SP S + SP PT + + +
Sbjct: 1559 TSPS-YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS--------------- 1602
Query: 121 RRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRP 180
Y P +P Y + P P P+ S
Sbjct: 1603 --------PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSY------SPTSPSYSPTSPSYS 1648
Query: 181 PHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLS 222
P SP Y+P+ P P S +S +YS + P S S
Sbjct: 1649 PTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1690
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 48/222 (21%), Positives = 68/222 (30%), Gaps = 50/222 (22%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSS-SLTPPPTTPALSPPSLSSLTPPPTSGAPP 59
P +P S +S + P +P+ P S S S T P +P S +S + PTS +
Sbjct: 1547 PTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1606
Query: 60 PSTPSDS-------------SPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAV 106
P++PS S SP S + SP PT
Sbjct: 1607 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT---------------- 1650
Query: 107 IVVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQ 166
Y P +P Y + P S ++ T
Sbjct: 1651 --------------SPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSY---SPTSPSYSPT- 1692
Query: 167 PPRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYS 208
P +P P S P SP Y+P P P + + S
Sbjct: 1693 SPNYSPTSPSYS--PTSPGYSPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 59/230 (25%), Positives = 79/230 (34%), Gaps = 55/230 (23%)
Query: 1 PPITPALGPPSSS-SLTPPPITPALRPPSSSSLTPPPTTPALSP--PSLSSLTPP--PTS 55
P +P G S S T P +P S +S + PT+P+ SP PS S +P PTS
Sbjct: 1529 APTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1588
Query: 56 GAPPPSTPSDSSPPSSNPVARSP---PSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSL 112
+ P++PS SP S + SP P+ P+ S
Sbjct: 1589 PSYSPTSPS-YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT------------------ 1629
Query: 113 LILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAP 172
Y P +P Y + P S A+ T P
Sbjct: 1630 ---------------SPSYSPTSPSYSPTSPSYSPTSPSYS---PTSPAYSPTSP----- 1666
Query: 173 PHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLS 222
S P SP Y+P+ P P S +S NYS + P S G S
Sbjct: 1667 -----SYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYS 1711
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 3e-09
Identities = 43/359 (11%), Positives = 92/359 (25%), Gaps = 85/359 (23%)
Query: 249 GQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG 308
G G G K + A+ + Q + F+ + +
Sbjct: 157 GVLGSG---KTWV------ALDVCLSYKVQCKMDFK--------IF---------WLNLK 190
Query: 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKG--LAYLHEDCHPK--IIH 364
+ L + + D + +K+ + + L + ++
Sbjct: 191 NCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL 250
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSD 424
+++ A F K+ L ++TR +L+ + L S
Sbjct: 251 LNVQNAKAWNAFNLSCKI----L----------LTTRFKQVTDFLSAATTTHISLDHHSM 296
Query: 425 VFSF--GVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHN 482
+ LL + CRP D E P + +++ + +
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDLPR---EVLTTNPR---RL------SIIAESIRDGLATW 344
Query: 483 EMARMVACAAACVRHSARRRPRISQIVRTLEGD------ASLADLNEGIR-PGQ--SSVY 533
+ + V C + I + LE L+ P S ++
Sbjct: 345 DNWKHVNCDK--LTTI------IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIW 396
Query: 534 GSLDYDTMQYNEDLKKFRKMALNSQEISASSEYNRPTSDYGLHSSSSSSEGHNTREIEM 592
+ + + K K +L E S + S + E +
Sbjct: 397 FDVIKSDVM--VVVNKLHKYSL--------VEKQPKESTISIPSIYLELKVKLENEYAL 445
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 2e-08
Identities = 33/282 (11%), Positives = 78/282 (27%), Gaps = 84/282 (29%)
Query: 266 EVAIKQLKAGSGQGER-----VFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320
E ++ L+ + + VF I + + L + ++V +
Sbjct: 360 ESSLNVLEPAEYR-KMFDRLSVFPPSAHIPTIL----LSLIWFDVIKSDVMVVVNKLHKY 414
Query: 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI-IHRDIKAA--NILLD-F 376
+ +E P I + + ++ + + + A ++D +
Sbjct: 415 SLVE-----------KQPKESTI---------SIP-SIYLELKVKLENEYALHRSIVDHY 453
Query: 377 KFEAKVADFGLAKLASD--VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLE 434
L D Y+H G+ + + + E+ +F ++ L+
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSH--------IGH----HLKNIEHPERMTLFR--MVFLD 499
Query: 435 LIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY---NHNEMARMV--- 488
F+E + +TL K + Y N + R+V
Sbjct: 500 F-----------RFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAI 548
Query: 489 -----ACAAACVRHSARRRPRISQIVRTLEGDASLADLNEGI 525
+ + + +I +L +E I
Sbjct: 549 LDFLPKIEENLICS---KYTDLLRI--------ALMAEDEAI 579
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 55/254 (21%), Positives = 84/254 (33%), Gaps = 72/254 (28%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH--------HKHL 298
LG G F V + K VA+K +K+ E E+ ++ V + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 299 VSLVGYYT----AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354
V L+ + G+ +V E + + L++ + + + P KI +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLDYL 162
Query: 355 HEDCHPKIIHRDIKAANILLDF-------------------------------------- 376
H C IIH DIK NILL
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 377 -----------KFEAKVADFGLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSD 424
K + K+AD G A +T + TR Y + E +D
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPAD 275
Query: 425 VFSFGVMLLELIIG 438
++S M EL G
Sbjct: 276 IWSTACMAFELATG 289
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 20/206 (9%)
Query: 248 LGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY- 305
+G G FG ++ G + +EVAIK + E +I + + V ++
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
G +LV + + + LE + R + T L +A + ++H +HR
Sbjct: 73 VEGDYNVLVMDLLGPS-LEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS---FLHR 127
Query: 366 DIKAANILLDFKFEAK---VADFGLAKLASDVYT--HVSTR----VMGTFGYLAPEYASS 416
DIK N L+ A + DFGLAK D T H+ R + GT Y A
Sbjct: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVNTHL 186
Query: 417 GK-LTEKSDVFSFGVMLLELIIGCRP 441
G + + D+ S G +L+ + G P
Sbjct: 187 GIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 55/219 (25%), Positives = 76/219 (34%), Gaps = 51/219 (23%)
Query: 2 PITPALGPPSSS-SLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
P +P+ P S S S T P +P S++S + PT+P+ SP S S PTS + P
Sbjct: 1580 PTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSY---SPTSPSYSP 1636
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRK 120
++PS SP S + SP PT
Sbjct: 1637 TSPS-YSPTSPSYSPTSPSYSPTSPSYSPT------------------------------ 1665
Query: 121 RRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRP 180
Y P +P Y + P++ P +P P S
Sbjct: 1666 -------SPSYSPTSPSYSPTSPSYSPTSPSY----SPTSPSYSPTSPSYSPTSPSYS-- 1712
Query: 181 PHSPVYTPSPP---PPPPFMSSSGGSSSNYSGSEAPIPP 216
P SP Y+P+ P P P S + S S S S +P P
Sbjct: 1713 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1751
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 47/240 (19%), Positives = 62/240 (25%), Gaps = 37/240 (15%)
Query: 1 PPITPALGPPSSSSLTPPPITPALR-PPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPP 59
T A +S L TP R P S P A SP G
Sbjct: 1464 AVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYG 1523
Query: 60 PSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRR 119
+ +P SP S G G S + + S
Sbjct: 1524 LLGAASPYKGVQSPGYTSPFSSAMSP-GYGLTSPSYSPSSPGYSTSPAYMPS-------- 1574
Query: 120 KRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQ----QNVPPSAAHVVTQP-------- 167
Y P +P Y + S ++ T P
Sbjct: 1575 --------SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPS 1626
Query: 168 -----PRPAPPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLS 222
P +P P S P SP Y+P+ P P S +S +YS + P S S
Sbjct: 1627 YSPTSPSYSPTSPSYS--PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1684
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 49/235 (20%), Positives = 71/235 (30%), Gaps = 58/235 (24%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTP--PPTTPALSPPSLSSLTPPPTSGAP 58
G ++S +P P SS+++P T+P+ SP S T P +
Sbjct: 1516 REGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSS 1575
Query: 59 P---PSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLIL 115
P P++PS SP S + SP PT
Sbjct: 1576 PSYSPTSPS-YSPTSPSYSPTSPSYSPT-------------------------------- 1602
Query: 116 RCRRKRRRRRDDEAGYCTLPP---PLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAP 172
Y P P +P P + P++ P +P
Sbjct: 1603 ------------SPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1650
Query: 173 PHPVASR-----PPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLS 222
P S P SP Y+P+ P P S +S +YS + P S S
Sbjct: 1651 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1705
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 54/232 (23%), Positives = 74/232 (31%), Gaps = 53/232 (22%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLS-SLTPP---PTSG 56
++P G S S P SS + PT+P+ SP S S S T P PTS
Sbjct: 1545 SAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1604
Query: 57 APPPSTP--SDSSP-PSSNPVARSPPSP---PTGDDGGGGVSTGLVVGLAIGGLAVIVVV 110
+ ++P S +SP S + SP SP PT
Sbjct: 1605 SYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT-------------------- 1644
Query: 111 SLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRP 170
Y P +P Y + P++ P
Sbjct: 1645 -----------------SPSYSPTSPSYSPTSPSYSPTSPSYS----PTSPSYSPTSPSY 1683
Query: 171 APPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPSLGLS 222
+P P S P SP Y+P+ P P S +S +YS + P S S
Sbjct: 1684 SPTSPSYS--PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1733
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 4e-06
Identities = 22/81 (27%), Positives = 31/81 (38%), Gaps = 1/81 (1%)
Query: 4 TPALGPPSSSSLTPPPITPALRPPSS-SSLTPPPTTPALSPPSLSSLTPPPTSGAPPPST 62
+SSLT P ++ PS SL P +P +S+L+ P PP S
Sbjct: 13 DKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSV 72
Query: 63 PSDSSPPSSNPVARSPPSPPT 83
S P S V +P +
Sbjct: 73 ISSPMGPHSMSVPTTPTLGFS 93
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 22/93 (23%), Positives = 32/93 (34%), Gaps = 2/93 (2%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
P + P+LGP S L P + PP + SP S++ P T
Sbjct: 36 PSLHPSLGPGIGSPGQLHSPISTLSSPINGM--GPPFSVISSPMGPHSMSVPTTPTLGFS 93
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDDGGGGVST 93
+ S P + + PP G +G V
Sbjct: 94 TGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPA 126
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 21/86 (24%), Positives = 28/86 (32%), Gaps = 2/86 (2%)
Query: 9 PPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSP 68
P S+ P + P+L P S LS P PP S P P S
Sbjct: 27 PTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGM--GPPFSVISSPMGPHSMSV 84
Query: 69 PSSNPVARSPPSPPTGDDGGGGVSTG 94
P++ + S SP S+
Sbjct: 85 PTTPTLGFSTGSPQLSSPMNPVSSSE 110
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 13/83 (15%), Positives = 25/83 (30%), Gaps = 3/83 (3%)
Query: 2 PITPA--LGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPP 59
P +P ++ + P TPA P ++ T P P + P A
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPA-PPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATV 63
Query: 60 PSTPSDSSPPSSNPVARSPPSPP 82
+ + + A + +
Sbjct: 64 AAGHATLREHLRDIKAENTDANF 86
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 12/67 (17%), Positives = 20/67 (29%), Gaps = 1/67 (1%)
Query: 17 PPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPSSNPVAR 76
P TP + ++ + P TPA + P P P+ P N
Sbjct: 6 TSPGTPGV-AAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 77 SPPSPPT 83
+ +
Sbjct: 65 AGHATLR 71
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 2e-05
Identities = 14/93 (15%), Positives = 19/93 (20%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
PP PA S + PP LTP ++ P
Sbjct: 31 PPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPL 90
Query: 61 STPSDSSPPSSNPVARSPPSPPTGDDGGGGVST 93
P+ P +P
Sbjct: 91 VDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQ 123
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 23/201 (11%), Positives = 40/201 (19%), Gaps = 49/201 (24%)
Query: 17 PPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPSSNPVAR 76
P + PP PA + S + PP P +P +
Sbjct: 13 QLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQ 72
Query: 77 SPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRRDDEAGYCTLPP 136
+ +
Sbjct: 73 IDQATT-----------------------------------------------SMNDMHL 85
Query: 137 PLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPPF 196
P VDP Q + Q P AP + S + + P
Sbjct: 86 HNVPLVDPNAYMQPQVPVQMGTPLQQ--QQQPMAAPAYGQPSAAMGQNMRPMNQLYPIDL 143
Query: 197 MSSSGGSSSNYSGSEAPIPPP 217
++ ++ + P+ P
Sbjct: 144 LTELPPPITDLTLPPPPLVIP 164
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-05
Identities = 13/84 (15%), Positives = 19/84 (22%), Gaps = 1/84 (1%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
P PA P + P + P P+ L
Sbjct: 22 PLQQPAQFMPPQDPAAAGMSYGQMGMPPQGA-VPSMGQQQFLTPAQEQLHQQIDQATTSM 80
Query: 61 STPSDSSPPSSNPVARSPPSPPTG 84
+ + P +P A P P
Sbjct: 81 NDMHLHNVPLVDPNAYMQPQVPVQ 104
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 2e-04
Identities = 18/168 (10%), Positives = 31/168 (18%), Gaps = 45/168 (26%)
Query: 51 PPPTSGAPPPSTPSDSSPPSSNPVARSPPSPPTGDDGGGGVSTGLVVGLAIGGLAVIVVV 110
A P P+ PP A G
Sbjct: 14 LQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGA--------------------- 52
Query: 111 SLLILRCRRKRRRRRDDEAGYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRP 170
P + + ++Q QQ + +
Sbjct: 53 ------------------------VPSMGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNV 88
Query: 171 APPHPVASRPPHSPVYTPSPPPPPPFMSSSGGSSSNYSGSEAPIPPPS 218
P A P PV +P ++ + + P +
Sbjct: 89 PLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMN 136
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 4e-04
Identities = 12/89 (13%), Positives = 21/89 (23%), Gaps = 2/89 (2%)
Query: 130 GYCTLPPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPS 189
Y P Q P +A + PP TP+
Sbjct: 8 VYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGM--SYGQMGMPPQGAVPSMGQQQFLTPA 65
Query: 190 PPPPPPFMSSSGGSSSNYSGSEAPIPPPS 218
+ + S ++ P+ P+
Sbjct: 66 QEQLHQQIDQATTSMNDMHLHNVPLVDPN 94
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 7e-04
Identities = 7/86 (8%), Positives = 12/86 (13%)
Query: 135 PPPLAPKVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPP 194
P P + P +
Sbjct: 21 TPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQATTSM 80
Query: 195 PFMSSSGGSSSNYSGSEAPIPPPSLG 220
M + + P P +G
Sbjct: 81 NDMHLHNVPLVDPNAYMQPQVPVQMG 106
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 6e-05
Identities = 21/83 (25%), Positives = 30/83 (36%), Gaps = 7/83 (8%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
+ L P S + P + ++L PP T P +PP P +G PP
Sbjct: 8 HHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPP----APAAGNPPD 63
Query: 61 STPSDSSPPSSNPVARSPPSPPT 83
+ DS + R P P T
Sbjct: 64 TVTGDSVLQ---RILRGPTGPGT 83
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 1e-04
Identities = 16/83 (19%), Positives = 24/83 (28%), Gaps = 2/83 (2%)
Query: 11 SSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPS 70
SS P S + P + + + L++L PP T P P P + +
Sbjct: 3 SSHHHHHHSSGLV--PRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGN 60
Query: 71 SNPVARSPPSPPTGDDGGGGVST 93
G G T
Sbjct: 61 PPDTVTGDSVLQRILRGPTGPGT 83
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 2e-04
Identities = 16/89 (17%), Positives = 29/89 (32%), Gaps = 6/89 (6%)
Query: 1 PPITPALGPPSSSSLT---PPPITPALRPPSSSSLTPPPTTPALSPPS-LSSLTPPPTSG 56
+ ++ +S L PP P PP + ++ S L + PT
Sbjct: 22 VIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTGDSVLQRILRGPT-- 79
Query: 57 APPPSTPSDSSPPSSNPVARSPPSPPTGD 85
P ++ + + P +P S P
Sbjct: 80 GPGTTSLAPAVRYGRQPGPEAPASAPPAA 108
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 13/83 (15%), Positives = 21/83 (25%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
+ L P P P P++ + T ++ L T P T+ P
Sbjct: 30 SAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTGDSVLQRILRGPTGPGTTSLAPA 89
Query: 61 STPSDSSPPSSNPVARSPPSPPT 83
P + A
Sbjct: 90 VRYGRQPGPEAPASAPPAAGRAV 112
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 15/87 (17%), Positives = 22/87 (25%), Gaps = 4/87 (4%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPP----PTSG 56
P + PS+S + A P + P P P T
Sbjct: 15 VPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPDTVTGDSVLQRI 74
Query: 57 APPPSTPSDSSPPSSNPVARSPPSPPT 83
P+ P +S + R P
Sbjct: 75 LRGPTGPGTTSLAPAVRYGRQPGPEAP 101
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 6e-04
Identities = 26/175 (14%), Positives = 41/175 (23%), Gaps = 58/175 (33%)
Query: 21 TPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPSSNPVARSPPS 80
+ SS + S S+ + + PP + P + PP P A +PP
Sbjct: 4 SHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPPD 63
Query: 81 PPTGDDGGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRRRDDEAGYCTLPPPLAP 140
TGD ++ +
Sbjct: 64 TVTGD-----------------------------------------------SVLQRILR 76
Query: 141 KVDPYGGRQQHWQQNVPPSAAHVVTQPPRPAPPHPVASRPPHSPVYTPSPPPPPP 195
P G ++ + R P AS PP + P P
Sbjct: 77 G--PTG---------PGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPV 120
|
| >3a58_A Exocyst complex component SEC3; protein complex, PH domain, GTPase, membrane traffic, coiled coil, exocytosis, phosphoprotein; HET: GNP; 2.60A {Saccharomyces cerevisiae} Length = 320 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 2e-04
Identities = 8/83 (9%), Positives = 22/83 (26%)
Query: 1 PPITPALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPP 60
++ + +++ T + S P+ + S P
Sbjct: 238 LDERSYQRAVITNRPGSVSPIKSPTSNFTTNTTQSVGSVPFSAPTERTRRSETESVNPVS 297
Query: 61 STPSDSSPPSSNPVARSPPSPPT 83
+ S + ++P S +
Sbjct: 298 TPASVEYHAGMKSLNKAPYSSNS 320
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 42.3 bits (98), Expect = 4e-04
Identities = 12/70 (17%), Positives = 20/70 (28%)
Query: 16 TPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPSDSSPPSSNPVA 75
T P S + T A A +T S+++ P+SN A
Sbjct: 24 TAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETASPASNEAA 83
Query: 76 RSPPSPPTGD 85
+ +
Sbjct: 84 TTETAEAASA 93
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 6e-04
Identities = 17/90 (18%), Positives = 27/90 (30%), Gaps = 3/90 (3%)
Query: 5 PALGPPSSSSLTPPPITPALRPPSSSSLTPPPTTPALSPPSLSSLTPPPTSGAPPPSTPS 64
P PPP P +S TP + S ++ P + +P S
Sbjct: 19 PNGYMTDLQRPQPPPPPP---SAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGG 75
Query: 65 DSSPPSSNPVARSPPSPPTGDDGGGGVSTG 94
SN V ++ + G +G
Sbjct: 76 GFFSSLSNAVKQTTAAAAATFSEQVGGGSG 105
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 608 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.82 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.79 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.74 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.66 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.59 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.52 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.26 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.21 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.11 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.1 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 97.97 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.95 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.81 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.72 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 97.65 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.63 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.57 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 97.54 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.48 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.36 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.22 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.0 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.57 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.54 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.13 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 95.42 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.8 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 94.8 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.36 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 92.14 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.54 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 90.88 | |
| 2llm_A | 43 | Amyloid beta A4 protein; alzheimer'S disease, prot | 90.23 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 89.5 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.27 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 89.08 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.72 | |
| 2klu_A | 70 | T-cell surface glycoprotein CD4; cell membrane, di | 82.37 | |
| 1q55_A | 880 | EP-cadherin, C-cadherin; trans interaction, desmos | 82.36 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 81.65 | |
| 2lp1_A | 122 | C99; alzheimer'S D membrane protein, transmembrane | 81.53 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=459.53 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=214.0
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...+.||+|+||.||+|++. +++.||||+++.......+.|.+|+++|++|+|||||+|+|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56778899999999999999863 477899999988777777889999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEE
Q 046502 314 VCEFVTSNTLEFHLHGKG-----------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl 382 (608)
|||||++|+|.++|+..+ ...++|.++++|+.|||+||.|||++ +||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 34699999999999999999999998 8999999999999999999999
Q ss_pred EEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHH
Q 046502 383 ADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 383 ~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
+|||+++...... ........||+.|||||++.++.|+.++|||||||+||||+| |+.||..... . .++ .
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~----~~~-~ 241 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---N----EVI-E 241 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---H----HHH-H
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---H----HHH-H
Confidence 9999998664432 223344679999999999999999999999999999999998 8999975432 1 122 2
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+..+.... .+......+.+|+.+||+.||++||+|.||++.|+..
T Consensus 242 ~i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 242 CITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 233343221 1222345688999999999999999999999999854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-56 Score=461.42 Aligned_cols=257 Identities=27% Similarity=0.406 Sum_probs=207.6
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...++||+|+||.||+|++. +++.||||+++.......+.|.+|+++|++|+|||||+|+|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45677789999999999999864 478899999988777777889999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 314 VCEFVTSNTLEFHLHGKG-------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
|||||++|+|.++|+... ...++|.++++|+.|||+||.|||+. +||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 999999999999997642 23599999999999999999999998 89999999999999999999
Q ss_pred EEEEeeccccccCc-ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHH
Q 046502 381 KVADFGLAKLASDV-YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLL 458 (608)
Q Consensus 381 kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~ 458 (608)
||+|||+++..... .........||+.|||||++.+..|+.++|||||||+||||+| |+.||..... . .++
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~----~~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---T----EAI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---H----HHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---H----HHH
Confidence 99999999866432 2333455789999999999999999999999999999999999 8999975432 1 122
Q ss_pred HHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 459 NRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 459 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
. .+..+.... .+......+.+|+.+||+.||++||+|.||+++|+...
T Consensus 271 ~-~i~~g~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 271 D-CITQGRELE---------RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp H-HHHHTCCCC---------CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred H-HHHcCCCCC---------CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 2 222332111 11223456888999999999999999999999998653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-56 Score=457.34 Aligned_cols=255 Identities=25% Similarity=0.391 Sum_probs=210.8
Q ss_pred CCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++...++||+|+||.||+|.+. +++.||||+++... ....+.|.+|+.+|++|+|||||+|+|+|.+++.++|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455688999999999999862 46789999997543 3345789999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc
Q 046502 314 VCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE 379 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~ 379 (608)
|||||++|+|.++|+... ...++|..+++|+.|||+||+|||++ +||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999997532 23589999999999999999999998 8999999999999999999
Q ss_pred eEEEEeeccccccCc-ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHH
Q 046502 380 AKVADFGLAKLASDV-YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPL 457 (608)
Q Consensus 380 ~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~ 457 (608)
+||+|||+++..... .........||+.|||||++.++.|+.++|||||||+||||+| |+.||..... . .
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~----~- 255 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q----D- 255 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---H----H-
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---H----H-
Confidence 999999999866432 2233455679999999999999999999999999999999998 8999975432 1 1
Q ss_pred HHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 458 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 458 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
+...+..+..... +.++...+.+|+.+||+.||++||+|.||+++|+.-
T Consensus 256 ~~~~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEMIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2223333432211 223445688999999999999999999999999853
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=450.58 Aligned_cols=257 Identities=29% Similarity=0.447 Sum_probs=203.5
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||+|++. ..||||+++... ....+.|.+|+.+|++++|||||+++|+|.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 56777889999999999999864 369999997543 3445789999999999999999999999865 568999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc-cc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-YT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~-~~ 396 (608)
|++|+|.++|+... ..++|..++.|+.|||+||+|||++ +||||||||+||||++++.+||+|||+|+..... ..
T Consensus 113 ~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 113 CEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999997654 3699999999999999999999998 8999999999999999999999999999876542 22
Q ss_pred ceeeeeecccCccChhhhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 397 HVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
......+||+.|||||++.. +.|+.++|||||||+||||+||+.||...... ..+...+..+.. .+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~~~----~p 257 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRGYA----SP 257 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTTCC----CC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCC----CC
Confidence 33455789999999999964 46899999999999999999999999754321 112222322221 11
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+ .....+....+.+|+.+||+.||++||+|.||+++|+..
T Consensus 258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 112223445788899999999999999999999998743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=453.73 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=207.0
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.++|..+++||+|+||.||+|+. .+|+.||||+++.. .....+.|.+|+++|++|+|||||+++++|.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999995 56999999999754 2334567999999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|||+||+|.++|.......+++...+.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999876666789999999999999999999999 99999999999999999999999999999765422
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||..... ..++.. +..+.+..+
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~-i~~~~~~~~----- 245 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVLK-IISGSFPPV----- 245 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHH-HHHTCCCCC-----
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHH-HHcCCCCCC-----
Confidence 223446799999999999999999999999999999999999999975432 112222 223333221
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... ....+.+|+.+||+.||++||++.|++++
T Consensus 246 ~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 SLH----YSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Ccc----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122 23467889999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=445.85 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=209.8
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+.|...++||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++|+|||||+|+++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4688999999999999999995 469999999997655555567889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++|+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 226 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 226 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence 999999999753 499999999999999999999999 999999999999999999999999999987754322 3
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+. .+.++....+.
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~-~i~~~~~~~~~------- 291 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMK-MIRDNLPPRLK------- 291 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHH-HHHHSSCCCCS-------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHH-HHHcCCCCCCC-------
Confidence 34578999999999999999999999999999999999999999754321 1122 22222111111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+|+.+||+.||++||++.|++++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111223567889999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=449.60 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=210.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+.|...++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++|+|||||+|+++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5699999999999999999995 469999999998766556667899999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++|+|.+++... .+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 999999999754 489999999999999999999999 999999999999999999999999999987754322 3
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+. .+..+....+..
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-------~~~~-~i~~~~~~~~~~------ 369 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMK-MIRDNLPPRLKN------ 369 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHH-HHHHSCCCCCSC------
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------HHHH-HHHcCCCCCCcc------
Confidence 34578999999999999999999999999999999999999999754321 1122 222221111111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+|+.+||+.||++||++.|++++
T Consensus 370 -~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 370 -LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp -TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11223467889999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=439.25 Aligned_cols=267 Identities=23% Similarity=0.345 Sum_probs=203.5
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----eeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS----QRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~----~~~lV~ 315 (608)
++|...++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+|+|+|.+++ .+||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3466778999999999999998 689999999975432 2233445677778899999999999998754 579999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC-----HPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~-----~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
|||++|+|.++|+.. .++|..+++|+.|+++||+|||+++ .++||||||||+|||||.++.+||+|||+++.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999864 4899999999999999999999863 45899999999999999999999999999987
Q ss_pred ccCcccc---eeeeeecccCccChhhhhcC------CCCCcchhhhHHHHHHHHHhCCCCCCCCcccc----c---chhh
Q 046502 391 ASDVYTH---VSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM----E---DNLA 454 (608)
Q Consensus 391 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~----~---~~l~ 454 (608)
....... .....+||+.|||||++.+. .++.++|||||||+||||+||+.||....... . ....
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6543222 22346799999999999754 36789999999999999999988775332110 0 0001
Q ss_pred HHHHHHHHhcCCCCcccCccccCc-CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 455 RPLLNRAIEDGNFDTLVDPKLHNE-YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 455 ~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
...+...+..+. +++.+... ...+....+.+|+.+||+.||++||||.||+++|+..
T Consensus 238 ~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111222222222 22333222 2345677889999999999999999999999999754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-53 Score=440.19 Aligned_cols=251 Identities=22% Similarity=0.258 Sum_probs=204.7
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+.|...++||+|+||.||+|+. .+|+.||||+++.... +.+|+.+|++|+|||||+++++|.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4677888999999999999995 5689999999976432 246999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-ceEEEEeeccccccCcccc
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~~~~ 397 (608)
+||+|.++|...+ .+++..++.|+.||+.||+|||++ +||||||||+||||+.++ ++||+|||+|+........
T Consensus 133 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 133 EGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp TTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999998654 599999999999999999999998 999999999999999987 6999999999876543211
Q ss_pred ----eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 398 ----VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 398 ----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
....++||+.|||||++.+..|+.++|||||||+||||++|+.||..... ..+.. .... +....
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~----~i~~-~~~~~---- 275 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR---GPLCL----KIAS-EPPPI---- 275 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC---SCCHH----HHHH-SCCGG----
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHHH----HHHc-CCCCc----
Confidence 12336799999999999999999999999999999999999999975432 11211 1111 11110
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+++......+.+|+.+||+.||.+||++.||+++|...
T Consensus 276 ---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 276 ---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp ---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 112223345678899999999999999999999998643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=445.98 Aligned_cols=259 Identities=28% Similarity=0.384 Sum_probs=211.8
Q ss_pred HhcCCCcCCccccCCceEEEEEEecC------CcEEEEEEcccCCch-hHHHHHHHHHHHHhcCC-CCccceeeEEEeC-
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLPN------GKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHH-KHLVSLVGYYTAG- 308 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~H-pniv~l~g~~~~~- 308 (608)
..++|...++||+|+||.||+|.+.. ++.||||+++..... ..+.|.+|+++|.++.| ||||+|+|+|.+.
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 45788999999999999999998532 368999999765433 45679999999999965 8999999999764
Q ss_pred CeeEEEEeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL 374 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl 374 (608)
+.++||||||++|+|.++|+... ...++|..++.|+.|||+||+|||++ +||||||||+||||
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceee
Confidence 56899999999999999997532 24589999999999999999999999 89999999999999
Q ss_pred ccCCceEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccch
Q 046502 375 DFKFEAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDN 452 (608)
Q Consensus 375 ~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 452 (608)
++++.+||+|||+|+...... ........||+.|||||++.++.|+.++|||||||+||||+| |+.||...... +
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--~- 295 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E- 295 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--H-
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH--H-
Confidence 999999999999998765432 223445779999999999999999999999999999999998 99999754321 1
Q ss_pred hhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 453 LARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 453 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+...+.++..... +.....++.+++..||+.||++||+|.||+++|+..
T Consensus 296 ----~~~~~i~~g~~~~~---------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 296 ----EFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp ----HHHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 12233333322111 112335678899999999999999999999999754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=426.09 Aligned_cols=247 Identities=27% Similarity=0.400 Sum_probs=198.3
Q ss_pred CcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCeeEEEE
Q 046502 243 SDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTA----GSQRMLVC 315 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~----~~~~~lV~ 315 (608)
...++||+|+||.||+|.. .+++.||||++... .....+.|.+|+++|++|+|||||+++++|.. ++.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 4456799999999999995 45889999999643 33445679999999999999999999999865 34589999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-CCceEEEEeeccccccCc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKLASDV 394 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-~~~~kl~DFGla~~~~~~ 394 (608)
|||++|+|.++|...+ .+++..+..|+.||+.||+|||++ .++||||||||+||||+. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 9999999999998654 599999999999999999999998 123999999999999985 799999999999865432
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.....+||+.|||||++. +.|+.++|||||||+||||+||+.||...... . .+...+..+.....++
T Consensus 186 ---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~------~-~~~~~i~~~~~~~~~~-- 252 (290)
T 3fpq_A 186 ---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------A-QIYRRVTSGVKPASFD-- 252 (290)
T ss_dssp ---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------H-HHHHHHTTTCCCGGGG--
T ss_pred ---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH------H-HHHHHHHcCCCCCCCC--
Confidence 234568999999999886 46999999999999999999999999643321 1 1222233332221111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .....+.+|+.+||+.||++||++.|++++
T Consensus 253 --~----~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 --K----VAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --G----CCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --c----cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 122357889999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=435.53 Aligned_cols=247 Identities=22% Similarity=0.357 Sum_probs=207.8
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|++|+|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4689999999999999999995 56899999999643 2233567899999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|||++|+|.++|...+ .+++.....++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997654 599999999999999999999999 99999999999999999999999999999765432
Q ss_pred -cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 -~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .. ++. .+..+.+.
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~----~~~-~i~~~~~~------ 252 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GL----IFA-KIIKLEYD------ 252 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HHH-HHHHTCCC------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HH----HHH-HHHcCCCC------
Confidence 2234557899999999999999999999999999999999999999975432 11 222 22233321
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIV 509 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv 509 (608)
+...+ ...+.+|+.+||+.||++||++.|++
T Consensus 253 ~p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 253 FPEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11122 34578899999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=420.47 Aligned_cols=246 Identities=24% Similarity=0.371 Sum_probs=192.1
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+++|++++|||||++++++.+.+..||||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999995 569999999996542 233467899999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+ +|+|.+++..++ .+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+...+..
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 678988887654 599999999999999999999999 99999999999999999999999999998765422
Q ss_pred cceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.....+||+.|||||++.+..+ +.++|||||||+||||++|+.||..... . .+.+.+..+.+.
T Consensus 167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~-----~~~~~i~~~~~~------ 230 (275)
T 3hyh_A 167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---P-----VLFKNISNGVYT------ 230 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H-----HHHHHHHHTCCC------
T ss_pred --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---H-----HHHHHHHcCCCC------
Confidence 2344689999999999988776 5799999999999999999999975322 1 112223333321
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+... ....+.+|+.+||+.||++||++.|++++
T Consensus 231 ~p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 231 LPKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCC----CCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111 23457889999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-52 Score=426.29 Aligned_cols=247 Identities=25% Similarity=0.310 Sum_probs=196.7
Q ss_pred cCCCcCCccccCCceEEEEEEe----cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL----PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...++||+|+||.||+|+. ..++.||||+++... ......+.+|+++|++|+|||||+++++|.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5689999999999999999985 247899999996532 2223467889999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
|||||+||+|.++|...+ .+++.....++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+...+
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999998654 599999999999999999999999 999999999999999999999999999986544
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... . .++.. +..+.+.
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~---~----~~~~~-i~~~~~~----- 244 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR---K----ETMTM-ILKAKLG----- 244 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H----HHHHH-HHHCCCC-----
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH---H----HHHHH-HHcCCCC-----
Confidence 322 23446899999999999999999999999999999999999999975432 1 12222 2223221
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRI-----SQIVR 510 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm-----~evv~ 510 (608)
+ +......+.+|+.+||+.||++||++ .|+++
T Consensus 245 -~----p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 245 -M----PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -C----CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -C----CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 11223457889999999999999984 56654
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=415.10 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=190.8
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--------
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGS-------- 309 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~-------- 309 (608)
++|...++||+|+||.||+|+. .+|+.||||+++.... ...+.+.+|+++|++|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4688999999999999999995 5689999999975443 34467899999999999999999999987544
Q ss_pred ----eeEEEEeeccCCcHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEE
Q 046502 310 ----QRMLVCEFVTSNTLEFHLHGKGR-PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD 384 (608)
Q Consensus 310 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~D 384 (608)
.+|||||||.+|+|.+++..... ...++..++.|+.||+.||+|||++ +||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 36999999999999999986543 2356778899999999999999999 999999999999999999999999
Q ss_pred eeccccccCcccc-----------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchh
Q 046502 385 FGLAKLASDVYTH-----------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL 453 (608)
Q Consensus 385 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l 453 (608)
||+|+........ ..+..+||+.|||||++.+..|+.++|||||||+||||++ ||..... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----R 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----H
Confidence 9999876542211 1234579999999999999999999999999999999996 6643211 1
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. ....+....+.... ......+.+|+.+||+.||++||++.||+++
T Consensus 234 ~~--~~~~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 VR--TLTDVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HH--HHHHHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HH--HHHHHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 11122233322111 1223345779999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=412.38 Aligned_cols=290 Identities=47% Similarity=0.776 Sum_probs=249.9
Q ss_pred cccCHHHHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEE
Q 046502 228 STFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYT 306 (608)
Q Consensus 228 ~~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~ 306 (608)
..|++.++....++|...++||+|+||.||+|...+|+.||||+++..... ....|.+|+.++++++|+||++++++|.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 468899999999999999999999999999999888999999999764322 2236889999999999999999999999
Q ss_pred eCCeeEEEEeeccCCcHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEE
Q 046502 307 AGSQRMLVCEFVTSNTLEFHLHGKG--RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD 384 (608)
Q Consensus 307 ~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~D 384 (608)
..+..++||||+.+++|.+++.... ...++|..++.|+.|++.||.|||+.+.++|+||||||+||||+.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999998753 33599999999999999999999998777899999999999999999999999
Q ss_pred eeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccc-cchhhHHHHHHHHh
Q 046502 385 FGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM-EDNLARPLLNRAIE 463 (608)
Q Consensus 385 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~ 463 (608)
||+++..............||..|+|||++.+..++.++|||||||++|||++|+.||+...... .......++...+.
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99998776554455556679999999999999999999999999999999999999996322111 11223344555556
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDAS 517 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~~ 517 (608)
...+..+.+..+...+...+...+.+++..||+.||.+||++.||+++|++...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 777888888888888999999999999999999999999999999999997543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=406.22 Aligned_cols=285 Identities=38% Similarity=0.642 Sum_probs=244.5
Q ss_pred ccCHHHHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 046502 229 TFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG 308 (608)
Q Consensus 229 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~ 308 (608)
.+.+.++...+++|...++||+|+||.||+|.+.+|+.||||++........+.+.+|+.++++++|+||++++++|.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 44555667788999999999999999999999888999999999877666778899999999999999999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGR--PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
+..++||||+++++|.+++..... ..++|..++.|+.|+++||.|||+. +|+||||||+||||+.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999999976532 3589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCc-ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 387 LAKLASDV-YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 387 la~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
+++..... .........||..|+|||++.++.++.++|||||||+||||++|+.||..........+. .+.......+
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~-~~~~~~~~~~ 263 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA-EWAVESHNNG 263 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHH-HHTHHHHTTT
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHH-HHhhhccccc
Confidence 99865432 222334456899999999999999999999999999999999999999765432222221 2333445667
Q ss_pred CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 046502 466 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDAS 517 (608)
Q Consensus 466 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~~ 517 (608)
.+..++++.+...........+.+++.+||+.||++||++.||+++|+....
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 7888888888888888999999999999999999999999999999986543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=412.05 Aligned_cols=260 Identities=20% Similarity=0.287 Sum_probs=200.5
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEe------CCe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTA------GSQ 310 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~------~~~ 310 (608)
++|...++||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++|+|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999995 569999999997543 2334668899999999999999999998753 367
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
+|||||||. |+|.+++...+ .+++..+..|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999996 67988887644 599999999999999999999999 999999999999999999999999999987
Q ss_pred ccCc---ccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC
Q 046502 391 ASDV---YTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466 (608)
Q Consensus 391 ~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 466 (608)
+... ........+||+.|||||++.+. .++.++|||||||+||||++|+.||...... + ....++. ..+.
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~--~-~l~~I~~---~~g~ 281 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV--H-QLQLIMM---VLGT 281 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--H-HHHHHHH---HHCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH--H-HHHHHHH---hcCC
Confidence 6432 12233457899999999998775 5799999999999999999999999754321 1 1111111 1111
Q ss_pred CCcccCcc------------ccC--cCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 467 FDTLVDPK------------LHN--EYN-----HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 467 ~~~~~d~~------------l~~--~~~-----~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........ +.. ... ......+++|+.+||+.||.+|||+.|++++
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11100000 000 000 0112457889999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=403.43 Aligned_cols=204 Identities=22% Similarity=0.344 Sum_probs=173.8
Q ss_pred HHHHHHhcCCCcCCccccCCceEEEEEEec----CCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEe
Q 046502 233 EELARATDGFSDANLLGQGGFGYVHKGVLP----NGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTA 307 (608)
Q Consensus 233 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~ 307 (608)
+.+....+.|...++||+|+||.||+|+.+ .++.||||++.... ....+.+|+++|.++ +|||||+++++|.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 344455688999999999999999999842 46889999987543 345678899999998 69999999999999
Q ss_pred CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEee
Q 046502 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFG 386 (608)
Q Consensus 308 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFG 386 (608)
.+.+|||||||++|+|.+++. .+++..+..++.||+.||+|||++ +||||||||+||||+.+ +.+||+|||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 999999999999999999984 489999999999999999999999 99999999999999887 799999999
Q ss_pred ccccccCccc---------------------------ceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhC
Q 046502 387 LAKLASDVYT---------------------------HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIG 438 (608)
Q Consensus 387 la~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG 438 (608)
+|+...+... ...+..+||++|||||++.+. .|+.++||||+||+||||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9986543211 112335799999999999775 589999999999999999999
Q ss_pred CCCCCCCc
Q 046502 439 CRPVDSTH 446 (608)
Q Consensus 439 ~~p~~~~~ 446 (608)
+.||....
T Consensus 244 ~~Pf~~~~ 251 (361)
T 4f9c_A 244 RYPFYKAS 251 (361)
T ss_dssp CSSSSCCS
T ss_pred CCCCCCCC
Confidence 99996543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=424.71 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=210.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+.+|++|+|||||+|+++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 36899999999999999999995 56999999999877666677899999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC--CceEEEEeeccccccCcc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK--FEAKVADFGLAKLASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~--~~~kl~DFGla~~~~~~~ 395 (608)
|++|+|.++|.... ..+++..+..++.||+.||.|||++ +|+||||||+||||+.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 99999999986543 2589999999999999999999999 99999999999999854 89999999999977543
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||..... . ..+. .+..+.+. +....
T Consensus 311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~----~~~~-~i~~~~~~--~~~~~ 379 (573)
T 3uto_A 311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---D----ETLR-NVKSCDWN--MDDSA 379 (573)
T ss_dssp -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---H----HHHH-HHHTTCCC--CCSGG
T ss_pred -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---H----HHHH-HHHhCCCC--CCccc
Confidence 233456799999999999999999999999999999999999999975432 1 1121 22222221 11111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... ....+.+|+..||+.||.+||++.|++++
T Consensus 380 ~~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 FSG----ISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp GTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111 23457789999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=418.69 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=200.3
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHH---HHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQ---AEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~---~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
.++|...++||+|+||.||+|+. .+|+.||||+++... ......+. .++.+++.++|||||+|+++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36799999999999999999995 469999999996421 12222333 346667778999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
|||||||+||+|.++|...+ .+++.....++.||+.||+|||++ +||||||||+||||+.+|.+||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999998654 599999999999999999999999 9999999999999999999999999999876
Q ss_pred cCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
.... ....+||+.|||||++.. ..|+.++||||||||||||++|+.||......... .+...+....+.
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-----~i~~~i~~~~~~-- 412 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTLTMAVE-- 412 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-----HHHHHHHHCCCC--
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHhhcCCCCC--
Confidence 5432 234689999999999975 47999999999999999999999999653321111 111222222211
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPR-----ISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~~ 511 (608)
++......+.+|+..||+.||.+|++ +.||+++
T Consensus 413 --------~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 413 --------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp --------CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred --------CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 11122345788999999999999998 6887754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=382.63 Aligned_cols=256 Identities=27% Similarity=0.408 Sum_probs=211.2
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
++|...++||+|+||.||+|.. .+++.||||++........+.|.+|++++++++|+||++++++|.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 5688889999999999999996 458999999998777777788999999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++..... .++|..++.|+.|+++||.|||+. +|+||||||+||||+.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMDS-QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCCT-TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 99999999987433 599999999999999999999999 89999999999999999999999999998764432211
Q ss_pred -------------eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchh--hHHHHHHHHh
Q 046502 399 -------------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL--ARPLLNRAIE 463 (608)
Q Consensus 399 -------------~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l--~~~~~~~~~~ 463 (608)
.....||+.|+|||++.+..++.++|||||||+||||++|..|+........... ....+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--- 242 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--- 242 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH---
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc---
Confidence 1145799999999999999999999999999999999999999865332111110 1111110
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.+ .......+.+++.+||+.||++||++.||++.|+...
T Consensus 243 ----------~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 243 ----------YC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ----------TC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------cC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 1112235788999999999999999999999998653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=371.92 Aligned_cols=279 Identities=35% Similarity=0.638 Sum_probs=229.7
Q ss_pred cccCHHHHHHHhcCCCcC------CccccCCceEEEEEEecCCcEEEEEEcccC----CchhHHHHHHHHHHHHhcCCCC
Q 046502 228 STFTYEELARATDGFSDA------NLLGQGGFGYVHKGVLPNGKEVAIKQLKAG----SGQGERVFQAEVEIISRVHHKH 297 (608)
Q Consensus 228 ~~~~~~el~~~~~~f~~~------~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~Ev~~l~~l~Hpn 297 (608)
..|++.++..++++|... ++||+|+||.||+|.. +++.||||++... .....+.|.+|+.++++++|+|
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 468999999999999988 8999999999999997 6889999998653 2334567899999999999999
Q ss_pred ccceeeEEEeCCeeEEEEeeccCCcHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc
Q 046502 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGK-GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF 376 (608)
Q Consensus 298 iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~ 376 (608)
|+++++++.+.+..++||||+++++|.+++... ....++|..++.|+.|++.||.|||+. +|+||||||+||||+.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 999999999999999999999999999998743 234699999999999999999999998 9999999999999999
Q ss_pred CCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH
Q 046502 377 KFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR 455 (608)
Q Consensus 377 ~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~ 455 (608)
++.+||+|||+++....... .......|+..|+|||.+.+ .++.++|||||||++|+|++|+.||+..... .+..
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~ 244 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP---QLLL 244 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS---SBTT
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch---HHHH
Confidence 99999999999986654322 22334579999999998864 5899999999999999999999999764321 1111
Q ss_pred HHHHHHH-hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 456 PLLNRAI-EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 456 ~~~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+..... ....+...++..+ ..........+.+++..||+.||.+||++.+|+++|+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1222111 1223344445444 345667788899999999999999999999999999854
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=371.07 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=210.4
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...++||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||++++++|..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46799999999999999999984 57899999999766666677889999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+++|.+++... .+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999764 489999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......||+.|+|||++.+..++.++|||||||+||||++|+.||...... . .+......+.. .+.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~-----~~~~~~~~~~~-~~~------ 237 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--R-----ALYLIATNGTP-ELQ------ 237 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--H-----HHHHHHHHCSC-CCS------
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--H-----HHHHHHhCCCC-CCC------
Confidence 233467999999999999999999999999999999999999999754321 0 11111122211 111
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++.+||+.||++||++.|++++
T Consensus 238 -~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 238 -NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112233567889999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=374.72 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=217.9
Q ss_pred ccccccCHHHHHHHhcC----------CCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhc
Q 046502 225 FLKSTFTYEELARATDG----------FSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRV 293 (608)
Q Consensus 225 ~~~~~~~~~el~~~~~~----------f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l 293 (608)
+....|+++++..+++. |...++||+|+||.||+|... +|+.||||++........+.+.+|+.+++++
T Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 20 FQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY 99 (321)
T ss_dssp -----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC
T ss_pred ecCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC
Confidence 34457899999998875 666789999999999999965 7999999999877666677899999999999
Q ss_pred CCCCccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEE
Q 046502 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANIL 373 (608)
Q Consensus 294 ~Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NIL 373 (608)
+|+||++++++|...+..++||||+++++|.+++... .++|..+..|+.|++.||.|||+. +|+||||||+|||
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 9999999999999999999999999999999998643 589999999999999999999998 9999999999999
Q ss_pred EccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchh
Q 046502 374 LDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL 453 (608)
Q Consensus 374 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l 453 (608)
|+.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~----- 247 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV----- 247 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----
T ss_pred ECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----
Confidence 99999999999999987654322 223467999999999999999999999999999999999999999754321
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+.. +.......+.. .......+.+++.+||+.||++||++.||+++
T Consensus 248 --~~~~~-~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 --QAMKR-LRDSPPPKLKN-------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --HHHHH-HHHSSCCCCTT-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --HHHHH-HhcCCCCCcCc-------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 22221111111 11223457889999999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=389.85 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=211.5
Q ss_pred hcCCCcCCccccCCceEEEEEEec--------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeC
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP--------NGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAG 308 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~ 308 (608)
.++|...+.||+|+||.||+|... ++..||||+++.... ...+.+.+|+.+|+++ +||||++++++|.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367888999999999999999852 356799999976533 3446789999999999 899999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGR--------------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL 374 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl 374 (608)
+..++||||+++|+|.+++..... ..+++..++.|+.||++||.|||++ +|+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999986532 3589999999999999999999999 99999999999999
Q ss_pred ccCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccch
Q 046502 375 DFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDN 452 (608)
Q Consensus 375 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 452 (608)
+.++.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||+||||++ |+.||..... ..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH
Confidence 9999999999999986654221 12233457889999999999999999999999999999999 9999875432 11
Q ss_pred hhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 046502 453 LARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDAS 517 (608)
Q Consensus 453 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~~ 517 (608)
++ ..+..+.... .+......+.+++..||+.||.+||++.||++.|+....
T Consensus 314 ----~~-~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 ----LF-KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ----HH-HHHHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HH-HHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 1222222111 112234568889999999999999999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=379.14 Aligned_cols=258 Identities=30% Similarity=0.460 Sum_probs=202.7
Q ss_pred HhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
..++|...++||+|+||.||+|.. +|+.||||++.... ....+.|.+|++++++++|+||++++++|...+..++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 356788999999999999999987 78899999997653 333467889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 316 EFVTSNTLEFHLHGKGR-PTMDWPTRLKIALGFAKGLAYLHEDCHPK--IIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
||+++++|.+++..... ..+++..++.|+.||++||.|||+. + |+||||||+||||+.++.+||+|||+++...
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 99999999999986432 2389999999999999999999998 7 9999999999999999999999999998654
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
.... ......||..|+|||++.+..++.++|||||||+||||++|+.||...... .............
T Consensus 191 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~~~~~~~~~~~~~---- 258 (309)
T 3p86_A 191 STFL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-------QVVAAVGFKCKRL---- 258 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHHHHHHSCCCC----
T ss_pred cccc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCC----
Confidence 4321 233457999999999999999999999999999999999999999754321 1111111111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.........+.+++.+||+.||.+||++.||++.|+...
T Consensus 259 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 259 -----EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111223346788999999999999999999999998643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=379.50 Aligned_cols=256 Identities=28% Similarity=0.421 Sum_probs=207.5
Q ss_pred cCCCcCCccccCCceEEEEEEec----CCcEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP----NGKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++||+|+||.||+|.+. .+..||||+++.. .....+.|.+|+.++++++|+||++++++|.+++..+||
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888899999999999999963 3456999999865 334456799999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++.... ..+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999997543 3599999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 395 YTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 395 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
... ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||...... .++. .+..+..
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~~~-~~~~~~~---- 272 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-------DVIS-SVEEGYR---- 272 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-------HHHH-HHHTTCC----
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-------HHHH-HHHcCCC----
Confidence 222 1223446778999999999999999999999999999999 99999654321 1122 2222211
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
..........+.+++..||+.||++||++.||++.|+...
T Consensus 273 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 273 -----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111223456888999999999999999999999998653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=367.74 Aligned_cols=254 Identities=30% Similarity=0.425 Sum_probs=211.4
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++|+||++++++|.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 56888899999999999999988899999999986543 34678999999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++.... ..+++..++.|+.|+++||.|||+. +|+||||||+||||+.++.+||+|||+++..........
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 999999997643 3689999999999999999999999 899999999999999999999999999987655333333
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....++..|+|||++....++.++||||||+++|||++ |+.||..... . .... .+..+.. ...
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~----~~~~-~~~~~~~--~~~------ 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---S----EVVE-DISTGFR--LYK------ 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H----HHHH-HHHTTCC--CCC------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---H----HHHH-HHhcCcc--CCC------
Confidence 34556788999999999999999999999999999999 9999975432 1 1111 1222211 111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.......+.+++..||+.||++||++.||+++|+..
T Consensus 229 -~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 229 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 111234578899999999999999999999999754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=386.84 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=198.4
Q ss_pred cCCCcCCccccCCceEEEEEEec----CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP----NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++||+|+||.||+|++. ++..||||+++... ....+.|.+|+.++++++|+||++++++|.+.+..+||
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999864 56789999997653 34456799999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.++++... ..+++..++.|+.||++||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999998653 3699999999999999999999998 8999999999999999999999999999876543
Q ss_pred cccee--eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 395 YTHVS--TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 395 ~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
..... ....++..|+|||++.+..++.++|||||||+||||++ |+.||..... . .++ ..+..+..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~----~~~-~~i~~~~~---- 268 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---Q----DVI-KAVDEGYR---- 268 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---H----HHH-HHHHTTEE----
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---H----HHH-HHHHcCCC----
Confidence 22211 12345778999999999999999999999999999998 9999865432 1 111 22222210
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..........+.+++..||+.||.+||+|.||++.|+..
T Consensus 269 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 269 -----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 111123345688999999999999999999999999865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=400.72 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=213.6
Q ss_pred hcCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...++||+|+||.||+|.+.. ++.||||+++.... ..+.|.+|+.+|++++|+|||+++++|...+..+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3567888999999999999999754 88999999986543 456789999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+|+|.++|.......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999876666799999999999999999999999 9999999999999999999999999999876543322
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
......++..|+|||++..+.++.++|||||||+||||++ |+.||...... . +. ..+..+. .
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~----~~-~~~~~~~---------~ 437 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q----VY-ELLEKDY---------R 437 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G----HH-HHHHTTC---------C
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---H----HH-HHHHcCC---------C
Confidence 2333456789999999999999999999999999999999 99998754321 1 11 1122211 1
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..........+.+|+.+||+.||++||+|.+|++.|+..
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111223345688899999999999999999999999865
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=374.52 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=207.4
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+++|++++|+||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999996 67999999999654 3334567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++...+ .+++..+..++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999987654 489999999999999999999999 99999999999999999999999999998665422
Q ss_pred cceeeeeecccCccChhhhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
......||+.|+|||++.+..+. .++|||||||+||||++|+.||+.... ..+. ..+..+.+..
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~-~~i~~~~~~~----- 233 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KELR-ERVLRGKYRI----- 233 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHH-HHHHHCCCCC-----
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HHHH-HHHHhCCCCC-----
Confidence 23446799999999999888775 799999999999999999999975432 1112 2222333211
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+......+.+++.+||+.||.+||++.|++++
T Consensus 234 -----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 234 -----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11123457789999999999999999999975
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=360.50 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=212.3
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.++|...+.||+|+||.||+|...++..||||+++.... ..+.+.+|++++.+++|+||++++++|.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467888999999999999999988888999999986543 3456889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++..... .+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.........
T Consensus 86 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 86 SNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 99999999976432 589999999999999999999999 99999999999999999999999999998765543333
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||+..... ..... +..+.. ...+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~-~~~~~~--~~~~---- 227 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------EVVLK-VSQGHR--LYRP---- 227 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------HHHHH-HHTTCC--CCCC----
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-------HHHHH-HHcCCC--CCCC----
Confidence 334456778999999999899999999999999999999 99999754321 11111 122211 1111
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
......+.+++..||+.||.+||++.||+++|+...
T Consensus 228 ---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 ---HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ---CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 112245788999999999999999999999998654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=365.41 Aligned_cols=260 Identities=24% Similarity=0.373 Sum_probs=206.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|+||.||+|.. .+++.||||++.... ....+.|.+|+.++++++|+||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 35788999999999999999995 468999999985432 33346789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++...+ .+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999997654 589999999999999999999999 8999999999999999999999999999876554
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+.. ....+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~-~~~~~---- 232 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQD-SVPNV---- 232 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSS-CCCCH----
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhc-cCCCc----
Confidence 333344567999999999999999999999999999999999999999754321 011111211 11111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcCc
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRP-RISQIVRTLEGDA 516 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-sm~evv~~L~~~~ 516 (608)
...........+.+++.+||+.||.+|| ++.++.+.|+...
T Consensus 233 -~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 233 -TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp -HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred -chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 1111222345688899999999999998 8999999998654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=382.34 Aligned_cols=268 Identities=27% Similarity=0.381 Sum_probs=214.9
Q ss_pred ccCHHHHHHHhcCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccc
Q 046502 229 TFTYEELARATDGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVS 300 (608)
Q Consensus 229 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~ 300 (608)
.+...+.....++|...++||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|++++.++ +|+||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344555556678999999999999999999973 2457899999976533 3446799999999999 7999999
Q ss_pred eeeEEEeCCe-eEEEEeeccCCcHHHHhhcCCC-----------------------------------------------
Q 046502 301 LVGYYTAGSQ-RMLVCEFVTSNTLEFHLHGKGR----------------------------------------------- 332 (608)
Q Consensus 301 l~g~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------- 332 (608)
++++|.+.+. .++||||+.+|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999987554 8999999999999999986532
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 333 -----------------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 333 -----------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
..+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1289999999999999999999999 99999999999999999999999999998664322
Q ss_pred -cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 396 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 396 -~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
........||..|+|||++.+..++.++|||||||+||||++ |+.||...... + .+...+..+.....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~-----~~~~~~~~~~~~~~--- 317 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--E-----EFCRRLKEGTRMRA--- 317 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--H-----HHHHHHHHTCCCCC---
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--H-----HHHHHHHcCCCCCC---
Confidence 223345678999999999999999999999999999999998 99999754321 1 11222222221111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.......+.+++..||+.||.+||+|.||+++|+..
T Consensus 318 ------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 318 ------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111234678899999999999999999999999854
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=392.21 Aligned_cols=256 Identities=28% Similarity=0.441 Sum_probs=211.8
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.++|...++||+|+||.||+|.+.+++.||||+++... ...+.|.+|+.+|++++|+|||+++++|. .+..+|||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 46788889999999999999999888999999998654 34678999999999999999999999986 56789999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+|+|.++|+......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.........
T Consensus 265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~ 341 (454)
T 1qcf_A 265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 341 (454)
T ss_dssp TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence 999999999865444689999999999999999999999 89999999999999999999999999998765432222
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++..+.++.++|||||||+||||++ |+.||..... .. ++ ..+..+.. +
T Consensus 342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~----~~-~~i~~~~~--~------- 404 (454)
T 1qcf_A 342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PE----VI-RALERGYR--M------- 404 (454)
T ss_dssp TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH----HH-HHHHHTCC--C-------
T ss_pred cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HH----HH-HHHHcCCC--C-------
Confidence 233456789999999999999999999999999999999 9999975332 11 11 12222211 0
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
..+......+.+++.+||+.||++||+|.+|++.|+...
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 011223456888999999999999999999999998654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.54 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=202.7
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHh--cCCCCccceeeEEEeC----CeeE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISR--VHHKHLVSLVGYYTAG----SQRM 312 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~--l~Hpniv~l~g~~~~~----~~~~ 312 (608)
.++|...++||+|+||.||+|.. +|+.||||++... ....+..|.+++.. ++|+||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46789999999999999999998 7899999998753 34556667777777 7899999999997642 4589
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeeccCCCcEEEccCCceEEEE
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH--------EDCHPKIIHRDIKAANILLDFKFEAKVAD 384 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH--------~~~~~~iiHrDIk~~NILl~~~~~~kl~D 384 (608)
+||||+++|+|.+++... .+++..+++|+.|++.||.||| +. +|+||||||+||||+.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEee
Confidence 999999999999999543 5999999999999999999999 66 899999999999999999999999
Q ss_pred eeccccccCcccce---eeeeecccCccChhhhhcC------CCCCcchhhhHHHHHHHHHhC----------CCCCCCC
Q 046502 385 FGLAKLASDVYTHV---STRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELIIG----------CRPVDST 445 (608)
Q Consensus 385 FGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~Gvll~elltG----------~~p~~~~ 445 (608)
||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998655432221 2234799999999999876 445799999999999999999 7777543
Q ss_pred cccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 446 HTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 446 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.... .....+.......+....+. ...+.......+.+++.+||+.||.+||++.||++.|+.
T Consensus 237 ~~~~--~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 237 VPND--PSFEDMRKVVCVDQQRPNIP----NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp SCSS--CCHHHHHHHHTTSCCCCCCC----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCC--cchhhhhHHHhccCCCCCCC----hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 2211 11111111111111111111 112334567889999999999999999999999999974
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=365.76 Aligned_cols=270 Identities=21% Similarity=0.250 Sum_probs=214.5
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--eeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS--QRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~--~~~lV~ 315 (608)
++|...++||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++|+||+++++++...+ ..+|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999964 48999999997543 233567889999999999999999999998765 779999
Q ss_pred eeccCCcHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE----ccCCceEEEEeecccc
Q 046502 316 EFVTSNTLEFHLHGKGR-PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL----DFKFEAKVADFGLAKL 390 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl----~~~~~~kl~DFGla~~ 390 (608)
||+++++|.+++..... ..+++..++.|+.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999986432 3499999999999999999999999 99999999999999 7888899999999987
Q ss_pred ccCcccceeeeeecccCccChhhhh--------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYAS--------SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
..... ......||..|+|||++. +..++.++|||||||+||||++|+.||........ ....+...+
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~ 240 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR---NKEVMYKII 240 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG---CHHHHHHHH
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch---hHHHHHHHh
Confidence 65432 223456999999999986 57889999999999999999999999964332111 111222222
Q ss_pred hcCCCC---cc-----------cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 046502 463 EDGNFD---TL-----------VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDAS 517 (608)
Q Consensus 463 ~~~~~~---~~-----------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~~ 517 (608)
...... .+ -+-.....+.......+.+++..||+.||++||++.|++++...+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 211100 00 01111224556777889999999999999999999999999876543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=383.84 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=194.2
Q ss_pred hcCCCcC-CccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHh-cCCCCccceeeEEEe----CCee
Q 046502 239 TDGFSDA-NLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISR-VHHKHLVSLVGYYTA----GSQR 311 (608)
Q Consensus 239 ~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~-l~Hpniv~l~g~~~~----~~~~ 311 (608)
.++|... ++||+|+||.||++... +|+.||||+++.. ..+.+|+.++.+ ++|+||++++++|.. .+.+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456665 68999999999999964 6899999999642 346778888755 589999999999875 5678
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---CCceEEEEeecc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGLA 388 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---~~~~kl~DFGla 388 (608)
|||||||.+|+|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+||||+. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999999876656799999999999999999999998 9999999999999998 789999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||........... +...+..+.+.
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----~~~~i~~~~~~ 285 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----MKTRIRMGQYE 285 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS----HHHHHHHTCCC
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH----HHHHHHcCccc
Confidence 8665321 23446789999999999999999999999999999999999999976543211100 11122233321
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .+.+ ......+.+|+..||+.||++||++.||+++
T Consensus 286 ~~-~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 FP-NPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC-TTTT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC-Cccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 1110 1223467889999999999999999999986
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=372.14 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=213.7
Q ss_pred HHHhcCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG 308 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~ 308 (608)
....++|...+.||+|+||.||+|... +++.||||+++... ....+.|.+|+.++++++|+||++++++|.++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 334678999999999999999999964 34889999998653 33456799999999999999999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeec
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKG----------------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrD 366 (608)
+..++||||+++++|.+++.... ...+++..++.|+.||++||.|||++ +|+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 99999999999999999997642 14689999999999999999999999 999999
Q ss_pred cCCCcEEEccCCceEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCC
Q 046502 367 IKAANILLDFKFEAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDS 444 (608)
Q Consensus 367 Ik~~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~ 444 (608)
|||+||||+.++.+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999998654322 122334568899999999999999999999999999999999 9999865
Q ss_pred CcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 445 THTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 445 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
... . .+...+..+....+ .......+.+++..||+.||.+||++.+|+++|+...
T Consensus 280 ~~~---~-----~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 280 MAH---E-----EVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp SCH---H-----HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCh---H-----HHHHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 432 1 12222333333211 1123356888999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=367.31 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=208.1
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.++|...++||+|+||.||+|...+++.||||+++.... ..+.+.+|++++.+++|+||++++++|.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 357888999999999999999998888999999986543 3467889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+++|.+++.... ..+++..++.|+.|++.||.|||++ +|+||||||+||||+.++.+||+|||+++.........
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 102 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp TTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999997633 2599999999999999999999999 99999999999999999999999999998765433223
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||...... . .. ..+..+.. ...
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~---~----~~-~~~~~~~~--~~~----- 242 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---E----TA-EHIAQGLR--LYR----- 242 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---H----HH-HHHHTTCC--CCC-----
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh---H----HH-HHHhcccC--CCC-----
Confidence 333456788999999999999999999999999999998 99999754321 1 11 11222211 001
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.......+.+++..||+.||.+||++.||+++|+..
T Consensus 243 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 243 --PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp --CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 111234688899999999999999999999999754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=366.57 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=206.3
Q ss_pred cCCCcCCccccCCceEEEEEEe-----cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-----PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~ 312 (608)
++|...++||+|+||.||+|++ .+++.||||++........+.|.+|++++++++|+||++++++|... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5788899999999999999984 35889999999877766677899999999999999999999998653 4589
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+++++|.+++..... .+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 90 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEeCCCCCHHHHHHhccc-ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 99999999999999976543 589999999999999999999998 99999999999999999999999999998765
Q ss_pred Cccc--ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc--------hhhHHHHHHHH
Q 046502 393 DVYT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED--------NLARPLLNRAI 462 (608)
Q Consensus 393 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~--------~l~~~~~~~~~ 462 (608)
.... .......++..|+|||++.+..++.++|||||||++|||++|..|+......... ......+...+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 4321 1223345677899999999999999999999999999999999998643211000 00000111122
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..+.. ..........+.+++..||+.||++||++.||++.|+..
T Consensus 246 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 246 KNNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 22111 111223345688899999999999999999999999754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=371.65 Aligned_cols=270 Identities=25% Similarity=0.348 Sum_probs=208.2
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----eeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS----QRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~----~~~lV 314 (608)
.++|...++||+|+||.||+|.. .++.||||++.... .....+..|+.++++++|+|||+++++|.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 36788999999999999999987 47999999997543 23345667999999999999999999998744 46999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeeeeccCCCcEEEccCCceEEEEeec
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC-------HPKIIHRDIKAANILLDFKFEAKVADFGL 387 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~-------~~~iiHrDIk~~NILl~~~~~~kl~DFGl 387 (608)
|||+++|+|.+++... .++|..++.|+.|++.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 9999999999999764 4899999999999999999999862 22699999999999999999999999999
Q ss_pred cccccCccc-ceeeeeecccCccChhhhhcC-----CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchh--------
Q 046502 388 AKLASDVYT-HVSTRVMGTFGYLAPEYASSG-----KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL-------- 453 (608)
Q Consensus 388 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l-------- 453 (608)
++....... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||..........+
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 257 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP 257 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC
Confidence 986654322 122335799999999999863 456688999999999999999999975432111111
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
....+............+...+ ........+.+++.+||+.||++||++.||++.|+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 258 SLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0111111111222111111111 12345677999999999999999999999999998643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=387.62 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=207.2
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-eeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS-QRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~-~~~lV~E~ 317 (608)
.++|...++||+|+||.||+|.+ .|+.||||+++... ..+.|.+|+.+|++++|+|||+++++|.+.+ ..+|||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 45688889999999999999998 57899999998654 4567899999999999999999999987765 78999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++|+|.+++...+...+++..++.++.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 9999999999876665689999999999999999999999 9999999999999999999999999999854332
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
.....++..|+|||++.+..++.++|||||||+||||++ |+.||..... .. .+ ..+..+...
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~----~~-~~i~~~~~~-------- 405 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KD----VV-PRVEKGYKM-------- 405 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT---TT----HH-HHHHTTCCC--------
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HH----HH-HHHHcCCCC--------
Confidence 122357889999999999999999999999999999998 9999975432 11 11 122222111
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..+......+.+++..||+.||.+||++.+|++.|+..
T Consensus 406 -~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 406 -DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11223345788899999999999999999999999753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=385.60 Aligned_cols=256 Identities=25% Similarity=0.347 Sum_probs=208.7
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...++||+|+||.||+|.+. +++.||||+++.... ...+.|.+|+++|++++|+||++++++|...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356788899999999999999975 689999999976532 334568899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+++|+|.+++...+ ..+++..++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999997543 2589999999999999999999999 899999999999999999999999999986544221
Q ss_pred ce-eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 397 HV-STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 397 ~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.. .....++..|+|||++..+.++.++|||||||+||||++ |+.||...... .+...+..+....
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~----- 335 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--------QTREFVEKGGRLP----- 335 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH--------HHHHHHHTTCCCC-----
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC-----
Confidence 11 122345778999999999999999999999999999998 99998754321 1112222222111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+......+.+++..||+.||++||++.+|++.|+..
T Consensus 336 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 336 ----CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1112335678899999999999999999999999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=382.24 Aligned_cols=258 Identities=29% Similarity=0.403 Sum_probs=209.0
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|...++||+|+||.||+|.+. +++.||||+++.. .......+.+|+.++++++|+|||+++++|...+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 57888999999999999999843 4678999999754 3444567889999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC---ceEEEE
Q 046502 313 LVCEFVTSNTLEFHLHGKG-----RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVAD 384 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~---~~kl~D 384 (608)
+||||+.+|+|.+++.... ...+++..++.|+.||++||.|||+. +|+||||||+||||+.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997643 23589999999999999999999999 999999999999999554 599999
Q ss_pred eeccccccCc-ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHH
Q 046502 385 FGLAKLASDV-YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 385 FGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
||+++..... .........||+.|+|||++.+..++.++|||||||+||||++ |+.||..... ..++.. +
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~~~~~-i 299 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEF-V 299 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHH-H
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH-H
Confidence 9999854321 1222334567899999999999999999999999999999998 9999975432 112222 2
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDAS 517 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~~ 517 (608)
..+.... ........+.+++.+||+.||.+||++.||+++|+....
T Consensus 300 ~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 300 TSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 2222111 111233468889999999999999999999999986543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=363.65 Aligned_cols=257 Identities=26% Similarity=0.371 Sum_probs=215.4
Q ss_pred HhcCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
..++|...++||+|+||.||+|.... ++.||||++.... ...+.+.+|+.++++++|+||++++++|.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35678889999999999999999654 8889999997643 345678899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.+++|.+++.......+++..++.|+.+++.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence 99999999999887666799999999999999999999999 999999999999999999999999999987765444
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... . +. ..+..+..
T Consensus 167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~----~~-~~~~~~~~-------- 230 (288)
T 3kfa_A 167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q----VY-ELLEKDYR-------- 230 (288)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G----HH-HHHHTTCC--------
T ss_pred ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H----HH-HHHhccCC--------
Confidence 44445667889999999999999999999999999999999 99998754321 1 11 11221111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..........+.+++..||+.||.+||++.||++.|+..
T Consensus 231 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 231 -MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 111122335688999999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=365.44 Aligned_cols=263 Identities=21% Similarity=0.280 Sum_probs=201.9
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...++||+|+||.||+|...+|+.||||+++.... .....+.+|++++++++|+||++++++|.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467899999999999999999988899999999975432 234678899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.+ +|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174 (311)
T ss_dssp CCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC
T ss_pred CCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc
Confidence 9985 7777776543 3589999999999999999999999 999999999999999999999999999987653322
Q ss_pred ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc------
Q 046502 397 HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT------ 469 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~------ 469 (608)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... + ....+. ..+.......
T Consensus 175 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~-~~~~i~-~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 175 -SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD--D-QLPKIF-SILGTPNPREWPQVQE 249 (311)
T ss_dssp ----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT--T-HHHHHH-HHHCCCCTTTSGGGTT
T ss_pred -cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH--H-HHHHHH-HHHCCCChHHhhhhhc
Confidence 2334568999999999876 56899999999999999999999999754331 1 111111 1111100000
Q ss_pred ----------ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 ----------LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ----------~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+..............+.+|+..||+.||++||++.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000000011123467899999999999999999999974
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=373.61 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=200.6
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCc----EEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGK----EVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...++||+|+||.||+|... +++ .||+|.++.. .....+.|.+|+.++++++|+||++++++|..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888999999999999999953 444 3588888643 2345578999999999999999999999998754 789
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+|+|.+++..... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 9999999999999987543 699999999999999999999999 999999999999999999999999999987654
Q ss_pred cccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
.... ......+|..|+|||++.+..++.++|||||||+||||++ |+.||+..... . +...+..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~-----~~~~~~~~~~~--- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E-----ISSILEKGERL--- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---G-----HHHHHHTTCCC---
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---H-----HHHHHHcCCCC---
Confidence 3222 2233456889999999999999999999999999999999 99999754321 1 11222222211
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.........+.+++.+||+.||.+||+|.||+++|+..
T Consensus 239 ------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~ 276 (327)
T 3poz_A 239 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred ------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 11122344688899999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=370.39 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=206.1
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|+||.||++... +|+.||||+++.. .......+.+|+.+|++++||||++++++|...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 367889999999999999999964 6899999999753 223345688999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 84 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999987643 589999999999999999999999 9999999999999999999999999999864332
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
. .......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. +... +..+.+.
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~----~~~~-i~~~~~~------ 223 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ER----LFEL-ILMEEIR------ 223 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HHHH-HHHCCCC------
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH---HH----HHHH-HHcCCCC------
Confidence 2 123446799999999999999999999999999999999999999975432 11 1111 2222211
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
++......+.+++..||+.||.+|| ++.||+++
T Consensus 224 ----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 1112234678899999999999999 89999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=373.25 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=203.1
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...++||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++|+||++++++|.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999964 789999999865432 234568899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc-
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY- 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~- 395 (608)
|+++++|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999987543 589999999999999999999998 99999999999999999999999999998654321
Q ss_pred cceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
........||+.|+|||++.+..+ +.++|||||||+||||++|+.||....... . .............
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~----~~~~~~~~~~~~~----- 229 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--Q----EYSDWKEKKTYLN----- 229 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--H----HHHHHHTTCTTST-----
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--H----HHHHHhcccccCC-----
Confidence 222345679999999999987775 779999999999999999999997543211 0 1111111111100
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+|+.+||+.||.+||++.||+++
T Consensus 230 ----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 011223456789999999999999999999875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=387.54 Aligned_cols=256 Identities=30% Similarity=0.444 Sum_probs=205.4
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.++|...++||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++|+||++++++|.+ +..+|||||+
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 35678889999999999999999888889999998654 335678999999999999999999999876 6789999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+|+|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999764444689999999999999999999999 99999999999999999999999999998765432222
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++..+.++.++|||||||+||||++ |+.||..... ...+. .+..+.. .
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~-~i~~~~~---------~ 400 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLD-QVERGYR---------M 400 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHH-HHHTTCC---------C
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHH-HHHcCCC---------C
Confidence 333457889999999999999999999999999999999 9999865332 11122 2222211 0
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
..+......+.+++..||+.||++||++.+|++.|+...
T Consensus 401 ~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 401 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 111233456888999999999999999999999998653
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=379.55 Aligned_cols=259 Identities=26% Similarity=0.384 Sum_probs=211.9
Q ss_pred hcCCCcCCccccCCceEEEEEEec--------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeC
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP--------NGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAG 308 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~ 308 (608)
.++|...++||+|+||.||+|... .++.||||+++.... ...+.+.+|+++++++ +|+|||+++++|..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357888999999999999999852 235799999976533 3446789999999999 899999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL 374 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl 374 (608)
+..++||||+.+++|.+++.... ...+++..++.|+.||+.||.|||+. +|+||||||+||||
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 99999999999999999998654 23589999999999999999999999 99999999999999
Q ss_pred ccCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccch
Q 046502 375 DFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDN 452 (608)
Q Consensus 375 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 452 (608)
+.++.+||+|||+++....... .......+|..|+|||++.+..++.++|||||||+||||++ |+.||..... .
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~---~- 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E- 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H-
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---H-
Confidence 9999999999999986654221 22334567889999999999999999999999999999999 9999865432 1
Q ss_pred hhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 046502 453 LARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDAS 517 (608)
Q Consensus 453 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~~ 517 (608)
. +...+..+..... .......+.+++..||+.||++||++.||+++|+....
T Consensus 301 ---~-~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 301 ---E-LFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp ---H-HHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---H-HHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1 1222222221111 11223468889999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=372.62 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=207.0
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCch------hHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQ------GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
.+.|...+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|+.+|++++||||++++++|.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467899999999999999999964 6899999999754322 346789999999999999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC----ceEEEEeec
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGL 387 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~----~~kl~DFGl 387 (608)
++||||+.+++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999997543 599999999999999999999998 999999999999998877 799999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .. .+. .+..+.+
T Consensus 166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~---~~----~~~-~i~~~~~ 235 (361)
T 2yab_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QE----TLA-NITAVSY 235 (361)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HH----HHH-HHHTTCC
T ss_pred ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HH----HHH-HHHhcCC
Confidence 98765432 23346799999999999999999999999999999999999999975432 11 111 2222222
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. ++..... .....+.+|+..||+.||.+||++.|++++
T Consensus 236 ~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 236 D--FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C--CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 1111111 123457889999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=368.51 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=194.1
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|... +|+.||||++.... ......+..|+..+.++ +|+||++++++|.+++..+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999965 78999999986542 23334455666666655 8999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+ +++|.+++...+ ..++|..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 999 568888877643 3699999999999999999999998 89999999999999999999999999998765422
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
......||++|+|||++.+ .++.++|||||||+||||++|..++..... . ..+..+.+.. .
T Consensus 212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~-~~~~~~~~~~----~- 272 (311)
T 3p1a_A 212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------W-QQLRQGYLPP----E- 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------H-HHHTTTCCCH----H-
T ss_pred --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------H-HHHhccCCCc----c-
Confidence 2334569999999998875 799999999999999999999877643211 0 1112221111 1
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.......+.+++..||+.||++||++.||+++
T Consensus 273 ---~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 ---FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ---cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111223568889999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=366.64 Aligned_cols=252 Identities=18% Similarity=0.296 Sum_probs=207.5
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...+.||+|+||.||+|... +++.||+|+++... .....+.+|+.++++++||||++++++|.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 467899999999999999999964 58899999987543 3456788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc--CCceEEEEeeccccccCcc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF--KFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~--~~~~kl~DFGla~~~~~~~ 395 (608)
+++++|.+++.... ..+++..++.++.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 99999999997543 3589999999999999999999999 9999999999999987 7899999999998765432
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
......||+.|+|||++.+..++.++|||||||+||||++|+.||..... . ..+.. +..+.+.. +...
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~----~~~~~-i~~~~~~~--~~~~ 226 (321)
T 1tki_A 159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---Q----QIIEN-IMNAEYTF--DEEA 226 (321)
T ss_dssp --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---H----HHHHH-HHHTCCCC--CHHH
T ss_pred --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH---H----HHHHH-HHcCCCCC--Chhh
Confidence 23446799999999999988899999999999999999999999975432 1 11222 22222110 1000
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .....+.+++..||+.||.+||++.|++++
T Consensus 227 ~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 FK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01 123467889999999999999999999985
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=366.83 Aligned_cols=258 Identities=19% Similarity=0.214 Sum_probs=206.8
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||+|.. .+|+.||||++..... ...+.+|+.++++| +|+||+++++++..++..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 5788999999999999999995 5789999999875432 23578899999999 899999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc-----eEEEEeecccccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE-----AKVADFGLAKLAS 392 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~-----~kl~DFGla~~~~ 392 (608)
+ +++|.+++.... ..+++..++.|+.||+.||.|||+. +|+||||||+||||+.++. +||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 87 L-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9 999999998653 3699999999999999999999999 9999999999999998887 9999999998764
Q ss_pred Ccccc------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC
Q 046502 393 DVYTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466 (608)
Q Consensus 393 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 466 (608)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..............+...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-~~ 240 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-TP 240 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH-SC
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc-CC
Confidence 43221 123567999999999999999999999999999999999999999764321111111111111000 00
Q ss_pred CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 467 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. ..+.. ... .+.+++..||+.||.+||++.+|++.|+..
T Consensus 241 ~-----~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 241 I-----EVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp H-----HHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred H-----HHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0 00001 112 788999999999999999999999999743
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.16 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=196.7
Q ss_pred hcCCCcCCccccCCceEEEEEEecC----CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
.++|...++||+|+||.||+|.... +..||||+++... ....+.|.+|+.++++++|+||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3678889999999999999998643 4579999987643 334567899999999999999999999984 567899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999997653 3589999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
..........+++.|+|||++....++.++|||||||++|||++ |+.||...... . .+. .+..+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~----~~~-~i~~~~~~~--- 237 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---D----VIG-RIENGERLP--- 237 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---G----HHH-HHHTTCCCC---
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---H----HHH-HHHcCCCCC---
Confidence 33323334457889999999999999999999999999999996 99999754321 1 111 222222111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
........+.+++..||+.||++||++.||+++|+..
T Consensus 238 ------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 238 ------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1122335678899999999999999999999999854
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=371.42 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=207.3
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
..++|...++||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++||||++++++|.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 456799999999999999999996 468999999997543 33446788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC---ceEEEEeeccccc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVADFGLAKLA 391 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~---~~kl~DFGla~~~ 391 (608)
|||+.+++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++ .+||+|||+++..
T Consensus 107 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp ECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999999999887543 589999999999999999999999 999999999999998654 5999999999876
Q ss_pred cCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . .+...+..+.+...
T Consensus 182 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~---~-----~~~~~i~~~~~~~~- 250 (362)
T 2bdw_A 182 NDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---H-----RLYAQIKAGAYDYP- 250 (362)
T ss_dssp TTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H-----HHHHHHHHTCCCCC-
T ss_pred cCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---H-----HHHHHHHhCCCCCC-
Confidence 5432 22346799999999999998999999999999999999999999965432 1 11122233332211
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+. .......+.+++..||+.||++||++.|++++
T Consensus 251 ~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 251 SPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 110 01223467889999999999999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=390.77 Aligned_cols=265 Identities=21% Similarity=0.260 Sum_probs=211.8
Q ss_pred cCHHHHHHHhcCCCcCCccccCCceEEEEEEecC-CcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEE
Q 046502 230 FTYEELARATDGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYY 305 (608)
Q Consensus 230 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~ 305 (608)
+.+.++....++|...++||+|+||.||+|+..+ ++.||||+++.... .....+.+|+.++.+++|+||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 3455666677899999999999999999999654 78899999975321 1123488899999999999999999999
Q ss_pred EeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 306 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
.+.+.++||||||++|+|.+++.... ..+++..++.++.||+.||.|||+. +||||||||+||||+.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999998643 3599999999999999999999998 9999999999999999999999999
Q ss_pred eccccccCcccceeeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 046502 386 GLAKLASDVYTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 386 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
|+++.............+||++|+|||++. .+.++.++|||||||+||||++|+.||..... ......++..
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~ 296 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGKIMNH 296 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHhhhhc
Confidence 999876554444445568999999999997 56789999999999999999999999975432 1111111111
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRISQIVRT 511 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPsm~evv~~ 511 (608)
. ..-.+.. .... ....+.+|+.+||..++++ |+++.||+++
T Consensus 297 ~-~~~~~p~-----~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 297 K-ERFQFPT-----QVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp H-HHCCCCS-----SCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred c-ccccCCc-----cccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0 0111111 1111 2345778899999888888 9999999975
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=357.85 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=195.5
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCc----hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG----QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|.. .|+.||||+++.... ...+.+.+|++++++++|+||++++++|.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 5788899999999999999997 589999999875432 22467889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc--------CCceEEEEeec
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF--------KFEAKVADFGL 387 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~--------~~~~kl~DFGl 387 (608)
||+++++|.+++... .+++..++.++.|++.||.|||++...+|+||||||+||||+. ++.+||+|||+
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 86 EFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp ECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 999999999998643 5899999999999999999999982222999999999999986 67899999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
++...... .....|+..|+|||++.+..++.++||||||+++|||++|+.||...... .... ....+..
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~-~~~~~~~ 231 (271)
T 3dtc_A 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAY-GVAMNKL 231 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHH-HHHTSCC
T ss_pred cccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-hhhcCCC
Confidence 98655422 22456899999999999999999999999999999999999999754321 0111 1111211
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.. .........+.+++.+||+.||.+||++.||+++|+.
T Consensus 232 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 AL--------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred CC--------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 1112233568889999999999999999999999974
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=365.24 Aligned_cols=258 Identities=28% Similarity=0.412 Sum_probs=211.3
Q ss_pred hcCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~ 310 (608)
.++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+.+++++ +|+||++++++|..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35788899999999999999984 3467899999976543 3456789999999999 89999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGR----------------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL 374 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl 374 (608)
.++||||+++++|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+||||
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999986543 2489999999999999999999999 99999999999999
Q ss_pred ccCCceEEEEeeccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccch
Q 046502 375 DFKFEAKVADFGLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDN 452 (608)
Q Consensus 375 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 452 (608)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||+||||++ |+.||...... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~- 255 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD--S- 255 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS--H-
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch--h-
Confidence 99999999999999876543222 2234567889999999999999999999999999999998 99998754321 1
Q ss_pred hhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 453 LARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 453 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+...+..+. ... ........+.+++.+||+.||.+||++.||+++|+..
T Consensus 256 ----~~~~~~~~~~-~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 256 ----KFYKMIKEGF-RML--------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp ----HHHHHHHHTC-CCC--------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHhccCC-CCC--------CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1111222221 111 1112235688899999999999999999999999854
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=366.04 Aligned_cols=251 Identities=20% Similarity=0.343 Sum_probs=200.2
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCC-------
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS------- 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~------- 309 (608)
.++|...++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|++++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999965 78999999997543 334577999999999999999999999986654
Q ss_pred --------------------------------------------------eeEEEEeeccCCcHHHHhhcCCC-CCCCHH
Q 046502 310 --------------------------------------------------QRMLVCEFVTSNTLEFHLHGKGR-PTMDWP 338 (608)
Q Consensus 310 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~ 338 (608)
..++||||+++++|.+++..... ....+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 27999999999999999987543 345777
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc-----------ceeeeeecccC
Q 046502 339 TRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-----------HVSTRVMGTFG 407 (608)
Q Consensus 339 ~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~ 407 (608)
.++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8999999999999999998 999999999999999999999999999987654321 12233569999
Q ss_pred ccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHH
Q 046502 408 YLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARM 487 (608)
Q Consensus 408 y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 487 (608)
|+|||++.+..++.++|||||||++|||++|..++... . .+......+.+.. ........+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--------~--~~~~~~~~~~~~~---------~~~~~~~~~ 302 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--------V--RIITDVRNLKFPL---------LFTQKYPQE 302 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--------H--HHHHHHHTTCCCH---------HHHHHCHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--------H--HHHHHhhccCCCc---------ccccCChhH
Confidence 99999999999999999999999999999987664210 0 1111122222211 112334567
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 488 VACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 488 ~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+++..||+.||++||++.||+++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 889999999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=367.22 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=205.3
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG------QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+.+|++++||||++++++|.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 56888999999999999999964 589999999975432 13567899999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC----ceEEEEeecc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGLA 388 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~----~~kl~DFGla 388 (608)
+||||+++++|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999997543 599999999999999999999998 999999999999999887 8999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. .+.. +....+.
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~----~~~~-~~~~~~~ 235 (326)
T 2y0a_A 166 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QE----TLAN-VSAVNYE 235 (326)
T ss_dssp EECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HH----HHHH-HHHTCCC
T ss_pred eECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HH----HHHH-HHhcCCC
Confidence 8765322 22345799999999999999999999999999999999999999965432 11 1111 1111111
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .... .......+.+++..||+.||++||++.|++++
T Consensus 236 ~--~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 236 F--EDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C--CHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred c--Cccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000 01123457889999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=370.90 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=208.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~ 310 (608)
.++|...++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.++ +||||++++++|...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46788999999999999999995 245689999997543 23346788999999999 89999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCC
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGR---------------------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKA 369 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~ 369 (608)
.++||||+++++|.+++..... ..+++..++.|+.||+.||.|||+. +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 9999999999999999986542 2489999999999999999999999 999999999
Q ss_pred CcEEEccCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcc
Q 046502 370 ANILLDFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHT 447 (608)
Q Consensus 370 ~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~ 447 (608)
+||||+.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||+||||++ |+.||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999986644322 22334567889999999999999999999999999999998 9999975432
Q ss_pred cccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 448 FMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 448 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
. . .+...+..+... .........+.+++..||+.||.+||++.||+++|+...
T Consensus 281 ~--~-----~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 333 (344)
T 1rjb_A 281 D--A-----NFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL 333 (344)
T ss_dssp S--H-----HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred H--H-----HHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 1 1 111222222111 111122456888999999999999999999999998643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=399.73 Aligned_cols=256 Identities=30% Similarity=0.443 Sum_probs=210.9
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.++|...++||+|+||.||+|.+.++..||||+++... ...+.|.+|+++|++|+|+|||+++++|.+ +..+|||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 45678889999999999999999888899999998654 345678999999999999999999999876 6789999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.+|+|.++|.......+++..++.|+.||++||.|||++ +|+|||||++||||+.++.+||+|||+++.........
T Consensus 344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 420 (535)
T 2h8h_A 344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420 (535)
T ss_dssp TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHT
T ss_pred cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceec
Confidence 999999999764434689999999999999999999999 99999999999999999999999999998765432222
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++..+.++.++|||||||+||||++ |+.||..... ..++. .+..+...
T Consensus 421 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~-~i~~~~~~--------- 483 (535)
T 2h8h_A 421 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLD-QVERGYRM--------- 483 (535)
T ss_dssp TCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHH-HHHTTCCC---------
T ss_pred ccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH-HHHcCCCC---------
Confidence 233456789999999999999999999999999999999 9999865322 11122 22222111
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.........+.+|+..||+.||++||++.+|++.|+...
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 111223456888999999999999999999999998653
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.72 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=198.4
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCC--CCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHH--KHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~H--pniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++| +||+++++++..++..+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568899999999999999999888999999998754 33344678999999999976 9999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|| +.+++|.+++.... .+++..+..|+.||+.||.|||+. +|+||||||+||||+ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 56789999998754 589999999999999999999999 899999999999997 678999999999876543
Q ss_pred ccc-eeeeeecccCccChhhhhc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 046502 395 YTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 395 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||...... . ..+...+
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~--~~~~~~~ 234 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ----I--SKLHAII 234 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH----H--HHHHHHH
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH----H--HHHHHHh
Confidence 222 2345679999999999975 67899999999999999999999999653221 0 0111111
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
++.....++......+.+++..||+.||.+||++.||+++.
T Consensus 235 ---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 235 ---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 11111112222234678899999999999999999999763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=375.07 Aligned_cols=257 Identities=22% Similarity=0.319 Sum_probs=204.0
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG---QGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~l 313 (608)
.++|...++||+|+||.||+++.. +++.||||+++.... ...+.+.+|+.+|.++ +|||||+++++|.+.+.++|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 367899999999999999999964 578899999975422 2234578899999887 89999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999997654 599999999999999999999999 999999999999999999999999999986332
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCccccc-chhhHHHHHHHHhcCCCCcccC
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME-DNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~d 472 (608)
.. ......+||+.|+|||++.+..++.++|||||||+||||++|+.||........ .......+...+..+.+.
T Consensus 206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---- 280 (396)
T 4dc2_A 206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---- 280 (396)
T ss_dssp TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC----
T ss_pred CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC----
Confidence 21 223456799999999999999999999999999999999999999964322111 111112222333333221
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRI------SQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm------~evv~~ 511 (608)
++......+.+|+..||+.||.+||++ .||+++
T Consensus 281 ------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 281 ------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ------CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 111223467889999999999999985 566654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=366.08 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=210.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
.++|...+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|++++++++|+||++++++|.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 46788899999999999999985 245789999997643 33456789999999999999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCC
Q 046502 312 MLVCEFVTSNTLEFHLHGKGR----------------------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKA 369 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~ 369 (608)
++||||+++++|.+++..... ..+++..++.|+.||++||.|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999986532 3489999999999999999999999 899999999
Q ss_pred CcEEEccCCceEEEEeeccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcc
Q 046502 370 ANILLDFKFEAKVADFGLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHT 447 (608)
Q Consensus 370 ~NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~ 447 (608)
+||||+.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999866443221 2233457889999999999999999999999999999999 9999975432
Q ss_pred cccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 448 FMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 448 ~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.. +...+..+.... ........+.+++..||+.||.+||++.||+++|+..
T Consensus 259 ---~~-----~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ---ER-----LFNLLKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp ---GG-----HHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HH-----HHHHhhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 112222222111 1122345688899999999999999999999999854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=372.75 Aligned_cols=249 Identities=27% Similarity=0.374 Sum_probs=201.2
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~l 313 (608)
.++|...++||+|+||.||+|+.. +|+.||||+++... ....+.+.+|+.+|.++ +|+||++++++|.+.+.+||
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999964 58999999997532 23345678899999998 69999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999997654 489999999999999999999999 999999999999999999999999999985433
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.. ......+||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. ++.. +..+.+.
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~----~~~~-i~~~~~~----- 242 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DD----LFEA-ILNDEVV----- 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HHHH-HHHCCCC-----
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HH----HHHH-HHcCCCC-----
Confidence 21 223446799999999999998999999999999999999999999975432 11 1222 2222211
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRI------SQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm------~evv~~ 511 (608)
++......+.+++..||+.||.+||++ .||+++
T Consensus 243 -----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 -----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred -----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 111223457889999999999999998 777764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=371.31 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=204.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC-----CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG-----SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
+.|...++||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.++++++||||++++++|.+++..+|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 5688999999999999999985 46899999998632 12245678999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc---eEEEEeecc
Q 046502 314 VCEFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLA 388 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~---~kl~DFGla 388 (608)
||||+++++|.+++... ....+++..++.|+.||+.||.|||++ +|+||||||+||||+.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999998877643 233589999999999999999999999 9999999999999987655 999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
+....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... . +.. .+..+.+.
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~----~~~-~i~~~~~~ 250 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----R----LFE-GIIKGKYK 250 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----H----HHH-HHHHTCCC
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----H----HHH-HHHcCCCC
Confidence 87654322 23345799999999999999999999999999999999999999975321 1 111 12222221
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .+.... .....+.+++.+||+.||++||++.|++++
T Consensus 251 ~--~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 M--NPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--Cccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 110001 123467889999999999999999999874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=373.47 Aligned_cols=262 Identities=18% Similarity=0.273 Sum_probs=205.1
Q ss_pred hcCCCcCCccccC--CceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 239 TDGFSDANLLGQG--GFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
.++|...++||+| +||.||+|... +|+.||||+++... ....+.+.+|+.++++++|+|||+++++|.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578899999999 99999999965 68999999997543 3345678899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+++++|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||++.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999876555799999999999999999999999 999999999999999999999999999865432
Q ss_pred ccc------ceeeeeecccCccChhhhhc--CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 394 VYT------HVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 394 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
... .......||..|+|||++.+ ..++.++|||||||+||||++|+.||...... +.+.. .+ .+
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~-~~-----~~ 252 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLE-KL-----NG 252 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST--THHHH-C--------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-Hh-----cC
Confidence 111 11122468999999999987 57999999999999999999999999754321 11100 00 00
Q ss_pred CCCcccCcc------------------------------------ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 046502 466 NFDTLVDPK------------------------------------LHNEYNHNEMARMVACAAACVRHSARRRPRISQIV 509 (608)
Q Consensus 466 ~~~~~~d~~------------------------------------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv 509 (608)
.+..+.+.. ....+.......+.+|+.+||+.||.+||++.|++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 000000000 00011222345688999999999999999999999
Q ss_pred HH
Q 046502 510 RT 511 (608)
Q Consensus 510 ~~ 511 (608)
++
T Consensus 333 ~h 334 (389)
T 3gni_B 333 NH 334 (389)
T ss_dssp TS
T ss_pred cC
Confidence 75
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=357.73 Aligned_cols=254 Identities=30% Similarity=0.425 Sum_probs=210.7
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...+.||+|+||.||+|...+++.||||+++.... ..+.+.+|++++++++|+||++++++|.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 56888899999999999999988889999999986543 34678999999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++..........
T Consensus 87 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 87 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp TCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 999999997653 3589999999999999999999999 899999999999999999999999999987654322223
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..... . ... ..+..+.. ...
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~----~~~-~~i~~~~~--~~~------ 226 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---S----EVV-EDISTGFR--LYK------ 226 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H----HHH-HHHHTTCC--CCC------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---H----HHH-HHHhcCCc--CCC------
Confidence 33457788999999999999999999999999999999 8999875432 1 111 12222211 111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.......+.+++.+||+.||++||++.||+++|+..
T Consensus 227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 227 -PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111234678899999999999999999999999754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=373.05 Aligned_cols=253 Identities=21% Similarity=0.331 Sum_probs=209.1
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...++||+|+||.||+|... +|+.||+|++..........+.+|+.+|++++|+||++++++|.+.+..+|||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467899999999999999999964 6899999999876666667899999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc--CCceEEEEeeccccccCcc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF--KFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~--~~~~kl~DFGla~~~~~~~ 395 (608)
+.+++|.+++.... ..+++..++.++.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999987543 3589999999999999999999998 9999999999999974 4779999999998765432
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ..+.. +..+.+. .+...
T Consensus 206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~~~~~-i~~~~~~--~~~~~ 273 (387)
T 1kob_A 206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQN-VKRCDWE--FDEDA 273 (387)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHHH-HHHCCCC--CCSST
T ss_pred --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------HHHHH-HHhCCCC--CCccc
Confidence 233457999999999999999999999999999999999999999754321 11111 2222211 11111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .....+.+++..||+.||++||++.|++++
T Consensus 274 ~~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 274 FS----SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11 223467889999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=359.56 Aligned_cols=263 Identities=19% Similarity=0.274 Sum_probs=201.0
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|...++||+|+||.||+|... +|+.||||+++... ......+.+|+.++++++|+||++++++|.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999964 68999999997543 2334678899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.++.+..+.... ..+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred cCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99875554444333 3599999999999999999999999 999999999999999999999999999987654322
Q ss_pred ceeeeeecccCccChhhhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhc---CCCCcc--
Q 046502 397 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIED---GNFDTL-- 470 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~-- 470 (608)
......||..|+|||++.+.. ++.++|||||||++|||++|..||...... ......+.. .... ..+..+
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~-~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFR-LLGTPTEEQWPSMTK 232 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHH-HHCCCCTTTCTTGGG
T ss_pred -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHH-HhCCCChhhhhhhcc
Confidence 233457899999999997766 899999999999999999999886433221 111111111 1100 000000
Q ss_pred -cC---------ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 -VD---------PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 -~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+ ..............+.+++..||+.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000011112334567899999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=368.64 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=191.7
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
..++|...++||+|+||.||+|... +++.||||+++... ..+.+.+|+++|++++|+||++++++|...+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3577999999999999999999965 57899999997543 34568899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---CCceEEEEeeccccccC
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGLAKLASD 393 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---~~~~kl~DFGla~~~~~ 393 (608)
|+++++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999997654 589999999999999999999999 9999999999999975 88999999999986654
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
. .......||+.|+|||++.+..++.++|||||||+||||++|+.||...... . .+...+..+.+.. ..
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~-----~~~~~i~~~~~~~-~~- 272 (349)
T 2w4o_A 204 Q--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--Q-----FMFRRILNCEYYF-IS- 272 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--H-----HHHHHHHTTCCCC-CT-
T ss_pred c--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--H-----HHHHHHHhCCCcc-CC-
Confidence 2 1233467999999999999999999999999999999999999999654321 1 1112222222211 11
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.........+.+++.+||+.||++||++.|++++
T Consensus 273 ----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 ----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111233467889999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=372.22 Aligned_cols=209 Identities=25% Similarity=0.317 Sum_probs=183.6
Q ss_pred ccCHHHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-----CCCcccee
Q 046502 229 TFTYEELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-----HKHLVSLV 302 (608)
Q Consensus 229 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-----Hpniv~l~ 302 (608)
.|++.+.....++|...++||+|+||.||+|.. .+++.||||+++.. ....+.+..|+.+++++. |+||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 345555555678999999999999999999996 56899999999743 344566788999999997 99999999
Q ss_pred eEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc------
Q 046502 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF------ 376 (608)
Q Consensus 303 g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~------ 376 (608)
++|...+..+|||||+ +++|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 178 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKS 178 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEE
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccccc
Confidence 9999999999999999 89999999877666799999999999999999999998 9999999999999975
Q ss_pred -------------------CCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh
Q 046502 377 -------------------KFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII 437 (608)
Q Consensus 377 -------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt 437 (608)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 179 LITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHH
Confidence 789999999999865442 234578999999999999999999999999999999999
Q ss_pred CCCCCCCCc
Q 046502 438 GCRPVDSTH 446 (608)
Q Consensus 438 G~~p~~~~~ 446 (608)
|+.||....
T Consensus 255 g~~pf~~~~ 263 (360)
T 3llt_A 255 GSLLFRTHE 263 (360)
T ss_dssp SSCSCCCSS
T ss_pred CCCCCCCCc
Confidence 999997643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=356.59 Aligned_cols=255 Identities=29% Similarity=0.433 Sum_probs=209.5
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.++|...+.||+|+||.||+|...+++.||||+++... ...+.+.+|++++++++|+||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 46788899999999999999998888899999997654 34567899999999999999999999986 45689999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 999999999754333589999999999999999999999 99999999999999999999999999998765533323
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++.++.++.++|||||||++|||++ |+.||..... .. ++ ..+..+... .
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~----~~-~~~~~~~~~-~------- 230 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PE----VI-QNLERGYRM-V------- 230 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HH----HH-HHHHTTCCC-C-------
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HH----HH-HHHhcccCC-C-------
Confidence 334457889999999998899999999999999999999 8999865432 11 11 122222110 0
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
........+.+++..||+.||++||++.+|++.|+..
T Consensus 231 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 1112235688899999999999999999999999854
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=357.15 Aligned_cols=261 Identities=18% Similarity=0.213 Sum_probs=209.3
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++.++ +|+||+++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35789999999999999999995 678999999986543 234578899999999 79999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc-----eEEEEeeccccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE-----AKVADFGLAKLA 391 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~-----~kl~DFGla~~~ 391 (608)
|+ +++|.+++...+. .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 9999999986543 599999999999999999999998 9999999999999987776 999999999876
Q ss_pred cCcccc------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 392 SDVYTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 392 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
...... ......||..|+|||++.+..++.++|||||||+||||++|+.||..............+.... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK-QST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-HHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc-cCc
Confidence 543221 2344679999999999999999999999999999999999999997643221111111111111 001
Q ss_pred CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 466 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 466 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.... +.. .....+.+++..||+.||++||++.+|++.|+...
T Consensus 241 ~~~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 241 PLRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp CHHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cHHH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 1101 111 22356888999999999999999999999998643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=377.54 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=207.5
Q ss_pred HHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
...++|...++||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+.++++++|||||+++++|.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3456799999999999999999985 5689999999975432 334678899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc---cCCceEEEEeecccc
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD---FKFEAKVADFGLAKL 390 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~---~~~~~kl~DFGla~~ 390 (608)
||||+.+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||||+ .++.+||+|||+++.
T Consensus 88 v~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp EECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999999987654 599999999999999999999999 999999999999998 457899999999987
Q ss_pred ccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
...... ......||+.|+|||++.+..++.++|||||||+||+|++|+.||..... . .+...+..+.+...
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~---~-----~~~~~i~~~~~~~~ 233 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ---H-----RLYQQIKAGAYDFP 233 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH---H-----HHHHHHHHTCCCCC
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH---H-----HHHHHHHhCCCCCC
Confidence 654322 23346799999999999998999999999999999999999999965432 1 11222333332211
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+.+ ......+.+++..||+.||.+||++.|++++
T Consensus 234 -~~~~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 -SPEW-----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -TTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -cccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1111 1223467889999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=359.40 Aligned_cols=262 Identities=22% Similarity=0.336 Sum_probs=200.7
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||+|...+|+.||||+++..... ..+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 578889999999999999999878999999999754322 236788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.+ +|.+++.... ..+++..+..++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence 986 8888887543 3589999999999999999999999 999999999999999999999999999986643221
Q ss_pred eeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC---CCc----
Q 046502 398 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN---FDT---- 469 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---~~~---- 469 (608)
......||..|+|||++.+. .++.++|||||||++|||++|+.||...... +.+ .... +.+.... +..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~-~~~~-~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA--DQL-MRIF-RILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH-HHHH-HHHCCCCTTTSTTGGGS
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHH-HHHCCCChhhchhhhcc
Confidence 22345689999999999764 5899999999999999999999999754321 111 1111 1111000 000
Q ss_pred -ccCcccc-------CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 -LVDPKLH-------NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 -~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..++.+. ..+.......+.+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0011100 01112234567899999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=371.77 Aligned_cols=266 Identities=17% Similarity=0.189 Sum_probs=203.7
Q ss_pred hcCCCcCCccccCCceEEEEEEecC------CcEEEEEEcccCCchhH-----------HHHHHHHHHHHhcCCCCccce
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPN------GKEVAIKQLKAGSGQGE-----------RVFQAEVEIISRVHHKHLVSL 301 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~Ev~~l~~l~Hpniv~l 301 (608)
.++|...++||+|+||.||+|.+.+ ++.||||++........ ..+..|+..+..++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4578999999999999999998754 47899999876543211 123446666777889999999
Q ss_pred eeEEEeC----CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc--
Q 046502 302 VGYYTAG----SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD-- 375 (608)
Q Consensus 302 ~g~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~-- 375 (608)
+++|... ...+|||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+. +|+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 9998764 4589999999 999999998653 3699999999999999999999999 999999999999999
Q ss_pred cCCceEEEEeeccccccCcccce------eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccc
Q 046502 376 FKFEAKVADFGLAKLASDVYTHV------STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM 449 (608)
Q Consensus 376 ~~~~~kl~DFGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~ 449 (608)
.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~- 267 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD- 267 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC-
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC-
Confidence 88999999999998765432211 13345999999999999999999999999999999999999999743211
Q ss_pred cchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 450 EDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 450 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
..... ...... ...+..+++..+.. ......+.+++..||+.+|.+||++.+|++.|+...
T Consensus 268 -~~~~~-~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 268 -PKYVR-DSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp -HHHHH-HHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred -HHHHH-HHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 11111 111111 11223333333221 122356788999999999999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=372.45 Aligned_cols=249 Identities=23% Similarity=0.321 Sum_probs=199.5
Q ss_pred CcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCC
Q 046502 243 SDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
...++||+|+||.||+|.. .+|+.||||+++.......+.|.+|+++|++++|+||++++++|.+.+..+|||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3357899999999999985 568999999998776667788999999999999999999999999999999999999999
Q ss_pred cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE--ccCCceEEEEeeccccccCccccee
Q 046502 322 TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL--DFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 322 sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl--~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+|.+++.... ..+++..++.|+.||++||.|||+. +|+||||||+|||| +.++.+||+|||+++...... ..
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 9998887543 2589999999999999999999999 89999999999999 567899999999998765432 22
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
....||+.|+|||++....++.++|||||||+||||++|+.||..... . ..+...+. ..+. +.+ ....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~----~~~~~i~~-~~~~-~~~-~~~~-- 313 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND---A----ETLNNILA-CRWD-LED-EEFQ-- 313 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH---H----HHHHHHHH-TCCC-SCS-GGGT--
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---H----HHHHHHHh-ccCC-CCh-hhhc--
Confidence 335699999999999998999999999999999999999999975432 1 11222222 1111 001 1111
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.....+.+|+..||+.||.+||++.|++++
T Consensus 314 --~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 --DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp --TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 223567889999999999999999999974
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=362.19 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=205.3
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|+||.||+++.. +|+.||||+++... ....+.+.+|+.+++.++||||++++++|.+.+..++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 357889999999999999999964 68999999997532 22345678899999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++|+|.+++.... .+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 99999999999998654 589999999999999999999998 9999999999999999999999999999876542
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||..... . ......+ .+.+.
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~----~~~~~i~-~~~~~------ 221 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT---M----KTYEKIL-NAELR------ 221 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---H----HHHHHHH-HCCCC------
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---H----HHHHHHH-hCCCC------
Confidence 2346799999999999999999999999999999999999999975432 1 1122222 22211
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
+ +......+.+++.+||+.||.+|| ++.||+++
T Consensus 222 ~----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 222 F----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C----CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 1 112234678899999999999999 88888864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=365.11 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=204.4
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++||+|+||.||+++.. +++.||||+++... ....+.+.+|+.++.++ +||||++++++|.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999964 58899999997542 23345688899999998 899999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999997643 589999999999999999999999 9999999999999999999999999999864322
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc-hhhHHHHHHHHhcCCCCcccCc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED-NLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
. .......||+.|+|||++.+..++.++|||||||+||||++|+.||......... ......+...+..+.+.
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----- 237 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----- 237 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC-----
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC-----
Confidence 1 2234467999999999999999999999999999999999999999753221110 01111222223233221
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRI------SQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm------~evv~~ 511 (608)
++......+.+++..||+.||.+||++ .||+++
T Consensus 238 -----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 238 -----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 111223467889999999999999995 566543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=384.36 Aligned_cols=258 Identities=22% Similarity=0.268 Sum_probs=207.5
Q ss_pred HHHHHhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 046502 234 ELARATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS 309 (608)
Q Consensus 234 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~ 309 (608)
++....++|...++||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.+++.++|||||+++++|.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 44445688999999999999999999964 58899999986421 112234788999999999999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
.+||||||+++|+|.+++... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999999764 489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcCC----CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSGK----LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
.............+||+.|+|||++.... ++.++|||||||+||||++|+.||..... ......++.... .-
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~~~i~~~~~-~~ 292 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTYSKIMNHKN-SL 292 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHTHHH-HC
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHHHHHHhccc-cc
Confidence 76654333344578999999999998665 78999999999999999999999975432 111111111100 00
Q ss_pred CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 046502 466 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR--RPRISQIVRT 511 (608)
Q Consensus 466 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~--RPsm~evv~~ 511 (608)
.+.. + . .....+.+|+.+||+.+|.+ ||++.||+++
T Consensus 293 ~~p~--~----~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 293 TFPD--D----N----DISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCCT--T----C----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cCCC--c----c----cccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1110 0 1 12345778999999999988 9999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=356.97 Aligned_cols=250 Identities=20% Similarity=0.297 Sum_probs=206.1
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~lV~ 315 (608)
++|...++||+|+||.||+|.. +++.||||+++... ....+.|.+|+.++++++|+||++++++|.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5788899999999999999998 58899999997653 34456799999999999999999999999877 7789999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK--IIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||+++++|.+++.......+++..++.|+.|++.||.|||+. + |+||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999887666799999999999999999999998 6 99999999999999999999999998764332
Q ss_pred cccceeeeeecccCccChhhhhcCCCCC---cchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTE---KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
....||+.|+|||++.+..++. ++|||||||++|||++|+.||...... .........+...
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~-- 230 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVALEGLRP-- 230 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHHSCCCC--
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHhcCCCC--
Confidence 2246899999999998765554 899999999999999999999754321 1112222222111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+ .......+.+++..||+.||++||++.||++.|+..
T Consensus 231 ---~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 231 ---TI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ---CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11 122334688899999999999999999999999753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.91 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=197.5
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch--------------------------hHHHHHHHHHHHH
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ--------------------------GERVFQAEVEIIS 291 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--------------------------~~~~~~~Ev~~l~ 291 (608)
.++|...++||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+++|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36789999999999999999985 46889999999654311 1246889999999
Q ss_pred hcCCCCccceeeEEEe--CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCC
Q 046502 292 RVHHKHLVSLVGYYTA--GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKA 369 (608)
Q Consensus 292 ~l~Hpniv~l~g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~ 369 (608)
+++|+||+++++++.+ ++..++||||+++++|.+++.. ..+++..++.++.||++||.|||+. +|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999986 5688999999999999886543 3699999999999999999999999 999999999
Q ss_pred CcEEEccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 046502 370 ANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELIIGCRPVDSTH 446 (608)
Q Consensus 370 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~Gvll~elltG~~p~~~~~ 446 (608)
+||||+.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||+||||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 999999999999999999987654322 233467999999999997655 3778999999999999999999997543
Q ss_pred ccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 447 TFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 447 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .+...+..+.+..... . .....+.+++.+||+.||++||++.||+++
T Consensus 245 ~~--------~~~~~~~~~~~~~~~~----~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 IM--------CLHSKIKSQALEFPDQ----P----DIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HH--------HHHHHHHHCCCCCCSS----S----CCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HH--------HHHHHHhcccCCCCCc----c----ccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 21 1111222222211100 1 123457889999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.61 Aligned_cols=257 Identities=29% Similarity=0.481 Sum_probs=196.5
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||+|... ..||||+++... ....+.|.+|+.++++++|+||+++++++ .....++||||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred cceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 57888999999999999999853 369999997543 33456799999999999999999999976 45678999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc-cc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-YT 396 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~-~~ 396 (608)
+.+++|.+++.... ..+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++..... ..
T Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 176 (289)
T 3og7_A 101 CEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS 176 (289)
T ss_dssp CCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----------
T ss_pred cCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccccc
Confidence 99999999997543 3699999999999999999999999 9999999999999999999999999999865432 12
Q ss_pred ceeeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 397 HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.......||..|+|||++. ...++.++|||||||++|||++|+.||...... + .+...+..+.+.....
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~-----~~~~~~~~~~~~~~~~- 248 (289)
T 3og7_A 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR--D-----QIIEMVGRGSLSPDLS- 248 (289)
T ss_dssp -------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH--H-----HHHHHHHHTSCCCCTT-
T ss_pred ccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH--H-----HHHHHhcccccCcchh-
Confidence 2234467999999999986 567888999999999999999999999754321 1 1222233333222111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.........+.+++..||+.||.+||++.||++.|+..
T Consensus 249 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 249 ----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp ----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 11223345788999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=356.18 Aligned_cols=251 Identities=33% Similarity=0.575 Sum_probs=202.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhH-------HHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGE-------RVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~-------~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
++|...++||+|+||.||+|.. .+++.||||++........ +.+.+|+.++++++|+||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5788889999999999999996 5789999999865432211 57889999999999999999999986554
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeeccCCCcEEEccCCc-----eEEEE
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK--IIHRDIKAANILLDFKFE-----AKVAD 384 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--iiHrDIk~~NILl~~~~~-----~kl~D 384 (608)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. + |+||||||+||||+.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999998887654 3699999999999999999999998 7 999999999999988776 99999
Q ss_pred eeccccccCcccceeeeeecccCccChhhh--hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 046502 385 FGLAKLASDVYTHVSTRVMGTFGYLAPEYA--SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 385 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
||+++.... ......|+..|+|||++ ....++.++|||||||++|||++|+.||....... . .+.....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~--~~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK---I--KFINMIR 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH---H--HHHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH---H--HHHHHHh
Confidence 999985443 23446799999999998 44567899999999999999999999997543211 1 1111111
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
..+ ... .........+.+++..||+.||.+||++.||++.|+.
T Consensus 244 ~~~-~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 244 EEG-LRP--------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HSC-CCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ccC-CCC--------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 211 111 1122234568899999999999999999999999974
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=354.32 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=203.9
Q ss_pred cCCCcCCccccCCceEEEEEEecC-C-------cEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-G-------KEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
++|...+.||+|+||.||+|.... + +.||+|++........+.+.+|+.++++++|+||++++++|.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 578889999999999999998543 3 47999999877666778899999999999999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc--------eEEE
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE--------AKVA 383 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~--------~kl~ 383 (608)
++||||+.+++|.+++..... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++. +||+
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGG-GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred EEEEECCCCCCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeec
Confidence 999999999999999986542 489999999999999999999999 8999999999999999887 9999
Q ss_pred EeeccccccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 046502 384 DFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 384 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
|||+++..... ....|+..|+|||++.+ ..++.++|||||||++|||++|..++...... . .......
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~--~----~~~~~~~ 232 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS--Q----RKLQFYE 232 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--H----HHHHHHH
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch--H----HHHHHhh
Confidence 99999765432 22458899999999987 67999999999999999999965554322110 0 0111111
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
....+... ....+.+++..||+.||.+||++.||+++|+...
T Consensus 233 ~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 233 DRHQLPAP------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp TTCCCCCC------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred ccCCCCCC------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11111111 1234778999999999999999999999998654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=375.18 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=198.6
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcC--CCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVH--HKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~--Hpniv~l~g~~~~~~~~~lV~ 315 (608)
+.|...++||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+|+ |+||+++++++...+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999878999999998654 3344577899999999996 599999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
| +.+++|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 67889999998754 589999999999999999999998 899999999999995 5799999999998765432
Q ss_pred cc-eeeeeecccCccChhhhhc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 396 TH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 396 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
.. ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ..+...+
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~~~~- 281 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAII- 281 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHH-
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH------HHHHHHh-
Confidence 21 2344679999999999975 468999999999999999999999996532210 0111111
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
..... ..++......+.+|+..||+.||.+||++.||+++-
T Consensus 282 ~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 282 DPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Ccccc--------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 11111 111111234678899999999999999999999753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=370.63 Aligned_cols=264 Identities=29% Similarity=0.355 Sum_probs=211.8
Q ss_pred cCCCcCCccccCCceEEEEEEe-----cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEE--eCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-----PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT--AGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~--~~~~~~ 312 (608)
++|...++||+|+||.||+|.+ .+++.||||++........+.+.+|++++++++|+||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999984 468899999998877667778999999999999999999999987 456789
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+++++|.+++..... .+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 99999999999999976432 589999999999999999999998 99999999999999999999999999998765
Q ss_pred Ccccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchh-------hHHHHHHHHh
Q 046502 393 DVYTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL-------ARPLLNRAIE 463 (608)
Q Consensus 393 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l-------~~~~~~~~~~ 463 (608)
..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........... ....+...+.
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 43221 22335678889999999999999999999999999999999999864322100000 0001111122
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.+. ...........+.+++..||+.||.+||++.||+++|+...
T Consensus 259 ~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 259 EGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred ccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 221 11122233456889999999999999999999999998653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=364.83 Aligned_cols=258 Identities=25% Similarity=0.360 Sum_probs=194.3
Q ss_pred hcCCCcCCccccCCceEEEEEEecCC-c---EEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee-
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNG-K---EVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR- 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g-~---~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~- 311 (608)
.++|...++||+|+||.||+|..... + .||||+++.. .....+.+.+|++++++++|+||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 46799999999999999999996443 2 7999999764 334457899999999999999999999999877665
Q ss_pred -----EEEEeeccCCcHHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEE
Q 046502 312 -----MLVCEFVTSNTLEFHLHGKG----RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382 (608)
Q Consensus 312 -----~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl 382 (608)
++||||+.+++|.+++.... ...+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 99999999999999986432 22589999999999999999999999 9999999999999999999999
Q ss_pred EEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHH
Q 046502 383 ADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 383 ~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||...... . +...
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~----~~~~ 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---E----IYNY 251 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---G----HHHH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---H----HHHH
Confidence 9999998664322 122233456889999999999999999999999999999999 99998754321 1 1222
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
........ ........+.+++.+||+.||.+||++.+|++.|+...
T Consensus 252 ~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 252 LIGGNRLK----------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHTTCCCC----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCCCC----------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22211111 11223356889999999999999999999999998653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=371.42 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=203.3
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||++.. .+++.||||++.... ....+.+.+|+.+|++++|||||+++++|.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5788999999999999999995 458899999986432 233467889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 9999999999998643 599999999999999999999999 9999999999999999999999999999876542
Q ss_pred cceeeeeecccCccChhhhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 396 THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
.......||+.|+|||++.. ..++.++|||||||+||||++|+.||.......... +. ..+.....
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~----~~-~~~~~~~~----- 237 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE----IV-HTFETTVV----- 237 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH----HH-HHHHHCCC-----
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH----HH-HHHhhccc-----
Confidence 22345679999999999964 458999999999999999999999997543211111 11 11221111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPR-ISQIVR 510 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-m~evv~ 510 (608)
.++......+.+++..||+.||.+||+ +.+|++
T Consensus 238 -----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 -----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred -----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111223356888999999999999998 777765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=361.90 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=195.6
Q ss_pred cCCCcCCccccCCceEEEEEEe----cCCcEEEEEEcccCC----chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL----PNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
++|...++||+|+||.||+++. .+|+.||||+++... ......+.+|+.+|++++|+||++++++|..++..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5788999999999999999986 478999999997642 22345678899999999999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+++++|.+++...+ .+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999997644 488999999999999999999999 9999999999999999999999999999854
Q ss_pred cCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. .+.... .+.+.
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~----~~~~i~-~~~~~--- 239 (327)
T 3a62_A 172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KK----TIDKIL-KCKLN--- 239 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH----HHHHHH-HTCCC---
T ss_pred ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HH----HHHHHH-hCCCC---
Confidence 33211 23345799999999999999999999999999999999999999975432 11 122222 12111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
+ +......+.+++.+||+.||.+|| ++.||+++
T Consensus 240 ---~----p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 240 ---L----PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---C----CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---C----CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1 112234678899999999999999 77888875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=365.32 Aligned_cols=259 Identities=29% Similarity=0.399 Sum_probs=206.3
Q ss_pred CCcCCccccCCceEEEEEEe-----cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeC--CeeEE
Q 046502 242 FSDANLLGQGGFGYVHKGVL-----PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQRML 313 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~~l 313 (608)
|...++||+|+||.||++.+ .+++.||||+++.... ...+.|.+|+++|++++|+||++++++|.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 47889999999999999864 2678999999986543 3456789999999999999999999999874 67899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+++++|.+++... .+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999765 389999999999999999999999 899999999999999999999999999987654
Q ss_pred ccc--ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCccccc-------chhhHHHHHHHHhc
Q 046502 394 VYT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME-------DNLARPLLNRAIED 464 (608)
Q Consensus 394 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~-------~~l~~~~~~~~~~~ 464 (608)
... .......++..|+|||++.+..++.++|||||||++|||++|+.||........ .......+...+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 322 223345678889999999999999999999999999999999999864321100 00011111222222
Q ss_pred CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 465 GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 465 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
+.. ..........+.+++.+||+.||++||++.||++.|+..
T Consensus 267 ~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 267 GER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 211 112223345788999999999999999999999999854
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=361.05 Aligned_cols=262 Identities=22% Similarity=0.341 Sum_probs=189.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...++||+|+||.||+|.. .+|+.||||+++..... ..+.+.+|+.++++++|+||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45788999999999999999985 46899999999754322 33668899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 317 FVTSNTLEFHLHGK----GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 317 ~~~~gsL~~~l~~~----~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
|+. ++|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 5888887643 223589999999999999999999998 99999999999999999999999999998765
Q ss_pred CcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc-
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL- 470 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~- 470 (608)
.... ......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... .....+.. .+ +.....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~-~~--~~~~~~~ 232 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFD-IM--GTPNESL 232 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH-HH--CSCCTTT
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHH-Hh--CCCChhH
Confidence 3222 2234568999999999976 46899999999999999999999999754321 11111111 11 100000
Q ss_pred ---------cCccc------------cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 ---------VDPKL------------HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ---------~d~~l------------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+.+ ...........+.+++..||+.||++||++.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000 000011123468899999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=380.48 Aligned_cols=263 Identities=20% Similarity=0.235 Sum_probs=208.5
Q ss_pred CHHHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEE
Q 046502 231 TYEELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYT 306 (608)
Q Consensus 231 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~ 306 (608)
.++++....++|...++||+|+||.||+++. .+|+.||||+++.... ...+.+.+|+.++.+++|+||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3445555678999999999999999999996 4689999999975321 12234788999999999999999999999
Q ss_pred eCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 307 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
+.+.+||||||+++|+|.+++...+. .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGE-RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999976432 589999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhh-------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYAS-------SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 459 (608)
+++.............+||+.|+|||++. .+.++.++|||||||+||||++|+.||..... ......++.
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~ 284 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGKIVH 284 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHHHHT
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHHHHh
Confidence 99876554333334568999999999997 35689999999999999999999999975432 111111111
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCC---CCHHHHHHH
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRR---PRISQIVRT 511 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R---Psm~evv~~ 511 (608)
.. ..-.+ +.+ .......+.+++.+||+ +|.+| |++.||+++
T Consensus 285 ~~-~~~~~-----p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YK-EHLSL-----PLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HH-HHCCC-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cc-cCcCC-----Ccc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00 00111 111 11223467889999999 99998 689998865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=368.83 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=201.8
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcE----EEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKE----VAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...++||+|+||.||+|... +++. ||+|++.... ......+.+|+.++++++|+||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888999999999999999953 4443 7888875432 223345778999999999999999999986 466899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+++|.+++.... ..+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999997643 3689999999999999999999999 899999999999999999999999999987654
Q ss_pred ccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
... .......|+..|+|||++.++.++.++|||||||+||||++ |+.||...... . +...+..+.....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~-----~~~~~~~~~~~~~- 238 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---E-----VPDLLEKGERLAQ- 238 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---H-----HHHHHHTTCBCCC-
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---H-----HHHHHHcCCCCCC-
Confidence 322 22344668889999999999999999999999999999999 99999754321 1 1122222221111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+ ......+.+++..||+.||.+||++.||+++|+...
T Consensus 239 -~-------~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 239 -P-------QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -C-------TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -C-------CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111224678999999999999999999999998653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.22 Aligned_cols=245 Identities=24% Similarity=0.304 Sum_probs=205.4
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||++... +|+.||||+++... ....+.+.+|+.+|++++||||+++++++.+.+..+|||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67889999999999999999964 68999999986532 223457888999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++...+ .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999998654 489999999999999999999998 9999999999999999999999999999876542
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||..... . .+. ..+..+.+. +
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~----~~~-~~i~~~~~~------~ 257 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---I----QIY-EKIVSGKVR------F 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H----HHH-HHHHHCCCC------C
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH---H----HHH-HHHHcCCCC------C
Confidence 2345799999999999999999999999999999999999999975432 1 112 222223221 1
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPR-----ISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~~ 511 (608)
+......+.+++..||+.||.+||+ +.||+++
T Consensus 258 ----p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 258 ----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1122346788999999999999998 8888764
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=357.11 Aligned_cols=267 Identities=20% Similarity=0.284 Sum_probs=200.3
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.++|...++||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++|+||++++++|...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367899999999999999999964 589999999865433 23467889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+++|.+++.... .+++..+..|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 82 e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp ECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999999887543 589999999999999999999999 99999999999999999999999999998765432
Q ss_pred cceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHH-------HHHHHhcCCC
Q 046502 396 THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL-------LNRAIEDGNF 467 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~-------~~~~~~~~~~ 467 (608)
. ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||............... ....+....+
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 2 2234578999999999976 67899999999999999999999999765431111000000 0000111100
Q ss_pred -C--cccCccccCc---CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 -D--TLVDPKLHNE---YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 -~--~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .+.++..... ........+.+++..||+.||.+||++.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0 0001000000 001233457889999999999999999999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=357.08 Aligned_cols=253 Identities=29% Similarity=0.443 Sum_probs=198.4
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...++||+|+||.||+|.. .++.||||++... ...+.|.+|++++++++|+||++++++|. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5678889999999999999997 5789999999753 34567899999999999999999999886 45899999999
Q ss_pred CCcHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc-eEEEEeeccccccCcccc
Q 046502 320 SNTLEFHLHGKGR-PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE-AKVADFGLAKLASDVYTH 397 (608)
Q Consensus 320 ~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~-~kl~DFGla~~~~~~~~~ 397 (608)
+++|.+++..... ..+++..++.++.|+++||.|||+....+|+||||||+||||+.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986543 34789999999999999999999942228999999999999998886 799999999765432
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....||..|+|||++.+..++.++|||||||++|||++|+.||+...... . ... .....+....+ ..
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~--~~~-~~~~~~~~~~~-----~~ 227 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA---F--RIM-WAVHNGTRPPL-----IK 227 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH---H--HHH-HHHHTTCCCCC-----BT
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH---H--HHH-HHHhcCCCCCc-----cc
Confidence 223468999999999999999999999999999999999999997533211 0 111 11222222111 12
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
. ....+.+++.+||+.||.+||++.||+++|+...
T Consensus 228 ~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 228 N----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred c----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 2 2345788999999999999999999999998653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=354.99 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=203.7
Q ss_pred hcCCCcCCccccCCceEEEEEEecC----CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
.++|...++||+|+||.||+|...+ +..||||+++... ....+.|.+|+.++++++|+||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678889999999999999998543 2369999997653 3445779999999999999999999999865 45789
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999997643 3589999999999999999999998 999999999999999999999999999987654
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
..........++..|+|||++.+..++.++|||||||++|||++ |+.||...... .. . ..+..+.....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~----~-~~~~~~~~~~~-- 235 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DV----I-GVLEKGDRLPK-- 235 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GH----H-HHHHHTCCCCC--
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HH----H-HHHhcCCCCCC--
Confidence 33323344557889999999999999999999999999999998 99999754321 11 1 11222211111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.......+.+++.+||+.||++||++.||+++|+...
T Consensus 236 -------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 236 -------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp -------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 1112345888999999999999999999999998643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=357.00 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=205.3
Q ss_pred cCCCcCCccccCCceEEEEEEe-----cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeC--Cee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-----PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG--SQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~--~~~ 311 (608)
+.|...++||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++++++|+||++++++|... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999983 468899999997543 33456789999999999999999999999876 668
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+++++|.+++.... ..+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999996543 2589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCccc--ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccc-------cchhhHHHHHHHH
Q 046502 392 SDVYT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM-------EDNLARPLLNRAI 462 (608)
Q Consensus 392 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~-------~~~l~~~~~~~~~ 462 (608)
..... .......||..|+|||++.+..++.++|||||||++|||++|+.|+....... ........+...+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 54322 22334567888999999999999999999999999999999998864321100 0000111111222
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
..+.. ..........+.+++..||+.||.+||++.||++.|+.
T Consensus 257 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 257 KEGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred hccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 22211 11122334568899999999999999999999999974
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=361.06 Aligned_cols=259 Identities=25% Similarity=0.406 Sum_probs=210.2
Q ss_pred hcCCCcCCccccCCceEEEEEEec--------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeC
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP--------NGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAG 308 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~ 308 (608)
.++|...+.||+|+||.||+|... +++.||||+++.... ...+.+.+|+.+++++ +|+||++++++|...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888999999999999999863 467899999976533 3456788999999999 899999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGR--------------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL 374 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl 374 (608)
+..++||||+.+++|.+++..... ..+++..++.|+.||+.||.|||+. +|+||||||+||||
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999986532 2489999999999999999999999 99999999999999
Q ss_pred ccCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccch
Q 046502 375 DFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDN 452 (608)
Q Consensus 375 ~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~ 452 (608)
+.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~ 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---HH
Confidence 9999999999999986654322 12233457889999999999899999999999999999999 9999865432 11
Q ss_pred hhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 046502 453 LARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDAS 517 (608)
Q Consensus 453 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~~ 517 (608)
+. ..+..+.... ........+.+++..||+.||.+||++.||++.|+....
T Consensus 268 ----~~-~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 268 ----LF-KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp ----HH-HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HH-HHHhcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11 2222222111 111233568889999999999999999999999987644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=356.98 Aligned_cols=267 Identities=24% Similarity=0.345 Sum_probs=203.3
Q ss_pred HHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhc--CCCCccceeeEEEeC----C
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV--HHKHLVSLVGYYTAG----S 309 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l--~Hpniv~l~g~~~~~----~ 309 (608)
....++|...++||+|+||.||+|.. .|+.||||++... ....+..|.+++..+ +|+||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34457899999999999999999997 4899999998643 233444555665554 899999999999887 7
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeeccCCCcEEEccCCceEEEE
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC-----HPKIIHRDIKAANILLDFKFEAKVAD 384 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~-----~~~iiHrDIk~~NILl~~~~~~kl~D 384 (608)
..++||||+++++|.+++... .+++..++.|+.|++.||.|||..+ ..+|+||||||+||||+.++.+||+|
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~D 185 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD 185 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred ceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEe
Confidence 899999999999999999764 4899999999999999999999762 33799999999999999999999999
Q ss_pred eeccccccCcccce---eeeeecccCccChhhhhcCCCCCc------chhhhHHHHHHHHHhC----------CCCCCCC
Q 046502 385 FGLAKLASDVYTHV---STRVMGTFGYLAPEYASSGKLTEK------SDVFSFGVMLLELIIG----------CRPVDST 445 (608)
Q Consensus 385 FGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k------sDVwS~Gvll~elltG----------~~p~~~~ 445 (608)
||+++......... .....||..|+|||++.+..+..+ +|||||||+||||++| +.||...
T Consensus 186 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp CTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99997664432221 123579999999999988777665 9999999999999999 5555432
Q ss_pred cccccchhhHHHHHHHHhcCCCCcccCccccCc-CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 446 HTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE-YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 446 ~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
... .... ..+.......... +.+... ........+.+++.+||+.||.+||++.||+++|+...
T Consensus 266 ~~~--~~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 330 (337)
T 3mdy_A 266 VPS--DPSY-EDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330 (337)
T ss_dssp SCS--SCCH-HHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC--CCch-hhhHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence 211 1111 1122222212111 111111 12366778999999999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=359.93 Aligned_cols=264 Identities=23% Similarity=0.283 Sum_probs=201.6
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc-----hhHHHHHHHHHHHHhcC---CCCccceeeEEEeC
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG-----QGERVFQAEVEIISRVH---HKHLVSLVGYYTAG 308 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~Ev~~l~~l~---Hpniv~l~g~~~~~ 308 (608)
..++|...++||+|+||.||+|.. .+|+.||||+++.... .....+.+|+.++++++ |+||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999995 5689999999864321 11245667887777764 99999999999876
Q ss_pred C-----eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEE
Q 046502 309 S-----QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 383 (608)
Q Consensus 309 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~ 383 (608)
. ..++||||+. ++|.+++.......+++..++.|+.||+.||+|||+. +|+||||||+||||+.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5799999998 5999999877666699999999999999999999999 89999999999999999999999
Q ss_pred EeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 384 DFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 384 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+. .+.
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~-~~~ 236 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFD-LIG 236 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHH-HHC
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHH-HhC
Confidence 999998665322 234467899999999999999999999999999999999999999764321 11111111 110
Q ss_pred c---CCCCccc---Ccccc-------CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 D---GNFDTLV---DPKLH-------NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 ~---~~~~~~~---d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. ..+.... ...+. .....+....+.+++.+||+.||++||++.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0 0000000 00000 00111233567889999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=362.28 Aligned_cols=267 Identities=27% Similarity=0.391 Sum_probs=214.3
Q ss_pred cCHHHHHHHhcCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccce
Q 046502 230 FTYEELARATDGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSL 301 (608)
Q Consensus 230 ~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l 301 (608)
+...+.....++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+.++.++ +|+||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44455555678899999999999999999984 3468899999976543 3446789999999999 79999999
Q ss_pred eeEEEeCC-eeEEEEeeccCCcHHHHhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeec
Q 046502 302 VGYYTAGS-QRMLVCEFVTSNTLEFHLHGKGR--------------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRD 366 (608)
Q Consensus 302 ~g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrD 366 (608)
+++|...+ ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||+. +|+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence 99988755 48999999999999999986542 2288999999999999999999999 999999
Q ss_pred cCCCcEEEccCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCC
Q 046502 367 IKAANILLDFKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDS 444 (608)
Q Consensus 367 Ik~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~ 444 (608)
|||+||||+.++.+||+|||+++....... .......|++.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999986644322 22334568899999999999999999999999999999998 9999965
Q ss_pred CcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 445 THTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 445 ~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.... .. +...+..+..... .......+.+++..||+.||.+||++.||+++|+..
T Consensus 254 ~~~~--~~-----~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 254 VKID--EE-----FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CCCS--HH-----HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cchh--HH-----HHHHhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 4321 11 1122222221111 111234678899999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=352.57 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=205.4
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEe---------
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA--------- 307 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--------- 307 (608)
..++|...++||+|+||.||+|... +|+.||||+++... ..+.+|++++++++|+||++++++|..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457899999999999999999975 78999999997654 246789999999999999999999864
Q ss_pred -------CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 308 -------GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 308 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
....++||||+++++|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 44579999999999999999765545799999999999999999999998 99999999999999999999
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
||+|||+++...... ......|+..|+|||++.+..++.++|||||||+||||++|..|+... . . ...
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~----~-~~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S----K-FFT 229 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H----H-HHH
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H----H-HHH
Confidence 999999998765432 223456899999999999999999999999999999999999886311 0 0 111
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.+..+.+. ..+ ...+.+++..||+.||.+||++.||+++|+...
T Consensus 230 ~~~~~~~~--------~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 230 DLRDGIIS--------DIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHTTCCC--------TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred Hhhccccc--------ccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 22222222 112 234678999999999999999999999998543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=367.21 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=204.0
Q ss_pred HHHhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~ 310 (608)
....++|...++||+|+||.||+|+.. +|+.||||+++... ....+.+..|..++.++ +||||++++++|.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999964 58999999997532 22345677899999887 89999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999997644 489999999999999999999999 999999999999999999999999999986
Q ss_pred ccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. +.. .+..+..
T Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~----~~~-~i~~~~~--- 235 (345)
T 1xjd_A 168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EE----LFH-SIRMDNP--- 235 (345)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HHH-HHHHCCC---
T ss_pred cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH---HH----HHH-HHHhCCC---
Confidence 43221 123456799999999999999999999999999999999999999975432 11 111 2222221
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRIS-QIVR 510 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~-evv~ 510 (608)
.+ +......+.+++.+||+.||.+||++. +|++
T Consensus 236 ---~~----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 236 ---FY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---CC----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CC----CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 11 112234678899999999999999997 6654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=361.66 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=182.9
Q ss_pred CCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEeeccCCc
Q 046502 245 ANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCEFVTSNT 322 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~~gs 322 (608)
.++||+|+||.||+|... +|+.||||++... ....+.+|+.++.++. |+||++++++|.+++..+|||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999964 6899999999743 4456788999999997 9999999999999999999999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC---ceEEEEeeccccccCccccee
Q 046502 323 LEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 323 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 399 (608)
|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++ .+||+|||+++....... ..
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~ 166 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL 166 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence 999998754 599999999999999999999999 999999999999997765 899999999986654322 23
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
....||..|+|||++.+..++.++|||||||++|||++|+.||..............++ ..+..+.+.. ....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~i~~~~~~~------~~~~ 239 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM-KKIKKGDFSF------EGEA 239 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHH-HHHTTTCCCC------CSHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHH-HHHHcCCCCC------Cccc
Confidence 34568999999999999999999999999999999999999997543211111111122 2233333211 0111
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++..||+.||.+||++.||+++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 11234568889999999999999999999854
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=350.37 Aligned_cols=254 Identities=27% Similarity=0.384 Sum_probs=206.6
Q ss_pred cCCCcCC-ccccCCceEEEEEEec---CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDAN-LLGQGGFGYVHKGVLP---NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~-~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...+ .||+|+||.||+|.+. +++.||||+++... ....+.+.+|++++++++|+||++++++| ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999853 57889999998653 34457789999999999999999999999 55678999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.+++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999997543 3699999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 395 YTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 395 ~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
... ......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .. +...+..+....
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~-----~~~~i~~~~~~~-- 233 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PE-----VMAFIEQGKRME-- 233 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HH-----HHHHHHTTCCCC--
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HH-----HHHHHhcCCcCC--
Confidence 221 1223456889999999998899999999999999999998 9999975432 11 112223332111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
........+.+++..||+.||.+||++.+|+++|+..
T Consensus 234 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 234 -------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp -------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1123345688899999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=362.49 Aligned_cols=263 Identities=24% Similarity=0.409 Sum_probs=212.9
Q ss_pred HHHHHhcCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEE
Q 046502 234 ELARATDGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYT 306 (608)
Q Consensus 234 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~ 306 (608)
++....++|...+.||+|+||.||+|... +++.||||++..... .....|.+|+.++++++|+||++++++|.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 33445678999999999999999999854 367899999975433 34457889999999999999999999999
Q ss_pred eCCeeEEEEeeccCCcHHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC
Q 046502 307 AGSQRMLVCEFVTSNTLEFHLHGKG--------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF 378 (608)
Q Consensus 307 ~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~ 378 (608)
+++..++||||+.+++|.+++.... ...+++..++.|+.||+.||.|||++ +|+||||||+||||+.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 9999999999999999999987521 23579999999999999999999999 999999999999999999
Q ss_pred ceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHH
Q 046502 379 EAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARP 456 (608)
Q Consensus 379 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 456 (608)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~----- 247 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---E----- 247 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---H-----
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---H-----
Confidence 999999999986543221 12233457889999999999999999999999999999999 8888865432 1
Q ss_pred HHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 457 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 457 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.+...+..+..... .......+.+++..||+.||.+||++.||+++|+...
T Consensus 248 ~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 248 QVLRFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 11122223322111 1123356788999999999999999999999998654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=393.16 Aligned_cols=247 Identities=27% Similarity=0.386 Sum_probs=199.6
Q ss_pred ccccCCceEEEEEEec---CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccCCc
Q 046502 247 LLGQGGFGYVHKGVLP---NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNT 322 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~gs 322 (608)
+||+|+||.||+|.+. ++..||||+++... ....+.|.+|+++|++++|+|||+++++|.. +..+|||||+.+|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999864 45679999998653 3356789999999999999999999999976 56899999999999
Q ss_pred HHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce--ee
Q 046502 323 LEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV--ST 400 (608)
Q Consensus 323 L~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~--~~ 400 (608)
|.+++.... ..+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++......... ..
T Consensus 422 L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 422 LHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp HHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred HHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 999997643 3699999999999999999999999 99999999999999999999999999998765432211 12
Q ss_pred eeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 401 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
...+++.|+|||++..+.++.++|||||||+||||++ |+.||...... . +...+..+... ..
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~-----~~~~i~~~~~~---------~~ 560 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---E-----VMAFIEQGKRM---------EC 560 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---H-----HHHHHHTTCCC---------CC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---H-----HHHHHHcCCCC---------CC
Confidence 2345689999999999999999999999999999998 99999754321 1 12223333211 11
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
+......+.+++..||+.||++||++.+|++.|+..
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 223445788999999999999999999999999854
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=361.82 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=195.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe----
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ---- 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~---- 310 (608)
.++|...++||+|+||.||+|.. .+++.||||+++.... .....|.+|+.++++++|+||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36788999999999999999995 6789999999976532 334578899999999999999999999876543
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.++||||+++++|.+++...+ .+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999997654 589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCccc--ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 391 ASDVYT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 391 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
...... .......||..|+|||++.+..++.++|||||||+||||++|+.||...... .............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~ 238 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-------SVAYQHVREDPIP 238 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------HHHHHHHHCCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhcCCCCC
Confidence 654322 1223456899999999999999999999999999999999999999754321 1111222221111
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .........+.+++.+||+.||++||++.+++++
T Consensus 239 ~~-------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 239 PS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp HH-------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred cc-------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 00 0011123467889999999999999987776643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=364.99 Aligned_cols=253 Identities=21% Similarity=0.279 Sum_probs=194.8
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...++||+|+||.||++... +++.||||++..... ..+.+.+|+.++++++|+||++++++|...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 357889999999999999999964 689999999976433 335678999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc--eEEEEeeccccccCcc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE--AKVADFGLAKLASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~--~kl~DFGla~~~~~~~ 395 (608)
+.+++|.+++...+ .+++..++.|+.|++.||.|||+. +|+||||||+||||+.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999987644 489999999999999999999998 9999999999999987765 999999999754321
Q ss_pred cceeeeeecccCccChhhhhcCCCCCc-chhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEK-SDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.......||+.|+|||++.+..+..+ +|||||||+||||++|+.||...... ......+.... ...+....+
T Consensus 172 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~~~~~~~-~~~~~~~~~-- 244 (361)
T 3uc3_A 172 -SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---RDYRKTIQRIL-SVKYSIPDD-- 244 (361)
T ss_dssp ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C---CCHHHHHHHHH-TTCCCCCTT--
T ss_pred -CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH---HHHHHHHHHHh-cCCCCCCCc--
Confidence 12234569999999999988887665 89999999999999999999754321 11111222222 111111101
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+.+|+.+||+.||.+||++.||+++
T Consensus 245 ------~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 ------IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ------SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ------CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0123467889999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=379.22 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=196.3
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|+||.||+|.. .+|+.||||+++.. .......+.+|+.+|++++|+||++++++|...+..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 36789999999999999999995 56899999999753 223345678899999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
|||+++++|.+++.... .+++..+..++.||+.||.|||+ . +|+||||||+||||+.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999987644 58999999999999999999998 6 899999999999999999999999999986443
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. +... +..+.+.
T Consensus 302 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~----~~~~-i~~~~~~----- 367 (446)
T 4ejn_A 302 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EK----LFEL-ILMEEIR----- 367 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HHHH-HHHCCCC-----
T ss_pred CCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HH----HHHH-HHhCCCC-----
Confidence 222 23446799999999999999999999999999999999999999965432 11 1111 1112111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
++......+.+|+..||+.||.+|| ++.|++++
T Consensus 368 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 -----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1112234678899999999999999 99999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=352.05 Aligned_cols=259 Identities=20% Similarity=0.331 Sum_probs=199.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|.. .+|+.||||+++.. .......+.+|+.++++++|+||++++++|...+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 5688999999999999999995 57899999999753 2344567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 316 EFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 316 E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||+.+++|.+++.. .....+++..++.++.+++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999998864 2334689999999999999999999999 999999999999999999999999999986654
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ...+...+..+.+..+..
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~- 260 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPPLPS- 260 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHHHTTCSCCCCT-
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHhhcccCCCCcc-
Confidence 322 223456899999999999999999999999999999999999998643221 011222233333332211
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
. .....+.+++..||+.||.+||++.+|++.|+...
T Consensus 261 ---~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 261 ---D----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp ---T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---c----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1 22346788999999999999999999999998643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=366.44 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=201.3
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++++++||||++++++|...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36789999999999999999995 678999999986432 12235688999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+ +|+|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 678888876544 599999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
. ......||+.|+|||++.+..+ +.++|||||||+||+|++|+.||+..... .+ +..+...
T Consensus 162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~-------------~~~i~~~ 223 (336)
T 3h4j_B 162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP---NL-------------FKKVNSC 223 (336)
T ss_dssp B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST---TC-------------BCCCCSS
T ss_pred c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH---HH-------------HHHHHcC
Confidence 2 2234579999999999987776 68999999999999999999999753321 00 0000000
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+......+.+++.+||+.||.+||++.||+++
T Consensus 224 --~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 --VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 001112233467889999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.98 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=202.2
Q ss_pred HHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC-----CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 046502 235 LARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG-----SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG 308 (608)
Q Consensus 235 l~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~ 308 (608)
+....++|...++||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++|+||++++++|.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 455677899999999999999999996 46889999998643 234456789999999999999999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCC--------------------------------------CCCCCHHHHHHHHHHHHHH
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKG--------------------------------------RPTMDWPTRLKIALGFAKG 350 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~ia~~ia~~ 350 (608)
+..++||||+++++|.+++.... ...+++..++.|+.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985210 1123567788999999999
Q ss_pred HHHHHhcCCCCeeeeccCCCcEEEccCC--ceEEEEeeccccccCccc---ceeeeeecccCccChhhhhc--CCCCCcc
Q 046502 351 LAYLHEDCHPKIIHRDIKAANILLDFKF--EAKVADFGLAKLASDVYT---HVSTRVMGTFGYLAPEYASS--GKLTEKS 423 (608)
Q Consensus 351 L~yLH~~~~~~iiHrDIk~~NILl~~~~--~~kl~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~t~ks 423 (608)
|.|||+. +|+||||||+||||+.++ .+||+|||+++....... .......||+.|+|||++.. ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 899999999999998776 899999999986543211 12344679999999999975 6789999
Q ss_pred hhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCC
Q 046502 424 DVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP 503 (608)
Q Consensus 424 DVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP 503 (608)
|||||||+||||++|+.||...... ..+...+... .. +..+. .......+.+++..||+.||.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~-------~~~~~~~~~~-~~-~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA-------DTISQVLNKK-LC-FENPN-----YNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHCC-CC-TTSGG-----GGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcc-cc-cCCcc-----cccCCHHHHHHHHHHcCCChhHCC
Confidence 9999999999999999999754321 1122222211 11 11111 111234678899999999999999
Q ss_pred CHHHHHHH
Q 046502 504 RISQIVRT 511 (608)
Q Consensus 504 sm~evv~~ 511 (608)
++.|++++
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999974
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.35 Aligned_cols=256 Identities=24% Similarity=0.315 Sum_probs=206.1
Q ss_pred hcCCCcCCccccCCceEEEEEEe----cCCcEEEEEEcccCC----chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL----PNGKEVAIKQLKAGS----GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGS 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~ 309 (608)
.++|...++||+|+||.||+++. .+|+.||||+++... ....+.+.+|+++|.++ +|+||++++++|...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36789999999999999999996 478999999987532 22334577899999999 6999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
..+|||||+++++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999997654 589999999999999999999998 89999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
..............||+.|+|||++.++ .++.++|||||||+||||++|+.||....... ....+...... ..
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~-~~- 282 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILK-SE- 282 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC---CHHHHHHHHHH-CC-
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc---hHHHHHHHHhc-cC-
Confidence 7654434344456799999999999853 47899999999999999999999997543211 11112222221 11
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHhh
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRTLE 513 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~L~ 513 (608)
+ .+.......+.+++.+||+.||.+|| ++.||+++.-
T Consensus 283 -----~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 283 -----P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp -----C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -----C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 1 11122334678899999999999999 9999998753
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.35 Aligned_cols=256 Identities=29% Similarity=0.434 Sum_probs=201.1
Q ss_pred cCCCcCCccccCCceEEEEEEecC-----CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-----GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
++|...++||+|+||.||+|.... +..||||+++... ......|.+|+.++++++|+||++++++|...+..+|
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456677899999999999998643 2359999997653 3344678999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+++++|.+++.... ..+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999997653 3689999999999999999999999 899999999999999999999999999987654
Q ss_pred cccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 394 VYTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 394 ~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
.... ......++..|+|||++.+..++.++|||||||+||||++ |+.||..... . .++ ..+..+....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~----~~~-~~~~~~~~~~- 270 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---H----EVM-KAINDGFRLP- 270 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H----HHH-HHHHTTCCCC-
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---H----HHH-HHHHCCCcCC-
Confidence 3211 1222346788999999999999999999999999999998 9999964332 1 112 2222221100
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
........+.+++.+||+.||.+||++.+|+++|+...
T Consensus 271 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 271 --------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11123456888999999999999999999999998654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=364.65 Aligned_cols=258 Identities=26% Similarity=0.377 Sum_probs=208.3
Q ss_pred hcCCCcCCccccCCceEEEEEEecC------CcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPN------GKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~ 310 (608)
.++|...+.||+|+||.||+|.... ++.||||+++.... ...+.+.+|+.+++++ +|+||++++++|...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 3678889999999999999999532 24799999976543 3456789999999999 89999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC
Q 046502 311 RMLVCEFVTSNTLEFHLHGKG------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF 378 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~ 378 (608)
.++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||||+.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 999999999999999987532 23589999999999999999999999 999999999999999999
Q ss_pred ceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHH
Q 046502 379 EAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARP 456 (608)
Q Consensus 379 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~ 456 (608)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~----- 274 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN--S----- 274 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS--H-----
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh--H-----
Confidence 999999999986543322 22334567889999999999999999999999999999998 99998654321 1
Q ss_pred HHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 457 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 457 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+...+..+.... ........+.+++..||+.||.+||++.||+++|+..
T Consensus 275 ~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 275 KFYKLVKDGYQMA---------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp HHHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhcCCCCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111222221100 1111235678899999999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=355.74 Aligned_cols=259 Identities=20% Similarity=0.257 Sum_probs=200.5
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
..++|...++||+|+||.||+|... +++.||||++..... ...+.+.+|+.++++++|+||+++++++..++..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 3578999999999999999999964 688999999975432 234678899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+++++|.+++.... .+++..++.|+.|+++||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 112 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999997643 589999999999999999999999 999999999999999999999999999987655
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
..........|+..|+|||++.+..++.++||||||++||||++|+.||...... .+...+..... ..
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~-~~--- 254 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--------VMGAHINQAIP-RP--- 254 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--------HHHHHHHSCCC-CG---
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--------HHHHHhccCCC-Cc---
Confidence 4333334567899999999999999999999999999999999999999753321 12222222111 10
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhcCc
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRP-RISQIVRTLEGDA 516 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-sm~evv~~L~~~~ 516 (608)
..........+.+++.+||+.||++|| ++.++++.|+...
T Consensus 255 ---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 255 ---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp ---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred ---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 011122234678899999999999999 9999999998654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=348.83 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=205.7
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...++||+|+||.||+|... +++.||+|++........+.+.+|++++++++|+||++++++|.+++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 467899999999999999999964 4778999999876556677899999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE---ccCCceEEEEeeccccccCc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl---~~~~~~kl~DFGla~~~~~~ 394 (608)
+++++|.+++.... .+++..++.|+.|++.||.|||+. +|+||||||+|||| +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999887644 489999999999999999999999 99999999999999 78899999999999876543
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
. ......||..|+|||++.+ .++.++||||||+++|||++|+.||..... .. .. ..+..+.+.... .
T Consensus 163 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~----~~-~~~~~~~~~~~~-~- 229 (277)
T 3f3z_A 163 K--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD---SE----VM-LKIREGTFTFPE-K- 229 (277)
T ss_dssp S--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HH-HHHHHCCCCCCH-H-
T ss_pred c--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH---HH----HH-HHHHhCCCCCCc-h-
Confidence 2 2234568999999999865 589999999999999999999999975432 11 11 122222221100 0
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... .....+.+++..||+.||++||++.|++++
T Consensus 230 ~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 230 DWL----NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhh----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 123567889999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=384.19 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=209.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|+||.||+|.. .+|+.||||++.... ......+.+|+++|.+++|+|||+++++|.+.+.++||
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46789999999999999999996 468999999996432 23345688999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++|+|.+++...+...+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999876666799999999999999999999999 9999999999999999999999999999876543
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||......... ..+...+.....
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~----~~i~~~i~~~~~------- 406 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR----EEVERLVKEVPE------- 406 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH----HHHHHHHHHCCC-------
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH----HHHHHHhhcccc-------
Confidence 2 223457999999999999989999999999999999999999999764321111 111222222211
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
.+.......+.+|+..||+.||.+|| ++.||+++
T Consensus 407 ---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 ---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11122335678899999999999999 78888865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=367.60 Aligned_cols=267 Identities=21% Similarity=0.258 Sum_probs=212.4
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--eeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS--QRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~--~~~lV~ 315 (608)
++|...++||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++|+||+++++++...+ ..+|||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888999999999999999964 48999999997543 233567789999999999999999999998765 779999
Q ss_pred eeccCCcHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE----ccCCceEEEEeecccc
Q 046502 316 EFVTSNTLEFHLHGKGR-PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL----DFKFEAKVADFGLAKL 390 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~-~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl----~~~~~~kl~DFGla~~ 390 (608)
||+++++|.+++..... ..+++..++.|+.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976432 3499999999999999999999999 99999999999999 7788899999999987
Q ss_pred ccCcccceeeeeecccCccChhhhhc--------CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASS--------GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
..... ......||..|+|||++.. ..++.++|||||||++|||++|+.||....... .....+...+
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~---~~~~~~~~~~ 240 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYKII 240 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT---TCHHHHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc---chHHHHHHHh
Confidence 65432 2234569999999999865 567889999999999999999999996432211 1112222222
Q ss_pred hcCCCCccc---------------CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 463 EDGNFDTLV---------------DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 463 ~~~~~~~~~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.. .....+ +..............+.+++..||+.||++||++.|+++.|+..
T Consensus 241 ~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 241 TG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HS-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred cC-CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 22 211110 11112234567778889999999999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=366.61 Aligned_cols=263 Identities=19% Similarity=0.227 Sum_probs=198.8
Q ss_pred cCCCcCCccccCCceEEEEEEec----CCcEEEEEEcccCCchh-----------HHHHHHHHHHHHhcCCCCccceeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP----NGKEVAIKQLKAGSGQG-----------ERVFQAEVEIISRVHHKHLVSLVGY 304 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~-----------~~~~~~Ev~~l~~l~Hpniv~l~g~ 304 (608)
++|...++||+|+||.||+|... ++..||||++....... ...+.+|+.++..++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57888999999999999999975 57889999987654221 1236678899999999999999999
Q ss_pred EEe----CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC--
Q 046502 305 YTA----GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-- 378 (608)
Q Consensus 305 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-- 378 (608)
+.. ....++||||+ +++|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 988 77899999999 999999997654 699999999999999999999999 999999999999999887
Q ss_pred ceEEEEeeccccccCcccc------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccch
Q 046502 379 EAKVADFGLAKLASDVYTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDN 452 (608)
Q Consensus 379 ~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 452 (608)
.+||+|||+++........ ......||..|+|||++.+..++.++|||||||+||||++|+.||...... .
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~ 267 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD---P 267 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC---H
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc---c
Confidence 9999999999876432211 113457999999999999999999999999999999999999999532111 0
Q ss_pred hhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 453 LARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 453 l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.........+.. .+...+...+. .......+.+++..||+.||++||++.+|++.|+..
T Consensus 268 ~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 100011111111 11111100000 002334688899999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=362.09 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=200.5
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
+.|...+.||+|+||.||+|.. .+|+.||||++..... ...+.|.+|++++++++|+||++++++|..++..+|||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588899999999999999995 5789999999975432 22357889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+. |+|.+++.... ..+++..++.|+.|+++||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9998 57777765432 3689999999999999999999999 8999999999999999999999999999866532
Q ss_pred cceeeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 396 THVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
....||+.|+|||++. .+.++.++|||||||+||||++|+.||...... ..+...... ....+..
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-------~~~~~~~~~-~~~~~~~ 275 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQN-ESPALQS 275 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHS-CCCCCCC
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhc-CCCCCCC
Confidence 2357999999999985 567899999999999999999999998654321 111222222 1111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
. .....+.+++..||+.||++||++.+|+++.
T Consensus 276 ----~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~ 307 (348)
T 1u5q_A 276 ----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 307 (348)
T ss_dssp ----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ----C----CCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 1 1234577899999999999999999998753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=347.60 Aligned_cols=252 Identities=25% Similarity=0.370 Sum_probs=205.8
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.++|...++||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++|+||++++++|.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999995 458999999986542 334467889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc---eEEEEeecccccc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKLAS 392 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~---~kl~DFGla~~~~ 392 (608)
||+.+++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||||+.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999988887653 589999999999999999999999 9999999999999987655 9999999998665
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..... . .+...+..+.+... .
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~---~-----~~~~~~~~~~~~~~-~ 228 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---H-----RLYAQIKAGAYDYP-S 228 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H-----HHHHHHHHTCCCCC-T
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch---h-----HHHHHHHhccccCC-c
Confidence 432 22345789999999999999999999999999999999999999965432 1 11122222322111 1
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+. .......+.+++..||+.||++||++.|++++
T Consensus 229 ~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 PE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 10 01223457889999999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=364.34 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=204.4
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~ 312 (608)
..++|...++||+|+||.||+|... +|+.||||+++... ....+.+..|..+|..+ +|+||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999965 47899999997532 23345678899999988 7999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
|||||+++|+|.+++...+ .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999997654 489999999999999999999999 99999999999999999999999999998643
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. +... +..+.+.
T Consensus 173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~----~~~~-i~~~~~~---- 239 (353)
T 2i0e_A 173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DE----LFQS-IMEHNVA---- 239 (353)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HHHH-HHHCCCC----
T ss_pred cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH---HH----HHHH-HHhCCCC----
Confidence 221 123446799999999999999999999999999999999999999975432 11 1222 2222221
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPR-----ISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~~ 511 (608)
++......+.+++..||+.||.+||+ +.+|+++
T Consensus 240 ------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 ------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp ------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11123356788999999999999995 5777654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=354.73 Aligned_cols=261 Identities=21% Similarity=0.332 Sum_probs=200.6
Q ss_pred cCCCcC-CccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDA-NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~-~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
+.|... ++||+|+||.||+|.. .+++.||||+++.........+.+|++++.++ +|+||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567764 7899999999999994 57899999999876666677889999999995 79999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc---eEEEEeeccccccC
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGLAKLASD 393 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~---~kl~DFGla~~~~~ 393 (608)
|+++++|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999997653 589999999999999999999999 9999999999999988776 99999999976532
Q ss_pred cc------cceeeeeecccCccChhhhhc-----CCCCCcchhhhHHHHHHHHHhCCCCCCCCccccc----chh---hH
Q 046502 394 VY------THVSTRVMGTFGYLAPEYASS-----GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME----DNL---AR 455 (608)
Q Consensus 394 ~~------~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~----~~l---~~ 455 (608)
.. ........||..|+|||++.. ..++.++|||||||++|||++|+.||........ ... ..
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 11 111223569999999999975 5688999999999999999999999975432110 000 01
Q ss_pred HHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 456 PLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 456 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+...+..+.+... +..+ . .....+.+++.+||+.||.+||++.||+++
T Consensus 247 ~~~~~~i~~~~~~~~-~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 247 NMLFESIQEGKYEFP-DKDW-A----HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHCCCCCC-HHHH-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHhccCcccC-chhc-c----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 112222333322110 0000 1 123467899999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=349.02 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=202.6
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEE-EeCCeeEEEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY-TAGSQRMLVC 315 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~-~~~~~~~lV~ 315 (608)
..++|...+.||+|+||.||+|.. .+++.||||++..... ...+.+|+.++.+++|+|++..+++| ..++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999995 6789999998764432 23578899999999988877776665 6677889999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE---ccCCceEEEEeecccccc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl---~~~~~~kl~DFGla~~~~ 392 (608)
||+ +++|.+++..... .+++..++.|+.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 9999999875433 599999999999999999999999 99999999999999 889999999999998765
Q ss_pred Cccc------ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC
Q 046502 393 DVYT------HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466 (608)
Q Consensus 393 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 466 (608)
.... .......||..|+|||++.+..++.++|||||||++|||++|+.||..................... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~ 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SC
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-ch
Confidence 4322 1223467999999999999999999999999999999999999999764432222222111111111 00
Q ss_pred CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 467 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. ..+... ....+.+++..||+.||++||++.+|++.|+..
T Consensus 239 ~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 239 I-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp H-----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred h-----hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 0 000011 234688999999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.23 Aligned_cols=260 Identities=20% Similarity=0.267 Sum_probs=205.8
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEE-EeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY-TAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~-~~~~~~~lV~E 316 (608)
.++|...++||+|+||.||+|.. .+|+.||||++..... ...+.+|+.++++++|++++..+++| ..++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46899999999999999999995 6789999999875433 23578999999999988877666655 66778899999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE---ccCCceEEEEeeccccccC
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl---~~~~~~kl~DFGla~~~~~ 393 (608)
|+ +++|.+++.... ..+++..++.|+.|++.||.|||++ +|+||||||+|||| +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 899999997543 3599999999999999999999999 99999999999999 5889999999999987654
Q ss_pred cccc------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 394 VYTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 394 ~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
.... ......||..|+|||++.+..++.++|||||||+||||++|+.||..............+...... ...
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~ 239 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI 239 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCH
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-Cch
Confidence 3221 124467999999999999999999999999999999999999999764332222222212111111 000
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
+.+.. .....+.+++..||+.||++||++.+|++.|+..
T Consensus 240 -----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 240 -----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -----HHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -----HHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 00111 1234688899999999999999999999999854
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=375.89 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=196.0
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC------C
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG------S 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~------~ 309 (608)
.++|...++||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|++++|+|||+++++|... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 57899999999999999999985 46899999999754 334456788999999999999999999999654 4
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
..||||||+.++ |.+.+.. .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCCC-HHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 579999999875 5555532 389999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH----------
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN---------- 459 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~---------- 459 (608)
..... .......||++|+|||++.+..|+.++|||||||+||||++|+.||...... +.+ ..++.
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~--~~~-~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQW-NKVIEQLGTPCPEFM 287 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH-HHHHHHHCSCCHHHH
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHHhcCCCCHHHH
Confidence 76542 2234567999999999999999999999999999999999999999764421 111 00100
Q ss_pred --------HHHhc-CCCC-----cccCccccC---cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 460 --------RAIED-GNFD-----TLVDPKLHN---EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 460 --------~~~~~-~~~~-----~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..++. ..+. .++...+.. +........+.+|+.+||+.||++||++.|++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00100 0000 000000000 0111225678899999999999999999999976
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.41 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=208.6
Q ss_pred HHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHh--cCCCCccceeeEEEeCC----
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISR--VHHKHLVSLVGYYTAGS---- 309 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~--l~Hpniv~l~g~~~~~~---- 309 (608)
....++|...++||+|+||.||+|.. +|+.||||++... ....+.+|++++.. ++|+||+++++++...+
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44567899999999999999999998 6899999999643 34567789999988 78999999999998876
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeeccCCCcEEEccCCceE
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH--------EDCHPKIIHRDIKAANILLDFKFEAK 381 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH--------~~~~~~iiHrDIk~~NILl~~~~~~k 381 (608)
..++||||+++++|.+++... .+++..++.++.|++.||.||| +. +|+||||||+||||+.++.+|
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEE
T ss_pred eeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEE
Confidence 789999999999999999764 5899999999999999999999 66 899999999999999999999
Q ss_pred EEEeeccccccCcccc---eeeeeecccCccChhhhhcCC------CCCcchhhhHHHHHHHHHhC----------CCCC
Q 046502 382 VADFGLAKLASDVYTH---VSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELIIG----------CRPV 442 (608)
Q Consensus 382 l~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDVwS~Gvll~elltG----------~~p~ 442 (608)
|+|||+++........ ......||..|+|||++.+.. ++.++|||||||+||||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999866543221 223457999999999997653 33689999999999999999 6677
Q ss_pred CCCcccccchhhHHHHHHHHhcCCCCcccCccccCc-CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 443 DSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE-YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 443 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
...... +.... .+...+..+.+ .+.+... ...+....+.+++.+||+.||++||++.||+++|+..
T Consensus 268 ~~~~~~--~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 268 YDLVPS--DPSVE-EMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TTTSCS--SCCHH-HHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCcC--cccHH-HHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 543221 11111 12222222222 1222111 2346777899999999999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=350.36 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=184.9
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
..++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 346789999999999999999996 5789999999964321 224678899999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+++++|.+++.... ..+++..++.++.|+++||.|||+. +|+||||||+||||+.++.+||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999997643 3689999999999999999999999 999999999999999999999999999986653
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... . .+.. +... +.
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~-----~~~~-~~~~------~~ 229 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--N-----TLNK-VVLA------DY 229 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSS------CC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--H-----HHHH-Hhhc------cc
Confidence 222 123356899999999999889999999999999999999999999754321 0 0100 0000 11
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+ +......+.+++.+||+.||++||++.+|+++
T Consensus 230 ~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 230 EM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11 11223467889999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=357.53 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=204.8
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCeeEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA----GSQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~----~~~~~l 313 (608)
.++|...++||+|+||.||++.. .+|+.||||++........+.+.+|+.++++++|+||++++++|.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46789999999999999999996 6789999999987666677889999999999999999999999872 347899
Q ss_pred EEeeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 314 VCEFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
||||+.+++|.+++... ....+++..++.|+.||++||.|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999988752 234699999999999999999999999 9999999999999999999999999998765
Q ss_pred cCcccc--------eeeeeecccCccChhhhhcCC---CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 046502 392 SDVYTH--------VSTRVMGTFGYLAPEYASSGK---LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 392 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
...... ......|+..|+|||++.... ++.++|||||||++|||++|+.||+..... .+.+ ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~-----~~ 258 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-GDSV-----AL 258 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT-TSCH-----HH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc-cchh-----hH
Confidence 321110 012245799999999987544 689999999999999999999998532110 0111 11
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.+.. ... + .........+.+++..||+.||.+||++.+|+++|+...
T Consensus 259 ~~~~-~~~-~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 AVQN-QLS-I-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHC-C---C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred Hhhc-cCC-C-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 1111 110 0 001122346888999999999999999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.22 Aligned_cols=252 Identities=26% Similarity=0.358 Sum_probs=206.5
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCch------hHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQ------GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
.++|...+.||+|+||.||+|... +|+.||||+++..... ..+.+.+|+.++++++|+||++++++|.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356889999999999999999964 6899999999754321 356789999999999999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC----ceEEEEeec
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGL 387 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~----~~kl~DFGl 387 (608)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||||+.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999997643 589999999999999999999999 999999999999999887 799999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
++...... ......||..|+|||++.+..++.++|||||||+||||++|+.||..... . ..+. .+..+.+
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~----~~~~-~i~~~~~ 235 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---Q----ETLA-NITSVSY 235 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---H----HHHH-HHHTTCC
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---H----HHHH-HHHhccc
Confidence 98765432 22345699999999999999999999999999999999999999965432 1 1111 1222211
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .+..+.. .....+.+++..||+.||++||++.|++++
T Consensus 236 ~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 D--FDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--cChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 1111111 123457889999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=354.01 Aligned_cols=250 Identities=28% Similarity=0.423 Sum_probs=199.3
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeC-CeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG-SQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~-~~~~lV~E~ 317 (608)
.++|...+.||+|+||.||++.. +|+.||||+++... ..+.|.+|+.++++++|+||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46788999999999999999987 58899999997543 456788999999999999999999997654 478999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 170 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc---
Confidence 9999999999765443488999999999999999999999 8999999999999999999999999999865432
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .. +.. .+..+..
T Consensus 171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~----~~~-~~~~~~~--------- 232 (278)
T 1byg_A 171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KD----VVP-RVEKGYK--------- 232 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GG----HHH-HHTTTCC---------
T ss_pred -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HH----HHH-HHhcCCC---------
Confidence 122357889999999999999999999999999999998 9999875432 11 111 1222211
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..........+.+++..||+.||.+||++.||++.|+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 111122345688899999999999999999999999854
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=350.30 Aligned_cols=247 Identities=27% Similarity=0.413 Sum_probs=201.7
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+.++++++|+||++++++|.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467899999999999999999854 57789999986432 22346788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++.... .+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999987653 489999999999999999999998 9999999999999999999999999998655432
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||...... . .. ..+....+.
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~-~~~~~~~~~------ 225 (279)
T 3fdn_A 163 ---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---E----TY-KRISRVEFT------ 225 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---H----HH-HHHHHTCCC------
T ss_pred ---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH---H----HH-HHHHhCCCC------
Confidence 223457899999999999999999999999999999999999999754321 1 11 111221111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
++......+.+++..||+.||++||++.||+++
T Consensus 226 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 226 ----FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111223457789999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.15 Aligned_cols=243 Identities=25% Similarity=0.353 Sum_probs=202.4
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc--------hhHHHHHHHHHHHHhcCCCCccceeeEEEeC
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG--------QGERVFQAEVEIISRVHHKHLVSLVGYYTAG 308 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~ 308 (608)
..++|...++||+|+||.||+|.. .+++.||||+++.... .....+.+|+.+|++++|+||++++++|.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999984 5688999999976431 1233577899999999999999999999999
Q ss_pred CeeEEEEeeccCC-cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeec
Q 046502 309 SQRMLVCEFVTSN-TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL 387 (608)
Q Consensus 309 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGl 387 (608)
+..++||||+.+| +|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 9999987654 599999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 466 (608)
++...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ...
T Consensus 177 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------~~~ 240 (335)
T 3dls_A 177 AAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------------EAA 240 (335)
T ss_dssp CEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT--------------TTC
T ss_pred ceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH--------------hhc
Confidence 98765432 2334679999999999988776 789999999999999999999996422100 000
Q ss_pred CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 467 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... .......+.+++..||+.||++||++.||+++
T Consensus 241 ----~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 241 ----IHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----CCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----cCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01123457889999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=361.67 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=199.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcE----EEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKE----VAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~----vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
.++|...++||+|+||.||+|.. .+++. ||+|.+... .....+.+.+|+.++++++|+||++++++|..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 36788999999999999999995 34543 577877543 3445678899999999999999999999998754 88
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+|+||+.+++|.+++..... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999986543 589999999999999999999999 99999999999999999999999999998764
Q ss_pred Cccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 393 DVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 393 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
.... .......++..|+|||++.+..++.++|||||||+||||++ |+.||...... . +...+..+....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~-----~~~~~~~~~~~~- 239 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E-----ISSILEKGERLP- 239 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---G-----HHHHHHTTCCCC-
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---H-----HHHHHHcCCCCC-
Confidence 4222 12233456789999999999999999999999999999999 99999754321 1 112222222111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
........+.+++..||+.||.+||++.||++.|+...
T Consensus 240 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 240 --------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11123346788999999999999999999999998653
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=350.07 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=207.6
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTA--GSQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~~l 313 (608)
.++|...+.||+|+||.||++... +|+.||||++.... ....+.+.+|+.++++++|+||++++++|.. +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467889999999999999999964 68999999997543 3345678999999999999999999998854 568899
Q ss_pred EEeeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeeeccCCCcEEEccCCceEEEEee
Q 046502 314 VCEFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPK-----IIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~-----iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
||||+++++|.+++... ....+++..++.|+.|++.||.|||+. + |+||||||+||||+.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 99999999999998753 234589999999999999999999998 6 9999999999999999999999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 466 (608)
+++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||..... . .+...+..+.
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~-----~~~~~i~~~~ 232 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---K-----ELAGKIREGK 232 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---H-----HHHHHHHHTC
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---H-----HHHHHHhhcc
Confidence 9986654221 12235689999999999999999999999999999999999999975432 1 1222333444
Q ss_pred CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 467 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+..+ .. .....+.+++.+||+.||.+||++.||++++....
T Consensus 233 ~~~~-----~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 233 FRRI-----PY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CCCC-----CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred cccC-----Cc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 3222 11 22356888999999999999999999999876543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=360.77 Aligned_cols=263 Identities=18% Similarity=0.262 Sum_probs=194.1
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
..++|...++||+|+||.||+|.. .+++.||||+++..... ..+.+.+|+.++++++|+||+++++++.+++..+||
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 346799999999999999999984 46899999999754332 235677899999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE-----ccCCceEEEEeeccc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL-----DFKFEAKVADFGLAK 389 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl-----~~~~~~kl~DFGla~ 389 (608)
|||+.+ +|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+|||| +.++.+||+|||+++
T Consensus 112 ~e~~~~-~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCSE-EHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCCC-CHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 999985 8998887654 489999999999999999999999 99999999999999 455569999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhc---C
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIED---G 465 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~ 465 (608)
....... ......||..|+|||++.+. .++.++|||||||++|||++|+.||...... +.+ ...+.. +.. .
T Consensus 186 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~-~~~~~~-~~~~~~~ 260 (329)
T 3gbz_A 186 AFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQL-FKIFEV-LGLPDDT 260 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH-HHHHHH-HCCCCTT
T ss_pred ccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHH-HHHHHH-hCCCchh
Confidence 7653322 23345689999999999874 4899999999999999999999999754321 111 111111 000 0
Q ss_pred C-------------CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 N-------------FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~-------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. +..+....+...........+.+|+.+||+.||.+||++.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 0 000000000000011123567899999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=356.81 Aligned_cols=263 Identities=24% Similarity=0.339 Sum_probs=208.7
Q ss_pred cCCCcCCccccCCceEEEEEEe-----cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC--eeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-----PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS--QRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~--~~~ 312 (608)
++|...++||+|+||.||++.+ .+|+.||||++........+.|.+|+.++++++|+||++++++|...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5678889999999999999984 368899999998776666778999999999999999999999987644 689
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+++++|.+++.... ..+++..++.++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 121 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999998653 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred Ccccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc--------hhhHHHHHHHH
Q 046502 393 DVYTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED--------NLARPLLNRAI 462 (608)
Q Consensus 393 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~--------~l~~~~~~~~~ 462 (608)
..... ......++..|+|||++.+..++.++|||||||+||||++|+.|+........+ ......+...+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence 43221 122345778899999999988999999999999999999999987532110000 00000111222
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..+... .........+.+++.+||+.||++||++.||++.|+..
T Consensus 277 ~~~~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 277 KNNGRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 222111 11122345688899999999999999999999999854
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=361.61 Aligned_cols=261 Identities=15% Similarity=0.217 Sum_probs=205.6
Q ss_pred cCCCcCCccccCCceEEEEEEecC---------CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccc----------
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN---------GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVS---------- 300 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~---------- 300 (608)
++|...++||+|+||.||+|.... ++.||||++... +.+.+|++++++++|+||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578899999999999999999653 789999998754 35788999999999999987
Q ss_pred -----eeeEEEe-CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE
Q 046502 301 -----LVGYYTA-GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL 374 (608)
Q Consensus 301 -----l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl 374 (608)
+++++.. ++..+|||||+ +++|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+||||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEE
Confidence 6778776 77899999999 99999999876445799999999999999999999999 99999999999999
Q ss_pred ccCC--ceEEEEeeccccccCcccc------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 046502 375 DFKF--EAKVADFGLAKLASDVYTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446 (608)
Q Consensus 375 ~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~ 446 (608)
+.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 8999999999876543221 1133479999999999999999999999999999999999999997543
Q ss_pred ccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 447 TFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 447 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
... ..+.. .... +. .....+.+..... ......+.+++..||+.||.+||++.+|++.|+...
T Consensus 273 ~~~-~~~~~-~~~~-~~-~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 273 PNT-EDIMK-QKQK-FV-DKPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TCH-HHHHH-HHHH-HH-HSCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCH-HHHHH-HHHh-cc-CChhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 111 11111 1111 11 1222222211111 112356888999999999999999999999998653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=391.38 Aligned_cols=246 Identities=27% Similarity=0.368 Sum_probs=198.5
Q ss_pred CccccCCceEEEEEEec---CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLP---NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|.+. .++.||||+++... ....+.|.+|+++|++++|+|||+++++|.. +..+|||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 46789999997643 3345789999999999999999999999964 568999999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc--ce
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT--HV 398 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~--~~ 398 (608)
|+|.+++.... .+++..++.|+.||+.||.|||+. +||||||||+||||+.++.+||+|||+++....... ..
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999997654 589999999999999999999999 999999999999999999999999999987654321 22
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....+++.|+|||++....++.++|||||||+||||++ |+.||...... .+...+..+....
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~~~-------- 592 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMG-------- 592 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCC--------
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCC--------
Confidence 333457889999999999999999999999999999998 99999754321 1222233332211
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.+......+.+++..||+.||++||++.+|++.|+.
T Consensus 593 -~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 593 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 122234578899999999999999999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=367.37 Aligned_cols=254 Identities=29% Similarity=0.406 Sum_probs=193.4
Q ss_pred CCCcCCccccCCceEEEEEEec--CC--cEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEe-CCeeEEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP--NG--KEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTA-GSQRMLV 314 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-~~~~~lV 314 (608)
.|...++||+|+||.||+|.+. ++ ..||||.++... ....+.|.+|+.++++++|+||++++++|.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 3566789999999999999853 22 368999987543 3445789999999999999999999999765 4578999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++.... ..+++..++.++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997644 3689999999999999999999999 9999999999999999999999999999865432
Q ss_pred cc---ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 395 YT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 395 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
.. .......++..|+|||++.+..++.++|||||||+||||++ |..||...... .+ .. .+..+.. .
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~----~~-~~~~~~~--~ 315 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DI----TV-YLLQGRR--L 315 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CH----HH-HHHTTCC--C
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HH----HH-HHHcCCC--C
Confidence 11 11233457889999999999999999999999999999999 66777543321 11 11 1222221 1
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.. +......+.+++..||+.||++||++.||++.|+..
T Consensus 316 ~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 316 LQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp CC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 112234688899999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=347.40 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=197.7
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||++.. .+++.||||++.... ....+.+.+|+++|++++|+||++++++|.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 5688899999999999999995 468899999987543 33457789999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE---ccCCceEEEEeecccccc
Q 046502 318 VTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 318 ~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl---~~~~~~kl~DFGla~~~~ 392 (608)
+++++|.+++... ....+++..++.|+.|++.||.|||+. +|+||||||+|||| +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 224699999999999999999999999 99999999999999 456789999999998765
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
... ......|+..|+|||++. +.++.++|||||||++|||++|+.||...... . .... ...........
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~---~----~~~~-~~~~~~~~~~~ 247 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE---E----VQQK-ATYKEPNYAVE 247 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHH-HHHCCCCCCC-
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH---H----HHhh-hccCCcccccc
Confidence 422 234457899999999986 57899999999999999999999999754321 1 1111 11111111100
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... ....+.+++.+||+.||++||++.||+++
T Consensus 248 ---~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 248 ---CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ---cCc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001 23457789999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=347.59 Aligned_cols=253 Identities=23% Similarity=0.374 Sum_probs=200.9
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+.|....+||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++|+||++++++|...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3456667999999999999995 568899999998776666678999999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-CCceEEEEeeccccccCccc
Q 046502 319 TSNTLEFHLHGKG-RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-KFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 319 ~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-~~~~kl~DFGla~~~~~~~~ 396 (608)
++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||||+. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999998653 33567899999999999999999999 9999999999999987 89999999999986654221
Q ss_pred ceeeeeecccCccChhhhhcCC--CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
......|+..|+|||++..+. ++.++|||||||++|||++|+.||....... ......... .. .+.
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~-~~-----~~~ 246 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ-----AAMFKVGMF-KV-----HPE 246 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH-----HHHHHHHHH-CC-----CCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh-----HHHHhhccc-cc-----ccc
Confidence 223456899999999997654 8899999999999999999999986432210 001111111 11 111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+ .......+.+++.+||+.||++||++.||+++
T Consensus 247 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 247 I----PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp C----CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred c----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 12233567889999999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=361.64 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=202.4
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...+.||+|+||.||++... +|+.||||+++..... +.+|++++.++ +||||++++++|.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 467999999999999999999964 6889999999765432 34688888888 79999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC----CceEEEEeecccccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK----FEAKVADFGLAKLAS 392 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~----~~~kl~DFGla~~~~ 392 (608)
|+.+|+|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||||.++ +.+||+|||+++...
T Consensus 97 ~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 97 LMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp CCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 999999999987654 589999999999999999999999 99999999999998443 359999999998765
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......... . +...+..+.+...
T Consensus 172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----~-~~~~i~~~~~~~~-- 243 (342)
T 2qr7_A 172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE----E-ILARIGSGKFSLS-- 243 (342)
T ss_dssp CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH----H-HHHHHHHCCCCCC--
T ss_pred CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH----H-HHHHHccCCcccC--
Confidence 4322 233457899999999998888999999999999999999999999753221111 1 2222333433211
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+.......+.+++..||+.||++||++.||+++
T Consensus 244 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 244 ----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11112234567889999999999999999999874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=373.63 Aligned_cols=247 Identities=28% Similarity=0.411 Sum_probs=205.3
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||+|... +|+.||||+++... ......+.+|+.+|++++||||+++++++...+..+|||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999964 79999999996532 123457889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++...+ .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 96 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999997543 599999999999999999999998 99999999999999999999999999998765422
Q ss_pred cceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
......||+.|+|||++.+..+ +.++|||||||+||||++|+.||+.... . .+. ..+..+.+..
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~----~~~-~~i~~~~~~~----- 235 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---P----TLF-KKICDGIFYT----- 235 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---H----HHH-HHHHTTCCCC-----
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---H----HHH-HHHhcCCcCC-----
Confidence 2334579999999999988765 6899999999999999999999975432 1 112 2222332211
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .....+.+++..||+.||.+||++.||+++
T Consensus 236 -p~----~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 236 -PQ----YLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -CT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -Cc----cCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 01 122457889999999999999999999974
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=359.57 Aligned_cols=258 Identities=29% Similarity=0.403 Sum_probs=205.0
Q ss_pred hcCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
.++|...+.||+|+||.||+|.+ .+++.||||++... .......+.+|+.++++++|+||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 36788999999999999999984 34678999999754 344556789999999999999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---CCceEEE
Q 046502 312 MLVCEFVTSNTLEFHLHGKGR-----PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVA 383 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---~~~~kl~ 383 (608)
++||||+++++|.+++..... ..+++..++.++.||+.||.|||+. +|+||||||+||||+. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999986532 3589999999999999999999999 9999999999999984 4569999
Q ss_pred EeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHH
Q 046502 384 DFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRA 461 (608)
Q Consensus 384 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~ 461 (608)
|||+++...... ........|+..|+|||++.+..++.++|||||||+||||++ |+.||..... . .++. .
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~----~~~~-~ 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---Q----EVLE-F 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H----HHHH-H
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---H----HHHH-H
Confidence 999997553321 122233567899999999999999999999999999999998 9999865432 1 1122 2
Q ss_pred HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 462 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 462 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+..+.... ........+.+++..||+.||.+||++.+|+++|+...
T Consensus 258 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 258 VTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 22222111 11122346788999999999999999999999998654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=362.59 Aligned_cols=264 Identities=21% Similarity=0.355 Sum_probs=192.2
Q ss_pred HHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCC--e
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGS--Q 310 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~--~ 310 (608)
...++|...++||+|+||.||+|.. .+|+.||||++... .......+.+|+.+|.++. |+||++++++|...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999985 56899999998643 3334466788999999997 999999999997544 6
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.|||||||. ++|..++... .+++..+..++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999998 5888888763 589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCc--------------------ccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccc
Q 046502 391 ASDV--------------------YTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM 449 (608)
Q Consensus 391 ~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~ 449 (608)
.... .....+..+||++|+|||++.+ ..++.++|||||||+||||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~- 237 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM- 237 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 5321 1112344679999999999976 67999999999999999999999999764421
Q ss_pred cchhhHHHHHHHHhcCCCCcc---------------------cCccccCcCC------------HHHHHHHHHHHHHhhh
Q 046502 450 EDNLARPLLNRAIEDGNFDTL---------------------VDPKLHNEYN------------HNEMARMVACAAACVR 496 (608)
Q Consensus 450 ~~~l~~~~~~~~~~~~~~~~~---------------------~d~~l~~~~~------------~~~~~~l~~l~~~Cl~ 496 (608)
+.+ ..++ ..+.......+ ....+...+. ......+.+|+.+||+
T Consensus 238 -~~~-~~i~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 -NQL-ERII-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp -HHH-HHHH-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred -HHH-HHHH-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 111 0011 00000000000 0000000000 0123457899999999
Q ss_pred cCCCCCCCHHHHHHH
Q 046502 497 HSARRRPRISQIVRT 511 (608)
Q Consensus 497 ~dp~~RPsm~evv~~ 511 (608)
.||++||++.|++++
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=350.81 Aligned_cols=256 Identities=25% Similarity=0.318 Sum_probs=202.5
Q ss_pred CCCcCCccccCCceEEEEEEec-CC---cEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee-EEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVLP-NG---KEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR-MLV 314 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~-~lV 314 (608)
.|...++||+|+||.||+|... ++ ..||||++..... ...+.|.+|+.++++++|+||++++++|.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3555688999999999999853 23 3799999976433 3456789999999999999999999999876655 999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.+++|.+++.... ..+++..++.|+.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 3689999999999999999999999 9999999999999999999999999999865432
Q ss_pred c---cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 395 Y---THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 395 ~---~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
. ........++..|+|||.+.+..++.++|||||||++|||++|..|+...... .. +...+..+....
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~-----~~~~~~~~~~~~-- 248 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FD-----LTHFLAQGRRLP-- 248 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GG-----HHHHHHTTCCCC--
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HH-----HHHHhhcCCCCC--
Confidence 2 11223356788999999999999999999999999999999966664332211 11 111222222111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
........+.+++..||+.||.+||++.+|++.|+...
T Consensus 249 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 249 -------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11122346888999999999999999999999998653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=359.03 Aligned_cols=257 Identities=20% Similarity=0.292 Sum_probs=204.0
Q ss_pred HHHhcCCCcC-CccccCCceEEEEEEec-CCcEEEEEEcccC--CchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCe
Q 046502 236 ARATDGFSDA-NLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG--SGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 236 ~~~~~~f~~~-~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~ 310 (608)
....+.|... ++||+|+||.||+|... +|+.||||+++.. .......+.+|+.++.++. |+||++++++|.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445567766 88999999999999964 5899999998753 2334577889999999994 6999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---CCceEEEEeec
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGL 387 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---~~~~kl~DFGl 387 (608)
.++||||+.+++|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 99999999999999998766556799999999999999999999999 9999999999999988 78999999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
++...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... . ... .+.....
T Consensus 181 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~----~~~-~i~~~~~ 250 (327)
T 3lm5_A 181 SRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ---E----TYL-NISQVNV 250 (327)
T ss_dssp CEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHH-HHHHTCC
T ss_pred ccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch---H----HHH-HHHhccc
Confidence 98765422 223457999999999999999999999999999999999999999754321 1 111 1111111
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. ...........+.+++..||+.||++||++.||+++
T Consensus 251 ~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 251 DY------SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CC------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred cc------CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 10 011111233567889999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=373.35 Aligned_cols=194 Identities=26% Similarity=0.335 Sum_probs=154.1
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEe-----CCe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTA-----GSQ 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-----~~~ 310 (608)
.++|...++||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|++++|+|||+++++|.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 36799999999999999999985 46899999998653 33345678899999999999999999999843 357
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
+||||||+. ++|.+++.... .+++..++.|+.||++||.|||+. +||||||||+||||+.++.+||+|||+++.
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeccc-cchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchh
Confidence 899999985 68888887543 599999999999999999999999 999999999999999999999999999987
Q ss_pred ccCccc--------------------------ceeeeeecccCccChhhh-hcCCCCCcchhhhHHHHHHHHHhC
Q 046502 391 ASDVYT--------------------------HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELIIG 438 (608)
Q Consensus 391 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~Gvll~elltG 438 (608)
...... ...+..+||++|+|||++ ....++.++|||||||+||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 642211 123446789999999986 456799999999999999999994
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.63 Aligned_cols=254 Identities=26% Similarity=0.345 Sum_probs=204.0
Q ss_pred hcCCCcCC-ccccCCceEEEEEEe---cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 239 TDGFSDAN-LLGQGGFGYVHKGVL---PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 239 ~~~f~~~~-~LG~G~fg~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
.++|...+ .||+|+||.||+|.+ .+++.||||+++... ....+.|.+|+.++++++|+||++++++| ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 999999999999964 346889999997543 23356799999999999999999999999 567789
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+.+++|.+++.... .+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 94 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999998754 489999999999999999999999 99999999999999999999999999998765
Q ss_pred Ccccce--eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 393 DVYTHV--STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 393 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
...... .....++..|+|||++.+..++.++||||||+++|||++ |+.||..... . .+...+..+....
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~-----~~~~~~~~~~~~~ 240 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---S-----EVTAMLEKGERMG 240 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---H-----HHHHHHHTTCCCC
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---H-----HHHHHHHcCCCCC
Confidence 432221 222346788999999998889999999999999999999 9999975432 1 1122233332111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
........+.+++..||+.||.+||++.+|++.|+..
T Consensus 241 ---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 241 ---------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1122345688899999999999999999999999853
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=365.34 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=196.1
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc---hhHHHHHHHHHH-HHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG---QGERVFQAEVEI-ISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ev~~-l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++||+|+||.||+|+.. +++.||||+++.... .....+..|..+ ++.++|+||++++++|.+.+.+|||
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57889999999999999999964 588999999975432 233456667766 5678999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999997643 588999999999999999999998 9999999999999999999999999999864332
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
. ......+||+.|+|||++.+..++.++|||||||+||||++|+.||..... .. .....+ .+.+.
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~----~~~~i~-~~~~~------ 257 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AE----MYDNIL-NKPLQ------ 257 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH---HH----HHHHHH-HSCCC------
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---HH----HHHHHH-hcccC------
Confidence 1 223456799999999999999999999999999999999999999975432 11 122222 22211
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
+... ....+.+++..||+.||.+||++.+.++.+...
T Consensus 258 ~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 258 LKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp CCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred CCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 1111 234578899999999999999986555444443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.38 Aligned_cols=249 Identities=16% Similarity=0.133 Sum_probs=201.9
Q ss_pred hcCCCcCCccccCCceEEEEEE------ecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC---CCCccceeeEEEeCC
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV------LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH---HKHLVSLVGYYTAGS 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~---Hpniv~l~g~~~~~~ 309 (608)
.++|...++||+|+||.||+|+ ..+++.||||+++... ...+..|++++.+++ |+||++++++|...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 4678889999999999999994 4568899999997643 446778888888887 999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc----------
Q 046502 310 QRMLVCEFVTSNTLEFHLHGK---GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---------- 376 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---------- 376 (608)
..+|||||+++|+|.+++... ....++|..++.|+.||++||+|||+. +||||||||+||||+.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 999999999999999999742 234699999999999999999999998 8999999999999998
Q ss_pred -CCceEEEEeeccccccC-cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhh
Q 046502 377 -KFEAKVADFGLAKLASD-VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLA 454 (608)
Q Consensus 377 -~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~ 454 (608)
++.+||+|||+++.... ..........||.+|+|||++.+..++.++|||||||+||||++|+.||........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---- 293 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC---- 293 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence 89999999999976532 122334556799999999999999999999999999999999999999853221000
Q ss_pred HHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCC-CCHHHHHHHhhcC
Q 046502 455 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRR-PRISQIVRTLEGD 515 (608)
Q Consensus 455 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~R-Psm~evv~~L~~~ 515 (608)
.++..+.... ....+.+++..||+.+|.+| |++.++.+.|+..
T Consensus 294 ---------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 294 ---------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 0011111111 13346678899999999988 6788888888753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=371.20 Aligned_cols=254 Identities=23% Similarity=0.378 Sum_probs=194.6
Q ss_pred HHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--------chhHHHHHHHHHHHHhcCCCCccceeeEEEe
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--------GQGERVFQAEVEIISRVHHKHLVSLVGYYTA 307 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--------~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~ 307 (608)
...++|...++||+|+||.||+|.. .+++.||||++.... ......+.+|+.+|++++||||++++++|.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4467899999999999999999985 458999999986532 111234789999999999999999999985
Q ss_pred CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC---CceEEEE
Q 046502 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVAD 384 (608)
Q Consensus 308 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~---~~~kl~D 384 (608)
.+..++||||+++++|.+++.... .+++..++.|+.|++.||.|||+. +|+||||||+||||+.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 456899999999999999887544 599999999999999999999998 89999999999999654 4599999
Q ss_pred eeccccccCcccceeeeeecccCccChhhhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 046502 385 FGLAKLASDVYTHVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRA 461 (608)
Q Consensus 385 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 461 (608)
||+++..... .......||+.|+|||++.. ..++.++|||||||+||||++|+.||...... .. +...
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~-----~~~~ 356 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VS-----LKDQ 356 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CC-----HHHH
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HH-----HHHH
Confidence 9999876542 22344679999999999853 67888999999999999999999999754321 11 1122
Q ss_pred HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 462 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 462 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+..+.+... +.... .....+.+++.+||+.||++||++.|++++
T Consensus 357 i~~~~~~~~--~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYNFI--PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCCCC--HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCC--chhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 233332211 00001 123568889999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.44 Aligned_cols=260 Identities=23% Similarity=0.384 Sum_probs=208.9
Q ss_pred CHHHHHHHhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--------hhHHHHHHHHHHHHhc-CCCCccc
Q 046502 231 TYEELARATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--------QGERVFQAEVEIISRV-HHKHLVS 300 (608)
Q Consensus 231 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~Ev~~l~~l-~Hpniv~ 300 (608)
.+.......++|...+.||+|+||.||+|.+. +|+.||||+++.... ...+.+.+|+.++.++ +|+||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 33445556678999999999999999999974 699999999875431 1135678899999999 7999999
Q ss_pred eeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 301 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
++++|...+..+|||||+++++|.+++.... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999997643 589999999999999999999998 99999999999999999999
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhcC------CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhh
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG------KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLA 454 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~ 454 (608)
||+|||++....... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||......
T Consensus 240 kl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------ 311 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------ 311 (365)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred EEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------
Confidence 999999998765422 22346799999999998643 5888999999999999999999999654321
Q ss_pred HHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 455 RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 455 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.....+..+.+... .+.+ . .....+.+++..||+.||++||++.||+++
T Consensus 312 --~~~~~i~~~~~~~~-~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 312 --LMLRMIMEGQYQFS-SPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp --HHHHHHHHTCCCCC-HHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHHHHHhCCCCCC-Cccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11112222222110 0000 1 123457889999999999999999999874
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=357.44 Aligned_cols=264 Identities=23% Similarity=0.376 Sum_probs=201.6
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.++|...++||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++|+||++++++|.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 367889999999999999999964 489999999865432 33466889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+++|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999998876544 499999999999999999999999 99999999999999999999999999998654422
Q ss_pred cceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH----------HHH-h
Q 046502 396 THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN----------RAI-E 463 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~----------~~~-~ 463 (608)
. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||...... +.+.. ... ..+ .
T Consensus 179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI--DQLYH-IMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH-HHHHHCSCCHHHHHHHHH
T ss_pred c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHH-HHHHhCCCChhhhhHhhh
Confidence 2 23345689999999999875 7899999999999999999999999765431 11110 000 000 1
Q ss_pred cCCCCcccCccccCcC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 DGNFDTLVDPKLHNEY-----NHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+.....+.+.... .......+.+|+.+||+.||++||++.||+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111111111111 11234568899999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.04 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=202.5
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC--------CCCccceeeEEE----
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH--------HKHLVSLVGYYT---- 306 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~--------Hpniv~l~g~~~---- 306 (608)
++|...++||+|+||.||+|+. .+++.||||+++.. ....+.+.+|+.+|++++ |+||++++++|.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 6789999999999999999985 56889999999754 334567889999999995 788999999987
Q ss_pred eCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC--------
Q 046502 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-------- 378 (608)
Q Consensus 307 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-------- 378 (608)
.+...+|||||+. ++|.+++.......+++..++.|+.||+.||.|||++| +|+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence 5567899999995 45555555444456999999999999999999999975 799999999999998775
Q ss_pred -----------------------------------------ceEEEEeeccccccCcccceeeeeecccCccChhhhhcC
Q 046502 379 -----------------------------------------EAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417 (608)
Q Consensus 379 -----------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 417 (608)
.+||+|||+++..... .....||..|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999876542 2345789999999999999
Q ss_pred CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc-hh-hHHHHHHH--------HhcCCCC-----------cccCccc-
Q 046502 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED-NL-ARPLLNRA--------IEDGNFD-----------TLVDPKL- 475 (608)
Q Consensus 418 ~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~-~l-~~~~~~~~--------~~~~~~~-----------~~~d~~l- 475 (608)
.++.++|||||||+||||++|+.||......... .. ....+... +..+.+. .+.+...
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 9999999999999999999999999754321110 00 00001110 0011110 0000000
Q ss_pred --------cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 --------HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 --------~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...........+.+|+.+||+.||++||++.||+++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 012346677789999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=358.25 Aligned_cols=254 Identities=28% Similarity=0.407 Sum_probs=203.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEE--EEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEV--AIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~v--avK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++||+|+||.||+|.. .+|+.+ |||+++... ....+.+.+|+++++++ +|+||++++++|.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5788899999999999999995 456644 999987532 33445788999999999 899999999999999999999
Q ss_pred EeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 315 CEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
|||+++++|.+++.... ...+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997643 24689999999999999999999999 99999999999999999999
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHH
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~ 459 (608)
||+|||+++..... .......++..|+|||++.+..++.++|||||||+||||++ |+.||...... .+.
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-------~~~- 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELY- 251 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHH-
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-------HHH-
Confidence 99999999744321 11233457889999999998889999999999999999998 99999654321 111
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..+..+.. ..........+.+++.+||+.||.+||++.||+++|+..
T Consensus 252 ~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 252 EKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 22222211 011112235688899999999999999999999999754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=350.02 Aligned_cols=255 Identities=27% Similarity=0.362 Sum_probs=200.4
Q ss_pred cCCCcCCccccCCceEEEEEEecC----CcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEE-eCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYT-AGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~-~~~~~~l 313 (608)
..|...++||+|+||.||+|.+.+ ...||||.++.... ...+.+.+|+.++++++|+||++++++|. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457788999999999999998533 23589999876433 34567899999999999999999999865 4567899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+++|.+++.... ..+++..++.|+.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997643 3689999999999999999999999 999999999999999999999999999986654
Q ss_pred ccc---ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhC-CCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 394 VYT---HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIG-CRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 394 ~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
... .......++..|+|||.+.+..++.++|||||||++|||++| ..||..... .. ... .+..+....
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~----~~~-~~~~~~~~~ 252 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FD----ITV-YLLQGRRLL 252 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TT----HHH-HHHTTCCCC
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HH----HHH-HHhcCCCCC
Confidence 321 122345678899999999999999999999999999999995 455543322 11 111 111221111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. .......+.+++..||+.||++||++.||++.|+..
T Consensus 253 --~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 253 --Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp --C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --C-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 111234688899999999999999999999999864
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.85 Aligned_cols=249 Identities=21% Similarity=0.350 Sum_probs=205.9
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++|+||++++++|.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 367888999999999999999964 5789999998654 234456788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.+++|.+++.... .+++..++.|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999887643 589999999999999999999999 9999999999999999999999999999876532
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.. ......|+..|+|||++.+..++.++|||||||+||||++|+.||...... . ... .+..+.+.
T Consensus 195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~----~~~-~~~~~~~~------ 259 (335)
T 2owb_A 195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK---E----TYL-RIKKNEYS------ 259 (335)
T ss_dssp TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH---H----HHH-HHHHTCCC------
T ss_pred cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH---H----HHH-HHhcCCCC------
Confidence 22 223456899999999999999999999999999999999999999754321 1 111 11222211
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+...+ ...+.+++.+||+.||++||++.||+++
T Consensus 260 ~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 260 IPKHI----NPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CCccC----CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112 2457789999999999999999999874
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.77 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=202.4
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG------QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|...+.||+|+||.||++... +|+.||||+++.... ...+.+.+|+.++++++|+||++++++|.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999965 689999999875422 23577899999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC----ceEEEEeecc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGLA 388 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~----~~kl~DFGla 388 (608)
+||||+++++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999997643 589999999999999999999998 999999999999998877 8999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
+...... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..... .. .+. .+......
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~----~~~-~~~~~~~~ 229 (283)
T 3bhy_A 160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK---QE----TLT-NISAVNYD 229 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HH----HHH-HHHTTCCC
T ss_pred eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch---HH----HHH-HhHhcccC
Confidence 8765422 22345689999999999999999999999999999999999999975432 11 111 11112111
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+.... ......+.+++.+||+.||.+||++.|++++
T Consensus 230 --~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 230 --FDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp --CCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred --Ccchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 011111 1123467889999999999999999999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=359.18 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=187.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEE--------eC
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYT--------AG 308 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~--------~~ 308 (608)
..+|...++||+|+||.||+|.. .+|+.||||++........+.+.+|+.++.++. |+||++++++|. ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 35788899999999999999995 468999999997776666778999999999996 999999999994 33
Q ss_pred CeeEEEEeeccCCcHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeeccCCCcEEEccCCceEEEEe
Q 046502 309 SQRMLVCEFVTSNTLEFHLHG-KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK--IIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
...++||||+. |+|.+++.. .....+++..++.|+.||+.||.|||+. + |+||||||+||||+.++.+||+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 45799999996 688887764 2233699999999999999999999998 7 999999999999999999999999
Q ss_pred eccccccCcccc-----------eeeeeecccCccChhhh---hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc
Q 046502 386 GLAKLASDVYTH-----------VSTRVMGTFGYLAPEYA---SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED 451 (608)
Q Consensus 386 Gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 451 (608)
|+++........ ......||+.|+|||++ .+..++.++|||||||+||||++|+.||......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--- 259 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL--- 259 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---
Confidence 999876542211 11134589999999998 5667899999999999999999999999643220
Q ss_pred hhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 452 NLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 452 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.++ .+.+..... . .....+.+++..||+.||.+||++.||+++|+...
T Consensus 260 ----~~~-----~~~~~~~~~----~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 260 ----RIV-----NGKYSIPPH----D----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp ---------------CCCCTT----C----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----Hhh-----cCcccCCcc----c----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011 111111101 1 11123678999999999999999999999998654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=354.40 Aligned_cols=258 Identities=25% Similarity=0.342 Sum_probs=196.4
Q ss_pred HhcCCCcCCccccCCceEEEEEEec----CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe-
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP----NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ- 310 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~- 310 (608)
..++|...++||+|+||.||+|.+. .++.||||+++... ....+.+.+|+.++++++|+||++++++|.+.+.
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3567888899999999999999853 34589999997543 3344678999999999999999999999987553
Q ss_pred ----eEEEEeeccCCcHHHHhhc----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEE
Q 046502 311 ----RMLVCEFVTSNTLEFHLHG----KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382 (608)
Q Consensus 311 ----~~lV~E~~~~gsL~~~l~~----~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl 382 (608)
.++||||+.+++|.+++.. .....+++..++.|+.||++||.|||+. +|+||||||+||||+.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEE
Confidence 4999999999999999853 2334699999999999999999999998 9999999999999999999999
Q ss_pred EEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHH
Q 046502 383 ADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 383 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
+|||+++....... .......++..|+|||++.+..++.++|||||||+||||++ |+.||...... . +...
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~----~~~~ 261 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---E----MYDY 261 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G----HHHH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---H----HHHH
Confidence 99999986643221 22233457889999999999999999999999999999999 88888654321 1 1111
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. ..+.... ........+.+++..||+.||.+||++.+|+++|+..
T Consensus 262 ~-~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 262 L-LHGHRLK---------QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp H-HTTCCCC---------CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H-HcCCCCC---------CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1 2221111 1112335688899999999999999999999999854
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-42 Score=356.26 Aligned_cols=270 Identities=21% Similarity=0.346 Sum_probs=198.7
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHH--HHhcCCCCccceeeEEEe-----CCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEI--ISRVHHKHLVSLVGYYTA-----GSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~--l~~l~Hpniv~l~g~~~~-----~~~~ 311 (608)
.++|...++||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++|+||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36788999999999999999987 78999999997533 2334444444 455899999999986543 2356
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeeccCCCcEEEccCCceEEEEe
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC------HPKIIHRDIKAANILLDFKFEAKVADF 385 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~------~~~iiHrDIk~~NILl~~~~~~kl~DF 385 (608)
+|||||+++|+|.+++.... ++|..++.|+.||++||.|||+.+ ..+|+||||||+||||+.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 89999999999999997653 589999999999999999999873 237999999999999999999999999
Q ss_pred eccccccCcc-------cceeeeeecccCccChhhhhc-------CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc
Q 046502 386 GLAKLASDVY-------THVSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED 451 (608)
Q Consensus 386 Gla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 451 (608)
|+++...... ........||..|+|||++.+ ..++.++|||||||+||||++|+.||.........
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 9998664321 111223569999999999976 35667899999999999999998776433221110
Q ss_pred hh----------hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCcc
Q 046502 452 NL----------ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDAS 517 (608)
Q Consensus 452 ~l----------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~~ 517 (608)
.. ....+............+...+ .........+.+++.+||+.||++||++.||++.|+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 00 0001111111111111111111 1123466779999999999999999999999999987553
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=370.84 Aligned_cols=260 Identities=20% Similarity=0.277 Sum_probs=205.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCC-CCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH-KHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~H-pniv~l~g~~~~~~~~~lV~E 316 (608)
.++|.+.++||+|+||.||+|+. .+++.||||+++..... ..+..|+++++.|+| ++|..+..++...+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999995 56899999998754322 347789999999986 556667777788889999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE---ccCCceEEEEeeccccccC
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl---~~~~~~kl~DFGla~~~~~ 393 (608)
|+ +++|.+++..... .+++..++.|+.||+.||.|||+. +||||||||+|||| +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 9999999975433 599999999999999999999999 99999999999999 6889999999999987654
Q ss_pred cccc------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 394 VYTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 394 ~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
.... ......||..|+|||++.+..++.++||||||||||||++|+.||..............+....+. ..+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-TSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-SCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-ccH
Confidence 3221 123567999999999999999999999999999999999999999764432211111111111110 111
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.. +.. .....+.+++..||+.+|++||++.+|++.|+..
T Consensus 238 ~~-----l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 238 EA-----LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp HH-----HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HH-----Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11 101 1235688999999999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=347.78 Aligned_cols=253 Identities=24% Similarity=0.323 Sum_probs=204.5
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467899999999999999999964 68999999986543 3345678999999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc-
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY- 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~- 395 (608)
|+++++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999986543 589999999999999999999998 99999999999999999999999999998654321
Q ss_pred cceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
........|+..|+|||++.+..+ +.++|||||||++|||++|+.||+...... . ............ .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~----~~~~~~~~~~~~---~-- 229 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--Q----EYSDWKEKKTYL---N-- 229 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--H----HHHHHHTTCTTS---T--
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--H----HHHHhhhccccc---C--
Confidence 122344678999999999987665 779999999999999999999997543211 0 111111111110 0
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++..||+.||.+||++.||+++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 ----PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 011223457789999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=356.13 Aligned_cols=267 Identities=22% Similarity=0.290 Sum_probs=198.5
Q ss_pred HHHhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchh-----HHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQG-----ERVFQAEVEIISRVHHKHLVSLVGYYTAGS 309 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-----~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~ 309 (608)
....++|...++||+|+||.||+|... +|+.||||+++...... .+.+.+|+.++++++|+||++++++|.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344678999999999999999999964 58999999997533211 246788999999999999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
..++||||+.+ +|.+++.... ..+++..++.++.|+++||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred ceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999986 7888876543 3588999999999999999999999 89999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|..||...... + ....++.. .......
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~-~~~~i~~~-~~~~~~~ 235 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--D-QLTRIFET-LGTPTEE 235 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--H-HHHHHHHH-HCCCCTT
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--H-HHHHHHHH-cCCCChh
Confidence 7654322 23345789999999999754 5899999999999999999999998754321 1 11111111 1000000
Q ss_pred ccc------Cccc---cCcCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 469 TLV------DPKL---HNEYN-----HNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 469 ~~~------d~~l---~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
.+. +... ..... ......+.+++..||+.||.+||++.|++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 0000 00001 12235788999999999999999999999863
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=345.52 Aligned_cols=246 Identities=21% Similarity=0.274 Sum_probs=200.9
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC--CchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG--SGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~l 313 (608)
..++|...++||+|+||.||+|... +++.||||+++.. .......+.+|+.++.++ +|+||++++++|.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3467899999999999999999964 7899999999754 234456788899999999 89999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---------------
Q 046502 314 VCEFVTSNTLEFHLHGKG--RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF--------------- 376 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~--------------- 376 (608)
||||+++++|.+++.... ...+++..++.|+.||+.||.|||++ +|+||||||+||||+.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999997642 24689999999999999999999999 9999999999999984
Q ss_pred ----CCceEEEEeeccccccCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc
Q 046502 377 ----KFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED 451 (608)
Q Consensus 377 ----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 451 (608)
...+||+|||+++...... ...|+..|+|||++.+. .++.++|||||||++|||++|..++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 4479999999998765422 23589999999999766 566899999999999999999887643211
Q ss_pred hhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 452 NLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 452 ~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+..+.+..+ ... ....+.+++..||+.||++||++.||+++
T Consensus 237 -------~~~~~~~~~~~~-----~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -------WHEIRQGRLPRI-----PQV----LSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -------HHHHHTTCCCCC-----SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -------HHHHHcCCCCCC-----Ccc----cCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 111223333221 112 23467889999999999999999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=360.96 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=203.8
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||++... +++.||+|+++... ....+.+.+|+.++++++|+||++++++|..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57889999999999999999964 68999999997653 33456789999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++.... .+++..+..|+.+++.||.|||+.+ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 99999999997654 4899999999999999999999842 7999999999999999999999999999755332
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhh-----------------------
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLA----------------------- 454 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~----------------------- 454 (608)
......||..|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 223457999999999999999999999999999999999999999754321100000
Q ss_pred ------------HHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 455 ------------RPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 455 ------------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..++.. +..+....+ ........+.+|+..||+.||.+||++.|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDY-IVNEPPPKL--------PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------CCCHHHHHHH-HHHSCCCCC--------CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCCCcccchhhhhH-HhccCCCCC--------CcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000 001110000 001123468899999999999999999999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.84 Aligned_cols=272 Identities=19% Similarity=0.238 Sum_probs=201.8
Q ss_pred ccCHHHHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCc-----------hhHHHHHHHHHHHHhcCCCC
Q 046502 229 TFTYEELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG-----------QGERVFQAEVEIISRVHHKH 297 (608)
Q Consensus 229 ~~~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-----------~~~~~~~~Ev~~l~~l~Hpn 297 (608)
.....++....++|...++||+|+||.||+|...+|+.||||++..... ...+.+.+|+.++++++|+|
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 90 (362)
T 3pg1_A 11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90 (362)
T ss_dssp HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence 3456788889999999999999999999999988899999999864321 12367899999999999999
Q ss_pred ccceeeEEEe-----CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcE
Q 046502 298 LVSLVGYYTA-----GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANI 372 (608)
Q Consensus 298 iv~l~g~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NI 372 (608)
|++++++|.. ....++||||+. ++|.+++.... ..+++..++.|+.||+.||.|||+. +|+||||||+||
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 9999999854 336799999998 57777776543 3699999999999999999999999 999999999999
Q ss_pred EEccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc
Q 046502 373 LLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED 451 (608)
Q Consensus 373 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 451 (608)
||+.++.+||+|||+++...... ......|+..|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99999999999999998544321 2334578999999999876 679999999999999999999999997643211
Q ss_pred hhhHHHHHH------------------HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 452 NLARPLLNR------------------AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 452 ~l~~~~~~~------------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+... ......+.......+ ..........+.+++..||+.||.+||++.|++++
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW-TAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH-HHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH-HhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 11111000 000000000000000 01111223457899999999999999999999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.96 Aligned_cols=249 Identities=29% Similarity=0.422 Sum_probs=207.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
+.|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++|+||++++++|.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 5688899999999999999985 468999999997543 33457789999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++... .+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||++........
T Consensus 102 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 102 LGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 9999999998643 589999999999999999999999 999999999999999999999999999987654322
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...... . .+ ..+..+... .+..
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~-~~~~~~~~~-----~~~~ 241 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM---K----VL-FLIPKNNPP-----TLEG 241 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---H----HH-HHHHHSCCC-----CCCS
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH---H----HH-HHhhcCCCC-----CCcc
Confidence 223456899999999999999999999999999999999999999754321 0 11 112222211 1222
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHh
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTL 512 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L 512 (608)
.+ ...+.+++..||+.||.+||++.||+++.
T Consensus 242 ~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 242 NY----SKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp SC----CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred cc----CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 22 34578899999999999999999998754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=350.64 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=204.2
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...++||+|+||.||++... +|+.||||+++.........+.+|+.++++++|+||++++++|.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457889999999999999999964 6899999999876555556788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE---ccCCceEEEEeeccccccCc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl---~~~~~~kl~DFGla~~~~~~ 394 (608)
+++++|.+++...+ .+++..++.++.|++.||.|||+. +|+||||||+|||| +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999887644 589999999999999999999999 99999999999999 78899999999999865432
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... . .++ ..+..+.+.. ...
T Consensus 163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~----~~~-~~i~~~~~~~--~~~ 229 (304)
T 2jam_A 163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE---S----KLF-EKIKEGYYEF--ESP 229 (304)
T ss_dssp ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH---H----HHH-HHHHHCCCCC--CTT
T ss_pred ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---H----HHH-HHHHcCCCCC--Ccc
Confidence 12234689999999999999999999999999999999999999965432 1 111 2222332211 111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
........+.+++..||+.||++||++.|++++
T Consensus 230 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 230 ----FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp ----TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111233568889999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=347.21 Aligned_cols=249 Identities=21% Similarity=0.351 Sum_probs=205.7
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|+||.||++... +++.||+|++... .....+.+.+|+.++++++|+||++++++|.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999965 5789999998654 233456788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++.... .+++..++.|+.|+++||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999887643 589999999999999999999999 9999999999999999999999999999876432
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.. ......|+..|+|||++.+..++.++||||||+++|||++|+.||...... + ... .+..+.+.
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~-----~~~-~~~~~~~~------ 233 (294)
T 2rku_A 169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--E-----TYL-RIKKNEYS------ 233 (294)
T ss_dssp TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--H-----HHH-HHHTTCCC------
T ss_pred cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H-----HHH-HHhhccCC------
Confidence 22 223456899999999999989999999999999999999999999754321 0 111 12222211
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.. .....+.+++.+||+.||++||++.||+++
T Consensus 234 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 234 IPK----HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred Ccc----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 122457789999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=352.16 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=187.5
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...++||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++|+||++++++|...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 57899999999999999999984 468999999987543 2334678899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 317 FVTSNTLEFHLHG------KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 317 ~~~~gsL~~~l~~------~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
|+++++|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999998864 1234589999999999999999999999 999999999999999999999999999976
Q ss_pred ccCcc----cceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC
Q 046502 391 ASDVY----THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465 (608)
Q Consensus 391 ~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~ 465 (608)
..... ........|+..|+|||++.. ..++.++|||||||+||||++|+.||...... + .+...+. +
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~-----~~~~~~~-~ 242 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--K-----VLMLTLQ-N 242 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--G-----HHHHHHT-S
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--h-----HHHHHhc-c
Confidence 54321 111234568999999999875 56899999999999999999999999764331 1 1111111 1
Q ss_pred CCCcc----cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 NFDTL----VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 ~~~~~----~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
....+ .+..+... ....+.+++.+||+.||.+||++.||+++
T Consensus 243 ~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SCCCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111 11112122 23467889999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.23 Aligned_cols=242 Identities=13% Similarity=0.144 Sum_probs=190.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHH---HHHHhcCCCCcccee-------eE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEV---EIISRVHHKHLVSLV-------GY 304 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev---~~l~~l~Hpniv~l~-------g~ 304 (608)
.++|...++||+|+||.||+|+. .+|+.||||++... .....+.|.+|+ ++|++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35688889999999999999995 56999999999743 334557789999 555666899999998 66
Q ss_pred EEeCCe-----------------eEEEEeeccCCcHHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 046502 305 YTAGSQ-----------------RMLVCEFVTSNTLEFHLHGKGR-----PTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362 (608)
Q Consensus 305 ~~~~~~-----------------~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~ia~~ia~~L~yLH~~~~~~i 362 (608)
+...+. .+|||||+ +|+|.+++..... ..++|..++.|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 665532 78999999 6899999975321 1234688899999999999999999 89
Q ss_pred eeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcC-----------CCCCcchhhhHHHH
Q 046502 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG-----------KLTEKSDVFSFGVM 431 (608)
Q Consensus 363 iHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDVwS~Gvl 431 (608)
+||||||+||||+.++.+||+|||+++.... ......| ..|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986443 2344567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 432 LLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 432 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
||||++|+.||....... .+..+.. .. .. ....+.+++..||+.||++||++.|++++
T Consensus 303 l~elltg~~Pf~~~~~~~----------------~~~~~~~-~~-~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG----------------GSEWIFR-SC-KN----IPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------C----------------CSGGGGS-SC-CC----CCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCccccccc----------------chhhhhh-hc-cC----CCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 999999999996432210 0111111 00 11 23467889999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=363.62 Aligned_cols=199 Identities=23% Similarity=0.318 Sum_probs=174.8
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhc------CCCCccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRV------HHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l------~Hpniv~l~g~~~~~~~~ 311 (608)
.++|...++||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++..+ +|+||++++++|...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 356889999999999999999854 5889999999754 33446678899998887 577999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc--eEEEEeeccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE--AKVADFGLAK 389 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~--~kl~DFGla~ 389 (608)
++||||+. ++|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+||||+.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999997 5888888876666799999999999999999999999 9999999999999999987 9999999997
Q ss_pred cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~ 446 (608)
..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 65432 233578999999999999999999999999999999999999997654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=348.20 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=200.4
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++|+||++++++|...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467899999999999999999965 5899999999876666677899999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+++++|.+++.... ..+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||++....... .
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999999887533 2589999999999999999999999 99999999999999999999999999986432211 1
Q ss_pred eeeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 398 VSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
......|+..|+|||++. ...++.++|||||||++|||++|+.||...... ..+..... +....+..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~-~~~~~~~~ 244 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAK-SDPPTLLT 244 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHH-SCCCCCSS
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhc-cCCcccCC
Confidence 123356899999999984 567899999999999999999999999754321 11112222 22111111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++..||+.||.+||++.||+++
T Consensus 245 -------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 245 -------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11223467889999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=344.89 Aligned_cols=246 Identities=28% Similarity=0.403 Sum_probs=204.4
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67889999999999999999964 57889999986432 223467889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999987654 489999999999999999999998 99999999999999999999999999997654321
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||...... . .. ..+....+ .+
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~----~~-~~~~~~~~------~~ 231 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT---E----TH-RRIVNVDL------KF 231 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---H----HH-HHHHTTCC------CC
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh---H----HH-HHHhcccc------CC
Confidence 23456899999999999999999999999999999999999999754321 1 11 11222211 11
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+......+.+++..||+.||.+||++.||+++
T Consensus 232 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 232 ----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11223467889999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=354.96 Aligned_cols=262 Identities=21% Similarity=0.328 Sum_probs=194.6
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhH-HHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGE-RVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~-~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||.||+|... +++.||||+++....... ..+.+|+.++++++|+||++++++|...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999964 689999999975432221 2455799999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+. ++|.+++..... .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN-IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 155 (324)
T ss_dssp CS-EEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence 98 488888776543 689999999999999999999999 999999999999999999999999999986543222
Q ss_pred eeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC---CCCcccC-
Q 046502 398 VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG---NFDTLVD- 472 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~~d- 472 (608)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||...... + ... .+.+.+... .+..+..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~-~~~-~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE--E-QLH-FIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H-HHH-HHHHHHCCCCTTTSTTGGGC
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--H-HHH-HHHHHhCCCChHhchhhhcc
Confidence 2234568999999999876 56899999999999999999999999764421 1 111 111111000 0000000
Q ss_pred --------ccccC----cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 --------PKLHN----EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 --------~~l~~----~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.... .........+.+|+..||+.||.+||++.||+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000 0011123457899999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=345.01 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=200.5
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC----chhHHHHHHHHHHHHhcCCCCccceeeEEE--eCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHHKHLVSLVGYYT--AGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~--~~~~~ 311 (608)
.++|...++||+|+||.||++.. .+++.||||+++... ....+.+.+|+.++++++|+||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 47899999999999999999996 468899999997532 234567899999999999999999999984 45578
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+.++ |.+++.......+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999987 66777665555799999999999999999999999 9999999999999999999999999999866
Q ss_pred cCcc-cceeeeeecccCccChhhhhcCC--CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 392 SDVY-THVSTRVMGTFGYLAPEYASSGK--LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 392 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
.... ........|+..|+|||++.+.. ++.++|||||||++|||++|+.||...... . +...+..+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~-~~~~i~~~~~~ 231 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY-------K-LFENIGKGSYA 231 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH-------H-HHHHHHHCCCC
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH-------H-HHHHHhcCCCC
Confidence 4321 22233456899999999997644 377999999999999999999999754321 1 11222233221
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+... ....+.+++.+||+.||.+||++.||+++
T Consensus 232 ------~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 ------IPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ------CCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ------CCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122 23467789999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=353.17 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=202.0
Q ss_pred CHHHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEe-
Q 046502 231 TYEELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTA- 307 (608)
Q Consensus 231 ~~~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~- 307 (608)
.+.++....++|...++||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++++ +|+||+++++++..
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 3334445678899999999999999999996 578999999997543 3346788999999999 79999999999987
Q ss_pred -----CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEE
Q 046502 308 -----GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382 (608)
Q Consensus 308 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl 382 (608)
.+..++||||+.+++|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEE
Confidence 56889999999999999999876545789999999999999999999999 9999999999999999999999
Q ss_pred EEeeccccccCcccceeeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHH
Q 046502 383 ADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPL 457 (608)
Q Consensus 383 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~ 457 (608)
+|||++........ ......|+..|+|||++. ...++.++|||||||+||||++|+.||...... . .
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~-----~ 242 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM--R-----A 242 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH--H-----H
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--H-----H
Confidence 99999986643221 223356899999999997 567899999999999999999999999654321 0 1
Q ss_pred HHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 458 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 458 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.. +..+....+.. .. ....+.+++..||+.||.+||++.||+++
T Consensus 243 ~~~-~~~~~~~~~~~----~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 243 LFL-IPRNPAPRLKS----KK----WSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHH-HHHSCCCCCSC----SC----SCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHH-hhcCccccCCc----cc----cCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 111 11222211111 11 23467889999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=347.87 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=198.7
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCeeEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTA----GSQRML 313 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~----~~~~~l 313 (608)
.|...++||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++|+||++++++|.. +...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 366777899999999999985 45789999998754 33445678999999999999999999999875 456899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeeccCCCcEEEc-cCCceEEEEeecccc
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK--IIHRDIKAANILLD-FKFEAKVADFGLAKL 390 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~--iiHrDIk~~NILl~-~~~~~kl~DFGla~~ 390 (608)
||||+++++|.+++.... .+++..++.|+.||+.||.|||+. + |+||||||+||||+ .++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999997643 589999999999999999999998 6 99999999999997 789999999999976
Q ss_pred ccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
.... ......|+..|+|||++. +.++.++|||||||++|+|++|+.||...... ..+. ..+..+.....
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~-~~~~~~~~~~~ 250 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA------AQIY-RRVTSGVKPAS 250 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------HHHH-HHHTTTCCCGG
T ss_pred cccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH------HHHH-HHHhccCCccc
Confidence 5442 223456999999999886 56999999999999999999999999753321 1111 12222221111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+ ......+.+++..||+.||.+||++.||+++
T Consensus 251 ~~--------~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 251 FD--------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp GG--------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cC--------CCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11 1122458889999999999999999999964
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=361.58 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=197.2
Q ss_pred HHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEe-------
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA------- 307 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~------- 307 (608)
....++|...++||+|+||.||+|.. .+|+.||||++..+.. .+.+|+++|++++|+|||+++++|..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34567899999999999999999985 5789999999875432 23469999999999999999999844
Q ss_pred -------------------------------CCeeEEEEeeccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHH
Q 046502 308 -------------------------------GSQRMLVCEFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYL 354 (608)
Q Consensus 308 -------------------------------~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yL 354 (608)
+...++||||+++ +|.+.+.. .....+++..++.|+.||++||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3348899999994 77766653 2234699999999999999999999
Q ss_pred HhcCCCCeeeeccCCCcEEEc-cCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHH
Q 046502 355 HEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVML 432 (608)
Q Consensus 355 H~~~~~~iiHrDIk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll 432 (608)
|+. +|+||||||+||||+ .++.+||+|||+++...... ......||..|+|||++.+. .++.++|||||||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 999999999999998 68899999999998664432 22345689999999998765 489999999999999
Q ss_pred HHHHhCCCCCCCCcccccchhhHHHHH--------HHH-hcCCCC-----cccCccccCcCCHHHHHHHHHHHHHhhhcC
Q 046502 433 LELIIGCRPVDSTHTFMEDNLARPLLN--------RAI-EDGNFD-----TLVDPKLHNEYNHNEMARMVACAAACVRHS 498 (608)
Q Consensus 433 ~elltG~~p~~~~~~~~~~~l~~~~~~--------~~~-~~~~~~-----~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d 498 (608)
|||++|+.||...... +.+. .++. ... .+..+. .+....+...+.......+.+|+.+||+.|
T Consensus 233 ~ell~g~~pf~~~~~~--~~~~-~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 233 GELILGKPLFSGETSI--DQLV-RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHSSCSSCCSSHH--HHHH-HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHhCCCCCCCCChH--HHHH-HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999764321 1111 1110 000 011111 111111111122234456889999999999
Q ss_pred CCCCCCHHHHHHH
Q 046502 499 ARRRPRISQIVRT 511 (608)
Q Consensus 499 p~~RPsm~evv~~ 511 (608)
|.+||++.|++++
T Consensus 310 P~~R~t~~e~l~h 322 (383)
T 3eb0_A 310 PDLRINPYEAMAH 322 (383)
T ss_dssp GGGSCCHHHHHTS
T ss_pred hhhCCCHHHHhcC
Confidence 9999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=374.59 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=206.0
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+|++++|+||++++++|...+.+||||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888999999999999999964 68999999996532 223456889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 316 EFVTSNTLEFHLHGKG--RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~--~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||+++|+|.+++.... ...+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999987643 44699999999999999999999999 999999999999999999999999999987654
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
... ......||+.|+|||++.+..++.++|||||||+||||++|+.||........ ...+....+ .+..
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~~~~~i~-~~~~------ 410 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRVL-EQAV------ 410 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHHHHHHHH-HCCC------
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHHHHHHHh-hccc------
Confidence 322 22345799999999999999999999999999999999999999976432111 111222222 2211
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRI-----SQIVR 510 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm-----~evv~ 510 (608)
.++......+.+++..||+.||.+||++ .+|++
T Consensus 411 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 ----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1112233567889999999999999975 56664
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=363.40 Aligned_cols=253 Identities=9% Similarity=0.031 Sum_probs=183.8
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---hhHHHHHHHHHHHHhc--CCCCcccee-------eEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---QGERVFQAEVEIISRV--HHKHLVSLV-------GYYT 306 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l--~Hpniv~l~-------g~~~ 306 (608)
.+|...++||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4578889999999999999995 4789999999987543 3345678886555555 699987754 4554
Q ss_pred eC-----------------CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCee
Q 046502 307 AG-----------------SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTR------LKIALGFAKGLAYLHEDCHPKII 363 (608)
Q Consensus 307 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~ia~~ia~~L~yLH~~~~~~ii 363 (608)
.. ...+|||||+. ++|.+++...+. .+.+..+ +.|+.||+.||+|||++ +|+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GLV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCc
Confidence 33 33799999999 899999986432 3466666 78889999999999999 899
Q ss_pred eeccCCCcEEEccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhc--CCCCCcchhhhHHHHHHHHHhCCCC
Q 046502 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELIIGCRP 441 (608)
Q Consensus 364 HrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvll~elltG~~p 441 (608)
||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876532 223457799999999987 6799999999999999999999999
Q ss_pred CCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 442 VDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 442 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
|..........+. ...........+...........+.+|+.+||+.||++||++.|+++
T Consensus 293 f~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSWK---------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCCC---------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccchh---------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9755321111100 00000011111111111233456888999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=352.83 Aligned_cols=262 Identities=21% Similarity=0.277 Sum_probs=199.4
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEe--------
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTA-------- 307 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-------- 307 (608)
.++|...++||+|+||.||+|.. .+|+.||||++..... .....+.+|+.++++++|+||++++++|..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36789999999999999999996 5789999999865432 224567889999999999999999999987
Q ss_pred CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeec
Q 046502 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL 387 (608)
Q Consensus 308 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGl 387 (608)
++..++||||+.+ +|...+.... ..+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4568999999986 6666665443 3599999999999999999999999 999999999999999999999999999
Q ss_pred cccccCcc---cceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 388 AKLASDVY---THVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 388 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .... .+....
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~-~i~~~~- 245 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLA-LISQLC- 245 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH-HHHHHH-
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHH-HHHHHh-
Confidence 98664221 122344578999999999876 45899999999999999999999999764321 1111 111111
Q ss_pred cCCCCcccCccc------------cC-cCC-HHH------HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 DGNFDTLVDPKL------------HN-EYN-HNE------MARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 ~~~~~~~~d~~l------------~~-~~~-~~~------~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+....-+.+ .. ... .+. ...+.+|+.+||+.||.+||++.|++++
T Consensus 246 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 246 -GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp -CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 11111000000 00 000 011 2347889999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=341.69 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=197.0
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++|+||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367889999999999999999965 68999999986532 22345788999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.+++|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999997654 489999999999999999999999 8999999999999999999999999999876542
Q ss_pred ccceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
. ......|+..|+|||++.+..+ +.++||||||+++|+|++|+.||+.... . .+. ..+..+.+.
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~----~~~-~~~~~~~~~----- 229 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV---P----TLF-KKIRGGVFY----- 229 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH---H----HHH-HHHHHCCCC-----
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH---H----HHH-HHhhcCccc-----
Confidence 2 2234568999999999987765 6899999999999999999999975432 1 111 122222211
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.. .....+.+++.+||+.||.+||++.||+++
T Consensus 230 -~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 230 -IPE----YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -Cch----hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 123457889999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=349.49 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=187.4
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.++|...++||+|+||.||+|.. .+|+.||||+++..... ..+.+.++..+++.++|+||++++++|.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788999999999999999995 57899999999764322 2234555566688889999999999999999999999
Q ss_pred eeccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 316 EFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 316 E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||+++ +|.+++.. .....+++..++.|+.|++.||.|||+++ +|+||||||+||||+.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99985 77776654 22346999999999999999999999864 799999999999999999999999999987654
Q ss_pred cccceeeeeecccCccChhhh----hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
... .....||..|+|||++ ....++.++|||||||++|||++|+.||+..... ...+...+......
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~- 233 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP------FQQLKQVVEEPSPQ- 233 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH------HHHHHHHHHSCCCC-
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch------HHHHHHHhccCCCC-
Confidence 322 2234689999999996 5567899999999999999999999999753221 11122222222211
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
... ......+.+++..||+.||++||++.||++
T Consensus 234 ~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 LPA--------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCT--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccc--------ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111 122346788999999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=348.81 Aligned_cols=259 Identities=19% Similarity=0.273 Sum_probs=201.2
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEe--CCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTA--GSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~--~~~~~lV~ 315 (608)
++|...++||+|+||.||+|.. .+++.||||+++... .+.+.+|+.++++++ |+||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6789999999999999999985 578999999997533 457889999999997 9999999999987 66789999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-ceEEEEeeccccccCc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKLASDV 394 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~ 394 (608)
||+.+++|.+++.. +++..++.|+.||+.||.|||+. +|+||||||+||||+.++ .+||+|||+++.....
T Consensus 113 e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp ECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999998853 88999999999999999999999 999999999999999776 8999999999876543
Q ss_pred ccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchh------hHHHHHHHHhcCCC
Q 046502 395 YTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL------ARPLLNRAIEDGNF 467 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l------~~~~~~~~~~~~~~ 467 (608)
. ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||.........-. ....+...+.....
T Consensus 185 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 185 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 2 2233568999999999977 6799999999999999999999999965432111100 00001111111110
Q ss_pred C--------------cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 D--------------TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~--------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. ...+..+...........+.+|+..||+.||.+||++.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0000011111112234578899999999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=356.56 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=196.1
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC------
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS------ 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~------ 309 (608)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|++++|+||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46789999999999999999996 56899999999643 2333467889999999999999999999997653
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
..++||||+ +++|.+++... .+++..+..++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 469999999 78999998763 589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC-
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF- 467 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~- 467 (608)
..... .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+ ...+. ..|..
T Consensus 177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l-~~i~~---~~g~~~ 246 (367)
T 1cm8_A 177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL--DQL-KEIMK---VTGTPP 246 (367)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH-HHHHH---HHCCCC
T ss_pred ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHH---hcCCCC
Confidence 76542 234578999999999887 67999999999999999999999999764421 111 10100 00100
Q ss_pred -------------------CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 -------------------DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 -------------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+ ..........+.+|+.+||+.||.+||++.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00000111 01112234567889999999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=351.90 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=197.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc--------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCC
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG--------QGERVFQAEVEIISRVHHKHLVSLVGYYTAGS 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~ 309 (608)
.++|...+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++|++++|+||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46799999999999999999996 4588999999865321 12245789999999999999999999987655
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc---eEEEEee
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFG 386 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~---~kl~DFG 386 (608)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 899999999999999887543 589999999999999999999998 9999999999999987654 9999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
+++...... ......|+..|+|||++. ...++.++|||||||+||||++|+.||...... ..+ ...+.
T Consensus 163 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~-----~~~~~ 233 (322)
T 2ycf_A 163 HSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSL-----KDQIT 233 (322)
T ss_dssp TCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCH-----HHHHH
T ss_pred cceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHH-----HHHHH
Confidence 998765421 223356899999999974 467899999999999999999999999754321 111 11222
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+.+... +.+.. .....+.+++..||+.||++||++.|++++
T Consensus 234 ~~~~~~~--~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 234 SGKYNFI--PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HTCCCCC--HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hCccccC--chhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 2322111 11111 123567889999999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.32 Aligned_cols=252 Identities=27% Similarity=0.371 Sum_probs=201.0
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
..++|...+.||+|+||.||+|... +|+.||||++.... ..+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3567999999999999999999964 58999999997643 23568899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.+++|.+++.... ..+++..++.++.+++.||.|||+. +|+||||||+||||+.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999999987432 3689999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||....... .+. .+..+....+..
T Consensus 181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~-~~~~~~~~~~~~---- 247 (314)
T 3com_A 181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR-------AIF-MIPTNPPPTFRK---- 247 (314)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHH-HHHHSCCCCCSS----
T ss_pred -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH-------HHH-HHhcCCCcccCC----
Confidence 2234568999999999999999999999999999999999999997543210 111 111111111111
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+++..||+.||.+||++.+|+++
T Consensus 248 ---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 248 ---PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp ---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11223467889999999999999999999863
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=349.51 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=197.0
Q ss_pred cCCCcCCccccCCceEEEEEEec--CCc--EEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP--NGK--EVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|...++||+|+||.||+|.+. +++ .||||+++.. .....+.+.+|++++++++|+||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57888999999999999999853 333 6899998754 2334567899999999999999999999998754 89
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+.+++|.+++.... ..+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999987643 2589999999999999999999999 99999999999999999999999999998765
Q ss_pred Ccccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 393 DVYTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 393 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
..... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... . .++......+...
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~----~~~~~~~~~~~~~- 244 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---S----QILHKIDKEGERL- 244 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H----HHHHHHHTSCCCC-
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---H----HHHHHHHccCCCC-
Confidence 43221 2233567889999999998889999999999999999999 9999975432 1 1222222221110
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.........+.+++..||+.||.+||++.+|++.|+...
T Consensus 245 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 245 --------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred --------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 011123456888999999999999999999999998643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=365.60 Aligned_cols=259 Identities=24% Similarity=0.323 Sum_probs=194.6
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeC----C--eeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG----S--QRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~----~--~~~ 312 (608)
.+|...++||+|+||.||+|++. +|+.||||++..... .+.+|+++|++|+|+|||+++++|... + .++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 35788899999999999999974 589999999875432 234699999999999999999998542 2 367
Q ss_pred EEEeeccCCcHHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEeeccc
Q 046502 313 LVCEFVTSNTLEFHLHG--KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAK 389 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFGla~ 389 (608)
+||||+++ +|.+++.. .....+++..++.++.||++||.|||+. +|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 45544432 2334699999999999999999999998 99999999999999965 568999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH-------H
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR-------A 461 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-------~ 461 (608)
...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||..... .+.+. .++.. .
T Consensus 206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~-~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLV-EIIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHH-HHHHHHCSCCHHH
T ss_pred hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHH-HHHHHhCCCCHHH
Confidence 764422 22345789999999999765 799999999999999999999999976432 11111 11110 0
Q ss_pred H--hcCCCCcccCccccC-----cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 462 I--EDGNFDTLVDPKLHN-----EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 462 ~--~~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+ ....+.++..+.+.. .+.......+.+|+.+||+.||.+||++.|++++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 111222221222111 1222234578899999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.48 Aligned_cols=260 Identities=20% Similarity=0.323 Sum_probs=205.4
Q ss_pred hcCCCcCCccccCCceEEEEEEe--cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC------ccceeeEEEeCCe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL--PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH------LVSLVGYYTAGSQ 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn------iv~l~g~~~~~~~ 310 (608)
.++|...++||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.++++++|+| |++++++|...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35789999999999999999986 36889999999754 334567889999999997654 9999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc--------------
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-------------- 376 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-------------- 376 (608)
.++||||+ +++|.+++.......+++..++.|+.||+.||.|||++ +|+||||||+||||+.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 88999999877666789999999999999999999999 9999999999999987
Q ss_pred -----CCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc
Q 046502 377 -----KFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED 451 (608)
Q Consensus 377 -----~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 451 (608)
++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||+||||++|+.||........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~- 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH- 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH-
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH-
Confidence 678999999999865432 2345789999999999999999999999999999999999999976432110
Q ss_pred hhhHHHHHHHH--------hcCCCCccc-Cc-------------------cc--cCcCCHHHHHHHHHHHHHhhhcCCCC
Q 046502 452 NLARPLLNRAI--------EDGNFDTLV-DP-------------------KL--HNEYNHNEMARMVACAAACVRHSARR 501 (608)
Q Consensus 452 ~l~~~~~~~~~--------~~~~~~~~~-d~-------------------~l--~~~~~~~~~~~l~~l~~~Cl~~dp~~ 501 (608)
+ . .+.... ......... .. .+ ...........+.+++..||+.||.+
T Consensus 243 -~-~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 243 -L-A-MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp -H-H-HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred -H-H-HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 0 0 011100 000000000 00 00 01122345678899999999999999
Q ss_pred CCCHHHHHHH
Q 046502 502 RPRISQIVRT 511 (608)
Q Consensus 502 RPsm~evv~~ 511 (608)
||++.||+++
T Consensus 320 Rpt~~ell~h 329 (339)
T 1z57_A 320 RITLREALKH 329 (339)
T ss_dssp SCCHHHHTTS
T ss_pred ccCHHHHhcC
Confidence 9999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.17 Aligned_cols=253 Identities=24% Similarity=0.318 Sum_probs=205.2
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---------chhHHHHHHHHHHHHhcC-CCCccceeeEEE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---------GQGERVFQAEVEIISRVH-HKHLVSLVGYYT 306 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~ 306 (608)
..++|...++||+|+||.||+|... +|+.||||+++... ....+.+.+|+++++++. |+||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3578999999999999999999964 68999999997543 122356889999999996 999999999999
Q ss_pred eCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 307 AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 307 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
.++..++||||+++++|.+++.... .+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999997643 589999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhh------cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYAS------SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
+++...... ......|+..|+|||++. ...++.++||||||++||||++|+.||..... . .+..
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~-----~~~~ 239 (298)
T 1phk_A 170 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---M-----LMLR 239 (298)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H-----HHHH
T ss_pred chhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH---H-----HHHH
Confidence 998765422 223456899999999985 45688999999999999999999999965432 1 1112
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+..+.+... .+ ........+.+++..||+.||.+||++.||+++
T Consensus 240 ~~~~~~~~~~-~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 MIMSGNYQFG-SP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHTCCCCC-TT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCCcccC-cc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 2222322211 11 111234568899999999999999999999863
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.14 Aligned_cols=199 Identities=26% Similarity=0.331 Sum_probs=167.2
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----Ce
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG-----SQ 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~-----~~ 310 (608)
.++|...++||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+.+|++++|+||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 46899999999999999999995 45889999999753 333456788999999999999999999999766 57
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.||||||+. ++|.+++.... .+++..++.|+.||++||.|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999997 59999887643 599999999999999999999999 999999999999999999999999999987
Q ss_pred ccCccc---------------------ceeeeeecccCccChhhh-hcCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 046502 391 ASDVYT---------------------HVSTRVMGTFGYLAPEYA-SSGKLTEKSDVFSFGVMLLELIIGCRPVD 443 (608)
Q Consensus 391 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~Gvll~elltG~~p~~ 443 (608)
...... ...+..+||++|+|||++ ....++.++|||||||+||||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 643221 123556799999999986 55679999999999999999998655543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.91 Aligned_cols=261 Identities=23% Similarity=0.312 Sum_probs=193.3
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC------
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS------ 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~------ 309 (608)
.++|...+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++++++|+||++++++|...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999985 46889999999753 2334467889999999999999999999997655
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
..++||||+.+ +|.+++.. .+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 78999999985 67777753 489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH--------------
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR-------------- 455 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~-------------- 455 (608)
..... .......||..|+|||++.+..++.++|||||||+||||++|+.||....... .+..
T Consensus 176 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 176 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID--QWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHC-CCCCCHHHHT
T ss_pred ccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHH
Confidence 66432 12334678999999999999999999999999999999999999997643210 0000
Q ss_pred ---HHHHHHHhcC-CC-----CcccCccccC---cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 456 ---PLLNRAIEDG-NF-----DTLVDPKLHN---EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 456 ---~~~~~~~~~~-~~-----~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+...+... .+ ..++...+.. .........+.+|+.+||+.||.+||++.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000001100 00 0000000000 1112235678899999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=369.56 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=199.8
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.+.|...++||+|+||.||+|... +++.||||+++... ......+.+|+.+|++++|||||+++++|.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456889999999999999999964 68899999997543 233567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC---CceEEEEeecccccc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVADFGLAKLAS 392 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~---~~~kl~DFGla~~~~ 392 (608)
||+.+|+|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.+ +.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999998887653 489999999999999999999999 99999999999999764 459999999998765
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||..... .. ++ ..+..+.+... .
T Consensus 191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~----~~-~~i~~~~~~~~-~ 258 (494)
T 3lij_A 191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QE----IL-RKVEKGKYTFD-S 258 (494)
T ss_dssp TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HH-HHHHHTCCCCC-S
T ss_pred CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HH----HH-HHHHhCCCCCC-c
Confidence 432 233457999999999986 5799999999999999999999999975432 11 12 22233322111 1
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+ . .....+.+++..||+.||.+||++.|++++
T Consensus 259 ~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 259 PEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp GGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred hhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 111 1 123457889999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=354.87 Aligned_cols=259 Identities=20% Similarity=0.282 Sum_probs=207.2
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchh-----------------HHHHHHHHHHHHhcCCCCccce
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQG-----------------ERVFQAEVEIISRVHHKHLVSL 301 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~Ev~~l~~l~Hpniv~l 301 (608)
.++|...++||+|+||.||+|.. +|+.||||++....... .+.|.+|+.++++++|+||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 99999999986432111 1678999999999999999999
Q ss_pred eeEEEeCCeeEEEEeeccCCcHHHH------hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeeeeccCCCcEEE
Q 046502 302 VGYYTAGSQRMLVCEFVTSNTLEFH------LHGKGRPTMDWPTRLKIALGFAKGLAYLHE-DCHPKIIHRDIKAANILL 374 (608)
Q Consensus 302 ~g~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~-~~~~~iiHrDIk~~NILl 374 (608)
+++|.+.+..++||||+++++|.++ +.......+++..++.|+.|++.||.|||+ . +|+||||||+||||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999998 655445679999999999999999999999 7 89999999999999
Q ss_pred ccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcC-CCCC-cchhhhHHHHHHHHHhCCCCCCCCcccccch
Q 046502 375 DFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG-KLTE-KSDVFSFGVMLLELIIGCRPVDSTHTFMEDN 452 (608)
Q Consensus 375 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDVwS~Gvll~elltG~~p~~~~~~~~~~~ 452 (608)
+.++.+||+|||+++..... ......|+..|+|||++.+. .++. ++|||||||++|||++|+.||...... ..
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~ 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--VE 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--HH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH
Confidence 99999999999999876443 23446789999999999877 5666 999999999999999999999754321 11
Q ss_pred hhHHHHHHHHhcCCCCcccCcc-----c----cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 453 LARPLLNRAIEDGNFDTLVDPK-----L----HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 453 l~~~~~~~~~~~~~~~~~~d~~-----l----~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+...+..+.+....+.. + ...........+.+++..||+.||.+||++.|++++
T Consensus 261 -----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 261 -----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp -----HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -----HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11222233222111100 0 000012234568899999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=349.62 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=203.8
Q ss_pred HHhcCCCcCCccccCCceEEEEEEe--cCCcEEEEEEcccCCch--hHHHHHHHHHHHHhc---CCCCccceeeEEE---
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVL--PNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRV---HHKHLVSLVGYYT--- 306 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l---~Hpniv~l~g~~~--- 306 (608)
.+.++|...+.||+|+||.||+|.. .+|+.||||+++..... ....+.+|+.+++++ +|+||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999997 46889999998643221 123456777777766 8999999999987
Q ss_pred --eCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEE
Q 046502 307 --AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD 384 (608)
Q Consensus 307 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~D 384 (608)
.....++||||+. ++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+||||+.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 5999999876656699999999999999999999999 999999999999999999999999
Q ss_pred eeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh-
Q 046502 385 FGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE- 463 (608)
Q Consensus 385 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~- 463 (608)
||+++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...... .....++.....
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCC
Confidence 99998765322 233457899999999999999999999999999999999999999764321 111111111000
Q ss_pred -cCCCCccc----------CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 -DGNFDTLV----------DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 -~~~~~~~~----------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+.... .......+.......+.+++.+||+.||.+||++.|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 0000011122334567889999999999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=369.43 Aligned_cols=251 Identities=24% Similarity=0.403 Sum_probs=205.8
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++|...++||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++||||++++++|.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888999999999999999964 78999999986432 33467789999999999999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE---ccCCceEEEEeeccccc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL---DFKFEAKVADFGLAKLA 391 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl---~~~~~~kl~DFGla~~~ 391 (608)
|||+.+++|.+++.... .+++..++.|+.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999887654 589999999999999999999999 99999999999999 56789999999999876
Q ss_pred cCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...... ..+ ..+..+.+....
T Consensus 180 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~-~~i~~~~~~~~~ 248 (484)
T 3nyv_A 180 EASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DIL-KKVEKGKYTFEL 248 (484)
T ss_dssp CCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHH-HHHHHCCCCCCS
T ss_pred cccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-------HHH-HHHHcCCCCCCC
Confidence 5432 2233569999999999875 7999999999999999999999999754321 112 223333322111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+. .......+.+++..||+.||.+||++.|++++
T Consensus 249 -~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 249 -PQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -GG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 11 11223567889999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=360.37 Aligned_cols=260 Identities=23% Similarity=0.313 Sum_probs=196.3
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe------eEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ------RML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~------~~l 313 (608)
.+|...++||+|+||.||+|....+..||||++..... ...+|+++|++++|+||++++++|...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888999999999999999987777899999865432 22369999999999999999999865433 789
Q ss_pred EEeeccCCcHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc-cCCceEEEEeeccccc
Q 046502 314 VCEFVTSNTLEFHLHG-KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKLA 391 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~-~~~~~kl~DFGla~~~ 391 (608)
||||+.++.+..+.+. .....+++..++.++.||++||.|||+. +|+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999998665544331 2234699999999999999999999999 999999999999999 7999999999999876
Q ss_pred cCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH-----------
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN----------- 459 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~----------- 459 (608)
.... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||...... +.+. .++.
T Consensus 193 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~--~~l~-~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI--DQLV-EIIKVLGTPSREQIK 267 (394)
T ss_dssp CTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH-HHHHHHCCCCHHHHH
T ss_pred cCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHH-HHHHHhCCCCHHHHH
Confidence 4422 22345789999999998765 5899999999999999999999999765421 1111 1111
Q ss_pred HH---HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 460 RA---IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 460 ~~---~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. +....+..+....+...+.......+.+|+.+||+.||.+||++.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00 00011111111111111222234578899999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=368.54 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=202.7
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc-------------hhHHHHHHHHHHHHhcCCCCccceee
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG-------------QGERVFQAEVEIISRVHHKHLVSLVG 303 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~Ev~~l~~l~Hpniv~l~g 303 (608)
..++|...++||+|+||.||+|... +++.||||+++.... ...+.+.+|+.+|++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999964 578999999975421 23467889999999999999999999
Q ss_pred EEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC---ce
Q 046502 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF---EA 380 (608)
Q Consensus 304 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~---~~ 380 (608)
+|.+....+||||||.+|+|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999887654 599999999999999999999999 999999999999998775 69
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
||+|||+++...... ......||+.|+|||++. +.++.++|||||||++|+|++|+.||..... . .++ .
T Consensus 189 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~----~~~-~ 257 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---Q----DII-K 257 (504)
T ss_dssp EECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H----HHH-H
T ss_pred EEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---H----HHH-H
Confidence 999999998765432 233457999999999987 5799999999999999999999999975432 1 112 2
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+..+.+.... .... .....+.+++..||+.||.+||++.|++++
T Consensus 258 ~i~~~~~~~~~--~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 258 KVEKGKYYFDF--NDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHCCCCCCH--HHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCCCCc--cccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 22333321110 0001 123467889999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=349.20 Aligned_cols=262 Identities=21% Similarity=0.314 Sum_probs=200.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----Cee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAG-----SQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~-----~~~ 311 (608)
.++|...++||+|+||.||+|.. .+++.||||++..... ...+.+.+|+++|.+++|+||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46799999999999999999985 4688999999975433 3346788999999999999999999999754 368
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+.+ +|.+++... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 106 ~iv~e~~~~-~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccCc-CHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 999999984 898888754 489999999999999999999999 9999999999999999999999999999876
Q ss_pred cCcccc--eeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC-
Q 046502 392 SDVYTH--VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF- 467 (608)
Q Consensus 392 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~- 467 (608)
...... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... .+ ..++. .+.....
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~-~~i~~-~~~~~~~~ 254 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QL-NHILG-ILGSPSQE 254 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HH-HHHHH-HHCSCCHH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HH-HHHHH-HhCCCCHH
Confidence 543221 1244679999999998754 458999999999999999999999997654311 11 11110 0000000
Q ss_pred --------------CcccCcccc--CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 --------------DTLVDPKLH--NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 --------------~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+...... ..........+.+|+.+||+.||++||++.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 00011123467899999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=367.10 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=203.1
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.++|...++||+|+||.||+|... +++.||||++... .......+.+|+++|++++||||++++++|.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457899999999999999999964 6899999998642 2234567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc---cCCceEEEEeecccccc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD---FKFEAKVADFGLAKLAS 392 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~---~~~~~kl~DFGla~~~~ 392 (608)
||+.+++|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999998887654 589999999999999999999999 999999999999995 45679999999998665
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
... ......||+.|+|||++.+ .++.++|||||||+||+|++|+.||..... . .++ ..+..+.+....
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~----~~~-~~i~~~~~~~~~- 243 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---Y----DIL-KRVETGKYAFDL- 243 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---H----HHH-HHHHHTCCCSCS-
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H----HHH-HHHHhCCCCCCC-
Confidence 422 2334579999999999875 699999999999999999999999965432 1 112 222333322111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+. .......+.+++..||+.||.+||++.|++++
T Consensus 244 ~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11 11223467889999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=382.50 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=205.0
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeE
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~ 312 (608)
..++|...++||+|+||.||+|.. .+++.||||+++... ....+.+..|..+|..+ +|+||++|++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 357899999999999999999995 458899999997531 22345677899999987 7999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
|||||+++|+|.++|...+ .+++..++.|+.||+.||.|||+. +||||||||+||||+.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999998654 499999999999999999999999 99999999999999999999999999998643
Q ss_pred CcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
.... ......||+.|+|||++.+..|+.++||||||||||||++|+.||..... .. ++. .+..+.+.
T Consensus 494 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~----~~~-~i~~~~~~---- 560 (674)
T 3pfq_A 494 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DE----LFQ-SIMEHNVA---- 560 (674)
T ss_dssp CTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HHH-HHHSSCCC----
T ss_pred cCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HH----HHH-HHHhCCCC----
Confidence 3222 23456799999999999999999999999999999999999999975432 11 122 22222211
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRI-----SQIVRT 511 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm-----~evv~~ 511 (608)
++......+.+|+..||+.||.+||++ .||+++
T Consensus 561 ------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 561 ------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp ------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred ------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 122234567889999999999999997 666653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=355.28 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=183.2
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeC------C
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG------S 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~------~ 309 (608)
.++|...+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|+.+|++++|+||++++++|... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999984 56899999999653 233456788999999999999999999998754 5
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
..++||||+ +++|.+++.. ..+++..+..++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 6899888865 2599999999999999999999998 99999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+ ..++. .+ |...
T Consensus 181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~l-~~i~~-~~--g~p~ 250 (367)
T 2fst_X 181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI--DQL-KLILR-LV--GTPG 250 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH-HHHHH-HH--CSCC
T ss_pred ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH-HHHHH-Hh--CCCC
Confidence 65432 334678999999999977 67999999999999999999999999764421 111 11110 00 1000
Q ss_pred -cccCc-----------ccc--CcCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 -TLVDP-----------KLH--NEYN-----HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 -~~~d~-----------~l~--~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+++.. .+. .... ......+.+|+.+||+.||.+||++.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000 000 0000 1123457889999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=350.40 Aligned_cols=202 Identities=25% Similarity=0.268 Sum_probs=173.7
Q ss_pred HhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CC-----CccceeeEEEeCCe
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HK-----HLVSLVGYYTAGSQ 310 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hp-----niv~l~g~~~~~~~ 310 (608)
..++|...++||+|+||.||+|... +++.||||+++.. ......+..|+.++..++ |+ +|++++++|...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999954 6889999999753 334566788999999885 55 49999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc--cCCceEEEEeecc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD--FKFEAKVADFGLA 388 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~--~~~~~kl~DFGla 388 (608)
.+|||||+. ++|.+++.......+++..++.|+.|++.||.|||.+ ..+|+||||||+||||+ .++.+||+|||++
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 999999997 4999998876655799999999999999999999952 12899999999999994 5788999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~ 446 (608)
+..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 209 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 876542 234578999999999999999999999999999999999999997643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=353.50 Aligned_cols=264 Identities=20% Similarity=0.314 Sum_probs=202.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-----------CCCccceeeEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-----------HKHLVSLVGYYTA 307 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-----------Hpniv~l~g~~~~ 307 (608)
++|...++||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 5789999999999999999995 56899999999753 334567888999999886 8999999999876
Q ss_pred CC----eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc------cC
Q 046502 308 GS----QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD------FK 377 (608)
Q Consensus 308 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~------~~ 377 (608)
.+ ..++||||+ +++|.+++.......+++..++.|+.||+.||.|||+++ +|+||||||+||||+ .+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTE
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCc
Confidence 54 789999999 899999998765556999999999999999999999964 799999999999994 34
Q ss_pred CceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCccccc---chhh
Q 046502 378 FEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME---DNLA 454 (608)
Q Consensus 378 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~---~~l~ 454 (608)
+.+||+|||+++..... .....||..|+|||++.+..++.++|||||||+||||++|+.||........ ....
T Consensus 175 ~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 250 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250 (373)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHH
Confidence 47999999999876542 2335789999999999999999999999999999999999999975432110 0001
Q ss_pred HHHHHH-------HHhcCC-----------CCcccCcc---------ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 046502 455 RPLLNR-------AIEDGN-----------FDTLVDPK---------LHNEYNHNEMARMVACAAACVRHSARRRPRISQ 507 (608)
Q Consensus 455 ~~~~~~-------~~~~~~-----------~~~~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~e 507 (608)
..++.. .+..+. +..+.... -...+.......+.+|+..||+.||++||++.|
T Consensus 251 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 111100 000000 00000000 011244667788999999999999999999999
Q ss_pred HHHH
Q 046502 508 IVRT 511 (608)
Q Consensus 508 vv~~ 511 (608)
|+++
T Consensus 331 ll~h 334 (373)
T 1q8y_A 331 LVNH 334 (373)
T ss_dssp HHTC
T ss_pred HhhC
Confidence 9974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=347.25 Aligned_cols=253 Identities=22% Similarity=0.317 Sum_probs=197.6
Q ss_pred HHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcC--CCCccceeeEEEeCCeeE
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVH--HKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~--Hpniv~l~g~~~~~~~~~ 312 (608)
...++|...++||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++ |+||+++++++...+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345678999999999999999999888999999999654 3344577899999999997 599999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||| +.+++|.+++.... .+++..++.|+.|+++||.|||+. +|+||||||+||||++ +.+||+|||+++...
T Consensus 105 lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred EEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 9999 66789999998654 589999999999999999999999 9999999999999964 899999999998765
Q ss_pred Ccccc-eeeeeecccCccChhhhhc-----------CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH
Q 046502 393 DVYTH-VSTRVMGTFGYLAPEYASS-----------GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR 460 (608)
Q Consensus 393 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~ 460 (608)
..... ......|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... ..+..
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~~ 251 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHA 251 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH------HHHHH
Confidence 43221 2234568999999999875 478889999999999999999999996533210 01111
Q ss_pred HHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+. ... ...+.......+.+++.+||+.||.+||++.||+++
T Consensus 252 ~~~-~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 IID-PNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHC-TTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHh-ccc--------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111 111 111111123467889999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=356.41 Aligned_cols=265 Identities=19% Similarity=0.254 Sum_probs=181.8
Q ss_pred CCCc-CCccccCCceEEEEEEec---CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEEE
Q 046502 241 GFSD-ANLLGQGGFGYVHKGVLP---NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLV 314 (608)
Q Consensus 241 ~f~~-~~~LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~~lV 314 (608)
.|.. .++||+|+||.||+|... +++.||||++..... ...+.+|+.+|++|+|+|||+++++|.. +...+||
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3554 568999999999999964 578999999975432 2457889999999999999999999954 6789999
Q ss_pred EeeccCCcHHHHhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE----ccCCceEEE
Q 046502 315 CEFVTSNTLEFHLHGK-------GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL----DFKFEAKVA 383 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl----~~~~~~kl~ 383 (608)
|||+.+ +|.+++... ....+++..++.|+.||+.||.|||+. +|+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999985 666665421 123489999999999999999999999 89999999999999 778999999
Q ss_pred EeeccccccCccc--ceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc--hhhHHHH
Q 046502 384 DFGLAKLASDVYT--HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED--NLARPLL 458 (608)
Q Consensus 384 DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~--~l~~~~~ 458 (608)
|||+++....... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||......... ......+
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987654221 223446799999999999874 5899999999999999999999999754321100 0011111
Q ss_pred HHHHh-cCCCCcccCccc-----------------cCcCCH---------HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 459 NRAIE-DGNFDTLVDPKL-----------------HNEYNH---------NEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 459 ~~~~~-~~~~~~~~d~~l-----------------~~~~~~---------~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+. .|......-..+ ...... .....+++|+..||+.||.+||++.|++++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11111 010000000000 000000 012457889999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.53 Aligned_cols=270 Identities=19% Similarity=0.236 Sum_probs=191.7
Q ss_pred HHHHHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe-
Q 046502 233 EELARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ- 310 (608)
Q Consensus 233 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~- 310 (608)
++.....++|...++||+|+||.||+|.. .+|+.||||++...... ...+.+|++.+..++|+||++++++|...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 45667789999999999999999999996 46899999998654322 2345678888999999999999999976443
Q ss_pred ------eEEEEeeccCCcHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeeeccCCCcEEEcc-CCce
Q 046502 311 ------RMLVCEFVTSNTLEFHLHG-KGRPTMDWPTRLKIALGFAKGLAYLH--EDCHPKIIHRDIKAANILLDF-KFEA 380 (608)
Q Consensus 311 ------~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~~L~yLH--~~~~~~iiHrDIk~~NILl~~-~~~~ 380 (608)
.++||||+.++.+..+... .....+++..+..++.|++.||.||| +. +|+||||||+||||+. ++.+
T Consensus 95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 7899999997544332221 23346899999999999999999999 76 8999999999999997 8999
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 459 (608)
||+|||+++...... ......||..|+|||++.+.. ++.++|||||||+||||++|+.||...... .....++.
T Consensus 172 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~~ 246 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIVR 246 (360)
T ss_dssp EECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH
T ss_pred EEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHHH
Confidence 999999998765432 223456899999999986654 899999999999999999999999764421 11111111
Q ss_pred -----------HHHhcCCCCcccC------ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 460 -----------RAIEDGNFDTLVD------PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 460 -----------~~~~~~~~~~~~d------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..........+.+ ..+...........+.+|+.+||+.||.+||++.||+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000000 000011122245678999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.46 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=195.4
Q ss_pred HhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEe---------
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA--------- 307 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--------- 307 (608)
..++|...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.++++++|+||++++++|.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 346789999999999999999995 47899999999653 3345678899999999999999999999865
Q ss_pred ----CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEE
Q 046502 308 ----GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVA 383 (608)
Q Consensus 308 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~ 383 (608)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||||+.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 356799999999999999998643 3578899999999999999999999 99999999999999999999999
Q ss_pred EeeccccccCcc-------------cceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccc
Q 046502 384 DFGLAKLASDVY-------------THVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFM 449 (608)
Q Consensus 384 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~ 449 (608)
|||+++...... ........|+..|+|||++.+. .++.++|||||||++|||++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 999998654321 1122345689999999999764 78999999999999999998 4432111
Q ss_pred cchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 450 EDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 450 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. ...+ ..+..... .+...+.......+.+++.+||+.||.+||++.||+++
T Consensus 234 ~----~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 R----VNIL-KKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H----HHHH-HHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred H----HHHH-Hhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 0 1111 12222211 11222333445567889999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.10 Aligned_cols=255 Identities=22% Similarity=0.344 Sum_probs=199.6
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...++||+|+||.||+|...+ .||||+++... ....+.|.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678899999999999999998743 49999987542 2223457789999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc-
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY- 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~- 395 (608)
|+++++|.+++.... ..+++..++.|+.||+.||.|||+. +|+||||||+||||+ ++.+||+|||+++......
T Consensus 110 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~ 184 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQA 184 (319)
T ss_dssp CCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-------
T ss_pred cccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccc
Confidence 999999999997643 3689999999999999999999999 999999999999998 6799999999987653211
Q ss_pred ---cceeeeeecccCccChhhhhc---------CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 396 ---THVSTRVMGTFGYLAPEYASS---------GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 396 ---~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
........|+..|+|||++.. ..++.++|||||||++|||++|+.||..... .. .. ..+.
T Consensus 185 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~----~~-~~~~ 256 (319)
T 2y4i_B 185 GRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EA----II-WQMG 256 (319)
T ss_dssp ---CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HH----HH-HHHH
T ss_pred cccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HH----HH-HHhc
Confidence 112233458999999999864 4578899999999999999999999975432 11 11 1222
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.+....+.... ....+.+++..||+.||++||++.+|+++|+...
T Consensus 257 ~~~~~~~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~ 301 (319)
T 2y4i_B 257 TGMKPNLSQIG--------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301 (319)
T ss_dssp TTCCCCCCCSS--------CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred cCCCCCCCcCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 22222221111 1234788999999999999999999999998654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=376.25 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=204.3
Q ss_pred hcCCCcCCccccCCceEEEEEEecC----CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
.++|...++||+|+||.||+|.+.. +..||||+++... ....+.|.+|+.++++++||||++++++|. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 4678889999999999999998632 4679999987643 334467899999999999999999999985 466899
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 468 v~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred EEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 999999999999998653 3589999999999999999999999 999999999999999999999999999987655
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
..........+++.|+|||++....++.++|||||||+||||++ |..||...... ..+. .+..+....
T Consensus 544 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~~~~-~i~~~~~~~--- 612 (656)
T 2j0j_A 544 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIG-RIENGERLP--- 612 (656)
T ss_dssp ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHH-HHHHTCCCC---
T ss_pred CcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------HHHH-HHHcCCCCC---
Confidence 43333334567889999999999999999999999999999997 99999754321 1111 222222111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
........+.+++..||+.||.+||++.||++.|+..
T Consensus 613 ------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 613 ------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1122335688899999999999999999999999854
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=350.80 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=196.2
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee----
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR---- 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~---- 311 (608)
.++|...++||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++|+||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 46889999999999999999985 468999999997643 33356788999999999999999999999877655
Q ss_pred --EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 312 --MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 312 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
++||||+. ++|.+++.. .+++..++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999998 578777743 489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
..... .....||..|+|||++.+ ..++.++|||||||+||||++|+.||...... +.+ ...+.. .+...
T Consensus 193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~-~~i~~~---~~~~~ 262 (371)
T 4exu_A 193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQL-TQILKV---TGVPG 262 (371)
T ss_dssp -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH-HHHHHH---HCCCC
T ss_pred ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHH-HHHHHH---hCCCc
Confidence 65432 234568999999999987 67999999999999999999999999764321 111 111100 00000
Q ss_pred -ccc---------------CccccC---cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 -TLV---------------DPKLHN---EYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 -~~~---------------d~~l~~---~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
++. ...... .........+.+|+..||+.||++||++.|++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 000000 0011224568899999999999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=341.80 Aligned_cols=263 Identities=21% Similarity=0.290 Sum_probs=194.7
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEE-----------
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT----------- 306 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~----------- 306 (608)
.++|...++||+|+||.||+|... +|+.||||++........+.+.+|+.++++++|+||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367889999999999999999965 48999999998776666778999999999999999999999873
Q ss_pred ---eCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc-cCCceEE
Q 046502 307 ---AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKV 382 (608)
Q Consensus 307 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~-~~~~~kl 382 (608)
+.+..++||||+. ++|.+++... .+++..++.++.|++.||.|||+. +|+||||||+||||+ .++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999998 5999988642 589999999999999999999999 999999999999997 5679999
Q ss_pred EEeeccccccCccc--ceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 046502 383 ADFGLAKLASDVYT--HVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 383 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 459 (608)
+|||+++....... .......++..|+|||++.. ..++.++|||||||+||||++|+.||....... .....+.
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~ 239 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLILE 239 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 99999987643221 11233457999999998875 678999999999999999999999997654211 1110110
Q ss_pred HH--------H-hcCCCCcccCcccc------CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 460 RA--------I-EDGNFDTLVDPKLH------NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 460 ~~--------~-~~~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. . ....+...+...+. ..........+.+++..||+.||++||++.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 00 0 00000000000000 00011224568899999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=343.07 Aligned_cols=258 Identities=19% Similarity=0.310 Sum_probs=201.0
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CC-cEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC------ccceeeEEEeCCe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NG-KEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH------LVSLVGYYTAGSQ 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn------iv~l~g~~~~~~~ 310 (608)
.++|...++||+|+||.||+|... ++ +.||||+++.. ....+.+.+|+.++++++|+| ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 367899999999999999999963 34 68999999753 344567888999999998766 8999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE----------------
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL---------------- 374 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl---------------- 374 (608)
.+|||||+ +++|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+||||
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 55666666655545799999999999999999999998 99999999999999
Q ss_pred ---ccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccc
Q 046502 375 ---DFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMED 451 (608)
Q Consensus 375 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~ 451 (608)
+.++.+||+|||+++..... .....||..|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-- 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-- 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence 67889999999999865432 234578999999999999999999999999999999999999997543211
Q ss_pred hhhHHHHHHHHhcCCCCc-----------ccCccc---------------------cCcCCHHHHHHHHHHHHHhhhcCC
Q 046502 452 NLARPLLNRAIEDGNFDT-----------LVDPKL---------------------HNEYNHNEMARMVACAAACVRHSA 499 (608)
Q Consensus 452 ~l~~~~~~~~~~~~~~~~-----------~~d~~l---------------------~~~~~~~~~~~l~~l~~~Cl~~dp 499 (608)
... .+.... +.+.. .....+ .......+...+.+|+.+||+.||
T Consensus 247 -~~~-~~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 247 -HLV-MMEKIL--GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp -HHH-HHHHHH--CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred -HHH-HHHHHc--CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 000 011100 00000 000000 001123445678899999999999
Q ss_pred CCCCCHHHHHHH
Q 046502 500 RRRPRISQIVRT 511 (608)
Q Consensus 500 ~~RPsm~evv~~ 511 (608)
.+||++.||+++
T Consensus 323 ~~Rpt~~e~l~h 334 (355)
T 2eu9_A 323 AQRITLAEALLH 334 (355)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCcCHHHHhcC
Confidence 999999999854
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=351.19 Aligned_cols=261 Identities=20% Similarity=0.285 Sum_probs=199.1
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeC-----Cee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAG-----SQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~-----~~~ 311 (608)
.++|...++||+|+||.||+|... +|+.||||+++... ......+.+|+.++++++|+||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467899999999999999999964 68999999997543 33346788999999999999999999998754 678
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
++||||+. ++|.+++... .+++..++.++.|++.||.|||+. +|+||||||+||||+.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999998 5898888763 589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCcccc---------eeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH
Q 046502 392 SDVYTH---------VSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRA 461 (608)
Q Consensus 392 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~ 461 (608)
...... ......||..|+|||++.. ..++.++|||||||+||||++|+.||...... +.+. .+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~--~~~~~ 238 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR--HQLL--LIFGI 238 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH--HHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHH--HHHHH
Confidence 532111 1123568999999998765 67899999999999999999999999764321 1110 00010
Q ss_pred HhcCC----CCccc---------------CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 462 IEDGN----FDTLV---------------DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 462 ~~~~~----~~~~~---------------d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.... ...+. ...+ ..........+.+++.+||+.||.+||++.||+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPL-EKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCH-HHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcch-hhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 00000 0000 00001223567889999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=344.25 Aligned_cols=255 Identities=25% Similarity=0.418 Sum_probs=178.7
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc-hhHHHHHHHHH-HHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG-QGERVFQAEVE-IISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~Ev~-~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|...+.||+|+||.||+|.. .+|+.||||+++.... .....+..|+. +++.++|+||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 6788899999999999999996 4689999999976532 33345556666 6777899999999999999999999999
Q ss_pred eccCCcHHHHhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 317 FVTSNTLEFHLHG---KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 317 ~~~~gsL~~~l~~---~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
|+.+ +|.+++.. .....+++..+..|+.+++.||.|||+.+ +|+||||||+||||+.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9986 77666652 23446899999999999999999999863 699999999999999999999999999987654
Q ss_pred cccceeeeeecccCccChhhh----hcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYA----SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
.. ......|+..|+|||++ .+..++.++|||||||++|||++|+.||........ .+.. +..+..
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~-~~~~~~-- 247 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD------QLTQ-VVKGDP-- 247 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CC-CCCSCC--
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH------HHHH-HhcCCC--
Confidence 32 22334689999999998 566789999999999999999999999975322100 0000 001111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+...........+.+++..||+.||++||++.||+++
T Consensus 248 ---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 ---PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp ---CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111112234568889999999999999999999864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=345.68 Aligned_cols=243 Identities=25% Similarity=0.363 Sum_probs=193.0
Q ss_pred HHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch------hHHHHHHHHHHHHhc----CCCCccceeeEE
Q 046502 237 RATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ------GERVFQAEVEIISRV----HHKHLVSLVGYY 305 (608)
Q Consensus 237 ~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~Ev~~l~~l----~Hpniv~l~g~~ 305 (608)
...++|...++||+|+||.||+|.. .+++.||||+++..... ....+.+|+.++.++ +|+||++++++|
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999985 56889999999754322 223456799999999 899999999999
Q ss_pred EeCCeeEEEEee-ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc-cCCceEEE
Q 046502 306 TAGSQRMLVCEF-VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVA 383 (608)
Q Consensus 306 ~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~-~~~~~kl~ 383 (608)
...+..++|||| +.+++|.+++.... .+++..++.++.||+.||.|||+. +|+|||||++||||+ .++.+||+
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 999999999999 78999999997644 589999999999999999999999 999999999999999 88999999
Q ss_pred EeeccccccCcccceeeeeecccCccChhhhhcCCCC-CcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 046502 384 DFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT-EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 384 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
|||+++...... .....|+..|+|||++.+..+. .++|||||||++|||++|+.||..... ..
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~---- 246 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------IL---- 246 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH----
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------Hh----
Confidence 999998765432 2345689999999999877764 589999999999999999999864211 11
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.... .+ .......+.+++.+||+.||++||++.||+++
T Consensus 247 -~~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 -EAEL------HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -HTCC------CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -hhcc------CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 01 11223467889999999999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=334.80 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=204.7
Q ss_pred HHHhcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
....++|...++||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344578999999999999999999964 68999999986532 234567889999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC---CceEEEEeeccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK---FEAKVADFGLAK 389 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~---~~~kl~DFGla~ 389 (608)
+||||+.+++|.+++.... .+++..++.|+.||+.||.|||+. +|+||||||+||||+.+ +.+||+|||+++
T Consensus 98 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999998886543 589999999999999999999999 99999999999999764 469999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
...... ......|+..|+|||++.+ .++.++||||||+++|+|++|+.||..... . .++ ..+..+.+..
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~----~~~-~~~~~~~~~~ 241 (287)
T 2wei_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---Y----DIL-KRVETGKYAF 241 (287)
T ss_dssp TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H----HHH-HHHHHCCCCC
T ss_pred eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---H----HHH-HHHHcCCCCC
Confidence 665422 1223458999999999875 589999999999999999999999975432 1 112 2223333221
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... ... .....+.+++..||+.||++||++.|++++
T Consensus 242 ~~~--~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 DLP--QWR----TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CSG--GGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cch--hhh----hcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 110 001 123467889999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=346.51 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=174.7
Q ss_pred hcCCCcCC-ccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCeeE
Q 046502 239 TDGFSDAN-LLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTA----GSQRM 312 (608)
Q Consensus 239 ~~~f~~~~-~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~----~~~~~ 312 (608)
.++|...+ +||+|+||.||+|... +|+.||||++.... ....+....+..++|+||++++++|.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46778754 6999999999999965 68999999997532 222233344667799999999999876 44589
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---CCceEEEEeeccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGLAK 389 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---~~~~kl~DFGla~ 389 (608)
+||||+++++|.+++.......+++..++.|+.||+.||.|||+. +|+||||||+||||+. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 999999999999999877666799999999999999999999999 9999999999999976 4559999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
..... ......||+.|+|||++....++.++|||||||+||+|++|+.||....... ... .....+..+.+.
T Consensus 180 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~-~~~~~~~~~~~~- 251 (336)
T 3fhr_A 180 ETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA---ISP-GMKRRIRLGQYG- 251 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------C-
T ss_pred ecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh---hhh-hHHHhhhccccc-
Confidence 65432 2234568999999999988889999999999999999999999996543211 000 001111111110
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+...........+.+++..||+.||.+||++.||+++
T Consensus 252 -----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 252 -----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0001111234567889999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=334.79 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=181.7
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchh--HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQG--ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
.++|...+.||+|+||.||+|... +|+.||||++....... .+.+.++..+++.++|+||++++++|.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999964 68999999997653322 234555566788889999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+ ++.+..++... ...+++..++.++.++++||.|||+.+ +|+||||||+||||+.++.+||+|||+++......
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 55665555432 236899999999999999999999832 79999999999999999999999999997654422
Q ss_pred cceeeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 396 THVSTRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
......|+..|+|||++. ...++.++|||||||+||||++|+.||...... ...+...+.. ....+
T Consensus 180 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~-~~~~~ 250 (318)
T 2dyl_A 180 --AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVLTKVLQE-EPPLL 250 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHHHHHS-CCCCC
T ss_pred --cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHHHHHhcc-CCCCC
Confidence 223456899999999994 567899999999999999999999999753321 1122222222 11111
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .......+.+++.+||+.||.+||++.||+++
T Consensus 251 ~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 251 PG-------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp CS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred Cc-------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 10 01123457889999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=352.26 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=188.7
Q ss_pred CCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeecc
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.+|.++ +|||||++++++.+++..+|||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34556889999999998776678999999998753 234678899999987 89999999999999999999999996
Q ss_pred CCcHHHHhhcCCCCC-----CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-------------CceE
Q 046502 320 SNTLEFHLHGKGRPT-----MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-------------FEAK 381 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~-----l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-------------~~~k 381 (608)
|+|.+++....... ..+..++.|+.||+.||.|||+. +|+||||||+||||+.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999998654211 12334578999999999999998 99999999999999754 4899
Q ss_pred EEEeeccccccCcccc---eeeeeecccCccChhhhhc-------CCCCCcchhhhHHHHHHHHHh-CCCCCCCCccccc
Q 046502 382 VADFGLAKLASDVYTH---VSTRVMGTFGYLAPEYASS-------GKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFME 450 (608)
Q Consensus 382 l~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~ 450 (608)
|+|||+++........ ......||++|+|||++.+ ..++.++|||||||+||||++ |+.||.......
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~- 247 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE- 247 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-
Confidence 9999999876543221 1234579999999999975 678999999999999999999 999996432210
Q ss_pred chhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 451 DNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 451 ~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+ ..+.+.. +.+...........+.+++.+||+.||.+||++.||+++
T Consensus 248 ----~~i-----~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 ----SNI-----IRGIFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp ----HHH-----HHTCCCC---CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHH-----hcCCCCc---ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111 1111110 111112234566788999999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=342.89 Aligned_cols=257 Identities=21% Similarity=0.314 Sum_probs=196.2
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe-----
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ----- 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~----- 310 (608)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++|+||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36788999999999999999996 468999999997542 2334678899999999999999999999987654
Q ss_pred -eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 311 -RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 311 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
.++||||+. ++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 588777643 489999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHH-------
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRA------- 461 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~------- 461 (608)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... + .....+...
T Consensus 175 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~-~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 175 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--D-QLTQILKVTGVPGTEF 247 (353)
T ss_dssp C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH--H-HHHHHHHHHCBCCHHH
T ss_pred CCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H-HHHHHHHHhCCCCHHH
Confidence 65432 234568999999999977 67899999999999999999999999754321 1 111111000
Q ss_pred Hhc----------CCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 462 IED----------GNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 462 ~~~----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.. ..+.......+ ..........+.+++.+||+.||++||++.|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00000000011 11112334578899999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.58 Aligned_cols=244 Identities=23% Similarity=0.369 Sum_probs=199.8
Q ss_pred HHHhcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch------hHHHHHHHHHHHHhcC--CCCccceeeEEE
Q 046502 236 ARATDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ------GERVFQAEVEIISRVH--HKHLVSLVGYYT 306 (608)
Q Consensus 236 ~~~~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~Ev~~l~~l~--Hpniv~l~g~~~ 306 (608)
....++|...++||+|+||.||+|.. .+++.||||+++..... ....+.+|+.++++++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 33457899999999999999999984 56899999999754221 2245678999999996 599999999999
Q ss_pred eCCeeEEEEeeccC-CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc-cCCceEEEE
Q 046502 307 AGSQRMLVCEFVTS-NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVAD 384 (608)
Q Consensus 307 ~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~-~~~~~kl~D 384 (608)
..+..++||||+.+ ++|.+++.... .+++..++.|+.||++||.|||+. +|+||||||+||||+ .++.+||+|
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D 193 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID 193 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence 99999999999986 89999987643 589999999999999999999998 999999999999999 789999999
Q ss_pred eeccccccCcccceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 385 FGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 385 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
||+++..... ......||..|+|||++.+..+ +.++|||||||+||||++|+.||..... ...
T Consensus 194 fg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------------~~~ 257 (320)
T 3a99_A 194 FGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIR 257 (320)
T ss_dssp CTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHH
T ss_pred Cccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-------------hhc
Confidence 9999876543 2234568999999999987765 6789999999999999999999964211 011
Q ss_pred cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.. . +... ....+.+++.+||+.||++||++.||+++
T Consensus 258 -~~~--~----~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 -GQV--F----FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -CCC--C----CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -ccc--c----cccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 0 1111 23467889999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=349.23 Aligned_cols=249 Identities=23% Similarity=0.313 Sum_probs=187.8
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
.+|...++||+|+||.||.....+|+.||||++...... .+.+|+.+|+++ +|||||++++++.+.+..+|||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 458888999999999966555568999999999754332 356799999999 7999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-----CCceEEEEeeccccccC
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-----KFEAKVADFGLAKLASD 393 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-----~~~~kl~DFGla~~~~~ 393 (608)
. |+|.+++..... .+.+..++.|+.||++||.|||+. +|+||||||+||||+. ...+||+|||+++....
T Consensus 101 ~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~ 175 (432)
T 3p23_A 101 A-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175 (432)
T ss_dssp S-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred C-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence 7 599999876543 344556678999999999999999 8999999999999943 34688999999987653
Q ss_pred ccc--ceeeeeecccCccChhhhh---cCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 394 VYT--HVSTRVMGTFGYLAPEYAS---SGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 394 ~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
... .......||++|+|||++. ...++.++|||||||+||||++ |..||...... ...........
T Consensus 176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~~ 247 (432)
T 3p23_A 176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--------QANILLGACSL 247 (432)
T ss_dssp ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--------HHHHHTTCCCC
T ss_pred CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--------HHHHHhccCCc
Confidence 321 1234467999999999997 4567889999999999999999 89998543210 11111111111
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+ . ........+.+++.+||+.||.+||++.||+++
T Consensus 248 ~~~-~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 248 DCL-H------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp TTS-C------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccc-C------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 111 1 112344557889999999999999999999953
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=364.61 Aligned_cols=237 Identities=20% Similarity=0.340 Sum_probs=192.4
Q ss_pred cCCCcCCccccCCceEEEEEEec--CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCe-----e
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP--NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ-----R 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~--~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~-----~ 311 (608)
++|.+.++||+|+||.||+|.+. +|+.||||++.... ......|.+|+.++++++|||||+++++|...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999974 58999999986543 3445678899999999999999999999987665 7
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~ 391 (608)
||||||+++++|.+++.. .++|..++.|+.||+.||.|||++ +||||||||+||||+.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999987754 599999999999999999999999 89999999999999886 9999999999876
Q ss_pred cCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
... ....||++|+|||++.++. +.++|||||||+||||++|..||..... ..+ .
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~---~~~-----------------~ 285 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYV---DGL-----------------P 285 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEEC---SSC-----------------C
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccc---ccc-----------------c
Confidence 542 3457999999999998754 8899999999999999999888753211 000 0
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHhhc
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPR-ISQIVRTLEG 514 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-m~evv~~L~~ 514 (608)
...........+.+++.+||+.||++||+ +.++.+.|.+
T Consensus 286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00001122356788999999999999995 5666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=320.07 Aligned_cols=230 Identities=10% Similarity=0.077 Sum_probs=182.0
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCc---hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG---QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|+.. +|+.||||+++.... ...+.|.+|+.++.+++|+||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 56888899999999999999964 489999999976533 33467899999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+++++|.+++... .....+.+|+.||+.||.|||++ +|+||||||+||||+.++.+||+++
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~---------- 173 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYP---------- 173 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSC----------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEec----------
Confidence 999999999999542 35557889999999999999999 9999999999999999999999743
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
+|++ .++.++|||||||+||||++|+.||............... ..+.. ..
T Consensus 174 -----------~~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~-----~~~~~---~~--- 224 (286)
T 3uqc_A 174 -----------ATMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERD-----TAGQP---IE--- 224 (286)
T ss_dssp -----------CCCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBC-----TTSCB---CC---
T ss_pred -----------cccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHH-----hccCC---CC---
Confidence 3443 3788999999999999999999999764431100000000 00000 00
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
...........+.+++.+||+.||++| ++.|+++.|+...
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 001112233568889999999999999 9999999998654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=363.33 Aligned_cols=264 Identities=25% Similarity=0.335 Sum_probs=199.5
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEe------CCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTA------GSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~------~~~~ 311 (608)
++|...++||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999985 46899999998764 33445678999999999999999999998765 6778
Q ss_pred EEEEeeccCCcHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCc---eEEEEeec
Q 046502 312 MLVCEFVTSNTLEFHLHGKG-RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFE---AKVADFGL 387 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~---~kl~DFGl 387 (608)
++||||+++++|.+++.... ...+++..++.|+.+++.||.|||+. +|+||||||+||||+.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998643 23589999999999999999999998 9999999999999997665 99999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCccccc--chhhHHHHHHHH---
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME--DNLARPLLNRAI--- 462 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~--~~l~~~~~~~~~--- 462 (608)
++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+.........
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 98765432 23446799999999999999999999999999999999999999975422100 000000000000
Q ss_pred -hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 046502 463 -EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQI 508 (608)
Q Consensus 463 -~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~ev 508 (608)
..+.+...................+.+++..||+.||++||++.|+
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0010000000011123444567789999999999999999999773
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=322.50 Aligned_cols=228 Identities=22% Similarity=0.324 Sum_probs=180.2
Q ss_pred hcCCCcC-CccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHH-HhcCCCCccceeeEEEe----CCee
Q 046502 239 TDGFSDA-NLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEII-SRVHHKHLVSLVGYYTA----GSQR 311 (608)
Q Consensus 239 ~~~f~~~-~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l-~~l~Hpniv~l~g~~~~----~~~~ 311 (608)
.++|... ++||+|+||.||++.. .+++.||||+++.. ..+.+|+.++ +.++|+||++++++|.. +...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3556666 7899999999999995 56899999999742 3567788888 55689999999999887 6778
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---CCceEEEEeecc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGLA 388 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---~~~~kl~DFGla 388 (608)
++||||+++++|.+++.......+++..++.|+.|++.||.|||+. +|+||||||+||||+. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999999887666799999999999999999999999 9999999999999998 788999999998
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
+.... ..++.++|||||||+||||++|+.||........ ......
T Consensus 168 ~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------------~~~~~~ 212 (299)
T 3m2w_A 168 KETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPGMKT 212 (299)
T ss_dssp EECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCC
T ss_pred ccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------------hHHHHH
Confidence 75432 3467799999999999999999999965432100 000000
Q ss_pred cccCccccCcCC----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYN----HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~----~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+.... ..+. ......+.+++..||+.||.+||++.||+++
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 213 RIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp SSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000000 0111 1224568889999999999999999999974
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=336.33 Aligned_cols=241 Identities=14% Similarity=0.118 Sum_probs=180.7
Q ss_pred hcCCCcCCccccCCceEEEEEE-ecCCcEEEEEEcccCCch---hHHHHHHHHHHHHhcCC-CCccc---------ee--
Q 046502 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQ---GERVFQAEVEIISRVHH-KHLVS---------LV-- 302 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~~Ev~~l~~l~H-pniv~---------l~-- 302 (608)
...|...++||+|+||.||+|+ ..+|+.||||+++..... ..+.|.+|+.++..++| .|... .+
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 4457778899999999999999 456999999998743322 24678999999999987 32211 11
Q ss_pred ----------eEEEe-----CCeeEEEEeeccCCcHHHHhh-----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 046502 303 ----------GYYTA-----GSQRMLVCEFVTSNTLEFHLH-----GKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362 (608)
Q Consensus 303 ----------g~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~i 362 (608)
.++.. ....+++|+++ +++|.+++. ......++|..++.|+.||++||.|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 11111 12346666655 578988884 22334588999999999999999999999 99
Q ss_pred eeeccCCCcEEEccCCceEEEEeeccccccCcccceeeeeecccCccChhhh----------hcCCCCCcchhhhHHHHH
Q 046502 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA----------SSGKLTEKSDVFSFGVML 432 (608)
Q Consensus 363 iHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDVwS~Gvll 432 (608)
|||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+|
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999999876542 344567 999999999 455688899999999999
Q ss_pred HHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 433 LELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 433 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
|||++|+.||....... . ...++... ..+ ...+.+|+..||+.||++||++.|+++
T Consensus 308 ~elltg~~Pf~~~~~~~---~-------------~~~~~~~~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALG---G-------------SEWIFRSC--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGS---C-------------SGGGGSSC--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhh---h-------------HHHHHhhc--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999997543211 0 11111100 112 256888999999999999999998875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=327.86 Aligned_cols=242 Identities=16% Similarity=0.158 Sum_probs=185.8
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCC--------chhHHHHHHHHHHHHhcC---------CCCccce
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS--------GQGERVFQAEVEIISRVH---------HKHLVSL 301 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~Ev~~l~~l~---------Hpniv~l 301 (608)
.++|...++||+|+||.||+|+. +|+.||||+++... ....+.+.+|+.+|++++ |+|||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35678889999999999999998 78999999997542 223367889999999886 7888877
Q ss_pred eeEEE------------------------------eCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 046502 302 VGYYT------------------------------AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGL 351 (608)
Q Consensus 302 ~g~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L 351 (608)
++++. ..+..+|||||+++|++.+.+.. ..+++..++.|+.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 77643 26789999999999976666643 3589999999999999999
Q ss_pred HHHH-hcCCCCeeeeccCCCcEEEccCC--------------------ceEEEEeeccccccCcccceeeeeecccCccC
Q 046502 352 AYLH-EDCHPKIIHRDIKAANILLDFKF--------------------EAKVADFGLAKLASDVYTHVSTRVMGTFGYLA 410 (608)
Q Consensus 352 ~yLH-~~~~~~iiHrDIk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~a 410 (608)
.||| +. +|+||||||+||||+.++ .+||+|||+++..... ...||..|||
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 88 899999999999999887 8999999999876542 3479999999
Q ss_pred hhhhhcCCCCCcchhhhHHHH-HHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHH
Q 046502 411 PEYASSGKLTEKSDVFSFGVM-LLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVA 489 (608)
Q Consensus 411 PE~~~~~~~t~ksDVwS~Gvl-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 489 (608)
||++.+.. +.++||||||++ +++++.|..||... ..........+....+... ............+.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFKTK----CNTPAMKQIKRKIQE 314 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCSSC----CCSHHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccCcc----cchhhhhhcCHHHHH
Confidence 99998655 889999998766 77788899887321 0001112222222111111 111223456678999
Q ss_pred HHHHhhhcCCCCCCCHHHHH
Q 046502 490 CAAACVRHSARRRPRISQIV 509 (608)
Q Consensus 490 l~~~Cl~~dp~~RPsm~evv 509 (608)
|+.+||+.| ++.|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=299.01 Aligned_cols=185 Identities=16% Similarity=0.105 Sum_probs=131.5
Q ss_pred ccccCCceEEEEEE-ecCCcEEEEEEcccCC----------chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 046502 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGS----------GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 247 ~LG~G~fg~Vy~~~-~~~g~~vavK~~~~~~----------~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV 314 (608)
.++.|++|.++.++ ..-|+.||||++.... ....++|.+|+++|+++ +|+||++|++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46777777777655 4468899999996542 12235799999999999 699999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
||||+|++|.++|...+ .++.. +|+.||+.||+|||++ +||||||||+||||+.++++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999998654 35543 5889999999999999 9999999999999999999999999999876554
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCC
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p 441 (608)
... ....+||++|||||++.+ .+..++|+|++|+++++|+++..+
T Consensus 393 ~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred Ccc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 334679999999999875 567789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=271.98 Aligned_cols=184 Identities=15% Similarity=0.173 Sum_probs=147.0
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCCc--------hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG--------QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
...++||+|+||.||+|.. .++.+++|++..... ...+.|.+|+++|++++|+||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 678899998644321 1134588999999999999999777777788888999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+++++|.+++.. ++.|+.|+++||.|||++ +|+||||||+||||+. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999865 568999999999999999 9999999999999998 9999999999987653
Q ss_pred ccce------eeeeecccCccChhhhhc--CCCCCcchhhhHHHHHHHHHhCCCCC
Q 046502 395 YTHV------STRVMGTFGYLAPEYASS--GKLTEKSDVFSFGVMLLELIIGCRPV 442 (608)
Q Consensus 395 ~~~~------~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvll~elltG~~p~ 442 (608)
.... .....||+.|||||++.. ..|+.++|+|+..+-.++.+.++.+|
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 234679999999999976 56888899999999988888777654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6e-25 Score=224.28 Aligned_cols=152 Identities=16% Similarity=0.117 Sum_probs=123.5
Q ss_pred HHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCc------------------hhHHHHHHHHHHHHhcCC
Q 046502 234 ELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG------------------QGERVFQAEVEIISRVHH 295 (608)
Q Consensus 234 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~Ev~~l~~l~H 295 (608)
.+......|...+.||+|+||.||+|...+|+.||||+++.... .....+.+|+.+|++++
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 34444556777799999999999999997799999999964321 13456889999999999
Q ss_pred CCccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc
Q 046502 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD 375 (608)
Q Consensus 296 pniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~ 375 (608)
| +++++++.. +..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+||||+
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 5 777776644 56799999999999988 421 13457999999999999998 999999999999999
Q ss_pred cCCceEEEEeeccccccCcccceeeeeecccCccChhhhhc
Q 046502 376 FKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS 416 (608)
Q Consensus 376 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 416 (608)
++.+||+|||+++. +..|+|||++..
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 99999999999863 345789998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.3e-20 Score=189.57 Aligned_cols=136 Identities=18% Similarity=0.138 Sum_probs=107.1
Q ss_pred CCcCCccccCCceEEEEEEe-cCCcE--EEEEEcccCCch------------------------hHHHHHHHHHHHHhcC
Q 046502 242 FSDANLLGQGGFGYVHKGVL-PNGKE--VAIKQLKAGSGQ------------------------GERVFQAEVEIISRVH 294 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~Ev~~l~~l~ 294 (608)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 78999 999987543111 1235788999999999
Q ss_pred CCCc--cceeeEEEeCCeeEEEEeeccC-C----cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeec
Q 046502 295 HKHL--VSLVGYYTAGSQRMLVCEFVTS-N----TLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH-EDCHPKIIHRD 366 (608)
Q Consensus 295 Hpni--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH-~~~~~~iiHrD 366 (608)
|+++ ..++++ +..+|||||+.+ | .|.+++.. +++..+..++.|++.+|.||| .. +|+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 8864 344432 356899999942 4 67766532 234467889999999999999 77 899999
Q ss_pred cCCCcEEEccCCceEEEEeeccccc
Q 046502 367 IKAANILLDFKFEAKVADFGLAKLA 391 (608)
Q Consensus 367 Ik~~NILl~~~~~~kl~DFGla~~~ 391 (608)
|||+||||+. .++|+|||++...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=3e-18 Score=180.42 Aligned_cols=137 Identities=15% Similarity=0.114 Sum_probs=100.1
Q ss_pred CCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCc--------------hhHHH--------HHHHHHHHHhcCCCCc
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG--------------QGERV--------FQAEVEIISRVHHKHL 298 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------------~~~~~--------~~~Ev~~l~~l~Hpni 298 (608)
-|.+.+.||.|+||.||+|...+|+.||||+++.... ..... ...|...|.+|++.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3888999999999999999988999999998753210 00111 2346666666654443
Q ss_pred cceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC
Q 046502 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF 378 (608)
Q Consensus 299 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~ 378 (608)
....-+.. ...+|||||++++.|..++.. .....++.||+.+|.|||+. +||||||||.||||++++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 22111111 224799999999988665321 23457889999999999998 899999999999998876
Q ss_pred c----------eEEEEeecccc
Q 046502 379 E----------AKVADFGLAKL 390 (608)
Q Consensus 379 ~----------~kl~DFGla~~ 390 (608)
. +.|+||+-+..
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEE
T ss_pred CcccccccccceEEEEeCCccc
Confidence 3 89999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.4e-13 Score=136.15 Aligned_cols=148 Identities=12% Similarity=0.036 Sum_probs=116.7
Q ss_pred HHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeE
Q 046502 234 ELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 234 el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~ 312 (608)
.+....++|.....++.|+++.||+... +++.++||+...........+.+|+.+++.|. +.++.++++++...+..|
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 3455667888888899999999999985 46889999987532122345888999999995 677889999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED----------------------------------- 357 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~----------------------------------- 357 (608)
+||||++|.+|.+.+.. ......++.+++++|..||..
T Consensus 87 lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 99999999999876321 123457889999999999981
Q ss_pred ---------------------CCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 358 ---------------------CHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 358 ---------------------~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
....++|+|+++.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01359999999999999876556799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-12 Score=129.80 Aligned_cols=138 Identities=15% Similarity=0.051 Sum_probs=102.0
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC--ccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH--LVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn--iv~l~g~~~~~~~~~lV~E~ 317 (608)
.+|....+.+.|.++.||+....+|+.++||+.... ....+..|+.+++.+.+.+ +.++++++..++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344443333456669999998777888999997654 2235778999999996545 45689988888889999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC--------------------------------------- 358 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~--------------------------------------- 358 (608)
++|.+|. ... .+ ...++.++++.|..||...
T Consensus 97 i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9999884 211 12 2367778888888888641
Q ss_pred ----------------CCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 359 ----------------HPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 359 ----------------~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
...++|+|+++.|||++.+..++|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998776677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=3.8e-11 Score=125.91 Aligned_cols=145 Identities=17% Similarity=0.193 Sum_probs=109.4
Q ss_pred CCcCCccccCCceEEEEEEecCCcEEEEEEcc--cCC-chhHHHHHHHHHHHHhcC--CCCccceeeEEEeC---CeeEE
Q 046502 242 FSDANLLGQGGFGYVHKGVLPNGKEVAIKQLK--AGS-GQGERVFQAEVEIISRVH--HKHLVSLVGYYTAG---SQRML 313 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~Ev~~l~~l~--Hpniv~l~g~~~~~---~~~~l 313 (608)
...++.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.|. +..+.+++.+|.+. +..++
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred CceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 345678999999999999875 4678899876 332 122456788999999997 45578999998776 45799
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC----------------------------------- 358 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~----------------------------------- 358 (608)
||||++|..+.+.. ...++...+..++.++++.|..||...
T Consensus 119 vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp EEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 99999998874321 124778888999999999999999730
Q ss_pred --------------------CCCeeeeccCCCcEEEccCCc--eEEEEeeccccc
Q 046502 359 --------------------HPKIIHRDIKAANILLDFKFE--AKVADFGLAKLA 391 (608)
Q Consensus 359 --------------------~~~iiHrDIk~~NILl~~~~~--~kl~DFGla~~~ 391 (608)
...+||+|+++.|||++.++. +.|+||+++...
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246999999999999987753 689999988753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=1.6e-11 Score=125.82 Aligned_cols=187 Identities=18% Similarity=0.202 Sum_probs=125.3
Q ss_pred cCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCC--ccceeeEEEeCC---eeEEEEee
Q 046502 244 DANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKH--LVSLVGYYTAGS---QRMLVCEF 317 (608)
Q Consensus 244 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpn--iv~l~g~~~~~~---~~~lV~E~ 317 (608)
.++.|+.|.+..||+.. +.++||+.... .....+.+|+++|+.+. +.. +.+++.++...+ ..|+||||
T Consensus 24 ~i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 24 TIEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eeEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 35678999999999853 56889986532 34567889999999984 333 345555443333 34899999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED---------------------------------------- 357 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~---------------------------------------- 357 (608)
++|..|...... .++..++..++.++++.|..||..
T Consensus 98 i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 98 IKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 999988754332 367778888889999999988861
Q ss_pred ---------------CCCCeeeeccCCCcEEEcc--CCceEEEEeeccccccCcccce-------------eeeeecccC
Q 046502 358 ---------------CHPKIIHRDIKAANILLDF--KFEAKVADFGLAKLASDVYTHV-------------STRVMGTFG 407 (608)
Q Consensus 358 ---------------~~~~iiHrDIk~~NILl~~--~~~~kl~DFGla~~~~~~~~~~-------------~~~~~gt~~ 407 (608)
..+.++|+|+++.|||++. +..+.|+||+.+........-. ...+...++
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 1135899999999999998 4567899999986543211000 000111112
Q ss_pred ccC-hhhhhcCCCCCcchhhhHHHHHHHHHhCCCCC
Q 046502 408 YLA-PEYASSGKLTEKSDVFSFGVMLLELIIGCRPV 442 (608)
Q Consensus 408 y~a-PE~~~~~~~t~ksDVwS~Gvll~elltG~~p~ 442 (608)
+.. |++.... ....+.|+++.++|.+.+|..+|
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 223 3332211 12368999999999999997664
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=1.6e-07 Score=96.07 Aligned_cols=136 Identities=18% Similarity=0.216 Sum_probs=95.6
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCC---CccceeeEEE-eCCeeEEEEeeccC
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHK---HLVSLVGYYT-AGSQRMLVCEFVTS 320 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hp---niv~l~g~~~-~~~~~~lV~E~~~~ 320 (608)
++.|+.|....||+. |+.++||+.. .......+..|+++|..|.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456888999999987 5678899853 223456788999999999753 2556777764 44567899999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED------------------------------------------- 357 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~------------------------------------------- 357 (608)
..|...... .++...+..++.++++.|..||..
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888763221 234444555555555555555532
Q ss_pred --------------CCCCeeeeccCCCcEEEcc---CCc-eEEEEeecccc
Q 046502 358 --------------CHPKIIHRDIKAANILLDF---KFE-AKVADFGLAKL 390 (608)
Q Consensus 358 --------------~~~~iiHrDIk~~NILl~~---~~~-~kl~DFGla~~ 390 (608)
..+.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.59 E-value=3.4e-07 Score=91.40 Aligned_cols=135 Identities=16% Similarity=0.078 Sum_probs=97.8
Q ss_pred ccccCCce-EEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 247 LLGQGGFG-YVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 247 ~LG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
.+..|..+ .||+.... ++..++||+-... ....+.+|..+|+.|. +--+-++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 44555555 69988754 4677999986542 3456788999999885 33366889999999999999999999888
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 046502 324 EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC--------------------------------------------- 358 (608)
Q Consensus 324 ~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~--------------------------------------------- 358 (608)
.+..... ......++.++++.|..||...
T Consensus 108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 7655321 1233456666677777777420
Q ss_pred ----------CCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 359 ----------HPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 359 ----------~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.+.++|+|+++.|||++.++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11379999999999999877777999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=9.2e-08 Score=99.81 Aligned_cols=80 Identities=10% Similarity=-0.002 Sum_probs=56.6
Q ss_pred CCcc-ccCCceEEEEEEec-------CCcEEEEEEcccCC---chhHHHHHHHHHHHHhcC-C--CCccceeeEEEeC--
Q 046502 245 ANLL-GQGGFGYVHKGVLP-------NGKEVAIKQLKAGS---GQGERVFQAEVEIISRVH-H--KHLVSLVGYYTAG-- 308 (608)
Q Consensus 245 ~~~L-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~-H--pniv~l~g~~~~~-- 308 (608)
.+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+|+.|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999998764 26789999865432 101235678899998885 3 3467888887665
Q ss_pred -CeeEEEEeeccCCcHH
Q 046502 309 -SQRMLVCEFVTSNTLE 324 (608)
Q Consensus 309 -~~~~lV~E~~~~gsL~ 324 (608)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.33 E-value=2.2e-06 Score=88.18 Aligned_cols=140 Identities=17% Similarity=0.233 Sum_probs=81.9
Q ss_pred CCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCC--CCccceee------EEEeCCeeEEEEe
Q 046502 245 ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH--KHLVSLVG------YYTAGSQRMLVCE 316 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~H--pniv~l~g------~~~~~~~~~lV~E 316 (608)
.+.|+.|..+.||+....+| .+++|+.... ...+..|+.++..|.. -.+.+++. +...++..++|||
T Consensus 37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34566677899999987555 5899998752 2233445666665531 12333332 2234677899999
Q ss_pred eccCCcHH--------------HHhhc--CC---C-------CCCCHHHHH-----------------------------
Q 046502 317 FVTSNTLE--------------FHLHG--KG---R-------PTMDWPTRL----------------------------- 341 (608)
Q Consensus 317 ~~~~gsL~--------------~~l~~--~~---~-------~~l~~~~~~----------------------------- 341 (608)
|++|..+. ..||. .. . ....|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 12221 10 0 012343211
Q ss_pred --HHHHHHHHHHHHHHh----------cCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 342 --KIALGFAKGLAYLHE----------DCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 342 --~ia~~ia~~L~yLH~----------~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
.+...+.+++.+|+. .....+||+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123446667763 123479999999999999888899999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.26 E-value=2.4e-06 Score=90.46 Aligned_cols=75 Identities=17% Similarity=0.121 Sum_probs=50.0
Q ss_pred CCccccCCceEEEEEEec-CCcEEEEEEcccCCc-------hhHHHHHHHHHHHHhcCC--CCc-cceeeEEEeCCeeEE
Q 046502 245 ANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSG-------QGERVFQAEVEIISRVHH--KHL-VSLVGYYTAGSQRML 313 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~Ev~~l~~l~H--pni-v~l~g~~~~~~~~~l 313 (608)
.+.||.|.++.||++... +++.|+||....... .....+..|+++|+.+.. +.+ .+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 567999999999999754 468899998653221 122346778999988742 333 455544 3455689
Q ss_pred EEeeccCC
Q 046502 314 VCEFVTSN 321 (608)
Q Consensus 314 V~E~~~~g 321 (608)
||||+.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.21 E-value=2.7e-06 Score=90.87 Aligned_cols=74 Identities=15% Similarity=0.183 Sum_probs=47.2
Q ss_pred cCCccccCCceEEEEEEecCCcEEEEEEcccC------C---chhHHHHHHHHHHHHh-cCCCCccceeeEEEeCCeeEE
Q 046502 244 DANLLGQGGFGYVHKGVLPNGKEVAIKQLKAG------S---GQGERVFQAEVEIISR-VHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 244 ~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~------~---~~~~~~~~~Ev~~l~~-l~Hpniv~l~g~~~~~~~~~l 313 (608)
..+.||.|..+.||+... +++.++||..... . ......+..|+..+.. .....+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 456799999999999975 5678999943211 0 1123344444443332 2234566777765 566799
Q ss_pred EEeec-cC
Q 046502 314 VCEFV-TS 320 (608)
Q Consensus 314 V~E~~-~~ 320 (608)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.11 E-value=9.8e-06 Score=83.02 Aligned_cols=139 Identities=15% Similarity=0.148 Sum_probs=94.2
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC---CCCccceeeEEEeCCeeEEEEeecc
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH---HKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~---Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
...+.|+.|.+..+|+... +++.++||+.... ....|..|+..|+.|. .-.+.+++.++...+..++||||++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3456799999999999886 5678899987642 3567888999999884 2567889999888888999999999
Q ss_pred CCcHH-----------HHhhcCCC-C-------------------CCCHHHHH---HHH--HH--------------HHH
Q 046502 320 SNTLE-----------FHLHGKGR-P-------------------TMDWPTRL---KIA--LG--------------FAK 349 (608)
Q Consensus 320 ~gsL~-----------~~l~~~~~-~-------------------~l~~~~~~---~ia--~~--------------ia~ 349 (608)
+..+. ..||.... . .-+|.... ++. .+ ++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87642 13333211 0 12565332 111 11 111
Q ss_pred H-HHHHHh-cCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 350 G-LAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 350 ~-L~yLH~-~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
- ...|.. ...+.+||+|+.+.|||++.++ +.|+||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123321 1245799999999999999887 8899973
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.10 E-value=5.7e-06 Score=83.53 Aligned_cols=79 Identities=16% Similarity=0.193 Sum_probs=59.4
Q ss_pred CCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCC---CccceeeEEEeCCeeEEEEee
Q 046502 241 GFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHK---HLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hp---niv~l~g~~~~~~~~~lV~E~ 317 (608)
.+..++.+|.|..+.||+.++.+|+.|+||+...........|..|+..|+.|.-- -+.+++++. .-++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 45567789999999999999999999999997655444455788999999998532 244555442 24789999
Q ss_pred ccCCcH
Q 046502 318 VTSNTL 323 (608)
Q Consensus 318 ~~~gsL 323 (608)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=97.97 E-value=1.7e-06 Score=58.46 Aligned_cols=35 Identities=17% Similarity=0.234 Sum_probs=26.3
Q ss_pred CCCCcccccEEEehHHHHHHHHHHHHHHhhhhccc
Q 046502 87 GGGGVSTGLVVGLAIGGLAVIVVVSLLILRCRRKR 121 (608)
Q Consensus 87 ~~~~~~~g~~vgi~v~~~~~~~~~~~~~~~~~~~~ 121 (608)
++++++.|+|+||+||+++.++++++++||++|||
T Consensus 4 ~~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rrr 38 (38)
T 2k1k_A 4 VSRGLTGGEIVAVIFGLLLGAALLLGILVFRSRRA 38 (38)
T ss_dssp SSTTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred CCCCCCCCceeeeehHHHHHHHHHHHHHHHHeecC
Confidence 35678899999999999877776666666666554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.95 E-value=2.6e-05 Score=79.78 Aligned_cols=158 Identities=11% Similarity=0.066 Sum_probs=92.2
Q ss_pred ccCHHHHHHHhcCCCc-----CCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC--ccce
Q 046502 229 TFTYEELARATDGFSD-----ANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH--LVSL 301 (608)
Q Consensus 229 ~~~~~el~~~~~~f~~-----~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn--iv~l 301 (608)
.++.+++......|.. .+.|+.|....+|+....+| .+++|+..... ....+..|+.++..|...+ +.++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3566777777777765 23466788899999987665 68899887521 1234556788877774222 2333
Q ss_pred ee------EEEeCCeeEEEEeeccCCcHH--------------HHhhcC----CCC---C---CCHHHHHH---------
Q 046502 302 VG------YYTAGSQRMLVCEFVTSNTLE--------------FHLHGK----GRP---T---MDWPTRLK--------- 342 (608)
Q Consensus 302 ~g------~~~~~~~~~lV~E~~~~gsL~--------------~~l~~~----~~~---~---l~~~~~~~--------- 342 (608)
+. +...++..++||+|++|..+. ..+|.. ... . ..|...+.
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 32 122346678999999986532 112211 100 0 12433111
Q ss_pred ---HHHHHHHHHHHHHhcC----CCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 343 ---IALGFAKGLAYLHEDC----HPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 343 ---ia~~ia~~L~yLH~~~----~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
+...+.+.+.+|+... ...+||+|+++.|||++.+..+.|+||+.+.
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 0112445566665431 2369999999999999887556899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.81 E-value=0.00013 Score=74.63 Aligned_cols=157 Identities=15% Similarity=0.104 Sum_probs=91.3
Q ss_pred cCHHHHHHHhcCCC-----cCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC--cccee
Q 046502 230 FTYEELARATDGFS-----DANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH--LVSLV 302 (608)
Q Consensus 230 ~~~~el~~~~~~f~-----~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn--iv~l~ 302 (608)
.+-+++......|. ....|+ |....||+....+|+.+++|+..... .....+..|+.++..|.... +.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeeccee
Confidence 34455555544443 234566 88889999887778789999986432 13446677888888875222 34444
Q ss_pred eE-----EEeCCeeEEEEeeccCCcHH-----H---------Hhhc--C-----CCCCCCHHHH----HHH---------
Q 046502 303 GY-----YTAGSQRMLVCEFVTSNTLE-----F---------HLHG--K-----GRPTMDWPTR----LKI--------- 343 (608)
Q Consensus 303 g~-----~~~~~~~~lV~E~~~~gsL~-----~---------~l~~--~-----~~~~l~~~~~----~~i--------- 343 (608)
.. ...++..++||||++|..+. . .+|. . ....+++... ..+
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 32 22355678899999885432 0 1221 0 1112333221 001
Q ss_pred ------HHHHHHHHHHHHhc----CCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 344 ------ALGFAKGLAYLHED----CHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 344 ------a~~ia~~L~yLH~~----~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
...+.+.+..|... ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333322 233589999999999999 4 899999987653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.72 E-value=4.9e-05 Score=81.45 Aligned_cols=73 Identities=19% Similarity=0.238 Sum_probs=51.1
Q ss_pred CCccccCCceEEEEEEecC--------CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEE
Q 046502 245 ANLLGQGGFGYVHKGVLPN--------GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-v~l~g~~~~~~~~~lV~ 315 (608)
++.|+.|-...||+....+ ++.|++|+.... .....+..|+.++..|...++ .++++++.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4568888899999998753 578999988432 111345579999998864344 577776542 3899
Q ss_pred eeccCCcH
Q 046502 316 EFVTSNTL 323 (608)
Q Consensus 316 E~~~~gsL 323 (608)
||++|..|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99987444
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.65 E-value=1.4e-05 Score=55.45 Aligned_cols=34 Identities=29% Similarity=0.467 Sum_probs=19.7
Q ss_pred cccccEEEehHHHHHHHHHHHHHHhhhhcccccc
Q 046502 91 VSTGLVVGLAIGGLAVIVVVSLLILRCRRKRRRR 124 (608)
Q Consensus 91 ~~~g~~vgi~v~~~~~~~~~~~~~~~~~~~~~~~ 124 (608)
..++.|++.+||++++++++++++|+++||||++
T Consensus 7 s~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~~ 40 (44)
T 2l2t_A 7 ARTPLIAAGVIGGLFILVIVGLTFAVYVRRKSIK 40 (44)
T ss_dssp CSSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred CCcceEEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence 3455666667766666555555555555555543
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.0002 Score=73.52 Aligned_cols=143 Identities=17% Similarity=0.142 Sum_probs=76.1
Q ss_pred CCccccCCceE-EEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCC--CccceeeEEEeCCeeEEEEeeccCC
Q 046502 245 ANLLGQGGFGY-VHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHK--HLVSLVGYYTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 245 ~~~LG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hp--niv~l~g~~~~~~~~~lV~E~~~~g 321 (608)
.+.|+.|+... +|+....+|+.+++|....... ..+..|+.++..|... .+.+++.++.+.+ ++|||++.+.
T Consensus 23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 44566665554 6677654477888887654321 2345577777777422 3556777644333 7899999876
Q ss_pred cHHHHhhcC---------------------C---CCCCCHHHHH-------H-------------HHHHHHHHHHHHHh-
Q 046502 322 TLEFHLHGK---------------------G---RPTMDWPTRL-------K-------------IALGFAKGLAYLHE- 356 (608)
Q Consensus 322 sL~~~l~~~---------------------~---~~~l~~~~~~-------~-------------ia~~ia~~L~yLH~- 356 (608)
.+..++... . ...++..... . ....+...+..|..
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 664433211 0 0112211100 0 00111222333321
Q ss_pred --cCCCCeeeeccCCCcEEEccC----CceEEEEeecccccc
Q 046502 357 --DCHPKIIHRDIKAANILLDFK----FEAKVADFGLAKLAS 392 (608)
Q Consensus 357 --~~~~~iiHrDIk~~NILl~~~----~~~kl~DFGla~~~~ 392 (608)
.....++|||+.+.|||++.+ ..+.|+||+.+....
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 123369999999999999874 679999999886543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.57 E-value=5.7e-05 Score=76.62 Aligned_cols=140 Identities=11% Similarity=0.107 Sum_probs=78.1
Q ss_pred CCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEeec-c
Q 046502 242 FSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVCEFV-T 319 (608)
Q Consensus 242 f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~-~ 319 (608)
+..++.|+.|....+|+. +.+++|+........ ....+|+.+++.+...++ .++++++ .+.-++|+||+ +
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 444678999999999998 568889876432111 123468888887753333 4666543 33457899999 6
Q ss_pred CCcHHH------------------HhhcCCC---CCCC-HHHHHHHHH--------------HHHHHHHHHH----h-cC
Q 046502 320 SNTLEF------------------HLHGKGR---PTMD-WPTRLKIAL--------------GFAKGLAYLH----E-DC 358 (608)
Q Consensus 320 ~gsL~~------------------~l~~~~~---~~l~-~~~~~~ia~--------------~ia~~L~yLH----~-~~ 358 (608)
+..|.. .||.... ...+ +.....+.. .+.+.+..|. . ..
T Consensus 92 g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~ 171 (301)
T 3dxq_A 92 AQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPL 171 (301)
T ss_dssp CEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCC
T ss_pred CccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCC
Confidence 654421 1122111 0011 111111110 1111112111 1 12
Q ss_pred CCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 359 ~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
...++|+|+.+.||| ..++.+.|+||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 235899999999999 5667889999987754
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.54 E-value=2.7e-05 Score=54.20 Aligned_cols=32 Identities=25% Similarity=0.239 Sum_probs=17.2
Q ss_pred cccEEEehHHHHHHHHHHHHHHhhhhcccccc
Q 046502 93 TGLVVGLAIGGLAVIVVVSLLILRCRRKRRRR 124 (608)
Q Consensus 93 ~g~~vgi~v~~~~~~~~~~~~~~~~~~~~~~~ 124 (608)
++.|++.+||++++++++++++|+++||||++
T Consensus 10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~~~ 41 (44)
T 2ks1_B 10 IPSIATGMVGALLLLLVVALGIGLFMRRRHIV 41 (44)
T ss_dssp SSSSTHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred cceEEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence 34555566665555555555555555555443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00022 Score=76.84 Aligned_cols=74 Identities=14% Similarity=0.090 Sum_probs=48.8
Q ss_pred CCccccCCceEEEEEEecC-CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEEeeccCCc
Q 046502 245 ANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVCEFVTSNT 322 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-v~l~g~~~~~~~~~lV~E~~~~gs 322 (608)
++.|+.|-...+|+....+ ++.|++|+......... ....|+.++..|...++ .++++++. + .+||||++|..
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888889999998755 47888998754321110 12479999999975555 47777763 2 25999998755
Q ss_pred H
Q 046502 323 L 323 (608)
Q Consensus 323 L 323 (608)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00028 Score=74.17 Aligned_cols=140 Identities=19% Similarity=0.201 Sum_probs=83.5
Q ss_pred CCccccCCceEEEEEEec--------CCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCeeEEEE
Q 046502 245 ANLLGQGGFGYVHKGVLP--------NGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++.|..|-...+|+.... +++.|++|+..... .....+.+|..+++.|. +.-..+++++|.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 456777888899999864 24789999864322 23445668999998885 3333567776643 2999
Q ss_pred eeccCCcHHH-----------------HhhcCC---CCCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 046502 316 EFVTSNTLEF-----------------HLHGKG---RPTMD--WPTRLKIALGFA-------------------KGLAYL 354 (608)
Q Consensus 316 E~~~~gsL~~-----------------~l~~~~---~~~l~--~~~~~~ia~~ia-------------------~~L~yL 354 (608)
||++|..|.. .||.-. ..... |.++.++..++. ..+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9999865531 122211 11122 444444443332 223344
Q ss_pred Hhc-----CCCCeeeeccCCCcEEEccC----CceEEEEeeccc
Q 046502 355 HED-----CHPKIIHRDIKAANILLDFK----FEAKVADFGLAK 389 (608)
Q Consensus 355 H~~-----~~~~iiHrDIk~~NILl~~~----~~~kl~DFGla~ 389 (608)
.+. ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 322 12359999999999999876 789999998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00026 Score=73.96 Aligned_cols=74 Identities=11% Similarity=0.072 Sum_probs=45.7
Q ss_pred CCccccCCceEEEEEEecC---------CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEE
Q 046502 245 ANLLGQGGFGYVHKGVLPN---------GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLV 314 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-v~l~g~~~~~~~~~lV 314 (608)
...|+.|....+|+....+ ++.+++|+........ .....|+.+++.|...++ .++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 4567888889999998654 2688899876432211 123568888888853343 4676554 2 2689
Q ss_pred EeeccCCcH
Q 046502 315 CEFVTSNTL 323 (608)
Q Consensus 315 ~E~~~~gsL 323 (608)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0014 Score=67.56 Aligned_cols=66 Identities=11% Similarity=0.083 Sum_probs=43.5
Q ss_pred CCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC---CCCccceeeE------EEeCCeeEEEEeeccCC
Q 046502 251 GGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH---HKHLVSLVGY------YTAGSQRMLVCEFVTSN 321 (608)
Q Consensus 251 G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~---Hpniv~l~g~------~~~~~~~~lV~E~~~~g 321 (608)
|....||+....+| .+++|+...... ..|+.++..|. -+++.+++.. +..++..++||+|++|.
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 33689999987677 899998765432 34566666553 2224444432 33456789999999987
Q ss_pred cH
Q 046502 322 TL 323 (608)
Q Consensus 322 sL 323 (608)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 65
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.57 E-value=0.00052 Score=47.50 Aligned_cols=28 Identities=18% Similarity=0.369 Sum_probs=13.7
Q ss_pred ccEEEehHHHHHHHHHHHHHHhhhhcccc
Q 046502 94 GLVVGLAIGGLAVIVVVSLLILRCRRKRR 122 (608)
Q Consensus 94 g~~vgi~v~~~~~~~~~~~~~~~~~~~~~ 122 (608)
..|+|++||++ +++++++++++++||||
T Consensus 12 ~~Ia~~vVGvl-l~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 12 TSIISAVVGIL-LVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHH-HHHHHHHHHHHHHHHHC
T ss_pred cchHHHHHHHH-HHHHHHHHHHhheehhh
Confidence 35666777744 44444444433433333
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.54 E-value=0.007 Score=57.83 Aligned_cols=100 Identities=15% Similarity=0.065 Sum_probs=65.9
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
.-+|.++|...+. .+++++.+.++.|.+++|.-+-...+ . ..+=+.+..|+|..+|.+.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~~~-PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQ-PINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cccHHHHHHHcCC-CcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 3479999987665 79999999999999999877622111 1 1333456899999999887753 1110
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII 437 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt 437 (608)
.....+.+||... ...+++.=|||||++||.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1122456777663 345788999999999999884
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.13 E-value=0.0093 Score=63.40 Aligned_cols=139 Identities=12% Similarity=0.144 Sum_probs=84.1
Q ss_pred CCccccCCceEEEEEEecC--------CcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCC-ccceeeEEEeCCeeEEEE
Q 046502 245 ANLLGQGGFGYVHKGVLPN--------GKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKH-LVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpn-iv~l~g~~~~~~~~~lV~ 315 (608)
++.|..|-...+|+....+ ++.|++|+........ -...+|..+++.|.-.+ ..++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 4567778889999998753 5789999875432111 12346888888885333 456665432 27899
Q ss_pred eeccCCcHHH-----------------Hhhc----C-------CCCCCCHHHHHHHHHH-------------------HH
Q 046502 316 EFVTSNTLEF-----------------HLHG----K-------GRPTMDWPTRLKIALG-------------------FA 348 (608)
Q Consensus 316 E~~~~gsL~~-----------------~l~~----~-------~~~~l~~~~~~~ia~~-------------------ia 348 (608)
||++|..|.. .||. . .....-|.++.++..+ +.
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999866421 1111 0 1111224444333322 22
Q ss_pred HHHHHHHhc---------------------CCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 349 KGLAYLHED---------------------CHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 349 ~~L~yLH~~---------------------~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
..+.+|.+. ....++|+|+.+.||| +.++.+.|+||..+.
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 233444321 1225899999999999 778899999998765
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.0038 Score=43.03 Aligned_cols=26 Identities=19% Similarity=0.300 Sum_probs=10.5
Q ss_pred cEEEehHHHHHHHHHHHHHHhhhhcc
Q 046502 95 LVVGLAIGGLAVIVVVSLLILRCRRK 120 (608)
Q Consensus 95 ~~vgi~v~~~~~~~~~~~~~~~~~~~ 120 (608)
+|++.+++++++++++++++|+++||
T Consensus 14 ~I~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 14 AVIGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred EEEeehhHHHHHHHHHHHHheeEeee
Confidence 44444444444444233334444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.80 E-value=0.065 Score=56.34 Aligned_cols=28 Identities=32% Similarity=0.436 Sum_probs=23.8
Q ss_pred eeeeccCCCcEEE------ccCCceEEEEeeccc
Q 046502 362 IIHRDIKAANILL------DFKFEAKVADFGLAK 389 (608)
Q Consensus 362 iiHrDIk~~NILl------~~~~~~kl~DFGla~ 389 (608)
++|+|+.+.|||+ +++..++|+||-+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 445679999998765
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=94.80 E-value=0.0067 Score=39.42 Aligned_cols=30 Identities=30% Similarity=0.598 Sum_probs=22.7
Q ss_pred CcccccEEEehHHHHHHHHHHHHHHhhhhc
Q 046502 90 GVSTGLVVGLAIGGLAVIVVVSLLILRCRR 119 (608)
Q Consensus 90 ~~~~g~~vgi~v~~~~~~~~~~~~~~~~~~ 119 (608)
+++.|.++||++|.+++.+++++++||+.|
T Consensus 3 ~L~~gaIaGIVvgdi~~t~~i~~~vy~~~r 32 (33)
T 2l34_A 3 TVSPGVLAGIVVGDLVLTVLIALAVYFLGR 32 (33)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred ccCcceEEeEeHHHHHHHHHHHHHHhheec
Confidence 356788999999998887777776666543
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.36 E-value=0.069 Score=37.05 Aligned_cols=23 Identities=30% Similarity=0.241 Sum_probs=15.6
Q ss_pred HHHHHHHHHHHHHhhhhcccccc
Q 046502 102 GGLAVIVVVSLLILRCRRKRRRR 124 (608)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~ 124 (608)
.++++++++.++++++||+++++
T Consensus 22 ~~~~ii~~~~~~~~RRr~~~~kR 44 (44)
T 2ks1_B 22 LLLLVVALGIGLFMRRRHIVRKR 44 (44)
T ss_dssp HHHHHHHHHHHHHHHTTTCCSCC
T ss_pred HHHHHHHHHHHHHhhhhHhhccC
Confidence 33344557777888888887764
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.14 E-value=0.042 Score=38.06 Aligned_cols=32 Identities=16% Similarity=0.262 Sum_probs=19.4
Q ss_pred ccccEEEehHHHHHHHHHHHHHHhhhhcccccc
Q 046502 92 STGLVVGLAIGGLAVIVVVSLLILRCRRKRRRR 124 (608)
Q Consensus 92 ~~g~~vgi~v~~~~~~~~~~~~~~~~~~~~~~~ 124 (608)
-.+.+|| ++.++++++++.++++++||+++++
T Consensus 12 IA~gVVg-Gv~~v~ii~~~~~~~~RRRr~~~kr 43 (44)
T 2l2t_A 12 IAAGVIG-GLFILVIVGLTFAVYVRRKSIKKKR 43 (44)
T ss_dssp HHHHHHH-HHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred EEEeehH-HHHHHHHHHHHHHHHhhhhhhhhcc
Confidence 3334443 3333444557777888888888776
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.54 E-value=0.39 Score=45.66 Aligned_cols=115 Identities=6% Similarity=0.042 Sum_probs=78.5
Q ss_pred CCCCccceeeEEEeCCeeEEEEeecc-CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcE
Q 046502 294 HHKHLVSLVGYYTAGSQRMLVCEFVT-SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANI 372 (608)
Q Consensus 294 ~Hpniv~l~g~~~~~~~~~lV~E~~~-~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NI 372 (608)
.|++++.. .+-.+++.+.+.|+.-. ..++.. +. .++...+++++..|+....+++.. +|--|+|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceE
Confidence 68888876 45666677777777655 333333 32 377889999999999988666544 6888999999
Q ss_pred EEccCCceEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 046502 373 LLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVD 443 (608)
Q Consensus 373 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~ 443 (608)
++|.++.++|.-.|+-..... . .+++..=.-.+=+++..+++++..|+
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDP------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTBSC------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCCCC------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999987776432221 1 11111122346678888999887764
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=90.88 E-value=0.031 Score=37.59 Aligned_cols=31 Identities=19% Similarity=0.323 Sum_probs=21.8
Q ss_pred CCCCcccccEEEehHHHHHHHHHHHHHHhhhh
Q 046502 87 GGGGVSTGLVVGLAIGGLAVIVVVSLLILRCR 118 (608)
Q Consensus 87 ~~~~~~~g~~vgi~v~~~~~~~~~~~~~~~~~ 118 (608)
-+.|...|++||+++|+++++++ ++++|++|
T Consensus 8 ls~GaIAGiVvG~v~gv~li~~l-~~~~~rrr 38 (38)
T 2k1k_A 8 LTGGEIVAVIFGLLLGAALLLGI-LVFRSRRA 38 (38)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHH-HHHHHCCC
T ss_pred CCCCceeeeehHHHHHHHHHHHH-HHHHeecC
Confidence 36778899999988777665554 45666654
|
| >2llm_A Amyloid beta A4 protein; alzheimer'S disease, protein fibril; NMR {Homo sapiens} PDB: 2loh_A | Back alignment and structure |
|---|
Probab=90.23 E-value=0.044 Score=37.24 Aligned_cols=28 Identities=21% Similarity=0.676 Sum_probs=18.7
Q ss_pred ccccEEEehHHHHHHHHHHHHHHhhhhc
Q 046502 92 STGLVVGLAIGGLAVIVVVSLLILRCRR 119 (608)
Q Consensus 92 ~~g~~vgi~v~~~~~~~~~~~~~~~~~~ 119 (608)
+.|+++|+.+++++++.++++.+++.||
T Consensus 15 srga~iGL~v~gVai~~vIVvsl~mlRr 42 (43)
T 2llm_A 15 NKGAIIGLMVGGVVIATVIVITLVMLKK 42 (43)
Confidence 5678888888777766655555555544
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.50 E-value=0.17 Score=36.47 Aligned_cols=25 Identities=16% Similarity=0.324 Sum_probs=12.7
Q ss_pred ccccEEEehHHHHHHHHHHHHHHhh
Q 046502 92 STGLVVGLAIGGLAVIVVVSLLILR 116 (608)
Q Consensus 92 ~~g~~vgi~v~~~~~~~~~~~~~~~ 116 (608)
..-+|++.++|++++++++++++|.
T Consensus 8 p~WiIi~svl~GLLLL~Lii~~LwK 32 (54)
T 2l8s_A 8 PLWVILLSAFAGLLLLMLLILALWK 32 (54)
T ss_dssp CTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3445555555555555555544443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.27 E-value=0.77 Score=43.74 Aligned_cols=83 Identities=10% Similarity=0.099 Sum_probs=60.8
Q ss_pred CCCCccceeeEEEeCCeeEEEEeeccCC-cHHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeeeccCCCc
Q 046502 294 HHKHLVSLVGYYTAGSQRMLVCEFVTSN-TLEFHLHGKGRPTMDWPTRLKIALGFAKGLA-YLHEDCHPKIIHRDIKAAN 371 (608)
Q Consensus 294 ~Hpniv~l~g~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~-yLH~~~~~~iiHrDIk~~N 371 (608)
.|+++ -..+-.+++.+.+.|+.-+++ ++. .+. .++...+++++..|+.... +++. -+|--|+|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57877 444446777777878776443 344 332 4778899999999888766 5554 4777899999
Q ss_pred EEEccCCceEEEEeeccc
Q 046502 372 ILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 372 ILl~~~~~~kl~DFGla~ 389 (608)
|++|.++.++|.-.|+-.
T Consensus 115 L~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp EEECTTCCEEESCCEETT
T ss_pred EEEeCCCcEEEEEcCCcc
Confidence 999999999998777643
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=89.08 E-value=0.039 Score=36.09 Aligned_cols=18 Identities=6% Similarity=0.283 Sum_probs=8.2
Q ss_pred HHHHHHHHHHHhhhhccc
Q 046502 104 LAVIVVVSLLILRCRRKR 121 (608)
Q Consensus 104 ~~~~~~~~~~~~~~~~~~ 121 (608)
+++++++++.+.+++|||
T Consensus 17 lll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 17 VLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHTTTTTHHHHHC
T ss_pred HHHHHHHHHHhheEEeec
Confidence 444444444444444444
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.72 E-value=0.11 Score=55.73 Aligned_cols=60 Identities=3% Similarity=-0.038 Sum_probs=18.0
Q ss_pred cCCccccCCceEEEEEEecC-CcEEEE------EEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEE
Q 046502 244 DANLLGQGGFGYVHKGVLPN-GKEVAI------KQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYT 306 (608)
Q Consensus 244 ~~~~LG~G~fg~Vy~~~~~~-g~~vav------K~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~ 306 (608)
..+.|| ||.||+|.+.. ..+||| |.++.... .....|.+|..++..++|+|++++++|..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 356676 99999999754 357888 77664322 22346788999999999999999998764
|
| >2klu_A T-cell surface glycoprotein CD4; cell membrane, disulfide bond, HOST- virus interaction, immune response, immunoglobulin domain, lipoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.37 E-value=1.1 Score=33.47 Aligned_cols=30 Identities=30% Similarity=0.435 Sum_probs=19.4
Q ss_pred cEEEehHHHHHHHHHHHHHHhhhhcccccc
Q 046502 95 LVVGLAIGGLAVIVVVSLLILRCRRKRRRR 124 (608)
Q Consensus 95 ~~vgi~v~~~~~~~~~~~~~~~~~~~~~~~ 124 (608)
+++|.+++.++++.+.++++..||+|||+.
T Consensus 12 ivlGg~~~lll~~glcI~ccvkcrhRrrqA 41 (70)
T 2klu_A 12 IVLGGVAGLLLFIGLGIFFSVRSRHRRRQA 41 (70)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHSSCCSSSC
T ss_pred HHHhHHHHHHHHHHHHHHHhhHHHHHHHHH
Confidence 567777777766666665566666655543
|
| >1q55_A EP-cadherin, C-cadherin; trans interaction, desmosome, junction, adhesion, structural protein; HET: NAG NDG; 30.00A {Mus musculus} SCOP: i.20.1.1 PDB: 1q5a_A* 1q5b_A* 1q5c_A* | Back alignment and structure |
|---|
Probab=82.36 E-value=0.26 Score=57.23 Aligned_cols=27 Identities=22% Similarity=0.383 Sum_probs=0.0
Q ss_pred CCCcccccEEEehHHHHHHHHHHHHHH
Q 046502 88 GGGVSTGLVVGLAIGGLAVIVVVSLLI 114 (608)
Q Consensus 88 ~~~~~~g~~vgi~v~~~~~~~~~~~~~ 114 (608)
..+++.+++++|++|++++|+++++++
T Consensus 699 ~~~l~~~aii~il~~~~~ll~~~ll~~ 725 (880)
T 1q55_A 699 VGGFDLPIILVILGSVLALLILFLLLL 725 (880)
T ss_dssp ---------------------------
T ss_pred ccCccHHHHHHHHHHHHHHHHHHHHHH
Confidence 457788888888877776655544433
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.65 E-value=0.35 Score=38.21 Aligned_cols=24 Identities=25% Similarity=0.336 Sum_probs=11.1
Q ss_pred ccccEEEehHHHHHHHHHHHHHHh
Q 046502 92 STGLVVGLAIGGLAVIVVVSLLIL 115 (608)
Q Consensus 92 ~~g~~vgi~v~~~~~~~~~~~~~~ 115 (608)
+..+||+.++|++++++++++++|
T Consensus 9 n~~~Iv~gvi~gilliGllllliw 32 (79)
T 2knc_B 9 DILVVLLSVMGAILLIGLAALLIW 32 (79)
T ss_dssp CSHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CchhhHHHHHHHHHHHHHHHHHHH
Confidence 344544444454444444444444
|
| >2lp1_A C99; alzheimer'S D membrane protein, transmembrane Pro; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.53 E-value=0.33 Score=40.43 Aligned_cols=27 Identities=22% Similarity=0.668 Sum_probs=16.6
Q ss_pred ccccEEEehHHHHHHHHHHHHHHhhhh
Q 046502 92 STGLVVGLAIGGLAVIVVVSLLILRCR 118 (608)
Q Consensus 92 ~~g~~vgi~v~~~~~~~~~~~~~~~~~ 118 (608)
+.++++|+.++++++++++++.+++.|
T Consensus 28 ~~~a~igL~v~~vai~~viVv~l~v~r 54 (122)
T 2lp1_A 28 NKGAIIGLMVGGVVIATVIVITLVMLK 54 (122)
Confidence 445778888777766555554444443
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 608 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-47 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-41 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 3e-67
Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 25/274 (9%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLK--AGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
+G G FG V+KG +VA+K L A + Q + F+ EV ++ + H +++ +G
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
Y T Q +V ++ ++L HLH + + IA A+G+ YLH II
Sbjct: 72 YST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH---AKSII 126
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDV-YTHVSTRVMGTFGYLAPEYA---SSGKL 419
HRD+K+ NI L K+ DFGLA + S +H ++ G+ ++APE
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479
+ +SDV++FG++L EL+ G P + + R + + G + P L +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQIIFMVGRG----YLSPDLS-KV 234
Query: 480 NHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
N M A C++ RP QI+ ++E
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-66
Identities = 76/268 (28%), Positives = 115/268 (42%), Gaps = 21/268 (7%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG G FG V G +VA+K LK GS + F AE ++ ++ H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVV 77
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
T ++ E++ + +L L + L +A A+G+A++ E IHR
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
D++AANIL+ K+ADFGLA+L D + APE + G T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 426 FSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMA 485
+SFG++L E++ R T E + + +E G +V P N
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPE-------VIQNLERGY--RMVRPD-------NCPE 237
Query: 486 RMVACAAACVRHSARRRPRISQIVRTLE 513
+ C + RP + LE
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (537), Expect = 4e-64
Identities = 67/288 (23%), Positives = 122/288 (42%), Gaps = 27/288 (9%)
Query: 248 LGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYT- 306
+G+G FG V +G G+EVA+K + + +AE+ + H++++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 307 ---AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC----- 358
+Q LV ++ +L +L+ R T+ +K+AL A GLA+LH +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN---RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKL---ASDVYTHVSTRVMGTFGYLAPEYAS 415
P I HRD+K+ NIL+ +AD GLA A+D +GT Y+APE
Sbjct: 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD 185
Query: 416 S------GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTF---MEDNLARPLLNRAIEDGN 466
+ +++D+++ G++ E+ C + D + +
Sbjct: 186 DSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245
Query: 467 FDTLVDPKLHNEYNHNEMARMVA-CAAACVRHSARRRPRISQIVRTLE 513
+ + P + N + E R++A C + R +I +TL
Sbjct: 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 7e-64
Identities = 74/268 (27%), Positives = 112/268 (41%), Gaps = 21/268 (7%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
+G G FG VH G N +VAIK ++ G+ E F E E++ ++ H LV L G
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
+ LV EF+ L R T L + L +G+AYL +IHR
Sbjct: 70 LEQAPICLVFEFMEHGCL-SDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHR 125
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
D+ A N L+ KV+DFG+ + D ST + +PE S + + KSDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185
Query: 426 FSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMA 485
+SFGV++ E+ + + E + I G L P+L +
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSE-------VVEDISTGF--RLYKPRLAST------- 229
Query: 486 RMVACAAACVRHSARRRPRISQIVRTLE 513
+ C + RP S+++R L
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-63
Identities = 58/252 (23%), Positives = 110/252 (43%), Gaps = 9/252 (3%)
Query: 238 ATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHH 295
D F + LG G G V K P+G +A K + R E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH 355
++V G + + + + E + +L+ L GR + K+++ KGL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYLR 121
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS 415
E KI+HRD+K +NIL++ + E K+ DFG++ D ++ +GT Y++PE
Sbjct: 122 EKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQ 176
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475
+ +SD++S G+ L+E+ +G P+ + + + + +
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236
Query: 476 HNEYNHNEMARM 487
+ Y + M
Sbjct: 237 LSSYGMDSRPPM 248
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (526), Expect = 1e-62
Identities = 72/303 (23%), Positives = 125/303 (41%), Gaps = 38/303 (12%)
Query: 229 TFTYEELARATDGFSDA---------NLLGQGGFGYVHKGVLPNGKE----VAIKQLKAG 275
FT+E+ A F+ ++G G FG V G L + VAIK LK+G
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 276 -SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPT 334
+ + R F +E I+ + H +++ L G T + M++ EF+ + +L+ L
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ- 124
Query: 335 MDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394
+ + G A G+ YL +HRD+ A NIL++ KV+DFGL++ D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 395 YTHVSTR----VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
+ + + APE K T SDV+S+G+++ E++ T +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 451 DNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
++N ++ + + + C + RP+ QIV
Sbjct: 242 ------VINA----------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 511 TLE 513
TL+
Sbjct: 286 TLD 288
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (513), Expect = 8e-61
Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 24/297 (8%)
Query: 228 STFTYEELARATDGFSDANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQGERVFQAE 286
S+ Y++ + + LG G +G V++GV VA+K LK + + E F E
Sbjct: 5 SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKE 63
Query: 287 VEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALG 346
++ + H +LV L+G T ++ EF+T L +L R + L +A
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 123
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
+ + YL + IHRD+ A N L+ KVADFGL++L +
Sbjct: 124 ISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466
+ APE + K + KSDV++FGV+L E+ +
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------- 224
Query: 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG---DASLAD 520
L++ E ++ AC + + RP ++I + E ++S++D
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 9e-61
Identities = 76/268 (28%), Positives = 111/268 (41%), Gaps = 21/268 (7%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LGQG FG V G VAIK LK G+ F E +++ ++ H+ LV L
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
+ +V E+++ +L L G+ + P + +A A G+AY+ +HR
Sbjct: 82 SEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
D++AANIL+ KVADFGLA+L D + APE A G+ T KSDV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197
Query: 426 FSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMA 485
+SFG++L EL R E +L++ V+
Sbjct: 198 WSFGILLTELTTKGRVPYPGMVNRE------VLDQ----------VERGYRMPCPPECPE 241
Query: 486 RMVACAAACVRHSARRRPRISQIVRTLE 513
+ C R RP + LE
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-60
Identities = 65/268 (24%), Positives = 107/268 (39%), Gaps = 21/268 (7%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG G FG V G +VAIK +K GS E F E +++ + H+ LV L G
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
T ++ E++ + L +L L++ + + YL + +HR
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 366 DIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDV 425
D+ A N L++ + KV+DFGL++ D S + PE K + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 426 FSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMA 485
++FGV++ E+ + T E I G L P L +E
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGL--RLYRPHLASE------- 228
Query: 486 RMVACAAACVRHSARRRPRISQIVRTLE 513
++ +C A RP ++ +
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-60
Identities = 70/269 (26%), Positives = 111/269 (41%), Gaps = 27/269 (10%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
+G+G FG V G G +VA+K +K + + F AE +++++ H +LV L+G
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 306 TAGSQRM-LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
+ +V E++ +L +L +GR + LK +L + + YL +H
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSD 424
RD+ A N+L+ AKV+DFGL K AS + APE K + KSD
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKKFSTKSD 182
Query: 425 VFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEM 484
V+SFG++L E+ R + + +E G D
Sbjct: 183 VWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGYKMDAPD---------GCP 226
Query: 485 ARMVACAAACVRHSARRRPRISQIVRTLE 513
+ C A RP Q+ LE
Sbjct: 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-59
Identities = 69/287 (24%), Positives = 119/287 (41%), Gaps = 28/287 (9%)
Query: 242 FSDANLLGQGGFGYVHKGVLPNGKE-----VAIKQLKAGSGQGERV-FQAEVEIISRVHH 295
+ ++G G FG V+KG+L VAIK LKAG + +RV F E I+ + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH 355
+++ L G + M++ E++ N + + + G A G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYME-NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA 127
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD--VYTHVSTRVMGTFGYLAPEY 413
+ +HRD+ A NIL++ KV+DFGL+++ D T+ ++ + APE
Sbjct: 128 ---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473
S K T SDV+SFG+++ E++ + E ++
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VMKAIND 228
Query: 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASLAD 520
+ + + C + RRP+ + IV L+ D
Sbjct: 229 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-57
Identities = 72/297 (24%), Positives = 112/297 (37%), Gaps = 43/297 (14%)
Query: 246 NLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGSGQGER-VFQAEVEIISRV-HHKH 297
LG G FG V + VA+K LK + ER +E++++S + +H +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKG----------------RPTMDWPTRL 341
+V+L+G T G +++ E+ L L K +D L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 342 KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVST 400
+ AKG+A+L IHRD+ A NILL K+ DFGLA+ + +D V
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 401 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR 460
++APE + T +SDV+S+G+ L EL
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------- 256
Query: 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDAS 517
F ++ + A M C +RP QIV+ +E S
Sbjct: 257 ------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 4e-57
Identities = 67/312 (21%), Positives = 108/312 (34%), Gaps = 49/312 (15%)
Query: 232 YEELARATDGFSDANLLGQGGFGYVHKGVLPN------GKEVAIKQLKAGSGQGERV-FQ 284
L + +G+G FG V + P VA+K LK + + FQ
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 285 AEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGR------------ 332
E +++ + ++V L+G G L+ E++ L L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 333 ----------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKV 382
P + +L IA A G+AYL K +HRD+ N L+ K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 383 ADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP 441
ADFGL++ + S Y ++ PE + T +SDV+++GV+L E+
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 442 VDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARR 501
E + + DGN + N + C
Sbjct: 242 PYYGMAHEE-------VIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPAD 285
Query: 502 RPRISQIVRTLE 513
RP I R L+
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 9e-57
Identities = 67/271 (24%), Positives = 109/271 (40%), Gaps = 30/271 (11%)
Query: 248 LGQGGFGYVHKGVLP-NGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGY 304
+G+G F V+KG+ EVA +L+ + + F+ E E++ + H ++V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 305 YTAGSQR----MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
+ + + +LV E +TS TL+ +L M KGL +LH P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFLHT-RTP 133
Query: 361 KIIHRDIKAANILLDFK-FEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
IIHRD+K NI + K+ D GLA L + V+GT ++APE K
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYE-EKY 189
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479
E DV++FG+ +LE+ P + + R + G D E
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------IYRRVTSGVKPASFDKVAIPE- 241
Query: 480 NHNEMARMVACAAACVRHSARRRPRISQIVR 510
+ C+R + R I ++
Sbjct: 242 -------VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-56
Identities = 64/277 (23%), Positives = 104/277 (37%), Gaps = 29/277 (10%)
Query: 244 DANLLGQGGFGYVHKGVLPN---GKEVAIKQLKAGSGQGERV--FQAEVEIISRVHHKHL 298
+ LG G FG V KG K VA+K LK + AE ++ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC 358
V ++G A S MLV E L +L + +++ + G+ YL
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLE--- 124
Query: 359 HPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR--VMGTFGYLAPEYASS 416
+HRD+ A N+LL + AK++DFGL+K + + + APE +
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 417 GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476
K + KSDV+SFGV++ E + E + +E G
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE---------R 228
Query: 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
M C + RP + + L
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 1e-56
Identities = 73/277 (26%), Positives = 113/277 (40%), Gaps = 29/277 (10%)
Query: 246 NLLGQGGFGYVHKGVLPNGK----EVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHLVS 300
++G+G FG V+ G L + A+K L + GE F E I+ H +++S
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 301 LVGYYT-AGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
L+G + ++V ++ L + + L AKG+
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASD---VYTHVSTRVMGTFGYLAPEYASS 416
K +HRD+ A N +LD KF KVADFGLA+ D H T ++A E +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 417 GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476
K T KSDV+SFGV+L EL+ P + + + G L+ P
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG--RRLLQP--- 256
Query: 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
EY + + + C A RP S++V +
Sbjct: 257 -EYCPDPLYEV---MLKCWHPKAEMRPSFSELVSRIS 289
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-56
Identities = 69/284 (24%), Positives = 120/284 (42%), Gaps = 28/284 (9%)
Query: 236 ARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGS--GQGERVFQAEVEIISR 292
+RA D + +G G +G K +GK + K+L GS +++ +EV ++
Sbjct: 1 SRAED-YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59
Query: 293 VHHKHLVSLVGYYTAGSQRML--VCEFVTSNTLEFHLH--GKGRPTMDWPTRLKIALGFA 348
+ H ++V + L V E+ L + K R +D L++
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 349 KGLAYLHE--DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
L H D ++HRD+K AN+ LD K K+ DFGLA++ + T + +GT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH-DTSFAKAFVGTP 178
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466
Y++PE + EKSD++S G +L EL P F + L I +G
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP------FTAFSQKE--LAGKIREGK 230
Query: 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
F ++ Y+ +E+ ++ + RP + +I+
Sbjct: 231 F-----RRIPYRYS-DELNEII---TRMLNLKDYHRPSVEEILE 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 3e-56
Identities = 69/288 (23%), Positives = 116/288 (40%), Gaps = 29/288 (10%)
Query: 232 YEELAR---ATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEV 287
YE + R D + LG G FG V+K A K + S + + E+
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60
Query: 288 EIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGF 347
+I++ H ++V L+ + + ++ EF ++ + RP + +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQT 119
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFG 407
L YLH+ KIIHRD+KA NIL + K+ADFG++ + + + GT
Sbjct: 120 LDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPY 175
Query: 408 YLAPEYA-----SSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462
++APE K+DV+S G+ L+E+ P E N R LL I
Sbjct: 176 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELNPMRVLLK--I 227
Query: 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
TL P + + + + C+ + R SQ+++
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKK-------CLEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-56
Identities = 65/269 (24%), Positives = 107/269 (39%), Gaps = 30/269 (11%)
Query: 246 NLLGQGGFGYVHKGVLP-NGKEVAIKQLK---AGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG+G FG V+ + +A+K L E + EVEI S + H +++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
GY+ ++ L+ E+ T+ L + D A L+Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCHS---KR 126
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
+IHRDIK N+LL E K+ADFG + A + GT YL PE E
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEGRMHDE 183
Query: 422 KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481
K D++S GV+ E ++G P F + + + F V +
Sbjct: 184 KVDLWSLGVLCYEFLVGKPP------FEANTYQETYKRISRVEFTFPDFVTEGARD---- 233
Query: 482 NEMARMVACAAACVRHSARRRPRISQIVR 510
+ ++H+ +RP + +++
Sbjct: 234 --------LISRLLKHNPSQRPMLREVLE 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-55
Identities = 70/288 (24%), Positives = 116/288 (40%), Gaps = 28/288 (9%)
Query: 233 EELARATDGFSDANL-LGQGGFGYVHKGVL---PNGKEVAIKQLKAGSGQGERV-FQAEV 287
++L D A++ LG G FG V +GV +VAIK LK G+ + + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 288 EIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGF 347
+I+ ++ + ++V L+G MLV E L L GK + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQV 118
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS--DVYTHVSTRVMGT 405
+ G+ YL +HRD+ A N+LL + AK++DFGL+K D Y +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 406 FGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG 465
+ APE + K + +SDV+S+GV + E + + E + IE G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG 228
Query: 466 NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
E + A + C + RP + + +
Sbjct: 229 K---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (476), Expect = 4e-55
Identities = 68/279 (24%), Positives = 110/279 (39%), Gaps = 33/279 (11%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV---FQAEVEIISRVH 294
FSD +G G FG V+ + N + VAIK++ Q EV + ++
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 295 HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354
H + + G Y LV E+ + + K + + G +GLAYL
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYA 414
H +IHRD+KA NILL K+ DFG A + + + +GT ++APE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVI 183
Query: 415 SS---GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471
+ G+ K DV+S G+ +EL P N L + A +
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPP------LFNMNAMSALYHIAQNE------- 230
Query: 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
P L + + V +C++ + RP +++
Sbjct: 231 SPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 4e-55
Identities = 66/297 (22%), Positives = 111/297 (37%), Gaps = 48/297 (16%)
Query: 247 LLGQGGFGYVHKGVLPN------GKEVAIKQLKAGSGQGERV-FQAEVEIISRV-HHKHL 298
+LG G FG V +VA+K LK + ER +E+++++++ H+++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRP---------------------TMDW 337
V+L+G T L+ E+ L +L K + +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 338 PTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYT 396
L A AKG+ +L +HRD+ A N+L+ K+ DFGLA+ + SD
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARP 456
V ++APE G T KSDV+S+G++L E+
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA------ 274
Query: 457 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
NF L+ + + +C +R+RP + L
Sbjct: 275 ---------NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 5e-54
Identities = 64/272 (23%), Positives = 113/272 (41%), Gaps = 26/272 (9%)
Query: 247 LLGQGGFGYVHKGVLPNGKE----VAIKQLKAGSGQGER-VFQAEVEIISRVHHKHLVSL 301
+G+G FG VH+G+ + + VAIK K + R F E + + H H+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
+G T ++ E T L + ++D + + A + LAYL +
Sbjct: 74 IGVITEN-PVWIIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
+HRDI A N+L+ K+ DFGL++ D + +++ ++APE + + T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 422 KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNH 481
SDV+ FGV + E+++ + + IE+G + P
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPM-PPNCPPT--- 237
Query: 482 NEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+ + C + RRPR +++ L
Sbjct: 238 -----LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 6e-54
Identities = 62/287 (21%), Positives = 117/287 (40%), Gaps = 29/287 (10%)
Query: 234 ELARATDGFSDANLLGQGGFGYVHKGV-LPNGKE----VAIKQLK-AGSGQGERVFQAEV 287
+ + T+ F +LG G FG V+KG+ +P G++ VAIK+L+ A S + + E
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 288 EIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGF 347
+++ V + H+ L+G + L+ + + L ++ + L +
Sbjct: 63 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQI 120
Query: 348 AKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTF 406
AKG+ YL +++HRD+ A N+L+ K+ DFGLAK L ++ + +
Sbjct: 121 AKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466
++A E T +SDV+S+GV + EL+ E
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------- 221
Query: 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
++++ + C A RP+ +++
Sbjct: 222 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-52
Identities = 60/275 (21%), Positives = 107/275 (38%), Gaps = 24/275 (8%)
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQL-KAGSGQGERVFQAEVEIISRVHHKH 297
+ + LG+G +G V V + VA+K + + + E+ I ++H++
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
+V G+ G+ + L E+ + L + M P + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMAGVVYLH-- 120
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTRVMGTFGYLAPEYASS 416
I HRDIK N+LLD + K++DFGLA + + ++ GT Y+APE
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 417 GKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475
+ E DV+S G++L ++ G P D + ++ K+
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-------EYSDWKEKKTYLNPWKKI 232
Query: 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
+ +A + + R I I +
Sbjct: 233 DSA--------PLALLHKILVENPSARITIPDIKK 259
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 5e-52
Identities = 70/287 (24%), Positives = 113/287 (39%), Gaps = 40/287 (13%)
Query: 246 NLLGQGGFGYVHKGVLPNG---KEVAIKQLK-AGSGQGERVFQAEVEIISRV-HHKHLVS 300
+++G+G FG V K + + AIK++K S R F E+E++ ++ HH ++++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGK--------------GRPTMDWPTRLKIALG 346
L+G L E+ L L T+ L A
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 347 FAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTF 406
A+G+ YL + + IHRD+ A NIL+ + AK+ADFGL++ T
Sbjct: 136 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPV 190
Query: 407 GYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466
++A E + T SDV+S+GV+L E++ T E L + G
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLPQG- 242
Query: 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
E N + C R RP +QI+ +L
Sbjct: 243 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-52
Identities = 66/289 (22%), Positives = 122/289 (42%), Gaps = 25/289 (8%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGY 304
+GQG G V+ + + G+EVAI+Q+ + + E+ ++ + ++V+ +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
Y G + +V E++ +L + MD + + L +LH + ++IH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 365 RDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSD 424
RDIK+ NILL K+ DFG + + ST V GT ++APE + K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 425 VFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEM 484
++S G+M +E+I G P ++ +N R L +G + KL
Sbjct: 199 IWSLGIMAIEMIEGEPP------YLNENPLR-ALYLIATNGTPELQNPEKLSAI------ 245
Query: 485 ARMVACAAACVRHSARRRPRISQIVRT--LEGDASLADLNEGIRPGQSS 531
C+ +R ++++ L+ L+ L I + +
Sbjct: 246 --FRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA 292
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 9e-51
Identities = 62/275 (22%), Positives = 101/275 (36%), Gaps = 29/275 (10%)
Query: 248 LGQGGFGYVHKGVLP----NGKEVAIKQLK---AGSGQGERVFQAEVEIISRVHHKHLVS 300
LG G FG V +G VA+K LK + F EV + + H++L+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
L G +M V E +L K + T + A+ A+G+ YL
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSL-LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---K 130
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLA--SDVYTHVSTRVMGTFGYLAPEYASSGK 418
+ IHRD+ A N+LL + K+ DFGL + +D + + F + APE +
Sbjct: 131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 190
Query: 419 LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478
+ SD + FGV L E+ + + +L++ ++G
Sbjct: 191 FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEG---------ERLP 235
Query: 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+ + C H RP + L
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 3e-49
Identities = 75/292 (25%), Positives = 114/292 (39%), Gaps = 42/292 (14%)
Query: 246 NLLGQGGFGYVHKGV------LPNGKEVAIKQLKAGSGQGE-RVFQAEVEIISR-VHHKH 297
LG+G FG V + + VA+K LK G+ E R +E++I+ HH +
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 298 LVSLVGYYT-AGSQRMLVCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLK 342
+V+L+G T G M++ EF L +L K + + +
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 343 IALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK-LASDVYTHVSTR 401
+ AKG+ +L K IHRD+ A NILL K K+ DFGLA+ + D
Sbjct: 139 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195
Query: 402 VMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRA 461
++APE T +SDV+SFGV+L E+ E+ R
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRR 249
Query: 462 IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+++G D M C +RP S++V L
Sbjct: 250 LKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 65/286 (22%), Positives = 118/286 (41%), Gaps = 35/286 (12%)
Query: 246 NLLGQGGFGYVHKGVLPN------GKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHKHL 298
LGQG FG V++GV VAIK + + ER+ F E ++ + H+
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 299 VSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGR--------PTMDWPTRLKIALGFAKG 350
V L+G + G +++ E +T L+ +L +++A A G
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 351 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV-YTHVSTRVMGTFGYL 409
+AYL K +HRD+ A N ++ F K+ DFG+ + + Y + + ++
Sbjct: 146 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202
Query: 410 APEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469
+PE G T SDV+SFGV+L E+ + + + R + +G
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVMEGGLLD 255
Query: 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515
D N + C +++ + RP +I+ +++ +
Sbjct: 256 KPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 4e-48
Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 44/298 (14%)
Query: 246 NLLGQGGFGYVHKGVLP--------NGKEVAIKQLKAGSGQGERV-FQAEVEIISRV-HH 295
LG+G FG V +VA+K LK+ + + + +E+E++ + H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRP--------------TMDWPTRL 341
K++++L+G T ++ E+ + L +L + P + +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 342 KIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTR 401
A A+G+ YL K IHRD+ A N+L+ K+ADFGLA+ + + T
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 402 VM-GTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR 460
++APE T +SDV+SFGV+L E+ E L +
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-------LFK 248
Query: 461 AIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDASL 518
+++G+ + N + C +RP Q+V L+ +L
Sbjct: 249 LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 167 bits (423), Expect = 3e-47
Identities = 61/265 (23%), Positives = 101/265 (38%), Gaps = 23/265 (8%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG G FG VH+ G A K + + + E++ +S + H LV+L +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
++ +++ EF++ L + + M ++ KGL ++HE+ +H
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHENN---YVHL 148
Query: 366 DIKAANILLDFKF--EAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKS 423
D+K NI+ K E K+ DFGL + T GT + APE A + +
Sbjct: 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYYT 206
Query: 424 DVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483
D++S GV+ L+ G P F +N L N D N D + +
Sbjct: 207 DMWSVGVLSYILLSGLSP------FGGENDDETLRNVKSCDWNMDDSAFSGISED----- 255
Query: 484 MARMVACAAACVRHSARRRPRISQI 508
+ R I Q
Sbjct: 256 ---GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 6e-46
Identities = 54/246 (21%), Positives = 95/246 (38%), Gaps = 16/246 (6%)
Query: 237 RATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLK---AGSGQGERVFQAEVEIISR 292
+ + F +LG+G F V L +E AIK L+ E +++SR
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 293 VHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLA 352
+ H V L + + + + L ++ G A+ ++
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-----TRFYTAEIVS 119
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS-DVYTHVSTRVMGTFGYLAP 411
L IIHRD+K NILL+ ++ DFG AK+ S + + +GT Y++P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 412 EYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471
E + + SD+++ G ++ +L+ G P F N + +F
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPP------FRAGNEYLIFQKIIKLEYDFPEKF 233
Query: 472 DPKLHN 477
PK +
Sbjct: 234 FPKARD 239
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 163 bits (414), Expect = 8e-46
Identities = 58/267 (21%), Positives = 104/267 (38%), Gaps = 23/267 (8%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG G FG VH+ V G+ K + + + E+ I++++HH L++L +
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
+ +L+ EF++ L + + M + +GL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE---HSIVHL 151
Query: 366 DIKAANILLDFKF--EAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKS 423
DIK NI+ + K K+ DFGLA + + T + APE + +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 424 DVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483
D+++ GV+ L+ G P F ++ L N D FD + E
Sbjct: 210 DMWAIGVLGYVLLSGLSP------FAGEDDLETLQNVKRCDWEFDEDAFSSVSPE----- 258
Query: 484 MARMVACAAACVRHSARRRPRISQIVR 510
++ R+R + +
Sbjct: 259 ---AKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 1e-44
Identities = 61/270 (22%), Positives = 110/270 (40%), Gaps = 26/270 (9%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQG-ERVFQAEVEIISRVHHKHLVSLVG 303
++LG G F V K VAIK + + +G E + E+ ++ ++ H ++V+L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
Y +G L+ + V+ L + KG ++ + YLH+ I+
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVKYLHDLG---IV 129
Query: 364 HRDIKAANILLDFKFE---AKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
HRD+K N+L E ++DFGL+K+ V + GT GY+APE + +
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 421 EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYN 480
+ D +S GV+ L+ G P F ++N A+ + FD+ + +
Sbjct: 188 KAVDCWSIGVIAYILLCGYPP------FYDENDAKLFEQILKAEYEFDSPYWDDISDS-- 239
Query: 481 HNEMARMVACAAACVRHSARRRPRISQIVR 510
+ +R Q ++
Sbjct: 240 ------AKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-44
Identities = 48/267 (17%), Positives = 107/267 (40%), Gaps = 24/267 (8%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
LG+G FG VH+ V + K K +K G + + + E+ I++ H++++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 306 TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHR 365
+ + +++ EF++ + ++ ++ + + L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS---HNIGHF 126
Query: 366 DIKAANILLDFKFEA--KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKS 423
DI+ NI+ + + K+ +FG A+ + Y APE ++ +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 424 DVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNE 483
D++S G ++ L+ G P F+ + + + N + FD ++ E
Sbjct: 185 DMWSLGTLVYVLLSGINP------FLAETNQQIIENIMNAEYTFDEEAFKEISIE----- 233
Query: 484 MARMVACAAACVRHSARRRPRISQIVR 510
+ + + R S+ ++
Sbjct: 234 ---AMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 160 bits (405), Expect = 2e-44
Identities = 65/232 (28%), Positives = 99/232 (42%), Gaps = 16/232 (6%)
Query: 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLK---AGSGQGERVFQAEVEIISRVH- 294
+ FS ++G+GGFG V+ GK A+K L QGE + E ++S V
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 295 --HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLA 352
+V + + + + + + L +HL G A GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLE 121
Query: 353 YLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE 412
++H +++RD+K ANILLD +++D GLA S H +GT GY+APE
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPE 175
Query: 413 YASSGK-LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463
G +D FS G ML +L+ G P T + + R L A+E
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 227
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-44
Identities = 60/293 (20%), Positives = 108/293 (36%), Gaps = 27/293 (9%)
Query: 237 RATDGFSDANLLGQGGFGYVHKG--VLPNGKEVAIKQLKAGSGQGERVFQAEVEI----- 289
RA + +G+G +G V K + G+ VA+K+++ +G+ E+
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 290 ISRVHHKHLVSLVGYYTAGSQR-----MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIA 344
+ H ++V L T LV E V + + P + T +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMM 122
Query: 345 LGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMG 404
+GL +LH +++HRD+K NIL+ + K+ADFGLA++ S T V+
Sbjct: 123 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV 177
Query: 405 TFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPV-DSTHTFMEDNLARPLLNRAIE 463
T Y APE D++S G + E+ S+ + + E
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 464 DGNFDTLVDPKLHNEYNHNEMARMVACAAA--------CVRHSARRRPRISQI 508
D D + + + + + + V C+ + +R
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (395), Expect = 5e-44
Identities = 71/282 (25%), Positives = 121/282 (42%), Gaps = 29/282 (10%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV---FQAEVEIISRVH 294
+D + +LG GG VH L ++VA+K L+A + F+ E + + ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 295 HKHLVSLVGYY----TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKG 350
H +V++ AG +V E+V TL +H +G M +++ +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 351 LAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV--STRVMGTFGY 408
L + H+ IIHRD+K ANI++ KV DFG+A+ +D V + V+GT Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 409 LAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468
L+PE A + +SDV+S G +L E++ G P F D+ ED
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP------FTGDSPVSVAYQHVREDPIPP 234
Query: 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
+ L + + A + + R + + +R
Sbjct: 235 SARHEGLSAD--------LDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 156 bits (395), Expect = 6e-44
Identities = 59/286 (20%), Positives = 102/286 (35%), Gaps = 38/286 (13%)
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSG---------QGERVFQAEVEI 289
+ + +LG+G V + + P KE A+K + G + EV+I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 290 ISRVH-HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFA 348
+ +V H +++ L Y + LV + + L +L K + KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALL 120
Query: 349 KGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGY 408
+ + LH+ I+HRD+K NILLD K+ DFG + V GT Y
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSY 175
Query: 409 LAPEYASSG------KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462
LAPE ++ D++S GV++ L+ G P F L
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP------FWHRKQMLMLRMIMS 229
Query: 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQI 508
+ F + + + + + ++R +
Sbjct: 230 GNYQFGSPEWDDYSDT--------VKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 49/246 (19%), Positives = 101/246 (41%), Gaps = 13/246 (5%)
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHK 296
+ F +G+G +G V+K G+ VA+K+++ + E+ ++ ++H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 297 HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE 356
++V L+ ++ LV EF+ + +F + + P +GLA+ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKF-MDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS 416
++HRD+K N+L++ + K+ADFGLA+ + V+ +
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177
Query: 417 GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476
+ D++S G + E++ F D+ L G D +V P +
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRAL------FPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 477 NEYNHN 482
+ ++
Sbjct: 232 SMPDYK 237
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (389), Expect = 5e-43
Identities = 52/278 (18%), Positives = 94/278 (33%), Gaps = 28/278 (10%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYY 305
+G G FG ++ G + G+EVAIK + + E +I + + + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 71
Query: 306 -TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
G ++V E + + + + T L +A + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSRK--FSLKTVLLLADQMISRIEYIHS---KNFIH 126
Query: 365 RDIKAANIL---LDFKFEAKVADFGLAKLASDVYTHV------STRVMGTFGYLAPEYAS 415
RD+K N L + DFGLAK D TH + + GT Y +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475
+ + + D+ S G +L+ +G P A + ++
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLK-------AATKRQKYERISEKKMSTPIEV 239
Query: 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+ +E A + C +P S + +
Sbjct: 240 LCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 6e-43
Identities = 58/236 (24%), Positives = 92/236 (38%), Gaps = 19/236 (8%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLK---AGSGQGERVFQAEVEIISRVHHKHLVSL 301
LG G FG VH NG+ A+K LK + E ++S V H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 302 VGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
G + Q ++ +++ L L R + L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALEYLHSKD 124
Query: 362 IIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTE 421
II+RD+K NILLD K+ DFG AK DV + GT Y+APE S+ +
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVSTKPYNK 180
Query: 422 KSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477
D +SFG+++ E++ G P F + N + + F + + +
Sbjct: 181 SIDWWSFGILIYEMLAGYTP------FYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (386), Expect = 1e-42
Identities = 47/280 (16%), Positives = 90/280 (32%), Gaps = 30/280 (10%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGY 304
+G+G FG + +G L N ++VAIK S + + E + + ++ +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYF 69
Query: 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIH 364
G +LV + + +LE L GR T A + +HE +++
Sbjct: 70 GQEGLHNVLVIDLL-GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSIHE---KSLVY 124
Query: 365 RDIKAANILLDFKFE-----AKVADFGLAKLASD------VYTHVSTRVMGTFGYLAPEY 413
RDIK N L+ V DFG+ K D + + GT Y++
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 414 ASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473
+ + + D+ + G + + + G + A + G
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRG-------SLPWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513
+ E + + + P +
Sbjct: 238 RELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFS 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 151 bits (381), Expect = 5e-42
Identities = 49/278 (17%), Positives = 106/278 (38%), Gaps = 18/278 (6%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLK--AGSGQGERVFQAEVEIISRVHHKHLVSLVG 303
+G+G +G V+K G+ A+K+++ E+ I+ + H ++V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 304 YYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKII 363
+ +LV E + + + +G ++ T L G+AY H+ +++
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 364 HRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKS 423
HRD+K N+L++ + E K+ADFGLA+ + ++ + S K +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 424 DVFSFGVMLLELIIGCRPVDSTHT-----------FMEDNLARPLLNRAIEDGNFDTLVD 472
D++S G + E++ G ++ P + + T+ +
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
P + + + ++ +R Q +
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 5e-41
Identities = 60/273 (21%), Positives = 103/273 (37%), Gaps = 29/273 (10%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGY 304
+LG G G V + ++ A+K L+ + EVE+ R H+V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 305 Y----TAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
Y ++V E + L + +G +I + + YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---I 130
Query: 361 KIIHRDIKAANILLDFKFE---AKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
I HRD+K N+L K K+ DFG AK + + + T Y+APE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPE 188
Query: 418 KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477
K + D++S GV++ L+ G P S H P + I G ++ P
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTRIRMGQYEF---PNPEW 241
Query: 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
E+ ++ ++ +R I++ +
Sbjct: 242 SEVSEEVKMLIRN---LLKTEPTQRMTITEFMN 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 9e-41
Identities = 59/237 (24%), Positives = 94/237 (39%), Gaps = 17/237 (7%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGE---RVFQAEVEIISRV-HHKHLVS 300
+LG+G FG V + AIK LK + E ++S H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 301 LVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHP 360
+ + V E++ L +H+ + D A GL +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHS---K 122
Query: 361 KIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLT 420
I++RD+K NILLD K+ADFG+ K +T GT Y+APE K
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQKYN 181
Query: 421 EKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477
D +SFGV+L E++IG P F + + +++ + ++ + +
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSP------FHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 7e-40
Identities = 67/294 (22%), Positives = 111/294 (37%), Gaps = 35/294 (11%)
Query: 228 STFTYEELARATDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV---- 282
+ F E + D + LG G F V K G + A K +K + R
Sbjct: 1 TVFRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 57
Query: 283 --FQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTR 340
+ EV I+ + H ++++L Y + +L+ E V L L K T + T
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 341 LKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD----FKFEAKVADFGLAKLASDVYT 396
+ L ++ +I H D+K NI+L K K+ DFGLA
Sbjct: 118 F-----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--G 170
Query: 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARP 456
+ + GT ++APE + L ++D++S GV+ L+ G P F+ D
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP------FLGDTKQET 224
Query: 457 LLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
L N + N + +EY N A + ++R I ++
Sbjct: 225 LAN--VSAVN------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-39
Identities = 54/293 (18%), Positives = 114/293 (38%), Gaps = 26/293 (8%)
Query: 239 TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV-FQAEVEIISRVHHK 296
+++ + +G+G +G V N VAIK++ Q E++I+ R H+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 297 HLVSLVGYYTAGSQRMLVCEFVT---SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAY 353
+++ + A + + ++ + L + +GL Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124
Query: 354 LHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD--VYTHVSTRVMGTFGYLAP 411
+H ++HRD+K +N+LL+ + K+ DFGLA++A +T T + T Y AP
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 412 EYASSGKL-TEKSDVFSFGVMLLELIIGCRP-------------VDSTHTFMEDNLARPL 457
E + K T+ D++S G +L E++ + + +++L +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 458 LNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510
+A + N N ++ + + + +R + Q +
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 18/221 (8%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLK------AGSGQGERVFQAEVEIISRVHHKH-- 297
LLG GGFG V+ G+ + + VAIK ++ G EV ++ +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 298 LVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
++ L+ ++ +L+ E F + + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHN- 128
Query: 358 CHPKIIHRDIKAANILLDF-KFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS 416
++HRDIK NIL+D + E K+ DFG L D V T GT Y PE+
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRY 183
Query: 417 GKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARP 456
+ + V+S G++L +++ G P + + +
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR 224
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 242 FSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVS 300
++D ++G G FG V++ L +G+ VAIK++ Q +R E++I+ ++ H ++V
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 301 LVGYYTAGSQRM------LVCEFVTSNTLEFHLH-GKGRPTMDWPTRLKIALGFAKGLAY 353
L ++ + ++ LV ++V H + + T+ + LAY
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 354 LHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPE 412
+H I HRDIK N+LLD K+ DFG AK + + +
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSYICSRYYRAPEL 193
Query: 413 YASSGKLTEKSDVFSFGVMLLELIIGCRP 441
+ T DV+S G +L EL++G
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 246 NLLGQGGFGYVHKGVLPN-GKEVAIKQLKAGSGQG-----ERVFQAEVEIISRVHHKHLV 299
+ LG+G F V+K N + VAIK++K G R E++++ + H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 300 SLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCH 359
L+ + S LV +F+ ++ + L +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 360 PKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL 419
I+HRD+K N+LLD K+ADFGLAK + +V T Y APE ++
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARM 177
Query: 420 -TEKSDVFSFGVMLLELIIGCRP 441
D+++ G +L EL++
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPF 200
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-37
Identities = 42/208 (20%), Positives = 82/208 (39%), Gaps = 8/208 (3%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLV 302
+G+G +G V K + VA+K+++ E+ ++ + HK++V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 303 GYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKI 362
+ + LV EF + ++ G + + L L +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGFCHSRNV 122
Query: 363 IHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEK 422
+HRD+K N+L++ E K+A+FGLA+ S V+ + + +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182
Query: 423 SDVFSFGVMLLELIIGCRPVDSTHTFME 450
D++S G + EL RP+ + +
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 5e-37
Identities = 56/242 (23%), Positives = 90/242 (37%), Gaps = 16/242 (6%)
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLK---AGSGQGERVFQAEVEIISRVHH 295
+ F LLG+G FG V G+ A+K L+ + E ++ H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH 355
L +L + + V E+ L FHL + T + A+ ++ L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSALE 119
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS 415
+++RDIK N++LD K+ DFGL K GT YLAPE
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPEVLE 178
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475
D + GV++ E++ G P F + R +E+ F + P+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP------FYNQDHERLFELILMEEIRFPRTLSPEA 232
Query: 476 HN 477
+
Sbjct: 233 KS 234
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 138 bits (349), Expect = 6e-37
Identities = 61/242 (25%), Positives = 88/242 (36%), Gaps = 19/242 (7%)
Query: 240 DGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERV---FQAEVEIISRVHH 295
D F LG G FG V +G A+K L + E I+ V+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH 355
LV L + S +V E+V + HL GR P A YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLH 158
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS 415
+I+RD+K N+L+D + +V DFG AK + + GT LAPE
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIIL 211
Query: 416 SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475
S + D ++ GV++ E+ G P F D + F + L
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPP------FFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 476 HN 477
+
Sbjct: 266 KD 267
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 9e-36
Identities = 56/254 (22%), Positives = 103/254 (40%), Gaps = 26/254 (10%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQG--ERVFQAEVEIISRVHHKHLVSLV 302
+GQG FG V K G++VA+K++ + + E++I+ + H+++V+L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 303 GYYTAGSQRM--------LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYL 354
+ LV +F + + + T+ R+ L L L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGL 130
Query: 355 HEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK---LASDVYTHVSTRVMGTFGYLAP 411
+ KI+HRD+KAAN+L+ K+ADFGLA+ LA + + T + T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 412 EYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470
E + D++ G ++ E+ + L + G+
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPI------MQGNTEQHQLALISQLCGSITPE 244
Query: 471 VDPKLHNEYNHNEM 484
V P + N + ++
Sbjct: 245 VWPNVDNYELYEKL 258
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-35
Identities = 57/274 (20%), Positives = 104/274 (37%), Gaps = 29/274 (10%)
Query: 227 KSTFTYEELARATDGFSDA----NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAG--SGQG 279
+S F +E+ + +G G +G V V G +VAIK+L S
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 280 ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR------MLVCEFVTSNTLEFHLHGKGRP 333
+ E+ ++ + H++++ L+ +T LV F+ ++ + H K
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--- 117
Query: 334 TMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393
+ + KGL Y+H HRD+K N+ ++ E K+ DFGLA+ A
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL 453
T V+ + + + T+ D++S G ++ E+I G F +
Sbjct: 174 EMT---GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL------FKGSDH 224
Query: 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARM 487
L G +L ++ N M +
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-33
Identities = 53/207 (25%), Positives = 86/207 (41%), Gaps = 16/207 (7%)
Query: 246 NLLGQGGFGYVHKGVL----PNGKEVAIKQLK----AGSGQGERVFQAEVEIISRV-HHK 296
+LG G +G V GK A+K LK + + E +++ +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 297 HLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHE 356
LV+L + ++ L+ +++ L HL + R T + + + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEIVLALEH 144
Query: 357 DCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASS 416
II+RDIK NILLD + DFGL+K T + GT Y+AP+
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 417 GK--LTEKSDVFSFGVMLLELIIGCRP 441
G + D +S GV++ EL+ G P
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 49/204 (24%), Positives = 85/204 (41%), Gaps = 19/204 (9%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVG 303
+G G G V + VAIK+L + + E+ ++ V+HK+++SL+
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 304 YYTA------GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHED 357
+T LV E + +N + +D + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQME-----LDHERMSYLLYQMLCGIKHLHSA 138
Query: 358 CHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSG 417
IHRD+K +NI++ K+ DFGLA+ A + + T + T Y APE
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGM 193
Query: 418 KLTEKSDVFSFGVMLLELIIGCRP 441
E D++S G ++ E++
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 114 bits (286), Expect = 1e-28
Identities = 43/211 (20%), Positives = 86/211 (40%), Gaps = 19/211 (9%)
Query: 246 NLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVG 303
LG+G + V + + + N ++V +K LK ++ + E++I+ + ++++L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97
Query: 304 YYTAGSQRM--LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPK 361
R LV E V + + T+ K L Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MG 149
Query: 362 IIHRDIKAANILLDFKF-EAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKL- 419
I+HRD+K N+++D + + ++ D+GLA+ + + + + PE ++
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMY 207
Query: 420 TEKSDVFSFGVMLLELIIGCRPVDSTHTFME 450
D++S G ML +I P H +
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (284), Expect = 3e-28
Identities = 48/224 (21%), Positives = 85/224 (37%), Gaps = 22/224 (9%)
Query: 247 LLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH---------- 295
LG G F V + N VA+K ++ E + E++++ RV+
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78
Query: 296 -KHLVSLVGYYTA----GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKG 350
H++ L+ ++ G ++V E + N L + R + +I+ G
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRG-IPLIYVKQISKQLLLG 137
Query: 351 LAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLAKLA-SDVYTHVSTRVMGTFGY 408
L Y+H IIH DIK N+L++ + +A L + Y T + T Y
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 409 LAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDN 452
+PE +D++S ++ ELI G +
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (282), Expect = 5e-28
Identities = 48/269 (17%), Positives = 97/269 (36%), Gaps = 25/269 (9%)
Query: 227 KSTFTYEELARA----TDGFSDANLLGQGGFGYVHKGV-LPNGKEVAIKQLKAGSGQGER 281
+ TF +EL + + + + + +G G +G V G VA+K+L
Sbjct: 1 RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 282 V--FQAEVEIISRVHHKHLVSLVGYYTAGSQRM----LVCEFVTSNTLEFHLHGKGRPTM 335
E+ ++ + H++++ L+ +T + ++ + +
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--L 118
Query: 336 DWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395
+ +GL Y+H HRD+K +N+ ++ E K+ DFGLA+ D
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175
Query: 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR 455
T V + + + D++S G ++ EL+ G F +
Sbjct: 176 T---GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL------FPGTDHID 226
Query: 456 PLLNRAIEDGNFDTLVDPKLHNEYNHNEM 484
L G + K+ +E N +
Sbjct: 227 QLKLILRLVGTPGAELLKKISSESARNYI 255
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.1 bits (233), Expect = 9e-23
Identities = 32/204 (15%), Positives = 60/204 (29%), Gaps = 33/204 (16%)
Query: 246 NLLGQGGFGYVHKGVLPNGKEVAIKQLKAGS----------GQGERVFQAEVEIISRVHH 295
L+G+G V E +K K G G+ F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 296 KHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLH 355
+ L L G V + + L + K + ++ + +A +
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 356 EDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYAS 415
I+H D+ N+L+ + + DF + V G L + +
Sbjct: 121 HRG---IVHGDLSQYNVLVS-EEGIWIIDFPQS---------VEVGEEGWREILERDVRN 167
Query: 416 -----SGKLTEKSDVFSFGVMLLE 434
S + D+ S +L+
Sbjct: 168 IITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 608 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.22 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.74 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.13 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.81 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=434.94 Aligned_cols=255 Identities=29% Similarity=0.417 Sum_probs=200.3
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...++||+|+||.||+|.+.+++.||||+++... ...+.|.+|++++++++|||||+++|+|...+..+|||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4678889999999999999999889999999998644 345679999999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+|+|.+++.... ..++|..++.|+.|||+||.|||+. +|+||||||+|||||.++.+||+|||+++..........
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 159 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 159 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence 999999987653 3689999999999999999999998 899999999999999999999999999987765444444
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
....||..|||||++.+..++.++|||||||+||||+|+..|+..... ... ++. .+..+.. ...+
T Consensus 160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~----~~~-~i~~~~~--~~~p------ 224 (263)
T d1sm2a_ 160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSE----VVE-DISTGFR--LYKP------ 224 (263)
T ss_dssp -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHH----HHH-HHHHTCC--CCCC------
T ss_pred cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHH----HHH-HHHhcCC--CCCc------
Confidence 456799999999999999999999999999999999996555432221 111 122 2222211 1111
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.....++.+++.+||+.||++||+|+||+++|+..
T Consensus 225 -~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 225 -RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 12235678999999999999999999999999853
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-54 Score=439.49 Aligned_cols=257 Identities=26% Similarity=0.328 Sum_probs=215.7
Q ss_pred hcCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|...++||+|+||.||+|++. +|+.||||+++.+.. ..+.|.+|+++|++++|||||+++|+|.+++..+|||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 356788899999999999999964 588999999976543 456789999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
|++|+|.+++.......++|..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++........
T Consensus 95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 9999999999877667899999999999999999999998 9999999999999999999999999999987665444
Q ss_pred eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 398 VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
......|++.|||||++.++.|+.++|||||||+||||++|..|+..... .. .+...+..+.. .
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~-----~~~~~i~~~~~---------~ 235 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LS-----QVYELLEKDYR---------M 235 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HH-----HHHHHHHTTCC---------C
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch--HH-----HHHHHHhcCCC---------C
Confidence 45556789999999999999999999999999999999998777643222 11 11222222211 1
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..+......+.+|+..||+.||++||+|.||++.|+..
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11222345688999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-54 Score=434.98 Aligned_cols=254 Identities=29% Similarity=0.416 Sum_probs=210.1
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...++||+|+||.||+|.+.+++.||||+++... ...+.|.+|+++|++++|||||+++|+|.+ +..+|||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 5688889999999999999999888999999997654 345679999999999999999999998865 56799999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+|+|.+++.......++|..+++|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++..........
T Consensus 91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 99999988765545699999999999999999999998 899999999999999999999999999998765444444
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
....||+.|||||++..+.++.++|||||||+||||+||..|+...... . .++ ..+..+.... .
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~----~~~-~~i~~~~~~~-----~---- 231 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--P----EVI-QNLERGYRMV-----R---- 231 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--H----HHH-HHHHTTCCCC-----C----
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--H----HHH-HHHHhcCCCC-----C----
Confidence 5567899999999999999999999999999999999976665432221 1 111 2223221111 1
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
+......+.+|+.+||+.||++||+|.||++.|+.
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 11223467889999999999999999999999874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=426.21 Aligned_cols=258 Identities=29% Similarity=0.460 Sum_probs=203.9
Q ss_pred hcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...++||+|+||.||+|++. ..||||+++.. .....+.|.+|+.+|++++|||||+++|++.+ +.++||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367888999999999999999863 36999999754 34456789999999999999999999999864 56899999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc-
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY- 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~- 395 (608)
||++|+|.++|+.... .++|..++.|+.||++||+|||++ +||||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~~~-~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSCC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 9999999999976443 599999999999999999999998 89999999999999999999999999998765422
Q ss_pred cceeeeeecccCccChhhhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC
Q 046502 396 THVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD 472 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d 472 (608)
........||+.|||||++.. +.|+.++|||||||+||||+||+.||...... ..+...+..+.....
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~~p~-- 230 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGYLSPD-- 230 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTSCCCC--
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCCCCc--
Confidence 223455679999999999964 35899999999999999999999999754321 112222222322111
Q ss_pred ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 473 PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 473 ~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
+ ..........+.+|+.+||+.||++||+|.||+++|+..
T Consensus 231 --~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 231 --L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp --G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 112223345788899999999999999999999999753
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-53 Score=436.47 Aligned_cols=266 Identities=29% Similarity=0.448 Sum_probs=204.6
Q ss_pred ccCHHHHHHHhcCC---------CcCCccccCCceEEEEEEecC-C---cEEEEEEcccC-CchhHHHHHHHHHHHHhcC
Q 046502 229 TFTYEELARATDGF---------SDANLLGQGGFGYVHKGVLPN-G---KEVAIKQLKAG-SGQGERVFQAEVEIISRVH 294 (608)
Q Consensus 229 ~~~~~el~~~~~~f---------~~~~~LG~G~fg~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~ 294 (608)
.|+|+++.+++.+| ...++||+|+||.||+|.+.. | ..||||++... .....+.|.+|+++|++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 46677777766544 446789999999999999642 3 25899998754 3344567999999999999
Q ss_pred CCCccceeeEEEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEE
Q 046502 295 HKHLVSLVGYYTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILL 374 (608)
Q Consensus 295 Hpniv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl 374 (608)
|||||+++|+|.+++..++|||||++|+|.+++..... .++|.+++.|+.||++||.|||+. +|+||||||+||||
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 99999999999999999999999999999998876443 699999999999999999999998 99999999999999
Q ss_pred ccCCceEEEEeeccccccCcccce----eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccc
Q 046502 375 DFKFEAKVADFGLAKLASDVYTHV----STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFM 449 (608)
Q Consensus 375 ~~~~~~kl~DFGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~ 449 (608)
+.++.+||+|||+++......... .....||+.|||||++.++.++.++|||||||+||||+| |+.||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-- 239 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-- 239 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--
Confidence 999999999999998765432211 122457899999999999999999999999999999998 8999865432
Q ss_pred cchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 450 EDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 450 ~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. .++.. +..+.. ...+.+....+.+|+.+||+.||++||+|.||++.|+..
T Consensus 240 -~----~~~~~-i~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 240 -Q----DVINA-IEQDYR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -H----HHHHH-HHTTCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -H----HHHHH-HHcCCC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 12222 222211 111223445688899999999999999999999999754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=416.08 Aligned_cols=253 Identities=25% Similarity=0.384 Sum_probs=214.1
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...++||+|+||+||+|++.+++.||||+++.... ..+.|.+|+.++++++|||||+++|+|.+.+..++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57899999999999999999998888999999986543 45679999999999999999999999999999999999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+|+|.+++..... .+.|..+++|+.|+++||.|||+. +|+|||||++||||+.++.+||+|||+++..........
T Consensus 83 ~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 158 (258)
T d1k2pa_ 83 NGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 158 (258)
T ss_dssp TEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred CCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence 9999998765443 689999999999999999999998 999999999999999999999999999987665444444
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
....||..|+|||++....++.|+|||||||++|||+| |+.||..... .. +...+..+.. +..+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~-----~~~~i~~~~~--~~~p----- 223 (258)
T d1k2pa_ 159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SE-----TAEHIAQGLR--LYRP----- 223 (258)
T ss_dssp CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HH-----HHHHHHTTCC--CCCC-----
T ss_pred cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HH-----HHHHHHhCCC--CCCc-----
Confidence 45678999999999999999999999999999999998 8989875432 11 1222333321 1111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
......+.+|+.+||+.||++||+|.||+++|..
T Consensus 224 --~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 --HLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1223568899999999999999999999999863
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=421.87 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=210.3
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
++|...++||+|+||.||+|.. .+|+.||||+++.......+.+.+|+++|++++|||||+++++|.+.+..|||||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4699999999999999999995 569999999997665556678999999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++|+|.+++..+ .+++..++.|+.||+.||.|||++ +||||||||+||||+.++++||+|||+++....... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 999999988754 489999999999999999999998 999999999999999999999999999987654322 2
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCc
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNE 478 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~ 478 (608)
.....||+.|||||++.++.++.++|||||||+||||++|+.||...... ..+......+.....
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~~~~~~-------- 237 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPELQ-------- 237 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHCSCCCS--------
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCCCCCCC--------
Confidence 34567999999999999999999999999999999999999999654321 112222233322111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 479 YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 479 ~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+......+.+|+.+||+.||++||++.|++++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223567889999999999999999999863
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=423.90 Aligned_cols=253 Identities=24% Similarity=0.321 Sum_probs=203.8
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|+..++||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35789999999999999999996 568999999997543 2334568999999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc-
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY- 395 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~- 395 (608)
||++|+|.++|.... .+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999986543 599999999999999999999998 99999999999999999999999999998765332
Q ss_pred cceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.......+||+.|||||++.+..+ +.++|||||||+||||++|+.||....... . ..............
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~----~~~~~~~~~~~~~~---- 228 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--Q----EYSDWKEKKTYLNP---- 228 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--H----HHHHHHTTCTTSTT----
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--H----HHHHHhcCCCCCCc----
Confidence 233455789999999999988776 578999999999999999999997543211 0 11111111111100
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+|+.+||+.||++||++.||+++
T Consensus 229 -----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 229 -----WKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11123456789999999999999999999753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=415.91 Aligned_cols=245 Identities=27% Similarity=0.418 Sum_probs=206.4
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5688999999999999999996 46899999998643 2233567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|||++|+|.+++...+ .+++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999997654 599999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
......||+.|||||++.+..++.++|||||||+||||++|+.||..... . ..+ ..+..+.+. +
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~----~~~-~~i~~~~~~------~ 223 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---Q----ETY-KRISRVEFT------F 223 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---H----HHH-HHHHTTCCC------C
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH---H----HHH-HHHHcCCCC------C
Confidence 23346799999999999999999999999999999999999999975432 1 112 222223221 1
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
+......+.+|+.+||+.||++||++.||++
T Consensus 224 ----p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 ----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1122346788999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=425.48 Aligned_cols=256 Identities=30% Similarity=0.429 Sum_probs=205.1
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeecc
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVT 319 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~ 319 (608)
++|...+.||+|+||.||+|++.+++.||||+++... ...+.|.+|+.+|++++|+|||+++|+|.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 5789999999999999999999888899999997654 345679999999999999999999999854 56899999999
Q ss_pred CCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccccee
Q 046502 320 SNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHVS 399 (608)
Q Consensus 320 ~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 399 (608)
+|+|..++.......++|..++.|+.||+.||.|||+. +|+||||||+|||||.++.+||+|||+++..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 99999988775555699999999999999999999998 899999999999999999999999999987765444444
Q ss_pred eeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccCcC
Q 046502 400 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEY 479 (608)
Q Consensus 400 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~ 479 (608)
....||+.|+|||++..+.++.++|||||||+||||++|..|+..... ...++.. +..+.. ...
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~------~~~~~~~-i~~~~~---------~~~ 235 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQ-VERGYR---------MPC 235 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHH-HHTTCC---------CCC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC------HHHHHHH-HHhcCC---------CCC
Confidence 556799999999999999999999999999999999998777643322 1112222 222211 111
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 480 NHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 480 ~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
+.....++.+++.+||+.||++||+|.+|+.+|+...
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 2223456889999999999999999999999998643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=422.92 Aligned_cols=257 Identities=27% Similarity=0.404 Sum_probs=201.5
Q ss_pred cCCCcCCccccCCceEEEEEEecCC-----cEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNG-----KEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g-----~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
..|...++||+|+||.||+|.+.+. ..||||+++.... .....|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999986542 3699999975533 334578999999999999999999999999999999
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
||||+.+++|.+++..... .++|..+++|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT-CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhcccc-cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 9999999999988776543 699999999999999999999998 899999999999999999999999999987654
Q ss_pred ccc--ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
... .......||+.|||||++.++.++.++|||||||+||||++|..|+..... .. .++ ..+..+.-
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~----~~~-~~i~~~~~---- 231 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NH----EVM-KAINDGFR---- 231 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HH----HHH-HHHHTTCC----
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC--HH----HHH-HHHhccCC----
Confidence 322 223345689999999999999999999999999999999997666543222 11 112 22333321
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
...+.+....+.+|+.+||+.||++||+|.||+++|+...
T Consensus 232 -----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 232 -----LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp -----CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -----CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 1122234467889999999999999999999999998643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-51 Score=417.15 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=206.3
Q ss_pred cCCCcCCc-cccCCceEEEEEEec---CCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANL-LGQGGFGYVHKGVLP---NGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~-LG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++ ||+|+||.||+|.+. ++..||||+++.... ...+.|.+|+++|++++|||||+++|+|.. +..|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45566664 999999999999753 355799999976543 345779999999999999999999999865 568999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
||||++|+|.+++.... ..++|..+++|+.||++||.|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999886543 3699999999999999999999998 9999999999999999999999999999876543
Q ss_pred cc--ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 395 YT--HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 395 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
.. .......||+.|||||++..+.++.++|||||||+||||+| |+.||..... . . +...+..+....+
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~----~-~~~~i~~~~~~~~- 233 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---P----E-VMAFIEQGKRMEC- 233 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---H----H-HHHHHHTTCCCCC-
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---H----H-HHHHHHcCCCCCC-
Confidence 22 22234568999999999999999999999999999999998 9999975432 1 1 1223333432211
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
+......+.+|+.+||+.||++||+|.+|++.|+.
T Consensus 234 --------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 234 --------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp --------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred --------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 12233567899999999999999999999999874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-52 Score=418.91 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=196.5
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEe--CCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTA--GSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~--~~~~~lV 314 (608)
++|...+.||+|+||.||+|+. .+|+.||||+++... ....+.|.+|+++|++++|||||+++++|.+ ++.+|||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6789999999999999999985 568999999987543 3344678999999999999999999999865 4568999
Q ss_pred EeeccCCcHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 315 CEFVTSNTLEFHLHGK--GRPTMDWPTRLKIALGFAKGLAYLHEDC--HPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~ia~~ia~~L~yLH~~~--~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
||||++|+|.+++... ....+++..++.|+.||+.||.|||+.+ ..+||||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 2346999999999999999999999872 12499999999999999999999999999987
Q ss_pred ccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL 470 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 470 (608)
...... ......||+.|||||++.+..|+.++|||||||+||||++|+.||..... . .+...+..+.+..+
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~-----~~~~~i~~~~~~~~ 234 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---K-----ELAGKIREGKFRRI 234 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---H-----HHHHHHHHTCCCCC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH---H-----HHHHHHHcCCCCCC
Confidence 654322 23456899999999999999999999999999999999999999975332 1 12223344444322
Q ss_pred cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+ ...+.+|+.+||+.||++||++.||+++
T Consensus 235 -----~~~~----s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 235 -----PYRY----SDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -----CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----Cccc----CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1222 3467889999999999999999999853
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=419.13 Aligned_cols=252 Identities=23% Similarity=0.336 Sum_probs=208.1
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+.|...+.||+|+||.||+|+. .+|+.||||+++.......+.|.+|+++|++++|||||+++++|.+.+..+||||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688899999999999999995 568999999998766666678899999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++|+|.+++..... .+++..+..|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++....... .
T Consensus 92 ~~g~L~~~~~~~~~-~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~ 166 (288)
T d2jfla1 92 AGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 166 (288)
T ss_dssp TTEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-H
T ss_pred CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-c
Confidence 99999998765432 599999999999999999999999 999999999999999999999999999986543221 2
Q ss_pred eeeeecccCccChhhhh-----cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 399 STRVMGTFGYLAPEYAS-----SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.....||+.|||||++. ...|+.++|||||||+||||++|+.||...... . .+..... +....+..
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~----~~~~i~~-~~~~~~~~- 237 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---R----VLLKIAK-SEPPTLAQ- 237 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---G----HHHHHHH-SCCCCCSS-
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---H----HHHHHHc-CCCCCCCc-
Confidence 23467999999999984 456899999999999999999999999754321 1 1222222 22222211
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+|+.+||+.||++||++.|++++
T Consensus 238 ------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 238 ------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ------cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12233567889999999999999999999763
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=427.94 Aligned_cols=201 Identities=27% Similarity=0.441 Sum_probs=178.3
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.++|...++||+|+||+||+|+. .+|+.||||+++... ......+.+|+.+|++++|||||+++++|.+.++.+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 46899999999999999999995 568999999997653 3345678999999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
||++|+|.+++...+ .+++..+..++.|+++||.|||+++ +|+||||||+||||+.++.+||+|||+|+...+.
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999997654 4899999999999999999999742 7999999999999999999999999999866432
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTH 446 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~ 446 (608)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||....
T Consensus 159 -~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 159 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp -TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred -ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 2344689999999999999999999999999999999999999997543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=427.04 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=206.7
Q ss_pred cCCCcCCccccCCceEEEEEEecC-C-----cEEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN-G-----KEVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~ 311 (608)
++|...++||+|+||.||+|+... + ..||||++.... ......|.+|+.+|.++ +|||||+++++|.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 578889999999999999998543 2 369999986543 33346788999999998 899999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCC
Q 046502 312 MLVCEFVTSNTLEFHLHGKGR---------------------PTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAA 370 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~ 370 (608)
+||||||++|+|.++|+.+.. ..++|..++.|+.||++||.|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999976432 3589999999999999999999998 9999999999
Q ss_pred cEEEccCCceEEEEeeccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCccc
Q 046502 371 NILLDFKFEAKVADFGLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTF 448 (608)
Q Consensus 371 NILl~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~ 448 (608)
|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||++ |+.||.....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999876543322 3345678999999999999999999999999999999997 8999975332
Q ss_pred ccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhh
Q 046502 449 MEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLE 513 (608)
Q Consensus 449 ~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~ 513 (608)
.. .+...+..+.- ...+......+.+|+.+||+.||++||||.||+++|.
T Consensus 273 -~~-----~~~~~~~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 -DA-----NFYKLIQNGFK---------MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -SH-----HHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HH-----HHHHHHhcCCC---------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11 12223333211 1112223456889999999999999999999999995
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-51 Score=415.57 Aligned_cols=246 Identities=27% Similarity=0.369 Sum_probs=199.0
Q ss_pred CccccCCceEEEEEEecC---CcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeeccC
Q 046502 246 NLLGQGGFGYVHKGVLPN---GKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFVTS 320 (608)
Q Consensus 246 ~~LG~G~fg~Vy~~~~~~---g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 320 (608)
++||+|+||.||+|.+.+ ++.||||+++... ....+.|.+|+++|++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998643 4689999997542 3335679999999999999999999999965 567899999999
Q ss_pred CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc--e
Q 046502 321 NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH--V 398 (608)
Q Consensus 321 gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~--~ 398 (608)
|+|.++++... .++|..+++|+.||++||.|||++ +||||||||+||||+.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999998654 599999999999999999999998 8999999999999999999999999999876543222 2
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....||+.|||||.+.++.++.++|||||||+||||++ |+.||..... . .+...+..+....
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~-----~~~~~i~~~~~~~-------- 230 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---S-----EVTAMLEKGERMG-------- 230 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---H-----HHHHHHHTTCCCC--------
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---H-----HHHHHHHcCCCCC--------
Confidence 334578999999999999999999999999999999998 8999975332 1 1222333332211
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
.+......+.+|+.+||+.||++||+|.+|+++|+.
T Consensus 231 -~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 231 -CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 112234568889999999999999999999998863
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-50 Score=406.16 Aligned_cols=247 Identities=27% Similarity=0.403 Sum_probs=197.6
Q ss_pred CcCCccccCCceEEEEEEe-cCCcEEEEEEcccC--CchhHHHHHHHHHHHHhcCCCCccceeeEEEe----CCeeEEEE
Q 046502 243 SDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG--SGQGERVFQAEVEIISRVHHKHLVSLVGYYTA----GSQRMLVC 315 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~----~~~~~lV~ 315 (608)
...++||+|+||.||+|+. .+++.||||++... .....+.|.+|+++|++++|||||+++++|.. +..++|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4456899999999999996 46889999998654 33445678999999999999999999999865 34679999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc-cCCceEEEEeeccccccCc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD-FKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~-~~~~~kl~DFGla~~~~~~ 394 (608)
||+++|+|.+++.... .+++..++.|+.||++||+|||++ .++|+||||||+||||+ +++.+||+|||+++.....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 9999999999997654 589999999999999999999998 12399999999999996 5789999999999865442
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
......||+.|||||++.+ .++.++|||||||+||||++|+.||...... . .+.+.+..+.....++
T Consensus 169 ---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~------~-~~~~~i~~~~~~~~~~-- 235 (270)
T d1t4ha_ 169 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA------A-QIYRRVTSGVKPASFD-- 235 (270)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH------H-HHHHHHTTTCCCGGGG--
T ss_pred ---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH------H-HHHHHHHcCCCCcccC--
Confidence 2345679999999998865 6999999999999999999999999643321 1 1222233332211111
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
......+.+|+.+||+.||++||++.|++++
T Consensus 236 ------~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 ------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ------GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ------ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1122357889999999999999999999863
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.6e-50 Score=419.99 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=210.6
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|.+.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++|+|||||+++++|.+++..||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35799999999999999999995 56899999999877666677899999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc--CCceEEEEeeccccccCcc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF--KFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~--~~~~kl~DFGla~~~~~~~ 395 (608)
|++|+|.+++..... .+++..++.|+.||+.||.|||++ +||||||||+||||+. ++.+||+|||+++......
T Consensus 105 ~~gg~L~~~l~~~~~-~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTTS-CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 999999999865433 599999999999999999999999 9999999999999954 6789999999998775432
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
......||+.|||||++.+..++.++|||||||+||||++|+.||..... .. .+.. +..+.+.. +...
T Consensus 181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~----~~~~-i~~~~~~~--~~~~ 248 (350)
T d1koaa2 181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DE----TLRN-VKSCDWNM--DDSA 248 (350)
T ss_dssp --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HHHH-HHHTCCCS--CCGG
T ss_pred --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH---HH----HHHH-HHhCCCCC--Cccc
Confidence 33456799999999999999999999999999999999999999975432 11 1222 22222211 1111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......+.+|+.+||+.||++|||+.||+++
T Consensus 249 ----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 249 ----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223467889999999999999999999985
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-51 Score=414.98 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=204.2
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+++|++++|||||+++++|.+++..||||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5689999999999999999996 568999999986432 233467899999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|||++|+|.+++...+ .+++..++.++.|++.||+|||+. +||||||||+||||+.++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999887654 599999999999999999999999 99999999999999999999999999998765432
Q ss_pred -cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 396 -THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 396 -~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.......+||+.|||||++.+..++.++|||||||+||||++|+.||..... .. ++ ..+..+.+.
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~----~~-~~i~~~~~~------ 228 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YL----IF-QKIIKLEYD------ 228 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HH-HHHHTTCCC------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH---HH----HH-HHHHcCCCC------
Confidence 2233456799999999999999999999999999999999999999975432 11 12 222233321
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRISQIVR 510 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~ 510 (608)
+.. .....+.+|+.+||+.||++|||+.|++.
T Consensus 229 ~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 229 FPE----KFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111 22345788999999999999999999754
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-50 Score=412.60 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=202.6
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCch---hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQ---GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.|+..+.||+|+||.||+|+. .+|+.||||+++..... ..+.|.+|+++|++++|||||+++++|.+.+..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488899999999999999985 56889999999765432 33568899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
||.+|+|..++..+. .+++..++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 999999987765543 599999999999999999999999 9999999999999999999999999999866442
Q ss_pred ceeeeeecccCccChhhhhc---CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 397 HVSTRVMGTFGYLAPEYASS---GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
....||+.|||||++.+ +.|+.++|||||||+||||++|+.||..... ...+..... +....+..
T Consensus 169 ---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~~-~~~~~~~~- 236 (309)
T d1u5ra_ 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQ-NESPALQS- 236 (309)
T ss_dssp ---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHH-SCCCCCSC-
T ss_pred ---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHh-CCCCCCCC-
Confidence 34579999999999864 4689999999999999999999999965432 111222222 22222211
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .....+.+|+..||+.||.+||++.||+++
T Consensus 237 ---~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 237 ---G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---C----CCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1 123467889999999999999999999863
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-50 Score=413.27 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=191.9
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
.+.|...++||+|+||.||+|+. .+|+.||||++..... .....+.+|+.+|++++|||||++++++.+++.+|||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46789999999999999999996 4689999999975432 234568899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc---cCCceEEEEeeccccccC
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD---FKFEAKVADFGLAKLASD 393 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~---~~~~~kl~DFGla~~~~~ 393 (608)
||++|+|.++|..++ .+++..+..|+.||+.||.|||+. +|+||||||+|||+. +++.+||+|||+++....
T Consensus 88 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999997654 599999999999999999999999 999999999999994 578999999999987654
Q ss_pred cccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 394 VYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 394 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .. ... .+..+.... ..
T Consensus 163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~----~~~-~i~~~~~~~--~~ 230 (307)
T d1a06a_ 163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AK----LFE-QILKAEYEF--DS 230 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH----HHH-HHHTTCCCC--CT
T ss_pred CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH---HH----HHH-HHhccCCCC--CC
Confidence 22 23346799999999999999999999999999999999999999975432 11 111 222222211 11
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. .......+.+|+..||+.||.+||++.|++++
T Consensus 231 ~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 231 PY----WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TT----TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cc----ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11 11223467889999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7.5e-50 Score=418.68 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=210.7
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
++|...++||+|+||.||+|+. .+|+.||||+++.......+.+.+|+.+|++|+|||||+++++|.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5689999999999999999995 579999999998776666678899999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc--cCCceEEEEeeccccccCccc
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD--FKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~--~~~~~kl~DFGla~~~~~~~~ 396 (608)
++|+|.+++...+ ..+++..++.|+.||+.||.|||++ +||||||||+||||+ .++.+||+|||+|+.....
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-- 182 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-- 182 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT--
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC--
Confidence 9999998876543 3599999999999999999999998 999999999999998 5789999999999877653
Q ss_pred ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLH 476 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~ 476 (608)
.......||+.|||||++.+..++.++|||||||+||||++|+.||...... ..+. .+..+.+.. .
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~-~i~~~~~~~--~---- 248 (352)
T d1koba_ 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQ-NVKRCDWEF--D---- 248 (352)
T ss_dssp SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------HHHH-HHHHCCCCC--C----
T ss_pred CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHhCCCCC--C----
Confidence 2344567999999999999999999999999999999999999999754321 1122 222232211 1
Q ss_pred CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 477 NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 477 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..........+.+|+.+||+.||.+||++.|++++
T Consensus 249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111233467889999999999999999999875
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-50 Score=410.10 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=211.0
Q ss_pred HhcCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCCch-hHHHHHHHHHHHHhcCCCCccceeeEEEeCCe
Q 046502 238 ATDGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGSGQ-GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 238 ~~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~ 310 (608)
-.++|...+.||+|+||.||+|+.. +++.||||+++..... ..+.|.+|+++|++++|+||++++++|...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4578999999999999999999853 3578999999765433 35679999999999999999999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccC
Q 046502 311 RMLVCEFVTSNTLEFHLHGKG----------------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIK 368 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk 368 (608)
.++||||+.+|+|.++|+... ...++|..++.|+.|++.||+|||+. +|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 999999999999999997432 23589999999999999999999998 99999999
Q ss_pred CCcEEEccCCceEEEEeeccccccCcc-cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCC-CCCCCCc
Q 046502 369 AANILLDFKFEAKVADFGLAKLASDVY-THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGC-RPVDSTH 446 (608)
Q Consensus 369 ~~NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~-~p~~~~~ 446 (608)
|+|||||.++.+||+|||+++...... ........|++.|+|||++.+..|+.++|||||||+||||++|. .||....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998654432 22334567899999999999999999999999999999999996 4665432
Q ss_pred ccccchhhHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 447 TFMEDNLARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 447 ~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
. .. ++ ..+.++....+ +.....++.+|+.+||+.+|.+||+|.||+++|+..
T Consensus 248 ~---~e----~~-~~v~~~~~~~~---------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 248 H---EE----VI-YYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp H---HH----HH-HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred H---HH----HH-HHHHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 2 11 12 23344443222 122335688999999999999999999999999854
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=407.53 Aligned_cols=248 Identities=28% Similarity=0.431 Sum_probs=198.1
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeC-CeeEEEEeec
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG-SQRMLVCEFV 318 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~-~~~~lV~E~~ 318 (608)
++|...++||+|+||.||+|.+ .|+.||||+++... ..+.|.+|++++++++|||||+++|+|.+. +.++|||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 4577889999999999999998 57899999997543 446789999999999999999999999654 5689999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
++|+|.++|+......++|..+++|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----
Confidence 999999999765544689999999999999999999998 9999999999999999999999999999865442
Q ss_pred eeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccccC
Q 046502 399 STRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKLHN 477 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l~~ 477 (608)
.....++..|+|||++.++.++.++|||||||++|||+| |+.||..... .. +.. .+.++...
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~----~~~-~i~~~~~~--------- 219 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KD----VVP-RVEKGYKM--------- 219 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GG----HHH-HHTTTCCC---------
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HH----HHH-HHHcCCCC---------
Confidence 223467899999999999999999999999999999998 6777654322 11 122 22222211
Q ss_pred cCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 478 EYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 478 ~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
..+.....++.+|+.+||+.||.+||+|.+|+++|+.
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 1222233568899999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-50 Score=405.81 Aligned_cols=253 Identities=26% Similarity=0.437 Sum_probs=196.4
Q ss_pred cCCCcCCccccCCceEEEEEEecC----CcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN----GKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++||+|+||.||+|+... +..||||+++... ....+.|.+|+.+|++++|||||+++|+|. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 578889999999999999998643 3568999987543 334567999999999999999999999996 4678999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
|||+.+|+|.+++.... ..+++..++.++.||++||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 86 ~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999877544 3689999999999999999999999 9999999999999999999999999999877654
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDP 473 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~ 473 (608)
.........||+.|+|||++..+.++.++|||||||+||||++ |+.||..... .. ++. .+..+....+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~----~~~-~i~~~~~~~~--- 230 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---ND----VIG-RIENGERLPM--- 230 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GG----HHH-HHHTTCCCCC---
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HH----HHH-HHHcCCCCCC---
Confidence 4444555678999999999999999999999999999999998 8889875433 11 122 2233322111
Q ss_pred cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 474 KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 474 ~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
+......+.+|+.+||+.||++||++.||+++|+.
T Consensus 231 ------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~ 265 (273)
T d1mp8a_ 231 ------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265 (273)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 12233568889999999999999999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-50 Score=412.86 Aligned_cols=254 Identities=25% Similarity=0.388 Sum_probs=201.8
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCc----EEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGK----EVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~l 313 (608)
.+|+.+++||+|+||.||+|.+. +|+ .||||+++.. .....+.|.+|+.+|++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999853 444 5899988653 344567899999999999999999999999864 5688
Q ss_pred EEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccC
Q 046502 314 VCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASD 393 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~ 393 (608)
+|||+.+++|.+++.... ..++|..+++|+.||++||.|||++ +||||||||+||||+.++.+||+|||+++....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 899999999998887654 3699999999999999999999998 999999999999999999999999999987654
Q ss_pred cccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 394 VYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 394 ~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
.... ......||+.|||||++.++.++.++|||||||+||||+| |+.||+.... .. +...+..+...
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~-----~~~~i~~~~~~--- 232 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SE-----ISSILEKGERL--- 232 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GG-----HHHHHHHTCCC---
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---HH-----HHHHHHcCCCC---
Confidence 3322 2334568999999999999999999999999999999998 7888875432 11 11222233211
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..+......+.+|+.+||+.||.+||+|.||+++|+..
T Consensus 233 ------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 ------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp ------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 11122345688899999999999999999999998753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=404.80 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=206.8
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC------chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS------GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~ 311 (608)
.+.|...+.||+|+||.||+|+. .+|+.||||+++... ....+.|.+|+.+|++|+|||||+++++|.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999996 568999999986432 12356799999999999999999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC----ceEEEEeec
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF----EAKVADFGL 387 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~----~~kl~DFGl 387 (608)
|||||||++|+|.++|...+ .+++..++.|+.|++.||.|||+. +|+||||||+||||+.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999997654 599999999999999999999999 999999999999998776 499999999
Q ss_pred cccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 388 AKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 388 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
++...... ......||+.|||||++.+..++.++|||||||+||||++|+.||..... .. .+. .+..+..
T Consensus 164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~----~~~-~i~~~~~ 233 (293)
T d1jksa_ 164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QE----TLA-NVSAVNY 233 (293)
T ss_dssp CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH----HHH-HHHTTCC
T ss_pred hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH---HH----HHH-HHHhcCC
Confidence 98765432 23446789999999999999999999999999999999999999975432 11 111 1222221
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. ...........+.+|+.+||+.||.+||++.||+++
T Consensus 234 ~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EF------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CC------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 000111223467889999999999999999999874
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=404.49 Aligned_cols=251 Identities=28% Similarity=0.385 Sum_probs=201.9
Q ss_pred CCccccCCceEEEEEEecCC----cEEEEEEcccC-CchhHHHHHHHHHHHHhcCCCCccceeeEEEe-CCeeEEEEeec
Q 046502 245 ANLLGQGGFGYVHKGVLPNG----KEVAIKQLKAG-SGQGERVFQAEVEIISRVHHKHLVSLVGYYTA-GSQRMLVCEFV 318 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g----~~vavK~~~~~-~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-~~~~~lV~E~~ 318 (608)
.++||+|+||+||+|++.++ ..||||+++.. .....+.|.+|+++|++++|||||+++|+|.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999996442 25899999754 44445789999999999999999999999876 45889999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc--
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT-- 396 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~-- 396 (608)
++|+|.++++.... .++|..+++++.|+++||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~-~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhccccc-cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 99999999886543 678999999999999999999998 899999999999999999999999999987654322
Q ss_pred -ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 397 -HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 397 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.......||..|+|||++..+.++.++|||||||+||||++|+.||...... .. +.. .+..|.. ...+
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~----~~~-~i~~g~~--~~~p-- 256 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FD----ITV-YLLQGRR--LLQP-- 256 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHH-HHHTTCC--CCCC--
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HH----HHH-HHHcCCC--CCCc--
Confidence 1233457899999999999999999999999999999999988887643221 11 111 2223321 1111
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
......+.+|+.+||+.||++||+|.||+++|+..
T Consensus 257 -----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 257 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12234678899999999999999999999999865
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=407.73 Aligned_cols=254 Identities=28% Similarity=0.399 Sum_probs=202.9
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCc--EEEEEEcccC-CchhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGK--EVAIKQLKAG-SGQGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|+..++||+|+||.||+|++. +|. .||||+++.. .....+.|.+|+++|+++ +|||||+++|+|.+++.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888899999999999999964 444 4788888643 333456799999999999 799999999999999999999
Q ss_pred EeeccCCcHHHHhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCce
Q 046502 315 CEFVTSNTLEFHLHGK--------------GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEA 380 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~ 380 (608)
|||+++|+|.++|+.. ....++|..+++++.||++||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999754 235699999999999999999999999 99999999999999999999
Q ss_pred EEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCC-CCCCCcccccchhhHHHHH
Q 046502 381 KVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCR-PVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 381 kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~-p~~~~~~~~~~~l~~~~~~ 459 (608)
||+|||+++....... .....||..|+|||.+..+.++.++|||||||+||||++|.. ||..... ..++
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-------~~~~- 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELY- 236 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHH-
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-------HHHH-
Confidence 9999999986554222 233468999999999999999999999999999999999765 5543221 1122
Q ss_pred HHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 460 RAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 460 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..+..+.. ...+......+.+|+.+||+.||++||+|.||+++|+..
T Consensus 237 ~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 237 EKLPQGYR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp HHGGGTCC---------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhcCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 22323221 111222345788999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-48 Score=403.61 Aligned_cols=245 Identities=26% Similarity=0.369 Sum_probs=206.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|...++||+|+||.||+|+. .+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5688999999999999999996 568999999996432 233567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|||.+|+|..++.... .+.+.....++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+...+.
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999988765 478889999999999999999999 9999999999999999999999999999877543
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....||+.|||||++.+..|+.++|||||||+||||++|+.||...... .++.. +..+.+. +
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~-i~~~~~~------~ 220 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEK-ILNAELR------F 220 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHH-HHHCCCC------C
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH-------HHHHH-HHcCCCC------C
Confidence 23467999999999999999999999999999999999999999754321 11222 2223221 1
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
+......+.+++.+||+.||.+|+ ++.+|+++
T Consensus 221 ----p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 221 ----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111224578899999999999996 89999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-49 Score=401.83 Aligned_cols=258 Identities=28% Similarity=0.388 Sum_probs=198.2
Q ss_pred hcCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhc-CCCCccceeeEEEeC-C
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRV-HHKHLVSLVGYYTAG-S 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~-~ 309 (608)
.++|...++||+|+||.||+|... +++.||||+++... ....+.+.+|+.++.++ +|+|||.+++++.+. +
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 367899999999999999999853 34689999997543 33456778888888877 689999999998764 4
Q ss_pred eeEEEEeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD 375 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~ 375 (608)
.+++|||||++|+|.++|+... ...++|..++.++.||++||.|||++ +||||||||+||||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 6899999999999999997542 23589999999999999999999998 999999999999999
Q ss_pred cCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCC-CCCCCCcccccchh
Q 046502 376 FKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGC-RPVDSTHTFMEDNL 453 (608)
Q Consensus 376 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~-~p~~~~~~~~~~~l 453 (608)
.++.+||+|||+++....... .......||+.|||||++.++.++.++|||||||++|||++|. .||..... .+
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--~~-- 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DE-- 244 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--SH--
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH--HH--
Confidence 999999999999987654322 2334567999999999999999999999999999999999875 56654322 11
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+...+..+....+ +......+.+++.+||+.||++||+|.||+++|+..
T Consensus 245 ---~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 245 ---EFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp ---HHHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCCCC---------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 12223333332221 112234678899999999999999999999999854
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-49 Score=401.90 Aligned_cols=254 Identities=25% Similarity=0.376 Sum_probs=196.4
Q ss_pred cCCCcCCccccCCceEEEEEEec--CC--cEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP--NG--KEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|+..+.||+|+||.||+|++. ++ ..||||+++.. .....+.|.+|+.+|++++|||||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888999999999999999853 23 36899998754 23345679999999999999999999999965 5678
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
+||||+++|+|.+++..... .++|..++.++.||++||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~~-~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG-GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhcccC-CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 99999999999988775433 599999999999999999999998 89999999999999999999999999999775
Q ss_pred Ccccc--eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchhhHHHHHHHHhcCCCCc
Q 046502 393 DVYTH--VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNLARPLLNRAIEDGNFDT 469 (608)
Q Consensus 393 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 469 (608)
..... ......|+..|+|||++.+..++.++|||||||+||||+| |+.||..... . ..+....+.+....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~----~~~~~i~~~~~~~~ 235 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---S----QILHKIDKEGERLP 235 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H----HHHHHHHTSCCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH---H----HHHHHHHhCCCCCC
Confidence 43222 2334568899999999999999999999999999999998 8999864332 1 12222233322111
Q ss_pred ccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 470 LVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 470 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
........+.+|+.+||+.||++||+|.||++.|+.
T Consensus 236 ---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 236 ---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111223468889999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=405.71 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=207.1
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccC---CchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAG---SGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|..+++||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|++++|||||+++++|.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5789999999999999999995 57999999999743 2233567889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
|||++|+|.+++...+ .+++...+.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+......
T Consensus 85 ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999988754 488999999999999999999999 99999999999999999999999999998654322
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||..... .. +...+..+.+. +
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~-----~~~~i~~~~~~------~ 224 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ER-----LFELILMEEIR------F 224 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH-----HHHHHHHCCCC------C
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HH-----HHHHHhcCCCC------C
Confidence 2 33457899999999999999999999999999999999999999975432 11 11222233321 1
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPR-----ISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~~ 511 (608)
+......+.+|+..||+.||.+|++ +.||+++
T Consensus 225 ----p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 ----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1122345788999999999999995 7888764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-49 Score=405.54 Aligned_cols=257 Identities=28% Similarity=0.386 Sum_probs=209.5
Q ss_pred cCCCcCCccccCCceEEEEEEe------cCCcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeCCee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL------PNGKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~~~ 311 (608)
++|...++||+|+||.||+|++ .+++.||||+++.... .....|.+|+.+++++ +|||||+++|+|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5678889999999999999985 3457899999986543 3445789999999999 699999999999999999
Q ss_pred EEEEeeccCCcHHHHhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc
Q 046502 312 MLVCEFVTSNTLEFHLHGKG----------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD 375 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~ 375 (608)
+||||||++|+|.++|+... ...+++..++.|+.||++||+|||++ +||||||||+||||+
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999997643 23589999999999999999999999 999999999999999
Q ss_pred cCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCC-CCCCcccccchh
Q 046502 376 FKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRP-VDSTHTFMEDNL 453 (608)
Q Consensus 376 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p-~~~~~~~~~~~l 453 (608)
.++.+||+|||+++....... .......||+.|+|||++.++.++.++|||||||+||||+|+..| |..... ..
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~---~~- 255 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---DS- 255 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---SH-
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH---HH-
Confidence 999999999999997765332 334457899999999999999999999999999999999995555 433221 11
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
.+...++.+... ..+......+.+|+.+||+.||++||+|.||+++|+..
T Consensus 256 ---~~~~~i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 256 ---KFYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ---HHHHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 122222332211 11122345688999999999999999999999999854
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=404.46 Aligned_cols=267 Identities=23% Similarity=0.350 Sum_probs=201.8
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----eeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS----QRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~----~~~lV~ 315 (608)
+.|...++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++++|.+.+ .++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4566778999999999999997 789999999975432 2223344666667889999999999998654 579999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC-----HPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~-----~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
|||++|+|.++|+.. .++|..+++++.++|.||.|||..+ ..+||||||||+||||+.++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999865 4899999999999999999999732 23899999999999999999999999999987
Q ss_pred ccCcccc---eeeeeecccCccChhhhhcCC------CCCcchhhhHHHHHHHHHhCCCCCCCCccc----cc---chhh
Q 046502 391 ASDVYTH---VSTRVMGTFGYLAPEYASSGK------LTEKSDVFSFGVMLLELIIGCRPVDSTHTF----ME---DNLA 454 (608)
Q Consensus 391 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDVwS~Gvll~elltG~~p~~~~~~~----~~---~~l~ 454 (608)
....... ......||+.|||||++.+.. ++.|+|||||||+||||+||..|+...... .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 6543221 234567999999999987643 567999999999999999999887432211 00 0011
Q ss_pred HHHHHHHHhcCCCCcccCccccCcC-CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 455 RPLLNRAIEDGNFDTLVDPKLHNEY-NHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 455 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
...+......+.+ ++.+.... ..+....+.+++.+||+.||++||+|.||+++|+..
T Consensus 238 ~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 238 VEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp HHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1122222222222 22222222 335667789999999999999999999999999743
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.4e-48 Score=393.28 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=201.8
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----e
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS----Q 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~----~ 310 (608)
.++|...+.||+|+||.||+|+. .+|+.||||+++... ......|.+|+++|++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 36789999999999999999995 579999999997543 233457899999999999999999999987644 3
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.||||||+++++|.+++...+ .+++.+++.|+.||+.||.|||++ +||||||||+||||+.++..+|+|||+++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999887654 599999999999999999999998 999999999999999999999999999875
Q ss_pred ccCcc--cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 391 ASDVY--THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 391 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
..... ........||+.|||||++.+..++.++|||||||+||||+||+.||..... ...+...+..+...
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVREDPIP 233 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCCCC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhcCCCC
Confidence 54322 2233456799999999999999999999999999999999999999975432 11223333332221
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHhhc
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-RISQIVRTLEG 514 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-sm~evv~~L~~ 514 (608)
.. .........+.+++.+||+.||.+|| ++.++++.|..
T Consensus 234 ~~-------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 PS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GG-------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred Cc-------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 10 11112235678899999999999999 89999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-48 Score=398.92 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=210.0
Q ss_pred cCCCcCCccccCCceEEEEEEec------CCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP------NGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|...+.||+|+||.||+|.+. +++.||||+++... ......|.+|++++++++|+|||+++|+|..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 57788899999999999999863 35789999997543 334457899999999999999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEE
Q 046502 313 LVCEFVTSNTLEFHLHGK--------GRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD 384 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~--------~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~D 384 (608)
+||||+.+|+|.++++.. ....++|..+.+|+.|+++||.|||++ +|+|||||++|||||.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 999999999999988742 224579999999999999999999998 899999999999999999999999
Q ss_pred eeccccccCcccc-eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCC-CCCCCCcccccchhhHHHHHHHH
Q 046502 385 FGLAKLASDVYTH-VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGC-RPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 385 FGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
||+++........ ......||+.|+|||.+.++.++.++|||||||+||||+||+ .||..... ..++. .+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-------~~~~~-~i 248 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------EQVLR-FV 248 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------HHHHH-HH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-------HHHHH-HH
Confidence 9999876543322 234457899999999999999999999999999999999985 55643221 11222 22
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.++...... ......+.+++.+||+.+|++||+|.||+++|+...
T Consensus 249 ~~~~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 249 MEGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HhCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 333322211 122356889999999999999999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.1e-48 Score=391.67 Aligned_cols=251 Identities=25% Similarity=0.338 Sum_probs=206.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc---------hhHHHHHHHHHHHHhcC-CCCccceeeEEEeC
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG---------QGERVFQAEVEIISRVH-HKHLVSLVGYYTAG 308 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---------~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~ 308 (608)
++|...++||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++ |||||+++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6789999999999999999995 5789999999865421 12245888999999997 99999999999999
Q ss_pred CeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecc
Q 046502 309 SQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLA 388 (608)
Q Consensus 309 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla 388 (608)
+..|||||||++|+|.++|...+ .+++..++.++.||++||+|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997654 599999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhc------CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHH
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASS------GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAI 462 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~ 462 (608)
+...... ......||..|+|||++.+ ..++.++|||||||+||||++|+.||..... . .....+
T Consensus 158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~---~-----~~~~~i 227 (277)
T d1phka_ 158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ---M-----LMLRMI 227 (277)
T ss_dssp EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H-----HHHHHH
T ss_pred eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH---H-----HHHHHH
Confidence 8776532 2344679999999999863 3468899999999999999999999975432 1 111222
Q ss_pred hcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 463 EDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 463 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+..... ..........+.+|+.+||+.||.+||++.||+++
T Consensus 228 ~~~~~~~~------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSGNYQFG------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHTCCCCC------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhCCCCCC------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 23332211 11111233568899999999999999999999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-49 Score=402.72 Aligned_cols=257 Identities=26% Similarity=0.383 Sum_probs=205.6
Q ss_pred cCCCcCCccccCCceEEEEEEecC--------CcEEEEEEcccCCc-hhHHHHHHHHHHHHhc-CCCCccceeeEEEeCC
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPN--------GKEVAIKQLKAGSG-QGERVFQAEVEIISRV-HHKHLVSLVGYYTAGS 309 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~~~ 309 (608)
++|...++||+|+||.||+|+... +..||||+++.+.. ....++.+|+.++.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 567888999999999999998522 24799999976544 3447788999999998 7999999999999999
Q ss_pred eeEEEEeeccCCcHHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKG--------------RPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD 375 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~ 375 (608)
..++||||+++|+|.++|.... ...++|..+++++.||+.||+|||+. +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999997543 23589999999999999999999999 999999999999999
Q ss_pred cCCceEEEEeeccccccCccc-ceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHh-CCCCCCCCcccccchh
Q 046502 376 FKFEAKVADFGLAKLASDVYT-HVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELII-GCRPVDSTHTFMEDNL 453 (608)
Q Consensus 376 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~ellt-G~~p~~~~~~~~~~~l 453 (608)
.++.+||+|||+++....... .......|++.|+|||++.++.|+.++|||||||+||||++ |..||..... .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~-- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---E-- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---H--
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---H--
Confidence 999999999999987654322 23345678999999999999999999999999999999998 6788764332 1
Q ss_pred hHHHHHHHHhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcCc
Q 046502 454 ARPLLNRAIEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGDA 516 (608)
Q Consensus 454 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~~ 516 (608)
.+...+..+..... +......+.+|+.+||+.||.+||+|.||++.|+...
T Consensus 245 ---~~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 245 ---ELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ---HHHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 12223333322111 1122346889999999999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-48 Score=404.38 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=205.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 315 (608)
++|..+++||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5789999999999999999996 569999999986432 233456889999999999999999999999999999999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVY 395 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~ 395 (608)
||+.+|+|..++...+ .+++..++.|+.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999987654 589999999999999999999999 9999999999999999999999999999977542
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.....||+.|||||++.+..++.++|||||||+||||++|+.||..... . .++. .+..+.+..
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~----~~~~-~i~~~~~~~------ 257 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---I----QIYE-KIVSGKVRF------ 257 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H----HHHH-HHHHCCCCC------
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH---H----HHHH-HHhcCCCCC------
Confidence 2346799999999999999999999999999999999999999975432 1 1122 222332211
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
+......+.+++..||+.||.+|+ ++.||+++
T Consensus 258 ----p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 258 ----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 112234678899999999999994 88998863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-48 Score=398.35 Aligned_cols=252 Identities=18% Similarity=0.312 Sum_probs=206.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... .....+.+|+++|++++|||||++++++.+++.+||||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 46789999999999999999996 468899999998654 3345688999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC--CceEEEEeeccccccCcc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK--FEAKVADFGLAKLASDVY 395 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~--~~~kl~DFGla~~~~~~~ 395 (608)
|++|+|.+++...+ ..+++.+++.|+.||+.||.|||+. +|+||||||+||||+.+ ..+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 99999999997653 2589999999999999999999998 99999999999999854 57999999999876542
Q ss_pred cceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 396 THVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 396 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
.......+++.|+|||.+.+..++.++|||||||+||||++|+.||..... .. ++.. +..+.+. ++...
T Consensus 158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~----~~~~-i~~~~~~--~~~~~ 226 (321)
T d1tkia_ 158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQ----IIEN-IMNAEYT--FDEEA 226 (321)
T ss_dssp -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HH----HHHH-HHHTCCC--CCHHH
T ss_pred -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HH----HHHH-HHhCCCC--CChhh
Confidence 233446789999999999999999999999999999999999999975432 11 2222 2222211 01101
Q ss_pred cCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 HNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
... ....+.+|+..||+.||.+||++.|++++
T Consensus 227 ~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 227 FKE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011 23457889999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-47 Score=403.21 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=198.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHH---HHHHHHhcCCCCccceeeEEEeCCeeE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQA---EVEIISRVHHKHLVSLVGYYTAGSQRM 312 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~---Ev~~l~~l~Hpniv~l~g~~~~~~~~~ 312 (608)
++|.+.++||+|+||.||+|+. .+|+.||||++.... ......+.+ |+.+++.++|||||+++++|.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 6799999999999999999995 469999999986421 122233444 466677778999999999999999999
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
||||||++|+|.++|.... .+++..++.++.||+.||.|||+. +||||||||+||||+.++.+||+|||+|+.+.
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999997654 588999999999999999999999 99999999999999999999999999998765
Q ss_pred CcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCccc
Q 046502 393 DVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLV 471 (608)
Q Consensus 393 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 471 (608)
... .....||+.|||||++.. ..|+.++|||||||+||||++|+.||....... .. .+.+.......
T Consensus 159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~--~~~~~~~~~~~---- 226 (364)
T d1omwa3 159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KH--EIDRMTLTMAV---- 226 (364)
T ss_dssp SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HH--HHHHHSSSCCC----
T ss_pred CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HH--HHHHhcccCCC----
Confidence 432 334579999999999975 468999999999999999999999997543211 10 11111111111
Q ss_pred CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 046502 472 DPKLHNEYNHNEMARMVACAAACVRHSARRRPR-----ISQIVRT 511 (608)
Q Consensus 472 d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----m~evv~~ 511 (608)
.+... ....+.+|+.+||+.||++||+ +.||+++
T Consensus 227 --~~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 --ELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --CCCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --CCCCC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 11112 2345788999999999999999 5788764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=393.21 Aligned_cols=257 Identities=23% Similarity=0.282 Sum_probs=195.2
Q ss_pred CCccccCCceEEEEEEe-cCCcEEEEEEcccCCchh-----HHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEeec
Q 046502 245 ANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQG-----ERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEFV 318 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-----~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 318 (608)
+++||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+.+|++++|||||+++++|.+++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999995 468999999997543221 245889999999999999999999999999999999999
Q ss_pred cCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccce
Q 046502 319 TSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTHV 398 (608)
Q Consensus 319 ~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 398 (608)
.++++..++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 83 ETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp SEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred cchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence 998887776543 3588899999999999999999999 9999999999999999999999999999876554322
Q ss_pred eeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccC-----
Q 046502 399 STRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVD----- 472 (608)
Q Consensus 399 ~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d----- 472 (608)
....+||+.|+|||++..+ .|+.++|||||||+||||++|+.||...... + ...... +.+.......+.+
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~-~l~~i~-~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--D-QLTRIF-ETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--H-HHHHHH-HHHCCCCTTTSSSTTSST
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH--H-HHHHHH-HhcCCCChhhccchhccc
Confidence 2335799999999998754 5799999999999999999999999754321 1 111111 1110000000000
Q ss_pred -c-cc--cCcCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 473 -P-KL--HNEYN-----HNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 473 -~-~l--~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .+ ..... ......+.+|+.+||+.||++|||+.|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 00 00011 1123468899999999999999999999874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=402.05 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=199.9
Q ss_pred hcCCCcCC-ccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhc-CCCCccceeeEEEe----CCee
Q 046502 239 TDGFSDAN-LLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRV-HHKHLVSLVGYYTA----GSQR 311 (608)
Q Consensus 239 ~~~f~~~~-~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l-~Hpniv~l~g~~~~----~~~~ 311 (608)
.++|.+.. +||+|+||.||+|+. .+|+.||||+++.. ..+.+|+.++.++ +|||||+++++|.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 36787764 699999999999995 56899999998642 3567899987665 89999999999865 4568
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc---CCceEEEEeecc
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF---KFEAKVADFGLA 388 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~---~~~~kl~DFGla 388 (608)
|||||||+||+|.++|..++...+++..++.|+.||+.||.|||+. +|+||||||+||||+. ++.+||+|||++
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccccccee
Confidence 9999999999999999876656799999999999999999999999 9999999999999986 467999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
+...... ......||+.|||||++.+..|+.++|||||||+||||+||+.||....... ... .+...+..+.+.
T Consensus 162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~---~~~-~~~~~i~~~~~~ 235 (335)
T d2ozaa1 162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISP-GMKTRIRMGQYE 235 (335)
T ss_dssp EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSS
T ss_pred eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH---HHH-HHHHHHhcCCCC
Confidence 8765432 2344679999999999999999999999999999999999999996433211 000 011111111110
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+...........+.+|+.+||+.||.+||++.|++++
T Consensus 236 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 236 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1011112334568899999999999999999999884
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=397.40 Aligned_cols=247 Identities=26% Similarity=0.348 Sum_probs=202.1
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC---chhHHHHHHHHHHHH-hcCCCCccceeeEEEeCCeeEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS---GQGERVFQAEVEIIS-RVHHKHLVSLVGYYTAGSQRMLV 314 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~Ev~~l~-~l~Hpniv~l~g~~~~~~~~~lV 314 (608)
++|...++||+|+||+||+|+. .+|+.||||+++... ....+.+..|+.++. .++|||||++++++.+++..|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5789999999999999999995 468999999996432 223345566766665 68999999999999999999999
Q ss_pred EeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCc
Q 046502 315 CEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 315 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~ 394 (608)
||||++|+|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999998654 488999999999999999999999 9999999999999999999999999999865543
Q ss_pred ccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCcc
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPK 474 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~ 474 (608)
.. ......||+.|+|||++.++.++.++|||||||+||||++|+.||..... .. +...+..+.+.
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~---~~-----~~~~i~~~~~~------ 221 (320)
T d1xjda_ 157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EE-----LFHSIRMDNPF------ 221 (320)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH-----HHHHHHHCCCC------
T ss_pred cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH---HH-----HHHHHHcCCCC------
Confidence 22 23446799999999999999999999999999999999999999975432 11 12222233221
Q ss_pred ccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 046502 475 LHNEYNHNEMARMVACAAACVRHSARRRPRIS-QIVR 510 (608)
Q Consensus 475 l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~-evv~ 510 (608)
+ +......+.+|+.+||+.||.+||++. ||++
T Consensus 222 ~----p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 Y----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1 112234578899999999999999995 6764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=389.55 Aligned_cols=261 Identities=21% Similarity=0.329 Sum_probs=201.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc--hhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG--QGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|..+++||+|+||.||+|.. .+|+.||||+++.... ...+.+.+|+++|++++|||||+++++|.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999995 5799999999965432 234678899999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
|+.++.+.. +.......+++..++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~-~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 82 FLHQDLKKF-MDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp CCSEEHHHH-HHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred ecCCchhhh-hhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence 998665544 4434444699999999999999999999998 899999999999999999999999999987654322
Q ss_pred ceeeeeecccCccChhhhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcccCccc
Q 046502 397 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTLVDPKL 475 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~d~~l 475 (608)
......||+.|+|||.+.... ++.++|||||||+||||++|+.||..... .+.+.. ... ..+...+...+..
T Consensus 158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~--~~~~~~-i~~---~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFR-IFR---TLGTPDEVVWPGV 230 (298)
T ss_dssp -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH-HHH---HHCCCCTTTSTTG
T ss_pred -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH--HHHHHH-HHH---hcCCCchhhcccc
Confidence 233457999999999887655 58899999999999999999999975432 111111 111 1111111111000
Q ss_pred ------cC------c-----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 476 ------HN------E-----YNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 476 ------~~------~-----~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. . ........+.+|+.+||+.||.+|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0 001123567889999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-46 Score=383.34 Aligned_cols=262 Identities=21% Similarity=0.320 Sum_probs=201.7
Q ss_pred cCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCch--hHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQ--GERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|...++||+|+||+||+|+..+|+.||||+++..... ..+.+.+|+.+|++++|||||+++++|...+..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 678999999999999999999989999999999765322 246788999999999999999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCcccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYTH 397 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 397 (608)
+.++.+..+.... ..+++..+..|+.||+.||+|||+. +||||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~- 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR- 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence 9988887776544 3599999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCCcc------
Q 046502 398 VSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFDTL------ 470 (608)
Q Consensus 398 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------ 470 (608)
......|++.|+|||.+... .++.++|||||||+||||++|+.||..... .+.+.+ ... .+........
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~~~~-i~~-~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQLMR-IFR-ILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH-HHH-HHCCCCTTTSTTGGGS
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH--HHHHHH-HHH-hhCCCChhhccchhhh
Confidence 22334689999999998754 579999999999999999999999975432 111111 111 0000000000
Q ss_pred ---------cCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 471 ---------VDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 471 ---------~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
..+.............+.+++.+||+.||++||++.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000011112223567899999999999999999999853
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=386.84 Aligned_cols=240 Identities=24% Similarity=0.373 Sum_probs=196.1
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCc------hhHHHHHHHHHHHHhcC--CCCccceeeEEEeCCe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSG------QGERVFQAEVEIISRVH--HKHLVSLVGYYTAGSQ 310 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~Ev~~l~~l~--Hpniv~l~g~~~~~~~ 310 (608)
++|.+.++||+|+||.||+|+. .+|+.||||+++.... .....+.+|+.+|++++ |+|||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5788999999999999999995 5789999999864321 11234668999999997 8999999999999999
Q ss_pred eEEEEeeccC-CcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccC-CceEEEEeecc
Q 046502 311 RMLVCEFVTS-NTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFK-FEAKVADFGLA 388 (608)
Q Consensus 311 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~-~~~kl~DFGla 388 (608)
.++||||+.+ +++.+++.... .+++..++.++.||++||.|||+. +|+||||||+||||+.+ +.+||+|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 57777776543 599999999999999999999998 99999999999999854 79999999999
Q ss_pred ccccCcccceeeeeecccCccChhhhhcCCC-CCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCC
Q 046502 389 KLASDVYTHVSTRVMGTFGYLAPEYASSGKL-TEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNF 467 (608)
Q Consensus 389 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~ 467 (608)
+..... ......||+.|||||++.+..+ +.++|||||||+||||++|+.||..... +..+..
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~~~~ 221 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRGQV 221 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHCCC
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------Hhhccc
Confidence 876542 2345679999999999987765 5679999999999999999999964211 111111
Q ss_pred CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+...+ ...+.+|+.+||+.||++|||+.|++++
T Consensus 222 ------~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 ------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111122 2467889999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-46 Score=383.01 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=197.7
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cC-CcEEEEEEcccCCch--hHHHHHHHHHHHHhc---CCCCccceeeEEEe----
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PN-GKEVAIKQLKAGSGQ--GERVFQAEVEIISRV---HHKHLVSLVGYYTA---- 307 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~-g~~vavK~~~~~~~~--~~~~~~~Ev~~l~~l---~Hpniv~l~g~~~~---- 307 (608)
.++|..+++||+|+||+||+|+. .+ ++.||||+++..... ....+.+|+.+|+.| +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999996 34 567999998653221 223455677777665 79999999999853
Q ss_pred -CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEee
Q 046502 308 -GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFG 386 (608)
Q Consensus 308 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFG 386 (608)
....+++|||+.++.+....... ...+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 34679999999998876555433 34689999999999999999999999 89999999999999999999999999
Q ss_pred ccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcC-
Q 046502 387 LAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDG- 465 (608)
Q Consensus 387 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~- 465 (608)
+++..... .......||+.|||||++.+..|+.++|||||||+||||++|+.||..... .+ .....+.......
T Consensus 162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~--~~-~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD--VD-QLGKILDVIGLPGE 236 (305)
T ss_dssp SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HH-HHHHHHHHHCCCCG
T ss_pred hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH--HH-HHHHHHHhhCCCch
Confidence 99865442 233456799999999999999999999999999999999999999975432 11 1111111100000
Q ss_pred -CCCc------cc----CccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 466 -NFDT------LV----DPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 466 -~~~~------~~----d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.+.. .. .......+.......+.+|+.+||+.||++|||+.|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00 0000011112233457789999999999999999999875
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-45 Score=381.95 Aligned_cols=260 Identities=23% Similarity=0.309 Sum_probs=194.8
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccceeeEEEeC------CeeEE
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSLVGYYTAG------SQRML 313 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~------~~~~l 313 (608)
.|...++||+|+||+||+|+. .+|+.||||+++.... .+.+|+++|++++|+|||+++++|... ..++|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 467788999999999999996 4699999999976543 234699999999999999999998543 34789
Q ss_pred EEeeccCCcHHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-ceEEEEeeccccc
Q 046502 314 VCEFVTSNTLEFHLHG-KGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKLA 391 (608)
Q Consensus 314 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-~~kl~DFGla~~~ 391 (608)
|||||+++.+..+.+. .....+++..++.|+.||+.||+|||++ +|+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999998765554432 2334699999999999999999999998 999999999999999775 8999999999876
Q ss_pred cCcccceeeeeecccCccChhhhhc-CCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhH----------HHHHH
Q 046502 392 SDVYTHVSTRVMGTFGYLAPEYASS-GKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLAR----------PLLNR 460 (608)
Q Consensus 392 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~----------~~~~~ 460 (608)
.... ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...... +.+.. ..+..
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~--~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH--HHHHHHHHHhCCChHHhhhh
Confidence 5432 2334579999999998865 46899999999999999999999999754321 11110 00000
Q ss_pred H---HhcCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 461 A---IEDGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 461 ~---~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
. .....+.......+...........+.+|+.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00111111111111111122334567889999999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=372.37 Aligned_cols=262 Identities=21% Similarity=0.264 Sum_probs=196.4
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEe--------
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTA-------- 307 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-------- 307 (608)
.++|..+++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|+||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999995 579999999986442 2334678899999999999999999998855
Q ss_pred CCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeec
Q 046502 308 GSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGL 387 (608)
Q Consensus 308 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGl 387 (608)
.+..++||||+.++.+..+.... ..+....++.|+.||+.||.|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecce
Confidence 34679999999988777655433 3588899999999999999999998 999999999999999999999999999
Q ss_pred cccccCccc---ceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh
Q 046502 388 AKLASDVYT---HVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE 463 (608)
Q Consensus 388 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~ 463 (608)
++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ... .+.+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~---~~~-~i~~~~- 238 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLA-LISQLC- 238 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH-HHHHHH-
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH---HHH-HHHHhc-
Confidence 986654221 122335799999999998765 68999999999999999999999997543211 111 111111
Q ss_pred cCCCCcccCccc-------------cCcCCHH-------HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 DGNFDTLVDPKL-------------HNEYNHN-------EMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 ~~~~~~~~d~~l-------------~~~~~~~-------~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
+.+........ ....... ....+++|+.+||+.||++|||+.|++++
T Consensus 239 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 239 -GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp -CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 11111110000 0000011 12346789999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-44 Score=366.78 Aligned_cols=264 Identities=19% Similarity=0.264 Sum_probs=204.6
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCCeeEEEEe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGSQRMLVCE 316 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 316 (608)
++|..+++||+|+||+||+|+. .+|+.||||+++... ......+.+|+.+|++++|+|||+++++|.+.+..++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 578999999986543 2345788999999999999999999999999999999999
Q ss_pred eccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccccccCccc
Q 046502 317 FVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLASDVYT 396 (608)
Q Consensus 317 ~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~~~~~ 396 (608)
++.+++|..++...+ .+++..+..++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999988876544 588999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceeeeeecccCccChhhhhcCC-CCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh--cCCC------
Q 046502 397 HVSTRVMGTFGYLAPEYASSGK-LTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE--DGNF------ 467 (608)
Q Consensus 397 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~~------ 467 (608)
......++..|+|||++.... ++.++|||||||++|||++|+.||...... ......+...... ...+
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhhhc
Confidence 223345788999999987665 689999999999999999999997543321 1111111111000 0000
Q ss_pred ------CcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 ------DTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...................+.+|+.+||+.||++|||+.||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000011122233467889999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=375.51 Aligned_cols=261 Identities=23% Similarity=0.326 Sum_probs=195.2
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEeCC------
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS------ 309 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~------ 309 (608)
.++|..+++||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++|+|||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999995 569999999997542 233467889999999999999999999997654
Q ss_pred eeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 310 QRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 310 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
+++|||||+ +.+|..+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 569999999 56777777543 599999999999999999999999 99999999999999999999999999998
Q ss_pred cccCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHH-------H
Q 046502 390 LASDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNR-------A 461 (608)
Q Consensus 390 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~-------~ 461 (608)
..... .+...||+.|+|||++.+. .++.++|||||||+||||++|+.||....... .+ ...... .
T Consensus 170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~--~~-~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QL-KEIMKVTGTPPAEF 242 (346)
T ss_dssp ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-HHHHHHHCCCCHHH
T ss_pred ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH--HH-HHHHhccCCCcHHH
Confidence 76543 2346799999999998764 57899999999999999999999997653211 11 000000 0
Q ss_pred HhcC----------CCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhc
Q 046502 462 IEDG----------NFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT--LEG 514 (608)
Q Consensus 462 ~~~~----------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~--L~~ 514 (608)
+... .+.......+. .........+++|+.+||+.||.+|||+.||+++ |+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~ 306 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred HhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence 0000 00011001110 1111223456789999999999999999999986 554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-44 Score=367.05 Aligned_cols=258 Identities=20% Similarity=0.254 Sum_probs=195.0
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCccce-eeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHLVSL-VGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpniv~l-~g~~~~~~~~~lV~E~ 317 (608)
++|...+.||+|+||.||+|+. .+|+.||||++..... ...+..|++++++++|+|+|.+ .+++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4689999999999999999985 5689999999875432 2357789999999987765555 5556778889999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEc---cCCceEEEEeeccccccCc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLD---FKFEAKVADFGLAKLASDV 394 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~---~~~~~kl~DFGla~~~~~~ 394 (608)
+.+ +|.+.+.... ..+++..++.++.|++.||+|||++ +||||||||+|||++ .+..+||+|||+++...+.
T Consensus 85 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LGP-SLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CCC-BHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cCC-chhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 965 5555554433 3599999999999999999999999 999999999999975 4567999999999976543
Q ss_pred ccc------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 395 YTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 395 ~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
... ......||+.|||||.+.+..++.++|||||||++|||++|+.||..................... ...
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~- 237 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI- 237 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SCH-
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CCh-
Confidence 221 234467999999999999999999999999999999999999999754331111111111110000 000
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhc
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEG 514 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~ 514 (608)
+.+.. .....+.+++..||+.+|++||++.+|.+.|+.
T Consensus 238 ----~~~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 ----EVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp ----HHHTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred ----hHhcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 01111 223567889999999999999999999888874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-44 Score=373.37 Aligned_cols=266 Identities=21% Similarity=0.304 Sum_probs=198.2
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC-chhHHHHHHHHHHHHhcCCCCccceeeEEEeCC----eeE
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS-GQGERVFQAEVEIISRVHHKHLVSLVGYYTAGS----QRM 312 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~~~----~~~ 312 (608)
..+|..+++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++|+|+|||+++++|.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45789999999999999999985 579999999997543 333467889999999999999999999997543 345
Q ss_pred EEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccccc
Q 046502 313 LVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKLAS 392 (608)
Q Consensus 313 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~~~ 392 (608)
++++|+.+|+|.+++... .+++..++.++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 666777899999999754 589999999999999999999999 99999999999999999999999999998664
Q ss_pred Cccc--ceeeeeecccCccChhhhh-cCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC---
Q 046502 393 DVYT--HVSTRVMGTFGYLAPEYAS-SGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN--- 466 (608)
Q Consensus 393 ~~~~--~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--- 466 (608)
.... ......+||+.|+|||++. ...++.++||||+||++|||++|+.||........ . .... ..+....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~-~~~~-~~~~~~~~~~ 236 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--L-NHIL-GILGSPSQED 236 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--H-HHHH-HHHCSCCHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH--H-HHHh-hhccCCChhh
Confidence 4322 1234567999999999984 45678999999999999999999999976432111 0 0000 0000000
Q ss_pred ---------------CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--hhcC
Q 046502 467 ---------------FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT--LEGD 515 (608)
Q Consensus 467 ---------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~--L~~~ 515 (608)
+.......+ .........++++|+..||+.||.+||++.|++++ |+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPW-NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCH-HHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhcccccCCccCCCCH-HHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000000000 00000112357889999999999999999999986 5543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8.7e-44 Score=363.62 Aligned_cols=259 Identities=18% Similarity=0.223 Sum_probs=203.9
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCC-CCccceeeEEEeCCeeEEEEee
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHH-KHLVSLVGYYTAGSQRMLVCEF 317 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~H-pniv~l~g~~~~~~~~~lV~E~ 317 (608)
++|.+.++||+|+||.||+|+. .+|+.||||++.... ....+++|++++..|.| +|++.+++++..+...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 5789999999999999999995 468999999986543 22356789999999975 8999999999999999999999
Q ss_pred ccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEcc-----CCceEEEEeecccccc
Q 046502 318 VTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDF-----KFEAKVADFGLAKLAS 392 (608)
Q Consensus 318 ~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~-----~~~~kl~DFGla~~~~ 392 (608)
+ +++|.+++...+. .+++..+..|+.|++.||+|||+. +||||||||+||||+. ++.+||+|||+++...
T Consensus 83 ~-~~~l~~~~~~~~~-~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR-KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhcc-chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 6889888876543 689999999999999999999999 9999999999999974 5789999999998765
Q ss_pred Ccccc------eeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCC
Q 046502 393 DVYTH------VSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGN 466 (608)
Q Consensus 393 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~ 466 (608)
+.... ......||+.|||||.+.+..++.++|||||||++|||++|+.||..............+... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~-~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK-KQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH-HHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc-cCCCC
Confidence 42211 223467999999999999999999999999999999999999999754332111111111111 11111
Q ss_pred CCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHhhcC
Q 046502 467 FDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRTLEGD 515 (608)
Q Consensus 467 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~L~~~ 515 (608)
..+ +...+ ..++.+++..|++.+|++||++..+.+.|+..
T Consensus 237 ~~~-----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 237 LRE-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHH-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hHH-----hcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 111 11122 24578889999999999999999998888653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=371.88 Aligned_cols=253 Identities=24% Similarity=0.313 Sum_probs=202.4
Q ss_pred cCCCcCCccccCCceEEEEEEe----cCCcEEEEEEcccCC----chhHHHHHHHHHHHHhcCC-CCccceeeEEEeCCe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL----PNGKEVAIKQLKAGS----GQGERVFQAEVEIISRVHH-KHLVSLVGYYTAGSQ 310 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~Ev~~l~~l~H-pniv~l~g~~~~~~~ 310 (608)
++|...++||+|+||+||+|.. .+|+.||||+++... ....+.+.+|+++|++++| +||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6699999999999999999984 247899999986432 2234567889999999966 899999999999999
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.++||||+.+|+|.+++...+ .+.......++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999998765 367788899999999999999998 999999999999999999999999999987
Q ss_pred ccCcccceeeeeecccCccChhhhhcC--CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHhcCCCC
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASSG--KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIEDGNFD 468 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~ 468 (608)
+............|++.|++||.+... .++.++|||||||+||||++|+.||...... .....+..... ....
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~---~~~~~i~~~~~-~~~~- 253 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK---NSQAEISRRIL-KSEP- 253 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC---CCHHHHHHHHH-HCCC-
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcc-cCCC-
Confidence 655444444556799999999999754 4788999999999999999999999754321 11111222211 1111
Q ss_pred cccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 046502 469 TLVDPKLHNEYNHNEMARMVACAAACVRHSARRRP-----RISQIVRT 511 (608)
Q Consensus 469 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----sm~evv~~ 511 (608)
.+......++.+|+.+||+.||++|| ++.|++++
T Consensus 254 ---------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 254 ---------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ---------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ---------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11123345788899999999999999 47888864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-43 Score=368.35 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=197.5
Q ss_pred cCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEe--CCeeEEEE
Q 046502 240 DGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTA--GSQRMLVC 315 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~--~~~~~lV~ 315 (608)
++|.++++||+|+||+||+|+. .+|+.||||+++... .+.+.+|+++|++++ |+||++++++|.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999995 568999999997543 456889999999995 9999999999974 45689999
Q ss_pred eeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC-ceEEEEeeccccccCc
Q 046502 316 EFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF-EAKVADFGLAKLASDV 394 (608)
Q Consensus 316 E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~-~~kl~DFGla~~~~~~ 394 (608)
|||.+++|..+.. .+++..+..++.||+.||.|||++ +|+||||||+||||+.++ .+||+|||+++.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999976642 489999999999999999999999 999999999999998755 6999999999876543
Q ss_pred ccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchh------hHHHHHHHHhcCCC
Q 046502 395 YTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNL------ARPLLNRAIEDGNF 467 (608)
Q Consensus 395 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l------~~~~~~~~~~~~~~ 467 (608)
. ......+|..|+|||.+.+. .++.++|||||||++|||++|+.||........... ..+..........+
T Consensus 184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 2 23445789999999998765 479999999999999999999999976543211100 00011111111111
Q ss_pred Cc------ccC--------ccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 468 DT------LVD--------PKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 468 ~~------~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.. ... ..............+++|+.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 000 000001111223467889999999999999999999863
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-43 Score=365.60 Aligned_cols=262 Identities=22% Similarity=0.291 Sum_probs=191.1
Q ss_pred cCCCcCCccccCCceEEEEEEec-CCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEe------CCe
Q 046502 240 DGFSDANLLGQGGFGYVHKGVLP-NGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTA------GSQ 310 (608)
Q Consensus 240 ~~f~~~~~LG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~------~~~ 310 (608)
++|..+++||+|+||+||+|+.. +|+.||||+++... ......+.+|+.+|++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999964 69999999997543 3344568899999999999999999999963 368
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
+|+|||||.++.+..+ +. .+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~iv~Ey~~~~l~~~~-~~----~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-QM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSEEHHHHH-TS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccchHHHHhh-hc----CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 8999999987666544 32 489999999999999999999999 999999999999999999999999999886
Q ss_pred ccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccch-h--------------hH
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDN-L--------------AR 455 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~-l--------------~~ 455 (608)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......... . ..
T Consensus 169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 246 (355)
T d2b1pa1 169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence 6542 23345679999999999999999999999999999999999999996543210000 0 00
Q ss_pred HHHHHHHhcC-CCC-----cccCcccc---CcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 456 PLLNRAIEDG-NFD-----TLVDPKLH---NEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 456 ~~~~~~~~~~-~~~-----~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
.......... ... .+....+. ..........+.+|+.+||+.||++|||+.||+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000111110 000 01111111 11123345678899999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-43 Score=364.59 Aligned_cols=259 Identities=20% Similarity=0.281 Sum_probs=195.4
Q ss_pred hcCCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCC--chhHHHHHHHHHHHHhcCCCCccceeeEEEe-----CCe
Q 046502 239 TDGFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGS--GQGERVFQAEVEIISRVHHKHLVSLVGYYTA-----GSQ 310 (608)
Q Consensus 239 ~~~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~Ev~~l~~l~Hpniv~l~g~~~~-----~~~ 310 (608)
.++|...++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|+|||++++++.. +..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999995 579999999997543 3334578899999999999999999999863 334
Q ss_pred eEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 311 RMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 311 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
.++||||+.+|+|.+++..+ .+++..+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 57778888999999998653 599999999999999999999999 999999999999999999999999999976
Q ss_pred ccCcccceeeeeecccCccChhhhhcC-CCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHHHHHh------
Q 046502 391 ASDVYTHVSTRVMGTFGYLAPEYASSG-KLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLNRAIE------ 463 (608)
Q Consensus 391 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~------ 463 (608)
.... .....|+..|+|||.+.+. .++.++|||||||++|+|++|+.||....... .....+.....
T Consensus 171 ~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 171 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAELL 243 (348)
T ss_dssp CTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHH
T ss_pred cCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChHHh
Confidence 5432 2345789999999987665 46899999999999999999999997543211 11101100000
Q ss_pred -----------cCCCCcccCccccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 046502 464 -----------DGNFDTLVDPKLHNEYNHNEMARMVACAAACVRHSARRRPRISQIVRT 511 (608)
Q Consensus 464 -----------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv~~ 511 (608)
...+.......+.. ........+.+|+.+||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchhh-hcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00000000000000 001123457889999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-39 Score=336.28 Aligned_cols=268 Identities=19% Similarity=0.277 Sum_probs=194.4
Q ss_pred CCCcCCccccCCceEEEEEEe-cCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-----------CCCccceeeEEEe-
Q 046502 241 GFSDANLLGQGGFGYVHKGVL-PNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-----------HKHLVSLVGYYTA- 307 (608)
Q Consensus 241 ~f~~~~~LG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-----------Hpniv~l~g~~~~- 307 (608)
+|..+++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++ |+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488999999999999999995 579999999998643 23456788999998886 4789999998764
Q ss_pred -CCeeEEEEeeccCCcH-HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCC------c
Q 046502 308 -GSQRMLVCEFVTSNTL-EFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKF------E 379 (608)
Q Consensus 308 -~~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~------~ 379 (608)
....+++|+++..+.. ...........+.+..+..++.||+.||+|||+.. +|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence 3456777777655443 33344445557899999999999999999999832 899999999999998765 3
Q ss_pred eEEEEeeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHHHHHHhCCCCCCCCcccccchhhHHHHH
Q 046502 380 AKVADFGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELIIGCRPVDSTHTFMEDNLARPLLN 459 (608)
Q Consensus 380 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll~elltG~~p~~~~~~~~~~~l~~~~~~ 459 (608)
+||+|||.++..... ....+||+.|+|||++....++.++|||||||+|+||++|+.||..............+..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999999865432 2346799999999999999999999999999999999999999975432111110000000
Q ss_pred ----------HHHhcCCC-----------CcccCc---------cccCcCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 046502 460 ----------RAIEDGNF-----------DTLVDP---------KLHNEYNHNEMARMVACAAACVRHSARRRPRISQIV 509 (608)
Q Consensus 460 ----------~~~~~~~~-----------~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dp~~RPsm~evv 509 (608)
..+..+.. ..+... .............+.+|+.+||+.||.+|||+.|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00000000 000000 011233456778899999999999999999999999
Q ss_pred HH--hhcC
Q 046502 510 RT--LEGD 515 (608)
Q Consensus 510 ~~--L~~~ 515 (608)
++ |+..
T Consensus 327 ~Hp~f~~~ 334 (362)
T d1q8ya_ 327 NHPWLKDT 334 (362)
T ss_dssp TCGGGTTC
T ss_pred cCcccCCC
Confidence 75 5533
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=5.3e-25 Score=209.15 Aligned_cols=169 Identities=14% Similarity=0.102 Sum_probs=121.6
Q ss_pred CcCCccccCCceEEEEEEecCCcEEEEEEcccCCc------------------hhHHHHHHHHHHHHhcCCCCccceeeE
Q 046502 243 SDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSG------------------QGERVFQAEVEIISRVHHKHLVSLVGY 304 (608)
Q Consensus 243 ~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~Ev~~l~~l~Hpniv~l~g~ 304 (608)
...++||+|+||.||+|...+|+.||||+++.... .....+..|+..+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35688999999999999988999999998753211 011235568899999999999998865
Q ss_pred EEeCCeeEEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeeccCCCcEEEccCCceEEEE
Q 046502 305 YTAGSQRMLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDCHPKIIHRDIKAANILLDFKFEAKVAD 384 (608)
Q Consensus 305 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~~~~iiHrDIk~~NILl~~~~~~kl~D 384 (608)
. ..+|||||+++..+.. +.+.....++.|++++|.|||+. +|+||||||+||||+++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 3 2379999999876543 33344668999999999999998 99999999999999865 589999
Q ss_pred eeccccccCcccceeeeeecccCccChhhhhcCCCCCcchhhhHHHHH
Q 046502 385 FGLAKLASDVYTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVML 432 (608)
Q Consensus 385 FGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvll 432 (608)
||+|+........... ......+ -|++ .+.|..++||||..--+
T Consensus 146 FG~a~~~~~~~~~~~l--~rd~~~~-~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREIL--ERDVRNI-ITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHHH--HHHHHHH-HHHH-HHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcHHHH--HHHHHHH-HHHH-cCCCCCcccHHHHHHHH
Confidence 9999765432111000 0000000 1222 35678899999965443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.80 E-value=9.7e-09 Score=99.83 Aligned_cols=150 Identities=12% Similarity=0.042 Sum_probs=107.0
Q ss_pred HHHHHHhcCCCcCCccccCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcC-CCCccceeeEEEeCCee
Q 046502 233 EELARATDGFSDANLLGQGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVH-HKHLVSLVGYYTAGSQR 311 (608)
Q Consensus 233 ~el~~~~~~f~~~~~LG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~-Hpniv~l~g~~~~~~~~ 311 (608)
.|+.+....|...+..+.+....||+... +++.++||+...........+.+|+.++..|. +--+.+++.++..++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 46777778888777666566679999875 56678889876544333445678999988875 43467888888888999
Q ss_pred EEEEeeccCCcHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 046502 312 MLVCEFVTSNTLEFHLHGKGRPTMDWPTRLKIALGFAKGLAYLHEDC--------------------------------- 358 (608)
Q Consensus 312 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~ia~~ia~~L~yLH~~~--------------------------------- 358 (608)
++||+++++..+....... .....++.++++.|..||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886543221 113344555666666666421
Q ss_pred -----------------------CCCeeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 359 -----------------------HPKIIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 359 -----------------------~~~iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
...++|+|+.+.|||++++...-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11379999999999999876667999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.22 E-value=1.4e-06 Score=83.57 Aligned_cols=75 Identities=15% Similarity=0.046 Sum_probs=55.1
Q ss_pred ccccCC-ceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCC--CccceeeEEEeCCeeEEEEeeccCCcH
Q 046502 247 LLGQGG-FGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHK--HLVSLVGYYTAGSQRMLVCEFVTSNTL 323 (608)
Q Consensus 247 ~LG~G~-fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hp--niv~l~g~~~~~~~~~lV~E~~~~gsL 323 (608)
.+..|. .+.||+....++..+++|....... ..+..|+..|+.|... .+.++++++.+++..++||||++|..+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344554 3689999987888899998765432 2466788888877533 356788888888889999999998765
Q ss_pred H
Q 046502 324 E 324 (608)
Q Consensus 324 ~ 324 (608)
.
T Consensus 94 ~ 94 (255)
T d1nd4a_ 94 L 94 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.74 E-value=4.4e-05 Score=78.25 Aligned_cols=77 Identities=17% Similarity=0.118 Sum_probs=48.7
Q ss_pred CCccccCCceEEEEEEecC-CcEEEEEEcccC------C-chhHHHHHHHHHHHHhcC-C--CCccceeeEEEeCCeeEE
Q 046502 245 ANLLGQGGFGYVHKGVLPN-GKEVAIKQLKAG------S-GQGERVFQAEVEIISRVH-H--KHLVSLVGYYTAGSQRML 313 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~-g~~vavK~~~~~------~-~~~~~~~~~Ev~~l~~l~-H--pniv~l~g~~~~~~~~~l 313 (608)
.+.||.|....||+....+ ++.|+||+-... . .........|++.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4579999999999998654 678999974321 0 111223445888887763 2 345566654 3456689
Q ss_pred EEeeccCCcH
Q 046502 314 VCEFVTSNTL 323 (608)
Q Consensus 314 V~E~~~~gsL 323 (608)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.45 E-value=0.00018 Score=71.52 Aligned_cols=135 Identities=15% Similarity=0.094 Sum_probs=80.8
Q ss_pred ceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-----ccee--eEEEeCCeeEEEEeeccCCcHH-
Q 046502 253 FGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-----VSLV--GYYTAGSQRMLVCEFVTSNTLE- 324 (608)
Q Consensus 253 fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-----v~l~--g~~~~~~~~~lV~E~~~~gsL~- 324 (608)
--.||+..+++|+.|++|+.+... ...+++..|+..+..|...+| +.+- ..+..++..+.|++|+.|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 458999999999999999987542 345667889998888853222 1111 1234567788999999875432
Q ss_pred -------------HHhhc----C---CCCCCCHHH-------------------HHHHHHHHHHHHHHHHhc----CCCC
Q 046502 325 -------------FHLHG----K---GRPTMDWPT-------------------RLKIALGFAKGLAYLHED----CHPK 361 (608)
Q Consensus 325 -------------~~l~~----~---~~~~l~~~~-------------------~~~ia~~ia~~L~yLH~~----~~~~ 361 (608)
..+|. . .+..+++.. +..+...+.+.+..+... ....
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 01111 0 112222221 111222223333333322 2336
Q ss_pred eeeeccCCCcEEEccCCceEEEEeecccc
Q 046502 362 IIHRDIKAANILLDFKFEAKVADFGLAKL 390 (608)
Q Consensus 362 iiHrDIk~~NILl~~~~~~kl~DFGla~~ 390 (608)
+||+|+.+.|||++++ ..|+||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899987753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.13 E-value=0.00048 Score=70.15 Aligned_cols=73 Identities=19% Similarity=0.224 Sum_probs=50.2
Q ss_pred CCccccCCceEEEEEEecCC--------cEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-cceeeEEEeCCeeEEEE
Q 046502 245 ANLLGQGGFGYVHKGVLPNG--------KEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-VSLVGYYTAGSQRMLVC 315 (608)
Q Consensus 245 ~~~LG~G~fg~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-v~l~g~~~~~~~~~lV~ 315 (608)
++.|+.|-.-.+|+....++ +.|.+++.-... ......+|..+++.+.-.+| .+++++|.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 45788899999999987543 456776654222 22345679999998863344 478887743 6899
Q ss_pred eeccCCcH
Q 046502 316 EFVTSNTL 323 (608)
Q Consensus 316 E~~~~gsL 323 (608)
||+++..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.81 E-value=0.003 Score=61.68 Aligned_cols=157 Identities=14% Similarity=0.038 Sum_probs=84.8
Q ss_pred cCHHHHHHHhcCCCcCCccc-----cCCceEEEEEEecCCcEEEEEEcccCCchhHHHHHHHHHHHHhcCCCCc-----c
Q 046502 230 FTYEELARATDGFSDANLLG-----QGGFGYVHKGVLPNGKEVAIKQLKAGSGQGERVFQAEVEIISRVHHKHL-----V 299 (608)
Q Consensus 230 ~~~~el~~~~~~f~~~~~LG-----~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~Ev~~l~~l~Hpni-----v 299 (608)
.+.+|+.....+|...++.. .|---+.|+....+|+ +++|+..... ...++..|++++..|...++ +
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 46688888888998755543 5555778999886665 8999986532 22344556777777743222 2
Q ss_pred cee-e--EEEeCCeeEEEEeeccCCcHH--------------HHhhc--C------CCCCC-CHHH--------------
Q 046502 300 SLV-G--YYTAGSQRMLVCEFVTSNTLE--------------FHLHG--K------GRPTM-DWPT-------------- 339 (608)
Q Consensus 300 ~l~-g--~~~~~~~~~lV~E~~~~gsL~--------------~~l~~--~------~~~~l-~~~~-------------- 339 (608)
... | +.........++.++.+.... ..++. . ..... .|..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 1 123345566777777654321 01110 0 00000 0000
Q ss_pred --HHHHHHHHHHHHHHHHh-cCCCCeeeeccCCCcEEEccCCceEEEEeeccc
Q 046502 340 --RLKIALGFAKGLAYLHE-DCHPKIIHRDIKAANILLDFKFEAKVADFGLAK 389 (608)
Q Consensus 340 --~~~ia~~ia~~L~yLH~-~~~~~iiHrDIk~~NILl~~~~~~kl~DFGla~ 389 (608)
....+..+...+.-++. ....++||+|+.+.|||++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 11122222222222221 122369999999999999988777899999764
|